Details of Disease

General Information of Disease (ID: DISZKGEW)

• Disease Name: Neoplasm
• Synonyms: other neoplasm; cell process disease; tumor disease; tumor; tumour disease; neoplastic growth; tumour; neoplastic disease; neoplasm (disease); disease of cellular proliferation; neoplasm; neoplasia
• Disease Class: 2A00-2F9Z: Solid tumour/cancer
• Definition: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.
• Disease Hierarchy:
  DISUVDVV: Neoplastic disease or syndrome
  DISZKGEW: Neoplasm
• ICD Code:
  ICD-11: ICD-11: 2A00-2F9Z
  ICD-10: ICD-10: C00-C96
  ICD-9: ICD-9: 140-229
  Expand ICD-9: 140,141,142,143,144,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000
• Disease Identifiers:
  MONDO ID: MONDO_0005070
  MESH ID: D009369
  UMLS CUI: C0027651
  MedGen ID: 10294
  HPO ID: HP:0002664
  SNOMED CT ID: 108369006

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Dostarlimab	DM78NWP	Approved	Antibody	[1]

This Disease is Treated as An Indication in 11 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
CX2009	DMU62I8	Phase 2	Probody drug conjugate	[2]
CAR.CD30 cells	DM6ZXWY	Phase 1/2	CAR T Cell Therapy	[3]
EMB-01	DMCAUKW	Phase 1/2	Antibody	[4]
ATLCAR.CD30 cells	DMZI4UX	Phase 1	CAR T Cell Therapy	[5]
ATLCAR.CD30.CCR4 cells	DM3IPSX	Phase 1	CAR T Cell Therapy	[5]
BAY 1238097	DMYPU8V	Phase 1	Small molecular drug	[6]
BI 754091	DMWHZFS	Phase 1	Antibody	[7]
BI 836880	DMRI6YT	Phase 1	Antibody	[8]
LMP400	DM4FW2E	Phase 1	Small molecular drug	[9]
MK-4280	DMCA1NX	Phase 1	Antibody	[10]
SYNB1891	DMZJNHM	Phase 1	NA	[11]

This Disease is Treated as An Indication in 3 Patented Agent(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Antibodie derivative 10	DMGP5AR	Patented	Antibody	[12]
Carboxylic acid derivative 1	DM86E2P	Patented	Small molecular drug	[12]
Methyl-piperidine compound 1	DM5PS6K	Patented	Small molecular drug	[12]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 1601 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ACACB	TTY84UG	Limited	Biomarker	[13]
ADAM8	TTQWYMD	Limited	Biomarker	[14]
ADAMTS5	TTXSU2Y	Limited	Biomarker	[15]
ADRA1B	TTBRKXS	Limited	Biomarker	[16]
AGPAT2	TT9AYVR	Limited	Biomarker	[17]
ANO7	TT2X79I	Limited	Altered Expression	[18]
AOC3	TT7HC21	Limited	Biomarker	[19]
ASGR1	TTYM94H	Limited	Biomarker	[20]
ASRGL1	TT4WT91	Limited	Altered Expression	[21]
ATP6AP1	TTWDM4U	Limited	Biomarker	[22]
AVPR1B	TTL9MHW	Limited	Biomarker	[23]
BCAT2	TTF9OQ6	Limited	Biomarker	[24]
BMP2	TTP3IGX	Limited	Biomarker	[25]
BST2	TT90BJT	Limited	Biomarker	[26]
BTLA	TTER58P	Limited	Altered Expression	[27]
C3AR1	TTI6B3F	Limited	Altered Expression	[28]
CA1	TTHQPL7	Limited	Biomarker	[29]
CACNA1C	TTZIFHC	Limited	Biomarker	[30]
CAD	TT2YT1K	Limited	Altered Expression	[31]
CAMKK2	TTV298Y	Limited	Biomarker	[32]
CCKAR	TTCG0AL	Limited	Altered Expression	[33]
CCL17	TTMPHAE	Limited	Altered Expression	[34]
CCNE2	TTLDRGX	Limited	Altered Expression	[35]
CD2	TTJDUNO	Limited	Altered Expression	[36]
CD300A	TTI2YFK	Limited	Biomarker	[37]
CD3E	TTZAT79	Limited	Biomarker	[38]
CD96	TT83C4X	Limited	Biomarker	[39]
CDC20	TTBKFDV	Limited	Biomarker	[40]
CDH11	TTRGWZC	Limited	Genetic Variation	[41]
CDH6	TT9QHUK	Limited	Biomarker	[42]
CDK18	TTUMFAR	Limited	Altered Expression	[43]
CDK19	TTNABU9	Limited	Biomarker	[44]
CDK6	TTO0FDJ	Limited	Biomarker	[45]
CDKL1	TTBTI6P	Limited	Biomarker	[46]
CERK	TT9XRNV	Limited	Biomarker	[47]
CFB	TTA0P7K	Limited	Biomarker	[48]
CFP	TTLA0VS	Limited	Biomarker	[49]
CHAT	TTKYFSB	Limited	Altered Expression	[50]
CLDN4	TTMTS9H	Limited	Biomarker	[51]
CLEC9A	TTGUSRB	Limited	Biomarker	[52]
CNP	TT71P0H	Limited	Biomarker	[53]
CNTN1	TTPR8FK	Limited	Altered Expression	[54]
CR2	TT0HUN7	Limited	Biomarker	[55]
CRLF2	TTRMZ0N	Limited	Altered Expression	[56]
CSK	TTX6F0Q	Limited	Altered Expression	[57]
CSNK1E	TTA8PLI	Limited	Altered Expression	[58]
CTSE	TTLXC4Q	Limited	Biomarker	[59]
CYP51A1	TT67TDP	Limited	Biomarker	[60]
DLG4	TT9PB26	Limited	Biomarker	[61]
DNMT3L	TT3FDAV	Limited	Altered Expression	[62]
DPP10	TTOVUPC	Limited	Altered Expression	[63]
DUT	TTH6MBO	Limited	Altered Expression	[64]
DYNAP	TTCVQYE	Limited	Biomarker	[65]
DYRK2	TT84OS6	Limited	Altered Expression	[66]
DYRK3	TTV4EX0	Limited	Biomarker	[67]
EIF4E2	TT2ZSKV	Limited	Biomarker	[68]
EIF5A	TTIVCNR	Limited	Altered Expression	[69]
ELAVL1	TTPC9D0	Limited	Altered Expression	[70]
ENPP1	TTZTIWS	Limited	Biomarker	[71]
ENTPD3	TT7ES5I	Limited	Biomarker	[72]
EPHA4	TTG84D3	Limited	Altered Expression	[73]
EPHA7	TTAHTVG	Limited	Biomarker	[74]
EPX	TTCIO0M	Limited	Biomarker	[75]
EYA2	TTUY9C6	Limited	Altered Expression	[76]
F8	TT1290U	Limited	Biomarker	[77]
FABP3	TT3TGLR	Limited	Altered Expression	[78]
FCGR2A	TTXT21W	Limited	Altered Expression	[79]
FDFT1	TTFQEO5	Limited	Biomarker	[80]
FFAR4	TT08JVB	Limited	Biomarker	[81]
FGF10	TTNPEFX	Limited	Altered Expression	[82]
FHL1	TTI7ENL	Limited	Biomarker	[83]
FN3K	TTP6W8J	Limited	Altered Expression	[84]
FSHB	TT13GFV	Limited	Genetic Variation	[85]
FTO	TTFW3BT	Limited	Biomarker	[86]
FURIN	TTH9WF6	Limited	Genetic Variation	[87]
G3BP1	TTG0R8Z	Limited	Biomarker	[88]
G6PC	TTBQMJ8	Limited	Biomarker	[89]
GABRA1	TT1MPAY	Limited	Genetic Variation	[90]
GCK	TTDLNGZ	Limited	Genetic Variation	[91]
GFRA3	TT63XRS	Limited	Altered Expression	[92]
GGCX	TT76OLR	Limited	Biomarker	[93]
GHSR	TTWDC17	Limited	Biomarker	[94]
GJA4	TTQO1VY	Limited	Altered Expression	[95]
GJA5	TTFQKZ7	Limited	Altered Expression	[96]
GJA8	TTJ7ATH	Limited	Biomarker	[97]
GJC2	TTPOCAL	Limited	Biomarker	[98]
GNAO1	TTAXD8Z	Limited	Biomarker	[99]
GPC3	TTJTSX4	Limited	Biomarker	[100]
GPR55	TTNET8J	Limited	Biomarker	[101]
GPR87	TTO897C	Limited	Biomarker	[102]
GPRC5D	TTHRAPJ	Limited	Biomarker	[103]
GRHL2	TTUGH4C	Limited	Biomarker	[104]
GRIA2	TTWM461	Limited	Biomarker	[105]
GRIN2A	TTKJEMQ	Limited	Biomarker	[106]
GRK3	TT5A4DX	Limited	Altered Expression	[107]
GRK5	TTTCXO0	Limited	Altered Expression	[108]
GRM3	TT8A9EF	Limited	Genetic Variation	[109]
GSK3A	TTQWAU1	Limited	Altered Expression	[110]
HAL	TTXQOZW	Limited	Biomarker	[111]
HCAR2	TTWNV8U	Limited	Biomarker	[112]
HCAR3	TT8WFXV	Limited	Biomarker	[113]
HCK	TT42OGM	Limited	Biomarker	[114]
HCN2	TT9EUT4	Limited	Biomarker	[115]
HCRT	TTU5HJP	Limited	Biomarker	[116]
HCRTR1	TT60Q8D	Limited	Biomarker	[116]
HDAC11	TT8K17W	Limited	Biomarker	[117]
HDAC8	TTT6LFV	Limited	Biomarker	[118]
HEXIM1	TTFOKAH	Limited	Biomarker	[119]
HLA-DQB2	TTL7VOU	Limited	Biomarker	[99]
HPN	TT25MVL	Limited	Biomarker	[120]
HSPA9	TTMTPG3	Limited	Biomarker	[121]
HTR2C	TTWJBZ5	Limited	Biomarker	[122]
HTR3A	TTPC4TU	Limited	Altered Expression	[123]
IDO2	TTALN9W	Limited	Biomarker	[124]
IFNL3	TTRF4Q2	Limited	Biomarker	[125]
IL10RB	TTJTRMK	Limited	Biomarker	[126]
IL12A	TTRTK6Y	Limited	Biomarker	[127]
IL12B	TTGW72V	Limited	Genetic Variation	[128]
IL12RB2	TT4SWR8	Limited	Altered Expression	[129]
IL16	TTW4R0B	Limited	Biomarker	[130]
IMP3	TTEJA2R	Limited	Biomarker	[131]
IMPDH2	TTTB4UP	Limited	Altered Expression	[132]
INPP5D	TTTP2Z1	Limited	Biomarker	[133]
IRAK1	TTXAJWN	Limited	Altered Expression	[134]
KAAG1	TTLWKP4	Limited	Altered Expression	[135]
KAT2B	TTVK7SB	Limited	Biomarker	[136]
KAT6A	TT6O1J0	Limited	Biomarker	[137]
KCNJ1	TTJ13ST	Limited	Altered Expression	[138]
KCNJ3	TTGM19J	Limited	Biomarker	[139]
KCNN4	TT7M9I6	Limited	Altered Expression	[123]
KDM1B	TT8VP2T	Limited	Biomarker	[140]
KDM3A	TTKXS4A	Limited	Altered Expression	[141]
KDM4C	TTV8CRH	Limited	Altered Expression	[142]
KDM5A	TTIG67W	Limited	Altered Expression	[143]
KIF20B	TTQECT2	Limited	Biomarker	[144]
KITLG	TTDJ51N	Limited	Biomarker	[145]
KLKB1	TTN0PCX	Limited	Biomarker	[146]
LAMB3	TT2WOUQ	Limited	Biomarker	[147]
LANCL1	TTZW8NS	Limited	Biomarker	[148]
LGALS2	TTRHK90	Limited	Altered Expression	[149]
LIMK2	TTASMD8	Limited	Biomarker	[150]
LPAR1	TTQ6S1K	Limited	Altered Expression	[151]
LPAR4	TT7ZMY4	Limited	Biomarker	[152]
LRRK2	TTK0FEA	Limited	Biomarker	[153]
LTA	TTP73TM	Limited	Biomarker	[154]
LTB4R2	TTVJX54	Limited	Biomarker	[155]
LYN	TT1RWNJ	Limited	Altered Expression	[156]
MAG	TT9XFON	Limited	Biomarker	[157]
MAGEA10	TT1VNVM	Limited	Altered Expression	[158]
MAOB	TTGP7BY	Limited	Biomarker	[159]
MAP2K2	TT8H9GB	Limited	Biomarker	[160]
MAP3K2	TTIX0ZU	Limited	Biomarker	[161]
MAP4K3	TTI0AHJ	Limited	Biomarker	[162]
MAPK10	TT056SO	Limited	Biomarker	[163]
MASP2	TTR01E9	Limited	Biomarker	[164]
MAZ	TT059DA	Limited	Altered Expression	[165]
MELTF	TT8OBT3	Limited	Altered Expression	[166]
METAP1	TT1L79K	Limited	Biomarker	[167]
MGAT2	TTJOW1I	Limited	Biomarker	[168]
MKRN1	TTITER7	Limited	Biomarker	[169]
MMP17	TTVSZKN	Limited	Biomarker	[170]
MMP21	TTYRF5E	Limited	Altered Expression	[171]
MYH2	TTBIL13	Limited	Altered Expression	[172]
NCF1	TTZ4JC3	Limited	Biomarker	[173]
NCL	TTK1V5Q	Limited	Altered Expression	[174]
NOD1	TTYSRXM	Limited	Altered Expression	[175]
NOP2	TTBLG3H	Limited	Altered Expression	[176]
NPPC	TTRK0B9	Limited	Biomarker	[177]
NPR2	TTNB7IF	Limited	Altered Expression	[178]
NPTX2	TTNJ5A6	Limited	Biomarker	[179]
NPY2R	TTJ6WK9	Limited	Biomarker	[180]
NUAK1	TT65FL0	Limited	Biomarker	[181]
OLR1	TTKSND3	Limited	Altered Expression	[182]
OXTR	TTSCIUP	Limited	Biomarker	[183]
PADI4	TTQHAXM	Limited	Biomarker	[184]
PAK2	TT279WO	Limited	Altered Expression	[185]
PCSK2	TT46F0P	Limited	Biomarker	[186]
PDE2A	TTJGW1Z	Limited	Altered Expression	[187]
PDE7B	TTWIEY9	Limited	Altered Expression	[188]
PDZK1	TTDTBLM	Limited	Biomarker	[189]
PLA2G4C	TTBYG4O	Limited	Genetic Variation	[190]
PLA2R1	TTHKW7D	Limited	Biomarker	[191]
PLEKHA5	TTCDZMO	Limited	Biomarker	[192]
PLK2	TT976FS	Limited	Biomarker	[193]
PLOD1	TTEKJP3	Limited	Biomarker	[194]
PPIB	TT6ZFQ4	Limited	Biomarker	[195]
PPID	TTNAFOU	Limited	Biomarker	[196]
PREP	TTNGKET	Limited	Biomarker	[197]
PROKR1	TTB9CIL	Limited	Biomarker	[198]
PROKR2	TTM67AX	Limited	Altered Expression	[199]
PRSS1	TT2WR1T	Limited	Biomarker	[200]
PTP4A2	TT1MHKD	Limited	Biomarker	[201]
PTP4A3	TT7YM8D	Limited	Altered Expression	[202]
PTPN11	TT7WUAV	Limited	Biomarker	[203]
PTPRB	TT64I9Q	Limited	Genetic Variation	[204]
PYGM	TTZHY6R	Limited	Altered Expression	[205]
RCE1	TT2AP5B	Limited	Biomarker	[206]
RENBP	TTZCG0Q	Limited	Biomarker	[207]
RGS12	TTP9AV7	Limited	Biomarker	[208]
RHBDF2	TTH1ZOP	Limited	Altered Expression	[209]
RORA	TT1TYN7	Limited	Biomarker	[210]
RPS6KA5	TTYXEPL	Limited	Altered Expression	[211]
S1PR5	TTDZCKV	Limited	Biomarker	[212]
SELPLG	TTS5K8U	Limited	Genetic Variation	[213]
SEMA3A	TTVKD3S	Limited	Biomarker	[214]
SENP1	TTW9HY5	Limited	Altered Expression	[215]
SH3GL1	TTTYNAM	Limited	Altered Expression	[216]
SHCBP1	TTZ9WGL	Limited	Biomarker	[217]
SIK2	TTCUGZR	Limited	Biomarker	[218]
SLC1A1	TTG2A6F	Limited	Genetic Variation	[219]
SLC23A2	TTOP832	Limited	Biomarker	[220]
SLC5A7	TTRV7W3	Limited	Biomarker	[221]
SLC6A8	TTYUHB5	Limited	Biomarker	[222]
SLCO4A1	TTV1YIE	Limited	Biomarker	[223]
SLITRK6	TTTVEKI	Limited	Altered Expression	[224]
SMAD1	TT9GR53	Limited	Altered Expression	[225]
SMPD2	TTE5VI6	Limited	Altered Expression	[226]
SNCA	TT08OSU	Limited	Biomarker	[227]
SPAG6	TTDAKTW	Limited	Biomarker	[228]
SPOCK1	TTF23RE	Limited	Biomarker	[229]
SPTBN1	TTS9BDA	Limited	Biomarker	[230]
SRD5A1	TTTU72V	Limited	Biomarker	[231]
SRGN	TTCHB06	Limited	Biomarker	[232]
SSX2IP	TTZXB07	Limited	Altered Expression	[233]
STEAP1	TT9E64S	Limited	Biomarker	[234]
STK33	TTP34DQ	Limited	Altered Expression	[235]
STS	TTHM0R1	Limited	Biomarker	[236]
SUCNR1	TT4FX9Y	Limited	Biomarker	[237]
SV2A	TTT3P91	Limited	Biomarker	[238]
TCIRG1	TTVRN05	Limited	Biomarker	[239]
TGFB3	TTWOMY8	Limited	Altered Expression	[240]
THRA	TTTSEPU	Limited	Altered Expression	[241]
TLR6	TTWRI8V	Limited	Biomarker	[242]
TLR8	TT8CWFK	Limited	Genetic Variation	[243]
TMEM219	TTY078U	Limited	Biomarker	[244]
TNFSF15	TTEST6I	Limited	Biomarker	[245]
TNS4	TT1K65C	Limited	Biomarker	[246]
TPBG	TT70MLA	Limited	Biomarker	[247]
TPH1	TTZSJHV	Limited	Biomarker	[248]
TPP1	TTOVYPT	Limited	Biomarker	[249]
TRB	TT84HCW	Limited	Biomarker	[250]
TRHR	TT4J8MF	Limited	Biomarker	[251]
TRPC1	TTA76X0	Limited	Biomarker	[200]
TRPM3	TTO3TD8	Limited	Altered Expression	[123]
TRPV1	TTMI6F5	Limited	Biomarker	[252]
TRPV2	TTBECWA	Limited	Genetic Variation	[253]
TTR	TTPOYU7	Limited	Biomarker	[254]
UCP1	TTI12YJ	Limited	Biomarker	[255]
USP33	TT4E85Q	Limited	Genetic Variation	[256]
USP44	TTJLTNM	Limited	Biomarker	[257]
VDAC3	TTT48SQ	Limited	Biomarker	[258]
VIPR1	TTCL30I	Limited	Biomarker	[259]
WWP2	TT6TU05	Limited	Biomarker	[260]
ZNF146	TTJD1TI	Limited	Biomarker	[261]
ALOX5AP	TTDMBF5	Disputed	Altered Expression	[262]
ARSA	TTYQANR	Disputed	Biomarker	[263]
BPHL	TTTZ3EU	Disputed	Biomarker	[264]
CACNA1E	TTYRP0M	Disputed	Genetic Variation	[265]
CBS	TTVZJ7G	Disputed	Biomarker	[266]
CUBN	TT9YLCR	Disputed	Biomarker	[267]
DGAT2	TTRHEQ4	Disputed	Genetic Variation	[268]
EIF2AK1	TTRUJBV	Disputed	Altered Expression	[269]
FDPS	TTIKWV4	Disputed	Altered Expression	[270]
GPR17	TTMPART	Disputed	Genetic Variation	[271]
HSPD1	TT9HL5R	Disputed	Biomarker	[272]
KLK5	TTULSEW	Disputed	Altered Expression	[273]
LY96	TT8S9AV	Disputed	Biomarker	[274]
MAPKAPK5	TT3UJ7Z	Disputed	Biomarker	[275]
MSRB1	TT1QUZV	Disputed	Biomarker	[276]
NPR3	TTWVLS6	Disputed	Biomarker	[277]
PRKCQ	TT1MS7X	Disputed	Altered Expression	[278]
SLC15A2	TT27Q3A	Disputed	Altered Expression	[279]
SLC15A3	TTAYPWS	Disputed	Altered Expression	[279]
SLC15A4	TTG2XRE	Disputed	Altered Expression	[279]
SLC2A12	TTZO36H	Disputed	Biomarker	[280]
TICAM1	TT2GQT6	Disputed	Altered Expression	[281]
TPX2	TT0PHL4	Disputed	Biomarker	[282]
UBE2E2	TTXJEOF	Disputed	Altered Expression	[283]
ZNF224	TT1CDXL	Disputed	Altered Expression	[284]
ABCC8	TTP835K	moderate	Altered Expression	[285]
ABCG1	TTMWDGU	moderate	Biomarker	[286]
ACVR2B	TTLFRKS	moderate	Biomarker	[287]
ADAMTS4	TTYG6BU	moderate	Altered Expression	[288]
ADCYAP1	TTW4LYC	moderate	Biomarker	[289]
ADORA3	TTJFY5U	moderate	Biomarker	[290]
AGTR2	TTQVOEI	moderate	Altered Expression	[291]
ATAT1	TTWUHQ1	moderate	Biomarker	[292]
BCHE	TT3MSAO	moderate	Altered Expression	[293]
BDKRB1	TTG5QIA	moderate	Biomarker	[294]
BDNF	TTSMLOH	moderate	Altered Expression	[295]
BMP1	TT0L58T	moderate	Altered Expression	[296]
CDK3	TTMYWL7	moderate	Altered Expression	[297]
CDKL2	TTMO45N	moderate	Altered Expression	[298]
CLCF1	TTI6V13	moderate	Biomarker	[299]
CLK2	TT85TPS	moderate	Biomarker	[300]
CNTFR	TTT2F9E	moderate	Biomarker	[299]
COPS5	TTSTNJR	moderate	Biomarker	[301]
CPS1	TT42M75	moderate	Altered Expression	[302]
CSE1L	TTTRULD	moderate	Altered Expression	[303]
CSF2RA	TT6MP2Z	moderate	Altered Expression	[304]
CSF3R	TTC70AJ	moderate	Biomarker	[305]
CSNK1D	TTH30UI	moderate	Biomarker	[306]
CYBB	TT5T8MR	moderate	Biomarker	[307]
DHPS	TTBO2A9	moderate	Biomarker	[308]
DUSP10	TTF3RJ0	moderate	Biomarker	[309]
ENPP3	TTD4TKP	moderate	Biomarker	[310]
F2RL1	TTQR74A	moderate	Biomarker	[311]
FER	TTRA9G0	moderate	Biomarker	[312]
FSTL3	TTWRPM8	moderate	Biomarker	[313]
GAA	TTLPC70	moderate	Biomarker	[314]
GABRA3	TT37EDJ	moderate	Biomarker	[315]
GMNN	TT390KA	moderate	Biomarker	[316]
GNE	TT4DP5S	moderate	Genetic Variation	[317]
GNG7	TTCMBKF	moderate	Biomarker	[318]
GRIK2	TT0K5RG	moderate	Biomarker	[319]
GUCY2D	TTWNFC2	moderate	Biomarker	[320]
HDC	TTV9GOF	moderate	Altered Expression	[321]
ICOS	TTE5VP6	moderate	Biomarker	[322]
ICOSLG	TTB9Z8R	moderate	Altered Expression	[323]
IL13RA2	TTMPZ7V	moderate	Altered Expression	[324]
IL1R2	TT51DEV	moderate	Altered Expression	[304]
INHBA	TTVB30D	moderate	Altered Expression	[325]
INPP1	TTW0PHM	moderate	Altered Expression	[326]
KCNA3	TTY3UE6	moderate	Biomarker	[327]
KCNMB4	TT1AQ50	moderate	Biomarker	[328]
KDM5B	TTCLI75	moderate	Biomarker	[119]
KIF26B	TTQWICZ	moderate	Altered Expression	[329]
KLB	TTARBVH	moderate	Altered Expression	[330]
KPNB1	TTHOJ5F	moderate	Biomarker	[331]
LAMP2	TTULDG7	moderate	Biomarker	[332]
LGR4	TTY6C71	moderate	Altered Expression	[333]
LILRB4	TTREOKA	moderate	Biomarker	[334]
LTBR	TTFO0PM	moderate	Altered Expression	[335]
MAN2A1	TT34DCN	moderate	Biomarker	[336]
MANF	TT56RYE	moderate	Altered Expression	[337]
MAPK12	TTYT93M	moderate	Biomarker	[338]
MMP15	TTNSTO3	moderate	Altered Expression	[339]
MMP8	TTGA1IV	moderate	Biomarker	[340]
MSTN	TTM8I2X	moderate	Altered Expression	[341]
MTM1	TTY2TCU	moderate	Biomarker	[342]
MYBPC3	TT9WOBN	moderate	Biomarker	[343]
NSD1	TTTSJ3H	moderate	Genetic Variation	[344]
OAT	TTTSCQ2	moderate	Altered Expression	[345]
PAH	TTGSVH2	moderate	Biomarker	[346]
PARG	TT39J16	moderate	Biomarker	[264]
PGD	TTZ3IFB	moderate	Biomarker	[347]
PLD1	TT3T17P	moderate	Altered Expression	[348]
POR	TTOQ9GZ	moderate	Biomarker	[349]
PRDX4	TTPBL9I	moderate	Biomarker	[350]
RHCG	TTN5MZ3	moderate	Biomarker	[351]
RIPK2	TTCQ2E5	moderate	Biomarker	[352]
RSPO1	TTI9HL4	moderate	Biomarker	[353]
RSPO3	TT7HJTF	moderate	Altered Expression	[354]
SELL	TT2IYXF	moderate	Biomarker	[355]
SIRT3	TTVZLIJ	moderate	Biomarker	[356]
SLC12A5	TTH6UZY	moderate	Altered Expression	[357]
SLC15A1	TT5LF3C	moderate	Altered Expression	[358]
SLC2A9	TTIF3GB	moderate	Biomarker	[359]
SLC5A4	TTN7Y4P	moderate	Biomarker	[360]
SLC6A12	TTQBMPI	moderate	Posttranslational Modification	[361]
STK32B	TT4D2GZ	moderate	Altered Expression	[362]
STOML2	TTOI329	moderate	Biomarker	[363]
TLR5	TTCXP8J	moderate	Altered Expression	[364]
TNFSF13	TTOI1RM	moderate	Biomarker	[365]
TRIM37	TTAMCSL	moderate	Biomarker	[366]
TRPA1	TTELV3W	moderate	Biomarker	[367]
UCHL3	TT23UD6	moderate	Biomarker	[368]
USP2	TTUEQ1W	moderate	Biomarker	[369]
USP8	TT1J07C	moderate	Biomarker	[370]
VIPR2	TT4O5P0	moderate	Biomarker	[371]
ABAT	TTT2LD9	Strong	Altered Expression	[372]
ABCA1	TTJW1GN	Strong	Biomarker	[373]
ABCA4	TTLB52K	Strong	Biomarker	[374]
ABCB4	TTJUXV6	Strong	Biomarker	[375]
ABCC2	TTFLHJV	Strong	Altered Expression	[376]
ABHD6	TTSINOV	Strong	Biomarker	[377]
ABL2	TT1A6HL	Strong	Altered Expression	[378]
ACAT1	TTK3C21	Strong	Biomarker	[379]
ACHE	TT1RS9F	Strong	Biomarker	[380]
ACKR1	TTKY2NS	Strong	Biomarker	[381]
ACLY	TT0Z6Y2	Strong	Altered Expression	[382]
ACO2	TTMTF2P	Strong	Altered Expression	[383]
ACR	TTAHE2N	Strong	Biomarker	[126]
ACTG1	TTGAZF9	Strong	Altered Expression	[384]
ACVR1	TTJNBQA	Strong	Biomarker	[385]
ACVRL1	TTGYPTC	Strong	Biomarker	[386]
ADA	TTLP57V	Strong	Biomarker	[387]
ADAM33	TTQICM2	Strong	Altered Expression	[388]
ADAMTS13	TTUREBK	Strong	Biomarker	[389]
ADCYAP1R1	TT5OREU	Strong	Genetic Variation	[390]
ADK	TTL732K	Strong	Biomarker	[391]
ADM	TTV14YH	Strong	Biomarker	[392]
ADM2	TTM642F	Strong	Biomarker	[393]
ADORA1	TTK25J1	Strong	Biomarker	[394]
ADORA2A	TTM2AOE	Strong	Biomarker	[395]
ADORA2B	TTNE7KG	Strong	Altered Expression	[396]
ADRA1A	TTNGILX	Strong	Biomarker	[397]
ADRA2A	TTWG9A4	Strong	Altered Expression	[398]
ADRA2B	TTWM4TY	Strong	Biomarker	[397]
ADRA2C	TT2NUT5	Strong	Altered Expression	[398]
ADRB3	TTMXGCW	Strong	Biomarker	[399]
AGER	TTMO9HF	Strong	Genetic Variation	[400]
AGK	TTJETQC	Strong	Biomarker	[401]
AGRP	TT4DE1O	Strong	Biomarker	[402]
AIF1	TT12MEP	Strong	Genetic Variation	[403]
AIMP2	TTXWHGF	Strong	Posttranslational Modification	[404]
AKR1B1	TTFBNVI	Strong	Biomarker	[405]
AKR1C3	TT5ZWB6	Strong	Biomarker	[406]
AKT2	TTH24WI	Strong	Biomarker	[407]
AKT3	TTO6SGY	Strong	Altered Expression	[408]
ALAS1	TTG1FXO	Strong	Biomarker	[409]
ALDH2	TTFLN4T	Strong	Genetic Variation	[410]
ALKBH5	TTOHB1M	Strong	Biomarker	[411]
ALOX12	TT12ABZ	Strong	Altered Expression	[412]
ALOX15	TTN9T81	Strong	Biomarker	[413]
ALPL	TTMR5UV	Strong	Biomarker	[414]
AMD1	TTBFROQ	Strong	Biomarker	[415]
AMHR2	TTZDCPK	Strong	Genetic Variation	[416]
AMOT	TTI48OS	Strong	Biomarker	[417]
AMY2A	TTCGSZ4	Strong	Biomarker	[418]
ANG	TTURHFP	Strong	Biomarker	[419]
ANGPT1	TTWNQ1T	Strong	Biomarker	[420]
ANGPT2	TTKLQTJ	Strong	Altered Expression	[421]
ANGPTL3	TT59GO7	Strong	Biomarker	[422]
ANK1	TTKFPMH	Strong	Posttranslational Modification	[423]
ANTXR2	TTOD34I	Strong	Altered Expression	[424]
ANXA10	TT0NL6U	Strong	Altered Expression	[425]
ANXA8	TTSW16P	Strong	Altered Expression	[426]
AOX1	TT3MOS2	Strong	Biomarker	[427]
APC2	TTSMK36	Strong	Biomarker	[428]
APCS	TTB7VAT	Strong	Biomarker	[429]
APEH	TTYWEDQ	Strong	Genetic Variation	[430]
APLN	TT87D3J	Strong	Biomarker	[431]
APLNR	TTJ8E43	Strong	Altered Expression	[432]
APOB	TTN1IE2	Strong	Altered Expression	[433]
APOBEC3G	TTP96KH	Strong	Biomarker	[434]
APOH	TT2OUI9	Strong	Biomarker	[435]
APP	TTE4KHA	Strong	Altered Expression	[436]
ARAF	TT5TURO	Strong	Altered Expression	[437]
ARG2	TTV1AG6	Strong	Biomarker	[438]
ARL2	TTIDSFT	Strong	Genetic Variation	[439]
ARRB1	TTMVD4A	Strong	Biomarker	[440]
ARRB2	TT8SO2I	Strong	Altered Expression	[441]
ASIC1	TTRJYB6	Strong	Biomarker	[442]
ASPA	TT6TLZP	Strong	Biomarker	[443]
ASPH	TT2KHP7	Strong	Biomarker	[444]
ATF3	TTCE793	Strong	Altered Expression	[445]
ATG7	TTLVB9Z	Strong	Biomarker	[446]
ATIC	TT9NVXQ	Strong	Biomarker	[447]
ATP1A1	TTWK8D0	Strong	Biomarker	[448]
ATP4A	TTF1QVM	Strong	Biomarker	[449]
ATP7B	TTOPO51	Strong	Altered Expression	[450]
ATR	TT8ZYBQ	Strong	Biomarker	[451]
AURKC	TTLYXIT	Strong	Biomarker	[452]
AVPR2	TTK8R02	Strong	Biomarker	[453]
AZGP1	TTUPYLV	Strong	Biomarker	[454]
BACE2	TT69DB8	Strong	Altered Expression	[455]
BACH1	TT2ME4S	Strong	Altered Expression	[456]
BAK1	TTFM7V0	Strong	Biomarker	[457]
BBC3	TT7JUKC	Strong	Biomarker	[458]
BCAT1	TTES57P	Strong	Genetic Variation	[459]
BCL11A	TTR61MW	Strong	Altered Expression	[460]
BCL2A1	TTGT9C7	Strong	Biomarker	[13]
BCL2L2	TTQ79W8	Strong	Biomarker	[461]
BGN	TT0JPVF	Strong	Altered Expression	[462]
BLK	TTNDSC3	Strong	Biomarker	[463]
BMP10	TTTG6H1	Strong	Biomarker	[464]
BMP7	TTKOBRA	Strong	Biomarker	[465]
BMPR2	TTGKF90	Strong	Altered Expression	[466]
BMX	TTN2I9E	Strong	Biomarker	[467]
BRD1	TTT09OB	Strong	Biomarker	[468]
BRD2	TTDP48B	Strong	Biomarker	[469]
BRD3	TTHE657	Strong	Biomarker	[470]
BRD4	TTSRAOU	Strong	Altered Expression	[471]
BRD7	TT07ZS1	Strong	Biomarker	[472]
BRD9	TTR7L5Y	Strong	Biomarker	[473]
BRIP1	TTZV7LJ	Strong	Altered Expression	[474]
BRS3	TTKYEPM	Strong	Biomarker	[397]
BRSK1	TTV6WMQ	Strong	Biomarker	[475]
BTG1	TTL7N2W	Strong	Biomarker	[476]
BTK	TTGM6VW	Strong	Biomarker	[477]
C1QBP	TTWTD7F	Strong	Genetic Variation	[478]
C5	TTKANGO	Strong	Biomarker	[479]
CA13	TTQPHSR	Strong	Biomarker	[480]
CA2	TTANPDJ	Strong	Biomarker	[481]
CA3	TTXUK5D	Strong	Biomarker	[482]
CA4	TTZHA0O	Strong	Biomarker	[483]
CA5A	TT75WPO	Strong	Genetic Variation	[484]
CA7	TTJC376	Strong	Altered Expression	[485]
CACNA1B	TT4FDG6	Strong	Biomarker	[486]
CACNA1D	TT7RGTM	Strong	Biomarker	[487]
CACNA1G	TT729IR	Strong	Posttranslational Modification	[488]
CACNA2D2	TTU8P3M	Strong	Biomarker	[489]
CACNA2D3	TTN7T29	Strong	Biomarker	[490]
CALCRL	TTY6O0Q	Strong	Biomarker	[491]
CAMP	TTULOB6	Strong	Altered Expression	[492]
CAPN2	TTG5QB7	Strong	Biomarker	[493]
CARM1	TTIZQFJ	Strong	Biomarker	[494]
CASP1	TTCQIBE	Strong	Biomarker	[495]
CASP10	TTX5HEK	Strong	Altered Expression	[496]
CASP4	TT6KIOT	Strong	Altered Expression	[497]
CASP5	TTWR48J	Strong	Biomarker	[498]
CASP6	TTKW4ML	Strong	Altered Expression	[499]
CASP7	TTM7Y45	Strong	Altered Expression	[500]
CAT	TTPS279	Strong	Altered Expression	[501]
CBLB	TTHRAIJ	Strong	Altered Expression	[502]
CBR1	TTVG0SN	Strong	Altered Expression	[503]
CBX7	TTBN3HC	Strong	Biomarker	[504]
CCK	TT90CMU	Strong	Biomarker	[505]
CCL11	TTCF05Y	Strong	Altered Expression	[506]
CCL20	TT2XAZY	Strong	Biomarker	[507]
CCL22	TTBTWI1	Strong	Biomarker	[508]
CCNA2	TTAMQ62	Strong	Altered Expression	[509]
CCND3	TT1JXNR	Strong	Biomarker	[510]
CCNE1	TTCEJ4F	Strong	Biomarker	[511]
CCR4	TT7HQD0	Strong	Altered Expression	[512]
CCR8	TTE836A	Strong	Biomarker	[513]
CCR9	TTIPS8B	Strong	Biomarker	[514]
CD14	TT6I7DC	Strong	Altered Expression	[515]
CD160	TTOFEAS	Strong	Biomarker	[516]
CD209	TTBXIM9	Strong	Biomarker	[517]
CD22	TTM6QSK	Strong	Altered Expression	[518]
CD248	TTYJWT7	Strong	Biomarker	[519]
CD320	TT0KV32	Strong	Biomarker	[520]
CD33	TTJVYO3	Strong	Biomarker	[521]
CD36	TTPJMCU	Strong	Biomarker	[522]
CD3G	TTV3XPL	Strong	Biomarker	[523]
CD40LG	TTIJP3Q	Strong	Biomarker	[524]
CD5	TTEGYK1	Strong	Genetic Variation	[525]
CD52	TTQT5S9	Strong	Altered Expression	[526]
CD55	TT5Z9WY	Strong	Altered Expression	[527]
CD58	TT5KSBY	Strong	Biomarker	[528]
CD59	TTBGTEJ	Strong	Biomarker	[529]
CD69	TTPQE9F	Strong	Biomarker	[530]
CD74	TTCMYP9	Strong	Genetic Variation	[478]
CD83	TTT9MRQ	Strong	Biomarker	[531]
CD86	TT53XHB	Strong	Altered Expression	[532]
CD9	TTZEIBV	Strong	Biomarker	[533]
CDA	TTQ12RK	Strong	Biomarker	[534]
CDC123	TT3PRUG	Strong	Biomarker	[535]
CDC25B	TTR0SWN	Strong	Altered Expression	[536]
CDC25C	TTESBNC	Strong	Biomarker	[537]
CDC37	TT5SOEU	Strong	Biomarker	[538]
CDC42BPA	TT5Z0EF	Strong	Biomarker	[539]
CDC7	TTSMTDI	Strong	Altered Expression	[540]
CDH2	TT1WS0T	Strong	Biomarker	[541]
CDH3	TTARMD9	Strong	Biomarker	[542]
CDK11B	TT5Q79O	Strong	Biomarker	[543]
CDK13	TTRIM0E	Strong	Genetic Variation	[544]
CDK5	TTL4Q97	Strong	Biomarker	[545]
CDK5R1	TTBYM6V	Strong	Biomarker	[546]
CDK7	TTQYF7G	Strong	Biomarker	[547]
CEL	TTTRNQW	Strong	Altered Expression	[548]
CELA1	TT3NKIB	Strong	Biomarker	[549]
CENPE	TTZD5QR	Strong	Biomarker	[550]
CES1	TTMF541	Strong	Biomarker	[551]
CFD	TT8D13I	Strong	Biomarker	[552]
CFH	TTUW6OP	Strong	Biomarker	[553]
CFI	TT6ATLX	Strong	Biomarker	[554]
CFLAR	TTJZQYH	Strong	Biomarker	[555]
CFTR	TTRLZHP	Strong	Biomarker	[556]
CGA	TTFC29G	Strong	Altered Expression	[557]
CGB3	TTUH273	Strong	Altered Expression	[557]
CHM	TTOA18V	Strong	Biomarker	[558]
CHRM1	TTZ9SOR	Strong	Genetic Variation	[559]
CHRM3	TTQ13Z5	Strong	Biomarker	[560]
CHRNA1	TT54JVQ	Strong	Biomarker	[561]
CHRNA4	TT4H1MQ	Strong	Biomarker	[562]
CHRNA5	TTH2QRX	Strong	Altered Expression	[563]
CHRNA9	TTQACP9	Strong	Biomarker	[561]
CHUK	TT1F8OQ	Strong	Biomarker	[564]
CIT	TT3BKTU	Strong	Biomarker	[565]
CLCA1	TT3AF4R	Strong	Altered Expression	[566]
CLCN3	TT8XNZ7	Strong	Altered Expression	[567]
CLDN18	TT6PKBX	Strong	Biomarker	[568]
CLDN6	TTKSV48	Strong	Biomarker	[569]
CLEC12A	TT70N8V	Strong	Biomarker	[570]
CLEC4C	TT7YT06	Strong	Altered Expression	[571]
CLIC1	TT8KZG6	Strong	Altered Expression	[572]
CLN3	TTORF9W	Strong	Altered Expression	[573]
CMA1	TT8VUE0	Strong	Biomarker	[574]
CMKLR1	TT4UGZL	Strong	Biomarker	[575]
CNGA3	TTW0QOV	Strong	Biomarker	[576]
CNR1	TT6OEDT	Strong	Biomarker	[577]
CNR2	TTMSFAW	Strong	Biomarker	[578]
CNTF	TTGEM5Q	Strong	Biomarker	[579]
CNTN2	TT2Z1WB	Strong	Biomarker	[580]
COASY	TT4YO0Z	Strong	Biomarker	[581]
COL6A3	TT5WCAH	Strong	Altered Expression	[582]
COL7A1	TTBCOKN	Strong	Biomarker	[583]
CPA1	TT3LJ6G	Strong	Biomarker	[584]
CPB2	TTP18AY	Strong	Altered Expression	[585]
CR1	TTEA8OW	Strong	Biomarker	[586]
CRAT	TTC8M31	Strong	Altered Expression	[587]
CREB1	TTH4AN3	Strong	Genetic Variation	[588]
CREBBP	TTFRCTK	Strong	Altered Expression	[589]
CRH	TTA7YIZ	Strong	Biomarker	[590]
CRHBP	TT3PKZE	Strong	Altered Expression	[591]
CRHR1	TT7EFHR	Strong	Biomarker	[592]
CRHR2	TTIY658	Strong	Biomarker	[593]
CRK	TTFEUYR	Strong	Posttranslational Modification	[404]
CRLF1	TT6YF5K	Strong	Biomarker	[594]
CRY1	TT5MLZR	Strong	Altered Expression	[595]
CRY2	TTAO58M	Strong	Altered Expression	[595]
CRYAB	TT7RUHB	Strong	Altered Expression	[596]
CRYZ	TTP6UO8	Strong	Biomarker	[597]
CS	TTZA6B3	Strong	Altered Expression	[598]
CSNK2A1	TTER6YH	Strong	Biomarker	[599]
CSNK2A2	TT7GR5W	Strong	Biomarker	[599]
CSPG4	TT7MYXI	Strong	Altered Expression	[600]
CTCFL	TTY0RZT	Strong	Biomarker	[601]
CTH	TTLQUZS	Strong	Biomarker	[602]
CTSB	TTF2LRI	Strong	Biomarker	[603]
CTSF	TTJOKD1	Strong	Altered Expression	[604]
CTSG	TTQAJF1	Strong	Biomarker	[605]
CTSH	TT3G406	Strong	Biomarker	[606]
CTSL	TT36ETB	Strong	Altered Expression	[607]
CTSS	TTUMQVO	Strong	Biomarker	[608]
CTSV	TTSD9T1	Strong	Altered Expression	[609]
CUL3	TTPCU0Q	Strong	Altered Expression	[610]
CUL7	TTI8R0P	Strong	Biomarker	[611]
CXCL1	TTLK1RW	Strong	Altered Expression	[612]
CXCL2	TTZF0K2	Strong	Altered Expression	[613]
CXCL9	TTWE5PB	Strong	Altered Expression	[614]
CXCR1	TTMWT8Z	Strong	Altered Expression	[615]
CXCR5	TTIW59R	Strong	Biomarker	[616]
CXCR6	TT2BVUA	Strong	Biomarker	[617]
CXXC5	TTVS4C3	Strong	Biomarker	[618]
CYP11B1	TTIQUX7	Strong	Genetic Variation	[619]
CYP11B2	TT9MNE2	Strong	Altered Expression	[620]
CYP21A2	TTP4GLG	Strong	Genetic Variation	[621]
CYP24A1	TT82UI1	Strong	Biomarker	[622]
CYP26A1	TTD7Q0R	Strong	Biomarker	[623]
CYP2A6	TTAQ6ZW	Strong	Biomarker	[624]
CYP2C19	TTZ58XG	Strong	Biomarker	[625]
CYP2C9	TTR40YJ	Strong	Altered Expression	[625]
CYP2J2	TTNE1C7	Strong	Altered Expression	[626]
CYP3A4	TTWP7HQ	Strong	Biomarker	[627]
CYP3A5	TTHS0OK	Strong	Altered Expression	[628]
CYP46A1	TT4EB85	Strong	Altered Expression	[629]
CYSLTR1	TTGKOY9	Strong	Altered Expression	[630]
CYSLTR2	TT0PZR5	Strong	Genetic Variation	[631]
DAG1	TT4X7PG	Strong	Biomarker	[632]
DAO	TT7Y3EJ	Strong	Biomarker	[633]
DCLK3	TTMYK4Z	Strong	Biomarker	[634]
DDC	TTN451K	Strong	Biomarker	[635]
DDIT4	TTVEOY6	Strong	Biomarker	[636]
DDX58	TTVB0O3	Strong	Biomarker	[637]
DEFB4A	TTIVY12	Strong	Biomarker	[638]
DEPDC1	TT8S9CM	Strong	Biomarker	[639]
DEPTOR	TTLYP6D	Strong	Biomarker	[640]
DFFA	TTYVQ9C	Strong	Altered Expression	[641]
DFFB	TT2SRE0	Strong	Biomarker	[642]
DGAT1	TT0GV3R	Strong	Altered Expression	[643]
DGKZ	TTSBBXL	Strong	Biomarker	[644]
DHCR24	TTTK0NH	Strong	Biomarker	[645]
DHFR	TTYZVDJ	Strong	Altered Expression	[646]
DHODH	TTLVP78	Strong	Genetic Variation	[647]
DIABLO	TTN74LE	Strong	Biomarker	[648]
DICER1	TTTEOPU	Strong	Genetic Variation	[649]
DIO1	TTU3X26	Strong	Genetic Variation	[650]
DKK1	TTE3RAC	Strong	Biomarker	[651]
DKK2	TTST5KX	Strong	Biomarker	[652]
DKK3	TTY2ZV6	Strong	Biomarker	[653]
DLL1	TT9CFQD	Strong	Biomarker	[654]
DLL3	TT1C9K6	Strong	Biomarker	[655]
DMD	TTWLFXU	Strong	Genetic Variation	[656]
DMPK	TTZQTY2	Strong	Biomarker	[657]
DNAJB1	TTPXAWS	Strong	Altered Expression	[658]
DNASE1	TTYWGOJ	Strong	Biomarker	[659]
DNM2	TTVRA5G	Strong	Biomarker	[660]
DOT1L	TTSZ8T1	Strong	Biomarker	[661]
DPEP1	TTYUENF	Strong	Biomarker	[662]
DRD1	TTZFYLI	Strong	Altered Expression	[663]
DRD2	TTEX248	Strong	Altered Expression	[664]
DRD5	TTS2PH3	Strong	Biomarker	[665]
DTL	TT8396I	Strong	Biomarker	[666]
DUSP1	TTG8HIM	Strong	Altered Expression	[667]
DUSP3	TTIFAYS	Strong	Altered Expression	[668]
DUSP5	TTZN92A	Strong	Biomarker	[669]
DUSP9	TT1GV6C	Strong	Altered Expression	[670]
DYRK1A	TTSBVFO	Strong	Altered Expression	[671]
DYRK1B	TTYGQ8A	Strong	Altered Expression	[672]
E2F2	TT5FYX0	Strong	Biomarker	[673]
E2F3	TTWIJYH	Strong	Biomarker	[674]
EDN2	TTMR0OP	Strong	Biomarker	[675]
EED	TTFNJ4R	Strong	Biomarker	[676]
EEF2K	TT1QFLA	Strong	Altered Expression	[677]
EGFL6	TTXJGAR	Strong	Altered Expression	[678]
EGFL7	TT7WD0H	Strong	Altered Expression	[679]
EGLN1	TT9ISBX	Strong	Altered Expression	[680]
EGR1	TTE8LGD	Strong	Altered Expression	[681]
EHMT1	TTOFXD7	Strong	Biomarker	[682]
EHMT2	TTS6RZT	Strong	Biomarker	[683]
EIF4EBP1	TTKGEBL	Strong	Biomarker	[684]
EIF4EBP2	TTNBTCW	Strong	Altered Expression	[685]
EIF5A2	TTH53G9	Strong	Altered Expression	[686]
ELANE	TTPLTSQ	Strong	Biomarker	[687]
ELK3	TT5OJMV	Strong	Genetic Variation	[688]
ENAH	TTY36UA	Strong	Altered Expression	[689]
ENPP2	TTSCIM2	Strong	Altered Expression	[690]
ENSA	TTQD0YT	Strong	Posttranslational Modification	[691]
EP300	TTGH73N	Strong	Biomarker	[692]
EPHA3	TTHS2LR	Strong	Altered Expression	[693]
EPHA5	TTV9KOD	Strong	Biomarker	[694]
EPHA6	TTFAHWI	Strong	Biomarker	[695]
EPHA8	TTHZ2LW	Strong	Altered Expression	[696]
EPHB1	TT8MDAC	Strong	Genetic Variation	[688]
ERF	TTGXULC	Strong	Altered Expression	[697]
ERN1	TTKIAT3	Strong	Altered Expression	[698]
ESRRA	TTPNQAC	Strong	Biomarker	[699]
ESRRB	TTKF0XS	Strong	Biomarker	[700]
ESRRG	TT9ZRHB	Strong	Posttranslational Modification	[701]
ETS1	TTTGPSD	Strong	Altered Expression	[702]
ETS2	TT9AH0M	Strong	Biomarker	[703]
F11	TTDM4ZU	Strong	Biomarker	[704]
F11R	TT3C8EG	Strong	Altered Expression	[705]
F12	TTRJSMV	Strong	Altered Expression	[706]
F13A1	TTXI2RA	Strong	Biomarker	[707]
F2	TT6L509	Strong	Biomarker	[708]
F2R	TTL935N	Strong	Altered Expression	[709]
F2RL2	TTVSEBF	Strong	Altered Expression	[710]
F7	TTF0EGX	Strong	Biomarker	[711]
FABP1	TTIV96N	Strong	Biomarker	[712]
FADS2	TTT2VDU	Strong	Biomarker	[713]
FAF1	TTSKL3G	Strong	Altered Expression	[714]
FAM83B	TT1Q347	Strong	Biomarker	[715]
FANCA	TTV5HJS	Strong	Genetic Variation	[716]
FAP	TTGPQ0F	Strong	Altered Expression	[717]
FASN	TT7AOUD	Strong	Altered Expression	[718]
FBXO11	TT6G10V	Strong	Altered Expression	[719]
FCAR	TTGUJAO	Strong	Biomarker	[720]
FCER1G	TTDGEC0	Strong	Biomarker	[721]
FCER2	TTCH6MU	Strong	Biomarker	[722]
FCGR2B	TT5RWKQ	Strong	Biomarker	[723]
FCGR3A	TTIFOC0	Strong	Biomarker	[724]
FCGRT	TTKLPHO	Strong	Altered Expression	[725]
FDXR	TT3W4IX	Strong	Biomarker	[405]
FECH	TTQ6VF4	Strong	Altered Expression	[726]
FFAR1	TTB8FUC	Strong	Altered Expression	[727]
FFAR2	TT0FYAN	Strong	Altered Expression	[728]
FGF19	TTGCH11	Strong	Biomarker	[729]
FGF21	TTQ916P	Strong	Biomarker	[730]
FGFBP1	TTV1YFT	Strong	Altered Expression	[731]
FGL2	TTYBS89	Strong	Biomarker	[732]
FGR	TTPOGS1	Strong	Biomarker	[733]
FKBP10	TT4P8O2	Strong	Biomarker	[734]
FKBP1A	TTMW94E	Strong	Biomarker	[735]
FKBP4	TTHY0FT	Strong	Biomarker	[736]
FKBP5	TT0J5KQ	Strong	Biomarker	[736]
FKBP7	TTO1ENI	Strong	Biomarker	[737]
FOLR2	TTT54CI	Strong	Altered Expression	[738]
FOSL2	TT689IR	Strong	Altered Expression	[739]
FOXC1	TTNT3YA	Strong	Biomarker	[740]
FOXC2	TTLBAP1	Strong	Altered Expression	[741]
FOXJ2	TTV1FDA	Strong	Altered Expression	[742]
FOXQ1	TTEJZOL	Strong	Altered Expression	[743]
FPR1	TT5Y4EM	Strong	Altered Expression	[744]
FPR2	TTOJ1NF	Strong	Biomarker	[745]
FTH1	TT975ZT	Strong	Biomarker	[343]
FUT3	TTUPAD7	Strong	Genetic Variation	[746]
FUT4	TTNV1KZ	Strong	Biomarker	[747]
FYN	TT2B9KF	Strong	Biomarker	[748]
G6PD	TTKN8W0	Strong	Altered Expression	[749]
GABRA5	TTNZPQ1	Strong	Biomarker	[750]
GABRP	TT3E0DI	Strong	Altered Expression	[751]
GAD2	TT7UY6K	Strong	Altered Expression	[752]
GADD45B	TTMDW9L	Strong	Biomarker	[753]
GALC	TT5IZRB	Strong	Altered Expression	[754]
GALR1	TTX3HNZ	Strong	Biomarker	[755]
GAP43	TTSGLN5	Strong	Biomarker	[756]
GAPDH	TTUGSWA	Strong	Altered Expression	[757]
GAS6	TT69QD2	Strong	Biomarker	[758]
GCGR	TT9O6WS	Strong	Biomarker	[759]
GCH1	TTLSWP6	Strong	Biomarker	[760]
GCLM	TTNFESW	Strong	Altered Expression	[761]
GDF5	TT37XV9	Strong	Altered Expression	[762]
GEM	TTAZF9M	Strong	Genetic Variation	[763]
GGT1	TTZVT7O	Strong	Biomarker	[764]
GGT7	TT62BC7	Strong	Altered Expression	[765]
GHR	TTHJWYD	Strong	Biomarker	[766]
GHRHR	TTG4R8V	Strong	Altered Expression	[767]
GIP	TT40HS5	Strong	Biomarker	[768]
GIPR	TTYMKBE	Strong	Altered Expression	[769]
GJA3	TTFZRG0	Strong	Biomarker	[770]
GJB1	TTSJIRP	Strong	Altered Expression	[771]
GJB4	TTBRDFI	Strong	Biomarker	[772]
GJB6	TTAU8SJ	Strong	Biomarker	[773]
GJC1	TTEP7OC	Strong	Posttranslational Modification	[774]
GLB1	TTNGJPH	Strong	Altered Expression	[775]
GLI2	TT045OH	Strong	Altered Expression	[776]
GLP1R	TTVIMDE	Strong	Biomarker	[777]
GLP2R	TT1YWO5	Strong	Altered Expression	[778]
GLUL	TTURQ2G	Strong	Biomarker	[779]
GNAI1	TTL1HWR	Strong	Biomarker	[780]
GNRHR	TT8R70G	Strong	Biomarker	[781]
GOT1	TTU507L	Strong	Biomarker	[782]
GP1BA	TTVB0Q9	Strong	Altered Expression	[783]
GP6	TTTJUVZ	Strong	Biomarker	[784]
GPBAR1	TTSDVTR	Strong	Altered Expression	[785]
GPD1	TTKTEAH	Strong	Altered Expression	[786]
GPR101	TTUKZVG	Strong	Altered Expression	[787]
GPR137	TTATO6X	Strong	Altered Expression	[788]
GPR183	TTME5YJ	Strong	Biomarker	[789]
GPR34	TTVXSTQ	Strong	Altered Expression	[790]
GPR39	TTTPCNU	Strong	Biomarker	[791]
GREM1	TTOUZN5	Strong	Genetic Variation	[792]
GRIA4	TTPJR0G	Strong	Biomarker	[793]
GRIK3	TTNP6O2	Strong	Biomarker	[794]
GRIK4	TTQV6BO	Strong	Biomarker	[795]
GRIN1	TTLD29N	Strong	Genetic Variation	[796]
GRIN2B	TTN9D8E	Strong	Posttranslational Modification	[797]
GRIN2C	TT1M8OW	Strong	Biomarker	[798]
GRK2	TTAZ3MN	Strong	Altered Expression	[799]
GRM1	TTVBPDM	Strong	Biomarker	[800]
GRM5	TTHS256	Strong	Biomarker	[801]
GRM8	TT0IFKL	Strong	Biomarker	[802]
GSK3B	TTRSMW9	Strong	Altered Expression	[803]
GSN	TTUH7OM	Strong	Altered Expression	[804]
GSTA1	TT4P8DE	Strong	Altered Expression	[805]
GUSB	TTHS7CM	Strong	Biomarker	[806]
HBB	TTM6HK1	Strong	Biomarker	[807]
HCAR1	TTVK4ZO	Strong	Biomarker	[808]
HDAC1	TT6R7JZ	Strong	Biomarker	[809]
HDAC10	TTYHPU6	Strong	Altered Expression	[810]
HDAC4	TTTQGH8	Strong	Altered Expression	[811]
HDAC6	TT5ZKDI	Strong	Biomarker	[812]
HDAC7	TTMUEK1	Strong	Biomarker	[813]
HDGF	TTKGV26	Strong	Biomarker	[814]
HGFAC	TTD96RW	Strong	Altered Expression	[815]
HHAT	TT1VNCG	Strong	Biomarker	[816]
HIPK2	TTOB49C	Strong	Biomarker	[817]
HKDC1	TTVUI8G	Strong	Biomarker	[818]
HMGB2	TTA78JQ	Strong	Altered Expression	[819]
HMGCR	TTPADOQ	Strong	Biomarker	[820]
HMGCS1	TTQF4TK	Strong	Biomarker	[821]
HMGCS2	TTS0EZJ	Strong	Biomarker	[822]
HMOX2	TTWZRL4	Strong	Biomarker	[823]
HNRNPA1	TTPJ9XK	Strong	Biomarker	[824]
HOXA13	TTN26OM	Strong	Biomarker	[825]
HOXA5	TTXSVQP	Strong	Altered Expression	[826]
HOXA7	TTMRE4Q	Strong	Biomarker	[827]
HOXB13	TTZ6I58	Strong	Biomarker	[828]
HP	TTLC8E1	Strong	Biomarker	[829]
HPGDS	TTCYE56	Strong	Biomarker	[830]
HRC	TTR4FKD	Strong	Altered Expression	[831]
HRH1	TTTIBOJ	Strong	Biomarker	[832]
HRH4	TTXJ178	Strong	Biomarker	[833]
HSD11B1	TTN7BL9	Strong	Altered Expression	[834]
HSD11B2	TT9H85R	Strong	Altered Expression	[835]
HSD17B4	TTL1WGS	Strong	Altered Expression	[836]
HSF1	TTN6STZ	Strong	Biomarker	[837]
HSP90AB1	TTH5YN2	Strong	Genetic Variation	[838]
HSP90B1	TTFPKXQ	Strong	Biomarker	[839]
HSPA12B	TTAI9ZQ	Strong	Altered Expression	[840]
HSPB8	TTY0OJN	Strong	Altered Expression	[841]
HTR1A	TTSQIFT	Strong	Altered Expression	[842]
HTR1B	TTK8CXU	Strong	Altered Expression	[843]
HTR2B	TT0K1SC	Strong	Biomarker	[844]
HTR4	TT07C3Y	Strong	Biomarker	[845]
HTR7	TTO9X1H	Strong	Biomarker	[846]
HTRA1	TT8POQR	Strong	Biomarker	[847]
ICA1	TTMX06B	Strong	Biomarker	[848]
ID2	TTW8A5N	Strong	Altered Expression	[849]
IDS	TTNY2AP	Strong	Altered Expression	[850]
IFNB1	TT4TZ8J	Strong	Biomarker	[851]
IFNGR2	TT13TL0	Strong	Altered Expression	[852]
IFNL1	TTM624L	Strong	Altered Expression	[853]
IGFBP5	TTDWEA8	Strong	Altered Expression	[854]
IGFBP6	TTLAYV8	Strong	Altered Expression	[855]
IKBKB	TTJ3E9X	Strong	Altered Expression	[856]
IKZF3	TTCZVFZ	Strong	Altered Expression	[857]
IL11	TTGUYTR	Strong	Biomarker	[858]
IL11RA	TTZPLJS	Strong	Altered Expression	[859]
IL13	TT0GVCH	Strong	Biomarker	[860]
IL13RA1	TTNEAMG	Strong	Altered Expression	[861]
IL15RA	TTGN89I	Strong	Altered Expression	[862]
IL17F	TT2B6PS	Strong	Biomarker	[863]
IL1R1	TTWOTEA	Strong	Altered Expression	[864]
IL1RAP	TTWS50K	Strong	Biomarker	[865]
IL1RL1	TT4GZA4	Strong	Altered Expression	[866]
IL20	TTNZMY2	Strong	Altered Expression	[867]
IL21	TT9QEJ6	Strong	Biomarker	[868]
IL21R	TTZO9B0	Strong	Altered Expression	[869]
IL22	TTLDX4N	Strong	Biomarker	[870]
IL23R	TT6H4QR	Strong	Altered Expression	[871]
IL25	TTVMO5W	Strong	Biomarker	[872]
IL31	TT1RJXK	Strong	Biomarker	[873]
IL31RA	TT9HPX0	Strong	Biomarker	[874]
IL32	TTD4G7L	Strong	Biomarker	[875]
IL33	TT5MD4P	Strong	Biomarker	[876]
IL37	TTQTX98	Strong	Biomarker	[877]
IL3RA	TTENHJ0	Strong	Biomarker	[878]
IL5	TTPREZD	Strong	Altered Expression	[879]
IL5RA	TTXH9AD	Strong	Biomarker	[880]
IL7R	TTAWI51	Strong	Altered Expression	[881]
ILK	TT7ALZG	Strong	Biomarker	[882]
INS	TTZOPHG	Strong	Biomarker	[883]
IRAK3	TTBPJOK	Strong	Biomarker	[884]
IRAK4	TTILUKB	Strong	Biomarker	[885]
IRF3	TTYR7OH	Strong	Genetic Variation	[886]
IRS2	TTF95B8	Strong	Altered Expression	[887]
ISG15	TTVOH3T	Strong	Biomarker	[888]
ITGA1	TTPERWV	Strong	Altered Expression	[889]
ITGA11	TTANXZ7	Strong	Biomarker	[890]
ITGA2	TTSJ542	Strong	Biomarker	[891]
ITGA4	TTJMF9P	Strong	Biomarker	[892]
ITGA6	TT165T3	Strong	Posttranslational Modification	[893]
ITGB3	TTJA1ZO	Strong	Biomarker	[894]
ITGB6	TTKQSXZ	Strong	Biomarker	[895]
ITGB8	TTIF29E	Strong	Biomarker	[896]
ITK	TT3C80U	Strong	Biomarker	[897]
ITPR1	TT5HWAT	Strong	Biomarker	[898]
ITPR3	TTH1769	Strong	Biomarker	[899]
JAG2	TTOJY1B	Strong	Biomarker	[900]
JAK1	TT6DM01	Strong	Biomarker	[901]
JAK3	TTT7PJU	Strong	Genetic Variation	[902]
JMJD1C	TTBISK4	Strong	Biomarker	[903]
KAT6B	TTH4VJL	Strong	Altered Expression	[904]
KCNA10	TTT4Y0X	Strong	Biomarker	[905]
KCNA5	TTW0CMT	Strong	Posttranslational Modification	[906]
KCNB1	TT5OEKU	Strong	Biomarker	[907]
KCNH2	TTQ6VDM	Strong	Biomarker	[908]
KCNH5	TTX8LQ0	Strong	Biomarker	[909]
KCNJ5	TTEO25X	Strong	Biomarker	[910]
KCNMA1	TTE87WJ	Strong	Biomarker	[911]
KCNQ1	TT846HF	Strong	Biomarker	[912]
KDM1A	TTNR0UQ	Strong	Biomarker	[913]
KDM2A	TT8XTY2	Strong	Biomarker	[914]
KDM4A	TTZHPB8	Strong	Biomarker	[915]
KDM5C	TT94UCF	Strong	Genetic Variation	[916]
KDM6B	TTDIJUQ	Strong	Biomarker	[917]
KHK	TTPAFR9	Strong	Altered Expression	[918]
KIF11	TTBGTCW	Strong	Altered Expression	[919]
KIR2DL1	TT4UXPE	Strong	Biomarker	[920]
KIR2DL3	TTEX3SI	Strong	Biomarker	[920]
KLF4	TTTI53X	Strong	Biomarker	[921]
KLK1	TT5T3P6	Strong	Biomarker	[922]
KLK2	TTJLNAW	Strong	Altered Expression	[923]
KLK6	TTLPF4X	Strong	Altered Expression	[924]
KLK7	TTE6GTB	Strong	Posttranslational Modification	[925]
KLK8	TTH5MRS	Strong	Biomarker	[926]
KLRC1	TTC4IMS	Strong	Biomarker	[927]
KLRG1	TT299E6	Strong	Biomarker	[928]
KMO	TTIY56R	Strong	Genetic Variation	[929]
KMT5A	TTGC95K	Strong	Biomarker	[930]
KRT17	TTKV0EC	Strong	Biomarker	[931]
KRT6A	TT2FX8W	Strong	Biomarker	[932]
KSR1	TTHL1TV	Strong	Biomarker	[933]
KYNU	TTWQM3J	Strong	Genetic Variation	[929]
LAG3	TTNVXAW	Strong	Altered Expression	[934]
LAIR1	TTSI7A8	Strong	Altered Expression	[935]
LAMC2	TTNS7H3	Strong	Biomarker	[936]
LAMP1	TTC214J	Strong	Altered Expression	[937]
LANCL2	TTMK3EX	Strong	Altered Expression	[938]
LARP1	TTSN1YP	Strong	Biomarker	[939]
LATS2	TTML7FG	Strong	Biomarker	[940]
LBP	TTVQJLY	Strong	Biomarker	[941]
LCT	TTA0OSE	Strong	Biomarker	[942]
LDLR	TTH0DUS	Strong	Altered Expression	[943]
LEPR	TT0HD6V	Strong	Biomarker	[944]
LGMN	TTPTWV5	Strong	Biomarker	[945]
LHCGR	TT2O4W9	Strong	Biomarker	[946]
LIF	TTGZ5WN	Strong	Altered Expression	[947]
LIFR	TTID542	Strong	Altered Expression	[948]
LILRB1	TTC0QRJ	Strong	Biomarker	[949]
LILRB2	TTHC6XU	Strong	Altered Expression	[950]
LIMK1	TTWL9TY	Strong	Biomarker	[951]
LINGO1	TTZYQ80	Strong	Altered Expression	[952]
LIPA	TTS8T1M	Strong	Biomarker	[682]
LIPE	TTLUQ8E	Strong	Biomarker	[953]
LIPG	TTHSZXO	Strong	Genetic Variation	[954]
LMO2	TTFX379	Strong	Altered Expression	[955]
LNPEP	TTY2KP7	Strong	Biomarker	[956]
LONP1	TTM1VPZ	Strong	Biomarker	[957]
LOXL2	TTFSUHX	Strong	Biomarker	[958]
LPAR2	TTB7Y8I	Strong	Biomarker	[397]
LPAR5	TTABCJ6	Strong	Biomarker	[959]
LPAR6	TTZDAGB	Strong	Altered Expression	[960]
LPL	TTOF3WZ	Strong	Altered Expression	[961]
LRP2	TTPH1AJ	Strong	Altered Expression	[962]
LRP5	TT7VMG4	Strong	Biomarker	[963]
LRP6	TTSXOWE	Strong	Altered Expression	[964]
LRRC32	TT0FAYT	Strong	Biomarker	[965]
LSM1	TT2KHSC	Strong	Biomarker	[966]
LSS	TT7O8ZA	Strong	Biomarker	[967]
LTB	TTHQ6US	Strong	Genetic Variation	[478]
LTB4R	TTN53ZF	Strong	Biomarker	[968]
LY75	TTG180Q	Strong	Biomarker	[969]
LY9	TTZCL1U	Strong	Biomarker	[970]
LYVE1	TTG8DNU	Strong	Altered Expression	[971]
LYZ	TTAOZBW	Strong	Biomarker	[972]
MAGEA2	TTOZT28	Strong	Biomarker	[973]
MAGEA4	TT9EQUY	Strong	Biomarker	[974]
MAGEA6	TTJIWMO	Strong	Altered Expression	[975]
MAP2K5	TTV3O87	Strong	Biomarker	[976]
MAP3K1	TTW8TJI	Strong	Genetic Variation	[977]
MAP3K11	TTETX6Q	Strong	Biomarker	[978]
MAP3K14	TT4LIAC	Strong	Biomarker	[979]
MAP3K20	TTTUZ3O	Strong	Biomarker	[980]
MAP3K21	TTSW9YL	Strong	Altered Expression	[981]
MAP3K3	TTJZNIG	Strong	Biomarker	[982]
MAP3K5	TTOQCD8	Strong	Altered Expression	[983]
MAP3K6	TT64GC2	Strong	Biomarker	[984]
MAP3K7	TTJQT60	Strong	Genetic Variation	[985]
MAP3K8	TTGECUM	Strong	Biomarker	[986]
MAP4	TT0VFPN	Strong	Altered Expression	[987]
MAP4K1	TTSHWUP	Strong	Genetic Variation	[988]
MAP4K4	TT6NI13	Strong	Altered Expression	[989]
MAPK11	TT73U6C	Strong	Altered Expression	[990]
MAPK14	TTQBR95	Strong	Posttranslational Modification	[404]
MAPK7	TTU6FSC	Strong	Biomarker	[991]
MAPK9	TT3IVG2	Strong	Altered Expression	[992]
MAPKAP1	TTWDKCL	Strong	Altered Expression	[993]
MAPKAPK2	TTMUG9D	Strong	Biomarker	[994]
MARCKS	TTHRM39	Strong	Altered Expression	[995]
MARK2	TTAJ45Y	Strong	Altered Expression	[996]
MAS1	TTOISYB	Strong	Biomarker	[997]
MAT2A	TTSMPXQ	Strong	Altered Expression	[998]
MBP	TT2RY5P	Strong	Altered Expression	[999]
MBTPS1	TTNSM2I	Strong	Altered Expression	[212]
MC4R	TTD0CIQ	Strong	Genetic Variation	[1000]
MCAM	TTHRE05	Strong	Altered Expression	[1001]
MCM6	TTQGKSD	Strong	Genetic Variation	[1002]
MCM7	TT1RM3F	Strong	Altered Expression	[1003]
MCOLN1	TT9XBVO	Strong	Altered Expression	[1004]
MELK	TTBZOTY	Strong	Biomarker	[1005]
MERTK	TTO7LKR	Strong	Biomarker	[1006]
METAP2	TTZL0OI	Strong	Biomarker	[1007]
MFGE8	TT1GLAJ	Strong	Biomarker	[1008]
MGAM	TTXWASR	Strong	Altered Expression	[1009]
MGAT1	TTYJRN5	Strong	Altered Expression	[1010]
MGLL	TTZ963I	Strong	Biomarker	[1011]
MIA	TT5HNVS	Strong	Biomarker	[1012]
MIF	TT6804T	Strong	Altered Expression	[1013]
MKNK1	TTEZAUX	Strong	Altered Expression	[1014]
MKNK2	TTRECN3	Strong	Genetic Variation	[1015]
MLYCD	TT9Z4YD	Strong	Biomarker	[1016]
MMP10	TTXLEG7	Strong	Altered Expression	[1017]
MMP16	TTNP4CU	Strong	Altered Expression	[1018]
MMP3	TTUZ2L5	Strong	Altered Expression	[1019]
MOG	TTQAFX5	Strong	Biomarker	[1020]
MPL	TTIHYA4	Strong	Altered Expression	[1021]
MRC2	TTYVR8M	Strong	Altered Expression	[1022]
MRM2	TTUQ7WN	Strong	Biomarker	[1023]
MSMB	TTYH1ZK	Strong	Altered Expression	[1024]
MSR1	TT2TDH9	Strong	Biomarker	[1025]
MST1R	TTBQ3OC	Strong	Altered Expression	[1026]
MTF1	TTTQDEO	Strong	Genetic Variation	[1027]
MTNR1B	TT32JK8	Strong	Altered Expression	[1028]
MTR	TTUTO39	Strong	Biomarker	[1029]
MUC15	TTGQ6MI	Strong	Altered Expression	[1030]
MYCBP	TTVW4XU	Strong	Altered Expression	[1031]
MYLK	TT18ETS	Strong	Altered Expression	[1032]
NACC1	TT4AQ5F	Strong	Biomarker	[1033]
NAGLU	TTDM6HZ	Strong	Biomarker	[1034]
NAMPT	TTD1WIG	Strong	Altered Expression	[1035]
NCK1	TTMA3VF	Strong	Biomarker	[1036]
NECTIN4	TTPO9EG	Strong	Altered Expression	[421]
NEDD4	TT1QU6G	Strong	Altered Expression	[1037]
NEDD8	TTNDC4K	Strong	Altered Expression	[1038]
NEK1	TTO5QT2	Strong	Altered Expression	[1039]
NEK2	TT3VZ24	Strong	Biomarker	[1040]
NEK6	TT8I2M7	Strong	Altered Expression	[1041]
NEK8	TT8AH9I	Strong	Biomarker	[1042]
NEK9	TTM57AW	Strong	Altered Expression	[1043]
NELL1	TT7H4BF	Strong	Biomarker	[1044]
NFKB2	TTKLNRV	Strong	Altered Expression	[1045]
NISCH	TT789FN	Strong	Biomarker	[1046]
NKX3-1	TT1E0JK	Strong	Biomarker	[1047]
NLRC5	TTWZC78	Strong	Altered Expression	[1048]
NLRP1	TTQX29T	Strong	Biomarker	[1049]
NLRX1	TTKT026	Strong	Altered Expression	[1050]
NNT	TTKIH76	Strong	Altered Expression	[1051]
NOTCH4	TTXDIK2	Strong	Altered Expression	[1052]
NPY	TT64REZ	Strong	Biomarker	[1053]
NPY4R	TTW4N16	Strong	Altered Expression	[1054]
NPY5R	TTY6EWA	Strong	Biomarker	[180]
NR0B2	TT25A9Q	Strong	Altered Expression	[1055]
NR1D1	TTAD1O8	Strong	Biomarker	[1056]
NR1H2	TTXA6PH	Strong	Altered Expression	[1057]
NR1H3	TTECBXN	Strong	Altered Expression	[1058]
NR1H4	TTS4UGC	Strong	Altered Expression	[1059]
NR1I2	TT7LCTF	Strong	Genetic Variation	[1060]
NR3C2	TT26PHO	Strong	Biomarker	[1061]
NR4A1	TTMXE2Q	Strong	Biomarker	[1062]
NR4A2	TT9HKN3	Strong	Biomarker	[1063]
NR5A2	TTAU3SY	Strong	Biomarker	[1064]
NRG4	TTWAGKJ	Strong	Altered Expression	[1065]
NRN1	TTS05MJ	Strong	Biomarker	[1066]
NTF4	TTIM2WO	Strong	Biomarker	[1067]
NTN1	TT0AH4L	Strong	Biomarker	[1068]
NTRK1	TTTDVOJ	Strong	Biomarker	[1069]
NTRK2	TTKN7QR	Strong	Biomarker	[1070]
NUAK2	TTHVOTQ	Strong	Biomarker	[1071]
NUF2	TTIXBFP	Strong	Biomarker	[1072]
OGFR	TT6IEYX	Strong	Altered Expression	[1073]
OLFM4	TTK1CX7	Strong	Biomarker	[1074]
OPA1	TTTU49Q	Strong	Biomarker	[457]
OPRD1	TT27RFC	Strong	Biomarker	[1075]
OPRK1	TTQW87Y	Strong	Biomarker	[1076]
OPRL1	TTNT7K8	Strong	Biomarker	[1077]
OPRM1	TTKWM86	Strong	Altered Expression	[1078]
OSM	TTIVXSE	Strong	Biomarker	[1079]
OSMR	TTAH0KM	Strong	Biomarker	[1080]
OTC	TT5KIO9	Strong	Altered Expression	[1081]
P2RX1	TTJW7B3	Strong	Biomarker	[1082]
P2RX3	TT2THBD	Strong	Biomarker	[1082]
P2RX4	TT1NLOA	Strong	Biomarker	[1082]
P2RY1	TTA93TL	Strong	Biomarker	[1082]
P2RY12	TTZ1DT0	Strong	Biomarker	[1083]
P2RY13	TT1FE3L	Strong	Biomarker	[1084]
P2RY2	TTOZHQC	Strong	Biomarker	[1085]
P4HA1	TTNH25W	Strong	Altered Expression	[1086]
PABPC1	TTHC8EF	Strong	Biomarker	[1087]
PAGE5	TTNWOIT	Strong	Biomarker	[1088]
PAM	TTF4ZPC	Strong	Biomarker	[1089]
PARP2	TTQ4V96	Strong	Altered Expression	[1090]
PARP3	TTD8MEH	Strong	Altered Expression	[1091]
PAX5	TTA4REJ	Strong	Altered Expression	[1092]
PBK	TTMY6BZ	Strong	Altered Expression	[1093]
PCSK7	TTD30LY	Strong	Biomarker	[1094]
PCSK9	TTNIZ2B	Strong	Biomarker	[1095]
PCYT1B	TTUAIKM	Strong	Altered Expression	[1096]
PDE10A	TTJW4LU	Strong	Biomarker	[1097]
PDE11A	TTTWC79	Strong	Genetic Variation	[1098]
PDE3A	TT06AWU	Strong	Altered Expression	[1099]
PDE3B	TTN34SQ	Strong	Biomarker	[1100]
PDE4A	TTZ97H5	Strong	Biomarker	[1101]
PDE4B	TTVIAT9	Strong	Genetic Variation	[1097]
PDE4C	TT6A59G	Strong	Biomarker	[1102]
PDE8A	TTIS4OW	Strong	Biomarker	[1103]
PDF	TT9SL3Q	Strong	Biomarker	[1104]
PDGFD	TTSN0GA	Strong	Biomarker	[1105]
PDK1	TTCZOF2	Strong	Biomarker	[1106]
PDK2	TTJGCKM	Strong	Biomarker	[1107]
PDK3	TTDEQIP	Strong	Biomarker	[1106]
PDPK1	TTYMGWX	Strong	Altered Expression	[1108]
PDXP	TT9UYG4	Strong	Biomarker	[1109]
PEMT	TT735V2	Strong	Altered Expression	[1110]
PEPD	TTLZXI0	Strong	Biomarker	[1111]
PF4	TTSG7Q5	Strong	Biomarker	[1112]
PGGT1B	TTX20QP	Strong	Biomarker	[1113]
PGRMC1	TTY3LAZ	Strong	Biomarker	[1114]
PHF8	TT81PFE	Strong	Altered Expression	[1115]
PHLDB3	TT1KS9D	Strong	Biomarker	[1116]
PI4KA	TTCUS9F	Strong	Altered Expression	[1117]
PIGU	TT2LHI6	Strong	Biomarker	[1118]
PIM1	TTTN5QW	Strong	Altered Expression	[1119]
PIM2	TT69J2Z	Strong	Posttranslational Modification	[1120]
PIM3	TTCGOIN	Strong	Biomarker	[1121]
PIN1	TTJNTSI	Strong	Altered Expression	[1122]
PIP5K1A	TTA7DU1	Strong	Biomarker	[1123]
PKLR	TT31N4S	Strong	Biomarker	[1124]
PKN2	TTTHO0M	Strong	Biomarker	[1125]
PLA2G2A	TTO8QRU	Strong	Altered Expression	[1126]
PLA2G4A	TTT1JVS	Strong	Biomarker	[1127]
PLA2G7	TTDNFMT	Strong	Biomarker	[1128]
PLAT	TTXAGYU	Strong	Biomarker	[1129]
PLCB1	TTLPGU7	Strong	Biomarker	[1130]
PLD2	TTRLMKF	Strong	Biomarker	[1131]
PLIN1	TTIV27N	Strong	Altered Expression	[1132]
PLN	TTMCVJF	Strong	Biomarker	[1133]
PLOD2	TT8MEUD	Strong	Biomarker	[1134]
PLP2	TTK5OG6	Strong	Altered Expression	[1135]
PLTP	TTZF6SN	Strong	Altered Expression	[1136]
PLXDC1	TTPSK7A	Strong	Biomarker	[1137]
PMS1	TTX1ISF	Strong	Altered Expression	[1138]
PNMT	TT0NZIC	Strong	Altered Expression	[1139]
PNP	TTMCF1Y	Strong	Biomarker	[1140]
POLB	TTA0XPV	Strong	Altered Expression	[1141]
PPARD	TT2JWF6	Strong	Biomarker	[1142]
PPARGC1B	TTKSQ3W	Strong	Biomarker	[1143]
PPIA	TTL2ADK	Strong	Altered Expression	[1144]
PPM1A	TTLA7IX	Strong	Altered Expression	[1145]
PPP2CA	TTHTKNY	Strong	Altered Expression	[1146]
PPP2R5A	TTLONKX	Strong	Biomarker	[1147]
PPP3CA	TTA4LDE	Strong	Biomarker	[1148]
PPP5C	TTTW7FJ	Strong	Altered Expression	[1149]
PPT1	TTSQC14	Strong	Altered Expression	[1150]
PPY	TTIB95A	Strong	Biomarker	[1151]
PRAME	TTPH7T0	Strong	Biomarker	[1152]
PRG4	TTSKF4V	Strong	Altered Expression	[1153]
PRKACA	TT5U49F	Strong	Altered Expression	[658]
PRKCD	TT7A1BO	Strong	Biomarker	[1154]
PRKCE	TT57MT2	Strong	Altered Expression	[1155]
PRKCH	TTONI0R	Strong	Biomarker	[1156]
PRKCI	TTWJTHX	Strong	Altered Expression	[1157]
PRKD1	TTSLUMT	Strong	Biomarker	[1158]
PRKDC	TTK3PY9	Strong	Biomarker	[1159]
PRLR	TTBPXMA	Strong	Genetic Variation	[1160]
PRMT5	TTR1D7X	Strong	Biomarker	[1161]
PROC	TTZUXYS	Strong	Biomarker	[1162]
PRSS8	TTT4N0Q	Strong	Biomarker	[1163]
PRTN3	TT5MLC4	Strong	Altered Expression	[1164]
PSCA	TT9T4AV	Strong	Altered Expression	[1165]
PSEN1	TTZ3S8C	Strong	Biomarker	[1166]
PSMB5	TT68GPI	Strong	Altered Expression	[1167]
PSMB6	TT8EPLT	Strong	Genetic Variation	[1168]
PSMB8	TTEAD9J	Strong	Altered Expression	[1169]
PSMD10	TT2H4LN	Strong	Altered Expression	[1170]
PTAFR	TTQL5VC	Strong	Altered Expression	[1171]
PTBP1	TTWMX0U	Strong	Altered Expression	[1172]
PTGER2	TT1ZAVI	Strong	Biomarker	[1173]
PTGIS	TTLXKZR	Strong	Biomarker	[1174]
PTH1R	TTFPD47	Strong	Altered Expression	[1175]
PTK6	TT6TH8V	Strong	Biomarker	[1176]
PTK7	TTXH2ZN	Strong	Biomarker	[1177]
PTP4A1	TTA8GFO	Strong	Biomarker	[1178]
PTPN1	TTELIN2	Strong	Altered Expression	[1179]
PTPN13	TT405FP	Strong	Altered Expression	[1180]
PTPN14	TTNIR6C	Strong	Biomarker	[1181]
PTPN2	TTY8PUS	Strong	Altered Expression	[1182]
PTPRJ	TTWMKXP	Strong	Biomarker	[1183]
PTPRZ1	TT4SEA8	Strong	Biomarker	[1184]
PYY	TTVFJLX	Strong	Biomarker	[1185]
QPCT	TTJ7YTV	Strong	Biomarker	[1186]
RAB22A	TTAJ746	Strong	Biomarker	[1187]
RAB7A	TTF6WAQ	Strong	Altered Expression	[1188]
RAC1	TT2M9CG	Strong	Biomarker	[1189]
RAC3	TT9BQ50	Strong	Biomarker	[1190]
RAPGEF3	TTOE7I0	Strong	Biomarker	[1191]
RARG	TT1Q3IE	Strong	Altered Expression	[1192]
RBCK1	TTIKUVC	Strong	Altered Expression	[1193]
RBP4	TT0C8BY	Strong	Biomarker	[207]
RBP5	TTV2DON	Strong	Altered Expression	[1194]
RBPJ	TT72D4Z	Strong	Altered Expression	[1195]
REG3A	TTL4H8N	Strong	Biomarker	[1196]
REG4	TTVZEHU	Strong	Biomarker	[1197]
REL	TT1ZCTH	Strong	Biomarker	[1198]
RGS16	TTFRES8	Strong	Posttranslational Modification	[1199]
RGS2	TTKB7T3	Strong	Altered Expression	[1200]
RGS8	TTWME23	Strong	Biomarker	[1201]
RHAG	TTVHFE8	Strong	Altered Expression	[1202]
RHD	TTLCKI8	Strong	Biomarker	[1203]
RHO	TTH0KSX	Strong	Biomarker	[1204]
RHOA	TTP2U16	Strong	Genetic Variation	[1205]
RHOB	TT6LPFO	Strong	Biomarker	[1206]
RIPK4	TTB4S01	Strong	Biomarker	[1207]
RNF43	TTD91BL	Strong	Genetic Variation	[1208]
RNF6	TT4S09X	Strong	Biomarker	[1209]
RNMT	TTG45HY	Strong	Genetic Variation	[1210]
RNPEP	TTD74YX	Strong	Biomarker	[1211]
ROBO4	TT3S9TY	Strong	Altered Expression	[1212]
ROCK1	TTZN7RP	Strong	Altered Expression	[1213]
ROCK2	TTGWKQJ	Strong	Altered Expression	[1214]
RORB	TTGB2LZ	Strong	Genetic Variation	[1215]
RORC	TTGV6LY	Strong	Altered Expression	[1216]
RPS6KA1	TTIXKA4	Strong	Biomarker	[1217]
RPS6KA2	TT0ZW9O	Strong	Biomarker	[1218]
RPS6KA6	TT3KYWB	Strong	Altered Expression	[1219]
RPS6KB2	TTMVQXO	Strong	Genetic Variation	[1220]
RRM2	TT1S4LJ	Strong	Altered Expression	[1221]
RTN4	TT7GXMU	Strong	Biomarker	[1222]
RTN4R	TTVRZUO	Strong	Biomarker	[1223]
RUNX1	TTWIN3H	Strong	Biomarker	[1224]
RXFP1	TTMAHD1	Strong	Altered Expression	[1225]
RXRA	TT6PEUO	Strong	Altered Expression	[1226]
RXRG	TTH029C	Strong	Altered Expression	[1227]
S100A3	TTCDFR1	Strong	Biomarker	[1228]
S1PR1	TT9JZCK	Strong	Biomarker	[1229]
S1PR2	TTVSMOH	Strong	Biomarker	[212]
S1PR3	TTDYP7I	Strong	Biomarker	[212]
SAA1	TTY0DN9	Strong	Biomarker	[941]
SCARB1	TTRE324	Strong	Biomarker	[1230]
SCGB1A1	TTONPVW	Strong	Biomarker	[1231]
SCN10A	TT90XZ8	Strong	Biomarker	[1232]
SCN1A	TTANOZH	Strong	Altered Expression	[1233]
SCN8A	TT54ERL	Strong	Biomarker	[1234]
SCT	TTOBVIN	Strong	Biomarker	[1235]
SCUBE2	TTWREQP	Strong	Biomarker	[1236]
SELE	TT1PL7M	Strong	Biomarker	[1237]
SEPTIN6	TTAGE7U	Strong	Biomarker	[1238]
SERPINA1	TTA7UJC	Strong	Biomarker	[1239]
SERPINB3	TT6QLPX	Strong	Biomarker	[1240]
SERPINB5	TT1KW50	Strong	Altered Expression	[1241]
SERPIND1	TT8XSKJ	Strong	Biomarker	[1242]
SERPING1	TTVQ6R9	Strong	Altered Expression	[1243]
SERPINH1	TTPSWQG	Strong	Biomarker	[1244]
SETD7	TTJ0FSU	Strong	Altered Expression	[1245]
SF3B1	TTL2WUI	Strong	Biomarker	[1246]
SFRP4	TTX8I1Y	Strong	Posttranslational Modification	[1247]
SFTPD	TTGLMU7	Strong	Biomarker	[1248]
SGCB	TTEDCQ0	Strong	Biomarker	[1249]
SGCG	TTSMT9W	Strong	Biomarker	[1250]
SGO1	TTBPKGD	Strong	Biomarker	[1251]
SGPP1	TTN0VRB	Strong	Altered Expression	[1252]
SHH	TTIENCJ	Strong	Biomarker	[1253]
SIGMAR1	TT5TPI6	Strong	Biomarker	[1254]
SIK1	TT1H6LC	Strong	Biomarker	[1255]
SIK3	TTW6L4V	Strong	Altered Expression	[1256]
SIRPA	TTBRJS9	Strong	Altered Expression	[1257]
SIRT2	TTLKF5M	Strong	Altered Expression	[1258]
SKP2	TT5B2EO	Strong	Biomarker	[1259]
SLAMF6	TTSIYJ6	Strong	Biomarker	[1260]
SLC11A2	TT2IS7P	Strong	Biomarker	[1261]
SLC12A6	TT8DFHE	Strong	Biomarker	[1262]
SLC13A5	TTFIMH7	Strong	Altered Expression	[1263]
SLC16A1	TTN1J82	Strong	Biomarker	[574]
SLC16A3	TTG6VD5	Strong	Biomarker	[574]
SLC17A5	TTFSUIA	Strong	Biomarker	[1264]
SLC18A2	TTNZRI3	Strong	Altered Expression	[1265]
SLC19A3	TT9BTWM	Strong	Altered Expression	[1266]
SLC1A3	TT8WRDA	Strong	Altered Expression	[21]
SLC1A5	TTF7WRM	Strong	Biomarker	[1267]
SLC22A1	TTM5Q4V	Strong	Biomarker	[1268]
SLC22A16	TTITAVR	Strong	Altered Expression	[1269]
SLC22A2	TT0XOJN	Strong	Biomarker	[1270]
SLC22A3	TTG2UMS	Strong	Altered Expression	[1271]
SLC25A1	TTTD730	Strong	Biomarker	[1272]
SLC27A4	TT20AYF	Strong	Biomarker	[1273]
SLC28A2	TTVP9IQ	Strong	Biomarker	[1274]
SLC29A1	TTLXAKE	Strong	Biomarker	[1275]
SLC2A1	TT79TKF	Strong	Altered Expression	[1276]
SLC2A4	TTP6MT5	Strong	Biomarker	[1277]
SLC34A2	TTQPZTM	Strong	Biomarker	[1278]
SLC36A1	TTUYIZW	Strong	Biomarker	[1279]
SLC37A4	TT1KPBZ	Strong	Altered Expression	[1280]
SLC38A1	TT1YE9Z	Strong	Biomarker	[1281]
SLC38A2	TTUSC27	Strong	Biomarker	[1281]
SLC38A3	TTMAVJQ	Strong	Altered Expression	[1282]
SLC38A7	TTEARWC	Strong	Posttranslational Modification	[1283]
SLC40A1	TT6Y1PG	Strong	Altered Expression	[1284]
SLC44A4	TT0NYDG	Strong	Altered Expression	[1285]
SLC52A2	TT6TKEN	Strong	Altered Expression	[709]
SLC5A1	TT2UE56	Strong	Altered Expression	[1286]
SLC6A14	TTB6H2S	Strong	Altered Expression	[1287]
SLC6A7	TT9LGO5	Strong	Biomarker	[1288]
SLC7A1	TT4S150	Strong	Altered Expression	[587]
SLC7A11	TTBZMIO	Strong	Biomarker	[1289]
SLC7A5	TTPH2JB	Strong	Biomarker	[1290]
SLC8A1	TTCF82X	Strong	Altered Expression	[1291]
SLC9A1	TTGSEFH	Strong	Altered Expression	[1292]
SLCO1A2	TTUGD21	Strong	Biomarker	[1293]
SLCO1B1	TTFGXEB	Strong	Biomarker	[1294]
SLCO1B3	TTU86P0	Strong	Biomarker	[1295]
SLCO2B1	TTDL3UZ	Strong	Altered Expression	[1296]
SLCO4C1	TTACFNR	Strong	Altered Expression	[1297]
SMARCA4	TTVQEZS	Strong	Biomarker	[1298]
SMO	TT8J1S3	Strong	Altered Expression	[1299]
SMYD2	TT7YJFO	Strong	Altered Expression	[1300]
SMYD3	TTKLJYX	Strong	Altered Expression	[1301]
SNAP25	TTYQWA0	Strong	Biomarker	[1302]
SNCG	TT5TQNZ	Strong	Altered Expression	[1303]
SOAT2	TTAK0IN	Strong	Altered Expression	[1304]
SORD	TTLSRBZ	Strong	Genetic Variation	[1305]
SORT1	TTRX9AV	Strong	Altered Expression	[1306]
SOST	TTYRO4F	Strong	Biomarker	[1307]
SOX5	TTXHSZK	Strong	Altered Expression	[1308]
SP1	TTZEP6S	Strong	Altered Expression	[1309]
SPHK1	TTOHFIY	Strong	Altered Expression	[1310]
SPHK2	TTCN0M9	Strong	Biomarker	[1311]
SPN	TTOZAX0	Strong	Biomarker	[1312]
SPRY1	TT0PSN6	Strong	Altered Expression	[1313]
SQLE	TTE14XG	Strong	Altered Expression	[1314]
SREBF1	TTER0UB	Strong	Biomarker	[1315]
SRPK2	TTCZEJ9	Strong	Altered Expression	[1316]
SRR	TTZFUY6	Strong	Biomarker	[1317]
SSRP1	TTETDKQ	Strong	Altered Expression	[1318]
SSTR3	TTJX3UE	Strong	Altered Expression	[1319]
SSTR4	TTAE1BR	Strong	Biomarker	[397]
SSTR5	TT2BC4G	Strong	Altered Expression	[1320]
ST14	TTPRO7W	Strong	Biomarker	[1321]
ST8SIA4	TTDP8YM	Strong	Biomarker	[1322]
STAB1	TTJFEOC	Strong	Biomarker	[1323]
STAR	TTEI40H	Strong	Altered Expression	[1324]
STAT1	TTN7R6K	Strong	Biomarker	[1325]
STC1	TTDLUER	Strong	Biomarker	[1326]
STC2	TT4EFTR	Strong	Altered Expression	[1327]
STK16	TTFGN19	Strong	Biomarker	[1328]
STK17A	TTEYF03	Strong	Biomarker	[1329]
STK38L	TTNM4ZH	Strong	Altered Expression	[1330]
STK39	TTYQTIU	Strong	Biomarker	[1331]
STK4	TTCPLVN	Strong	Biomarker	[1332]
STRAP	TT165DP	Strong	Biomarker	[1333]
STXBP4	TTKS60G	Strong	Biomarker	[1334]
SULF2	TTLQTHB	Strong	Altered Expression	[1335]
SUV39H1	TTUWQTK	Strong	Biomarker	[637]
SVIL	TTBLQS5	Strong	Biomarker	[1336]
SYK	TT2HUPM	Strong	Biomarker	[1337]
SYVN1	TT8XKYM	Strong	Altered Expression	[1338]
TAAR5	TTCO25G	Strong	Biomarker	[1339]
TACC3	TTQ4UFD	Strong	Altered Expression	[1340]
TACR3	TTBPGLU	Strong	Biomarker	[1341]
TAGLN	TTDRZ9H	Strong	Biomarker	[1342]
TAGLN2	TTP6BIJ	Strong	Biomarker	[1343]
TBK1	TTMP03S	Strong	Biomarker	[1344]
TBL1X	TTAL6S1	Strong	Genetic Variation	[1345]
TBL1XR1	TTYXT16	Strong	Biomarker	[1346]
TBX21	TTNF9PH	Strong	Genetic Variation	[1347]
TBXA2R	TT2O84V	Strong	Biomarker	[1348]
TCF7L2	TT80QAL	Strong	Genetic Variation	[1349]
TDG	TTEXRQD	Strong	Biomarker	[1350]
TDGF1	TTN7HMG	Strong	Biomarker	[1351]
TDP2	TTYF26D	Strong	Biomarker	[1352]
TEC	TT1ZV49	Strong	Biomarker	[1353]
TEK	TT9VGXW	Strong	Biomarker	[1354]
TEP1	TTQGAVX	Strong	Altered Expression	[1355]
TF	TT8WXAV	Strong	Biomarker	[1356]
TFAP2A	TTDY4BS	Strong	Altered Expression	[1357]
TFPI	TT068JH	Strong	Biomarker	[1358]
TFRC	TT8MG4S	Strong	Altered Expression	[1359]
TGM1	TT7A949	Strong	Biomarker	[1360]
TH	TTUHP71	Strong	Biomarker	[1361]
THBD	TTAPV67	Strong	Biomarker	[1362]
THPO	TTCG5PE	Strong	Biomarker	[1363]
THRB	TTGER3L	Strong	Biomarker	[1364]
TIE1	TTT4236	Strong	Genetic Variation	[1365]
TIGIT	TTWNL74	Strong	Biomarker	[1366]
TKT	TT04R7I	Strong	Altered Expression	[1367]
TKTL1	TTNQ1J3	Strong	Biomarker	[1368]
TLN1	TTQSMFG	Strong	Genetic Variation	[1369]
TLR3	TTD24Y0	Strong	Biomarker	[1370]
TLR7	TTRJ1K4	Strong	Biomarker	[1371]
TMEM97	TT9NXW4	Strong	Biomarker	[1372]
TMPRSS11D	TTWHYC8	Strong	Altered Expression	[1373]
TMPRSS15	TTXL0GC	Strong	Altered Expression	[1374]
TMPRSS6	TTL9KE7	Strong	Biomarker	[1375]
TMSB4X	TTMVAIU	Strong	Altered Expression	[1376]
TNFRSF11A	TT3K9S2	Strong	Biomarker	[1377]
TNFRSF12A	TTKPS7V	Strong	Altered Expression	[1378]
TNFRSF13B	TTL9OD4	Strong	Biomarker	[1379]
TNFRSF13C	TT7NJSE	Strong	Altered Expression	[1380]
TNFRSF18	TTG6LA7	Strong	Biomarker	[1381]
TNFRSF1A	TTG043C	Strong	Biomarker	[1382]
TNFRSF21	TT8UA0T	Strong	Altered Expression	[1383]
TNFRSF4	TTL31H0	Strong	Biomarker	[1384]
TNFSF12	TTBTDM1	Strong	Biomarker	[1385]
TNFSF13B	TTWMIDN	Strong	Altered Expression	[1386]
TNFSF14	TTKVENM	Strong	Biomarker	[1387]
TNIK	TTPB1W3	Strong	Biomarker	[1388]
TNK1	TTWS7I3	Strong	Biomarker	[1389]
TNK2	TTIET93	Strong	Biomarker	[1390]
TNKS	TTVUSO7	Strong	Biomarker	[1391]
TNKS2	TTFQI4H	Strong	Altered Expression	[1392]
TNNC1	TT8RDXP	Strong	Altered Expression	[1393]
TNNI3	TTNLDK6	Strong	Biomarker	[1394]
TOP1	TTGTQHC	Strong	Altered Expression	[1395]
TPCN1	TTODQE2	Strong	Biomarker	[1396]
TPO	TT52XDZ	Strong	Biomarker	[1397]
TPP2	TTQ7R2V	Strong	Biomarker	[1398]
TPSAB1	TTM1TDX	Strong	Genetic Variation	[1399]
TPSD1	TTNWD8O	Strong	Biomarker	[1400]
TPT1	TT3PTB6	Strong	Biomarker	[1401]
TRBC1	TT1DHW2	Strong	Biomarker	[1402]
TREM1	TTHZQP0	Strong	Biomarker	[1403]
TREM2	TTQRMSJ	Strong	Altered Expression	[1404]
TRH	TT2Z39D	Strong	Altered Expression	[1405]
TRIM28	TTQ2BKV	Strong	Biomarker	[1406]
TRIM59	TT613U4	Strong	Altered Expression	[1407]
TRPC3	TTNVC34	Strong	Biomarker	[1408]
TRPC4	TTX0H5W	Strong	Biomarker	[1409]
TRPC7	TT06GRA	Strong	Biomarker	[1410]
TRPM1	TTTDAI9	Strong	Altered Expression	[1411]
TRPM2	TTEBMN7	Strong	Biomarker	[1412]
TRPM4	TTJ2HKA	Strong	Altered Expression	[1413]
TRPM7	TTFPVZO	Strong	Altered Expression	[1414]
TRPM8	TTXDKTO	Strong	Altered Expression	[1415]
TRPV4	TTKP2SU	Strong	Biomarker	[1416]
TRPV6	TTBK14N	Strong	Biomarker	[1417]
TSHR	TT6NYJA	Strong	Biomarker	[1418]
TSLP	TTHMW3T	Strong	Biomarker	[1419]
TSPAN7	TTMT6VE	Strong	Biomarker	[1420]
TSPO	TTPTXIN	Strong	Biomarker	[560]
TST	TT51OTS	Strong	Biomarker	[1421]
TXNIP	TTTLDZK	Strong	Biomarker	[1422]
TYRO3	TTIEMFN	Strong	Biomarker	[1423]
TYRP1	TTFRV98	Strong	Biomarker	[1424]
UBC	TTBP3XA	Strong	Biomarker	[1425]
UBE2T	TT0A1R8	Strong	Altered Expression	[1426]
UCP2	TTSC2YM	Strong	Biomarker	[1427]
USP1	TTG9MT5	Strong	Biomarker	[1428]
USP13	TTVJIO2	Strong	Biomarker	[1429]
USP14	TTVSYP9	Strong	Biomarker	[1430]
USP20	TT07QDI	Strong	Altered Expression	[1431]
USP37	TTJDELN	Strong	Altered Expression	[1432]
USP5	TTGYTMA	Strong	Altered Expression	[1433]
USP7	TTXU3EQ	Strong	Biomarker	[1434]
UTRN	TTNO1VA	Strong	Altered Expression	[1435]
UTS2	TTERU0T	Strong	Biomarker	[1436]
UTS2R	TTW5UDX	Strong	Biomarker	[1437]
VDAC1	TTAMKGB	Strong	Altered Expression	[1438]
VDAC2	TTM1I7L	Strong	Biomarker	[1439]
VIP	TTGTWLF	Strong	Altered Expression	[1440]
WAS	TTE8T73	Strong	Biomarker	[1441]
WDR5	TT7OFWB	Strong	Biomarker	[1442]
WEE1	TTJFOAL	Strong	Altered Expression	[1443]
WNK1	TTJ9UMX	Strong	Biomarker	[1444]
WRN	TT2H5WQ	Strong	Altered Expression	[1445]
WWP1	TTBWMKT	Strong	Altered Expression	[1446]
XDH	TT7RJY8	Strong	Biomarker	[1447]
XPA	TTGT87E	Strong	Genetic Variation	[1448]
XPNPEP2	TTI9MBZ	Strong	Altered Expression	[1449]
XPO1	TTCJUR4	Strong	Biomarker	[1450]
XRCC5	TTCB9KW	Strong	Biomarker	[1451]
YES1	TT0SQ8J	Strong	Altered Expression	[1452]
YY1AP1	TTYED1Q	Strong	Biomarker	[1453]
ZAP70	TTUMHT8	Strong	Biomarker	[1454]
ZEB2	TTT2WK4	Strong	Biomarker	[1455]
ZFP36L1	TT8QVJO	Strong	Altered Expression	[1456]
ZNF217	TTY3BRA	Strong	Altered Expression	[1457]
ZUP1	TTZC0KV	Strong	Biomarker	[126]
ZWINT	TTWY768	Strong	Biomarker	[1458]
AADAT	TTT3IXG	Definitive	Biomarker	[1459]
ABCB11	TTUXCAF	Definitive	Altered Expression	[1059]
AQP1	TTSF1KH	Definitive	Biomarker	[1460]
ARF1	TT70KXY	Definitive	Posttranslational Modification	[1461]
ASIC2	TTVMWLP	Definitive	Biomarker	[1462]
ATAD2	TT9A0HI	Definitive	Genetic Variation	[1463]
C5AR1	TTHXFA1	Definitive	Biomarker	[1464]
CDCA8	TT04YCM	Definitive	Biomarker	[1465]
CEACAM6	TTIGH2W	Definitive	Biomarker	[1466]
CHRNB4	TTTVAFQ	Definitive	Genetic Variation	[1467]
CPB1	TT4UJX5	Definitive	Altered Expression	[1468]
CPM	TTVOH2M	Definitive	Biomarker	[1469]
CPN1	TT8V2KD	Definitive	Biomarker	[1470]
CSNK1A1	TTFQEMX	Definitive	Biomarker	[1471]
CSNK1G2	TT0UZJ9	Definitive	Altered Expression	[1472]
CSNK1G3	TT34L5N	Definitive	Altered Expression	[1472]
DCPS	TTLSW9V	Definitive	Biomarker	[1473]
DLK1	TTF4AVB	Definitive	Biomarker	[1474]
DPP4	TTDIGC1	Definitive	Biomarker	[1475]
DPYSL2	TTZCW3T	Definitive	Altered Expression	[202]
EDNRA	TTKRD0G	Definitive	Biomarker	[1476]
ENOX2	TTUJZRL	Definitive	Biomarker	[1477]
EPHX2	TT7WVHI	Definitive	Altered Expression	[1478]
EZH1	TTNJA0C	Definitive	Genetic Variation	[1479]
FASLG	TTO7014	Definitive	Biomarker	[1480]
FBXO3	TTUX14L	Definitive	Biomarker	[1481]
FSCN1	TTTRS9B	Definitive	Altered Expression	[1482]
FZD7	TTUQMO5	Definitive	Altered Expression	[1483]
GAD1	TTKGEP3	Definitive	Altered Expression	[1484]
GATA4	TT1VDN2	Definitive	Biomarker	[1485]
GDF15	TT4MXVG	Definitive	Biomarker	[1486]
GLIPR1	TTEQF1O	Definitive	Biomarker	[1487]
GLRX	TTRJCNG	Definitive	Biomarker	[1488]
GPI	TT19JIZ	Definitive	Altered Expression	[1489]
GPR132	TTNBW4F	Definitive	Biomarker	[1490]
GPR182	TTT23CG	Definitive	Biomarker	[1491]
GRIA1	TTVPQTF	Definitive	Biomarker	[1492]
GRM6	TTWRP2F	Definitive	Biomarker	[1493]
HAX1	TT21BYA	Definitive	Altered Expression	[1494]
HNMT	TT2B6EV	Definitive	Biomarker	[1495]
HOXA11	TTEX4ZA	Definitive	Altered Expression	[1496]
HSPE1	TTWYMFE	Definitive	Biomarker	[1497]
IL7	TT8FRMO	Definitive	Biomarker	[1498]
KDM7A	TT0NYMP	Definitive	Altered Expression	[1499]
KLK4	TT4319X	Definitive	Altered Expression	[1500]
LASP1	TTZJA87	Definitive	Altered Expression	[1501]
M6PR	TT95ICL	Definitive	Altered Expression	[1502]
MAD1L1	TTNE9U7	Definitive	Altered Expression	[1503]
MAOA	TT3WG5C	Definitive	Altered Expression	[1504]
MSI1	TTSM4BA	Definitive	Biomarker	[1505]
NAAA	TTMN4HY	Definitive	Biomarker	[1506]
NAPRT	TTVR1FW	Definitive	Biomarker	[1507]
NLRP3	TT4EN8X	Definitive	Biomarker	[1508]
NODAL	TTK2O1Q	Definitive	Biomarker	[1509]
NR4A3	TTJQB49	Definitive	Biomarker	[1510]
OGDH	TTH8T6I	Definitive	Biomarker	[1511]
PCSK1	TTED9LZ	Definitive	Biomarker	[932]
PDE4D	TTSKMI8	Definitive	Biomarker	[1512]
PDE7A	TT1BC3A	Definitive	Biomarker	[1513]
PFKFB3	TTTHMQJ	Definitive	Altered Expression	[1514]
PKD2L1	TTAHD89	Definitive	Biomarker	[1515]
PLAUR	TTNOSTX	Definitive	Biomarker	[1516]
PNKP	TTHR3IE	Definitive	Biomarker	[1517]
PNLIP	TTXMY0J	Definitive	Biomarker	[1518]
PORCN	TTNFBTO	Definitive	Biomarker	[1519]
PPIF	TTRFQTB	Definitive	Biomarker	[196]
PPP1CA	TTFLH0E	Definitive	Biomarker	[1520]
PRKG2	TTDWFCQ	Definitive	Biomarker	[1521]
PRMT1	TTVOJAI	Definitive	Altered Expression	[1522]
PTGIR	TTOFYT1	Definitive	Biomarker	[1523]
RBBP9	TTUA38Z	Definitive	Altered Expression	[1524]
RECK	TTRZBW7	Definitive	Biomarker	[1525]
RPS6KA3	TTUM2ZR	Definitive	Biomarker	[1526]
S100A6	TT716MY	Definitive	Altered Expression	[1527]
SCD	TT6RIOV	Definitive	Biomarker	[1528]
SCN3A	TTAXZ0K	Definitive	Biomarker	[1529]
SDC2	TT5H2F0	Definitive	Biomarker	[1530]
SERPINC1	TT4QPUL	Definitive	Biomarker	[1531]
SGPL1	TT618Q2	Definitive	Biomarker	[1532]
SIGLEC15	TTBSZPF	Definitive	Biomarker	[1533]
SLC12A1	TTS087L	Definitive	Genetic Variation	[1534]
SLC12A7	TTU2PCD	Definitive	Biomarker	[1535]
SLCO2A1	TTKVTQO	Definitive	Genetic Variation	[1536]
SLK	TT8K4DE	Definitive	Biomarker	[1537]
SSTR1	TTIND6G	Definitive	Altered Expression	[1538]
TAP1	TT7JZI8	Definitive	Genetic Variation	[1539]
TARDBP	TT9RZ03	Definitive	Biomarker	[1540]
TDP1	TT64IHJ	Definitive	Biomarker	[1541]
TNFAIP3	TT5W0IO	Definitive	Genetic Variation	[1542]
TRPC5	TT32NQ1	Definitive	Altered Expression	[1543]
TRPC6	TTRBT3W	Definitive	Biomarker	[1544]
UCHL5	TTSX29Z	Definitive	Biomarker	[1545]
UCP3	TT12RJK	Definitive	Altered Expression	[1546]
ULK3	TTYENHQ	Definitive	Altered Expression	[1547]
VANGL1	TT18WJB	Definitive	Genetic Variation	[1548]
VKORC1	TTEUC8H	Definitive	Biomarker	[1549]
VSIR	TT51SK8	Definitive	Altered Expression	[1550]
YWHAH	TTADIOY	Definitive	Altered Expression	[1551]

This Disease Is Related to 105 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
ABCA5	DT195NK	Limited	Altered Expression	[1552]
ABCC11	DTWN7FC	Limited	Biomarker	[1553]
ATP7A	DT0LT17	Limited	Biomarker	[1554]
SLC11A1	DT650XW	Limited	Genetic Variation	[1555]
SLC14A2	DT8QC7K	Limited	Biomarker	[1556]
SLC16A7	DTLT3UG	Limited	Biomarker	[1557]
SLC25A20	DTQOUM4	Limited	Genetic Variation	[1558]
SLC25A22	DTJCWP8	Limited	Altered Expression	[1559]
SLC25A37	DTLBGTZ	Limited	Biomarker	[1560]
SLC28A3	DT4YL5R	Limited	Altered Expression	[1561]
SLC2A10	DT3BI6S	Limited	Biomarker	[1562]
SLC35A2	DT0567K	Limited	Biomarker	[1563]
SLC35A4	DT2OPRB	Limited	Biomarker	[1564]
SLC39A3	DTH08M7	Limited	Biomarker	[1565]
SLC41A1	DTB37ZE	Limited	Altered Expression	[1566]
SLC43A1	DTBMSWG	Limited	Biomarker	[1567]
SLC45A3	DTGEFXH	Limited	Biomarker	[1568]
SLC4A7	DT03V27	Limited	Biomarker	[1569]
SLC50A1	DTI9CQU	Limited	Altered Expression	[1570]
SLC7A10	DTVL2JY	Limited	Altered Expression	[1571]
SLC7A13	DTMWE5P	Limited	Genetic Variation	[1572]
ABCA2	DTJ4NEG	Disputed	Biomarker	[1573]
SLC16A9	DTQK5O9	Disputed	Biomarker	[1574]
SLC2A6	DTS4MKQ	Disputed	Biomarker	[280]
SLC2A8	DT2I7BM	Disputed	Biomarker	[280]
SLC39A7	DTDQSAM	Disputed	Altered Expression	[1575]
SLC12A2	DTHKL3Q	moderate	Altered Expression	[1576]
SLC26A1	DTJ785O	moderate	Altered Expression	[1577]
SLC31A2	DT8Q56F	moderate	Biomarker	[1578]
SLC3A1	DTBCKVM	moderate	Biomarker	[1579]
SLC52A3	DTBVQIO	moderate	Altered Expression	[1580]
SLC9A7	DTQPK6R	moderate	Biomarker	[1581]
SLCO5A1	DTYVQ5M	moderate	Biomarker	[1582]
ABCA10	DTVU0E3	Strong	Altered Expression	[1583]
ABCA3	DT2T6VQ	Strong	Biomarker	[1584]
ABCA8	DT9NXMV	Strong	Altered Expression	[1552]
ABCA9	DTE3V8W	Strong	Altered Expression	[1552]
ABCB6	DTF9Y2V	Strong	Biomarker	[1585]
ABCB7	DT2IMBW	Strong	Genetic Variation	[1586]
ABCC10	DTPS120	Strong	Biomarker	[1587]
ABCC5	DTYVM24	Strong	Biomarker	[1588]
ABCC6	DT582KR	Strong	Biomarker	[1589]
ABCD1	DTKM9DZ	Strong	Biomarker	[1590]
ANXA11	DTGQ2CF	Strong	Altered Expression	[1591]
ATP12A	DT5NLZA	Strong	Biomarker	[449]
SLC16A10	DTPAQJO	Strong	Biomarker	[1592]
SLC16A6	DT8ZFIO	Strong	Biomarker	[1593]
SLC17A7	DTNK0FR	Strong	Biomarker	[1594]
SLC17A9	DT9BI8W	Strong	Altered Expression	[1595]
SLC18A1	DTM953D	Strong	Altered Expression	[1596]
SLC22A4	DT2EG60	Strong	Biomarker	[1597]
SLC25A10	DTJYKDQ	Strong	Posttranslational Modification	[1598]
SLC25A11	DT0YAUQ	Strong	Biomarker	[1599]
SLC25A12	DT85HYR	Strong	Biomarker	[1600]
SLC25A13	DTDSYAQ	Strong	Biomarker	[1601]
SLC25A15	DTHEMTY	Strong	Biomarker	[1602]
SLC25A16	DTNU9EW	Strong	Biomarker	[1603]
SLC25A21	DT2UQYR	Strong	Altered Expression	[1604]
SLC25A23	DTLQ0EZ	Strong	Altered Expression	[1605]
SLC25A27	DT0HW5C	Strong	Biomarker	[1606]
SLC25A38	DTV8SWX	Strong	Biomarker	[1607]
SLC25A5	DTL1TRY	Strong	Altered Expression	[1608]
SLC26A2	DTFSLX5	Strong	Biomarker	[1609]
SLC26A3	DTN1FMD	Strong	Genetic Variation	[1610]
SLC27A3	DTEW95J	Strong	Biomarker	[1611]
SLC28A1	DT0EQPW	Strong	Altered Expression	[1612]
SLC2A11	DTJK135	Strong	Biomarker	[1613]
SLC2A13	DT0NSKB	Strong	Biomarker	[1593]
SLC2A2	DTUJPOL	Strong	Altered Expression	[1614]
SLC2A5	DTOR02F	Strong	Altered Expression	[1615]
SLC30A2	DTIAF6C	Strong	Biomarker	[1616]
SLC31A1	DTP8L4F	Strong	Biomarker	[1617]
SLC35B2	DT81RKJ	Strong	Altered Expression	[1618]
SLC38A6	DTZUHR9	Strong	Altered Expression	[1282]
SLC38A9	DTF7MYK	Strong	Biomarker	[1619]
SLC39A1	DTLWPXS	Strong	Biomarker	[1620]
SLC39A10	DTK02RZ	Strong	Altered Expression	[1621]
SLC39A11	DTEOAND	Strong	Genetic Variation	[1622]
SLC39A5	DTN9ACR	Strong	Biomarker	[1623]
SLC39A8	DTLPQGT	Strong	Altered Expression	[1624]
SLC43A3	DTGBPR5	Strong	Biomarker	[1625]
SLC44A1	DT3I2SU	Strong	Biomarker	[1626]
SLC45A2	DTNCJAT	Strong	Biomarker	[1627]
SLC4A11	DTH2J1G	Strong	Altered Expression	[1628]
SLC4A2	DTF7GAL	Strong	Biomarker	[1629]
SLC4A4	DTWDEIL	Strong	Biomarker	[1630]
SLC4A9	DTSQY0W	Strong	Biomarker	[1631]
SLC52A1	DT7NOKR	Strong	Biomarker	[1632]
SLC5A8	DTE3TAW	Strong	Altered Expression	[1633]
SLC5A9	DT1CP40	Strong	Biomarker	[1634]
SLC6A6	DTHWCVA	Strong	Biomarker	[1635]
SLC8A2	DTUASRF	Strong	Biomarker	[1636]
SLC9A5	DTI6LSR	Strong	Biomarker	[1637]
KCNK2	DTENHUP	Definitive	Biomarker	[1638]
SLC13A2	DTUO05P	Definitive	Altered Expression	[1263]
SLC16A2	DTQ8MP1	Definitive	Altered Expression	[1639]
SLC16A8	DT39AOM	Definitive	Altered Expression	[1640]
SLC22A11	DT06JWZ	Definitive	Altered Expression	[1612]
SLC22A13	DT38SZL	Definitive	Biomarker	[1641]
SLC22A17	DTXI9E6	Definitive	Altered Expression	[1642]
SLC22A5	DT3HUVD	Definitive	Biomarker	[1643]
SLC25A19	DTT82QK	Definitive	Biomarker	[1644]
SLC29A2	DTW78DQ	Definitive	Genetic Variation	[1645]
SLC7A6	DTTBSQG	Definitive	Biomarker	[1567]
SLC7A7	DTE4HJ8	Definitive	Biomarker	[1567]

This Disease Is Related to 147 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
ADH5	DEIOH6A	Limited	Biomarker	[1646]
CPA4	DEXKD7J	Limited	Altered Expression	[1647]
CYP2F1	DED5AT3	Limited	Biomarker	[1648]
CYP4F12	DED26GV	Limited	Altered Expression	[1649]
CYP4F2	DE3GT9C	Limited	Altered Expression	[1649]
CYP7B1	DE36TMY	Limited	Altered Expression	[1650]
DIO3	DET89OV	Limited	Genetic Variation	[1651]
FAAH	DEUM1EX	Limited	Genetic Variation	[1652]
GALK1	DE3OP9S	Limited	Biomarker	[1653]
GMDS	DE8K7F3	Limited	Biomarker	[1654]
HAGH	DE05IKP	Limited	Biomarker	[1655]
HK1	DEDMAGE	Limited	Biomarker	[1656]
HSD17B12	DE915QP	Limited	Altered Expression	[1657]
LDHC	DEQG7F9	Limited	Altered Expression	[1658]
PCYT1A	DEQYXD4	Limited	Biomarker	[1659]
PGM1	DEA3VM1	Limited	Altered Expression	[1660]
PMM2	DEBRX3L	Limited	Biomarker	[1661]
PTGR1	DE4Q2OE	Limited	Biomarker	[1662]
SCLY	DEH4TD6	Limited	Biomarker	[1663]
UGT1A10	DEL5N6Y	Limited	Genetic Variation	[1664]
UGT1A8	DE2GB8N	Limited	Genetic Variation	[1664]
UGT2B15	DENZ6B1	Limited	Genetic Variation	[1664]
UGT2B4	DENUPDX	Limited	Genetic Variation	[1664]
UPP1	DEFZWAX	Limited	Altered Expression	[1665]
WARS1	DEPVE0M	Limited	Altered Expression	[1666]
AKR1C4	DEAJN47	Disputed	Altered Expression	[1667]
CYP3A7	DERD86B	Disputed	Biomarker	[1668]
HSD17B3	DEX8J7E	Disputed	Biomarker	[1669]
MMEL1	DEYCUQ2	Disputed	Biomarker	[1670]
AKR1B10	DEP6GT1	moderate	Biomarker	[1671]
AKR7A2	DE4G629	moderate	Genetic Variation	[1672]
CYB5R3	DE4A3BL	moderate	Altered Expression	[1673]
FADS1	DE05S8C	moderate	Biomarker	[1674]
SULT1A3	DEP7E8X	moderate	Biomarker	[1675]
UBASH3B	DE10BJ5	moderate	Altered Expression	[334]
ACP5	DESITDW	Strong	Biomarker	[1676]
ACSS2	DEE76VW	Strong	Biomarker	[1677]
ADH1C	DEM1HNL	Strong	Biomarker	[1678]
ADHFE1	DE8RJ3F	Strong	Altered Expression	[1679]
AK2	DEY1FJO	Strong	Biomarker	[1680]
AKR1A1	DED2FW3	Strong	Biomarker	[1681]
AKR1C1	DE7P2FB	Strong	Altered Expression	[1682]
AKR1C2	DEOY5ZM	Strong	Altered Expression	[1683]
ALDH1A2	DEKN1H4	Strong	Altered Expression	[1684]
ALDH1B1	DEXI4UQ	Strong	Biomarker	[1685]
APRT	DE2MV1R	Strong	Altered Expression	[1686]
ASMT	DEHGR57	Strong	Biomarker	[1687]
ASNS	DEXISVQ	Strong	Altered Expression	[1688]
BAAT	DERA3OF	Strong	Biomarker	[1689]
BLMH	DECH1VP	Strong	Biomarker	[1690]
CBR3	DEIVKZ8	Strong	Genetic Variation	[1691]
CES2	DETHCPD	Strong	Biomarker	[1692]
CHAC2	DEB4JZV	Strong	Biomarker	[1693]
CHDH	DEAHED0	Strong	Biomarker	[1694]
CHST3	DEQIZP2	Strong	Altered Expression	[1695]
CMPK1	DEMPH4I	Strong	Biomarker	[1696]
CRMP1	DE0EUXB	Strong	Altered Expression	[1435]
CYB5A	DE9A2LB	Strong	Biomarker	[1697]
CYP27A1	DEBS639	Strong	Biomarker	[1698]
CYP27B1	DE3FYEM	Strong	Biomarker	[1699]
CYP2C8	DES5XRU	Strong	Biomarker	[1700]
CYP2S1	DE6NMGO	Strong	Altered Expression	[1701]
CYP3A43	DEO1IE3	Strong	Genetic Variation	[1702]
CYP4A11	DE2XQGW	Strong	Altered Expression	[1703]
CYP4B1	DEMF740	Strong	Altered Expression	[1704]
CYP4F11	DEIZLTN	Strong	Altered Expression	[1705]
CYP4F3	DEFCMPI	Strong	Altered Expression	[1706]
DCXR	DE3FEV8	Strong	Biomarker	[1707]
DHRS3	DEXPVUN	Strong	Biomarker	[1708]
DHRS7	DEEXSKI	Strong	Biomarker	[1709]
DHRS9	DEGTU5I	Strong	Biomarker	[1710]
DTYMK	DEOTVYU	Strong	Biomarker	[1711]
EGLN3	DEMQTKH	Strong	Biomarker	[1712]
FMO5	DEBMX7C	Strong	Biomarker	[1713]
FPGS	DECWT2V	Strong	Biomarker	[1714]
FXN	DEXVHDB	Strong	Altered Expression	[1715]
GGCT	DEKW6PB	Strong	Biomarker	[1716]
GLDC	DEIN8FB	Strong	Altered Expression	[1717]
GLS	DE3E0VT	Strong	Biomarker	[1718]
GPT	DER5HFI	Strong	Biomarker	[1719]
GSTA4	DEH7XYP	Strong	Biomarker	[1720]
GSTM4	DERQ52Z	Strong	Altered Expression	[1721]
GSTO2	DEHMPZR	Strong	Biomarker	[1722]
GSTZ1	DEQPEMB	Strong	Biomarker	[1723]
HINT1	DEWJATF	Strong	Biomarker	[1724]
HPGD	DEHKSC6	Strong	Biomarker	[1725]
HPRT1	DEVXTP5	Strong	Biomarker	[1726]
HSD17B14	DEGTB1K	Strong	Altered Expression	[1727]
HSD3B1	DERDQWN	Strong	Genetic Variation	[1728]
INPP4A	DEBJ2NL	Strong	Biomarker	[1729]
IPMK	DESA9EX	Strong	Genetic Variation	[1730]
MAT1A	DEQ6NC9	Strong	Biomarker	[1731]
MAT2B	DEKF1OH	Strong	Altered Expression	[1732]
MGST1	DEAPJSO	Strong	Biomarker	[1733]
MINPP1	DE5Q1SP	Strong	Genetic Variation	[1734]
MSMO1	DE5FUD0	Strong	Biomarker	[1735]
MT2A	DEFKGT7	Strong	Biomarker	[1736]
MTRR	DE6NIY9	Strong	Genetic Variation	[1737]
NAT1	DE7OAB3	Strong	Biomarker	[1738]
NAT10	DEZV4AP	Strong	Biomarker	[1739]
NMNAT1	DE4D159	Strong	Biomarker	[1740]
NMNAT2	DE2HB58	Strong	Altered Expression	[1741]
NNMT	DECVGJ3	Strong	Biomarker	[1742]
NT5C	DE4E31Z	Strong	Genetic Variation	[796]
NT5C2	DE1DOKJ	Strong	Biomarker	[1743]
P3H2	DELB5PA	Strong	Biomarker	[1744]
P4HA3	DE2L4RX	Strong	Altered Expression	[1745]
PAPSS1	DEDG68B	Strong	Biomarker	[1746]
PARK7	DEPOVCH	Strong	Biomarker	[1747]
PCK1	DEPLH5Z	Strong	Biomarker	[1748]
PCYT2	DEIX1PO	Strong	Altered Expression	[1749]
PGPEP1	DEVDR46	Strong	Biomarker	[1750]
PLPP1	DE6WXTH	Strong	Altered Expression	[1751]
PON2	DEHJU7E	Strong	Biomarker	[1752]
PON3	DETXQZ1	Strong	Altered Expression	[1753]
PRKCSH	DE073GW	Strong	Altered Expression	[1754]
PRODH	DEVJIHS	Strong	Biomarker	[1755]
SAT1	DEMWO83	Strong	Altered Expression	[1756]
SI	DE5EO4Y	Strong	Altered Expression	[1009]
SMOX	DEOH5V3	Strong	Biomarker	[1757]
SPR	DEJVDAT	Strong	Altered Expression	[1758]
SULT1C2	DEYMAD4	Strong	Altered Expression	[1759]
SULT1E1	DESTKG6	Strong	Biomarker	[1760]
TGM3	DEOEB3Q	Strong	Biomarker	[1761]
TGM7	DERWDYE	Strong	Biomarker	[592]
UCK2	DETN1O0	Strong	Biomarker	[1762]
UGDH	DE48Q2Z	Strong	Biomarker	[1763]
UGT1A3	DEF2WXN	Strong	Altered Expression	[1764]
UGT1A4	DELOY3P	Strong	Biomarker	[1765]
UGT1A7	DEZO4N3	Strong	Altered Expression	[1766]
UGT1A9	DE85D2P	Strong	Biomarker	[1765]
UGT2B28	DEB7I4M	Strong	Altered Expression	[1767]
UGT2B7	DEB3CV1	Strong	Biomarker	[1768]
UPP2	DEBQ2WU	Strong	Biomarker	[1769]
UPRT	DE20ETR	Strong	Biomarker	[1770]
WARS2	DEPTKBQ	Strong	Altered Expression	[1771]
XPNPEP1	DE8E6X9	Strong	Genetic Variation	[1772]
AGMAT	DEG5L6E	Definitive	Biomarker	[1773]
BCO1	DE6BOK3	Definitive	Altered Expression	[1774]
DCTD	DEXL3P2	Definitive	Biomarker	[1775]
DHRS1	DE1LZID	Definitive	Biomarker	[1646]
ME1	DE97WM8	Definitive	Biomarker	[1776]
MSRA	DEU2ZBY	Definitive	Altered Expression	[1777]
MSRB2	DEMQOF7	Definitive	Genetic Variation	[1778]
P4HA2	DE5EGK0	Definitive	Altered Expression	[1164]
THOP1	DE95LJC	Definitive	Altered Expression	[1779]
UGP2	DE4U39Y	Definitive	Altered Expression	[1780]

This Disease Is Related to 4765 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
A2M	OTFTX90K	Limited	Biomarker	[1781]
ABHD5	OTY829Z3	Limited	Biomarker	[1782]
ABR	OTZQK8JF	Limited	Biomarker	[1783]
ACBD5	OT7L16DY	Limited	Biomarker	[1784]
ACKR4	OTZPWT2N	Limited	Biomarker	[1785]
ACTN2	OT9FOLD7	Limited	Biomarker	[1786]
ACVR1C	OTOTYERF	Limited	Biomarker	[1787]
ADAM15	OTZ7VLTP	Limited	Biomarker	[1788]
ADAM32	OTUJR3Q3	Limited	Biomarker	[1789]
ADAMTS12	OTG7HEA2	Limited	Altered Expression	[1790]
ADAMTS8	OT2KFY1S	Limited	Altered Expression	[1791]
ADAMTSL4	OTBILJMW	Limited	Biomarker	[1792]
ADAT2	OT8AG6ZN	Limited	Biomarker	[1793]
ADGRE5	OTTSB84Q	Limited	Biomarker	[1794]
ADGRL2	OTCXD2YR	Limited	Genetic Variation	[219]
AGA	OTNWT1WB	Limited	Biomarker	[1795]
AHCYL1	OTX8L3M5	Limited	Altered Expression	[1796]
AJUBA	OTNW7YPK	Limited	Altered Expression	[1797]
AKAP4	OTL4Z99V	Limited	Biomarker	[1798]
AKR7A3	OTW3GO4Y	Limited	Biomarker	[1799]
ALG2	OT77B384	Limited	Biomarker	[1800]
ALKBH1	OTADGU5D	Limited	Altered Expression	[1801]
ALPK2	OTWZZDQ9	Limited	Biomarker	[1802]
AMBN	OTWASIMQ	Limited	Biomarker	[1803]
AMPH	OTWPGWZX	Limited	Biomarker	[1804]
ANGPTL6	OTOQ5W67	Limited	Biomarker	[1805]
ANGPTL8	OTQFINCD	Limited	Biomarker	[1806]
ANKRD49	OTG9XX92	Limited	Altered Expression	[1807]
ANP32A	OTRHPFO2	Limited	Biomarker	[1808]
ANTXR1	OT5W1GPC	Limited	Altered Expression	[1809]
ANXA9	OTKNYMU2	Limited	Altered Expression	[425]
AP1B1	OTY0K84R	Limited	Biomarker	[1810]
APBA2	OTXD8ID1	Limited	Biomarker	[1811]
APCDD1	OTV9AD0L	Limited	Biomarker	[1812]
APOD	OTT77XW8	Limited	Altered Expression	[1813]
APPBP2	OTLNFV4J	Limited	Biomarker	[1814]
APPL1	OT8VR95S	Limited	Biomarker	[1815]
ARHGAP29	OT8JH4TY	Limited	Altered Expression	[1816]
ARHGAP4	OTXV053R	Limited	Biomarker	[1817]
ARHGEF10	OTHJ1Y4I	Limited	Biomarker	[1818]
ARHGEF2	OTBQTFRT	Limited	Biomarker	[148]
ARID5B	OTUQ4CQY	Limited	Biomarker	[1819]
ARL6IP5	OTYZ6BEQ	Limited	Altered Expression	[1820]
ARMC12	OTBT9GZ8	Limited	Altered Expression	[1821]
ARMH1	OTTJC0D6	Limited	Biomarker	[148]
ARRDC3	OTAKW7R9	Limited	Biomarker	[1822]
ASF1A	OT4S44GP	Limited	Biomarker	[1823]
ASF1B	OTKXX12I	Limited	Altered Expression	[1824]
ASH1L	OTUT5NLJ	Limited	Altered Expression	[1825]
ATAD1	OTJ02XFL	Limited	Genetic Variation	[1826]
ATF7IP	OTU6ZA7F	Limited	Genetic Variation	[1827]
ATG10	OTVRPC5X	Limited	Genetic Variation	[1828]
ATG12	OTJRO09Y	Limited	Biomarker	[1829]
ATG16L2	OTJYU0W8	Limited	Genetic Variation	[1828]
ATG9A	OTAZWZH7	Limited	Biomarker	[1830]
ATL1	OTR2788Y	Limited	Biomarker	[1831]
ATP11B	OTQOXTH2	Limited	Altered Expression	[1832]
ATP5F1B	OTLFZUQK	Limited	Biomarker	[1833]
ATP5MC2	OTA5F480	Limited	Biomarker	[1834]
ATP6V0A2	OTJBDX0Y	Limited	Biomarker	[1835]
ATRNL1	OTY5JUX2	Limited	Altered Expression	[1836]
AUNIP	OTXBB7R3	Limited	Biomarker	[1837]
B3GALNT2	OTOF6O2B	Limited	Altered Expression	[1838]
B9D1	OTWTXO75	Limited	Biomarker	[1839]
BAG5	OT0J97C6	Limited	Altered Expression	[1840]
BAIAP2L1	OTZ71SK9	Limited	Genetic Variation	[1841]
BBS1	OTXSXB1K	Limited	Biomarker	[1842]
BCAS2	OTRMF2WY	Limited	Genetic Variation	[1843]
BCL2L12	OTS6IFZY	Limited	Biomarker	[1844]
BCO2	OTP1L0BZ	Limited	Biomarker	[1845]
BIRC6	OTCQJAB0	Limited	Altered Expression	[1846]
BPIFB1	OTOZYJMO	Limited	Biomarker	[1847]
BRF2	OT2C6TH2	Limited	Altered Expression	[1848]
BRK1	OTTUB5KS	Limited	Biomarker	[1849]
BST1	OTAV5SE7	Limited	Altered Expression	[1850]
BVES	OT4GT1WC	Limited	Biomarker	[1851]
C11orf58	OTUHIICR	Limited	Biomarker	[164]
C16orf74	OTLLVHH0	Limited	Biomarker	[1852]
C1orf87	OTHV6MDM	Limited	Genetic Variation	[1853]
C1QTNF4	OTHD4Y9D	Limited	Biomarker	[1854]
C2	OTHMF4YM	Limited	Biomarker	[1855]
C20orf204	OT0GVQPP	Limited	Biomarker	[1856]
C4BPB	OTJ70B0K	Limited	Altered Expression	[1857]
C4orf3	OT6TFN1O	Limited	Biomarker	[1858]
CABIN1	OT4G5CIK	Limited	Biomarker	[1859]
CALU	OTSYQN71	Limited	Biomarker	[1860]
CAMK2B	OTS9YK3E	Limited	Altered Expression	[1861]
CANX	OTYP1F6J	Limited	Biomarker	[1862]
CAPN3	OTCHG3YK	Limited	Biomarker	[1863]
CAPZA1	OTAXA66U	Limited	Altered Expression	[1864]
CAPZA2	OTHAO4V2	Limited	Biomarker	[1865]
CARD16	OT4NUHWB	Limited	Biomarker	[1866]
CATSPERZ	OTQVGMG4	Limited	Biomarker	[1867]
CAVIN2	OTFHHDRU	Limited	Biomarker	[1868]
CBFA2T3	OTOJ10S1	Limited	Genetic Variation	[1869]
CBY1	OTAKMUS2	Limited	Genetic Variation	[1870]
CCDC154	OTFGNMNP	Limited	Biomarker	[1871]
CCDC34	OTZ3AGSQ	Limited	Altered Expression	[1872]
CCL3L1	OTQXCYB1	Limited	Altered Expression	[1873]
CCL8	OTCTWYN8	Limited	Biomarker	[1874]
CCNT1	OTDYVGCP	Limited	Biomarker	[1875]
CCS	OTXHT3QO	Limited	Biomarker	[1876]
CCT6A	OTCYWL5F	Limited	Altered Expression	[1877]
CD180	OTITK5E6	Limited	Biomarker	[1878]
CD1B	OT4D5EG7	Limited	Biomarker	[1879]
CD207	OTI9RUDN	Limited	Biomarker	[1880]
CD3D	OTRBLP0R	Limited	Biomarker	[1881]
CD48	OT83ZNPP	Limited	Biomarker	[1882]
CD63	OT2UGZA9	Limited	Biomarker	[1883]
CD8B	OTMZ1T7J	Limited	Biomarker	[1884]
CDH15	OTJ1TO02	Limited	Biomarker	[1885]
CDH4	OT8LH3HN	Limited	Biomarker	[1886]
CDHR2	OTTHEUPO	Limited	Biomarker	[1887]
CDSN	OTQW4HV6	Limited	Biomarker	[1888]
CDT1	OTVY53VG	Limited	Biomarker	[1889]
CEACAM4	OT0C7YUD	Limited	Biomarker	[1890]
CENPF	OT7AG0SW	Limited	Altered Expression	[1891]
CEP104	OTOLRJLH	Limited	Biomarker	[1892]
CEP131	OT6PF80T	Limited	Altered Expression	[1893]
CEP350	OT5Q3AEA	Limited	Biomarker	[1894]
CEP70	OTMY5KAE	Limited	Biomarker	[1895]
CETN1	OTGQ8JOZ	Limited	Biomarker	[1896]
CFAP97	OT0RSQO4	Limited	Biomarker	[1897]
CFL2	OTE2W0DH	Limited	Biomarker	[1898]
CGB7	OTBJO30D	Limited	Biomarker	[1899]
CHAF1A	OTXSSY4H	Limited	Biomarker	[136]
CHAMP1	OTBGWU86	Limited	Genetic Variation	[1900]
CHCHD2	OTL5PA3Y	Limited	Altered Expression	[1901]
CHMP1A	OTVQ5UWX	Limited	Biomarker	[1902]
CHORDC1	OT3W6F1U	Limited	Altered Expression	[1903]
CHP1	OTHTXN1A	Limited	Genetic Variation	[1904]
CHP2	OT4UMKUR	Limited	Biomarker	[1905]
CIRBP	OTXWTPBL	Limited	Altered Expression	[1906]
CISD1	OT0MTVGF	Limited	Biomarker	[1907]
CITED4	OTR6NHI2	Limited	Altered Expression	[1908]
CKAP5	OTEMFY7X	Limited	Altered Expression	[999]
CLDN15	OT9K0KI7	Limited	Altered Expression	[1909]
CLDN5	OTUX60YO	Limited	Biomarker	[1910]
CLDN8	OT7IIWXG	Limited	Altered Expression	[1911]
CLIP2	OTSCIQIY	Limited	Genetic Variation	[1912]
CMC4	OTT2YVJ7	Limited	Altered Expression	[1913]
CMTM1	OTKN7E89	Limited	Biomarker	[1914]
CMTM4	OTA3Z072	Limited	Biomarker	[1915]
CNN1	OTVPG39Z	Limited	Biomarker	[1916]
CNNM4	OTUXJRM1	Limited	Biomarker	[49]
CNOT3	OT4D5Z9L	Limited	Biomarker	[1917]
CNTNAP1	OT5Y03EU	Limited	Biomarker	[1918]
COIL	OTP4I4DL	Limited	Biomarker	[1919]
COL10A1	OTC4G2YC	Limited	Biomarker	[1920]
COL3A1	OTT1EMLM	Limited	Altered Expression	[1921]
COL4A6	OTUREU5Z	Limited	Altered Expression	[1922]
COL6A1	OTYKSCOB	Limited	Altered Expression	[1923]
COL6A6	OT4MVGRW	Limited	Altered Expression	[1745]
COMMD10	OT1ANQLQ	Limited	Biomarker	[1924]
COMMD5	OT6R7DXN	Limited	Altered Expression	[1925]
COPB2	OT82JIGC	Limited	Altered Expression	[1926]
CORIN	OT4SK7DK	Limited	Biomarker	[1927]
COX3	OTNNGBYJ	Limited	Altered Expression	[1928]
COX6C	OT3V7JE5	Limited	Biomarker	[1929]
CP	OTM8JE4Y	Limited	Biomarker	[1930]
CPEB3	OTP1GQCH	Limited	Biomarker	[1931]
CPEB4	OTW1SCZW	Limited	Altered Expression	[1932]
CPSF1	OTAU1KOM	Limited	Altered Expression	[1933]
CPT1C	OT8F1MBF	Limited	Biomarker	[1934]
CREB3L4	OTSGQGT2	Limited	Altered Expression	[1935]
CREG1	OTRHJ8HK	Limited	Altered Expression	[1936]
CRIP1	OT0EICG3	Limited	Biomarker	[1937]
CRNKL1	OTWBQNGU	Limited	Biomarker	[1927]
CRYBG1	OTIPDI15	Limited	Biomarker	[1938]
CRYGC	OTYSTQWI	Limited	Biomarker	[1939]
CRYM	OTRGSR6B	Limited	Altered Expression	[1940]
CSDE1	OT15D7GH	Limited	Altered Expression	[1941]
CSN2	OT22C0PD	Limited	Altered Expression	[1942]
CTAGE1	OTWM7KSJ	Limited	Biomarker	[1943]
CTDP1	OTHHFW17	Limited	Altered Expression	[1944]
CTDSPL	OTZJ0CZK	Limited	Biomarker	[1945]
CTNNBL1	OT6KLHPA	Limited	Biomarker	[1946]
CTRB1	OTFFF738	Limited	Genetic Variation	[1947]
CTRL	OTB6NA5O	Limited	Biomarker	[1460]
CUL1	OTXPE1UZ	Limited	Biomarker	[1948]
CUZD1	OTDQJVZ8	Limited	Altered Expression	[1949]
CYP2D7	OTYJTL3S	Limited	Biomarker	[1950]
CYP2W1	OTXSB1AE	Limited	Altered Expression	[1701]
CYREN	OT5ZL00R	Limited	Biomarker	[1951]
CYYR1	OTKNFPUY	Limited	Altered Expression	[1952]
DAP3	OTNPEZYM	Limited	Altered Expression	[1953]
DBF4	OTBL7JHQ	Limited	Biomarker	[1954]
DCAF1	OT3ZDVOE	Limited	Biomarker	[1955]
DDRGK1	OT3KCK0U	Limited	Altered Expression	[1956]
DDX11	OT1WR3MD	Limited	Biomarker	[1957]
DDX41	OT6KEIHP	Limited	Genetic Variation	[1958]
DDX46	OTB2X9TO	Limited	Biomarker	[1959]
DDX56	OTGURA53	Limited	Altered Expression	[1960]
DENND2B	OT7UH61B	Limited	Genetic Variation	[1961]
DIP2C	OTVNSS2T	Limited	Biomarker	[1962]
DIS3	OT7UPHJS	Limited	Genetic Variation	[1963]
DLG1	OTCRZYWT	Limited	Biomarker	[1964]
DLG3	OTH591WK	Limited	Biomarker	[1965]
DLK2	OT56Y83S	Limited	Biomarker	[1966]
DMKN	OTRIGZMK	Limited	Altered Expression	[1967]
DNAH8	OTGES2OU	Limited	Genetic Variation	[1968]
DNAJA1	OT38BZQQ	Limited	Altered Expression	[1969]
DNAJA3	OT61924T	Limited	Biomarker	[1970]
DNAJB11	OTDDK2SY	Limited	Altered Expression	[1971]
DNAJC11	OTYLMZWW	Limited	Biomarker	[1972]
DNAJC12	OTNU59PT	Limited	Altered Expression	[1973]
DNASE1L1	OT9ZOFN9	Limited	Biomarker	[1974]
DNASE1L3	OTEUIMC2	Limited	Biomarker	[1975]
DPPA3	OTS7N4Q9	Limited	Altered Expression	[1976]
DRG1	OTIFYMI3	Limited	Altered Expression	[1977]
DSN1	OTHROI0H	Limited	Altered Expression	[1978]
DTNBP1	OT9UQT2S	Limited	Altered Expression	[1979]
EBNA1BP2	OTBRVMZH	Limited	Biomarker	[148]
EEF1A1	OT00THXS	Limited	Altered Expression	[1980]
EGR3	OTGPJIRA	Limited	Altered Expression	[1981]
EIF2B1	OT4NCVY1	Limited	Biomarker	[1982]
EIF2B2	OTQQMHM1	Limited	Biomarker	[1982]
EIF2B4	OTTM5SX1	Limited	Biomarker	[1982]
EIF2S2	OTXF0B09	Limited	Biomarker	[1982]
EIF3D	OTDOMP80	Limited	Altered Expression	[1983]
EIF4A1	OTMTBX6N	Limited	Biomarker	[1984]
EIF4B	OTE8TXA8	Limited	Posttranslational Modification	[1985]
ELF1	OTV5LKIA	Limited	Altered Expression	[1986]
ELK4	OTVSSEOE	Limited	Altered Expression	[1987]
ELOF1	OT8BXS5U	Limited	Altered Expression	[1986]
ELOVL7	OT89NYVC	Limited	Biomarker	[1988]
EMD	OTR8ZANE	Limited	Biomarker	[1989]
EMG1	OTFDX7HY	Limited	Biomarker	[1990]
EN1	OT2DKIDK	Limited	Posttranslational Modification	[1991]
ENDOG	OT5IM7B3	Limited	Genetic Variation	[1833]
ENY2	OTTNU8RK	Limited	Biomarker	[1992]
ERAS	OT528IZO	Limited	Biomarker	[1993]
ERBIN	OTNWTUA8	Limited	Altered Expression	[1994]
ERC1	OTYBGGNO	Limited	Genetic Variation	[1995]
ERCC5	OTQAKFJM	Limited	Genetic Variation	[1996]
ERCC6	OT2QZKSF	Limited	Genetic Variation	[1997]
ERLEC1	OTQO3Z0R	Limited	Biomarker	[1998]
ESCO1	OTZ9P12A	Limited	Altered Expression	[1999]
ESCO2	OTJEMAQU	Limited	Biomarker	[2000]
ETNK1	OTDKB4DQ	Limited	Biomarker	[2001]
EVI2B	OT98X1OE	Limited	Biomarker	[2002]
EXTL2	OT8U672K	Limited	Altered Expression	[2003]
FAH	OTGZA1YR	Limited	Biomarker	[2004]
FAM110B	OTLYN2T1	Limited	Altered Expression	[2005]
FAM168A	OTDXQCS5	Limited	Biomarker	[2006]
FAM3C	OTBR6U9G	Limited	Biomarker	[2007]
FAM83A	OTBI16V7	Limited	Altered Expression	[2008]
FANCB	OTMZTXB5	Limited	Genetic Variation	[2009]
FAT3	OT3C6H8W	Limited	Genetic Variation	[219]
FATE1	OTPYXV64	Limited	Altered Expression	[2010]
FBXL14	OTBTN6WS	Limited	Biomarker	[2011]
FBXO22	OTEJ5MO0	Limited	Altered Expression	[2012]
FBXW5	OT5TQK3H	Limited	Altered Expression	[2013]
FCGR2C	OTNLMNYB	Limited	Genetic Variation	[2014]
FCRL3	OTIFXFWL	Limited	Altered Expression	[2015]
FCRLA	OT6MK4M1	Limited	Biomarker	[2016]
FDCSP	OT8KGE9M	Limited	Biomarker	[2017]
FERMT3	OTFQOT3C	Limited	Altered Expression	[2018]
FGD1	OTV3T64P	Limited	Biomarker	[2019]
FGD5	OT5VIRP2	Limited	Biomarker	[2020]
FGF11	OT6513W2	Limited	Biomarker	[2021]
FGF16	OT6BHWZP	Limited	Biomarker	[2022]
FGF6	OTRJ679P	Limited	Altered Expression	[2023]
FHOD1	OTROM7N3	Limited	Biomarker	[2024]
FIP1L1	OTF91GTL	Limited	Genetic Variation	[2025]
FITM1	OTBKC6PT	Limited	Altered Expression	[2026]
FMNL3	OTRP8R4W	Limited	Biomarker	[2027]
FMOD	OT9EJ5H8	Limited	Biomarker	[2028]
FNDC3A	OTUX3S2I	Limited	Altered Expression	[1927]
FOXK1	OTLZGS7J	Limited	Biomarker	[2029]
FOXN4	OTE3MWYJ	Limited	Biomarker	[2030]
FOXP2	OTVX6A59	Limited	Biomarker	[2031]
FRAT1	OT1PS84E	Limited	Altered Expression	[2032]
FSIP1	OTYLL6GM	Limited	Altered Expression	[2033]
FZD1	OTZATHVS	Limited	Altered Expression	[2034]
GALNT13	OT650121	Limited	Genetic Variation	[2035]
GALNT5	OTCV61V1	Limited	Altered Expression	[2036]
GALNT7	OTUJSCAO	Limited	Biomarker	[2037]
GALT	OTCATU66	Limited	Biomarker	[2038]
GAMT	OTVC87ES	Limited	Altered Expression	[2039]
GAREM1	OTQYIOUN	Limited	Altered Expression	[2040]
GASK1B	OT2HPHEI	Limited	Biomarker	[2041]
GATAD2A	OTFM8D3O	Limited	Biomarker	[2042]
GCA	OTAJ7ZHG	Limited	Biomarker	[2043]
GCNT3	OTQ9ALTR	Limited	Altered Expression	[2044]
GID8	OT0HJ277	Limited	Altered Expression	[2045]
GINS4	OTCVOO3S	Limited	Altered Expression	[2046]
GLDN	OTA8TQU9	Limited	Biomarker	[2047]
GLIS2	OTOUUV1X	Limited	Biomarker	[2048]
GLUD2	OTF3GGYY	Limited	Biomarker	[2049]
GLYAT	OT3WWYXD	Limited	Genetic Variation	[314]
GMPR2	OTKZSZPE	Limited	Altered Expression	[2050]
GNA15	OTFYRZGV	Limited	Altered Expression	[2051]
GNPTAB	OT2Z03OB	Limited	Biomarker	[2052]
GNRH2	OTORRM53	Limited	Biomarker	[2053]
GPAT2	OTZ8VP2Y	Limited	Altered Expression	[2054]
GPR158	OTYOC1RQ	Limited	Altered Expression	[2055]
GPX4	OTRAFFX2	Limited	Biomarker	[2056]
GSE1	OT3J7CJB	Limited	Altered Expression	[2057]
GTF2B	OTAH5NSO	Limited	Biomarker	[2058]
GTF2IRD1	OTEG9KU1	Limited	Altered Expression	[2059]
GTF3A	OTVROUVQ	Limited	Biomarker	[2060]
GTSE1	OTPP742Z	Limited	Altered Expression	[2061]
GUK1	OTLI0HRU	Limited	Biomarker	[2062]
GZMA	OT43R33L	Limited	Altered Expression	[2063]
HADHB	OT4Y1I62	Limited	Biomarker	[2064]
HAS1	OTJIAG1W	Limited	Altered Expression	[2065]
HERC4	OTU4DSDE	Limited	Biomarker	[2066]
HES4	OTCGMQDT	Limited	Altered Expression	[2067]
HES5	OTW7JEHV	Limited	Altered Expression	[2068]
HIPK3	OT4WYQM2	Limited	Altered Expression	[2069]
HLA-DPA1	OT7OG7Y2	Limited	Biomarker	[2070]
HLA-DPB1	OTW8JHU2	Limited	Altered Expression	[2071]
HLA-DQB1	OTVVI3UI	Limited	Altered Expression	[2072]
HMBOX1	OTPKTBVI	Limited	Biomarker	[2073]
HMGN1	OTSMGH99	Limited	Biomarker	[2074]
HNRNPL	OT0DJX74	Limited	Altered Expression	[2075]
HORMAD1	OT7DR5T2	Limited	Biomarker	[2076]
HORMAD2	OTL2ENWI	Limited	Altered Expression	[2077]
HOXA3	OTIX5XFB	Limited	Biomarker	[2078]
HOXB2	OTTD6HMV	Limited	Biomarker	[2079]
HOXD10	OT0NOWU2	Limited	Biomarker	[2080]
HOXD11	OT9XGA4G	Limited	Genetic Variation	[2081]
HSPB9	OTB97F1J	Limited	Altered Expression	[2082]
HSPBP1	OTRS37HK	Limited	Altered Expression	[2083]
HYAL3	OTG6VUSP	Limited	Altered Expression	[2084]
HYLS1	OT3SW5UC	Limited	Biomarker	[2085]
IARS2	OTDX4SCA	Limited	Genetic Variation	[2086]
ICAM2	OT3E070F	Limited	Biomarker	[2087]
ICMT	OT8CNKBO	Limited	Biomarker	[2088]
ID4	OTPMJ39I	Limited	Biomarker	[2089]
IFI44L	OTXKORJP	Limited	Biomarker	[2090]
IFIT3	OTPGHZB9	Limited	Altered Expression	[2091]
IFITM5	OTLP5QEJ	Limited	Genetic Variation	[2092]
IFNA10	OTO2FEXF	Limited	Altered Expression	[2093]
IGDCC4	OTANDZ8W	Limited	Altered Expression	[2094]
IK	OTWSSXX0	Limited	Biomarker	[67]
IL12RB1	OTM1IJO2	Limited	Genetic Variation	[2095]
IL18BP	OTW0LRYZ	Limited	Biomarker	[2096]
IL1F10	OTJAASGC	Limited	Biomarker	[2097]
IL26	OT2WYCW4	Limited	Altered Expression	[2098]
IL2RG	OTRZ3OMY	Limited	Biomarker	[2099]
ILF3	OTKMZ5K5	Limited	Biomarker	[2100]
INPP5A	OT9CMGMS	Limited	Altered Expression	[2101]
INPP5K	OTQFLQKA	Limited	Altered Expression	[2102]
INSIG2	OTX4VY51	Limited	Altered Expression	[2103]
INTS13	OTWE6180	Limited	Biomarker	[2104]
IRF7	OTC1A2PQ	Limited	Posttranslational Modification	[2105]
IRF9	OTK4MYQJ	Limited	Biomarker	[2106]
IRS4	OTTOL40K	Limited	Altered Expression	[2107]
IRX3	OTLJ48FG	Limited	Altered Expression	[2108]
IST1	OTSFEZ2O	Limited	Altered Expression	[2109]
ITGA10	OTM0V5AO	Limited	Biomarker	[2110]
ITGA3	OTBCH21D	Limited	Biomarker	[2111]
ITGA7	OTTBTAYW	Limited	Altered Expression	[2112]
ITIH4	OT460OO1	Limited	Biomarker	[2113]
ITLN1	OT7ZLJVV	Limited	Altered Expression	[2114]
ITSN1	OT8YF3S5	Limited	Biomarker	[2115]
JADE1	OTBPJIRI	Limited	Biomarker	[2116]
JCAD	OT7G1WJW	Limited	Biomarker	[2117]
JPT1	OT6CRZEU	Limited	Biomarker	[2118]
JPT2	OTJGPA4T	Limited	Altered Expression	[2119]
KANK3	OTEZFS98	Limited	Biomarker	[2120]
KCNE3	OTKWKR91	Limited	Altered Expression	[123]
KCNE4	OTNYW0OL	Limited	Altered Expression	[123]
KCNRG	OTXHYFOD	Limited	Altered Expression	[2121]
KDM4D	OTN6KAE6	Limited	Biomarker	[2122]
KDM5D	OTEKG0KD	Limited	Altered Expression	[2123]
KHDRBS3	OTUG02U7	Limited	Biomarker	[2124]
KIAA0513	OT7AVTFB	Limited	Biomarker	[1789]
KIF15	OTJRJEXL	Limited	Biomarker	[2125]
KIFAP3	OT450PAO	Limited	Biomarker	[164]
KLF10	OT4F4UGS	Limited	Biomarker	[2126]
KLF8	OTUC5CDB	Limited	Altered Expression	[2127]
KLF9	OTBFEJRQ	Limited	Biomarker	[2128]
KLHDC4	OTJ4UL5S	Limited	Biomarker	[2129]
KLHL7	OT2OF1O8	Limited	Altered Expression	[2130]
KLRB1	OTQ2959Y	Limited	Biomarker	[2131]
KLRC2	OTT4N86S	Limited	Biomarker	[2132]
L3MBTL4	OTERBGKR	Limited	Biomarker	[2133]
LAMA4	OTHI7TA0	Limited	Genetic Variation	[2134]
LAMTOR3	OTG93MCO	Limited	Genetic Variation	[2135]
LAPTM5	OT2XI2JG	Limited	Biomarker	[2136]
LEFTY2	OT3RX4QF	Limited	Biomarker	[2137]
LEMD1	OTII3FTO	Limited	Biomarker	[2138]
LETM1	OT8N4MRU	Limited	Altered Expression	[2139]
LETMD1	OTZTZ4RD	Limited	Altered Expression	[2140]
LGALS7	OTMSVI7R	Limited	Altered Expression	[2141]
LHPP	OT9AGAIJ	Limited	Biomarker	[2142]
LIAS	OTOSW67J	Limited	Biomarker	[2143]
LIMD1	OTN1CG6R	Limited	Biomarker	[2144]
LIMS1	OT729S0T	Limited	Altered Expression	[2145]
LMNB1	OT100T3P	Limited	Biomarker	[2146]
LMX1B	OTM8145D	Limited	Altered Expression	[2147]
LRBA	OTOUZN9G	Limited	Biomarker	[2148]
LRIG3	OT6TKZTU	Limited	Biomarker	[2149]
LRP8	OTZ71YV2	Limited	Altered Expression	[2150]
LRRN2	OTGP2DCY	Limited	Biomarker	[2151]
LUC7L3	OTKDED8A	Limited	Genetic Variation	[2152]
LY6G6C	OTV7F59X	Limited	Genetic Variation	[2153]
LYPD5	OTGP7UKA	Limited	Altered Expression	[2154]
LYPD8	OT5B9NNM	Limited	Biomarker	[2155]
MACROD1	OTWFEVRW	Limited	Altered Expression	[2156]
MAD2L1BP	OT2O2IUJ	Limited	Altered Expression	[2157]
MAGEC3	OT0KDWZN	Limited	Biomarker	[112]
MAML3	OTZFV53Z	Limited	Biomarker	[2158]
MAMLD1	OT9EVMQY	Limited	Altered Expression	[2159]
MAP1S	OT5WUD4C	Limited	Biomarker	[2160]
MAP3K12	OT5HODDD	Limited	Altered Expression	[2161]
MAP3K13	OTS93BTX	Limited	Biomarker	[2162]
MAP9	OTZD5099	Limited	Biomarker	[2163]
MAPRE1	OTCVQD60	Limited	Altered Expression	[2164]
MARVELD2	OTKB96L5	Limited	Biomarker	[2165]
MASP1	OTWWCNZP	Limited	Biomarker	[167]
MASTL	OTQ7YKK5	Limited	Altered Expression	[2166]
MAVS	OTTQ0J64	Limited	Altered Expression	[2167]
MCCC2	OTQDHSMI	Limited	Altered Expression	[2168]
MDGA1	OTVXEF85	Limited	Altered Expression	[2169]
MDGA2	OTIJ0T5J	Limited	Biomarker	[2170]
MEAF6	OTAFDRYT	Limited	Biomarker	[2171]
MED27	OT40PZ9R	Limited	Biomarker	[2172]
MEGF10	OTILSPJ6	Limited	Altered Expression	[2173]
MEOX2	OTKZCJCB	Limited	Biomarker	[2174]
MEPE	OTXJRUW0	Limited	Altered Expression	[2175]
METTL9	OT3YR9B2	Limited	Biomarker	[2176]
MIA2	OTOGTUTU	Limited	Genetic Variation	[2177]
MIA3	OTBVIZQD	Limited	Biomarker	[583]
MIB2	OTJCC3HS	Limited	Biomarker	[2178]
MID1	OTWN1PGU	Limited	Biomarker	[2179]
MLF2	OTU3B4WU	Limited	Biomarker	[2180]
MLXIPL	OTR9MLLW	Limited	Genetic Variation	[2181]
MMP23B	OT2OR6TS	Limited	Altered Expression	[171]
MMS19	OTAXB34N	Limited	Biomarker	[2182]
MN1	OTVQR4R9	Limited	Altered Expression	[2183]
MOGS	OT99MBGB	Limited	Genetic Variation	[2184]
MORF4L1	OTEA6FYJ	Limited	Biomarker	[2185]
MOSPD2	OTTN4NR7	Limited	Altered Expression	[2186]
MOV10L1	OTP978LK	Limited	Genetic Variation	[1900]
MPC1	OT6DYFUO	Limited	Altered Expression	[143]
MPDU1	OT27UPHN	Limited	Biomarker	[2187]
MPHOSPH8	OTYI2WNS	Limited	Altered Expression	[2188]
MPIG6B	OTVNKQWA	Limited	Biomarker	[2189]
MPP1	OTA2ENZQ	Limited	Biomarker	[2190]
MRGBP	OTXBPDMS	Limited	Biomarker	[2191]
MRO	OT5U38CP	Limited	Biomarker	[2192]
MRPL39	OTN9VRD2	Limited	Biomarker	[2193]
MRPL40	OTB2QZDY	Limited	Altered Expression	[2194]
MSRB3	OT4UZXMN	Limited	Altered Expression	[2195]
MTBP	OTWLCW9C	Limited	Altered Expression	[2196]
MTCP1	OT4O23TK	Limited	Altered Expression	[1913]
MTG1	OTC9U1LI	Limited	Altered Expression	[2197]
MTMR2	OTNCYGBP	Limited	Biomarker	[2198]
MUC12	OTYDC13T	Limited	Altered Expression	[2199]
MUCL3	OTGAD3I0	Limited	Biomarker	[2200]
MYEOV	OTDC7UHL	Limited	Altered Expression	[2201]
MYF6	OTLLMHMI	Limited	Altered Expression	[2202]
MYL6B	OTWTRGT7	Limited	Biomarker	[2203]
MYO10	OTHB78ZQ	Limited	Altered Expression	[1632]
MYOF	OTRFC3IJ	Limited	Altered Expression	[2204]
MYOT	OTCEW5XW	Limited	Biomarker	[2205]
NABP2	OTQU8081	Limited	Genetic Variation	[2206]
NAF1	OTMJKJAK	Limited	Altered Expression	[1907]
NARS1	OTFS4J1W	Limited	Biomarker	[2207]
NASP	OTNE4THC	Limited	Altered Expression	[2208]
NBDY	OTV8WY4S	Limited	Altered Expression	[2209]
NCKAP1L	OTADCEUK	Limited	Biomarker	[2210]
NCS1	OT6JHAWM	Limited	Biomarker	[2211]
NCSTN	OT5QBTA4	Limited	Biomarker	[2212]
ND5	OT45LW1K	Limited	Genetic Variation	[2213]
NDUFA4	OTDVH3QG	Limited	Biomarker	[2214]
NEBL	OT2WH1NC	Limited	Altered Expression	[2215]
NEXN	OTKB0B0H	Limited	Biomarker	[2216]
NFE2L3	OT1MGXT0	Limited	Biomarker	[2217]
NFKBIZ	OTU728KS	Limited	Biomarker	[2218]
NGLY1	OTZBQD5Q	Limited	Biomarker	[2219]
NHLH2	OT88N84O	Limited	Altered Expression	[2220]
NIF3L1	OT4MP90J	Limited	Biomarker	[760]
NKAPL	OTIU393R	Limited	Posttranslational Modification	[2221]
NKX2-3	OTF4IL5J	Limited	Altered Expression	[2222]
NME2	OTCYGLHV	Limited	Altered Expression	[2223]
NMT1	OT42GQ3D	Limited	Biomarker	[2224]
NOL4	OTWI587R	Limited	Biomarker	[2225]
NOP14	OTKPM0Z5	Limited	Altered Expression	[2226]
NOP16	OT2829ZC	Limited	Altered Expression	[2227]
NOX5	OTHTH59G	Limited	Biomarker	[2228]
NPAT	OT1ZU6JB	Limited	Altered Expression	[2229]
NPM3	OTIAM1A3	Limited	Altered Expression	[2230]
NRF1	OTOXWNV8	Limited	Biomarker	[2231]
NRTN	OT4PAKUY	Limited	Biomarker	[2232]
NSD3	OT3677ZG	Limited	Biomarker	[966]
NUFIP2	OTZBZ224	Limited	Biomarker	[2233]
OIP5	OTI5C2DE	Limited	Biomarker	[2234]
OMD	OTFRELBB	Limited	Genetic Variation	[41]
OPCML	OT93PQ6Y	Limited	Altered Expression	[2235]
ORAI3	OTUP3OH3	Limited	Biomarker	[2236]
OSR1	OTB19LEQ	Limited	Biomarker	[2237]
OSTF1	OT8D7CDO	Limited	Genetic Variation	[219]
OTX2	OTTV05B1	Limited	Genetic Variation	[2238]
OXCT1	OT536PE7	Limited	Biomarker	[2239]
OXR1	OTPIDMT3	Limited	Posttranslational Modification	[2240]
P3H3	OTRC8QCM	Limited	Altered Expression	[2241]
P3H4	OTZPXYSH	Limited	Biomarker	[2242]
PAFAH1B1	OT9T2TCJ	Limited	Biomarker	[1246]
PAFAH1B2	OTRDWN2V	Limited	Biomarker	[2243]
PANX3	OTKRQZ1T	Limited	Altered Expression	[2244]
PARP12	OTCQTYIO	Limited	Biomarker	[2245]
PBOV1	OT67PERT	Limited	Altered Expression	[2246]
PCBD2	OTXV0ZD0	Limited	Biomarker	[63]
PCBP2	OTXCN9CG	Limited	Biomarker	[2247]
PCDH18	OTTLQWRN	Limited	Biomarker	[2248]
PCDHGA12	OT3JJI7L	Limited	Biomarker	[2249]
PCDHGA9	OTKJE2H2	Limited	Biomarker	[2250]
PCF11	OT54GCY6	Limited	Biomarker	[2251]
PCSK1N	OT7ZRW2F	Limited	Altered Expression	[2252]
PDCD6	OT2YA5M8	Limited	Biomarker	[1800]
PDCL	OTDNHIXG	Limited	Biomarker	[2253]
PDIA2	OTC2WMXS	Limited	Biomarker	[2254]
PDK4	OTCMHMBZ	Limited	Biomarker	[2255]
PDLIM2	OTEURRPD	Limited	Biomarker	[2256]
PDLIM3	OTVXQC81	Limited	Altered Expression	[1836]
PDS5B	OT3U3X8Z	Limited	Genetic Variation	[2257]
PDSS1	OTXGVHAB	Limited	Biomarker	[2258]
PES1	OTMZK7XE	Limited	Biomarker	[2259]
PFDN4	OT5NRHER	Limited	Genetic Variation	[2260]
PFDN5	OTTKPTUP	Limited	Biomarker	[2261]
PFKFB1	OTTHX4NB	Limited	Biomarker	[2262]
PGAM1	OTZ5DB06	Limited	Biomarker	[2263]
PHACTR4	OT29P1FM	Limited	Altered Expression	[2264]
PIK3C3	OTLUM9L7	Limited	Altered Expression	[2265]
PIK3R3	OTXGJ8N1	Limited	Biomarker	[2266]
PIP4K2B	OTF1VGJ9	Limited	Altered Expression	[2267]
PIWIL3	OTQ1B8R4	Limited	Altered Expression	[2268]
PKP2	OTJOVF68	Limited	Biomarker	[2269]
PLA1A	OT2IXYNX	Limited	Genetic Variation	[2270]
PLA2G2D	OTU604XM	Limited	Biomarker	[2271]
PLAAT1	OTM3M6P4	Limited	Biomarker	[2272]
PLAAT4	OTI66SAJ	Limited	Biomarker	[2273]
PLAGL1	OTZAO900	Limited	Biomarker	[2274]
PLCB4	OTPA0QHW	Limited	Biomarker	[2275]
PLEK	OTB73XXA	Limited	Genetic Variation	[2276]
PLEKHB1	OTC7TNAX	Limited	Biomarker	[2277]
PLP1	OT8CM9CX	Limited	Biomarker	[2278]
PLSCR1	OTGY9B5T	Limited	Altered Expression	[2279]
PLXNA3	OTMZIBVG	Limited	Biomarker	[2280]
PLXNC1	OTJ5XKYY	Limited	Altered Expression	[2281]
PNPT1	OTBR2Q0F	Limited	Altered Expression	[2282]
POLE	OTFM3MMU	Limited	Genetic Variation	[2283]
POLG2	OTDBMZJB	Limited	Biomarker	[2190]
POLK	OTKZ38JH	Limited	Altered Expression	[2284]
PPFIBP2	OTXQO55Y	Limited	Altered Expression	[2285]
PPP1R15B	OTL5RWA8	Limited	Biomarker	[2286]
PPP1R1C	OTVH6BND	Limited	Biomarker	[2287]
PPP1R8	OTH5KB2P	Limited	Altered Expression	[2288]
PPP2R3B	OT5Y53WZ	Limited	Biomarker	[2289]
PPP2R5C	OTF7CGO2	Limited	Biomarker	[2290]
PRCD	OT64DNLW	Limited	Biomarker	[2291]
PRDM12	OTOAUVAM	Limited	Biomarker	[2292]
PRKAR2A	OTZ7P17Z	Limited	Altered Expression	[199]
PRM1	OT6HWA11	Limited	Biomarker	[2293]
PROCA1	OT1MY922	Limited	Biomarker	[2294]
PRPF8	OTU39JZI	Limited	Biomarker	[2295]
PRR14L	OT290EDE	Limited	Biomarker	[2296]
PRRX2	OT8UR4AU	Limited	Genetic Variation	[2297]
PRSS2	OTOMVUWL	Limited	Biomarker	[2298]
PRSS21	OT8ZYC7G	Limited	Posttranslational Modification	[2299]
PRSS50	OTC5JAVO	Limited	Altered Expression	[2300]
PRXL2A	OTR4X7UH	Limited	Altered Expression	[2301]
PSG7	OT1IXGBX	Limited	Biomarker	[2302]
PSG8	OT00UZBM	Limited	Biomarker	[2302]
PSMD12	OTWICA51	Limited	Biomarker	[2190]
PSMD3	OT585WY8	Limited	Altered Expression	[2303]
PSMD7	OT7PZZ4K	Limited	Biomarker	[148]
PTPN4	OT6SXU5Y	Limited	Biomarker	[2304]
PTPRD	OTZPJ3GX	Limited	Posttranslational Modification	[2305]
PUF60	OTG90DYF	Limited	Altered Expression	[2306]
PUM2	OT2H7NXV	Limited	Biomarker	[207]
PUM3	OTN1IPNS	Limited	Altered Expression	[2252]
PURG	OTXPQDWN	Limited	Biomarker	[2307]
PVALB	OTZW1WVQ	Limited	Biomarker	[2308]
PXDN	OTFGGM9R	Limited	Biomarker	[2309]
RAB11FIP1	OT0T71OW	Limited	Biomarker	[2310]
RAB31	OTMLXQZ0	Limited	Biomarker	[2311]
RAB5A	OTFR2KM4	Limited	Altered Expression	[2312]
RABEPK	OTCZSREH	Limited	Biomarker	[148]
RAD1	OT886MA8	Limited	Altered Expression	[2313]
RALGDS	OTG36NI7	Limited	Biomarker	[2314]
RALY	OT78NNWY	Limited	Altered Expression	[2315]
RASA4	OTW0178L	Limited	Genetic Variation	[2316]
RASEF	OTGSAM2E	Limited	Biomarker	[2317]
RASGRF2	OT67DAGF	Limited	Altered Expression	[2318]
RASSF6	OT25GVWY	Limited	Biomarker	[2319]
RBM24	OTQI1AR1	Limited	Biomarker	[2320]
RBM6	OTI99KAZ	Limited	Altered Expression	[2321]
RCN2	OTIU8JWD	Limited	Altered Expression	[2322]
RDM1	OTBSJEAG	Limited	Biomarker	[2323]
REG3G	OTLIUY8Z	Limited	Biomarker	[2324]
REPS2	OTSE3TRP	Limited	Altered Expression	[2325]
RETREG1	OTYOSLZX	Limited	Altered Expression	[2326]
RFX2	OTK6VQ1B	Limited	Biomarker	[2327]
RGN	OTD04KB1	Limited	Altered Expression	[2328]
RGS10	OTQ8N1QH	Limited	Posttranslational Modification	[2329]
RGS7	OTDQA90X	Limited	Genetic Variation	[2330]
RHBDF1	OTCQ7UDS	Limited	Altered Expression	[209]
RHOD	OTALMEIN	Limited	Biomarker	[2331]
RHOV	OTW4N3QN	Limited	Altered Expression	[2332]
RIMS2	OTQASWDH	Limited	Biomarker	[2333]
RMND1	OT7I6RBT	Limited	Biomarker	[2334]
RNASE3	OTVE2XD1	Limited	Biomarker	[2335]
RNASE7	OTIXO0Z4	Limited	Biomarker	[2336]
RNF146	OTE4CO7E	Limited	Genetic Variation	[2337]
RNF180	OT2GKIKE	Limited	Altered Expression	[2338]
RNF187	OTXTN1HP	Limited	Altered Expression	[2339]
RNF4	OTCMXQRE	Limited	Altered Expression	[2340]
RNF44	OTGWL4U4	Limited	Altered Expression	[2341]
RNF8	OTRR43PZ	Limited	Biomarker	[2342]
RNH1	OT6EC79B	Limited	Genetic Variation	[2343]
ROBO2	OTFJ9FQW	Limited	Altered Expression	[2344]
RP9	OTGQY66H	Limited	Biomarker	[2176]
RPIA	OT805SMH	Limited	Altered Expression	[2345]
RPL13	OTFKNTD6	Limited	Genetic Variation	[2346]
RPL14	OTZZW7TK	Limited	Biomarker	[2347]
RPL17	OTTYMPS6	Limited	Biomarker	[227]
RPL19	OT33LM66	Limited	Altered Expression	[2348]
RPL37	OTB6SDZ1	Limited	Biomarker	[2349]
RPL37A	OTAMQLY7	Limited	Biomarker	[2350]
RPL39	OTL8TZHQ	Limited	Biomarker	[2351]
RPL5	OTM8EBRI	Limited	Biomarker	[2352]
RPLP0	OT3XKD6Y	Limited	Altered Expression	[2353]
RPS15	OT0WYZYG	Limited	Altered Expression	[2354]
RRAGC	OTV3XCV8	Limited	Biomarker	[2355]
RRP1B	OTHDRVML	Limited	Altered Expression	[2356]
RSAD2	OTCA9WCM	Limited	Altered Expression	[1874]
RSRC1	OTFCJ4S0	Limited	Biomarker	[2357]
RSRC2	OTLE0KQM	Limited	Biomarker	[2358]
RTL5	OT9ZJR3N	Limited	Genetic Variation	[2359]
RTN3	OTGZ51QF	Limited	Biomarker	[2360]
RUBCNL	OTMQIDOI	Limited	Biomarker	[2361]
RUNX1T1	OT30DED5	Limited	Biomarker	[2362]
S100A10	OTI71243	Limited	Biomarker	[2363]
SARNP	OTE0OVK5	Limited	Biomarker	[2364]
SCAF1	OT16TM3N	Limited	Biomarker	[2365]
SCD5	OTSSUQ3Z	Limited	Altered Expression	[2366]
SCGB1D1	OTA20BF2	Limited	Altered Expression	[2367]
SCML2	OT8EB87R	Limited	Altered Expression	[2368]
SCRN1	OTELM5C2	Limited	Altered Expression	[2369]
SDC4	OTKUVUGZ	Limited	Altered Expression	[2370]
SEC23A	OTBRNIJ3	Limited	Biomarker	[2371]
SELENOI	OTX2A47A	Limited	Genetic Variation	[2372]
SELENOK	OTKM7N7P	Limited	Biomarker	[2373]
SEM1	OTASLBM1	Limited	Biomarker	[2374]
SEMA3B	OTCZCPMS	Limited	Biomarker	[2375]
SEMA3F	OTQFMS8S	Limited	Altered Expression	[2376]
SEMA4A	OT8901H3	Limited	Altered Expression	[2377]
SEMA6D	OTU0UAZS	Limited	Altered Expression	[2378]
SERPINB1	OT5RDUFO	Limited	Altered Expression	[2379]
SET	OTGYYQJO	Limited	Altered Expression	[2380]
SETMAR	OTE2MIMZ	Limited	Biomarker	[2381]
SF1	OTLEDM2S	Limited	Altered Expression	[2382]
SF3B4	OTGB9OR9	Limited	Altered Expression	[2383]
SFI1	OTI1P52G	Limited	Biomarker	[2384]
SFTPC	OTIZJD09	Limited	Biomarker	[2385]
SFXN1	OTL66767	Limited	Biomarker	[2386]
SGMS1	OTZQE7PW	Limited	Biomarker	[2387]
SH2B1	OTJZO2CI	Limited	Biomarker	[2388]
SHB	OTF2HSC0	Limited	Genetic Variation	[2389]
SHISA3	OTE8TPCP	Limited	Biomarker	[2390]
SIAH2	OTKED2XN	Limited	Biomarker	[2231]
SIGIRR	OTNC3XFD	Limited	Biomarker	[2391]
SIPA1	OTXY5RXC	Limited	Altered Expression	[2392]
SKP1	OT5BPAZ4	Limited	Biomarker	[2393]
SLN	OTERIU75	Limited	Genetic Variation	[2394]
SLURP1	OT89YD2E	Limited	Biomarker	[2395]
SNAI3	OTG9DI66	Limited	Altered Expression	[2396]
SNCB	OTELSEK6	Limited	Biomarker	[2397]
SNX10	OT05B7BT	Limited	Biomarker	[2398]
SOCS2	OTBPNKJQ	Limited	Altered Expression	[2399]
SOX3	OT1CRCOB	Limited	Biomarker	[2400]
SOX8	OTEJXYZM	Limited	Altered Expression	[2401]
SP6	OTRAB1PN	Limited	Altered Expression	[2402]
SP7	OT07ETZT	Limited	Biomarker	[2179]
SPAM1	OTMPOB4E	Limited	Biomarker	[2403]
SPATA2	OTOA45GL	Limited	Biomarker	[227]
SPDYA	OTYKC1AJ	Limited	Biomarker	[2404]
SPINK6	OTYKZANJ	Limited	Altered Expression	[2405]
SPNS1	OTSJ3BJ2	Limited	Biomarker	[2207]
SPRY4	OT2VK9N0	Limited	Biomarker	[2406]
SPSB1	OTGY26U4	Limited	Genetic Variation	[2206]
SPTAN1	OT6VY3A3	Limited	Altered Expression	[2407]
SRGAP3	OT9ZS72C	Limited	Biomarker	[2408]
SRM	OT4N5MDP	Limited	Altered Expression	[2409]
SRRM4	OTALUISN	Limited	Altered Expression	[2410]
SSR3	OTJQP0IZ	Limited	Altered Expression	[2411]
ST18	OTPRIMTA	Limited	Biomarker	[2412]
ST6GALNAC2	OT9PBQVT	Limited	Altered Expression	[2413]
STAG3	OTEV0AOD	Limited	Biomarker	[2414]
STAM	OT6X5RR1	Limited	Altered Expression	[2415]
STAT5A	OTBSJGN3	Limited	Biomarker	[2416]
STIM2	OTYNXAW0	Limited	Altered Expression	[2417]
STK17B	OT4NYNO8	Limited	Altered Expression	[2418]
STMN3	OT20F289	Limited	Altered Expression	[2419]
STMN4	OT7ZUKW6	Limited	Altered Expression	[2344]
STOM	OTC8R6EH	Limited	Biomarker	[2420]
STOML1	OTSIO2QA	Limited	Biomarker	[2421]
STX1A	OTSBUZB4	Limited	Biomarker	[2422]
STX2	OTO2IDDR	Limited	Altered Expression	[2423]
STX7	OTHW3GEI	Limited	Biomarker	[2424]
STXBP1	OTRYA8C3	Limited	Altered Expression	[2425]
STYX	OT8W6Y1J	Limited	Altered Expression	[2426]
SUCO	OT3I9VO9	Limited	Biomarker	[2427]
SUGP1	OT7W0EB8	Limited	Biomarker	[207]
SUPT20H	OTTMC0LH	Limited	Biomarker	[1564]
SUPT5H	OTCS9LW3	Limited	Biomarker	[2428]
SUSD6	OTZS4SKF	Limited	Altered Expression	[2429]
SYN3	OTSGYNA5	Limited	Biomarker	[2430]
TAC4	OTYWPPM3	Limited	Biomarker	[2431]
TACC1	OTGX20TE	Limited	Altered Expression	[2432]
TAF1	OTDYS5G4	Limited	Biomarker	[2433]
TAP2	OTWSYFI7	Limited	Altered Expression	[2434]
TBC1D25	OT11OABF	Limited	Genetic Variation	[2435]
TBC1D8	OT2011SS	Limited	Biomarker	[2436]
TBCEL	OT2PZLLL	Limited	Altered Expression	[2437]
TBXT	OTHCO2F0	Limited	Altered Expression	[2438]
TCF4	OTB9ASTK	Limited	Biomarker	[2439]
TCIM	OTARUXQF	Limited	Biomarker	[2440]
TCP1	OT1MGUX9	Limited	Biomarker	[2441]
TDRD9	OTS4UBI8	Limited	Biomarker	[2085]
TEAD2	OTM8YMYT	Limited	Genetic Variation	[2442]
TENM4	OT91K3FC	Limited	Genetic Variation	[263]
TFDP1	OT6RZ7VT	Limited	Biomarker	[2443]
TFDP3	OTI4K6MN	Limited	Altered Expression	[2444]
TGIF2LX	OTLBWKZA	Limited	Biomarker	[2445]
THBS4	OTA1T9KK	Limited	Altered Expression	[2446]
TIMM44	OTXP7MXN	Limited	Biomarker	[126]
TIMP4	OT8A68SW	Limited	Altered Expression	[2447]
TLE4	OT4QEH6T	Limited	Biomarker	[2448]
TLK1	OTICTXI8	Limited	Biomarker	[2449]
TM4SF5	OTPAV531	Limited	Altered Expression	[2450]
TMEM11	OTL9HDEY	Limited	Altered Expression	[2451]
TMEM119	OT0HFEIC	Limited	Altered Expression	[2452]
TMEM41A	OTAAULKY	Limited	Altered Expression	[2453]
TMEM54	OTPQEFR0	Limited	Altered Expression	[2454]
TNFAIP8L1	OTVVKOTV	Limited	Biomarker	[2455]
TNN	OTQK2AMX	Limited	Altered Expression	[2456]
TNP1	OTKQH7E5	Limited	Altered Expression	[2457]
TNR	OTVJGAFN	Limited	Genetic Variation	[2458]
TNXB	OTVBWAV5	Limited	Biomarker	[2459]
TOX	OTE8BL5Z	Limited	Biomarker	[2460]
TP53AIP1	OT1XVNDP	Limited	Altered Expression	[2461]
TP53I11	OTFPDYZU	Limited	Biomarker	[2462]
TP53I13	OTSUH9V8	Limited	Altered Expression	[2463]
TP53INP1	OT2363Z9	Limited	Altered Expression	[2464]
TPD52L2	OTTOG0NK	Limited	Biomarker	[2465]
TPM3	OT5RU5G6	Limited	Biomarker	[2466]
TPR	OTUBBA4W	Limited	Altered Expression	[2467]
TPTE	OT0JNP52	Limited	Genetic Variation	[2468]
TRERF1	OTA7UQF1	Limited	Biomarker	[2469]
TREX1	OTQG7K12	Limited	Biomarker	[2470]
TRIM2	OT0V1YVC	Limited	Biomarker	[2471]
TRIM3	OT704FQ0	Limited	Genetic Variation	[2472]
TRIM35	OTT9V87M	Limited	Biomarker	[2473]
TRIM47	OTM9DGUD	Limited	Altered Expression	[2474]
TRIM52	OTKTKCT1	Limited	Altered Expression	[2475]
TRIM69	OTTEGTRD	Limited	Biomarker	[2476]
TSC22D3	OT03UM03	Limited	Altered Expression	[2477]
TSHB	OTFDI39D	Limited	Biomarker	[2478]
TSHZ1	OTYQ9ECW	Limited	Biomarker	[2479]
TSR2	OTSIWJQJ	Limited	Biomarker	[2480]
ACOX1	OTM0A0DY	Disputed	Biomarker	[2481]
ACP1	OTJ9CKLU	Disputed	Biomarker	[2482]
ADGRG2	OTPAD5S1	Disputed	Biomarker	[2483]
ADO	OTRLGQ7V	Disputed	Biomarker	[2484]
ALLC	OTZE4XV7	Disputed	Biomarker	[2485]
AMOTL1	OT40G45S	Disputed	Altered Expression	[2486]
ARHGAP15	OT9CKHDC	Disputed	Biomarker	[2487]
ARHGAP5	OTOQELUN	Disputed	Altered Expression	[2488]
ARL15	OT00YSWZ	Disputed	Biomarker	[2489]
B3GNT3	OTVT1Q25	Disputed	Altered Expression	[2490]
BCR	OTCN76C1	Disputed	Biomarker	[2491]
BLVRB	OTHCFN2C	Disputed	Genetic Variation	[2492]
BMP5	OTC0Y6E0	Disputed	Biomarker	[2493]
BOP1	OTMZMQDO	Disputed	Altered Expression	[2494]
BRF1	OTQC6DMG	Disputed	Biomarker	[2495]
BUD31	OTN3HZYF	Disputed	Biomarker	[2496]
C17orf49	OTKPULAA	Disputed	Biomarker	[2497]
C19orf33	OTOYH74A	Disputed	Altered Expression	[2498]
CAND1	OTGB6NU0	Disputed	Biomarker	[2499]
CARF	OTWE0T6Q	Disputed	Genetic Variation	[2500]
CCL16	OTOOQI1F	Disputed	Genetic Variation	[2501]
CDC14B	OTAESVOZ	Disputed	Biomarker	[2502]
CDC34	OTNBK390	Disputed	Altered Expression	[2503]
CHD4	OTBDEHDP	Disputed	Altered Expression	[2504]
CNN2	OTH3CSXA	Disputed	Altered Expression	[2505]
COPS3	OTZWPJ24	Disputed	Biomarker	[2506]
CREB5	OTJDUJPI	Disputed	Altered Expression	[2507]
CRISP2	OT8HLTV5	Disputed	Biomarker	[2508]
CRTAM	OTXNF0NQ	Disputed	Biomarker	[2509]
DDX43	OTK1RYSK	Disputed	Biomarker	[2510]
DHX40	OTOL02QN	Disputed	Biomarker	[2511]
DMAP1	OT1ZMQTU	Disputed	Biomarker	[2512]
DNAAF3	OT3OHO0O	Disputed	Biomarker	[2513]
DNAH5	OTC21RUS	Disputed	Biomarker	[2513]
DOK7	OTR2V7HO	Disputed	Altered Expression	[2514]
DR1	OTR081M4	Disputed	Biomarker	[2515]
DUS2	OTVBE313	Disputed	Altered Expression	[2516]
EHF	OTY6TPWD	Disputed	Biomarker	[2517]
ELL2	OTZJRTFM	Disputed	Altered Expression	[2518]
EPM2A	OTJU4IAG	Disputed	Biomarker	[2519]
EYA3	OTHLP1J3	Disputed	Biomarker	[2520]
FAM13A	OTZ6GN0Q	Disputed	Altered Expression	[2521]
FAM163A	OT0MYZ0F	Disputed	Altered Expression	[2522]
FAM20C	OTW5YZ7X	Disputed	Biomarker	[2523]
FOXB2	OTJE3RRR	Disputed	Biomarker	[2524]
GALNT12	OTVIBUST	Disputed	Genetic Variation	[2525]
GDPD3	OTOHM9QM	Disputed	Biomarker	[2526]
GEMIN5	OTSF03K2	Disputed	Altered Expression	[2527]
GIMAP8	OT6P54HC	Disputed	Altered Expression	[2528]
GNA13	OTVDL515	Disputed	Altered Expression	[2529]
GNB3	OTA6HYBA	Disputed	Genetic Variation	[2530]
GPM6B	OT8Q1582	Disputed	Altered Expression	[2531]
GREM2	OTE91EWT	Disputed	Genetic Variation	[2532]
GTSF1	OTV7PQJF	Disputed	Biomarker	[2533]
H1-0	OTRLJK4Z	Disputed	Biomarker	[2534]
H6PD	OTO7TNDD	Disputed	Altered Expression	[2535]
HEMGN	OTZPYUOY	Disputed	Biomarker	[2536]
HOXD13	OTWSC8TF	Disputed	Biomarker	[2537]
HSD17B8	OTX1DWEF	Disputed	Altered Expression	[2538]
HSPA14	OTZCA5LK	Disputed	Biomarker	[272]
IFIT2	OTI4EOAR	Disputed	Altered Expression	[2539]
IFNA4	OTII5O0G	Disputed	Altered Expression	[2540]
IGLL1	OTRTNVOG	Disputed	Altered Expression	[1667]
IRX2	OTBHXXQ2	Disputed	Altered Expression	[2541]
KIR2DS4	OT00N6UJ	Disputed	Biomarker	[2542]
LRFN4	OT7RWBKE	Disputed	Altered Expression	[2543]
LRRN1	OT6MMO6L	Disputed	Altered Expression	[2544]
MAD2L2	OT24ZO59	Disputed	Biomarker	[2545]
MAP2K4	OTZPZX11	Disputed	Altered Expression	[2546]
MDC1	OTEUQH4J	Disputed	Biomarker	[2547]
MEF2B	OT880SE6	Disputed	Altered Expression	[2548]
MEF2C	OTZGF1Y5	Disputed	Altered Expression	[1017]
MKKS	OTLF5T11	Disputed	Genetic Variation	[1359]
MMP24	OTF8T3JM	Disputed	Biomarker	[2549]
MMP27	OTLYV27W	Disputed	Altered Expression	[2550]
MNX1	OTXP9FH1	Disputed	Biomarker	[2551]
MORC2	OT52A8BJ	Disputed	Biomarker	[2552]
MOSPD3	OTV3J7WF	Disputed	Biomarker	[2553]
MPI	OTBH6ZK1	Disputed	Biomarker	[2554]
MRPL48	OTVAELNS	Disputed	Biomarker	[2555]
MRPS30	OTDXIAGG	Disputed	Biomarker	[1196]
MS4A12	OTUCF3GW	Disputed	Altered Expression	[2556]
MSMP	OT20VCWP	Disputed	Biomarker	[2557]
MYCBPAP	OT3W21WR	Disputed	Altered Expression	[2558]
MYH14	OT1TZEJK	Disputed	Biomarker	[2559]
MYO1F	OTOAV4AR	Disputed	Biomarker	[2560]
NAA50	OTFJ8S47	Disputed	Altered Expression	[2561]
ND4L	OTTMZA4Q	Disputed	Genetic Variation	[2562]
NFIX	OT1DPZAE	Disputed	Altered Expression	[2563]
NIBAN2	OTVDQSPI	Disputed	Altered Expression	[2564]
NPS	OTEG25A2	Disputed	Biomarker	[2565]
NRCAM	OT80HHQ2	Disputed	Biomarker	[2566]
NRGN	OTVGE10W	Disputed	Altered Expression	[2567]
ONECUT2	OTHUE5YY	Disputed	Altered Expression	[2568]
PCBD1	OTDSRUD5	Disputed	Biomarker	[2513]
PCDH8	OTDDOQM2	Disputed	Biomarker	[2569]
PCDHGA3	OTTOGYJA	Disputed	Altered Expression	[2570]
PCGF1	OTHOU68T	Disputed	Biomarker	[2571]
PDAP1	OTJSWMOD	Disputed	Biomarker	[1196]
PDCD10	OTCHJTSF	Disputed	Altered Expression	[2572]
PFKFB4	OTQYEXL2	Disputed	Altered Expression	[2573]
PIK3AP1	OTMW1B47	Disputed	Biomarker	[2574]
PLEK2	OTUBWUUK	Disputed	Altered Expression	[2575]
PLEKHG2	OTMGR6I6	Disputed	Altered Expression	[2576]
PLET1	OTUXMPIH	Disputed	Biomarker	[2577]
PLXNA2	OTNNBJMQ	Disputed	Biomarker	[2578]
POLR3E	OT69PWBM	Disputed	Biomarker	[2579]
PPP2CB	OT24GMCM	Disputed	Biomarker	[2580]
PRR15	OTJHSY8G	Disputed	Altered Expression	[2581]
PRSS55	OTXXWI5Y	Disputed	Biomarker	[2508]
PSMA6	OTJ6RPX5	Disputed	Biomarker	[2582]
RABEP2	OTO61X27	Disputed	Biomarker	[2583]
RAD18	OTQ9PLNT	Disputed	Biomarker	[2584]
RNF167	OTNNKBYS	Disputed	Biomarker	[2585]
ROPN1	OTPXKZTX	Disputed	Altered Expression	[2586]
RPS14	OTB90KV5	Disputed	Biomarker	[2587]
RPS4X	OTIH80EK	Disputed	Altered Expression	[2588]
RUSC1	OTYB8ZMT	Disputed	Altered Expression	[2589]
SAFB	OTGRV2LW	Disputed	Biomarker	[2360]
SCAMP1	OTFS4IKJ	Disputed	Altered Expression	[2590]
SERTAD3	OTQP9BWM	Disputed	Biomarker	[2591]
SHARPIN	OTU1J2KH	Disputed	Biomarker	[2592]
SHC1	OT1J5IRN	Disputed	Genetic Variation	[2593]
SHROOM3	OTQKC5X2	Disputed	Biomarker	[2216]
SIGLEC9	OTZC7SIM	Disputed	Biomarker	[2594]
SLIRP	OT2M7VH6	Disputed	Altered Expression	[2595]
SNPH	OTL6XBFA	Disputed	Biomarker	[2596]
SON	OT9VWV18	Disputed	Biomarker	[2597]
SPINK1	OTSUVAL2	Disputed	Biomarker	[2598]
SPRED2	OTUX685J	Disputed	Altered Expression	[2599]
SPZ1	OTQH8HJ5	Disputed	Biomarker	[2508]
SRI	OT4R3EAC	Disputed	Altered Expression	[2600]
SRPX	OT5B9LXS	Disputed	Altered Expression	[2601]
SRPX2	OT6A63TX	Disputed	Altered Expression	[2602]
STK40	OT4R325X	Disputed	Biomarker	[2603]
SYNE2	OTBUXGQ0	Disputed	Altered Expression	[2604]
TAS2R14	OTWA9CYC	Disputed	Altered Expression	[2605]
TCF25	OTTFHHU9	Disputed	Biomarker	[2606]
TEX14	OTBL9LPZ	Disputed	Altered Expression	[2607]
TFAP4	OT1KQIUX	Disputed	Biomarker	[2608]
TGIF2	OTMKKE3W	Disputed	Altered Expression	[2507]
TMEM88	OTA96YEL	Disputed	Biomarker	[2609]
TNFSF18	OT3ANRX1	Disputed	Biomarker	[2610]
TOM1L2	OTUXXUH8	Disputed	Biomarker	[2611]
TRIM22	OTJBLG5R	Disputed	Biomarker	[2612]
TSPAN4	OTKFK57F	Disputed	Biomarker	[2613]
TSPAN8	OT1F68WQ	Disputed	Biomarker	[2614]
ABI1	OT5H4M62	moderate	Biomarker	[2615]
ACADS	OTGFANYQ	moderate	Posttranslational Modification	[2616]
ADAM29	OTGLTTKU	moderate	Altered Expression	[2617]
ADGRB3	OT1EWGRW	moderate	Biomarker	[2618]
AGFG1	OTI8ZKC4	moderate	Biomarker	[1955]
AIRE	OTA7G1Y1	moderate	Biomarker	[2619]
AKAP3	OT42QOFG	moderate	Altered Expression	[2620]
ALDH18A1	OT6W40XU	moderate	Biomarker	[2621]
ALDOB	OT7FR69A	moderate	Biomarker	[2622]
ALPG	OTCIM29R	moderate	Biomarker	[2623]
ANAPC10	OTM03SME	moderate	Altered Expression	[2624]
ANKRD11	OTV0V70M	moderate	Biomarker	[2625]
ANKRD12	OTK16BL9	moderate	Biomarker	[2625]
ANLN	OTXJY54C	moderate	Altered Expression	[2626]
AP2B1	OTL6LZJ4	moderate	Biomarker	[2627]
APLP2	OTTFE53M	moderate	Altered Expression	[2628]
APOBEC3H	OTXIH4X4	moderate	Genetic Variation	[2629]
ARHGAP35	OTJ8POG0	moderate	Genetic Variation	[2630]
ARMCX1	OTOGL58Z	moderate	Altered Expression	[2631]
ARPC1B	OTYE3DN2	moderate	Altered Expression	[2632]
ARRDC1	OTMCTFHC	moderate	Biomarker	[1822]
ART1	OT7FBG5W	moderate	Biomarker	[2633]
ATAD3B	OTL508AF	moderate	Biomarker	[2634]
ATP5F1E	OTMPLAIS	moderate	Biomarker	[2635]
ATP6V0C	OTKPL09B	moderate	Biomarker	[2636]
B3GALNT1	OT8GFSQL	moderate	Altered Expression	[2637]
B3GAT1	OTXFP98E	moderate	Altered Expression	[2638]
B4GALNT1	OTCY80HS	moderate	Altered Expression	[2639]
BAG3	OTVXYUDQ	moderate	Biomarker	[2640]
BCS1L	OT5PY5CY	moderate	Altered Expression	[2641]
BDH1	OT62RL5P	moderate	Altered Expression	[2642]
BFSP1	OTXZ3YIU	moderate	Biomarker	[2643]
BFSP2	OT3QREFR	moderate	Biomarker	[2643]
BMP8B	OTJC3AB9	moderate	Biomarker	[2644]
BNC2	OTU22H9Z	moderate	Biomarker	[2645]
BRI3BP	OTWCFPRM	moderate	Altered Expression	[2140]
BRMS1L	OTJIW47U	moderate	Altered Expression	[2646]
BZW2	OTBT0A1B	moderate	Altered Expression	[2647]
CA8	OT9Y8GA8	moderate	Altered Expression	[2648]
CAB39L	OTQEBL0W	moderate	Biomarker	[2649]
CAPN6	OT8K5PR5	moderate	Biomarker	[2650]
CAPS	OTC9GZ2M	moderate	Biomarker	[2651]
CARTPT	OTTE4V9S	moderate	Biomarker	[2652]
CAVIN4	OTB1DM2C	moderate	Altered Expression	[2653]
CD109	OTDADBM4	moderate	Biomarker	[2654]
CD177	OTS79FNF	moderate	Biomarker	[2655]
CD1C	OT4XINUJ	moderate	Biomarker	[2656]
CDC27	OTDT45XJ	moderate	Altered Expression	[2657]
CDC6	OTX93FE7	moderate	Biomarker	[2658]
CENPJ	OTZCQZN5	moderate	Altered Expression	[2659]
CFAP100	OTHHFM2Z	moderate	Posttranslational Modification	[2660]
CHAD	OT7PF813	moderate	Altered Expression	[2661]
CHAF1B	OTOMK4KH	moderate	Biomarker	[2662]
CIZ1	OT3UKHPI	moderate	Biomarker	[2663]
CKB	OTUCKOTT	moderate	Altered Expression	[2664]
CLEC11A	OT9KBH7C	moderate	Biomarker	[2665]
CLPTM1	OT14QP7N	moderate	Biomarker	[2666]
CLTA	OTLHOXMQ	moderate	Biomarker	[320]
CLTCL1	OT6W5BNR	moderate	Biomarker	[2667]
CMTM2	OTSJISGF	moderate	Biomarker	[2668]
CNKSR1	OTSNAEQ9	moderate	Biomarker	[2276]
CNOT8	OT6CMCS0	moderate	Biomarker	[2669]
CNOT9	OT1NIIQD	moderate	Biomarker	[2670]
CNTN4	OTULXVE0	moderate	Biomarker	[2671]
CNTRL	OTQI3VBA	moderate	Biomarker	[2672]
COL5A1	OT24078H	moderate	Altered Expression	[2673]
COL5A2	OT5VOSQE	moderate	Altered Expression	[2674]
COL9A3	OTCUJOEK	moderate	Biomarker	[1234]
COPS6	OTG9AAG0	moderate	Biomarker	[2675]
CPSF2	OTU6QXZE	moderate	Genetic Variation	[2676]
CREB3L2	OT09MHV0	moderate	Altered Expression	[2677]
CWC22	OT22MEO6	moderate	Biomarker	[2678]
CXCL16	OTD49T9R	moderate	Altered Expression	[2679]
CXCL6	OTFTCQ4O	moderate	Biomarker	[2680]
CYB5R2	OTTLM7XN	moderate	Posttranslational Modification	[2681]
CYFIP1	OTOBEH24	moderate	Biomarker	[2682]
CYP2A7	OTRJ3P2Z	moderate	Biomarker	[2683]
DBN1	OTZVKG8A	moderate	Altered Expression	[2684]
DCUN1D1	OT8UJLZU	moderate	Altered Expression	[2685]
DEDD	OTIL349E	moderate	Biomarker	[2686]
DEFB1	OT5SV0E4	moderate	Biomarker	[2687]
DHRS4	OTTPOIOP	moderate	Biomarker	[2688]
DHX15	OT4F98TK	moderate	Altered Expression	[2689]
DLG5	OTU9Z17K	moderate	Biomarker	[2690]
DNAAF4	OTVDYBJE	moderate	Altered Expression	[2691]
DOCK3	OTF3YS2W	moderate	Biomarker	[2692]
DOCK4	OTH3XY8B	moderate	Biomarker	[2693]
DOCK5	OT63I0CL	moderate	Genetic Variation	[2694]
DPAGT1	OTYEJAGZ	moderate	Altered Expression	[2695]
DRAM1	OTIJTXEN	moderate	Biomarker	[2696]
DTX1	OTYX91DX	moderate	Altered Expression	[2697]
ECEL1	OTJ6GNUP	moderate	Altered Expression	[2698]
EFEMP1	OTZVUOOB	moderate	Altered Expression	[2699]
EFNA2	OTEAUKRX	moderate	Altered Expression	[2700]
EFNA3	OTJGOUMZ	moderate	Biomarker	[2701]
EHD1	OTDMEKLV	moderate	Biomarker	[2702]
EIF2B5	OTV3R4RB	moderate	Biomarker	[2703]
EIF3B	OTF67VPH	moderate	Biomarker	[2704]
EIF4E3	OTTWVS2R	moderate	Altered Expression	[2705]
ELAC2	OTY3BOF6	moderate	Altered Expression	[2706]
EMC6	OT9IHH51	moderate	Biomarker	[2707]
EML2	OTRX2NTA	moderate	Biomarker	[2708]
EML5	OT0EFCPB	moderate	Biomarker	[2708]
EMSY	OTBQ3KQE	moderate	Biomarker	[2709]
EN2	OT7EZCM2	moderate	Biomarker	[2710]
ENDOU	OTB7OF7Y	moderate	Biomarker	[2363]
ENTPD2	OTZ2PKPM	moderate	Biomarker	[2711]
EPB41	OTGCFPV8	moderate	Biomarker	[2712]
ERCC3	OTVAW3P1	moderate	Altered Expression	[2713]
EXOC4	OT5EWXAN	moderate	Altered Expression	[2714]
EXOSC3	OTNCF906	moderate	Altered Expression	[2715]
EXOSC5	OTADUQ7H	moderate	Biomarker	[2716]
EXOSC6	OTAC10N6	moderate	Biomarker	[2363]
EXT2	OT8IR5QN	moderate	Genetic Variation	[2717]
EXTL1	OTMSNY9N	moderate	Genetic Variation	[2718]
FAM171A1	OT33BHEP	moderate	Biomarker	[2719]
FAM83F	OTGGJRO7	moderate	Altered Expression	[2720]
FKBP14	OT55W5WC	moderate	Biomarker	[2721]
FNIP1	OTB1CC41	moderate	Biomarker	[2722]
FNIP2	OT7EX8JJ	moderate	Biomarker	[2722]
FOXI1	OT2UFOE2	moderate	Biomarker	[2723]
FOXK2	OTFXDZ3R	moderate	Biomarker	[2724]
FTCD	OTX9HZT5	moderate	Altered Expression	[2725]
FZD5	OTXFFY56	moderate	Biomarker	[2726]
FZD6	OTBCPII8	moderate	Biomarker	[2727]
G3BP2	OTAWW3KI	moderate	Biomarker	[2728]
GAB1	OTQKE6V4	moderate	Biomarker	[1118]
GABPB1	OTEXDEJN	moderate	Altered Expression	[2729]
GALNT2	OTZZ5386	moderate	Biomarker	[2730]
GBX2	OTW0ZI4D	moderate	Biomarker	[2731]
GCHFR	OTEOT8GI	moderate	Biomarker	[127]
GDPD5	OTUM65JL	moderate	Altered Expression	[2732]
GFPT1	OTQBDO45	moderate	Altered Expression	[2733]
GINS1	OTVQZMMQ	moderate	Biomarker	[2734]
GNA14	OTYZ1ZI0	moderate	Genetic Variation	[2735]
GNAT1	OTK2SNJA	moderate	Biomarker	[2736]
GPAA1	OTWVRR35	moderate	Altered Expression	[1489]
GPC2	OT3WSQE1	moderate	Biomarker	[2737]
GPLD1	OTUUQOVY	moderate	Biomarker	[1131]
GPT2	OTS5VF7N	moderate	Altered Expression	[2738]
GPX2	OTXI2NTI	moderate	Altered Expression	[2739]
GRAMD1B	OTCG1GX2	moderate	Altered Expression	[2740]
GRK6	OT4LZTP9	moderate	Biomarker	[2741]
GTF2H2	OTK72L9I	moderate	Altered Expression	[2713]
HAND1	OTN4IPVV	moderate	Biomarker	[2742]
HASPIN	OTI0SMF2	moderate	Altered Expression	[2743]
HEATR6	OTD3MYS0	moderate	Biomarker	[2744]
HERC5	OTZ5PR39	moderate	Biomarker	[1874]
HIPK1	OTSEA8RS	moderate	Biomarker	[2745]
HJURP	OTWMV16B	moderate	Altered Expression	[2746]
HLA-DRB4	OTNXIHQU	moderate	Biomarker	[2747]
HMG20B	OTY94WRA	moderate	Biomarker	[2748]
HMGCL	OTRO9RII	moderate	Genetic Variation	[2749]
HMGN2	OTN20MEF	moderate	Biomarker	[2750]
HNF4G	OTTSIHJP	moderate	Altered Expression	[2751]
HOXB5	OTU74TB8	moderate	Biomarker	[2752]
HP1BP3	OTTJ5LX2	moderate	Biomarker	[2753]
IL17C	OTKXIVNQ	moderate	Biomarker	[2754]
IL17RC	OTEFOBSS	moderate	Biomarker	[2577]
ILF2	OTWWVM9X	moderate	Altered Expression	[2755]
ILRUN	OTE8FHQD	moderate	Biomarker	[2756]
INA	OT1D33T4	moderate	Altered Expression	[2757]
INTS1	OT7TY1M1	moderate	Altered Expression	[2758]
ITGA2B	OT4Y17PY	moderate	Biomarker	[2759]
JMJD6	OTILR7E4	moderate	Biomarker	[2760]
KCTD10	OT5HFZXU	moderate	Biomarker	[2761]
KCTD16	OTGSOX3C	moderate	Biomarker	[2762]
KLHDC7B	OT2H5BNX	moderate	Altered Expression	[2763]
KRT6B	OTBXJYHY	moderate	Altered Expression	[2764]
LAMA2	OTFROQWE	moderate	Posttranslational Modification	[2765]
LARP7	OTLLOZTL	moderate	Biomarker	[2766]
LBR	OT1HG3HG	moderate	Biomarker	[2767]
LIMD2	OTSIFTD8	moderate	Biomarker	[2768]
LMX1A	OTEEYD5L	moderate	Altered Expression	[2769]
LPCAT1	OTCV7AGV	moderate	Biomarker	[2770]
LPIN2	OTRRTMXX	moderate	Biomarker	[2771]
LPP	OT6TU8SE	moderate	Altered Expression	[2772]
LRATD2	OTEZBUUL	moderate	Altered Expression	[2773]
LRRC26	OTXEFL76	moderate	Biomarker	[2774]
LRRC4	OT7XJ70N	moderate	Biomarker	[2775]
LRWD1	OTHRVJQC	moderate	Biomarker	[2776]
LSP1	OTSPSIFO	moderate	Biomarker	[2777]
MAL2	OTVPEI80	moderate	Biomarker	[2778]
MAPK6	OTDDNF3Q	moderate	Biomarker	[338]
MARCHF5	OTBK6BBM	moderate	Altered Expression	[2779]
MBD3	OTRL76H5	moderate	Posttranslational Modification	[2780]
MCF2	OTB9N93T	moderate	Altered Expression	[2781]
MCM8	OTC93H3S	moderate	Altered Expression	[2782]
MCPH1	OTYT3TT5	moderate	Altered Expression	[2783]
MED13	OTP5LEJE	moderate	Altered Expression	[2784]
MEGF9	OTDQWTY4	moderate	Altered Expression	[2785]
MEX3C	OT8AJG1I	moderate	Biomarker	[2786]
MFSD2A	OTVG1VG0	moderate	Biomarker	[2787]
MICAL3	OTD229X7	moderate	Altered Expression	[2788]
MIEN1	OTCQ8DAD	moderate	Altered Expression	[2789]
MINDY3	OT6YZPWC	moderate	Altered Expression	[2648]
MINK1	OTKB0RA8	moderate	Biomarker	[2790]
MIPOL1	OTLPN3D0	moderate	Biomarker	[2791]
MLH3	OT91PPBI	moderate	Genetic Variation	[2792]
MLLT10	OTURMDV7	moderate	Biomarker	[2793]
MPZ	OTAR2YXH	moderate	Biomarker	[311]
MPZL1	OTJSUUHR	moderate	Altered Expression	[2794]
MRI1	OTOP49DM	moderate	Genetic Variation	[1951]
MRPL58	OTPTWLZY	moderate	Altered Expression	[2795]
MTFMT	OT1OIVJL	moderate	Biomarker	[2796]
MTHFD2	OT1LQSGX	moderate	Altered Expression	[2797]
MTMR3	OTBIT23O	moderate	Biomarker	[342]
MYL12B	OTXMLQOT	moderate	Biomarker	[2798]
MYO5A	OTMWLP3E	moderate	Altered Expression	[2799]
NAA80	OTLWR71Z	moderate	Biomarker	[2800]
NACA	OTLP1KR3	moderate	Altered Expression	[2801]
NANOS2	OTFM2IDJ	moderate	Genetic Variation	[2802]
NCKAP1	OTEZQXXJ	moderate	Biomarker	[2803]
NEIL3	OTBCI2NS	moderate	Altered Expression	[2804]
NELFB	OTCFH88S	moderate	Altered Expression	[2805]
NETO2	OT0YAMC0	moderate	Altered Expression	[2806]
NIPSNAP1	OTKXKUT8	moderate	Biomarker	[2771]
NLN	OTFRITPU	moderate	Biomarker	[2807]
NMBR	OTBJEGPN	moderate	Biomarker	[2808]
NOVA1	OT6A9KHY	moderate	Altered Expression	[2809]
NR2F1	OTGWZWYL	moderate	Biomarker	[2810]
NSD2	OTQ6SW4R	moderate	Altered Expression	[2811]
NSMAF	OTYNVZ23	moderate	Biomarker	[2672]
NTM	OTHF0UQU	moderate	Biomarker	[2812]
ODAM	OTT666SJ	moderate	Altered Expression	[2813]
OPN4	OT1LZ7TS	moderate	Biomarker	[2807]
OPRPN	OT6K1ZD6	moderate	Biomarker	[2814]
ORMDL3	OTAB7MZF	moderate	Genetic Variation	[2815]
OSBPL8	OTD50E5Y	moderate	Altered Expression	[2816]
OTP	OTS0JN6Y	moderate	Biomarker	[2817]
OTUD5	OTMCR6JM	moderate	Biomarker	[2818]
PARN	OTTG4PE3	moderate	Biomarker	[2819]
PARP14	OTFXJAKK	moderate	Biomarker	[2820]
PCDH9	OTX3BFV4	moderate	Biomarker	[2821]
PCDHA4	OTJH4515	moderate	Biomarker	[2822]
PCDHGB6	OT1Y20JS	moderate	Genetic Variation	[2823]
PEBP4	OTKDCVC6	moderate	Altered Expression	[2824]
PELI1	OTMLBCLC	moderate	Biomarker	[2825]
PENK	OT8P3HMP	moderate	Altered Expression	[2826]
PEX14	OT98BZHE	moderate	Biomarker	[2827]
PHF13	OT89FV4A	moderate	Biomarker	[2828]
PHLDA2	OTMV9DPP	moderate	Biomarker	[2829]
PICK1	OT8QE6EU	moderate	Altered Expression	[2830]
PLCD1	OT6WFVXZ	moderate	Biomarker	[2831]
PLEKHG5	OTL0S21W	moderate	Biomarker	[2832]
PMP22	OTXWYWCZ	moderate	Biomarker	[311]
POLR2A	OTHJQ1DZ	moderate	Altered Expression	[2833]
POLR3G	OTU3TGQ9	moderate	Altered Expression	[2834]
POTEF	OTV3WXYE	moderate	Altered Expression	[2835]
POU2F3	OTIOOJWD	moderate	Altered Expression	[2836]
POU3F3	OT6BBXPD	moderate	Altered Expression	[2837]
PPA1	OTHZK1QB	moderate	Biomarker	[2838]
PPP1CB	OTYFTYFR	moderate	Biomarker	[2839]
PPP1R3B	OTVCRXEZ	moderate	Biomarker	[2840]
PPP1R9B	OTDCTHTT	moderate	Biomarker	[2841]
PRDM13	OTUNAFQW	moderate	Biomarker	[2842]
PRDM5	OTU1GB68	moderate	Posttranslational Modification	[2843]
PRELP	OT9EEBUJ	moderate	Altered Expression	[2844]
PRICKLE1	OT9HHEM9	moderate	Altered Expression	[2845]
PROK1	OT8S7RUG	moderate	Biomarker	[2846]
PRSS27	OTC4G4UF	moderate	Genetic Variation	[2847]
PSD3	OTTN9B9O	moderate	Altered Expression	[2848]
PSMA7	OTPHI6ST	moderate	Biomarker	[2849]
PTPN23	OT5WDPXB	moderate	Biomarker	[2850]
PTS	OTTYWQXR	moderate	Biomarker	[2851]
PWP1	OTUKXP1E	moderate	Altered Expression	[2713]
RAB17	OT7NBUGQ	moderate	Biomarker	[2852]
RAB18	OTNMAQLS	moderate	Biomarker	[2853]
RAB1B	OTAFCUAS	moderate	Biomarker	[2854]
RAB25	OTW0W6NP	moderate	Biomarker	[2855]
RAB32	OTTR4H7S	moderate	Biomarker	[2856]
RAB38	OTU0NZU0	moderate	Biomarker	[2857]
RAD9A	OTJ3AJQU	moderate	Biomarker	[2858]
RAE1	OT54OKC3	moderate	Biomarker	[2336]
RAMP3	OTX6XLLM	moderate	Biomarker	[2859]
RANBP9	OTM8COM5	moderate	Biomarker	[2860]
RASD1	OT2BAJHK	moderate	Biomarker	[2861]
RBP2	OTR8QG5V	moderate	Altered Expression	[2862]
RBP7	OT0J3CPT	moderate	Biomarker	[2863]
RCBTB1	OTAYELI8	moderate	Biomarker	[682]
REC8	OT6JAVXE	moderate	Altered Expression	[2864]
RECQL	OTPCH3JH	moderate	Altered Expression	[2865]
RER1	OTTBAUBP	moderate	Biomarker	[2866]
RETN	OTW5Z1NH	moderate	Altered Expression	[2867]
RFC2	OTJ9N6BD	moderate	Altered Expression	[2868]
RFC3	OT1MS7AO	moderate	Altered Expression	[2869]
RFX5	OT73KJ5P	moderate	Biomarker	[2870]
RGS17	OT5RVUDS	moderate	Biomarker	[2871]
RHOJ	OTWI65OA	moderate	Biomarker	[2872]
RHPN1	OTYZ1NV8	moderate	Altered Expression	[2873]
RNF125	OTBD1Q3X	moderate	Altered Expression	[2874]
RPL28	OTEVRCBO	moderate	Altered Expression	[2875]
RPL41	OTFW5IFO	moderate	Biomarker	[2876]
RPS11	OTILZE44	moderate	Altered Expression	[2877]
RTL10	OTHGB81W	moderate	Biomarker	[2878]
RTN4IP1	OTHUZANE	moderate	Altered Expression	[2879]
RUNDC3B	OT8ZPQLC	moderate	Biomarker	[2880]
RYR2	OT0PF19E	moderate	Altered Expression	[2881]
SCAMP3	OTUNPYCE	moderate	Altered Expression	[2882]
SCTR	OTC80IMR	moderate	Altered Expression	[2883]
SELENOW	OTVSKPAN	moderate	Biomarker	[2884]
SENP3	OTFQDOMC	moderate	Biomarker	[2885]
SEPTIN2	OT3G33TM	moderate	Biomarker	[1238]
SERPINA7	OTUYVTSU	moderate	Biomarker	[2886]
SERPINB4	OT88LHZ8	moderate	Biomarker	[1240]
SERPINF2	OTZGAF8B	moderate	Biomarker	[2887]
SGPP2	OTIDIJCR	moderate	Biomarker	[2888]
SGTA	OTKOJ3JB	moderate	Biomarker	[2889]
SH3BP2	OT90JNBS	moderate	Biomarker	[2890]
SIGLEC1	OTNWSQA9	moderate	Altered Expression	[2891]
SIX4	OTG2HFH0	moderate	Biomarker	[2892]
SKA3	OTLHEVJD	moderate	Biomarker	[2893]
SKI	OT4KJ8F6	moderate	Biomarker	[2894]
SMC3	OTWGFRHD	moderate	Genetic Variation	[2895]
SNRNP25	OT2MR6O2	moderate	Biomarker	[328]
SNRPA	OT02TSQT	moderate	Altered Expression	[2896]
SNX5	OT6ZOWMU	moderate	Biomarker	[2897]
SPTLC1	OTN0Z98K	moderate	Biomarker	[2898]
SRARP	OTR3TNTJ	moderate	Altered Expression	[2899]
ST3GAL4	OTNENJZQ	moderate	Biomarker	[2900]
STK25	OT4YPNTF	moderate	Altered Expression	[2901]
STK31	OT3ZLRH0	moderate	Biomarker	[2902]
STRN4	OTHK2ZN6	moderate	Biomarker	[2790]
SUV39H2	OTU0F4LL	moderate	Biomarker	[2903]
TARBP2	OT1QQ8H3	moderate	Biomarker	[1584]
TCEAL9	OT4UHDB5	moderate	Biomarker	[2904]
TCHHL1	OTAMOJGN	moderate	Altered Expression	[2905]
TENM3	OTWY13GR	moderate	Genetic Variation	[2906]
TENT5C	OTOWVQ4O	moderate	Biomarker	[2907]
TEX101	OTNO747E	moderate	Biomarker	[452]
TFCP2L1	OT7QIJ0X	moderate	Altered Expression	[2908]
TIMD4	OTGGC20G	moderate	Biomarker	[2909]
TIMM50	OTWJNUQL	moderate	Biomarker	[2910]
TIMM9	OTK7PDNN	moderate	Altered Expression	[2911]
TIPIN	OT9PZHXV	moderate	Biomarker	[2912]
TLE5	OTEH0BFG	moderate	Biomarker	[2913]
TLNRD1	OTNOLROI	moderate	Biomarker	[2914]
TMBIM4	OT8712PP	moderate	Altered Expression	[2915]
TMEM45B	OTVQCO8N	moderate	Altered Expression	[2916]
TMOD1	OTTRYF9Y	moderate	Biomarker	[2917]
TOPAZ1	OTJ7NW4W	moderate	Posttranslational Modification	[2918]
TPD52	OTPKSK43	moderate	Biomarker	[2919]
TPST1	OTDPQKEA	moderate	Altered Expression	[2920]
TRIM23	OTVIGJ4T	moderate	Altered Expression	[2921]
TRIM26	OTS0DJIP	moderate	Biomarker	[2922]
TRIM56	OTFGU8E3	moderate	Biomarker	[2923]
TRIO	OT71X1AK	moderate	Altered Expression	[2110]
TSEN54	OT7MR9LY	moderate	Biomarker	[2924]
TSGA10	OTIF1O1T	moderate	Altered Expression	[2925]
A1CF	OTJBKFA1	Strong	Biomarker	[2926]
A2ML1	OTWNUXIS	Strong	Genetic Variation	[2927]
AADAC	OT8VACT2	Strong	Altered Expression	[2928]
AANAT	OTUBJ7SX	Strong	Altered Expression	[2929]
AATF	OT1QOKLD	Strong	Altered Expression	[2930]
ABCE1	OTH19LOA	Strong	Biomarker	[2931]
ABCG4	OT2XJIOG	Strong	Altered Expression	[2932]
ABI3	OTQTDSHP	Strong	Biomarker	[2933]
ABI3BP	OTW8DN50	Strong	Biomarker	[2934]
ACACA	OT5CQPZY	Strong	Biomarker	[2935]
ACADL	OTP7Y0UF	Strong	Altered Expression	[614]
ACAN	OTUOCW8K	Strong	Biomarker	[1600]
ACCS	OTHIHI9D	Strong	Biomarker	[1677]
ACD	OTC54EPO	Strong	Biomarker	[2936]
ACIN1	OTK81F92	Strong	Genetic Variation	[2937]
ACKR2	OTWYY14H	Strong	Biomarker	[2938]
ACO1	OT2VUR7L	Strong	Genetic Variation	[2939]
ACOT7	OT7C68YV	Strong	Altered Expression	[2940]
ACRBP	OT0MK3L1	Strong	Biomarker	[2941]
ACSBG1	OTM040MW	Strong	Genetic Variation	[2942]
ACSL1	OTB06ESI	Strong	Biomarker	[1273]
ACSL4	OTI71MUJ	Strong	Altered Expression	[2943]
ACSL5	OT3L9XO3	Strong	Biomarker	[2944]
ACSS1	OT6C1WQD	Strong	Altered Expression	[2945]
ACSS3	OTWB58F5	Strong	Altered Expression	[2946]
ACTA1	OTOVGLPG	Strong	Altered Expression	[2947]
ACTBL2	OTD6B81U	Strong	Altered Expression	[2940]
ACTG2	OTRDWUO0	Strong	Altered Expression	[2940]
ACTL6A	OT0EC5BQ	Strong	Altered Expression	[2948]
ACTR1B	OTGBCKLO	Strong	Biomarker	[932]
ACTR2	OT3C8U5T	Strong	Altered Expression	[2949]
ACTR3	OT05LJSH	Strong	Biomarker	[2950]
ACY1	OT9WU7X3	Strong	Biomarker	[2951]
ACY3	OTZWAB73	Strong	Altered Expression	[2951]
ACYP2	OTRB4S6X	Strong	Genetic Variation	[2952]
ADA2	OTGCV24S	Strong	Biomarker	[2953]
ADAM23	OTVWT6JZ	Strong	Posttranslational Modification	[2954]
ADAMTS14	OTFJ1PDB	Strong	Biomarker	[2955]
ADAMTS15	OTYB6JS3	Strong	Genetic Variation	[2956]
ADAMTS16	OTTKUH99	Strong	Biomarker	[2957]
ADAMTS2	OTTK22NO	Strong	Biomarker	[707]
ADAMTS20	OTU0EKLN	Strong	Genetic Variation	[2958]
ADAMTS6	OTSZE6L4	Strong	Altered Expression	[2959]
ADAMTS9	OTV3Q0DS	Strong	Biomarker	[2960]
ADAMTSL3	OTMC2WFG	Strong	Altered Expression	[2961]
ADARB1	OTGKSZEV	Strong	Altered Expression	[105]
ADARB2	OTDJKS39	Strong	Biomarker	[2962]
ADCY10	OTYSTB0R	Strong	Genetic Variation	[2963]
ADCY8	OTR1WCZX	Strong	Biomarker	[2964]
ADD1	OTTF68DC	Strong	Biomarker	[2314]
ADGRA2	OTBT4W36	Strong	Biomarker	[2965]
ADGRB1	OTJSEXRC	Strong	Biomarker	[2966]
ADGRE2	OTUYJVYG	Strong	Biomarker	[2967]
ADGRF1	OTRAOBYH	Strong	Altered Expression	[2968]
ADGRF5	OTWU7AOO	Strong	Biomarker	[2969]
ADGRG1	OTQBB8NT	Strong	Biomarker	[2970]
ADGRG6	OTY2UBXO	Strong	Genetic Variation	[2971]
ADGRL4	OTN1GAG7	Strong	Biomarker	[2972]
ADI1	OT8IOD03	Strong	Biomarker	[2973]
ADIPOR2	OT2HDTL8	Strong	Biomarker	[2974]
ADNP	OTEGICWR	Strong	Biomarker	[2975]
ADRM1	OTOU4EY6	Strong	Altered Expression	[2976]
ADSS1	OTF6FE38	Strong	Biomarker	[2977]
AEBP1	OTBI1RZ6	Strong	Altered Expression	[2978]
AFAP1	OTR473H8	Strong	Altered Expression	[2979]
AFAP1L2	OTJBI0VN	Strong	Biomarker	[2980]
AFF1	OTT2C78E	Strong	Biomarker	[2981]
AFF3	OTR0705Z	Strong	Altered Expression	[2982]
AFM	OTPOR8IO	Strong	Biomarker	[2983]
AGAP2	OTEYO9TM	Strong	Biomarker	[2984]
AGBL2	OTCX9987	Strong	Altered Expression	[2985]
AGFG2	OTXQZHCR	Strong	Genetic Variation	[2986]
AGGF1	OTA7U2T8	Strong	Biomarker	[2987]
AGL	OTWBM7WY	Strong	Altered Expression	[2988]
AGO1	OTD3R434	Strong	Altered Expression	[2989]
AGO2	OT4JY32Q	Strong	Biomarker	[2990]
AGPS	OTFBFPV4	Strong	Biomarker	[2991]
AGR3	OTONJPDP	Strong	Altered Expression	[2992]
AHI1	OT8K2YWY	Strong	Biomarker	[2993]
AHNAK	OT6KH1WG	Strong	Biomarker	[2994]
AHRR	OTSJ12W6	Strong	Biomarker	[2995]
AHSA1	OTC7AFHT	Strong	Posttranslational Modification	[404]
AIFM3	OTSWKCAO	Strong	Altered Expression	[2996]
AIM2	OT86QUI8	Strong	Biomarker	[2997]
AIMP1	OTTA5C3U	Strong	Biomarker	[2998]
AK6	OT84OHHP	Strong	Biomarker	[2999]
AKAP1	OTIIB2JB	Strong	Genetic Variation	[3000]
AKAP10	OTPNFTOU	Strong	Biomarker	[3001]
AKAP12	OTCVRDDX	Strong	Biomarker	[3002]
AKAP9	OT7Z2YRP	Strong	Biomarker	[3003]
AKIP1	OT7XPG27	Strong	Altered Expression	[3004]
AKIRIN2	OTQ6WSKW	Strong	Biomarker	[3005]
AKT1S1	OT4JHN4Y	Strong	Biomarker	[3006]
ALDH1A3	OT1C9NKQ	Strong	Posttranslational Modification	[3007]
ALDH1L1	OT15HOJX	Strong	Biomarker	[3008]
ALDH3A1	OTAYZZE6	Strong	Altered Expression	[3009]
ALDOA	OTWRFTIB	Strong	Biomarker	[3010]
ALG3	OTPOL1QW	Strong	Biomarker	[3011]
ALKAL2	OTTLHL64	Strong	Biomarker	[3012]
ALKBH2	OTSQW0BG	Strong	Altered Expression	[3013]
ALKBH3	OTS1CD9Z	Strong	Biomarker	[3014]
ALOX15B	OTWQQ08W	Strong	Biomarker	[3015]
ALPK1	OTBW6SGD	Strong	Altered Expression	[3016]
ALX1	OTZVARA5	Strong	Biomarker	[3017]
ALX3	OTXZ25PZ	Strong	Biomarker	[3018]
ALX4	OTNS9A29	Strong	Biomarker	[3019]
ALYREF	OTOF2ADD	Strong	Biomarker	[3020]
AMBP	OTLU8GU8	Strong	Altered Expression	[3021]
AMBRA1	OTY0YGT9	Strong	Biomarker	[3022]
AMER1	OT8EFJPM	Strong	Genetic Variation	[3023]
AMH	OT5FH4BD	Strong	Biomarker	[3024]
AMIGO2	OTPAIT1O	Strong	Biomarker	[3025]
AMN	OTS1TJXG	Strong	Biomarker	[3026]
AMPD1	OTU17BCI	Strong	Altered Expression	[3027]
AMPD2	OTBS30JU	Strong	Altered Expression	[3027]
AMT	OTQYEWZQ	Strong	Biomarker	[3028]
ANAPC11	OTK2SJXR	Strong	Altered Expression	[3029]
ANAPC2	OTAGLIAO	Strong	Altered Expression	[1605]
ANGPT4	OT881M3K	Strong	Biomarker	[3030]
ANGPTL1	OTXIN6V5	Strong	Altered Expression	[3031]
ANGPTL2	OTB6JG41	Strong	Biomarker	[3032]
ANKHD1	OTVYQ7ZL	Strong	Biomarker	[3033]
ANKLE2	OTHCYR6Y	Strong	Altered Expression	[3034]
ANKRD22	OT6CRQ67	Strong	Altered Expression	[3035]
ANKRD26	OT2ENKKV	Strong	Biomarker	[3036]
ANKRD30A	OTJXYAE5	Strong	Biomarker	[3037]
ANKRD9	OT7VGO6G	Strong	Biomarker	[3038]
ANKS1B	OT26DGM9	Strong	Altered Expression	[3039]
ANKS4B	OT1MREUS	Strong	Biomarker	[3040]
ANO2	OT650E98	Strong	Biomarker	[3041]
ANO5	OTOW8R6H	Strong	Genetic Variation	[3042]
ANOS1	OTZJT4KN	Strong	Genetic Variation	[1359]
ANP32B	OT3SQMLU	Strong	Biomarker	[3043]
ANP32D	OTAGQSQ6	Strong	Biomarker	[3044]
ANP32E	OTTWELUQ	Strong	Biomarker	[3045]
ANXA13	OTM33P73	Strong	Altered Expression	[3046]
ANXA3	OTDD8OI7	Strong	Biomarker	[3047]
ANXA4	OTUCRYXL	Strong	Biomarker	[3048]
ANXA7	OTLMD0TK	Strong	Altered Expression	[3049]
AOPEP	OT0MMANL	Strong	Altered Expression	[3050]
AP1S2	OTZHJFYI	Strong	Altered Expression	[3051]
AP2A1	OTEFZB21	Strong	Altered Expression	[1357]
AP5Z1	OTXIPLFH	Strong	Biomarker	[3052]
APBA1	OTUH9JPD	Strong	Biomarker	[3053]
APBB1IP	OTN02KUV	Strong	Biomarker	[3054]
APBB3	OTNUTR0N	Strong	Altered Expression	[3055]
APELA	OTYY0P69	Strong	Biomarker	[3056]
APH1A	OT97F1TU	Strong	Altered Expression	[3057]
API5	OTYX9YCZ	Strong	Biomarker	[3058]
APIP	OT8ZABOU	Strong	Altered Expression	[3059]
APLP1	OTD176ZS	Strong	Biomarker	[3060]
APOBEC1	OTY8QX2R	Strong	Biomarker	[3061]
APOBEC3A	OTYO6F5P	Strong	Genetic Variation	[3062]
APOC2	OTLINYIQ	Strong	Altered Expression	[1605]
APOM	OTI3FQQC	Strong	Biomarker	[3063]
APPL2	OT9S4C4K	Strong	Biomarker	[3064]
AQP4	OTA9MYD5	Strong	Altered Expression	[3065]
AQP8	OT99JKME	Strong	Biomarker	[3066]
AQR	OTMNDXM1	Strong	Biomarker	[3067]
ARC	OTN2QQPG	Strong	Biomarker	[3068]
ARF3	OTYYQX85	Strong	Biomarker	[2854]
ARF6	OTVV7KJO	Strong	Biomarker	[3069]
ARFGAP1	OTM3KHIE	Strong	Genetic Variation	[3070]
ARFGEF1	OTPAU0L4	Strong	Biomarker	[3071]
ARFGEF3	OTGQV0CU	Strong	Biomarker	[3072]
ARHGAP1	OT0H2ZBZ	Strong	Biomarker	[3073]
ARHGAP10	OT84ATF5	Strong	Biomarker	[3074]
ARHGAP17	OTEABPLV	Strong	Biomarker	[3075]
ARHGAP18	OTYMJP6H	Strong	Altered Expression	[3076]
ARHGAP26	OTNGQU7A	Strong	Biomarker	[3077]
ARHGAP45	OTL86FEQ	Strong	Biomarker	[3078]
ARHGAP6	OTNVXXFX	Strong	Altered Expression	[3079]
ARHGAP9	OTJNHX96	Strong	Altered Expression	[3080]
ARHGDIA	OTEXWJDO	Strong	Altered Expression	[3081]
ARHGDIB	OT9PD6CS	Strong	Biomarker	[3082]
ARHGEF1	OTXU4HBW	Strong	Altered Expression	[3083]
ARHGEF11	OTDOMEH6	Strong	Altered Expression	[3084]
ARHGEF12	OTM2D3LT	Strong	Biomarker	[3085]
ARHGEF26	OTX0U8PX	Strong	Biomarker	[3086]
ARHGEF28	OT3F32IU	Strong	Altered Expression	[3087]
ARHGEF39	OT9UKTQ5	Strong	Altered Expression	[3088]
ARHGEF7	OT9BPJCL	Strong	Biomarker	[3089]
ARID1B	OTILK3Q7	Strong	Biomarker	[3090]
ARID2	OTIRJXWM	Strong	Genetic Variation	[3091]
ARID4A	OT1XKBZ0	Strong	Biomarker	[3092]
ARID4B	OTYLPILE	Strong	Altered Expression	[3093]
ARIH1	OTO3XDR2	Strong	Biomarker	[3094]
ARL11	OTF6UDDB	Strong	Altered Expression	[3095]
ARL13B	OT9PYPV1	Strong	Biomarker	[3096]
ARMC5	OTO7IV74	Strong	Genetic Variation	[3097]
ARMC9	OT0MZER2	Strong	Altered Expression	[3098]
ARNT2	OTAQD3YV	Strong	Altered Expression	[3099]
ARPIN	OTNNYP9A	Strong	Biomarker	[3100]
ARPP19	OTZS3IT6	Strong	Altered Expression	[3101]
ARPP21	OTWXZN5I	Strong	Biomarker	[3102]
ARSF	OTC0L12N	Strong	Biomarker	[3103]
ARSI	OTIANNWW	Strong	Altered Expression	[3104]
ART3	OT68OFVT	Strong	Genetic Variation	[3105]
ARTN	OTWIWGL6	Strong	Biomarker	[3106]
ASAH1	OT1DNGXL	Strong	Altered Expression	[3107]
ASAP1	OT4DLRYY	Strong	Biomarker	[1196]
ASAP2	OTGEXULW	Strong	Biomarker	[1196]
ASB4	OTI4AFZL	Strong	Biomarker	[3108]
ASCC1	OTH4VAP9	Strong	Biomarker	[3089]
ASCC2	OT3B204T	Strong	Biomarker	[282]
ASCL1	OTI4X44G	Strong	Altered Expression	[3109]
ASCL2	OT3D62WB	Strong	Biomarker	[3110]
ASL	OTI2NGQR	Strong	Biomarker	[3111]
ASPG	OT5E2EKR	Strong	Biomarker	[3112]
ASPM	OTKXQMNA	Strong	Altered Expression	[3113]
ASPN	OTYJM80N	Strong	Biomarker	[3114]
ASPSCR1	OTXTOD10	Strong	Biomarker	[3115]
ASTL	OTB9KA3F	Strong	Biomarker	[3116]
ASXL1	OTX931AW	Strong	Genetic Variation	[3117]
ASXL2	OTNG4E2M	Strong	Altered Expression	[3118]
ATAD3A	OTWF6HBP	Strong	Biomarker	[3119]
ATAD5	OTI8ABKF	Strong	Biomarker	[3120]
ATE1	OT3QNM39	Strong	Altered Expression	[3121]
ATF2	OTNIZPEA	Strong	Biomarker	[3122]
ATF6	OTAFHAVI	Strong	Altered Expression	[3123]
ATG101	OTG8QUXY	Strong	Biomarker	[3124]
ATG13	OTYMHNEJ	Strong	Biomarker	[3125]
ATG16L1	OTEOYC5D	Strong	Genetic Variation	[3126]
ATG3	OT28VBVK	Strong	Altered Expression	[3127]
ATG4B	OTQ4RNRM	Strong	Altered Expression	[3128]
ATG4D	OTSWUO4R	Strong	Biomarker	[3129]
ATG5	OT4T5SMS	Strong	Altered Expression	[3130]
ATMIN	OTEADE76	Strong	Biomarker	[3131]
ATOH1	OTBZYG2R	Strong	Altered Expression	[3132]
ATOH8	OT7SY3BN	Strong	Altered Expression	[2454]
ATP1A3	OTM8EG6H	Strong	Altered Expression	[662]
ATP2A3	OTFYDEES	Strong	Altered Expression	[3133]
ATP2B2	OT1NPZ9T	Strong	Genetic Variation	[3134]
ATP2B3	OT9DIEOP	Strong	Biomarker	[3135]
ATP2B4	OTMWFDAC	Strong	Altered Expression	[3136]
ATP2C1	OTQN51T3	Strong	Biomarker	[3137]
ATP5PD	OTAJDLE2	Strong	Biomarker	[3138]
ATP6AP2	OT0IABVV	Strong	Biomarker	[3139]
ATP6V0D2	OTMOZJO0	Strong	Altered Expression	[3140]
ATP6V1C1	OT2LI8ZG	Strong	Biomarker	[3141]
ATRN	OTTCLOPV	Strong	Altered Expression	[3142]
AUTS2	OTAEXHSC	Strong	Genetic Variation	[3143]
AWAT1	OT8OTY3E	Strong	Altered Expression	[1304]
AXIN2	OTRMGQNU	Strong	Altered Expression	[3144]
AZIN1	OTX5W77I	Strong	Biomarker	[3145]
AZU1	OTHXU264	Strong	Biomarker	[3146]
B3GAT3	OTDSN5XF	Strong	Altered Expression	[3147]
B3GNT2	OTE69HV8	Strong	Biomarker	[3148]
B3GNT6	OTAX8BNJ	Strong	Altered Expression	[3149]
B3GNTL1	OTYWGHF1	Strong	Biomarker	[3148]
B4GALNT2	OT85V4QV	Strong	Genetic Variation	[3150]
B4GALT1	OTBCXEK7	Strong	Altered Expression	[3151]
B4GALT3	OTHX77K8	Strong	Biomarker	[3152]
B4GALT5	OTHMZY12	Strong	Biomarker	[3150]
BABAM2	OTOY7FNT	Strong	Biomarker	[3153]
BAD	OT63ERYM	Strong	Altered Expression	[3154]
BAG2	OTI6LD27	Strong	Altered Expression	[3155]
BAG4	OTUPX3M2	Strong	Biomarker	[3156]
BAGE4	OT2LPTMI	Strong	Biomarker	[3157]
BANF1	OTP7Z38L	Strong	Biomarker	[3158]
BANP	OT1JMTBD	Strong	Biomarker	[3159]
BARX2	OT0R3QD3	Strong	Biomarker	[3160]
BATF3	OTI61WXQ	Strong	Altered Expression	[3161]
BBS2	OTPF9JIB	Strong	Biomarker	[3162]
BCAP31	OTKSACR4	Strong	Biomarker	[3163]
BCCIP	OTFFKG79	Strong	Biomarker	[3164]
BCKDHB	OT8OSVYU	Strong	Altered Expression	[3165]
BCL2L10	OTYXQJ3I	Strong	Altered Expression	[3166]
BCL2L11	OTNQQWFJ	Strong	Altered Expression	[3167]
BCL2L13	OT2VRFTM	Strong	Altered Expression	[3168]
BCL3	OT1M5B95	Strong	Biomarker	[3169]
BCL6B	OT1T5KM6	Strong	Biomarker	[3170]
BCL7A	OTYFUJTP	Strong	Biomarker	[3171]
BCL7B	OT8DQQRD	Strong	Biomarker	[3172]
BCL9	OTRBIPR4	Strong	Genetic Variation	[3173]
BCLAF1	OT7T8H6A	Strong	Biomarker	[3174]
BCOR	OTG013AX	Strong	Genetic Variation	[3175]
BCORL1	OTPTFQN5	Strong	Altered Expression	[3176]
BDH2	OTDD7G8S	Strong	Biomarker	[3177]
BDP1	OTJ408I9	Strong	Altered Expression	[3178]
BEND2	OTI9Y5IC	Strong	Biomarker	[3179]
BEX1	OTBQIF0H	Strong	Altered Expression	[3180]
BEX2	OT4G5SIC	Strong	Biomarker	[3181]
BEX3	OTW1V1L5	Strong	Biomarker	[3182]
BEX4	OT3LXD15	Strong	Biomarker	[3183]
BHLHE22	OTZUQY5L	Strong	Altered Expression	[3184]
BHLHE40	OTITX14U	Strong	Biomarker	[3185]
BHLHE41	OTY9GJ1Y	Strong	Biomarker	[3186]
BHMT	OTYB6PXZ	Strong	Altered Expression	[3187]
BHMT2	OTWYGLDU	Strong	Altered Expression	[3188]
BICRA	OTDTPGW0	Strong	Altered Expression	[3189]
BID	OTOSHSHU	Strong	Altered Expression	[3190]
BIK	OTTH1T3D	Strong	Biomarker	[3191]
BLCAP	OTGJVU0C	Strong	Biomarker	[3192]
BLID	OT479VJV	Strong	Altered Expression	[3193]
BLNK	OTSSPF6F	Strong	Altered Expression	[3194]
BMF	OT90NSLI	Strong	Biomarker	[3195]
BMP3	OTCTI0UW	Strong	Altered Expression	[3196]
BMPR1A	OTQOA4ZH	Strong	Biomarker	[3197]
BMPR1B	OTGFN0OD	Strong	Biomarker	[3198]
BMS1	OTEGQ8ZO	Strong	Biomarker	[3199]
BNC1	OTGJ5WUF	Strong	Biomarker	[3200]
BNIP3	OT4SO7J4	Strong	Altered Expression	[921]
BNIP3L	OTJKOMXE	Strong	Biomarker	[3201]
BOLA2	OTVZP6YB	Strong	Altered Expression	[3202]
BORCS5	OTAT6H8Q	Strong	Biomarker	[3203]
BPTF	OTD1RZAD	Strong	Biomarker	[3204]
BRAP	OTB7BAFQ	Strong	Altered Expression	[3205]
BRCC3	OTK0ZN7Y	Strong	Biomarker	[3206]
BRINP3	OT4VFHWN	Strong	Biomarker	[3207]
BTBD7	OTNUV6MQ	Strong	Biomarker	[3208]
BTBD8	OT3A3RD7	Strong	Genetic Variation	[3209]
BTC	OTW4B2O0	Strong	Biomarker	[3210]
BTF3	OT5ZZFJL	Strong	Altered Expression	[3211]
BTG2	OTZF6K1H	Strong	Altered Expression	[3212]
BTG3	OT9ANHVT	Strong	Biomarker	[3213]
BTG4	OTT3TKPI	Strong	Biomarker	[3214]
BTN3A1	OTGZADIX	Strong	Biomarker	[3215]
BTN3A3	OTKMSJRA	Strong	Altered Expression	[3216]
BTNL2	OTTTEMZA	Strong	Altered Expression	[3217]
BTNL9	OT3PWOH6	Strong	Altered Expression	[3216]
BTRC	OT2EZDGR	Strong	Biomarker	[3218]
BUB1B	OT8KME51	Strong	Genetic Variation	[3219]
C10orf90	OT6DNZC4	Strong	Biomarker	[3220]
C12orf75	OTFVI3EY	Strong	Biomarker	[3221]
C15orf48	OT85J32K	Strong	Biomarker	[3222]
C16orf82	OT77Z5Y5	Strong	Biomarker	[3223]
C1GALT1	OT2ZSZ6P	Strong	Altered Expression	[3224]
C1GALT1C1	OTRTZUF5	Strong	Genetic Variation	[3225]
C1orf52	OT8RQW3W	Strong	Biomarker	[3155]
C1QA	OT6XKVVA	Strong	Biomarker	[3226]
C1QL1	OTNQ0G3E	Strong	Biomarker	[3227]
C4BPA	OTHNH6Y8	Strong	Biomarker	[3228]
C5AR2	OTP1Q82J	Strong	Biomarker	[3229]
C6orf141	OTUS3SIQ	Strong	Biomarker	[3230]
CA11	OT8RX3AJ	Strong	Biomarker	[3231]
CABLES1	OTMN4XSX	Strong	Biomarker	[3232]
CABLES2	OTGD9A2A	Strong	Genetic Variation	[954]
CABP1	OTLSSRGG	Strong	Biomarker	[3233]
CACFD1	OT45BDJU	Strong	Altered Expression	[3234]
CACNB3	OTP30DIU	Strong	Altered Expression	[3235]
CACUL1	OT6P1ZVP	Strong	Biomarker	[611]
CACYBP	OTJMZD2T	Strong	Altered Expression	[3236]
CADM2	OT45PVKC	Strong	Biomarker	[3237]
CADM4	OT0TFMFE	Strong	Altered Expression	[3238]
CAGE1	OTF3HI3N	Strong	Biomarker	[3239]
CALB1	OTM7IXDG	Strong	Altered Expression	[3240]
CALB2	OTSNMCG9	Strong	Biomarker	[3241]
CALHM6	OTLX9B4Y	Strong	Biomarker	[3242]
CALN1	OTN2XE4T	Strong	Altered Expression	[3243]
CAMK1D	OTU24HAU	Strong	Biomarker	[3244]
CAMK2N1	OTKCR5XL	Strong	Biomarker	[3245]
CAMK4	OT47RDGV	Strong	Biomarker	[3246]
CAMTA1	OTAN1S5B	Strong	Biomarker	[3247]
CAP2	OTC1WFNO	Strong	Altered Expression	[3248]
CAPG	OTJ86KI6	Strong	Biomarker	[3249]
CAPNS1	OT95EBBD	Strong	Altered Expression	[3250]
CAPRIN2	OTDYKD95	Strong	Biomarker	[3251]
CAPZB	OTF1A4N0	Strong	Biomarker	[3252]
CARD10	OT2RPM4I	Strong	Biomarker	[3253]
CARD11	OTRCTLYC	Strong	Biomarker	[3254]
CARD14	OTADQHOV	Strong	Biomarker	[3228]
CARD8	OTXXZYWU	Strong	Altered Expression	[3255]
CARD9	OTJ81AWD	Strong	Biomarker	[3256]
CASK	OT8EF7ZF	Strong	Genetic Variation	[3257]
CASP8AP2	OTTWT68S	Strong	Biomarker	[3258]
CAST	OTBXZZGF	Strong	Biomarker	[3259]
CASZ1	OTWJ2OR8	Strong	Altered Expression	[3260]
CAV3	OTWSFDB4	Strong	Altered Expression	[2653]
CAVIN1	OTFO915U	Strong	Altered Expression	[3261]
CAVIN3	OTOLBK79	Strong	Biomarker	[3262]
CBFA2T2	OTNOIB23	Strong	Biomarker	[3263]
CBFB	OTIAC6W4	Strong	Genetic Variation	[3264]
CBLIF	OTNE20WU	Strong	Biomarker	[3265]
CBLL2	OTB4AD3V	Strong	Genetic Variation	[3266]
CBX1	OT2L4XZX	Strong	Biomarker	[3267]
CBX2	OTOQ5WS4	Strong	Biomarker	[3268]
CBX3	OTOP9RLD	Strong	Altered Expression	[3269]
CBX4	OT4XVRRF	Strong	Biomarker	[3270]
CBX5	OT8VYY84	Strong	Altered Expression	[3271]
CBX6	OTO1I9W0	Strong	Biomarker	[3272]
CBX8	OT4U5V1T	Strong	Biomarker	[932]
CC2D1A	OTVPU04K	Strong	Altered Expression	[3273]
CCAR1	OTUXLQZZ	Strong	Biomarker	[3274]
CCAR2	OTLUDG5T	Strong	Biomarker	[3275]
CCDC106	OTWUTA1W	Strong	Biomarker	[3276]
CCDC115	OT04AZNZ	Strong	Altered Expression	[3277]
CCDC136	OTPOV391	Strong	Biomarker	[3278]
CCDC158	OTT3RXZN	Strong	Genetic Variation	[3105]
CCDC170	OTNQOJ6S	Strong	Biomarker	[3279]
CCDC22	OT1A1ZXH	Strong	Genetic Variation	[3280]
CCDC68	OT4KF6TL	Strong	Biomarker	[3281]
CCDC8	OTO295IH	Strong	Altered Expression	[3282]
CCDC80	OTOZSYEM	Strong	Biomarker	[3283]
CCDC83	OTF1ETS6	Strong	Altered Expression	[3284]
CCDC85C	OT1AOJCS	Strong	Altered Expression	[3285]
CCDC88C	OTIU02BS	Strong	Biomarker	[3286]
CCHCR1	OT22C116	Strong	Altered Expression	[3287]
CCL1	OT23NON8	Strong	Biomarker	[3288]
CCL14	OT8QETQU	Strong	Altered Expression	[3289]
CCL19	OTQ2UJMH	Strong	Biomarker	[3290]
CCL24	OT9LGHV0	Strong	Biomarker	[3291]
CCL25	OTLWJ8CJ	Strong	Biomarker	[3292]
CCL27	OTUZYC61	Strong	Biomarker	[3293]
CCL28	OTY6XNQ7	Strong	Biomarker	[3294]
CCL4	OT6B8P25	Strong	Altered Expression	[3295]
CCL7	OTDIS99H	Strong	Biomarker	[3296]
CCN3	OTOW5YL4	Strong	Biomarker	[3297]
CCN6	OTRFHQ2Z	Strong	Altered Expression	[3298]
CCNB2	OTIEXTDK	Strong	Altered Expression	[3299]
CCNB3	OT5V72D3	Strong	Biomarker	[3300]
CCNC	OTMVK4K4	Strong	Biomarker	[3301]
CCNDBP1	OTBWG1M0	Strong	Biomarker	[3302]
CCNG1	OT17IA9L	Strong	Biomarker	[3303]
CCNI	OT8863O1	Strong	Altered Expression	[3304]
CCNJ	OTCR4WVV	Strong	Altered Expression	[3305]
CCNL1	OTAJSS3D	Strong	Biomarker	[3306]
CCNL2	OT0NIKYM	Strong	Biomarker	[3307]
CCNO	OT68CH0B	Strong	Biomarker	[3308]
CCNT2	OTBDRH1J	Strong	Biomarker	[3309]
CCNY	OTK1KG5W	Strong	Biomarker	[3310]
CCP110	OTNOVXA2	Strong	Biomarker	[3311]
CCR10	OT7ZWSSD	Strong	Biomarker	[3312]
CCT2	OTW1VV4E	Strong	Biomarker	[3313]
CCT5	OTPZ38BT	Strong	Biomarker	[3314]
CCT8	OTA7GQN9	Strong	Altered Expression	[3315]
CD164	OTZ7FIU8	Strong	Biomarker	[3316]
CD226	OT4UG0KB	Strong	Altered Expression	[3317]
CD244	OTSMR85N	Strong	Biomarker	[3318]
CD247	OT45FGUX	Strong	Biomarker	[3319]
CD2AP	OTC76KQM	Strong	Biomarker	[3320]
CD5L	OTPY4WQR	Strong	Biomarker	[3321]
CD81	OTQFXNAZ	Strong	Altered Expression	[3322]
CD8A	OTDWQJXK	Strong	Altered Expression	[3323]
CD93	OT6HZT6H	Strong	Biomarker	[3324]
CD99	OTPUZ5DE	Strong	Biomarker	[3325]
CDC20B	OTO5F8CF	Strong	Genetic Variation	[3326]
CDC23	OTC4O83E	Strong	Biomarker	[3327]
CDC42	OT5QBC5M	Strong	Biomarker	[3328]
CDC42EP4	OTCPHZGJ	Strong	Biomarker	[3329]
CDC45	OT6NNLOD	Strong	Altered Expression	[3330]
CDC5L	OTTPFUU5	Strong	Biomarker	[3331]
CDCA3	OTUI8QK3	Strong	Altered Expression	[3332]
CDCA5	OTZLCQ5U	Strong	Biomarker	[3333]
CDCA7	OT12HDZY	Strong	Altered Expression	[3334]
CDCA7L	OT1FFWKC	Strong	Altered Expression	[3335]
CDCP1	OTD7RRWK	Strong	Biomarker	[3336]
CDH10	OTK3D5WP	Strong	Genetic Variation	[3337]
CDH12	OTF2HCGA	Strong	Altered Expression	[3338]
CDH19	OTH31KJO	Strong	Biomarker	[3339]
CDH22	OTQEUWQN	Strong	Altered Expression	[3340]
CDH23	OTOJGQ7S	Strong	Altered Expression	[3341]
CDH7	OTQEXCKU	Strong	Altered Expression	[3342]
CDH8	OTS3SRZ6	Strong	Posttranslational Modification	[3343]
CDHR5	OTTBWQMN	Strong	Biomarker	[3344]
CDK10	OTKP7TTR	Strong	Altered Expression	[3345]
CDK11A	OTN5TSGQ	Strong	Genetic Variation	[3346]
CDK16	OTUBXIIT	Strong	Altered Expression	[3347]
CDK2AP2	OTR99SJ8	Strong	Biomarker	[3348]
CDK5RAP3	OTC0Q2QS	Strong	Biomarker	[545]
CDKN2AIP	OT80RRQJ	Strong	Biomarker	[3349]
CDKN3	OTBE3H07	Strong	Altered Expression	[3350]
CDR2	OTD3ZJST	Strong	Altered Expression	[3351]
CDR2L	OT5UVB1J	Strong	Genetic Variation	[2513]
CDS1	OT2F591M	Strong	Biomarker	[3352]
CDS2	OTKC393S	Strong	Biomarker	[3353]
CEBPE	OTKZA25M	Strong	Genetic Variation	[3354]
CEBPZ	OT11BATG	Strong	Biomarker	[3355]
CELA3A	OT9JAL80	Strong	Biomarker	[549]
CELA3B	OTGU8BE9	Strong	Biomarker	[3356]
CELF1	OT6JQ5RS	Strong	Altered Expression	[3357]
CELF2	OTLJJ4VT	Strong	Biomarker	[3358]
CELF6	OT111JZ3	Strong	Biomarker	[3359]
CELSR2	OTON6JSZ	Strong	Altered Expression	[3360]
CEMIP	OTK80FYN	Strong	Biomarker	[3361]
CENPA	OT0NEJ4X	Strong	Altered Expression	[3362]
CENPH	OTPOO9LK	Strong	Altered Expression	[3363]
CENPI	OTWRIMZ3	Strong	Altered Expression	[3364]
CENPK	OTKPUF8K	Strong	Altered Expression	[3365]
CENPS	OTZ4J391	Strong	Biomarker	[3366]
CENPU	OTQ4TZRS	Strong	Biomarker	[3367]
CEP135	OT1O9XYJ	Strong	Biomarker	[3329]
CEP41	OTKZTBOX	Strong	Posttranslational Modification	[3368]
CEP57	OTPOHLIX	Strong	Biomarker	[3369]
CEP78	OTTAI5S2	Strong	Altered Expression	[3370]
CEP97	OTX7ELQ0	Strong	Biomarker	[3311]
CER1	OTTAJJ63	Strong	Genetic Variation	[3371]
CERS1	OT6EYRM3	Strong	Biomarker	[3372]
CERS2	OTRAHYYP	Strong	Altered Expression	[3373]
CERS6	OTOP4GV1	Strong	Biomarker	[3374]
CFAP45	OT8I8ZHH	Strong	Biomarker	[3375]
CFC1	OT5DHGI8	Strong	Genetic Variation	[3376]
CFHR1	OT72R16T	Strong	Genetic Variation	[3377]
CGAS	OTJYIXNB	Strong	Biomarker	[3378]
CGRRF1	OTLMNRCL	Strong	Altered Expression	[3379]
CHD1	OT9R9G0H	Strong	Biomarker	[3380]
CHD1L	OT7CZK7C	Strong	Altered Expression	[3381]
CHD3	OTDBU4F3	Strong	Altered Expression	[1694]
CHD5	OTS5EVHH	Strong	Genetic Variation	[3382]
CHD7	OTHNIZWZ	Strong	Biomarker	[3383]
CHD8	OTS7A6AF	Strong	Genetic Variation	[3384]
CHD9	OTWNFDKJ	Strong	Biomarker	[3385]
CHI3L2	OT26R3HQ	Strong	Genetic Variation	[3386]
CHL1	OT6E6E8P	Strong	Biomarker	[3387]
CHMP2B	OTZA7RJB	Strong	Biomarker	[1261]
CHODL	OTVCNOUQ	Strong	Altered Expression	[3388]
CHRDL1	OTGMWVVA	Strong	Biomarker	[3389]
CHRDL2	OTJU2I5H	Strong	Altered Expression	[3390]
CHST11	OTNJJ5Q1	Strong	Altered Expression	[3391]
CHST2	OTV11IZF	Strong	Biomarker	[1128]
CHST4	OTESMIW5	Strong	Biomarker	[3392]
CHST9	OT1DEZRM	Strong	Genetic Variation	[3393]
CHSY1	OTB1XSSF	Strong	Altered Expression	[3394]
CIAO2A	OTYPPL5X	Strong	Biomarker	[3395]
CIAPIN1	OTWS90F9	Strong	Biomarker	[3396]
CIDEC	OTMDZ56K	Strong	Biomarker	[3397]
CIITA	OTRJNZFO	Strong	Genetic Variation	[3398]
CINP	OTZ31XOT	Strong	Biomarker	[3399]
CISD2	OTVS7S2H	Strong	Altered Expression	[3400]
CISD3	OT0MM1MW	Strong	Genetic Variation	[3401]
CITED1	OTUJQ3VL	Strong	Biomarker	[3402]
CITED2	OT812TV7	Strong	Biomarker	[3403]
CKAP2	OTCLTC0J	Strong	Altered Expression	[3404]
CKLF	OTHLPHA0	Strong	Altered Expression	[3405]
CKMT1A	OTCINHH5	Strong	Altered Expression	[3406]
CKS1B	OTNUPLUJ	Strong	Altered Expression	[3407]
CLASP2	OT5YX0YB	Strong	Altered Expression	[3408]
CLCA2	OTF191LZ	Strong	Biomarker	[3409]
CLCA4	OTCRR1M9	Strong	Altered Expression	[3410]
CLDN10	OT2CVAKY	Strong	Biomarker	[3411]
CLDN11	OTNN6UTL	Strong	Biomarker	[3412]
CLDN12	OTO55YZI	Strong	Altered Expression	[3413]
CLDN14	OTS7GKOI	Strong	Biomarker	[3414]
CLDN16	OTTHAIKR	Strong	Altered Expression	[3415]
CLDN2	OTRF3D6Y	Strong	Altered Expression	[3416]
CLDN3	OT71MN9S	Strong	Altered Expression	[3417]
CLEC10A	OTD8HQT6	Strong	Biomarker	[1011]
CLEC1B	OTO38TRG	Strong	Biomarker	[3418]
CLEC2B	OT0W0M0L	Strong	Biomarker	[3419]
CLEC2D	OTVRLKPM	Strong	Altered Expression	[2131]
CLEC3B	OTFD29NF	Strong	Biomarker	[3420]
CLEC4D	OTT7X1UC	Strong	Biomarker	[3421]
CLEC7A	OTRTBH27	Strong	Biomarker	[3422]
CLIC3	OT5KUZ3A	Strong	Posttranslational Modification	[3423]
CLIC4	OT6KTPKD	Strong	Biomarker	[3424]
CLIP1	OTTGAEJE	Strong	Biomarker	[3425]
CLOCK	OTNEOJY7	Strong	Biomarker	[3426]
CLPTM1L	OTDJWQXI	Strong	Altered Expression	[3427]
CLSPN	OTZZXNDK	Strong	Biomarker	[3428]
CLTC	OTBFASMA	Strong	Biomarker	[3429]
CLTRN	OTXGFJ3F	Strong	Altered Expression	[3430]
CMPK2	OTOG90R0	Strong	Biomarker	[1696]
CMTM3	OTS75IGC	Strong	Biomarker	[3431]
CMTM5	OTMS7NDP	Strong	Altered Expression	[3432]
CMTM8	OTG28GH2	Strong	Biomarker	[3433]
CNBP	OTTGM9NK	Strong	Altered Expression	[3434]
CNDP2	OTJR9436	Strong	Biomarker	[3435]
CNGB1	OTA5DE38	Strong	Biomarker	[965]
CNN3	OTJTAXAP	Strong	Biomarker	[3436]
CNOT4	OTM8I5RH	Strong	Biomarker	[3437]
CNOT7	OTJBKCPI	Strong	Altered Expression	[3438]
CNPY2	OTGY8ESX	Strong	Altered Expression	[3439]
CNTN3	OTC1274J	Strong	Genetic Variation	[3440]
COA1	OTHSX40F	Strong	Biomarker	[3441]
COG3	OTKJMB1Q	Strong	Biomarker	[1863]
COL11A1	OTB0DRMS	Strong	Genetic Variation	[3442]
COL12A1	OTHLTV53	Strong	Altered Expression	[3443]
COL14A1	OTLNJ13O	Strong	Biomarker	[3444]
COL15A1	OTTFKK18	Strong	Altered Expression	[3445]
COL23A1	OTYE0N3I	Strong	Altered Expression	[3446]
COL4A2	OTJK1LKN	Strong	Biomarker	[3447]
COL4A3	OT6SB8X5	Strong	Biomarker	[3448]
COL4A5	OTHG60RE	Strong	Biomarker	[1562]
COL9A1	OTWBR27Y	Strong	Biomarker	[1234]
COL9A2	OT1ZBDBV	Strong	Biomarker	[1234]
COLCA1	OT8BP6UD	Strong	Genetic Variation	[954]
COLEC10	OTMBADGZ	Strong	Biomarker	[570]
COLQ	OT4BHUGQ	Strong	Biomarker	[3449]
COMMD1	OT7WUD5R	Strong	Altered Expression	[3450]
COMMD6	OTRZQJFW	Strong	Biomarker	[3451]
COMMD7	OTWWJ97D	Strong	Biomarker	[3452]
COMP	OTS2FPMI	Strong	Biomarker	[3453]
COP1	OT6J2K12	Strong	Genetic Variation	[3454]
COPA	OTZ1DTXU	Strong	Biomarker	[3455]
COPS8	OTNAD2S4	Strong	Altered Expression	[3456]
COPZ1	OTJXGQQW	Strong	Biomarker	[3457]
CORO1B	OT7C4BMQ	Strong	Biomarker	[3458]
CORO1C	OTXDF9T3	Strong	Biomarker	[3459]
CORO6	OT9TFSVB	Strong	Genetic Variation	[3460]
CORT	OTX3GUHB	Strong	Altered Expression	[3461]
COTL1	OT6YCNLF	Strong	Altered Expression	[3462]
COX14	OTQ378WN	Strong	Altered Expression	[3463]
COX4I1	OTU0FC24	Strong	Biomarker	[3464]
COX4I2	OTB98B21	Strong	Biomarker	[3464]
COX5A	OTP0961M	Strong	Biomarker	[3465]
COX5B	OTDP94F3	Strong	Altered Expression	[3466]
COX7A2	OTVT146E	Strong	Altered Expression	[3467]
COX7A2L	OTY21FKV	Strong	Altered Expression	[3039]
CPD	OT2CS64Y	Strong	Altered Expression	[3468]
CPEB1	OTLCXC6H	Strong	Biomarker	[3469]
CPEB2	OTKES4YR	Strong	Biomarker	[3470]
CPNE1	OTH5YKSL	Strong	Altered Expression	[3471]
CPOX	OTIAY121	Strong	Biomarker	[3465]
CPSF3	OTS3KSNG	Strong	Biomarker	[3472]
CPSF4	OT53UK5L	Strong	Altered Expression	[3473]
CPT1A	OTI862QH	Strong	Biomarker	[3474]
CPT2	OTIN6G20	Strong	Biomarker	[3474]
CPVL	OTOJL31C	Strong	Biomarker	[3475]
CPXM1	OTRCSQPG	Strong	Biomarker	[3476]
CPXM2	OTDJNOTR	Strong	Altered Expression	[3477]
CPZ	OT5HUR28	Strong	Biomarker	[3478]
CRABP1	OTISDG5X	Strong	Altered Expression	[3479]
CRABP2	OTY01V9G	Strong	Altered Expression	[3480]
CRACD	OTII2U6L	Strong	Biomarker	[3481]
CRADD	OT02TZ4S	Strong	Genetic Variation	[3482]
CRAMP1	OT0X95YA	Strong	Altered Expression	[3483]
CRB3	OTQKPTMU	Strong	Biomarker	[3484]
CRCT1	OTPYME8V	Strong	Biomarker	[3485]
CREB3	OT9617UO	Strong	Altered Expression	[3486]
CREB3L1	OT2JHIHM	Strong	Altered Expression	[3487]
CREBL2	OT58JBNU	Strong	Biomarker	[3488]
CREBRF	OT2GK1HI	Strong	Altered Expression	[3489]
CRIP2	OTVVJSYX	Strong	Biomarker	[3490]
CRIP3	OT7H1YOY	Strong	Biomarker	[1134]
CRISP3	OTBSWMPL	Strong	Biomarker	[3491]
CRISPLD2	OTVSFHTL	Strong	Biomarker	[3492]
CRKL	OTOYSD1R	Strong	Biomarker	[3493]
CRLF3	OTT9TMXN	Strong	Genetic Variation	[3494]
CRLS1	OT7XNL0K	Strong	Altered Expression	[3495]
CRNN	OTAORBR4	Strong	Altered Expression	[3496]
CROCC	OTVNOZSM	Strong	Biomarker	[3497]
CRX	OTH435SV	Strong	Biomarker	[3498]
CRYBB2	OTL0Z8E6	Strong	Biomarker	[3499]
CRYBG3	OTHXQCX7	Strong	Biomarker	[3500]
CRYGD	OTW29JC4	Strong	Biomarker	[3501]
CSH1	OT33HTRR	Strong	Biomarker	[3502]
CSH2	OTW8JVAN	Strong	Biomarker	[3502]
CSHL1	OTQKU2F5	Strong	Altered Expression	[1195]
CSMD1	OTIVDSC4	Strong	Biomarker	[3503]
CSMD2	OT541Z3W	Strong	Altered Expression	[3504]
CSMD3	OTAT75SW	Strong	Biomarker	[3505]
CSN1S1	OTXOW6XJ	Strong	Genetic Variation	[3506]
CSN3	OTR61MI8	Strong	Altered Expression	[3507]
CSRNP1	OTDK1FPH	Strong	Biomarker	[3508]
CSRP1	OTUS7RM2	Strong	Biomarker	[3509]
CST1	OTE4I83Q	Strong	Altered Expression	[3510]
CST2	OTRKRW50	Strong	Altered Expression	[3511]
CST3	OTNZ6AO4	Strong	Biomarker	[3512]
CST5	OTHJXNJG	Strong	Altered Expression	[3513]
CST6	OTZVHJTF	Strong	Biomarker	[3514]
CST7	OTQWZUVQ	Strong	Biomarker	[3515]
CSTA	OT1K68KE	Strong	Altered Expression	[3516]
CSTB	OT3U0JF8	Strong	Altered Expression	[3517]
CSTF3	OT1Y7B5U	Strong	Altered Expression	[3518]
CT45A1	OT80VTZO	Strong	Biomarker	[3519]
CT55	OTQC0H27	Strong	Altered Expression	[3520]
CT83	OTQEGHAB	Strong	Biomarker	[3521]
CTAG2	OT8HISP4	Strong	Biomarker	[3522]
CTBP1	OTVYH2DH	Strong	Altered Expression	[3523]
CTBP2	OTGZGT87	Strong	Biomarker	[3524]
CTBS	OT135K92	Strong	Altered Expression	[1096]
CTHRC1	OTV88X2G	Strong	Genetic Variation	[3525]
CTNNA2	OTJ8G92T	Strong	Biomarker	[3526]
CTNNA3	OT9Z0P1E	Strong	Biomarker	[3527]
CTNNAL1	OTESJ6JD	Strong	Biomarker	[3528]
CTNND1	OTUMPSHR	Strong	Biomarker	[3529]
CTNND2	OTYKE30Y	Strong	Biomarker	[3530]
CTR9	OTP151PZ	Strong	Biomarker	[3531]
CTSZ	OTSCX2LL	Strong	Biomarker	[3532]
CTTN	OTJRG4ES	Strong	Biomarker	[3533]
CTU1	OTNTM9D1	Strong	Genetic Variation	[3534]
CUEDC2	OTWMOLAJ	Strong	Biomarker	[3535]
CUL4A	OTTBV70J	Strong	Biomarker	[3536]
CUL4B	OT2QX4DO	Strong	Altered Expression	[3537]
CUL5	OTMTZD47	Strong	Biomarker	[3538]
CUL9	OTPUCLZT	Strong	Biomarker	[3539]
CXCL17	OTRCEVIZ	Strong	Biomarker	[3540]
CXCL3	OTSL94KH	Strong	Altered Expression	[3541]
CXXC1	OTO10D1N	Strong	Biomarker	[3542]
CYB5R1	OTMDHMLA	Strong	Altered Expression	[3543]
CYBA	OT16N9ZO	Strong	Biomarker	[3544]
CYC1	OT0962IM	Strong	Altered Expression	[3545]
CYFIP2	OTCAY35T	Strong	Genetic Variation	[3546]
CYGB	OTX153DQ	Strong	Biomarker	[3547]
CYLC1	OTM0LL34	Strong	Altered Expression	[3548]
CYP4V2	OTQKNK0D	Strong	Altered Expression	[1649]
CYP4Z1	OTKRGJBG	Strong	Altered Expression	[3549]
CYRIB	OTLRN4L1	Strong	Biomarker	[3550]
CYTB	OTAHB98A	Strong	Altered Expression	[3551]
CYTH3	OTBXAT3Z	Strong	Altered Expression	[3552]
CYTL1	OTLYUPUY	Strong	Biomarker	[3553]
DAB1	OTPL9MA3	Strong	Biomarker	[3554]
DACH1	OTMKNAGG	Strong	Biomarker	[3555]
DACH2	OT33KEUZ	Strong	Altered Expression	[3556]
DACT1	OT19Z704	Strong	Biomarker	[3557]
DACT2	OTNLCC0K	Strong	Posttranslational Modification	[3558]
DAND5	OTWNWQDJ	Strong	Altered Expression	[3559]
DAPK2	OTWODUQG	Strong	Altered Expression	[1435]
DBI	OT884QY9	Strong	Biomarker	[1470]
DBP	OTE0W7LN	Strong	Genetic Variation	[3560]
DBX2	OT2OBSP0	Strong	Biomarker	[3561]
DCAF12	OT24XM7T	Strong	Biomarker	[3562]
DCAF4	OTQU0EUO	Strong	Genetic Variation	[3563]
DCAF6	OT3EYK1J	Strong	Biomarker	[3564]
DCD	OTV5PBGJ	Strong	Biomarker	[3565]
DCDC2	OTSUFH1H	Strong	Biomarker	[3566]
DCLRE1C	OTW3KB1I	Strong	Biomarker	[3567]
DCT	OTYVNTBG	Strong	Biomarker	[3568]
DCTN1	OT5B51FJ	Strong	Genetic Variation	[3569]
DCTN3	OTQOSUES	Strong	Genetic Variation	[1904]
DCTN4	OTM7C943	Strong	Biomarker	[3570]
DCX	OTISR7K3	Strong	Biomarker	[3571]
DDB1	OTTR2L3Z	Strong	Biomarker	[3572]
DDB2	OTO8HVVB	Strong	Altered Expression	[3573]
DDOST	OT39PDMS	Strong	Biomarker	[3574]
DDT	OTF5HTYL	Strong	Biomarker	[3575]
DDX1	OT3U8FD0	Strong	Biomarker	[3576]
DDX10	OTH48438	Strong	Biomarker	[3577]
DDX17	OTXRMMBP	Strong	Biomarker	[3578]
DDX27	OT64NCZ6	Strong	Biomarker	[3579]
DDX39A	OT0Z6E1K	Strong	Biomarker	[3580]
DDX3X	OTDO4TRX	Strong	Altered Expression	[3581]
DDX3Y	OTKL1FNX	Strong	Altered Expression	[3582]
DDX4	OTQOV093	Strong	Altered Expression	[3583]
DDX51	OTLMA7AH	Strong	Altered Expression	[3584]
DDX6	OTKWXVDY	Strong	Biomarker	[3585]
DDX60	OTVPHA0C	Strong	Altered Expression	[3586]
DEAF1	OTCLX3ZW	Strong	Biomarker	[3587]
DECR1	OTCDIR6X	Strong	Altered Expression	[3588]
DEFA1	OT5N1B9B	Strong	Altered Expression	[3589]
DEFA3	OTO3N8E1	Strong	Altered Expression	[3589]
DEFB103B	OT8RWY64	Strong	Biomarker	[3590]
DEFB104A	OTLQZR6K	Strong	Biomarker	[3591]
DENND2D	OTXEFJWM	Strong	Altered Expression	[3592]
DENR	OTXP9HOY	Strong	Altered Expression	[1435]
DEPDC1B	OTMVFOT1	Strong	Biomarker	[3593]
DEPDC5	OTE70JLY	Strong	Biomarker	[3594]
DERL1	OTJUS74N	Strong	Altered Expression	[3595]
DERL2	OTI3TUUZ	Strong	Biomarker	[3596]
DERL3	OTRZRT6Q	Strong	Biomarker	[3597]
DESI1	OTFNIW98	Strong	Biomarker	[3598]
DESI2	OTHUOKOC	Strong	Biomarker	[3599]
DET1	OTHYSDX3	Strong	Genetic Variation	[3454]
DEUP1	OTXLM86J	Strong	Altered Expression	[3600]
DGCR2	OTEGL17Z	Strong	Biomarker	[1585]
DGKB	OTTT9SZJ	Strong	Altered Expression	[923]
DGKG	OTBL32T3	Strong	Altered Expression	[3601]
DGKI	OTDZ602D	Strong	Posttranslational Modification	[3602]
DGUOK	OT78HUZB	Strong	Biomarker	[3603]
DHH	OT3B7721	Strong	Altered Expression	[3604]
DHX33	OTREUESJ	Strong	Biomarker	[3605]
DHX58	OT19BYB1	Strong	Altered Expression	[3606]
DHX9	OT5AAOQI	Strong	Altered Expression	[3607]
DIAPH1	OTZBYPLH	Strong	Biomarker	[3039]
DIAPH2	OTBEYFEZ	Strong	Biomarker	[3608]
DIAPH3	OTPOT23F	Strong	Biomarker	[3609]
DIDO1	OT9PB547	Strong	Altered Expression	[3610]
DIP2A	OTXPTR8R	Strong	Biomarker	[3611]
DIRAS1	OT07F6PE	Strong	Altered Expression	[3612]
DIRAS3	OT3XHLQA	Strong	Biomarker	[3613]
DIS3L2	OTWABM04	Strong	Biomarker	[3614]
DIXDC1	OT87DXEG	Strong	Altered Expression	[3615]
DLEU7	OTVKX1YP	Strong	Biomarker	[3616]
DLG2	OTQ3BD8U	Strong	Biomarker	[3617]
DLGAP1	OTF2PUUI	Strong	Biomarker	[3618]
DLGAP5	OTWCN39U	Strong	Altered Expression	[3619]
DLST	OTBDF9HJ	Strong	Genetic Variation	[3620]
DLX1	OT7BH057	Strong	Altered Expression	[3621]
DLX2	OTKC2DQ0	Strong	Altered Expression	[3622]
DLX4	OTLWVCN4	Strong	Biomarker	[3623]
DLX5	OTEEFBEU	Strong	Biomarker	[3624]
DLX6	OT0FIJHY	Strong	Altered Expression	[3625]
DMBX1	OT43YF6N	Strong	Altered Expression	[3626]
DMC1	OT1FHMW4	Strong	Biomarker	[3627]
DMP1	OTBWBWW7	Strong	Biomarker	[3628]
DMRT1	OT5PU9U1	Strong	Biomarker	[1261]
DMTF1	OTDKO9OO	Strong	Biomarker	[3628]
DNA2	OT4DJFFU	Strong	Biomarker	[3629]
DNAAF1	OTYLQLHO	Strong	Biomarker	[3630]
DNAH9	OTI2QIZQ	Strong	Biomarker	[3631]
DNAI1	OTF6C65Q	Strong	Biomarker	[2513]
DNAJB4	OTUD01BK	Strong	Altered Expression	[3632]
DNAJB7	OT4BOECZ	Strong	Biomarker	[3633]
DNAJB8	OT2CDBH6	Strong	Altered Expression	[3634]
DNAJC10	OTD2EG0R	Strong	Therapeutic	[3635]
DNAJC15	OTNDUKAA	Strong	Biomarker	[3636]
DNAJC2	OT3JDA0R	Strong	Biomarker	[3637]
DNAJC27	OTJRPCUR	Strong	Altered Expression	[3638]
DNAJC6	OT1P6ZIE	Strong	Biomarker	[3639]
DND1	OTHLC8TA	Strong	Biomarker	[3640]
DNER	OT2GH2E5	Strong	Biomarker	[3641]
DNLZ	OT48CG1W	Strong	Biomarker	[3642]
DNM1L	OTXK1Q1G	Strong	Altered Expression	[1435]
DNM3	OTDMUGCR	Strong	Altered Expression	[3643]
DNTT	OTFSEF12	Strong	Biomarker	[3644]
DOC2A	OT5G9V94	Strong	Biomarker	[3645]
DOCK1	OTCFV3ON	Strong	Biomarker	[3646]
DOCK2	OTZTS3PA	Strong	Altered Expression	[3647]
DOK1	OTGVRLW6	Strong	Biomarker	[3648]
DOK2	OTIJ38UF	Strong	Altered Expression	[3649]
DPH1	OT0QU3JY	Strong	Biomarker	[3650]
DPPA4	OTAEOACS	Strong	Biomarker	[3651]
DPY30	OTLHCJ6C	Strong	Altered Expression	[3652]
DPYS	OTLTUIVL	Strong	Biomarker	[3653]
DPYSL4	OT3SBS2S	Strong	Altered Expression	[3654]
DRAM2	OTBOCZH8	Strong	Altered Expression	[3655]
DRG2	OTFYAWE5	Strong	Genetic Variation	[3656]
DROSHA	OTCE68KZ	Strong	Genetic Variation	[3657]
DSC1	OTNII6GZ	Strong	Biomarker	[3658]
DSC2	OTODVH8K	Strong	Biomarker	[3659]
DSC3	OTYG47F8	Strong	Biomarker	[3659]
DSCC1	OTPUVLZT	Strong	Altered Expression	[3660]
DSE	OTQ108VJ	Strong	Altered Expression	[3661]
DSG2	OTJPB2TO	Strong	Biomarker	[3662]
DSP	OTB2MOP8	Strong	Biomarker	[3663]
DSPP	OT1TYNDN	Strong	Altered Expression	[3664]
DTD1	OT63V2KK	Strong	Altered Expression	[3665]
DTX3L	OTCCO2QZ	Strong	Biomarker	[3666]
DUOX1	OTQ2AEW0	Strong	Altered Expression	[3667]
DUOX2	OTU14HCN	Strong	Altered Expression	[3668]
DUSP11	OTU6C41M	Strong	Altered Expression	[3669]
DUSP16	OTK7S078	Strong	Biomarker	[3670]
DUSP23	OTE2PG54	Strong	Biomarker	[3671]
DUSP28	OTDYDBN7	Strong	Biomarker	[3672]
DUSP4	OT6WAO12	Strong	Biomarker	[3673]
DVL1	OTD67RF1	Strong	Genetic Variation	[3674]
DVL2	OTMNYNCM	Strong	Biomarker	[3675]
DVL3	OTPRROHJ	Strong	Biomarker	[3676]
DYNC1H1	OTD1KRKO	Strong	Genetic Variation	[1904]
DYNC1I1	OTFX1KCG	Strong	Altered Expression	[1311]
DYNLL2	OTLIT58K	Strong	Altered Expression	[3677]
E2F4	OTB3JFH4	Strong	Genetic Variation	[3678]
E2F5	OT1XWING	Strong	Biomarker	[3679]
E2F6	OT2PN28R	Strong	Altered Expression	[3680]
E2F7	OTWW358N	Strong	Altered Expression	[3681]
E2F8	OTQKZGFP	Strong	Altered Expression	[3682]
EAF1	OTN27MJW	Strong	Biomarker	[3683]
EAF2	OTSOET5L	Strong	Genetic Variation	[3684]
ECD	OT3L3PCU	Strong	Biomarker	[3685]
ECHS1	OTS0593S	Strong	Biomarker	[3686]
ECRG4	OTHZYUXX	Strong	Biomarker	[3687]
EDA	OTAKS5WS	Strong	Biomarker	[773]
EDAR	OT3W2UQS	Strong	Altered Expression	[3688]
EDIL3	OTDVVNS0	Strong	Altered Expression	[3689]
EDN3	OTN7Q9BE	Strong	Posttranslational Modification	[3690]
EEF1B2	OTW64NPU	Strong	Biomarker	[3691]
EEF1D	OTM5ZD8Y	Strong	Altered Expression	[3692]
EEF2	OTZ7SZ39	Strong	Biomarker	[3693]
EFEMP2	OT0I2B4J	Strong	Altered Expression	[3694]
EFNA1	OTU2NUA2	Strong	Biomarker	[3695]
EFNA4	OTITKZQH	Strong	Altered Expression	[3696]
EFNB1	OT7JJW8P	Strong	Altered Expression	[3697]
EFNB2	OT0DCUOM	Strong	Biomarker	[3698]
EFNB3	OT12WTXQ	Strong	Posttranslational Modification	[3699]
EGR4	OT4R3ECK	Strong	Biomarker	[3700]
EHD2	OTTX391J	Strong	Altered Expression	[3701]
EHD3	OTOKC2G5	Strong	Biomarker	[3702]
EID3	OTAND0C7	Strong	Altered Expression	[3703]
EIF1	OTB4GZ0V	Strong	Biomarker	[1317]
EIF1AX	OTWG2LAB	Strong	Genetic Variation	[3704]
EIF2S1	OTM0GDTP	Strong	Altered Expression	[3705]
EIF3C	OTR8RF9X	Strong	Biomarker	[3706]
EIF3E	OTI0WG98	Strong	Biomarker	[3707]
EIF3F	OTU20K6L	Strong	Altered Expression	[3708]
EIF3G	OT5L1SRY	Strong	Biomarker	[3709]
EIF3I	OTE07WND	Strong	Altered Expression	[3710]
EIF3K	OTGTKVGO	Strong	Genetic Variation	[3711]
EIF3M	OTVWEV60	Strong	Biomarker	[3712]
EIF4A3	OTYYFE7K	Strong	Biomarker	[3713]
EIF4G3	OTZCRXLJ	Strong	Biomarker	[3714]
EIF4H	OTGZI072	Strong	Biomarker	[3715]
EIF5	OT79PQUN	Strong	Altered Expression	[3716]
EIF5AL1	OTLA4ONW	Strong	Altered Expression	[3716]
EIF5B	OTZTT22W	Strong	Biomarker	[3717]
EIF6	OTEXMUED	Strong	Biomarker	[3718]
ELAVL4	OT3YH6J6	Strong	Biomarker	[3719]
ELF2	OTEI347F	Strong	Altered Expression	[3720]
ELF3	OTUTLEQO	Strong	Altered Expression	[3721]
ELF4	OT167PR5	Strong	Biomarker	[3722]
ELF5	OTLRU8YF	Strong	Biomarker	[3723]
ELL	OTCBN5LF	Strong	Biomarker	[3724]
ELMO3	OTQHO9VM	Strong	Altered Expression	[3725]
ELN	OTFSO7PG	Strong	Biomarker	[3726]
ELOB	OTZ3X84T	Strong	Biomarker	[2393]
ELOC	OT0XHHWP	Strong	Biomarker	[2393]
ELOVL1	OTIDTQ8R	Strong	Biomarker	[3727]
ELOVL6	OTB26UJJ	Strong	Altered Expression	[3728]
ELP1	OTYEWBF7	Strong	Biomarker	[3729]
ELP3	OTT5UKSZ	Strong	Altered Expression	[3730]
EME1	OTD9RKD9	Strong	Altered Expression	[3731]
EMILIN1	OT94R6M1	Strong	Altered Expression	[3732]
EMILIN2	OTOYK5A8	Strong	Altered Expression	[3733]
EMILIN3	OT2BZTSU	Strong	Biomarker	[3734]
EML1	OTOP2E01	Strong	Biomarker	[3735]
EMP1	OTSZHUHQ	Strong	Biomarker	[3736]
EMP2	OTPS2H0L	Strong	Biomarker	[3737]
EMP3	OTODMJ1D	Strong	Biomarker	[3738]
EMX1	OT7NG5MJ	Strong	Altered Expression	[3739]
EMX2	OT0V8OYK	Strong	Biomarker	[3740]
ENC1	OTJEUB6U	Strong	Altered Expression	[3741]
ENDOD1	OTME0ZW5	Strong	Biomarker	[3742]
ENKUR	OTXXBBQT	Strong	Altered Expression	[3743]
ENO1	OTB1KWJS	Strong	Biomarker	[3744]
ENOSF1	OT65D3ZK	Strong	Genetic Variation	[3745]
ENPP7	OTWOBMQ9	Strong	Genetic Variation	[3746]
ENTPD5	OTFH05B9	Strong	Altered Expression	[3747]
ENTR1	OT5F18V3	Strong	Biomarker	[3748]
EOMES	OTB9VQFA	Strong	Altered Expression	[3749]
EP400	OTVQ75NX	Strong	Altered Expression	[3750]
EPB41L3	OTS6CHG2	Strong	Altered Expression	[3751]
EPB41L4B	OT2K30P7	Strong	Biomarker	[3752]
EPN1	OT4Q1NIV	Strong	Biomarker	[3753]
EPN3	OTNNYDT6	Strong	Altered Expression	[3754]
EPRS1	OTXK0FLB	Strong	Altered Expression	[3755]
EPS15	OT7NPP8U	Strong	Biomarker	[3756]
EPS8	OTZ6ES6V	Strong	Biomarker	[3757]
ERCC2	OT1C8HQ4	Strong	Genetic Variation	[3758]
ERCC4	OTFIOPG1	Strong	Biomarker	[3759]
ERCC6L	OTE9V7D9	Strong	Altered Expression	[3760]
ERGIC3	OT8RWHN3	Strong	Altered Expression	[3761]
ERLIN2	OT551BVG	Strong	Biomarker	[3762]
ERN2	OTUS6GKR	Strong	Altered Expression	[698]
ERP29	OTNKANMH	Strong	Biomarker	[3763]
ERRFI1	OT7VZ2IZ	Strong	Biomarker	[3764]
ERVW-1	OTWV8DXJ	Strong	Biomarker	[3765]
ESAM	OTF518AI	Strong	Biomarker	[3766]
ESD	OTUSIBPS	Strong	Biomarker	[3767]
ESM1	OT331Y8V	Strong	Altered Expression	[3768]
ESPL1	OTMGEVOK	Strong	Altered Expression	[3769]
ESRP1	OTNCS4SL	Strong	Biomarker	[3770]
ESRP2	OTVTKJ4I	Strong	Biomarker	[3771]
ETFB	OT6Q6FBD	Strong	Biomarker	[3772]
ETNPPL	OTSXO9P6	Strong	Altered Expression	[3773]
ETV5	OTE2OBM4	Strong	Altered Expression	[3774]
ETV7	OTIAADPA	Strong	Altered Expression	[3775]
EVI2A	OTR8RUXQ	Strong	Biomarker	[3776]
EVI5	OTOPAP55	Strong	Altered Expression	[3777]
EVPL	OTZIAFEK	Strong	Biomarker	[3778]
EVX1	OT4A84VD	Strong	Altered Expression	[3779]
EXOC7	OT4YA137	Strong	Altered Expression	[3780]
EYA1	OTHU807A	Strong	Biomarker	[1465]
EYA4	OTINGR3Z	Strong	Biomarker	[3781]
EZHIP	OTDP2O9X	Strong	Genetic Variation	[3782]
FA2H	OT8HA13U	Strong	Altered Expression	[3783]
FABP7	OTRE2H4G	Strong	Altered Expression	[3784]
FADD	OTV7GFHH	Strong	Biomarker	[3785]
FAIM2	OT6QINVO	Strong	Altered Expression	[3786]
FAM107B	OT5RG4J0	Strong	Altered Expression	[3787]
FAM111B	OT9IQ9NV	Strong	Biomarker	[3788]
FAM162B	OTZ31RP5	Strong	Biomarker	[126]
FAM168B	OT312DUH	Strong	Biomarker	[3789]
FAM3B	OTC2S91N	Strong	Altered Expression	[3790]
FAM53A	OT92WJE6	Strong	Biomarker	[3791]
FAM53B	OTVD7OU6	Strong	Biomarker	[3792]
FAM72A	OTBZYSR3	Strong	Genetic Variation	[3793]
FAM72B	OT6AOG64	Strong	Genetic Variation	[3793]
FAM83H	OTN0SF11	Strong	Altered Expression	[3794]
FAM98A	OTBLMZXO	Strong	Altered Expression	[3795]
FAN1	OT1LM1HZ	Strong	Biomarker	[3796]
FANCC	OTTIDM3P	Strong	Biomarker	[3797]
FANCG	OT7MC8TZ	Strong	Genetic Variation	[3798]
FANCM	OTNJG99Z	Strong	Biomarker	[3799]
FARP2	OTNRQIMK	Strong	Biomarker	[3800]
FASTKD2	OTD635WX	Strong	Biomarker	[3801]
FAT2	OTRGT3E8	Strong	Altered Expression	[3802]
FAT4	OT7QONNV	Strong	Biomarker	[3803]
FAU	OTGTVOWK	Strong	Altered Expression	[3804]
FBL	OTRODIE5	Strong	Biomarker	[3805]
FBLIM1	OTFHXMON	Strong	Biomarker	[3806]
FBLN1	OT5MHHOP	Strong	Biomarker	[2902]
FBLN5	OTLVNZ8U	Strong	Biomarker	[3807]
FBN1	OTYCJT63	Strong	Biomarker	[3808]
FBN2	OT3KYJQL	Strong	Biomarker	[3809]
FBN3	OTEWLXTH	Strong	Biomarker	[3810]
FBP2	OT9R1LF7	Strong	Altered Expression	[3811]
FBRS	OTUVH446	Strong	Biomarker	[3812]
FBXL2	OT5EZ7PD	Strong	Biomarker	[899]
FBXL3	OTDQ1QKV	Strong	Biomarker	[3813]
FBXO16	OTTEJJVJ	Strong	Biomarker	[3814]
FBXO17	OTDSRA7P	Strong	Altered Expression	[3815]
FBXO25	OTDFA7F4	Strong	Biomarker	[3816]
FBXO28	OTKTMVC4	Strong	Altered Expression	[3817]
FBXO31	OTF96IC2	Strong	Biomarker	[3818]
FBXO32	OTUE978R	Strong	Biomarker	[3819]
FBXO38	OTSZ3768	Strong	Biomarker	[3820]
FBXO39	OTPRR6SK	Strong	Altered Expression	[3821]
FBXO4	OT6VYX67	Strong	Biomarker	[3822]
FBXO45	OTD4D2OP	Strong	Biomarker	[3823]
FBXO47	OTMAOLX2	Strong	Altered Expression	[3824]
FBXO6	OT58MKP3	Strong	Biomarker	[3825]
FBXO8	OTZNGJGW	Strong	Biomarker	[3812]
FBXW10	OTLBLG11	Strong	Biomarker	[3826]
FBXW11	OT2A6RLR	Strong	Biomarker	[3827]
FBXW12	OTA7XY4B	Strong	Genetic Variation	[3828]
FBXW2	OTCHPUCP	Strong	Biomarker	[3829]
FBXW4	OTEGSZOX	Strong	Altered Expression	[2928]
FCGR3B	OTSLSPZG	Strong	Biomarker	[724]
FCN1	OTK6ZHXH	Strong	Biomarker	[3830]
FCN2	OTTHJBKZ	Strong	Biomarker	[3830]
FCRL1	OTXOYT29	Strong	Altered Expression	[3831]
FCRL4	OT3DVTRV	Strong	Altered Expression	[3832]
FCRL6	OTLIXQMQ	Strong	Altered Expression	[3833]
FDX1	OT7I3DN0	Strong	Altered Expression	[3834]
FEN1	OT6QGG7O	Strong	Altered Expression	[3835]
FERMT1	OT626PBA	Strong	Altered Expression	[3836]
FERMT2	OTZNPWWX	Strong	Biomarker	[3837]
FETUB	OT7V07NI	Strong	Altered Expression	[3838]
FEV	OTYEC4IR	Strong	Biomarker	[3839]
FEZ1	OTWCXPRE	Strong	Biomarker	[3028]
FEZF1	OTRX4NOT	Strong	Altered Expression	[3840]
FEZF2	OTU4TXIW	Strong	Altered Expression	[3841]
FGD4	OTYXJQCW	Strong	Biomarker	[3842]
FGF12	OTBM9QIO	Strong	Altered Expression	[3843]
FGF13	OTHNNVSG	Strong	Biomarker	[3844]
FGF17	OTAQSFZ2	Strong	Biomarker	[3845]
FGF5	OTQXGHBY	Strong	Altered Expression	[3846]
FGF9	OT2SKDGM	Strong	Biomarker	[3847]
FGFRL1	OT8HZ3ZL	Strong	Biomarker	[3848]
FGL1	OTT0QHQ1	Strong	Biomarker	[3849]
FH	OTEQWU6Q	Strong	Biomarker	[3850]
FHL2	OT0OAYWT	Strong	Altered Expression	[2245]
FHL5	OT6C00Z1	Strong	Altered Expression	[2940]
FILIP1L	OTPY8IMS	Strong	Biomarker	[3851]
FIS1	OT2HL10J	Strong	Altered Expression	[3548]
FJX1	OT8SVTSS	Strong	Altered Expression	[3852]
FKBP11	OTY2GC67	Strong	Altered Expression	[3853]
FKBPL	OTR9ND6K	Strong	Biomarker	[3854]
FLAD1	OTY8R02L	Strong	Altered Expression	[3235]
FLG	OTE9QDV6	Strong	Biomarker	[3855]
FLNB	OTPCOYL6	Strong	Biomarker	[3856]
FLNC	OT3F8J6Y	Strong	Altered Expression	[3857]
FLOT1	OT0JPPJZ	Strong	Biomarker	[3858]
FLOT2	OTZ0QR5L	Strong	Altered Expression	[3859]
FLRT2	OTGD8TID	Strong	Biomarker	[3860]
FLVCR1	OT9XCFOC	Strong	Biomarker	[3861]
FMN2	OTUY7BSV	Strong	Altered Expression	[3862]
FMNL2	OT9OVWCV	Strong	Genetic Variation	[3863]
FMR1	OTWEV0T5	Strong	Biomarker	[3864]
FNDC3B	OTBILGDR	Strong	Altered Expression	[3865]
FNDC5	OT5CSK9X	Strong	Altered Expression	[3866]
FOCAD	OT83QOSI	Strong	Biomarker	[3867]
FOSB	OTW6C05J	Strong	Altered Expression	[3868]
FOXD1	OT80PRHS	Strong	Biomarker	[3869]
FOXD2	OTAF63YV	Strong	Altered Expression	[3870]
FOXE1	OT5IR5IT	Strong	Altered Expression	[3871]
FOXF1	OT2CJZ5K	Strong	Biomarker	[3872]
FOXF2	OTV20NGX	Strong	Biomarker	[3873]
FOXG1	OTAW57J4	Strong	Biomarker	[3874]
FOXJ1	OT7LLBZ7	Strong	Altered Expression	[3875]
FOXL1	OT89XFPN	Strong	Altered Expression	[3876]
FOXN1	OTE80D6I	Strong	Biomarker	[3877]
FOXN2	OTBPLTCM	Strong	Altered Expression	[3878]
FOXN3	OTOJYJZP	Strong	Altered Expression	[3879]
FOXO4	OT90X9LN	Strong	Biomarker	[3880]
FOXP4	OTHCGIEZ	Strong	Altered Expression	[3881]
FOXS1	OTPM9TZ5	Strong	Altered Expression	[3882]
FRK	OTEKV1SC	Strong	Biomarker	[1325]
FRMD4A	OTJDTIK2	Strong	Altered Expression	[3883]
FRMD5	OTC73XJK	Strong	Biomarker	[3884]
FRS3	OTTNP6H7	Strong	Biomarker	[3885]
FRY	OT74IAG2	Strong	Altered Expression	[3886]
FSTL1	OT6KEZUD	Strong	Biomarker	[3887]
FSTL5	OT18C29S	Strong	Altered Expression	[3888]
FTMT	OTIUX6XG	Strong	Biomarker	[3889]
FUBP1	OT77SC9N	Strong	Altered Expression	[2306]
FUCA1	OTW71IK4	Strong	Altered Expression	[3890]
FUNDC1	OTA6IVKQ	Strong	Altered Expression	[3891]
FUT2	OTLXM6WI	Strong	Altered Expression	[3892]
FUT6	OTBZUQ7F	Strong	Altered Expression	[3893]
FUT7	OTJF6BSN	Strong	Altered Expression	[3894]
FUT8	OTJJCVG1	Strong	Altered Expression	[3895]
FUT9	OTLIJBQY	Strong	Biomarker	[3896]
FXR1	OTEMQ1SR	Strong	Biomarker	[3822]
FZD2	OT952ML1	Strong	Altered Expression	[3897]
FZD3	OTIWDN78	Strong	Altered Expression	[3898]
FZD8	OTZ9IRFL	Strong	Biomarker	[3899]
FZD9	OTTZ9MKK	Strong	Biomarker	[3900]
FZR1	OT0WGWZS	Strong	Biomarker	[3901]
GAB3	OTKX1KEC	Strong	Altered Expression	[3902]
GABARAP	OTAQUX6E	Strong	Biomarker	[3903]
GABARAPL1	OT4U7SBG	Strong	Biomarker	[3904]
GADD45G	OT8V1J4M	Strong	Posttranslational Modification	[3905]
GADD45GIP1	OT4IZ4TP	Strong	Biomarker	[3906]
GAGE1	OT53E50E	Strong	Altered Expression	[3907]
GAGE6	OT5WRC1N	Strong	Biomarker	[3908]
GAGE7	OTF8BTR9	Strong	Biomarker	[3909]
GAL3ST1	OTSFFZRD	Strong	Biomarker	[3910]
GALNT14	OT9BSDDQ	Strong	Genetic Variation	[3911]
GALNT3	OT7M67WT	Strong	Altered Expression	[3912]
GALNT4	OT6WKC13	Strong	Altered Expression	[3913]
GALNT9	OTFRD9RI	Strong	Altered Expression	[3914]
GAS1	OTKJXG52	Strong	Altered Expression	[3915]
GAS2	OT50JKXQ	Strong	Biomarker	[3916]
GAS7	OT0M5TNY	Strong	Biomarker	[3917]
GAS8	OT8KT2AK	Strong	Biomarker	[3918]
GATA5	OTO81B63	Strong	Biomarker	[665]
GATA6	OTO2BC0F	Strong	Biomarker	[3919]
GATAD1	OT0UZ3EP	Strong	Biomarker	[3920]
GBE1	OTK2N05B	Strong	Biomarker	[3921]
GBP1	OTUM7RPJ	Strong	Biomarker	[3922]
GBP3	OT6WBFXS	Strong	Biomarker	[3923]
GBP4	OTSPNGKX	Strong	Biomarker	[113]
GBP5	OTS4AO4A	Strong	Altered Expression	[3924]
GC	OTWS63BY	Strong	Genetic Variation	[3925]
GCM1	OT5CPAUT	Strong	Altered Expression	[3926]
GCM2	OTSKNPTI	Strong	Altered Expression	[3926]
GCN1	OTBFVD7Z	Strong	Altered Expression	[3927]
GCNT2	OTRUIMC4	Strong	Altered Expression	[3928]
GCSAM	OTZNOPYK	Strong	Biomarker	[3929]
GDF1	OTZ1VRBH	Strong	Genetic Variation	[2343]
GDF10	OTEVXGJ7	Strong	Biomarker	[3930]
GDF11	OTOSNMND	Strong	Biomarker	[3931]
GDF6	OTERXWJU	Strong	Biomarker	[3932]
GDI2	OTGLY3I7	Strong	Biomarker	[3933]
GDPD2	OTKEPVWI	Strong	Altered Expression	[3934]
GEMIN2	OT4L6TLL	Strong	Altered Expression	[3935]
GEN1	OT1XFQXF	Strong	Altered Expression	[3936]
GFER	OTVK43OK	Strong	Biomarker	[3937]
GFM1	OTUN4V3N	Strong	Biomarker	[3938]
GFRA1	OT3WBVYB	Strong	Biomarker	[3939]
GFRA2	OT34CXNN	Strong	Biomarker	[3940]
GGA2	OT43HO27	Strong	Biomarker	[3941]
GGNBP2	OT7K9YZV	Strong	Biomarker	[3942]
GGPS1	OTVEHG28	Strong	Biomarker	[3943]
GGTLC1	OTWJKUHQ	Strong	Biomarker	[3944]
GH2	OT32TR4C	Strong	Altered Expression	[3945]
GIMAP5	OTMND7IR	Strong	Altered Expression	[3946]
GIMAP6	OTDKV8V8	Strong	Altered Expression	[3946]
GINS3	OT8NVXTD	Strong	Biomarker	[3947]
GIPC1	OTXLVCPJ	Strong	Biomarker	[3948]
GIPC2	OT68YFO1	Strong	Altered Expression	[3949]
GIT1	OTHO92S5	Strong	Biomarker	[3950]
GKN2	OTR9DOYG	Strong	Biomarker	[3951]
GLI3	OTKDOE94	Strong	Altered Expression	[3952]
GLIS1	OTBDNB26	Strong	Altered Expression	[3953]
GLRX3	OTUPAU1N	Strong	Altered Expression	[3954]
GLS2	OT08MSHL	Strong	Biomarker	[3955]
GLUD1	OTXKOCUH	Strong	Biomarker	[2049]
GMEB1	OT4F8RFH	Strong	Biomarker	[3956]
GNAT3	OTS96V19	Strong	Biomarker	[3957]
GNB1	OTLL7L74	Strong	Genetic Variation	[3958]
GNB2	OT3JPRCQ	Strong	Genetic Variation	[3959]
GNG4	OTOXNDI9	Strong	Altered Expression	[3960]
GNL3	OTILGYO4	Strong	Altered Expression	[3961]
GNLY	OTZJKA8C	Strong	Biomarker	[3962]
GNMT	OT0O2OQO	Strong	Biomarker	[3963]
GOLGA2	OT5S9KYM	Strong	Altered Expression	[3964]
GOLGA6A	OTHU9MRX	Strong	Biomarker	[682]
GOLGB1	OT2S0GK8	Strong	Genetic Variation	[3965]
GOLIM4	OTB5NV8A	Strong	Biomarker	[3966]
GOPC	OTRBGH71	Strong	Biomarker	[3967]
GORAB	OTP65YD7	Strong	Biomarker	[3968]
GORASP1	OTQS91S7	Strong	Biomarker	[1444]
GOSR1	OTX8TMVU	Strong	Biomarker	[3969]
GOT2	OT6XBWN0	Strong	Altered Expression	[3970]
GPAT3	OTJUGPK0	Strong	Biomarker	[3971]
GPC1	OTQKRSSV	Strong	Biomarker	[3972]
GPC5	OT8NR7GC	Strong	Biomarker	[3973]
GPC6	OTNJBESF	Strong	Altered Expression	[3974]
GPD2	OTV232Y7	Strong	Altered Expression	[3975]
GPKOW	OTGS3H0M	Strong	Biomarker	[3976]
GPR161	OT80FYA3	Strong	Genetic Variation	[3977]
GPR162	OTK4LT3K	Strong	Biomarker	[3978]
GPR37L1	OTOV08EV	Strong	Altered Expression	[3979]
GPR4	OTIBF32I	Strong	Altered Expression	[3980]
GPR42	OTEB0ROY	Strong	Biomarker	[397]
GPR50	OT0EJBM4	Strong	Biomarker	[3981]
GPR68	OT1NXSMN	Strong	Biomarker	[3982]
GPR75	OT8SPUGC	Strong	Biomarker	[3983]
GPRC5C	OT45AJT3	Strong	Biomarker	[103]
GPS1	OT97FRYE	Strong	Genetic Variation	[3506]
GPS2	OT065FSS	Strong	Biomarker	[3984]
GPSM1	OTA0SJBG	Strong	Biomarker	[3985]
GPSM2	OT6RPMRM	Strong	Altered Expression	[3986]
GPX3	OT6PK94R	Strong	Altered Expression	[3987]
GRAMD1A	OTV6U1ZN	Strong	Biomarker	[3988]
GRAP2	OTS5NIZ3	Strong	Posttranslational Modification	[404]
GRB10	OTCKXGRC	Strong	Altered Expression	[3989]
GRB7	OTF8Y9XY	Strong	Biomarker	[3990]
GREB1	OTU6ZA26	Strong	Altered Expression	[3991]
GRHL1	OTZ4MNEW	Strong	Altered Expression	[3992]
GRHL3	OT1V4ZEH	Strong	Altered Expression	[3993]
GRWD1	OT6M13ZV	Strong	Biomarker	[3994]
GSAP	OT33HG7E	Strong	Biomarker	[3995]
GSC	OT4DH7PR	Strong	Biomarker	[3996]
GSDMB	OTWA7P10	Strong	Biomarker	[3997]
GSDMC	OTVM43E3	Strong	Altered Expression	[3998]
GSDMD	OTH39BKI	Strong	Altered Expression	[826]
GSDME	OT1ZWY32	Strong	Biomarker	[3999]
GSG1L	OTP5YU8J	Strong	Genetic Variation	[4000]
GSTM3	OTLA2WJT	Strong	Biomarker	[4001]
GSX2	OTLA7BAI	Strong	Biomarker	[3734]
GTF2A1L	OTDQHVAI	Strong	Biomarker	[2983]
GTF2H1	OTCRXC6B	Strong	Biomarker	[3570]
GTF2H4	OTPD1DIU	Strong	Altered Expression	[4002]
GTF3C2	OTWDANLJ	Strong	Biomarker	[3425]
GTPBP4	OT6ZHAWC	Strong	Biomarker	[113]
GUCA2A	OTUSF75G	Strong	Biomarker	[1109]
GUCA2B	OTZERX04	Strong	Biomarker	[4003]
GYPB	OTESHUIX	Strong	Biomarker	[4004]
GYPE	OTBHAG6A	Strong	Biomarker	[4004]
GYS2	OTCKIUYR	Strong	Biomarker	[4005]
GZMM	OTEC5CWT	Strong	Biomarker	[4006]
H2AC14	OT5Y4MMC	Strong	Altered Expression	[1054]
H2AX	OT18UX57	Strong	Biomarker	[4007]
H2AZ1	OT3KJJNQ	Strong	Posttranslational Modification	[4008]
H3-3B	OT9XHQ3C	Strong	Genetic Variation	[4009]
H3-4	OTY6ITYF	Strong	Genetic Variation	[4010]
H3C1	OTGBGOZW	Strong	Genetic Variation	[4011]
H4C1	OTB71W46	Strong	Biomarker	[4012]
HABP2	OTAUIPW0	Strong	Altered Expression	[4013]
HACD1	OTEC7EP7	Strong	Biomarker	[956]
HADHA	OTO557N2	Strong	Biomarker	[4014]
HAND2	OTCXYW4Y	Strong	Biomarker	[4015]
HAP1	OT6SG0JQ	Strong	Altered Expression	[4016]
HAPLN1	OTXWR9TJ	Strong	Genetic Variation	[4017]
HAS3	OTPM8IL8	Strong	Biomarker	[4018]
HAT1	OT307KEN	Strong	Biomarker	[4019]
HAUS3	OTFNDWNE	Strong	Altered Expression	[4020]
HBD	OTRQG4WA	Strong	Biomarker	[4021]
HBP1	OTDPGGDV	Strong	Biomarker	[4022]
HBZ	OTMHGFSS	Strong	Biomarker	[4023]
HCCS	OTQE88BE	Strong	Genetic Variation	[4024]
HCFC1	OT0UCK62	Strong	Biomarker	[4025]
HCFC1R1	OTGDPS5C	Strong	Biomarker	[4026]
HCP5	OTV0YRI8	Strong	Altered Expression	[4027]
HCST	OTILCB4K	Strong	Biomarker	[4028]
HDGFL2	OTWX2GHS	Strong	Biomarker	[4029]
HDGFL3	OTNN7WYH	Strong	Biomarker	[4030]
HEATR1	OTOWIB9Z	Strong	Biomarker	[4031]
HEATR3	OTB52FZ4	Strong	Biomarker	[4032]
HECTD3	OTTGP4OK	Strong	Genetic Variation	[4033]
HELLS	OTVVV668	Strong	Altered Expression	[4034]
HELT	OTI77HDK	Strong	Biomarker	[4035]
HELZ	OTMKFJZY	Strong	Altered Expression	[4036]
HEPACAM	OT1MJ51D	Strong	Biomarker	[4037]
HERPUD1	OT9EROL6	Strong	Altered Expression	[4038]
HES1	OT8P19W2	Strong	Altered Expression	[4039]
HES6	OTWO5SCF	Strong	Altered Expression	[4040]
HEY1	OTJQL0I3	Strong	Altered Expression	[4041]
HEY2	OTU4J3ZI	Strong	Biomarker	[4042]
HEYL	OTN7BH79	Strong	Altered Expression	[4043]
HGD	OTTKLQOO	Strong	Biomarker	[4044]
HGS	OTCYYCAC	Strong	Altered Expression	[4045]
HHEX	OTLIUVYX	Strong	Biomarker	[4046]
HHIP	OT77RQYS	Strong	Altered Expression	[4047]
HHLA2	OTYBTVQS	Strong	Altered Expression	[4048]
HIBCH	OTU2VHWR	Strong	Altered Expression	[4049]
HIC1	OTI9TWY4	Strong	Biomarker	[4050]
HILPDA	OTEID3ZM	Strong	Biomarker	[4051]
HINT2	OTW9GS0U	Strong	Altered Expression	[4052]
HIP1	OT7AKCFQ	Strong	Biomarker	[4053]
HIVEP1	OT7CAG4A	Strong	Genetic Variation	[4054]
HK3	OTZKONGB	Strong	Genetic Variation	[4055]
HLA-C	OTV38BUJ	Strong	Genetic Variation	[4056]
HLA-DOA	OTZE5Q7R	Strong	Altered Expression	[4057]
HLA-DRB3	OT5PM9N7	Strong	Genetic Variation	[4058]
HLA-DRB5	OTUX5TWM	Strong	Genetic Variation	[4058]
HLA-E	OTX1CTFB	Strong	Biomarker	[927]
HLA-F	OT76CM19	Strong	Altered Expression	[4059]
HLF	OTTRK9XN	Strong	Genetic Variation	[4060]
HLTF	OTRX2OSF	Strong	Genetic Variation	[4061]
HLX	OT7DTH46	Strong	Biomarker	[4062]
HM13	OTGEO1LP	Strong	Biomarker	[4063]
HMGB3	OTCJ2EZY	Strong	Biomarker	[4064]
HMGN5	OTUUAHVQ	Strong	Altered Expression	[4065]
HMMR	OT4M0JTZ	Strong	Biomarker	[4066]
HNRNPF	OTSMBXMF	Strong	Biomarker	[4067]
HNRNPH1	OTFRWOLM	Strong	Altered Expression	[4068]
HNRNPK	OTNPRM8U	Strong	Biomarker	[4069]
HNRNPM	OTFU3OEZ	Strong	Biomarker	[4070]
HNRNPR	OT3FITK2	Strong	Biomarker	[1891]
HNRNPU	OTLQN1E2	Strong	Biomarker	[4071]
HOOK1	OTTTKV7V	Strong	Altered Expression	[4072]
HOOK2	OTPO4NQV	Strong	Altered Expression	[4073]
HOPX	OTBSR6C9	Strong	Biomarker	[4074]
HOXA1	OTMSOJ7D	Strong	Altered Expression	[4075]
HOXA10	OTB6GQ09	Strong	Biomarker	[4076]
HOXA2	OT6G6ZIK	Strong	Posttranslational Modification	[4077]
HOXA4	OTNVTQDT	Strong	Altered Expression	[4078]
HOXA6	OTHJP8M2	Strong	Altered Expression	[4079]
HOXB1	OTGC0EKI	Strong	Biomarker	[4080]
HOXB3	OT9UC5PE	Strong	Altered Expression	[4081]
HOXB4	OTH1HRW5	Strong	Altered Expression	[4082]
HOXB7	OTC7WYU8	Strong	Biomarker	[4083]
HOXB9	OTMVHQOU	Strong	Altered Expression	[4084]
HOXC10	OT5WF17M	Strong	Altered Expression	[4085]
HOXC11	OT8NMHM6	Strong	Biomarker	[4086]
HOXC13	OT52AVNA	Strong	Altered Expression	[4087]
HOXC4	OT52VJ6V	Strong	Altered Expression	[4088]
HOXC6	OTBCRAZV	Strong	Biomarker	[4089]
HOXC8	OTJUYU8J	Strong	Altered Expression	[4090]
HOXC9	OT60K4M0	Strong	Biomarker	[4091]
HOXD3	OTBUZ35T	Strong	Biomarker	[4092]
HOXD4	OTQR4WCG	Strong	Biomarker	[4093]
HOXD8	OTJ5H7AT	Strong	Biomarker	[4094]
HOXD9	OTZ4GVR1	Strong	Biomarker	[4095]
HPCA	OTERUPP6	Strong	Biomarker	[4096]
HPS5	OTLO2374	Strong	Biomarker	[3566]
HPSE2	OTGEPP8V	Strong	Biomarker	[4097]
HRG	OTPLUFOG	Strong	Altered Expression	[4098]
HRK	OTR4GWJ0	Strong	Biomarker	[4099]
HRNR	OT560QR5	Strong	Genetic Variation	[4100]
HS3ST2	OTWFA0GJ	Strong	Biomarker	[4101]
HS6ST3	OTTW9PDL	Strong	Biomarker	[4102]
HSD17B6	OTSB55D2	Strong	Biomarker	[4103]
HSDL2	OT4IN0MV	Strong	Altered Expression	[4104]
HSF2	OTXNJIJ9	Strong	Biomarker	[683]
HSPA1A	OTKGIE76	Strong	Biomarker	[4105]
HSPA2	OTSDET7B	Strong	Altered Expression	[4106]
HSPB7	OTLATAOV	Strong	Biomarker	[2899]
HSPH1	OTVRR73T	Strong	Biomarker	[4107]
HTRA2	OTC7616F	Strong	Altered Expression	[4108]
HTRA3	OTXJ0H4X	Strong	Biomarker	[4109]
HUNK	OTZR4GBH	Strong	Biomarker	[4110]
HUS1	OTY1XON9	Strong	Biomarker	[4111]
HUS1B	OT3VFQWS	Strong	Genetic Variation	[4112]
HUWE1	OTFH6BJS	Strong	Biomarker	[4113]
HYAL1	OT2SJN0X	Strong	Biomarker	[4114]
HYAL2	OTTVINXW	Strong	Biomarker	[4115]
HYOU1	OTBGBSOV	Strong	Biomarker	[4116]
IARS1	OT9WXH5N	Strong	Biomarker	[4117]
IBSP	OT29944Y	Strong	Biomarker	[4118]
IBTK	OTB2GM4G	Strong	Biomarker	[4119]
ICA1L	OTOAWHOI	Strong	Genetic Variation	[4120]
ICAM3	OTTZ5A5D	Strong	Biomarker	[4121]
ICAM5	OTDGGAFH	Strong	Genetic Variation	[1369]
ID3	OTUULW5Z	Strong	Biomarker	[4122]
IER2	OT5OY8BO	Strong	Biomarker	[4123]
IER5	OTJPTXMD	Strong	Biomarker	[4124]
IFI30	OT9DERT1	Strong	Biomarker	[4125]
IFIT1	OTXOQDSG	Strong	Altered Expression	[2091]
IFITM1	OTECO1G8	Strong	Altered Expression	[4126]
IFNA17	OTHXRYG3	Strong	Biomarker	[4127]
IFNA8	OTW0PCKU	Strong	Biomarker	[4128]
IFRD1	OT4SQMLQ	Strong	Biomarker	[4129]
IFRD2	OT2URF18	Strong	Biomarker	[4130]
IFT122	OTSK3OAD	Strong	Biomarker	[4131]
IFT20	OTKJS2BZ	Strong	Biomarker	[4132]
IFT88	OTDR3VBD	Strong	Biomarker	[4133]
IGF2BP1	OT9G360P	Strong	Biomarker	[4134]
IGF2BP2	OT4ZSEEE	Strong	Biomarker	[4135]
IGF2BP3	OTB97VIK	Strong	Altered Expression	[4136]
IGFBP4	OT2HZRBD	Strong	Biomarker	[4137]
IGLL5	OT9XQFL5	Strong	Genetic Variation	[881]
IGSF21	OTUFCXBS	Strong	Biomarker	[4138]
IGSF8	OTU22IKI	Strong	Altered Expression	[4139]
IHH	OT1DWGXC	Strong	Altered Expression	[4140]
IKBKG	OTNWJWSD	Strong	Genetic Variation	[302]
IL10RA	OTOX3D1D	Strong	Biomarker	[4141]
IL17B	OTS86H50	Strong	Biomarker	[4142]
IL17RA	OTVVI8ER	Strong	Biomarker	[4143]
IL17RB	OT0KDNSF	Strong	Biomarker	[4144]
IL18R1	OT83XMPQ	Strong	Biomarker	[4145]
IL22RA1	OTGVKLBR	Strong	Biomarker	[4146]
IL4I1	OTK54C63	Strong	Biomarker	[4147]
IL6R	OTCQL07Z	Strong	Altered Expression	[4148]
IL6ST	OT1N9C70	Strong	Biomarker	[4149]
IL9R	OTILCLXA	Strong	Biomarker	[4150]
IMMP1L	OTA6LOLR	Strong	Biomarker	[4063]
IMMP2L	OT9WGAFD	Strong	Biomarker	[4151]
IMPA1	OTBUVW1Z	Strong	Biomarker	[4152]
IMPACT	OTQ923OB	Strong	Biomarker	[1255]
INF2	OT8ZM13C	Strong	Biomarker	[4153]
ING3	OTDIJXFP	Strong	Biomarker	[4154]
ING5	OTRNNSFM	Strong	Biomarker	[4155]
INHA	OT7HWCO3	Strong	Biomarker	[4156]
INO80	OTJBMS8T	Strong	Biomarker	[4157]
INPP4B	OTLROA7G	Strong	Biomarker	[4158]
INPP5E	OTJF2AZ9	Strong	Biomarker	[4159]
INPPL1	OTCDAVBQ	Strong	Biomarker	[4160]
INSL3	OT7KUNTE	Strong	Biomarker	[4161]
INSL4	OTK9F0LX	Strong	Altered Expression	[4162]
INSRR	OT3F75WA	Strong	Altered Expression	[4163]
INTS11	OTOFT19G	Strong	Biomarker	[4164]
INTS3	OT7NX4CD	Strong	Biomarker	[4165]
IPO11	OTG19WN0	Strong	Altered Expression	[4166]
IPO9	OT1DGLQE	Strong	Biomarker	[4167]
IQGAP1	OTZRWTGA	Strong	Biomarker	[4168]
IQSEC1	OTK1PBFD	Strong	Biomarker	[4169]
IRF2	OTAZRUW3	Strong	Biomarker	[4170]
IRF5	OT8SIIAP	Strong	Biomarker	[4171]
IRF6	OTKJ44EV	Strong	Biomarker	[4172]
IRX1	OT0ZN9EJ	Strong	Biomarker	[4173]
IRX5	OT05J514	Strong	Biomarker	[4174]
ISCU	OTSW6DQP	Strong	Altered Expression	[4175]
ISL1	OTVNVKAX	Strong	Biomarker	[4176]
ISM1	OTZTK2TV	Strong	Biomarker	[4177]
ISOC1	OTAO7Z87	Strong	Altered Expression	[4178]
ITFG1	OTX0PCR3	Strong	Biomarker	[4179]
ITGB3BP	OT6Q7GR3	Strong	Biomarker	[4180]
ITGB5	OT21MF51	Strong	Altered Expression	[4181]
ITGBL1	OTJDHE17	Strong	Biomarker	[4182]
ITIH1	OTSXJGQF	Strong	Biomarker	[4183]
ITIH5	OTP46PZM	Strong	Biomarker	[4184]
ITM2A	OT590V63	Strong	Altered Expression	[4185]
ITM2B	OTMXEPXB	Strong	Biomarker	[4186]
ITPKB	OTSVVPAV	Strong	Biomarker	[4187]
IVL	OT4VPNGY	Strong	Biomarker	[3855]
IVNS1ABP	OTYHL4I7	Strong	Biomarker	[4188]
JADE3	OTEQR3MN	Strong	Biomarker	[4189]
JAM3	OTX0F9QL	Strong	Altered Expression	[4190]
JARID2	OT14UM8H	Strong	Biomarker	[4191]
JAZF1	OTXTYSYD	Strong	Genetic Variation	[4192]
JMJD8	OT4LA861	Strong	Biomarker	[4193]
JPH3	OTHTJO2I	Strong	Altered Expression	[4194]
JPH4	OTRLNPJK	Strong	Biomarker	[4195]
JTB	OT314JB6	Strong	Genetic Variation	[1060]
JUNB	OTG2JXV5	Strong	Altered Expression	[3868]
JUND	OTNKACJD	Strong	Altered Expression	[3868]
KANK1	OT2E7A6W	Strong	Altered Expression	[4196]
KANK2	OT3SZIWM	Strong	Biomarker	[4197]
KANSL1	OTYNSNNZ	Strong	Biomarker	[592]
KARS1	OT0EU4SV	Strong	Biomarker	[4198]
KATNB1	OT7CLZKS	Strong	Biomarker	[4199]
KCMF1	OTVTKFAU	Strong	Biomarker	[4200]
KCNE2	OTUO214Y	Strong	Biomarker	[4201]
KCNIP4	OTB1BS0X	Strong	Biomarker	[4202]
KCNJ12	OTYN1E1R	Strong	Altered Expression	[4203]
KCNJ8	OTZ8G8FE	Strong	Biomarker	[1128]
KCNK17	OTG2NEZM	Strong	Biomarker	[4204]
KCTD11	OT64DFBU	Strong	Biomarker	[4205]
KDM2B	OTDMCVW7	Strong	Biomarker	[4206]
KDM3B	OTZU5J5S	Strong	Biomarker	[4207]
KDM4B	OT5P1UPY	Strong	Biomarker	[4208]
KDM8	OTCN5ST8	Strong	Biomarker	[4209]
KIAA0753	OTMFT2I9	Strong	Biomarker	[4210]
KIAA1549	OTA5B18F	Strong	Genetic Variation	[4211]
KIDINS220	OTLBH2MA	Strong	Biomarker	[4212]
KIF18A	OTSMBJ24	Strong	Altered Expression	[4213]
KIF18B	OTOBUDOE	Strong	Biomarker	[4214]
KIF1A	OT3JVEGV	Strong	Biomarker	[4215]
KIF20A	OTXOQHE0	Strong	Altered Expression	[4216]
KIF21A	OT511XD9	Strong	Biomarker	[4217]
KIF22	OTY6X6BL	Strong	Biomarker	[4218]
KIF23	OTY850JC	Strong	Altered Expression	[4219]
KIF2A	OT2WQ6QD	Strong	Altered Expression	[4220]
KIF2C	OTJ8G3NP	Strong	Genetic Variation	[4221]
KIF3A	OTMUBSSK	Strong	Biomarker	[4222]
KIF4A	OT3UWL7D	Strong	Altered Expression	[4223]
KIF5B	OTT34MT8	Strong	Altered Expression	[4224]
KIF5C	OT35570Y	Strong	Altered Expression	[4225]
KIF7	OT1J6NAW	Strong	Biomarker	[4226]
KIFC1	OTNQDS00	Strong	Altered Expression	[4227]
KIN	OTB2DNQU	Strong	Biomarker	[682]
KIR3DL1	OTPOSXFX	Strong	Genetic Variation	[763]
KLC4	OTACUFB2	Strong	Biomarker	[4228]
KLF11	OTKVQDJD	Strong	Biomarker	[4229]
KLF12	OTVH4KD4	Strong	Altered Expression	[4230]
KLF13	OTMIKHZ4	Strong	Biomarker	[4231]
KLF14	OT8BXLBS	Strong	Altered Expression	[2402]
KLF15	OTGMQMVR	Strong	Altered Expression	[4232]
KLF17	OT5NWVP7	Strong	Biomarker	[4233]
KLF2	OTIP1UFX	Strong	Biomarker	[4234]
KLF3	OTIIAC18	Strong	Altered Expression	[4235]
KLHDC2	OTBHH882	Strong	Biomarker	[4236]
KLHDC8B	OTKP6LCR	Strong	Biomarker	[3389]
KLHL1	OTAX6SAD	Strong	Altered Expression	[376]
KLHL2	OT1NG8V7	Strong	Biomarker	[4237]
KLHL21	OT28Y2LQ	Strong	Altered Expression	[4238]
KLHL22	OTNRE2DW	Strong	Biomarker	[4239]
KLHL31	OTXZVWDL	Strong	Biomarker	[4240]
KLHL35	OT1DL3FY	Strong	Genetic Variation	[3460]
KLHL5	OTRDVST4	Strong	Biomarker	[4240]
KLHL6	OTLDECOX	Strong	Biomarker	[4241]
KLHL9	OTRGEG3Z	Strong	Biomarker	[4242]
KLK10	OTD573EL	Strong	Altered Expression	[4243]
KLK11	OT5PKX7Y	Strong	Altered Expression	[4244]
KLK15	OT7BVG17	Strong	Altered Expression	[4245]
KLK9	OTGJWBIF	Strong	Altered Expression	[4244]
KLLN	OTV3FPH0	Strong	Biomarker	[4246]
KLRD1	OTMYLOV4	Strong	Biomarker	[4247]
KLRF1	OTGHZ7FU	Strong	Altered Expression	[4248]
KMT2B	OTMMAZQX	Strong	Altered Expression	[4249]
KMT2C	OTC59BCO	Strong	Genetic Variation	[4250]
KMT2D	OTTVHCLY	Strong	Altered Expression	[4249]
KMT2E	OTYOLNOG	Strong	Biomarker	[4251]
KNL1	OT4Q3LHV	Strong	Altered Expression	[4252]
KPNA3	OTLI3TM2	Strong	Altered Expression	[4253]
KPNA4	OTP0EX18	Strong	Biomarker	[4254]
KREMEN1	OTGJFSAC	Strong	Genetic Variation	[4255]
KRT1	OTIOJWA4	Strong	Biomarker	[4256]
KRT10	OTSVRD3Q	Strong	Biomarker	[4257]
KRT13	OTTYSKGX	Strong	Biomarker	[4258]
KRT18	OTVLQFIP	Strong	Altered Expression	[4259]
KRT23	OTQW6UAG	Strong	Biomarker	[4260]
KRT31	OTB6RCAH	Strong	Biomarker	[3078]
KRT36	OT4O2GDY	Strong	Biomarker	[3397]
KRT4	OT24PHPM	Strong	Biomarker	[745]
KRT75	OT28B9E6	Strong	Genetic Variation	[4261]
KRT76	OT2V7AP3	Strong	Biomarker	[4262]
KRT8	OTTM4X11	Strong	Altered Expression	[4263]
KRT80	OTAU54U3	Strong	Altered Expression	[4264]
KTN1	OTQAV541	Strong	Genetic Variation	[4265]
L1TD1	OTB2W20Y	Strong	Biomarker	[4266]
L3MBTL1	OT8M52QY	Strong	Biomarker	[4267]
L3MBTL2	OTKX1XIX	Strong	Biomarker	[4267]
LACTB	OTRWGNBF	Strong	Biomarker	[4268]
LAD1	OT6YGTVX	Strong	Altered Expression	[4269]
LAMA1	OTQZMP86	Strong	Biomarker	[4270]
LAMA3	OTFME7HT	Strong	Genetic Variation	[4271]
LAMA5	OTIIXE4M	Strong	Biomarker	[4272]
LAMC1	OTIG527N	Strong	Biomarker	[4273]
LAMP3	OTN0XL3W	Strong	Biomarker	[1883]
LAMTOR2	OTHEDISB	Strong	Biomarker	[3348]
LARGE1	OTUH7H9F	Strong	Biomarker	[4274]
LARP4	OTB10IJH	Strong	Biomarker	[4275]
LARP4B	OT2HI0QE	Strong	Biomarker	[4276]
LARS1	OT4557NF	Strong	Altered Expression	[4277]
LAT	OTZC1XZ1	Strong	Biomarker	[1290]
LAT2	OTWJDKIH	Strong	Biomarker	[4278]
LATS1	OTOOCG4R	Strong	Biomarker	[2066]
LAYN	OT9A9Q1X	Strong	Altered Expression	[4279]
LCN1	OT8BWXTV	Strong	Biomarker	[4280]
LCOR	OT1K7DKB	Strong	Altered Expression	[4281]
LCP1	OTK61F2A	Strong	Genetic Variation	[4282]
LDB1	OT20EAPR	Strong	Altered Expression	[4283]
LDHB	OT9B1CT3	Strong	Genetic Variation	[4284]
LDLRAP1	OT6QTX7R	Strong	Biomarker	[1359]
LECT2	OTSFZ9JD	Strong	Biomarker	[4285]
LEF1	OTWS5I5H	Strong	Biomarker	[4286]
LEFTY1	OT51HVC4	Strong	Altered Expression	[4287]
LEMD2	OT0YLT7L	Strong	Biomarker	[4288]
LGALS3BP	OT9AGQKH	Strong	Biomarker	[4289]
LGALS4	OTKQCG0H	Strong	Biomarker	[4290]
LGALS8	OT71LJ8T	Strong	Biomarker	[4291]
LGALS9	OT7MF91K	Strong	Altered Expression	[4292]
LGSN	OTQG5Z82	Strong	Biomarker	[4293]
LHFPL3	OTG1EI22	Strong	Biomarker	[4294]
LHFPL6	OTY6LHJY	Strong	Genetic Variation	[4295]
LHX1	OT6WI2XS	Strong	Altered Expression	[4296]
LHX2	OTK61NP8	Strong	Biomarker	[4297]
LHX6	OT47UQZ5	Strong	Altered Expression	[4298]
LIG1	OTEEQS43	Strong	Altered Expression	[4299]
LIG4	OT40DNXU	Strong	Altered Expression	[4300]
LILRA2	OT1O2K47	Strong	Biomarker	[2521]
LIMA1	OTONPC9R	Strong	Biomarker	[4301]
LIMCH1	OTYPC4XA	Strong	Altered Expression	[4302]
LIME1	OTJWUQSK	Strong	Altered Expression	[4303]
LIN28B	OTVWP0FN	Strong	Biomarker	[4304]
LIN7A	OTFL3PUX	Strong	Biomarker	[4305]
LIN9	OTLHW00C	Strong	Biomarker	[4306]
LIPC	OTZY5SC9	Strong	Altered Expression	[4307]
LIPI	OTSO833D	Strong	Biomarker	[4308]
LITAF	OTT5JX1F	Strong	Biomarker	[4309]
LLGL2	OTU8ZDC4	Strong	Biomarker	[4310]
LMAN1	OTYHKDEO	Strong	Biomarker	[4311]
LMLN	OTQF0JPY	Strong	Posttranslational Modification	[4312]
LMNB2	OTXRDUOS	Strong	Altered Expression	[4313]
LMO1	OTB59SKB	Strong	Altered Expression	[4314]
LMO4	OT5NDCT9	Strong	Altered Expression	[4315]
LMO7	OTDLY6TC	Strong	Biomarker	[4316]
LMTK2	OT93MVIC	Strong	Biomarker	[4317]
LNX1	OTZWFMAZ	Strong	Biomarker	[4318]
LORICRIN	OTFRPVEO	Strong	Altered Expression	[4319]
LOXL1	OTA0NEJU	Strong	Biomarker	[4320]
LOXL3	OTLLY1QI	Strong	Biomarker	[4321]
LPCAT3	OTWI96P4	Strong	Biomarker	[4322]
LPIN1	OTQ75KF2	Strong	Biomarker	[4323]
LPXN	OTUNV3CK	Strong	Altered Expression	[4324]
LRATD1	OT65IL83	Strong	Altered Expression	[4325]
LRIG1	OTY5HZN5	Strong	Biomarker	[4326]
LRIG2	OTDUBLIH	Strong	Altered Expression	[4327]
LRP11	OTQNI7L8	Strong	Biomarker	[4328]
LRP1B	OT4YZG2N	Strong	Biomarker	[4329]
LRPAP1	OT6DVD2Q	Strong	Biomarker	[4330]
LRPPRC	OTXSK5LP	Strong	Biomarker	[4149]
LRRC1	OTSVD30Q	Strong	Altered Expression	[4331]
LRRC15	OTX7JL8H	Strong	Biomarker	[4332]
LRRC2	OTX6P291	Strong	Biomarker	[4333]
LRRC3B	OT9VDGPR	Strong	Biomarker	[4334]
LRRC8A	OT23OE7H	Strong	Altered Expression	[4335]
LSR	OTR8Y32X	Strong	Biomarker	[4336]
LST1	OTUVG424	Strong	Biomarker	[4337]
LTBP1	OTR7Q75L	Strong	Biomarker	[2851]
LTBP2	OTS88GSD	Strong	Biomarker	[4338]
LTBP3	OTME98V7	Strong	Biomarker	[4339]
LTBP4	OTC8WL2V	Strong	Altered Expression	[4340]
LTO1	OTQ17ZDT	Strong	Altered Expression	[4341]
LUZP2	OTGGOSPW	Strong	Altered Expression	[4342]
LXN	OTZQ2M6Y	Strong	Biomarker	[4343]
LY6E	OTMG16BZ	Strong	Altered Expression	[4344]
LYG1	OT9ET9XJ	Strong	Biomarker	[4345]
LYPD3	OTLR2PYX	Strong	Biomarker	[4346]
LYPD4	OTYNO8BS	Strong	Biomarker	[4347]
LYPLA1	OTENU47T	Strong	Biomarker	[4348]
LYRM2	OTET3S6H	Strong	Biomarker	[4349]
LYST	OTIUB1B3	Strong	Biomarker	[4350]
LZTFL1	OTIEIOEW	Strong	Biomarker	[4351]
LZTS1	OTXXL864	Strong	Biomarker	[3028]
LZTS2	OTQFSQEE	Strong	Posttranslational Modification	[4352]
LZTS3	OTFFMOJN	Strong	Biomarker	[4353]
MACF1	OTVIHD77	Strong	Altered Expression	[4354]
MACROH2A1	OTV2DQDD	Strong	Genetic Variation	[4355]
MACROH2A2	OTAKSVYV	Strong	Biomarker	[4356]
MAD2L1	OTXNGZCG	Strong	Altered Expression	[4357]
MADD	OTUFYVGG	Strong	Biomarker	[4358]
MAEL	OTZ2VU30	Strong	Biomarker	[4359]
MAF	OT1GR3IZ	Strong	Biomarker	[4360]
MAF1	OTKB0N8Q	Strong	Altered Expression	[4361]
MAFB	OTH2N3T8	Strong	Altered Expression	[4362]
MAFG	OTBQFUZH	Strong	Altered Expression	[4363]
MAGEB2	OTAGUVU5	Strong	Altered Expression	[3520]
MAGEB6	OTOTV1FU	Strong	Biomarker	[4364]
MAGED1	OT6EOLFC	Strong	Biomarker	[4365]
MAGEE1	OTOQQO2X	Strong	Biomarker	[808]
MAGEF1	OTUU40U3	Strong	Biomarker	[4366]
MAGEH1	OTVE05K7	Strong	Biomarker	[4367]
MAGI1	OTMV4ASV	Strong	Biomarker	[4368]
MAGI3	OTDJ5QUH	Strong	Altered Expression	[4369]
MAK	OTEU2G41	Strong	Biomarker	[4370]
MAK16	OTD546E5	Strong	Biomarker	[4371]
MALL	OTKGZ89D	Strong	Genetic Variation	[4372]
MAML1	OTQA4DDN	Strong	Altered Expression	[4373]
MAN1A1	OT6LIGJP	Strong	Biomarker	[4374]
MAN1C1	OT44TM7D	Strong	Biomarker	[4375]
MAP1B	OTVXW089	Strong	Posttranslational Modification	[2660]
MAP1LC3A	OTPMGIU4	Strong	Biomarker	[4376]
MAP1LC3C	OTM4ECDK	Strong	Biomarker	[3129]
MAP2K3	OTI2OREX	Strong	Biomarker	[4377]
MAP2K6	OTK13JKC	Strong	Biomarker	[4378]
MAP6	OTPUI00F	Strong	Genetic Variation	[4379]
MAPK15	OT8SW0L7	Strong	Biomarker	[4380]
MAPK4	OTVWWUYS	Strong	Altered Expression	[4381]
MAPK8IP2	OTDUHLN0	Strong	Biomarker	[4382]
MAPRE2	OTAE3MX4	Strong	Altered Expression	[3039]
MARCHF1	OTI2EYO6	Strong	Biomarker	[4383]
MARCHF11	OTODNSYN	Strong	Biomarker	[4384]
MARCHF8	OTH7PNN2	Strong	Biomarker	[4385]
MARCHF9	OTWF84QT	Strong	Biomarker	[4386]
MARCO	OT0NW2Q0	Strong	Biomarker	[4387]
MARK1	OTP7KL47	Strong	Biomarker	[4388]
MARVELD1	OT5CPOJE	Strong	Biomarker	[4389]
MAST2	OT85GLPP	Strong	Altered Expression	[4390]
MATN3	OTH9H74J	Strong	Biomarker	[4391]
MAU2	OTALDF8Q	Strong	Biomarker	[4392]
MB	OTYWYL2D	Strong	Altered Expression	[4393]
MBD1	OTD19VO6	Strong	Biomarker	[4394]
MBD6	OTDHBSFS	Strong	Altered Expression	[4395]
MBNL1	OTOV7J85	Strong	Biomarker	[3020]
MBTD1	OT2P6943	Strong	Biomarker	[4396]
MCAT	OTH07FIW	Strong	Biomarker	[574]
MCC	OTQVI1EM	Strong	Biomarker	[4397]
MCF2L	OTEURA8N	Strong	Biomarker	[3574]
MCIDAS	OTK1JVAH	Strong	Genetic Variation	[4000]
MCM10	OTV0O3JN	Strong	Biomarker	[4398]
MCM2	OTGGORIQ	Strong	Altered Expression	[1003]
MCM3AP	OT895FEC	Strong	Biomarker	[4399]
MCM4	OT19PNNG	Strong	Altered Expression	[4400]
MCM9	OTALGFW8	Strong	Biomarker	[4401]
MCOLN2	OTU3V04B	Strong	Biomarker	[4402]
MCRS1	OT8K2X8P	Strong	Biomarker	[4403]
MCTS1	OT7SAOJP	Strong	Biomarker	[574]
MDFI	OTIA6YUG	Strong	Biomarker	[4404]
MDFIC	OTSRYBWZ	Strong	Biomarker	[4404]
MDH1	OTJEO4E8	Strong	Biomarker	[4405]
MDH2	OT7364GY	Strong	Biomarker	[4406]
MDP1	OTLUZISP	Strong	Altered Expression	[4407]
ME3	OT3XMLYG	Strong	Biomarker	[4408]
MED18	OT6M6CQ8	Strong	Biomarker	[4409]
MED19	OTT9RT5N	Strong	Biomarker	[4410]
MED20	OTWLPQAP	Strong	Biomarker	[4411]
MED23	OTKZQT0R	Strong	Altered Expression	[4412]
MED24	OTU4SJQ1	Strong	Biomarker	[4411]
MED25	OTDBY87B	Strong	Biomarker	[4413]
MED29	OTFD4SGK	Strong	Biomarker	[4414]
MED30	OTM3INJN	Strong	Biomarker	[4415]
MED7	OTGF64SM	Strong	Altered Expression	[4416]
MEF2A	OTV2SF6E	Strong	Altered Expression	[2548]
MEF2D	OT7CEIG0	Strong	Biomarker	[4417]
MEFV	OTRJ6S6K	Strong	Biomarker	[3722]
MEGF6	OTEUYTP1	Strong	Biomarker	[4418]
MEGF8	OT5G38CH	Strong	Altered Expression	[4419]
MEIS1	OTH9DKAD	Strong	Biomarker	[4420]
MEIS2	OTG4ADLM	Strong	Biomarker	[4420]
MESP1	OTY5QDBN	Strong	Biomarker	[4421]
MEST	OT8Q4U8Y	Strong	Altered Expression	[4422]
METTL1	OTRQC5ER	Strong	Altered Expression	[4423]
METTL3	OTSXP1M3	Strong	Posttranslational Modification	[4424]
METTL4	OT061H4E	Strong	Altered Expression	[4425]
METTL8	OT7E09Y4	Strong	Biomarker	[4179]
MFAP1	OTZN4FT3	Strong	Altered Expression	[1686]
MFAP5	OT46VXSG	Strong	Altered Expression	[4426]
MFF	OTEVIXOM	Strong	Altered Expression	[1438]
MFN1	OTCBXQZF	Strong	Biomarker	[4427]
MFSD12	OT54Y9TN	Strong	Biomarker	[4428]
MFSD13A	OTP306N2	Strong	Biomarker	[4429]
MFSD4A	OTUO018X	Strong	Biomarker	[4430]
MGAT3	OTXI5X4T	Strong	Biomarker	[149]
MGAT5	OTU4DD4G	Strong	Altered Expression	[4431]
MGP	OTZWU3FU	Strong	Biomarker	[4432]
MICB	OTS2DVDW	Strong	Altered Expression	[4433]
MICU1	OTS7N0LE	Strong	Posttranslational Modification	[4434]
MIEF1	OTFSP3FS	Strong	Biomarker	[4435]
MIER3	OTL5BGOB	Strong	Biomarker	[4436]
MIF4GD	OTEUG1GR	Strong	Altered Expression	[4437]
MIIP	OT79EXZ7	Strong	Biomarker	[4438]
MINDY4	OTBZ2SZB	Strong	Biomarker	[4439]
MIP	OTEBLU3E	Strong	Biomarker	[4440]
MITF	OT6XJCZH	Strong	Altered Expression	[4441]
MKS1	OT83W5PB	Strong	Biomarker	[1776]
MLC1	OTCNZLSP	Strong	Biomarker	[4442]
MLEC	OTOPGRF5	Strong	Biomarker	[4443]
MLKL	OTDSLC81	Strong	Altered Expression	[4444]
MLLT11	OTG5RVHC	Strong	Biomarker	[4445]
MLLT3	OTXH4DDG	Strong	Posttranslational Modification	[4446]
MLN	OTBZ5SE5	Strong	Biomarker	[4447]
MLPH	OT7ADCXL	Strong	Altered Expression	[4448]
MLST8	OT8DNJSD	Strong	Genetic Variation	[4449]
MLXIP	OT30UNI7	Strong	Biomarker	[4385]
MMD	OTB5I4OC	Strong	Biomarker	[4450]
MMP19	OTLSTT2B	Strong	Altered Expression	[4451]
MMP20	OT16S5S3	Strong	Biomarker	[4452]
MMP25	OT3BG37V	Strong	Altered Expression	[4452]
MMP26	OT9O89KU	Strong	Biomarker	[4453]
MMP28	OTHQZXM1	Strong	Biomarker	[4454]
MMRN1	OT7ZNYHT	Strong	Biomarker	[4455]
MMUT	OTBBBV70	Strong	Genetic Variation	[4456]
MNAT1	OTXLOYCB	Strong	Biomarker	[4457]
MNT	OTPC4ANL	Strong	Genetic Variation	[4458]
MOB1A	OTSPBZ4Z	Strong	Biomarker	[4459]
MOB1B	OTRE19ZS	Strong	Biomarker	[4460]
MOB2	OTMBE0NS	Strong	Biomarker	[4461]
MOB4	OTOQRMAS	Strong	Biomarker	[4459]
MOK	OTQK7M9V	Strong	Biomarker	[605]
MORN3	OTIHVIPR	Strong	Altered Expression	[4462]
MPC2	OT0GHXGG	Strong	Altered Expression	[4463]
MPDZ	OT9WY1QM	Strong	Posttranslational Modification	[4464]
MPEG1	OT7DAO0F	Strong	Biomarker	[4465]
MPG	OTAHW80B	Strong	Genetic Variation	[4466]
MPHOSPH10	OT8DJTO7	Strong	Biomarker	[4467]
MPHOSPH6	OT6E2S48	Strong	Biomarker	[4468]
MPP2	OTPH8CZY	Strong	Altered Expression	[4469]
MPP3	OTNOL0HA	Strong	Altered Expression	[4470]
MPPE1	OTINBJVE	Strong	Biomarker	[4471]
MR1	OTZU3XX7	Strong	Altered Expression	[4472]
MRGPRD	OTTMOJ8U	Strong	Altered Expression	[4473]
MRPL13	OT6D8Y9G	Strong	Altered Expression	[4474]
MRPL41	OTG5URO4	Strong	Biomarker	[4475]
MRPS23	OTDVWT5V	Strong	Altered Expression	[4476]
MS4A3	OT0CEJOO	Strong	Altered Expression	[4477]
MSC	OTBRPZL5	Strong	Biomarker	[4478]
MSX1	OT5U41ZP	Strong	Altered Expression	[4479]
MSX2	OT1WDKE1	Strong	Biomarker	[3491]
MTA3	OTIA6C79	Strong	Biomarker	[4480]
MTF2	OTNL1O2O	Strong	Biomarker	[4481]
MTFP1	OT3L6F7U	Strong	Altered Expression	[4482]
MTHFD1L	OTV01EFP	Strong	Biomarker	[4483]
MTMR11	OTHL2O08	Strong	Genetic Variation	[2152]
MTMR7	OT47NVYM	Strong	Altered Expression	[4484]
MTO1	OT7HCZ1D	Strong	Altered Expression	[4485]
MTPAP	OT6HQ02S	Strong	Biomarker	[1196]
MTSS1	OT5DTDO2	Strong	Biomarker	[4486]
MTUS1	OTBPALMU	Strong	Biomarker	[4487]
MTX1	OTLSDNZO	Strong	Biomarker	[4488]
MUC20	OTYYE1GK	Strong	Biomarker	[4489]
MUC21	OTQ8GP5L	Strong	Altered Expression	[4490]
MUC5B	OTPW6K5C	Strong	Biomarker	[4491]
MUCL1	OT9QUFL3	Strong	Altered Expression	[4492]
MUL1	OT2JC9YR	Strong	Genetic Variation	[3266]
MUS81	OTVZ4E60	Strong	Genetic Variation	[4493]
MXD1	OTS5CTHX	Strong	Altered Expression	[4494]
MXD4	OTUCXFRO	Strong	Biomarker	[4495]
MYBBP1A	OTIVEMIU	Strong	Biomarker	[4496]
MYBL2	OTZ3JX8Q	Strong	Altered Expression	[4497]
MYBPH	OTQJBPUR	Strong	Biomarker	[4498]
MYCL	OT1MFQ5U	Strong	Biomarker	[4499]
MYCT1	OTZ8A9L3	Strong	Biomarker	[4500]
MYF5	OTTVO2S5	Strong	Biomarker	[4501]
MYH6	OT3YNCH1	Strong	Biomarker	[4502]
MYH8	OT9F350W	Strong	Genetic Variation	[4112]
MYL2	OT78PC0C	Strong	Biomarker	[3960]
MYL9	OT6B22JB	Strong	Altered Expression	[4503]
MYLIP	OTL0PFGV	Strong	Altered Expression	[4504]
MYO18B	OTGYY4NK	Strong	Biomarker	[4505]
MYO1A	OTS80FOD	Strong	Altered Expression	[4506]
MYO1B	OTGZUJ0I	Strong	Altered Expression	[4507]
MYO1C	OT69L39Y	Strong	Altered Expression	[4508]
MYO1D	OTP2RGPN	Strong	Biomarker	[4509]
MYO1E	OTM9YSIZ	Strong	Altered Expression	[4508]
MYO5B	OTCKL3W3	Strong	Biomarker	[4510]
MYOCD	OTSJNHTH	Strong	Biomarker	[4511]
MYOD1	OTV2S79X	Strong	Biomarker	[4512]
MYOG	OTPLJKFA	Strong	Biomarker	[4512]
MYPOP	OTXR94P3	Strong	Biomarker	[4513]
MYRF	OTKF6AEB	Strong	Biomarker	[4514]
MYSM1	OTO73N00	Strong	Biomarker	[4515]
MYT1	OTC3660I	Strong	Genetic Variation	[1027]
MYT1L	OTV45MAS	Strong	Biomarker	[4516]
MZB1	OT071TET	Strong	Biomarker	[289]
NAA10	OTYB9R6I	Strong	Altered Expression	[4517]
NAA15	OT53SIZG	Strong	Biomarker	[4518]
NAA25	OTS3QVF1	Strong	Biomarker	[4071]
NAA40	OTFLRVQO	Strong	Altered Expression	[4519]
NABP1	OTFTNFHW	Strong	Biomarker	[4520]
NAIF1	OT0B3H72	Strong	Biomarker	[4521]
NAIP	OTLA925F	Strong	Biomarker	[4522]
NANOG	OTUEY1FM	Strong	Biomarker	[4523]
NANOS1	OT3UNZZY	Strong	Biomarker	[4524]
NANP	OTR0RNB1	Strong	Biomarker	[1634]
NANS	OTMQ2FUH	Strong	Biomarker	[4525]
NAP1L1	OTI7WBZV	Strong	Biomarker	[4526]
NAT8L	OTA96AVN	Strong	Biomarker	[4527]
NAV3	OT97M1TR	Strong	Genetic Variation	[4528]
NAXE	OTRZPISQ	Strong	Biomarker	[4529]
NBAS	OTW9IBRI	Strong	Biomarker	[1034]
NBEA	OTYLY5TY	Strong	Biomarker	[4530]
NBEAL2	OTMCAXWR	Strong	Altered Expression	[4531]
NBL1	OTT37U4O	Strong	Biomarker	[4532]
NBPF1	OTAZ55UQ	Strong	Biomarker	[4533]
NCAPD3	OTOZY2UL	Strong	Biomarker	[4534]
NCAPG	OT1AI9EO	Strong	Biomarker	[4535]
NCAPG2	OTZYENKO	Strong	Altered Expression	[4536]
NCK2	OTUYPF55	Strong	Biomarker	[4537]
NCKIPSD	OT24UORN	Strong	Biomarker	[4538]
NCOA1	OTLIUJQD	Strong	Biomarker	[4539]
NCOA5	OTOGWTWB	Strong	Posttranslational Modification	[4540]
NCOA6	OTOMIGTV	Strong	Altered Expression	[4541]
NCOR1	OT04XNOU	Strong	Biomarker	[4542]
NCR2	OT2H13BX	Strong	Altered Expression	[4543]
NCR3	OT20M764	Strong	Altered Expression	[4544]
NCR3LG1	OT15YWU7	Strong	Altered Expression	[4545]
ND3	OT1OC3K3	Strong	Genetic Variation	[4546]
NDC1	OTF2GQC1	Strong	Altered Expression	[4547]
NDC80	OTS7D306	Strong	Biomarker	[669]
NDE1	OT2N8Q17	Strong	Biomarker	[4548]
NDRG3	OTJTJCHD	Strong	Altered Expression	[4549]
NDRG4	OTJBOTD8	Strong	Altered Expression	[4550]
NDST1	OT9E10W2	Strong	Biomarker	[4551]
NDST4	OTEKG7JJ	Strong	Biomarker	[4552]
NDUFA4L2	OTK0PG7R	Strong	Biomarker	[4553]
NDUFAB1	OTF906UR	Strong	Biomarker	[4554]
NDUFB6	OTIXNT91	Strong	Biomarker	[4555]
NDUFS1	OTTIZDFR	Strong	Biomarker	[4556]
NDUFS8	OTMEAWKO	Strong	Biomarker	[4556]
NECTIN1	OTTE5ZR6	Strong	Biomarker	[3139]
NECTIN2	OTIE0W6O	Strong	Altered Expression	[4557]
NEDD4L	OT1B19RU	Strong	Biomarker	[4558]
NEFH	OTMSCW5I	Strong	Biomarker	[4559]
NEFM	OT8VCBNF	Strong	Biomarker	[4560]
NEGR1	OT57ECW9	Strong	Altered Expression	[4561]
NEIL2	OTV6JEON	Strong	Genetic Variation	[4562]
NEK10	OTN0JAYL	Strong	Biomarker	[4563]
NELFCD	OTOLTZPU	Strong	Altered Expression	[4564]
NELL2	OTS4MJZ7	Strong	Biomarker	[4565]
NEMF	OT9DK06P	Strong	Biomarker	[4566]
NEO1	OTGJ1997	Strong	Biomarker	[4567]
NEU4	OTM16O9F	Strong	Altered Expression	[4568]
NEUROD2	OTJMMX9K	Strong	Biomarker	[4569]
NEUROG1	OTMJZP9G	Strong	Biomarker	[4570]
NEUROG3	OT6DIPWC	Strong	Genetic Variation	[4571]
NFASC	OTBDUXZT	Strong	Altered Expression	[4572]
NFAT5	OTKIE59S	Strong	Biomarker	[4573]
NFATC3	OTYOORME	Strong	Altered Expression	[4574]
NFATC4	OTTDCUAO	Strong	Altered Expression	[4575]
NFE2	OTLM94BI	Strong	Genetic Variation	[4576]
NFE2L1	OT1QHOS2	Strong	Biomarker	[4577]
NFIA	OTDHQ9CG	Strong	Altered Expression	[4578]
NFIC	OTLMCUIB	Strong	Biomarker	[4579]
NFIL3	OTQH9HM3	Strong	Altered Expression	[4580]
NFYA	OTWFFOVH	Strong	Altered Expression	[4581]
NGB	OTW0SIUY	Strong	Biomarker	[4582]
NHS	OTKE8QAT	Strong	Biomarker	[4583]
NIBAN1	OTYOLI12	Strong	Biomarker	[4584]
NID1	OTKLBLS6	Strong	Altered Expression	[4585]
NID2	OTHC33FF	Strong	Posttranslational Modification	[4586]
NINJ1	OTLRZ1EU	Strong	Biomarker	[4587]
NINL	OTWIK6HT	Strong	Biomarker	[4588]
NIPBL	OTF6OOLU	Strong	Altered Expression	[4589]
NIT1	OT1KHPKJ	Strong	Biomarker	[4590]
NIT2	OTC1RAH3	Strong	Biomarker	[4591]
NKAP	OT7K7I8Q	Strong	Biomarker	[4592]
NKD1	OTY3MO97	Strong	Biomarker	[4593]
NKD2	OTCYT3I6	Strong	Altered Expression	[4594]
NKRF	OTUVY0P6	Strong	Altered Expression	[4595]
NKX2-5	OTS1SAWM	Strong	Altered Expression	[4596]
NKX2-8	OT6Q3DJ0	Strong	Genetic Variation	[4597]
NKX6-2	OT7FI94W	Strong	Biomarker	[4598]
NLGN2	OTHDYL3H	Strong	Biomarker	[4599]
NLGN3	OTKDEC1Q	Strong	Biomarker	[4600]
NLGN4X	OTDJGBK8	Strong	Genetic Variation	[4601]
NLK	OT2LETFS	Strong	Biomarker	[4602]
NLRC3	OTWLLFFN	Strong	Altered Expression	[4603]
NLRC4	OTAIA3NA	Strong	Altered Expression	[4604]
NLRP6	OTEREN4W	Strong	Biomarker	[4605]
NMB	OT4NLN6H	Strong	Biomarker	[4606]
NMI	OTYVG3NM	Strong	Biomarker	[4607]
NMS	OTFYS4LO	Strong	Altered Expression	[4608]
NMU	OTW9X7BQ	Strong	Biomarker	[4609]
NNAT	OTNRLO7G	Strong	Altered Expression	[2502]
NOC2L	OTNT7R33	Strong	Biomarker	[4610]
NOL3	OT1K0L0D	Strong	Biomarker	[4611]
NOL7	OTIJ1KQI	Strong	Biomarker	[4612]
NOL9	OTCCIJ8I	Strong	Altered Expression	[4613]
NOLC1	OTKDZU0D	Strong	Biomarker	[4614]
NOMO1	OTIALEI1	Strong	Genetic Variation	[4615]
NOP53	OTA2YKO6	Strong	Biomarker	[4616]
NOP56	OTT67SRZ	Strong	Biomarker	[4617]
NOS1AP	OTDFOBRU	Strong	Biomarker	[4618]
NOXO1	OTW29FB4	Strong	Biomarker	[4619]
NPAS2	OTMRT2TS	Strong	Altered Expression	[4620]
NPAS3	OT8D1ILB	Strong	Biomarker	[4621]
NPPA	OTMQNTNX	Strong	Altered Expression	[4622]
NPRL2	OTOB10MO	Strong	Biomarker	[4623]
NPTN	OTAQKSAU	Strong	Altered Expression	[4624]
NPTX1	OTKVHCV0	Strong	Altered Expression	[4625]
NR2C2	OTDZWVOJ	Strong	Genetic Variation	[985]
NR2C2AP	OTNP4LEO	Strong	Altered Expression	[4626]
NR2E1	OTW47GKM	Strong	Biomarker	[4627]
NR2E3	OTO3GBHQ	Strong	Biomarker	[1339]
NR2F2	OTJFS67N	Strong	Biomarker	[4628]
NR2F6	OTNVO2B6	Strong	Biomarker	[4629]
NR5A1	OTOULYR4	Strong	Biomarker	[4630]
NR6A1	OTFZOOQ9	Strong	Altered Expression	[4631]
NRARP	OTMYHUV2	Strong	Altered Expression	[4632]
NRBP1	OTRWEJ65	Strong	Biomarker	[4633]
NRDC	OTWBBCXO	Strong	Biomarker	[4634]
NREP	OT2AZPKK	Strong	Altered Expression	[4635]
NRL	OT65MFKQ	Strong	Biomarker	[4636]
NSA2	OTRU5QPO	Strong	Altered Expression	[4637]
NSG2	OTJ0NSPL	Strong	Biomarker	[4638]
NSMCE3	OTBD4MSP	Strong	Biomarker	[4639]
NSUN2	OTZCNM33	Strong	Altered Expression	[176]
NSUN5	OTBN7RS8	Strong	Biomarker	[4071]
NT5C1A	OTS7UF36	Strong	Biomarker	[4640]
NT5C1B-RDH14	OTTYUS4D	Strong	Biomarker	[4641]
NT5C3A	OT67KZJA	Strong	Biomarker	[4642]
NTHL1	OTPQXPT1	Strong	Biomarker	[4643]
NTMT1	OTLRH78U	Strong	Biomarker	[4644]
NTN4	OTDRRMP3	Strong	Biomarker	[4645]
NTNG1	OTF48IID	Strong	Genetic Variation	[4000]
NTNG2	OTTY88DL	Strong	Biomarker	[4646]
NTS	OTPGDNQS	Strong	Biomarker	[4647]
NUBP1	OTE8RAKZ	Strong	Altered Expression	[4648]
NUCB2	OTHO6JWN	Strong	Biomarker	[4649]
NUCKS1	OTL4VJC5	Strong	Altered Expression	[4650]
NUDT1	OTZSES3W	Strong	Altered Expression	[4651]
NUDT21	OTZHKWAR	Strong	Biomarker	[4652]
NUDT5	OTHYCBA6	Strong	Biomarker	[4653]
NUP107	OTG4RDYS	Strong	Biomarker	[4654]
NUP153	OTCAS0AR	Strong	Altered Expression	[4655]
NUP214	OTWEA19O	Strong	Altered Expression	[4656]
NUP54	OTHOIRMG	Strong	Genetic Variation	[3105]
NUP62	OTMN63DH	Strong	Biomarker	[3570]
NUP88	OT647WOR	Strong	Biomarker	[4657]
NUP93	OT4J2VAL	Strong	Altered Expression	[4658]
NUP98	OTNT12G2	Strong	Altered Expression	[105]
NUPR1	OT4FU8C0	Strong	Biomarker	[4659]
NUS1	OT4DQ82L	Strong	Biomarker	[4660]
NUTM2A	OTQ4VQXE	Strong	Genetic Variation	[4661]
NWD1	OT4JMFPH	Strong	Biomarker	[4662]
NXF1	OTEFHXG6	Strong	Biomarker	[3856]
NXPE4	OTWDLYH5	Strong	Altered Expression	[4663]
OAS1	OT8ZLOCY	Strong	Biomarker	[4664]
OAS3	OT6E5FYS	Strong	Biomarker	[282]
OAZ1	OTPT0PKZ	Strong	Biomarker	[4665]
OBP2A	OTBIJ5TI	Strong	Biomarker	[4666]
OCA2	OTDWIGBF	Strong	Altered Expression	[4667]
OCIAD2	OTSWB4SZ	Strong	Altered Expression	[4668]
OCM	OTQRML29	Strong	Biomarker	[4669]
ODF1	OTTSURLA	Strong	Biomarker	[4670]
OGA	OT7ZBWT1	Strong	Altered Expression	[4671]
OGDHL	OT1AZK6R	Strong	Biomarker	[4672]
OGN	OTKP5S4L	Strong	Biomarker	[4673]
OGT	OT1Z1ZXE	Strong	Biomarker	[4674]
OLIG1	OTIMFI31	Strong	Altered Expression	[4675]
OMA1	OT0JRVY7	Strong	Biomarker	[457]
OMG	OTXA5C6L	Strong	Biomarker	[4676]
OMP	OT7JH0DY	Strong	Biomarker	[4677]
ONECUT1	OTK1QUQT	Strong	Biomarker	[4678]
OPN1LW	OTFNUZ7O	Strong	Altered Expression	[589]
OPN1MW	OTPJ7LX4	Strong	Biomarker	[4679]
OR2AG1	OTEITRP4	Strong	Biomarker	[4680]
OR51E1	OTB7Q65H	Strong	Biomarker	[4681]
ORC5	OTFPW8DE	Strong	Biomarker	[4682]
ORM2	OTRJGZP8	Strong	Biomarker	[4683]
OSBP	OT7R0OQQ	Strong	Biomarker	[4684]
OSBPL7	OTUU2X2Q	Strong	Altered Expression	[4685]
OSCP1	OTZ4IFGJ	Strong	Altered Expression	[4686]
OSGIN1	OT9KIVZW	Strong	Biomarker	[4687]
OTOP2	OTDXHLKN	Strong	Biomarker	[4688]
OTUB1	OT8WWM9O	Strong	Altered Expression	[4689]
OTUB2	OTZUMPH2	Strong	Altered Expression	[4690]
OTUD4	OT7U62SW	Strong	Posttranslational Modification	[4691]
OTUD7B	OTMVM8R7	Strong	Altered Expression	[4692]
OTX1	OTRGSGH9	Strong	Biomarker	[2238]
OVCA2	OT5LSKCS	Strong	Biomarker	[4693]
OVGP1	OTL2W9M5	Strong	Altered Expression	[4694]
P2RX2	OT0LF34A	Strong	Biomarker	[1082]
P2RX5	OTLBR20R	Strong	Altered Expression	[4695]
P2RX6	OT1FNTXA	Strong	Biomarker	[1082]
P4HTM	OTKELL7F	Strong	Altered Expression	[4696]
PABPC4	OTICKKBQ	Strong	Genetic Variation	[1772]
PABPN1	OT3MC5SE	Strong	Biomarker	[4697]
PACC1	OTKBS8CC	Strong	Biomarker	[4698]
PACRG	OT1NYNNW	Strong	Altered Expression	[4699]
PACS2	OTPU9HUA	Strong	Biomarker	[4700]
PADI1	OT13WAQX	Strong	Biomarker	[2254]
PAF1	OTDDGUBQ	Strong	Biomarker	[4701]
PAG1	OTFOJUIQ	Strong	Altered Expression	[589]
PAICS	OTMZN747	Strong	Altered Expression	[4390]
PAIP2	OTFNVLSK	Strong	Altered Expression	[4702]
PAIP2B	OT7MUY3B	Strong	Biomarker	[4703]
PAK3	OT80M3BV	Strong	Biomarker	[1589]
PAK5	OT32WQGL	Strong	Altered Expression	[4704]
PAK6	OTAHPZTT	Strong	Altered Expression	[4705]
PALD1	OTLGUM8H	Strong	Altered Expression	[4706]
PALLD	OTZ2MUJZ	Strong	Altered Expression	[4706]
PAMR1	OT83ZH5U	Strong	Biomarker	[4707]
PANK2	OTFBW889	Strong	Biomarker	[3040]
PANX1	OTXPEDOK	Strong	Biomarker	[4708]
PAPOLA	OTPHD65D	Strong	Biomarker	[1196]
PAPPA	OTTTG9PG	Strong	Biomarker	[4709]
PAQR4	OTNO659U	Strong	Biomarker	[4710]
PAQR7	OTIWX5AM	Strong	Biomarker	[4711]
PARD3	OTH5BPLO	Strong	Biomarker	[4712]
PARD3B	OTGZ43YI	Strong	Biomarker	[4713]
PARD6G	OTIIJWXC	Strong	Altered Expression	[4714]
PARM1	OTDNK7EX	Strong	Biomarker	[4663]
PARP6	OTWSXW4O	Strong	Altered Expression	[4715]
PARVB	OT9OGVWX	Strong	Altered Expression	[4716]
PAX1	OT0Y3MIM	Strong	Biomarker	[4717]
PAX6	OTOC9876	Strong	Biomarker	[4718]
PAXIP1	OTRHTKG3	Strong	Altered Expression	[4719]
PBLD	OTI3A8RS	Strong	Biomarker	[4720]
PBX1	OTORABGO	Strong	Biomarker	[4721]
PBX3	OT8WMVM4	Strong	Biomarker	[4722]
PBXIP1	OTEAAUBY	Strong	Biomarker	[4026]
PC	OT6O0V51	Strong	Genetic Variation	[4723]
PCBP1	OTHN0TD7	Strong	Biomarker	[948]
PCDH17	OTRK0M05	Strong	Biomarker	[4724]
PCDH20	OTFSNRXK	Strong	Biomarker	[4725]
PCDH7	OTP091X8	Strong	Biomarker	[4726]
PCDHB3	OTEDVXZY	Strong	Biomarker	[4727]
PCDHGA7	OTDW7R39	Strong	Altered Expression	[4728]
PCDHGC3	OTDXTUMI	Strong	Biomarker	[4729]
PCM1	OTFM133C	Strong	Genetic Variation	[4730]
PCNT	OTW4Z65J	Strong	Biomarker	[4731]
PDC	OT1UUVYY	Strong	Biomarker	[4732]
PDCD5	OT6T2DDL	Strong	Biomarker	[4733]
PDE6D	OTIFVXWD	Strong	Altered Expression	[4734]
PDE6H	OTMLRB1D	Strong	Biomarker	[4735]
PDE8B	OT4217NK	Strong	Biomarker	[4736]
PDGFRL	OTJPRECT	Strong	Biomarker	[4737]
PDHA1	OTGEU8IK	Strong	Biomarker	[4738]
PDIA4	OTVFUJ13	Strong	Biomarker	[4739]
PDIA6	OT8YBR17	Strong	Biomarker	[4740]
PDIK1L	OTISF4KG	Strong	Altered Expression	[4741]
PDLIM1	OT4EGCPG	Strong	Biomarker	[4742]
PDLIM4	OT23LZYY	Strong	Altered Expression	[4743]
PDLIM5	OTLQVV22	Strong	Biomarker	[4744]
PDP1	OT82RTMT	Strong	Biomarker	[4745]
PDRG1	OT8ZMFZE	Strong	Altered Expression	[4746]
PDS5A	OT34P56Z	Strong	Biomarker	[4747]
PDZD2	OTPPVRGY	Strong	Altered Expression	[4748]
PDZK1IP1	OTWA6M5K	Strong	Biomarker	[4749]
PDZRN3	OTQ891OS	Strong	Biomarker	[4750]
PDZRN4	OTHPD5LB	Strong	Biomarker	[4751]
PEA15	OTKCKTSX	Strong	Altered Expression	[4752]
PEAK1	OTVVM637	Strong	Biomarker	[4753]
PEG10	OTWD2278	Strong	Biomarker	[4754]
PEG3	OTHQW98S	Strong	Genetic Variation	[4755]
PELP1	OTVXQNOT	Strong	Altered Expression	[4756]
PER2	OTU2B1DJ	Strong	Genetic Variation	[4757]
PER3	OTVKYVJA	Strong	Genetic Variation	[1215]
PERP	OTP0YL53	Strong	Biomarker	[3462]
PEX19	OTQIDE9Z	Strong	Biomarker	[4758]
PF4V1	OT2CXM6L	Strong	Altered Expression	[4759]
PFDN1	OT9837QM	Strong	Altered Expression	[4760]
PFKM	OT1QY9JM	Strong	Altered Expression	[4761]
PFKP	OTFP7AA8	Strong	Altered Expression	[4762]
PFN1	OTHTGA1H	Strong	Biomarker	[4763]
PGK1	OT6V1ICH	Strong	Biomarker	[4764]
PGLYRP1	OTBTPR2T	Strong	Biomarker	[4765]
PGP	OT6QQ7OR	Strong	Biomarker	[4766]
PGRMC2	OTH6G1CV	Strong	Altered Expression	[4767]
PHB2	OTCAX3AW	Strong	Biomarker	[457]
PHC3	OTTTLIAP	Strong	Biomarker	[4768]
PHEX	OTG7N3J7	Strong	Biomarker	[4769]
PHF14	OTZT3GV1	Strong	Altered Expression	[4770]
PHF19	OTF6RUCR	Strong	Biomarker	[4771]
PHF2	OTJCIQR2	Strong	Biomarker	[4772]
PHF20	OTCBVH5P	Strong	Genetic Variation	[4773]
PHF20L1	OTCLYOCL	Strong	Biomarker	[4774]
PHF21A	OTU3FFG4	Strong	Biomarker	[4775]
PHF21B	OTU5GLCQ	Strong	Biomarker	[4776]
PHF5A	OTS94JFM	Strong	Altered Expression	[4777]
PHF6	OT8DXI40	Strong	Biomarker	[4778]
PHLDA3	OTXFUDO2	Strong	Biomarker	[4779]
PHLDB2	OTDKMB2G	Strong	Altered Expression	[4780]
PHPT1	OTFYWNFX	Strong	Biomarker	[4781]
PHRF1	OT21KEGX	Strong	Altered Expression	[4782]
PI3	OT47MTC3	Strong	Altered Expression	[4783]
PIAS1	OTZVAHZI	Strong	Biomarker	[4014]
PIAS2	OTJLSC3V	Strong	Biomarker	[4784]
PIAS4	OTB7SVMZ	Strong	Biomarker	[4785]
PIBF1	OTCBT1A1	Strong	Genetic Variation	[4786]
PID1	OT5YJ7FI	Strong	Altered Expression	[4787]
PIDD1	OTWFM930	Strong	Biomarker	[4788]
PIEZO2	OTQ7AT38	Strong	Altered Expression	[4789]
PIGF	OTJKE6VW	Strong	Biomarker	[4790]
PIGH	OTMCFF0K	Strong	Biomarker	[4791]
PIGK	OTAFSYLD	Strong	Altered Expression	[4792]
PIGR	OT6GLSUL	Strong	Biomarker	[4793]
PIK3C2A	OTFBU4GD	Strong	Biomarker	[4794]
PIK3C2B	OTY2PROB	Strong	Biomarker	[4795]
PIK3IP1	OTWE5G4T	Strong	Biomarker	[4796]
PIK3R2	OTZSUQK5	Strong	Biomarker	[3263]
PIK3R4	OTRL8QP8	Strong	Altered Expression	[4797]
PIK3R5	OT4LNXJU	Strong	Altered Expression	[4798]
PIMREG	OTKC8T3E	Strong	Biomarker	[4799]
PIN4	OT403QC1	Strong	Biomarker	[4800]
PINK1	OT50NR57	Strong	Biomarker	[4801]
PIP	OTH719AH	Strong	Altered Expression	[4802]
PIP4K2A	OTO9JO9U	Strong	Genetic Variation	[4803]
PIR	OT8ALXHU	Strong	Biomarker	[4804]
PISD	OTP9COQT	Strong	Biomarker	[4805]
PITPNM1	OTIUYAG5	Strong	Biomarker	[4806]
PITPNM3	OTHLZY8D	Strong	Biomarker	[4807]
PITX1	OTA0UN4C	Strong	Altered Expression	[4808]
PIWIL1	OT7CRGZ3	Strong	Altered Expression	[4809]
PIWIL2	OT1PXQIF	Strong	Altered Expression	[4809]
PIWIL4	OTDA9MY0	Strong	Altered Expression	[4810]
PJA2	OT45TMC4	Strong	Biomarker	[4811]
PKD2	OTIXBU8H	Strong	Altered Expression	[4812]
PKHD1	OTAH8SMF	Strong	Genetic Variation	[4813]
PKNOX1	OTUDMNHX	Strong	Biomarker	[4814]
PKP1	OT9HSQ8F	Strong	Biomarker	[4815]
PKP3	OTPL1HRB	Strong	Biomarker	[4816]
PKP4	OTQHOF8L	Strong	Altered Expression	[3529]
PLA2G10	OTRZ2L5A	Strong	Altered Expression	[1126]
PLA2G15	OT6VJTPA	Strong	Biomarker	[1677]
PLA2G3	OT3K7TMY	Strong	Biomarker	[4817]
PLA2G5	OTQRSKCZ	Strong	Genetic Variation	[4818]
PLAA	OTZ7NJGA	Strong	Altered Expression	[4819]
PLAAT3	OTVXXJ5K	Strong	Biomarker	[2272]
PLCB2	OTPAHDGO	Strong	Altered Expression	[4820]
PLCG2	OTGVC9MY	Strong	Biomarker	[4821]
PLCL1	OTJL2C79	Strong	Biomarker	[4822]
PLEC	OTU4XDEG	Strong	Biomarker	[4731]
PLEKHA7	OTNUMAZ0	Strong	Altered Expression	[4823]
PLEKHA8	OT03870U	Strong	Biomarker	[4824]
PLEKHF1	OT9OL16U	Strong	Biomarker	[4825]
PLEKHM2	OT4ZYV73	Strong	Biomarker	[4826]
PLEKHO1	OTMVUQ9W	Strong	Biomarker	[4827]
PLEKHS1	OT1ZGH1K	Strong	Biomarker	[4828]
PLIN2	OTRXJ9UN	Strong	Biomarker	[4257]
PLK3	OT19CT2Z	Strong	Biomarker	[4829]
PLK5	OTW5YPKM	Strong	Biomarker	[4830]
PLOD3	OTT00T7Q	Strong	Biomarker	[4831]
PLPP2	OT0BQAXX	Strong	Biomarker	[1252]
PLPP3	OTSSF7BK	Strong	Altered Expression	[1252]
PLRG1	OTIVZ5LL	Strong	Biomarker	[1178]
PLS1	OTWURB8U	Strong	Biomarker	[4832]
PLS3	OTYBM4PK	Strong	Altered Expression	[4833]
PLXNA1	OTN0BING	Strong	Biomarker	[3297]
PLXNA4	OT5XKB3Q	Strong	Biomarker	[4834]
PLXNB1	OTCA7JIT	Strong	Biomarker	[1670]
PLXND1	OTNK9ALK	Strong	Biomarker	[4835]
PMF1	OT8PQPZ1	Strong	Genetic Variation	[4836]
PMPCA	OT5X1G9Q	Strong	Biomarker	[4837]
PMPCB	OTRMBHNM	Strong	Biomarker	[4838]
PNKD	OT6G9UXN	Strong	Biomarker	[4839]
PNN	OT0HXICH	Strong	Biomarker	[4191]
PNO1	OT010GIS	Strong	Biomarker	[4371]
PNPLA2	OTR3ERMR	Strong	Biomarker	[4840]
PNRC1	OTQMLEE1	Strong	Biomarker	[4841]
PODXL	OTPNQXF3	Strong	Biomarker	[4842]
POFUT1	OTOBJZIT	Strong	Biomarker	[4843]
POGLUT1	OTDX7GZD	Strong	Biomarker	[4844]
POLD4	OTG578YH	Strong	Biomarker	[4845]
POLDIP2	OT8SZSJ6	Strong	Posttranslational Modification	[404]
POLE3	OTOELRF6	Strong	Genetic Variation	[3793]
POLE4	OTCMWUT6	Strong	Biomarker	[4845]
POLH	OTN07WXU	Strong	Altered Expression	[2284]
POLI	OTBA4DCE	Strong	Posttranslational Modification	[4846]
POLR1D	OTOCZQNA	Strong	Altered Expression	[4847]
POLR1E	OTCBMKW6	Strong	Biomarker	[4848]
POLR2C	OTZ0ULJ9	Strong	Biomarker	[4849]
POLR3A	OT5MSK10	Strong	Biomarker	[4850]
POLR3B	OT3FS9MB	Strong	Biomarker	[4851]
POMP	OTMPM1P5	Strong	Biomarker	[4852]
POPDC3	OTN4FJ5J	Strong	Altered Expression	[4853]
POTED	OTAUSTUK	Strong	Altered Expression	[4854]
POTEG	OTGGSJW3	Strong	Altered Expression	[4855]
POTEM	OT7L2HGH	Strong	Altered Expression	[2940]
POU2F1	OTK7ELJ0	Strong	Biomarker	[4856]
POU2F2	OTPV0J0C	Strong	Biomarker	[1270]
POU3F1	OTYARA94	Strong	Altered Expression	[1269]
POU3F2	OT30NFOC	Strong	Biomarker	[4857]
POU5F1B	OT0FKQ51	Strong	Altered Expression	[4858]
POU6F2	OTNSW95F	Strong	Altered Expression	[4859]
PPARGC1A	OTHCDQ22	Strong	Biomarker	[4860]
PPFIA1	OTYYFA9C	Strong	Biomarker	[2143]
PPIC	OTY5Q42N	Strong	Biomarker	[4800]
PPIG	OTZ8BTTM	Strong	Altered Expression	[4861]
PPIL3	OT0GPU73	Strong	Altered Expression	[4862]
PPL	OTTM4WDO	Strong	Altered Expression	[4863]
PPM1H	OTKSVU7S	Strong	Biomarker	[4864]
PPM1L	OTGGNG6M	Strong	Altered Expression	[4865]
PPP1R11	OTSHYPPW	Strong	Biomarker	[4866]
PPP1R12A	OT4AVU95	Strong	Biomarker	[4867]
PPP1R12B	OTONIS87	Strong	Biomarker	[4753]
PPP1R12C	OT9Q86JO	Strong	Biomarker	[3263]
PPP1R13B	OTC88VQO	Strong	Biomarker	[3263]
PPP1R13L	OTNCPLWE	Strong	Genetic Variation	[2343]
PPP1R14A	OTQODWZB	Strong	Altered Expression	[4868]
PPP1R14C	OTZ3F6D2	Strong	Biomarker	[4869]
PPP1R15A	OTYG179K	Strong	Genetic Variation	[4870]
PPP1R1B	OTSIJMQ9	Strong	Biomarker	[4871]
PPP1R3A	OTJL9VYP	Strong	Altered Expression	[4872]
PPP1R7	OTY5IE69	Strong	Biomarker	[4873]
PPP2R1B	OTFIHQGD	Strong	Altered Expression	[4874]
PPP2R2A	OT9297OG	Strong	Altered Expression	[4875]
PPP2R2D	OTCZPP0N	Strong	Altered Expression	[4876]
PPP2R3A	OTSK5GFC	Strong	Biomarker	[4877]
PPP2R5E	OT8GPFT5	Strong	Biomarker	[4878]
PPP3CB	OTEGNEHW	Strong	Altered Expression	[4879]
PPP6R3	OTIXD60Q	Strong	Altered Expression	[4880]
PPRC1	OT6GB3WR	Strong	Biomarker	[4881]
PRAC2	OT56IBFQ	Strong	Biomarker	[4882]
PRAF2	OT1QN4LV	Strong	Altered Expression	[4883]
PRAP1	OT48QD82	Strong	Biomarker	[4884]
PRB1	OTV0SYMD	Strong	Biomarker	[4885]
PRB2	OTAD4JZ0	Strong	Biomarker	[4886]
PRDM1	OTQLSVBS	Strong	Altered Expression	[4887]
PRDM11	OT6DX554	Strong	Altered Expression	[4888]
PRDM14	OTWZKY4L	Strong	Biomarker	[4889]
PRDM16	OT0BGA27	Strong	Biomarker	[4890]
PRDM6	OTKY12D9	Strong	Biomarker	[2825]
PRDM8	OTRA3265	Strong	Biomarker	[4891]
PRDM9	OTWAHLUR	Strong	Posttranslational Modification	[4892]
PRDX1	OTZ3BEC4	Strong	Biomarker	[4893]
PRDX2	OTLWCY9T	Strong	Biomarker	[4894]
PRDX3	OTLB2WEU	Strong	Biomarker	[4895]
PRDX6	OTS8KC8A	Strong	Altered Expression	[4896]
PREX1	OTUTPVA9	Strong	Biomarker	[4897]
PREX2	OTYT1J6J	Strong	Altered Expression	[4898]
PRF1	OTFVXD7H	Strong	Biomarker	[4899]
PRG2	OT0BCPQG	Strong	Genetic Variation	[4054]
PRIM1	OTWWP8Y6	Strong	Altered Expression	[4900]
PRKACB	OT6RMDCE	Strong	Biomarker	[4901]
PRKAG1	OTW00PRY	Strong	Genetic Variation	[4902]
PRKD2	OTIFSVI8	Strong	Genetic Variation	[4903]
PRKD3	OT987HJI	Strong	Biomarker	[4904]
PRKN	OTJBN41W	Strong	Genetic Variation	[4905]
PRKRA	OTUTVZZU	Strong	Biomarker	[4906]
PRLH	OTJBP360	Strong	Biomarker	[4046]
PRM3	OT6574BF	Strong	Altered Expression	[4907]
PRMT6	OT5V3XIN	Strong	Altered Expression	[4908]
PRND	OTH4EEMI	Strong	Altered Expression	[4909]
PROK2	OT70IFEZ	Strong	Biomarker	[4910]
PROP1	OT8GF6N8	Strong	Biomarker	[4911]
PRPF19	OTQ1STV3	Strong	Biomarker	[4912]
PRPF3	OTUA4OLZ	Strong	Biomarker	[4913]
PRPF40A	OT6EXJZN	Strong	Biomarker	[4914]
PRPF6	OT3U0ABN	Strong	Biomarker	[4915]
PRPS1	OTN3A6CN	Strong	Biomarker	[4916]
PRR11	OT2JJ08Z	Strong	Biomarker	[4917]
PRR13	OTXPP37T	Strong	Altered Expression	[4918]
PRR14	OTZMIMOK	Strong	Altered Expression	[4919]
PRR5	OTYHSGJL	Strong	Biomarker	[4920]
PRRC2C	OTBX3MXM	Strong	Altered Expression	[4921]
PRRX1	OTTZK5G8	Strong	Biomarker	[4922]
PRSS16	OTVCZ5V1	Strong	Biomarker	[4923]
PRSS23	OT6DQAM1	Strong	Biomarker	[4924]
PRTFDC1	OTKJ44KY	Strong	Biomarker	[4925]
PRUNE2	OTGW2974	Strong	Altered Expression	[4926]
PSAP	OTUOEKY7	Strong	Biomarker	[4927]
PSD	OTUZIXUZ	Strong	Biomarker	[4928]
PSG1	OT1U4ZZW	Strong	Biomarker	[2302]
PSMA1	OTNBVM2U	Strong	Genetic Variation	[1347]
PSMA2	OTJRT2ZL	Strong	Biomarker	[4929]
PSMA4	OTAD2XXI	Strong	Genetic Variation	[4930]
PSMA5	OT38E6Y1	Strong	Biomarker	[3052]
PSMB4	OTOJ9OHA	Strong	Biomarker	[4931]
PSMC3IP	OT9UB5UO	Strong	Biomarker	[4932]
PSMC4	OTS3XN41	Strong	Posttranslational Modification	[4933]
PSMC5	OTJOORMR	Strong	Biomarker	[4934]
PSMD14	OTJWHMZ5	Strong	Altered Expression	[4935]
PSMG1	OTZ5I6UM	Strong	Genetic Variation	[390]
PSMG2	OTEMF20S	Strong	Biomarker	[4936]
PSORS1C2	OTK43GE4	Strong	Altered Expression	[4937]
PSPH	OTV1PVAX	Strong	Biomarker	[4938]
PSTPIP1	OT4PGEAB	Strong	Altered Expression	[4939]
PTBP3	OTVVYKIF	Strong	Biomarker	[4940]
PTCHD3	OTFQ1VGM	Strong	Biomarker	[4941]
PTCHD4	OTGJ8NRP	Strong	Altered Expression	[4942]
PTCRA	OTQTO5QZ	Strong	Biomarker	[704]
PTF1A	OT7SWA57	Strong	Altered Expression	[4943]
PTGES3	OTPPQWI0	Strong	Biomarker	[4944]
PTGFRN	OTBG4SA2	Strong	Altered Expression	[4945]
PTMA	OT2W4T1M	Strong	Biomarker	[4946]
PTOV1	OT94WT5X	Strong	Biomarker	[4947]
PTPN12	OT5WA666	Strong	Biomarker	[4948]
PTPN3	OTSLZBVY	Strong	Biomarker	[4949]
PTPN5	OT2H1KDK	Strong	Altered Expression	[4950]
PTPN9	OTNAR1I2	Strong	Altered Expression	[4951]
PTPRG	OT9N2WOF	Strong	Biomarker	[4952]
PTPRH	OTDUHQGF	Strong	Genetic Variation	[4953]
PTPRK	OTAP5AT3	Strong	Biomarker	[4954]
PTPRM	OTCEL6PN	Strong	Altered Expression	[4955]
PTPRN2	OTL6SH28	Strong	Altered Expression	[4956]
PTPRO	OTFLKWOY	Strong	Biomarker	[4957]
PTPRT	OTV5TXNN	Strong	Altered Expression	[4958]
PTRH1	OTOAOS93	Strong	Biomarker	[4959]
PTTG1IP	OTX21QTE	Strong	Biomarker	[4960]
PUM1	OTTMWP8L	Strong	Biomarker	[4961]
PWWP3A	OTXQVL4U	Strong	Altered Expression	[4962]
PYCR1	OTQHB52T	Strong	Biomarker	[4963]
PYDC1	OTC2DD7L	Strong	Biomarker	[4964]
PYGO2	OTZHB2OI	Strong	Biomarker	[4965]
QKI	OTTAUGLB	Strong	Biomarker	[4966]
QRSL1	OTJDU2UG	Strong	Posttranslational Modification	[4967]
QSOX1	OT4ZPK4P	Strong	Biomarker	[4968]
QTRT1	OTC33MCV	Strong	Genetic Variation	[4969]
RAB10	OT8ZN26V	Strong	Biomarker	[4970]
RAB11A	OTC4FW0J	Strong	Biomarker	[4971]
RAB11FIP2	OTTX9RWE	Strong	Altered Expression	[4764]
RAB11FIP3	OTDFFCZA	Strong	Biomarker	[3017]
RAB11FIP4	OTIGHER7	Strong	Altered Expression	[4971]
RAB14	OTF1J0TB	Strong	Biomarker	[4972]
RAB1A	OTKPHRD0	Strong	Altered Expression	[4973]
RAB27B	OTPF9D0K	Strong	Biomarker	[4974]
RAB34	OTHKTSA0	Strong	Altered Expression	[4975]
RAB35	OTRH1E2T	Strong	Biomarker	[4976]
RAB37	OTRL8IUO	Strong	Biomarker	[4977]
RAB3A	OT2GIUO5	Strong	Altered Expression	[4978]
RAB3D	OTGKRR3C	Strong	Altered Expression	[4979]
RAB3GAP1	OT4DQ8F2	Strong	Biomarker	[4614]
RAB3GAP2	OTQTE0GI	Strong	Altered Expression	[4797]
RAB5B	OT06PN42	Strong	Altered Expression	[2432]
RAB6A	OTLS86J5	Strong	Genetic Variation	[4980]
RAB6B	OT5N57RK	Strong	Biomarker	[2854]
RAB7B	OT60A0E9	Strong	Altered Expression	[1188]
RAB8A	OTPB54Y3	Strong	Biomarker	[4981]
RABAC1	OTGB32NG	Strong	Biomarker	[4848]
RABGAP1	OT4HPZPP	Strong	Biomarker	[4982]
RABL6	OTJLVIQ1	Strong	Biomarker	[4983]
RAC2	OTAOHFNH	Strong	Altered Expression	[4984]
RACGAP1	OTQE8IEH	Strong	Altered Expression	[4985]
RAD17	OT1I93DT	Strong	Biomarker	[4986]
RAD21	OTQS84ZF	Strong	Biomarker	[4987]
RAD23B	OT0PGOG3	Strong	Biomarker	[4988]
RAD51B	OTCJVRMY	Strong	Genetic Variation	[4989]
RAD51C	OTUD6SY5	Strong	Genetic Variation	[4990]
RAD52	OT0OTDHI	Strong	Biomarker	[4991]
RAD54B	OTMWB2P2	Strong	Biomarker	[4992]
RAD54L	OTEGMAKG	Strong	Biomarker	[4993]
RAET1E	OTLR3CEC	Strong	Biomarker	[4994]
RAET1G	OTLZD0FO	Strong	Altered Expression	[4995]
RAG2	OTG9UYTW	Strong	Biomarker	[4996]
RAI14	OT6USGBK	Strong	Biomarker	[4997]
RAI2	OTR8LX4J	Strong	Biomarker	[4998]
RALGAPA2	OTFFGNPT	Strong	Biomarker	[4999]
RALGAPB	OTY8CGA3	Strong	Biomarker	[5000]
RAMP2	OTGQXLH5	Strong	Biomarker	[392]
RAN	OT2TER5M	Strong	Biomarker	[5001]
RANBP2	OTFG5CVF	Strong	Biomarker	[3568]
RAP1B	OTHEIIMM	Strong	Altered Expression	[5002]
RAP1GAP	OTC31ONQ	Strong	Altered Expression	[5003]
RAP1GDS1	OTH70UHD	Strong	Altered Expression	[5004]
RAP2A	OT0JB5S4	Strong	Altered Expression	[5005]
RAP2B	OTD2NDQP	Strong	Altered Expression	[5006]
RAP2C	OT4HBPHE	Strong	Biomarker	[5007]
RAPGEF5	OT53VS75	Strong	Biomarker	[5008]
RAPH1	OTMQXW7S	Strong	Genetic Variation	[2942]
RARRES2	OT1BJE8K	Strong	Altered Expression	[5009]
RARS1	OTHPZ6JN	Strong	Posttranslational Modification	[5010]
RASAL2	OTGMMX6W	Strong	Biomarker	[5011]
RASGRF1	OTNWJ7EN	Strong	Biomarker	[537]
RASGRP1	OTX9WN2E	Strong	Biomarker	[5012]
RASGRP3	OTEMEV3P	Strong	Altered Expression	[5013]
RASIP1	OTCRY2AN	Strong	Biomarker	[5014]
RASL10A	OTEXTN6I	Strong	Biomarker	[5015]
RASSF10	OTGB7EBG	Strong	Biomarker	[5016]
RASSF2	OT2JHDO4	Strong	Biomarker	[5017]
RASSF3	OT4V9SRK	Strong	Biomarker	[5018]
RASSF4	OT7YLOFH	Strong	Biomarker	[5019]
RASSF7	OT0V4EIZ	Strong	Genetic Variation	[5020]
RASSF8	OTXKGIB3	Strong	Biomarker	[5021]
RB1CC1	OTZK8PFX	Strong	Biomarker	[5022]
RBBP4	OTG3BT3M	Strong	Biomarker	[5023]
RBBP5	OT12W2MK	Strong	Altered Expression	[5024]
RBBP6	OTTVG4HU	Strong	Biomarker	[5025]
RBBP7	OTLB56HX	Strong	Biomarker	[5026]
RBBP8	OTRHJ3GI	Strong	Biomarker	[5027]
RBFOX2	OTXY1WVH	Strong	Altered Expression	[5028]
RBFOX3	OTL0F3D6	Strong	Biomarker	[5029]
RBL1	OTDEBFYC	Strong	Biomarker	[5030]
RBM10	OTES2MES	Strong	Biomarker	[5031]
RBM14	OTO9GMBD	Strong	Biomarker	[5032]
RBM15	OT8ZPGWF	Strong	Biomarker	[5033]
RBM17	OT9ROJCL	Strong	Biomarker	[5034]
RBM3	OTAJ7R31	Strong	Altered Expression	[5035]
RBM38	OTPO8EXU	Strong	Biomarker	[5036]
RBM39	OTCMPTF9	Strong	Altered Expression	[5037]
RBM46	OT0EBW2J	Strong	Altered Expression	[5038]
RBM47	OT6W67VM	Strong	Biomarker	[5039]
RBMS2	OTTX6071	Strong	Biomarker	[5040]
RBMS3	OTFSC9MR	Strong	Biomarker	[5041]
RBMX	OTFZN66E	Strong	Biomarker	[5042]
RBMXL1	OTMGCWWB	Strong	Genetic Variation	[5043]
RBMY1A1	OTM2F25H	Strong	Genetic Variation	[5043]
RBP3	OTIWM4GT	Strong	Altered Expression	[5044]
RBPMS	OT1RDKR9	Strong	Biomarker	[5045]
RCAN1	OT1MVXC7	Strong	Altered Expression	[2955]
RCAN2	OTGGWTWS	Strong	Biomarker	[5046]
RCBTB2	OTECBF4R	Strong	Biomarker	[5047]
RCC1	OT25AGMB	Strong	Altered Expression	[5048]
RCC2	OTUJVTLS	Strong	Biomarker	[5049]
RCHY1	OTAE7504	Strong	Altered Expression	[5050]
RCN1	OT3JBGAG	Strong	Altered Expression	[5051]
RD3	OT2L9Y6M	Strong	Biomarker	[5052]
RDH10	OTL9FSGF	Strong	Altered Expression	[5053]
RDH16	OTCJ915F	Strong	Biomarker	[5054]
RDX	OTNSYUN6	Strong	Altered Expression	[5055]
RECQL4	OT59LSW7	Strong	Altered Expression	[5056]
RECQL5	OTVZMP1Q	Strong	Biomarker	[5057]
REEP5	OTZU4TJI	Strong	Biomarker	[5058]
REG1B	OTSC2133	Strong	Altered Expression	[5059]
RELB	OTU3QYEF	Strong	Altered Expression	[5060]
RELN	OTLKMW1O	Strong	Altered Expression	[5061]
REM1	OTUXL0HC	Strong	Altered Expression	[5062]
REPIN1	OTVTPXNX	Strong	Biomarker	[5063]
RERG	OTF6MMLV	Strong	Genetic Variation	[4000]
RETNLB	OT9JJQQQ	Strong	Altered Expression	[5064]
REV1	OTHIKICX	Strong	Biomarker	[5065]
RFX1	OTZUDMPR	Strong	Biomarker	[5066]
RFXANK	OTDX1026	Strong	Biomarker	[5067]
RFXAP	OTX46DKQ	Strong	Biomarker	[5068]
RGCC	OTYJMLWM	Strong	Altered Expression	[5069]
RGPD2	OTMUZ0HX	Strong	Genetic Variation	[2986]
RGS11	OTIAZ36F	Strong	Genetic Variation	[5070]
RGS19	OTBIELDO	Strong	Biomarker	[5071]
RGS20	OT6CGYHW	Strong	Biomarker	[5072]
RGS22	OTCTFGW6	Strong	Biomarker	[5073]
RGS3	OTYG5OXI	Strong	Altered Expression	[5074]
RGS9	OTRA1LOC	Strong	Altered Expression	[518]
RGSL1	OTNNYLGW	Strong	Genetic Variation	[1201]
RHBDD1	OTL5J132	Strong	Genetic Variation	[5075]
RHBDD2	OTX54ILM	Strong	Altered Expression	[5076]
RHBDL1	OTSCUCQV	Strong	Biomarker	[5077]
RHCE	OTS18IZ5	Strong	Altered Expression	[5078]
RHEB	OTFLTSEC	Strong	Altered Expression	[5079]
RHOBTB1	OTGE8K45	Strong	Biomarker	[5080]
RHOBTB2	OT2DATFX	Strong	Biomarker	[5081]
RHOC	OTOLE1FT	Strong	Altered Expression	[5082]
RHOF	OTPA3F8Q	Strong	Biomarker	[5083]
RHOQ	OTUBTU57	Strong	Biomarker	[5084]
RIF1	OTPE49OE	Strong	Biomarker	[5085]
RIMS1	OT10T7CK	Strong	Biomarker	[5086]
RIN1	OTPBROUD	Strong	Altered Expression	[5087]
RIN2	OTCY73U9	Strong	Genetic Variation	[5088]
RING1	OTCWTAX0	Strong	Biomarker	[5089]
RINT1	OTMO19ZD	Strong	Biomarker	[5090]
RIOK1	OT1OS3H3	Strong	Biomarker	[5091]
RIOX1	OTN41QXP	Strong	Altered Expression	[5092]
RIOX2	OT2YFPI2	Strong	Altered Expression	[5093]
RIPK3	OTL1D484	Strong	Biomarker	[5094]
RIPOR2	OTXB6LIR	Strong	Altered Expression	[5095]
RIT1	OTVNOGOH	Strong	Biomarker	[5096]
RITA1	OTUH8IPS	Strong	Genetic Variation	[5075]
RLBP1	OTCY4D6B	Strong	Altered Expression	[5097]
RLN2	OTY3OG71	Strong	Biomarker	[5098]
RMC1	OT7K8MTJ	Strong	Biomarker	[5099]
RMDN1	OTE1NB6U	Strong	Biomarker	[5100]
RMDN2	OTK5WSFI	Strong	Biomarker	[5100]
RMDN3	OTKO7AUM	Strong	Biomarker	[5100]
RMND5A	OTXJ7HNB	Strong	Biomarker	[2860]
RNASE1	OTKZ7CO9	Strong	Biomarker	[5101]
RNASE2	OT8Z4FNE	Strong	Biomarker	[5102]
RNASEH2A	OT8G3G7K	Strong	Genetic Variation	[5103]
RNASEH2C	OTJL9ZRN	Strong	Biomarker	[3985]
RND1	OTOC223Z	Strong	Biomarker	[5104]
RND3	OTXMXPIH	Strong	Biomarker	[5105]
RNF111	OTO3QT6Q	Strong	Altered Expression	[5106]
RNF112	OT0Q9OUQ	Strong	Genetic Variation	[5107]
RNF113A	OTR6N7HU	Strong	Altered Expression	[5108]
RNF114	OTF06FRP	Strong	Altered Expression	[5109]
RNF126	OTTECSYY	Strong	Biomarker	[5110]
RNF128	OTJO86CJ	Strong	Altered Expression	[1317]
RNF138	OTPU0CO4	Strong	Biomarker	[5111]
RNF139	OT0PR1X5	Strong	Genetic Variation	[5112]
RNF144A	OTCG27CT	Strong	Biomarker	[4106]
RNF168	OT6AZXX8	Strong	Altered Expression	[5113]
RNF181	OT7YB7WD	Strong	Biomarker	[5114]
RNF183	OTWPNZF9	Strong	Biomarker	[5115]
RNF19A	OTKWCV80	Strong	Posttranslational Modification	[404]
RNF2	OTFPLOIN	Strong	Biomarker	[5116]
RNF20	OT9NK6ZT	Strong	Biomarker	[5117]
RNF213	OT4OVE9O	Strong	Biomarker	[5118]
RNF216	OTR1XEZ3	Strong	Biomarker	[5119]
RNF25	OTQJSBEG	Strong	Biomarker	[5120]
RNF31	OT4BZONL	Strong	Biomarker	[5121]
RNF38	OTRLV4WZ	Strong	Altered Expression	[5122]
RNF40	OTC8SDA3	Strong	Altered Expression	[5123]
RNF41	OTN1DQOY	Strong	Biomarker	[3236]
RNF5	OTDQGI37	Strong	Biomarker	[5014]
RNGTT	OT59E0KX	Strong	Biomarker	[5124]
RNPC3	OTW5MKC1	Strong	Altered Expression	[5125]
ROBO3	OTPVG40S	Strong	Biomarker	[637]
ROMO1	OTIEYVBW	Strong	Altered Expression	[5126]
ROPN1L	OTRWZJ68	Strong	Biomarker	[443]
RPA1	OT76POLP	Strong	Altered Expression	[5127]
RPA2	OTZ54WAF	Strong	Altered Expression	[5128]
RPA3	OT8JAQGL	Strong	Biomarker	[5129]
RPAIN	OTBMXAYK	Strong	Biomarker	[1955]
RPGRIP1L	OT6Z069I	Strong	Biomarker	[5130]
RPH3AL	OT9VFJEL	Strong	Genetic Variation	[5131]
RPL10	OTBHOZGC	Strong	Biomarker	[3297]
RPL11	OT3VZ6OE	Strong	Biomarker	[5132]
RPL22L1	OTNWGF5C	Strong	Altered Expression	[5133]
RPL23	OTXI1YLM	Strong	Biomarker	[3994]
RPL29	OTUFIBJL	Strong	Biomarker	[5134]
RPL3	OTX6VXLB	Strong	Biomarker	[5135]
RPL34	OT0U9VMQ	Strong	Biomarker	[5136]
RPL36	OT9R9LWG	Strong	Altered Expression	[5137]
RPL36A	OT1LYV85	Strong	Biomarker	[3764]
RPL39L	OTAV1MJQ	Strong	Altered Expression	[5138]
RPL8	OTHMZ1R9	Strong	Biomarker	[5139]
RPN2	OTJ1SKOA	Strong	Altered Expression	[5140]
RPP14	OT4OYFSK	Strong	Biomarker	[3348]
RPRD1B	OTB41D5K	Strong	Biomarker	[5141]
RPRM	OTNNBAS1	Strong	Biomarker	[5142]
RPS15A	OT0BUA12	Strong	Altered Expression	[5143]
RPS18	OTFO45UM	Strong	Biomarker	[5144]
RPS19	OTBKGP48	Strong	Biomarker	[5145]
RPS2	OTSMTZVB	Strong	Biomarker	[5146]
RPS25	OTKLWED2	Strong	Altered Expression	[5147]
RPS27	OTFXKY7P	Strong	Biomarker	[4465]
RPS27A	OTIIGGZ2	Strong	Biomarker	[1425]
RPS3	OT0K3TMH	Strong	Biomarker	[5148]
RPS6	OTT4D1LN	Strong	Biomarker	[5149]
RPS6KA4	OTTK8MUO	Strong	Biomarker	[5150]
RPS7	OTIK25WI	Strong	Biomarker	[5151]
RPS9	OTPV69Q0	Strong	Biomarker	[5152]
RRAD	OTW2O4GD	Strong	Altered Expression	[384]
RRAGA	OTKISLG4	Strong	Biomarker	[5153]
RRAS2	OT83NCEB	Strong	Altered Expression	[5154]
RRBP1	OT4ZTPTM	Strong	Biomarker	[5155]
RREB1	OT62460U	Strong	Biomarker	[5156]
RRS1	OTTNCZN6	Strong	Biomarker	[5157]
RSPO2	OT3HHXU0	Strong	Biomarker	[5158]
RSU1	OTO5GHT1	Strong	Biomarker	[5159]
RTCA	OTSJRVTD	Strong	Biomarker	[5160]
RTCB	OTUED31V	Strong	Altered Expression	[5161]
RTEL1	OTI3PJCT	Strong	Biomarker	[5162]
RTKN	OTSS8XR6	Strong	Altered Expression	[5163]
RTKN2	OTV2AXQM	Strong	Biomarker	[5164]
RTP3	OTZUDJ6Q	Strong	Biomarker	[5165]
RTRAF	OTJ6NVMW	Strong	Biomarker	[5166]
RTTN	OT5PB986	Strong	Genetic Variation	[4112]
RUVBL2	OTGWJ4T4	Strong	Altered Expression	[5167]
RWDD3	OTE76DY5	Strong	Biomarker	[5168]
RYBP	OTZZ4P2Z	Strong	Biomarker	[5169]
S100A11	OTI57KDN	Strong	Biomarker	[5170]
S100A13	OT582SUS	Strong	Biomarker	[5171]
S100A14	OTVFJJ91	Strong	Altered Expression	[5172]
S100A16	OT3ERKQI	Strong	Altered Expression	[5173]
S100A7	OTJFVJRF	Strong	Altered Expression	[5174]
S100A7A	OTNM8DCP	Strong	Biomarker	[5175]
SAA2	OTYAVJWG	Strong	Altered Expression	[5176]
SAE1	OT18HFX5	Strong	Altered Expression	[5177]
SAFB2	OTQ1IH80	Strong	Genetic Variation	[5178]
SAGE1	OT4H6FFA	Strong	Biomarker	[5179]
SALL1	OTYYZGLH	Strong	Biomarker	[5180]
SALL2	OTQWI68Q	Strong	Biomarker	[5181]
SALL3	OTJ2LZKQ	Strong	Posttranslational Modification	[5182]
SAMD4A	OT4MKCC8	Strong	Altered Expression	[5183]
SAMD9	OTDG48P0	Strong	Biomarker	[5184]
SAMHD1	OTBCIBC7	Strong	Biomarker	[3012]
SAMM50	OTRYFYIU	Strong	Biomarker	[5185]
SAMSN1	OT7N88T1	Strong	Altered Expression	[5186]
SAR1A	OTSSRVGV	Strong	Biomarker	[5187]
SARDH	OTQ49Q27	Strong	Genetic Variation	[1305]
SARS1	OTFKXQ1O	Strong	Biomarker	[5188]
SARS2	OTU4T99W	Strong	Biomarker	[5188]
SART1	OTHMOGO1	Strong	Altered Expression	[706]
SASH1	OTQA8BD4	Strong	Biomarker	[5189]
SASH3	OT0XGQ93	Strong	Biomarker	[5190]
SAT2	OT28QL7H	Strong	Biomarker	[5191]
SAV1	OTSAEV92	Strong	Biomarker	[5192]
SBK1	OTCO4NEI	Strong	Altered Expression	[5193]
SBNO1	OTNX3RL0	Strong	Biomarker	[5194]
SBNO2	OT1C6J3K	Strong	Biomarker	[5194]
SBSN	OT89RKJH	Strong	Altered Expression	[5195]
SCAF11	OTX59D0X	Strong	Altered Expression	[3935]
SCAND1	OTRG0AGH	Strong	Altered Expression	[5196]
SCARA5	OTOVA96E	Strong	Altered Expression	[5197]
SCARB2	OTN929M8	Strong	Genetic Variation	[3105]
SCG2	OTXWUQQL	Strong	Biomarker	[5198]
SCGB3A1	OTIR98RB	Strong	Biomarker	[5199]
SCGB3A2	OTB63PHR	Strong	Biomarker	[5200]
SCIN	OT6U09OL	Strong	Genetic Variation	[5201]
SCN7A	OTK05PXY	Strong	Biomarker	[1034]
SCNN1B	OT61QQTL	Strong	Biomarker	[5202]
SCRIB	OTW4N3FV	Strong	Biomarker	[5203]
SCRT1	OTWTE24S	Strong	Biomarker	[5204]
SCUBE3	OT2EADLC	Strong	Genetic Variation	[3460]
SDC3	OT1P0LJM	Strong	Biomarker	[92]
SDCBP	OTS3NCC5	Strong	Altered Expression	[5205]
SDCBP2	OT1AT2OL	Strong	Altered Expression	[5206]
SDF4	OTQ7WFYW	Strong	Biomarker	[1896]
SDHAF2	OT0UG9H5	Strong	Altered Expression	[5207]
SDR9C7	OTQY8SJ3	Strong	Biomarker	[5208]
SDS	OT5WTJ2M	Strong	Genetic Variation	[1305]
SEC11A	OT06L834	Strong	Biomarker	[5209]
SEC11C	OTP3WS0U	Strong	Biomarker	[5210]
SEC14L1	OTA75FET	Strong	Altered Expression	[5211]
SEC62	OTCWEL5F	Strong	Altered Expression	[5212]
SECISBP2L	OTMSOLZU	Strong	Biomarker	[5213]
SELENOF	OT2JFB3S	Strong	Biomarker	[5214]
SELENOP	OT02B8IR	Strong	Biomarker	[1670]
SEMA3C	OTEGUY7F	Strong	Biomarker	[5215]
SEMA3D	OTD5TJV1	Strong	Biomarker	[5216]
SEMA3E	OTD4S36H	Strong	Biomarker	[5217]
SEMA4F	OTVP97ZV	Strong	Biomarker	[5218]
SEMA4G	OT7BCPU7	Strong	Biomarker	[5219]
SEMA5A	OTUOIOJV	Strong	Altered Expression	[5220]
SEMA6A	OTDQ7QAW	Strong	Biomarker	[5221]
SEMA6B	OT3VVVUO	Strong	Altered Expression	[4834]
SEMA7A	OT0ZJK64	Strong	Biomarker	[5222]
SEMG1	OT6Z4BPQ	Strong	Biomarker	[5223]
SENP2	OTPQJXIR	Strong	Biomarker	[5224]
SEPHS1	OTZ19I59	Strong	Biomarker	[2258]
SEPTIN1	OT4GVSU3	Strong	Biomarker	[5225]
SEPTIN10	OTPPNZUA	Strong	Altered Expression	[5226]
SEPTIN11	OTX2O0ZX	Strong	Genetic Variation	[5227]
SEPTIN4	OTD16B30	Strong	Biomarker	[5228]
SEPTIN7	OTJI08YX	Strong	Biomarker	[5229]
SERINC1	OTF3UASX	Strong	Biomarker	[5230]
SERINC2	OTZ039U0	Strong	Biomarker	[5230]
SERINC3	OTQ1LAJ1	Strong	Altered Expression	[5230]
SERPINA4	OTBK0GG7	Strong	Biomarker	[5231]
SERPINA5	OTTZXPGD	Strong	Biomarker	[5232]
SERPINB13	OTILBHCE	Strong	Biomarker	[5233]
SERPINB6	OT7G55IK	Strong	Biomarker	[956]
SERPINB9	OTJ811IF	Strong	Biomarker	[5234]
SERPINE2	OTYF5340	Strong	Biomarker	[5235]
SERPINI1	OTUJHIJW	Strong	Altered Expression	[5236]
SERTAD1	OTBHKZQP	Strong	Altered Expression	[5237]
SERTAD2	OTYIG6TP	Strong	Altered Expression	[5238]
SETBP1	OTKGCOSR	Strong	Genetic Variation	[5239]
SETD3	OTO5RAU2	Strong	Biomarker	[5240]
SETD4	OTBMCZQA	Strong	Biomarker	[5241]
SETDB1	OTWVUA1B	Strong	Biomarker	[5242]
SETDB2	OTBVVP9Q	Strong	Altered Expression	[4721]
SEZ6L2	OTUIKN2I	Strong	Biomarker	[1328]
SF3B2	OTNW2U4Y	Strong	Altered Expression	[5243]
SF3B3	OTAC9LZT	Strong	Biomarker	[5244]
SF3B6	OTPRKS6S	Strong	Biomarker	[3348]
SFPQ	OTLCIAPJ	Strong	Altered Expression	[3057]
SFRP2	OT8GZ0CA	Strong	Altered Expression	[5245]
SFTPA1	OT87XL1U	Strong	Biomarker	[5246]
SFTPB	OTOHS07E	Strong	Biomarker	[5247]
SGK3	OTQ6QO99	Strong	Genetic Variation	[5248]
SGMS2	OT3NHO99	Strong	Biomarker	[5249]
SGSM3	OTIB1P8A	Strong	Biomarker	[5250]
SH2D1A	OTLU49I5	Strong	Biomarker	[429]
SH2D1B	OTZG59LW	Strong	Biomarker	[5251]
SH2D4A	OTH562MY	Strong	Biomarker	[5252]
SH3BGRL	OTUOCTMT	Strong	Biomarker	[5253]
SH3BGRL3	OTKMW34I	Strong	Altered Expression	[5254]
SH3BP1	OTGED7Z2	Strong	Biomarker	[5255]
SH3BP4	OTVIRKW7	Strong	Altered Expression	[5256]
SH3BP5	OTOOEGUJ	Strong	Biomarker	[5257]
SH3GLB1	OTAZ5OP8	Strong	Altered Expression	[5258]
SH3PXD2A	OTYRQJIH	Strong	Biomarker	[5259]
SHC3	OT305NPA	Strong	Genetic Variation	[2343]
SHC4	OTQ0H76H	Strong	Biomarker	[5260]
SHOX2	OTLCZZJW	Strong	Biomarker	[5261]
SHPRH	OTKCBWWS	Strong	Biomarker	[5262]
SHQ1	OTFBXX2H	Strong	Biomarker	[5263]
SIAH1	OT29A838	Strong	Biomarker	[5264]
SIDT1	OTJM5S74	Strong	Biomarker	[5265]
SIGLEC8	OTQ5TRRV	Strong	Biomarker	[5266]
SIL1	OTDI85I5	Strong	Altered Expression	[5267]
SIM1	OTYKFPKZ	Strong	Posttranslational Modification	[5268]
SIM2	OT0QWHK4	Strong	Altered Expression	[5269]
SIN3A	OTM8OZWV	Strong	Biomarker	[5270]
SIN3B	OTFB59FK	Strong	Biomarker	[5271]
SIRPB1	OTGHALWJ	Strong	Biomarker	[126]
SIRPD	OTOTLOZJ	Strong	Biomarker	[126]
SIRT4	OT5S0J23	Strong	Biomarker	[5272]
SIRT7	OT5M4OT4	Strong	Biomarker	[5273]
SIVA1	OTDT0XZK	Strong	Biomarker	[5274]
SIX2	OTYOVGSC	Strong	Biomarker	[5275]
SIX3	OTP5E3VU	Strong	Biomarker	[5276]
SIX6	OTD1RD9D	Strong	Altered Expression	[5277]
SKA1	OTDYJ12A	Strong	Biomarker	[5278]
SKAP1	OTD4ZKAL	Strong	Biomarker	[5279]
SLC16A4	OT1YXBKC	Strong	Biomarker	[574]
SLC25A43	OTY6MWVD	Strong	Genetic Variation	[5280]
SLC26A8	OTNCW8RJ	Strong	Biomarker	[1592]
SLC2A4RG	OTW3LX8D	Strong	Biomarker	[5281]
SLC35F2	OTSAD4EQ	Strong	Biomarker	[5282]
SLC35F5	OT1FX2QO	Strong	Altered Expression	[5283]
SLC35G1	OTKZUA8O	Strong	Biomarker	[3598]
SLC49A4	OTXL3KAM	Strong	Biomarker	[5284]
SLC66A1	OTUM63MK	Strong	Biomarker	[5285]
SLC7A4	OTAVC6QS	Strong	Altered Expression	[5286]
SLFN11	OTJWFPMY	Strong	Biomarker	[5287]
SLFN12	OTTBXM25	Strong	Altered Expression	[5288]
SLIT1	OT35RBNT	Strong	Posttranslational Modification	[5289]
SLIT3	OTU8MKEU	Strong	Altered Expression	[5290]
SLITRK2	OTPVI22J	Strong	Genetic Variation	[4100]
SLITRK3	OT018P93	Strong	Altered Expression	[5291]
SLPI	OTUNFUU8	Strong	Biomarker	[5292]
SLU7	OTZUUICN	Strong	Biomarker	[5293]
SLX4	OTF6236I	Strong	Biomarker	[5294]
SMAGP	OT57BZII	Strong	Altered Expression	[5295]
SMAP1	OTQN3BVL	Strong	Genetic Variation	[3070]
SMARCA1	OT0Y6PTU	Strong	Biomarker	[5296]
SMARCA2	OTSGJ8SV	Strong	Biomarker	[5297]
SMARCAD1	OT90AZTX	Strong	Biomarker	[5298]
SMARCAL1	OTTKXLUZ	Strong	Biomarker	[5299]
SMARCC1	OTUOMBE7	Strong	Biomarker	[494]
SMARCD1	OTHFFT6G	Strong	Altered Expression	[5300]
SMARCD2	OTQTBWHW	Strong	Biomarker	[5301]
SMARCE1	OTAX4ITH	Strong	Genetic Variation	[5302]
SMC1A	OT9ZMRK9	Strong	Biomarker	[5303]
SMC4	OTEJE6AG	Strong	Biomarker	[5304]
SMC5	OT91M6N4	Strong	Altered Expression	[5305]
SMCHD1	OTBV52DR	Strong	Biomarker	[5306]
SMDT1	OTDBR8D1	Strong	Altered Expression	[5307]
SMG1	OTTS3SXE	Strong	Biomarker	[5308]
SMG6	OTRCEJQL	Strong	Biomarker	[5309]
SMG8	OTY9PCZY	Strong	Biomarker	[1573]
SMIM10L2B	OT04IG2N	Strong	Biomarker	[5310]
SMOC1	OTJG2JQY	Strong	Genetic Variation	[5311]
SMOC2	OTK1EQ49	Strong	Biomarker	[5312]
SMPD3	OTHQBETH	Strong	Biomarker	[5313]
SMPX	OTLSHGBF	Strong	Altered Expression	[1195]
SMR3A	OT6NAJJI	Strong	Altered Expression	[5314]
SMR3B	OTL5HNM8	Strong	Biomarker	[5315]
SMTN	OT4R2TYK	Strong	Biomarker	[5316]
SMURF1	OT5UIZR8	Strong	Biomarker	[5317]
SMURF2	OT3TRVL7	Strong	Altered Expression	[5318]
SMYD4	OTT349CJ	Strong	Biomarker	[1300]
SNAI1	OTDPYAMC	Strong	Altered Expression	[5319]
SNAP23	OTY2MYBX	Strong	Biomarker	[5320]
SND1	OTT734JN	Strong	Altered Expression	[5321]
SNED1	OTBQVXY5	Strong	Altered Expression	[5322]
SNIP1	OTL3RA91	Strong	Altered Expression	[5323]
SNRPA1	OTWJZFAP	Strong	Biomarker	[5324]
SNRPG	OTWX4XK1	Strong	Altered Expression	[5183]
SNW1	OTKWG3PS	Strong	Altered Expression	[2102]
SNX1	OTXQSJ1J	Strong	Altered Expression	[5325]
SNX27	OTVPS7S0	Strong	Biomarker	[5326]
SNX9	OTLNQ0ZM	Strong	Altered Expression	[5327]
SOAT1	OTB4Y5RJ	Strong	Biomarker	[5328]
SOBP	OTI8OO0M	Strong	Genetic Variation	[3143]
SOCS4	OTIRULFZ	Strong	Altered Expression	[5329]
SOCS5	OTN1ABYR	Strong	Biomarker	[5330]
SOCS6	OT2O5ZBK	Strong	Biomarker	[5331]
SOCS7	OT503VJG	Strong	Biomarker	[5332]
SOD3	OTIOZQAB	Strong	Altered Expression	[5333]
SOHLH2	OTB9EM6C	Strong	Altered Expression	[5334]
SORBS1	OTWH8762	Strong	Biomarker	[956]
SORBS2	OTJSX44Y	Strong	Biomarker	[5335]
SORBS3	OTVEUODC	Strong	Biomarker	[5252]
SOSTDC1	OTAKDNSM	Strong	Biomarker	[5336]
SOX1	OTVI1RAR	Strong	Biomarker	[5337]
SOX10	OTF25ULQ	Strong	Biomarker	[5338]
SOX12	OT93P8C9	Strong	Biomarker	[5339]
SOX13	OTCIF6KC	Strong	Biomarker	[5340]
SOX15	OTTB37I1	Strong	Altered Expression	[5341]
SOX17	OT9H4WWE	Strong	Altered Expression	[5342]
SOX18	OTPUMHWA	Strong	Altered Expression	[5343]
SOX21	OTNT50CC	Strong	Biomarker	[5344]
SOX4	OTSS40SS	Strong	Altered Expression	[5345]
SOX6	OTT0W0LE	Strong	Biomarker	[5346]
SOX7	OTOZOFAG	Strong	Biomarker	[428]
SPAAR	OTWXG2R8	Strong	Biomarker	[5347]
SPACA3	OTM1JKTC	Strong	Altered Expression	[5348]
SPAG1	OT29JZKW	Strong	Biomarker	[5349]
SPAG11A	OTNQ9UB0	Strong	Biomarker	[1173]
SPAG16	OTIFUPYD	Strong	Altered Expression	[5350]
SPAG17	OTUF58WZ	Strong	Biomarker	[5350]
SPAG4	OTVXS2SM	Strong	Biomarker	[5351]
SPAG5	OTCLJ56M	Strong	Biomarker	[5352]
SPAG9	OT45AHMB	Strong	Biomarker	[5353]
SPANXA1	OTMK3QIS	Strong	Biomarker	[5354]
SPART	OTIVOS2I	Strong	Altered Expression	[5355]
SPAST	OTIF3AJI	Strong	Altered Expression	[5356]
SPATA18	OTOEHTHU	Strong	Biomarker	[5357]
SPATA19	OT47CHQR	Strong	Altered Expression	[5358]
SPC24	OT1HVYV4	Strong	Biomarker	[5359]
SPECC1	OTPEML48	Strong	Biomarker	[5360]
SPECC1L	OT3WGZ73	Strong	Biomarker	[5361]
SPEN	OT37A2MD	Strong	Genetic Variation	[3401]
SPHKAP	OT5RHUYJ	Strong	Altered Expression	[2102]
SPIB	OTO4YKYI	Strong	Altered Expression	[5362]
SPIN1	OT69VAOX	Strong	Biomarker	[5363]
SPIN3	OT5PTQSH	Strong	Biomarker	[4961]
SPINK13	OTEU2OSU	Strong	Altered Expression	[5364]
SPINK5	OT61IIAO	Strong	Biomarker	[5365]
SPINT1	OT1CLR5L	Strong	Altered Expression	[5366]
SPINT2	OTQV7BKQ	Strong	Biomarker	[5367]
SPOCD1	OTF4K46N	Strong	Biomarker	[5368]
SPON2	OTE7JLNM	Strong	Altered Expression	[5369]
SPP2	OTX254AR	Strong	Biomarker	[5370]
SPPL2A	OTCVF6MM	Strong	Biomarker	[5371]
SPPL3	OT2HLJF6	Strong	Biomarker	[4151]
SPRED1	OTKX7P8G	Strong	Biomarker	[5372]
SPRR2A	OT62ZU6B	Strong	Altered Expression	[5373]
SPRR3	OTN9QJKG	Strong	Altered Expression	[5374]
SPRY3	OT0SHIZ6	Strong	Altered Expression	[5375]
SPTB	OT1Q9ABM	Strong	Biomarker	[5376]
SRA1	OTYOGMTG	Strong	Biomarker	[5377]
SRCIN1	OTQZNQQ5	Strong	Biomarker	[5378]
SRGAP2	OTUWFMCQ	Strong	Biomarker	[5379]
SRPRB	OTUUFHQS	Strong	Biomarker	[5380]
SRRM2	OTSIMMC9	Strong	Biomarker	[4371]
SRRT	OTMYPSWV	Strong	Biomarker	[5381]
SRSF1	OTF61HOV	Strong	Biomarker	[5382]
SRSF10	OTY6IJ11	Strong	Altered Expression	[5383]
SRSF11	OTZSV6CZ	Strong	Genetic Variation	[5384]
SRSF2	OTVDHO6U	Strong	Altered Expression	[5385]
SRSF3	OTOFT707	Strong	Biomarker	[5386]
SRSF4	OTLI7CU1	Strong	Biomarker	[5387]
SRSF5	OTC5WP98	Strong	Altered Expression	[5388]
SRSF6	OTGLOSYE	Strong	Altered Expression	[5389]
SRY	OT516T6D	Strong	Biomarker	[5390]
SSBP2	OTYG1G80	Strong	Biomarker	[4520]
SSH1	OT4BE2M4	Strong	Biomarker	[5391]
SSH2	OT8NCK82	Strong	Biomarker	[5392]
SSR2	OTQJSL7M	Strong	Altered Expression	[64]
SSX3	OTGJV5UZ	Strong	Altered Expression	[5393]
SSX4	OT0E4H2D	Strong	Altered Expression	[5394]
ST13	OTNML6UP	Strong	Biomarker	[5395]
ST3GAL1	OTFCO8QX	Strong	Altered Expression	[5396]
ST3GAL3	OTOORKUE	Strong	Altered Expression	[5397]
ST3GAL6	OTB17Q43	Strong	Biomarker	[5398]
ST6GAL1	OT7US3NO	Strong	Biomarker	[5399]
ST6GALNAC4	OTJCJQI7	Strong	Altered Expression	[5400]
ST7L	OT0I8XNI	Strong	Biomarker	[5401]
ST8SIA1	OTGND2YZ	Strong	Altered Expression	[5402]
ST8SIA2	OTRBBBD8	Strong	Biomarker	[5403]
STAG1	OT564IX4	Strong	Biomarker	[5404]
STAG2	OTR6X1Q7	Strong	Biomarker	[5405]
STAM2	OT9OBWPH	Strong	Altered Expression	[5406]
STARD10	OTWVNFV4	Strong	Altered Expression	[5407]
STARD13	OTB4U1HY	Strong	Biomarker	[3073]
STARD3	OTSTC5B5	Strong	Biomarker	[5408]
STARD7	OTDUZ296	Strong	Biomarker	[5409]
STARD8	OTY9IAKW	Strong	Biomarker	[5410]
STAT2	OTO9G2RZ	Strong	Altered Expression	[5411]
STAU1	OTTR5311	Strong	Biomarker	[5412]
STEAP4	OTFTLAEZ	Strong	Biomarker	[5413]
STIL	OT9799VN	Strong	Biomarker	[5414]
STING1	OTDAP4G0	Strong	Biomarker	[5415]
STK10	OTC33Y2F	Strong	Biomarker	[5416]
STK11IP	OTLQ6P8R	Strong	Biomarker	[2143]
STK24	OTGUHOIL	Strong	Biomarker	[5417]
STK26	OTW4QE0D	Strong	Biomarker	[5418]
STK3	OTLNSCQD	Strong	Posttranslational Modification	[5419]
STK32C	OTN4HBAA	Strong	Biomarker	[5420]
STK35	OTLEMU48	Strong	Biomarker	[5421]
STOML3	OTLQGALK	Strong	Biomarker	[5422]
STON1	OT2HPUAI	Strong	Biomarker	[2983]
STRA6	OT2IDF27	Strong	Altered Expression	[5423]
STUB1	OTSUYI9A	Strong	Biomarker	[5424]
STX11	OTHFRSFP	Strong	Biomarker	[5425]
STX3	OT4CIWLJ	Strong	Biomarker	[5426]
STX4	OTQ7YUX1	Strong	Biomarker	[5427]
STX6	OTC5F5M6	Strong	Altered Expression	[5428]
STXBP5	OTE3M7QB	Strong	Genetic Variation	[4750]
SUDS3	OTZ1AARI	Strong	Biomarker	[5429]
SUFU	OT0IRYG1	Strong	Altered Expression	[5430]
SULF1	OTJCNCO0	Strong	Altered Expression	[5431]
SULT4A1	OT7AL3KJ	Strong	Biomarker	[5432]
SUMO1	OTJFD4P5	Strong	Biomarker	[5433]
SUMO2	OT1Y5IKN	Strong	Altered Expression	[5434]
SUN2	OT2IQJUC	Strong	Biomarker	[5435]
SUPV3L1	OT416O2G	Strong	Genetic Variation	[5436]
SURF4	OTCSXJ9C	Strong	Biomarker	[5437]
SUSD2	OTSJTAZP	Strong	Biomarker	[5438]
SV2B	OTAO5WIU	Strong	Biomarker	[5439]
SVEP1	OTOBICRD	Strong	Biomarker	[5440]
SVIP	OTVKVR34	Strong	Altered Expression	[5441]
SYBU	OT3FQV7N	Strong	Biomarker	[5100]
SYCE1	OTTOIXW8	Strong	Altered Expression	[5442]
SYCE1L	OTXU44F3	Strong	Altered Expression	[376]
SYCP2	OTBH622S	Strong	Biomarker	[5443]
SYCP3	OTKOF54H	Strong	Altered Expression	[5444]
SYF2	OTY2ZW1H	Strong	Altered Expression	[5445]
SYN2	OTK0DEGH	Strong	Biomarker	[5446]
SYNE1	OTSBSLUH	Strong	Biomarker	[5447]
SYNJ2BP	OT2Q677P	Strong	Altered Expression	[5448]
SYNM	OTOI8TRJ	Strong	Biomarker	[748]
SYNPO2	OTC3U0YH	Strong	Biomarker	[5449]
SYT7	OTBWAOWY	Strong	Biomarker	[5450]
SYTL2	OTUIOWKL	Strong	Altered Expression	[5451]
TAB1	OTPM6F85	Strong	Altered Expression	[5452]
TAC1	OTM842YW	Strong	Altered Expression	[5453]
TAC3	OTOJGM38	Strong	Biomarker	[5454]
TACC2	OTW4M7HI	Strong	Biomarker	[5455]
TADA3	OTNUAIO9	Strong	Altered Expression	[5456]
TAF15	OTNE038N	Strong	Biomarker	[5457]
TAF1L	OT9Z7EVA	Strong	Genetic Variation	[5458]
TAF8	OTWWGCHV	Strong	Biomarker	[5459]
TAFA5	OT2SWBT6	Strong	Altered Expression	[5460]
TAL1	OTX4K6QZ	Strong	Biomarker	[5461]
TANK	OTZSGFIK	Strong	Biomarker	[5462]
TAOK2	OTNUMOZ1	Strong	Biomarker	[1328]
TAPBPL	OTTS1YNP	Strong	Biomarker	[5463]
TARBP1	OT14Z6RJ	Strong	Altered Expression	[5464]
TAS1R3	OTOVM44D	Strong	Biomarker	[5465]
TAS2R16	OT67HLNS	Strong	Biomarker	[5466]
TAT	OT2CJ91O	Strong	Biomarker	[3073]
TATDN1	OTQ3S9AL	Strong	Biomarker	[5467]
TAX1BP1	OTGJMGJ9	Strong	Biomarker	[5468]
TAX1BP3	OTQ6IB4T	Strong	Biomarker	[5469]
TBC1D24	OTKZUSMD	Strong	Biomarker	[5470]
TBCA	OTCCWMGK	Strong	Biomarker	[5471]
TBP	OT6C0S52	Strong	Biomarker	[5472]
TBRG1	OTMV5L8H	Strong	Biomarker	[5473]
TBX15	OTAZ9QDX	Strong	Biomarker	[5474]
TBX18	OT3BEBLN	Strong	Biomarker	[5475]
TBX2	OTTOT7A9	Strong	Altered Expression	[5476]
TBX3	OTM64N7K	Strong	Biomarker	[5477]
TBX4	OTW58FG4	Strong	Biomarker	[2258]
TBX5	OT70PISV	Strong	Biomarker	[3827]
TC2N	OT6482WN	Strong	Altered Expression	[5478]
TCEA1	OTBFO594	Strong	Biomarker	[2393]
TCEAL7	OTNPDZCN	Strong	Biomarker	[5479]
TCF12	OTZVONNU	Strong	Biomarker	[3491]
TCF7	OT1ID822	Strong	Altered Expression	[5480]
TCF7L1	OTTUTF0O	Strong	Altered Expression	[5481]
TCFL5	OTJL4348	Strong	Altered Expression	[3669]
TCHH	OT4J7EFT	Strong	Biomarker	[5482]
TCN1	OTW6A49Y	Strong	Biomarker	[5483]
TCOF1	OT4BOYTM	Strong	Genetic Variation	[5484]
TCP10L	OTWEW67K	Strong	Biomarker	[5485]
TCTN1	OTG5KEV8	Strong	Altered Expression	[5486]
TCTN2	OTKR3I3L	Strong	Biomarker	[5487]
TDRD3	OTG83E2C	Strong	Biomarker	[5488]
TDRD7	OTK639ET	Strong	Biomarker	[5489]
TEAD4	OTJS0T2B	Strong	Biomarker	[5490]
TENM2	OTPLUYEF	Strong	Biomarker	[5491]
TENT5B	OTO2P28B	Strong	Altered Expression	[5492]
TES	OTL8PP6V	Strong	Biomarker	[5493]
TET1	OTZDHT1D	Strong	Altered Expression	[5494]
TET2	OTKKT03T	Strong	Biomarker	[1246]
TET3	OT76U3YF	Strong	Genetic Variation	[5495]
TEX10	OTNTU9CB	Strong	Biomarker	[5496]
TEX19	OTY6MIZ9	Strong	Altered Expression	[5497]
TEX35	OT80OVC0	Strong	Biomarker	[5498]
TFAM	OTXXV5V7	Strong	Biomarker	[1435]
TFAP2B	OTR1T8E9	Strong	Altered Expression	[5499]
TFCP2	OTA246TE	Strong	Biomarker	[5500]
TFDP2	OTKQFX5H	Strong	Biomarker	[5501]
TFEB	OTJUJJQY	Strong	Genetic Variation	[5502]
TFEC	OTUST8MR	Strong	Biomarker	[3505]
TFG	OT2KJENI	Strong	Biomarker	[5503]
TFR2	OTMYCCEO	Strong	Altered Expression	[5504]
TGFB1I1	OTIK337D	Strong	Altered Expression	[5505]
THADA	OTYZQX0F	Strong	Biomarker	[5506]
THAP11	OTEMWLZ0	Strong	Altered Expression	[5507]
THAP12	OTAG4LPL	Strong	Genetic Variation	[5508]
THAP7	OTZDVYC8	Strong	Altered Expression	[5509]
THEMIS2	OTI1OBLN	Strong	Biomarker	[5510]
THOC1	OTVABJ4Z	Strong	Altered Expression	[5511]
THOC5	OTHY50SK	Strong	Altered Expression	[5512]
THRSP	OTKYE01L	Strong	Biomarker	[5513]
THSD1	OTKPGFHS	Strong	Biomarker	[5514]
THSD7A	OT7249HH	Strong	Altered Expression	[5515]
THUMPD1	OTKU8KWH	Strong	Biomarker	[5516]
THY1	OTVONVTB	Strong	Altered Expression	[1271]
TIAL1	OTV2KFZH	Strong	Biomarker	[5517]
TIGAR	OTR7NMRJ	Strong	Biomarker	[5518]
TIMM8A	OTDX9687	Strong	Biomarker	[5519]
TIPRL	OTS2FZ8O	Strong	Biomarker	[4179]
TJP1	OTBDCUPK	Strong	Altered Expression	[5520]
TJP2	OTQUY6BV	Strong	Altered Expression	[5521]
TLCD3A	OTVZUR1Z	Strong	Biomarker	[5522]
TLE3	OTR9PH95	Strong	Altered Expression	[5523]
TLK2	OTZ09CG8	Strong	Altered Expression	[5524]
TLR10	OTQ1KVJO	Strong	Genetic Variation	[5525]
TLX1	OTVN0MNW	Strong	Biomarker	[5526]
TLX2	OTPFAUM8	Strong	Biomarker	[5527]
TLX3	OTBUHHK3	Strong	Altered Expression	[5528]
TM4SF18	OTDES2NC	Strong	Altered Expression	[5529]
TM7SF2	OTILU5S7	Strong	Biomarker	[420]
TM9SF2	OTA0C202	Strong	Biomarker	[5530]
TM9SF4	OT85D4H9	Strong	Biomarker	[5531]
TMBIM1	OTE47B57	Strong	Altered Expression	[5532]
TMC8	OTUAD95X	Strong	Genetic Variation	[5533]
TMED10	OTUXSHH7	Strong	Biomarker	[5534]
TMED9	OTYGAQS0	Strong	Biomarker	[546]
TMEFF1	OTH6M3CH	Strong	Biomarker	[5535]
TMEFF2	OT1WZ2QO	Strong	Genetic Variation	[4966]
TMEM100	OTRJ6OHY	Strong	Biomarker	[5536]
TMEM106A	OTHTBYDN	Strong	Biomarker	[5537]
TMEM129	OTJU5VDZ	Strong	Genetic Variation	[5538]
TMEM132A	OTNUI7O1	Strong	Biomarker	[4014]
TMEM132D	OTV6I4Z0	Strong	Biomarker	[5539]
TMEM158	OT0KUBBI	Strong	Altered Expression	[5540]
TMEM17	OTEU00OH	Strong	Altered Expression	[5541]
TMEM170B	OT4AS8RJ	Strong	Biomarker	[5542]
TMEM176A	OTOZDWXX	Strong	Biomarker	[5543]
TMEM176B	OTEGF2BV	Strong	Biomarker	[5544]
TMEM184C	OTCA2HUW	Strong	Biomarker	[5545]
TMEM196	OTPFLB1R	Strong	Altered Expression	[5546]
TMEM201	OTZBZ4MC	Strong	Genetic Variation	[5547]
TMEM215	OTLJT3Q2	Strong	Altered Expression	[5548]
TMEM225	OTRDE6V0	Strong	Altered Expression	[5038]
TMEM26	OTHZCXYB	Strong	Biomarker	[5549]
TMEM30A	OTR6N5J2	Strong	Biomarker	[5550]
TMEM40	OTSJKKNA	Strong	Biomarker	[5551]
TMEM41B	OTW0B0KS	Strong	Biomarker	[1569]
TMEM45A	OT54KJG6	Strong	Altered Expression	[5552]
TMEM47	OTAJ4CPX	Strong	Biomarker	[5553]
TMEM74	OT3IZBM0	Strong	Biomarker	[1830]
TMEM8B	OTJZWPS6	Strong	Biomarker	[5554]
TMEM98	OTKDUEED	Strong	Altered Expression	[5555]
TMOD4	OTXLGJ4R	Strong	Biomarker	[5556]
TMPO	OTL68EL4	Strong	Altered Expression	[5557]
TMPRSS11A	OTB35677	Strong	Biomarker	[5558]
TMPRSS11E	OTO5U2TK	Strong	Biomarker	[5559]
TMPRSS13	OTMAOAP3	Strong	Posttranslational Modification	[4312]
TMPRSS3	OT0GTO1Z	Strong	Biomarker	[5560]
TMSB10	OTLVZ13T	Strong	Biomarker	[5561]
TMUB1	OTR4RO3N	Strong	Biomarker	[5562]
TNFAIP1	OT37EWR0	Strong	Biomarker	[5563]
TNFAIP2	OTRZH80H	Strong	Altered Expression	[5564]
TNFAIP6	OT1SLUZH	Strong	Altered Expression	[5565]
TNFAIP8	OT1G9297	Strong	Biomarker	[5566]
TNFAIP8L2	OTII0RM0	Strong	Altered Expression	[5567]
TNFAIP8L3	OTHSBS1B	Strong	Altered Expression	[5568]
TNFRSF10C	OTVHOL9B	Strong	Altered Expression	[5569]
TNFRSF19	OTTVT4MB	Strong	Biomarker	[5570]
TNFSF9	OTV9L89D	Strong	Biomarker	[5571]
TNIP1	OTRAOTEW	Strong	Biomarker	[5572]
TNMD	OTHLVA9G	Strong	Biomarker	[5573]
TNNT1	OT8PBOAR	Strong	Biomarker	[3223]
TOB1	OTNW949D	Strong	Biomarker	[5574]
TOGARAM1	OTG6CYJ0	Strong	Biomarker	[5575]
TOMM20	OT76TPR2	Strong	Altered Expression	[5576]
TOMM34	OTH6MITE	Strong	Altered Expression	[5577]
TOMM70	OT8QBYZ0	Strong	Biomarker	[5578]
TONSL	OTBWODM9	Strong	Biomarker	[5579]
TOP1MT	OT2H77ID	Strong	Biomarker	[5580]
TOPBP1	OT6UPZPD	Strong	Altered Expression	[5581]
TOPORS	OT1ERFFQ	Strong	Biomarker	[5582]
TOX2	OT7RZRVK	Strong	Biomarker	[5583]
TOX3	OTC9NR4W	Strong	Genetic Variation	[5584]
TP53BP2	OTOWJ2Y4	Strong	Altered Expression	[5585]
TP53I3	OTSCM68G	Strong	Biomarker	[4475]
TPD52L1	OTSA6U0I	Strong	Altered Expression	[5586]
TPGS2	OT25O8ME	Strong	Biomarker	[5587]
TPM2	OTA1L0P8	Strong	Biomarker	[5588]
TPM4	OTN4YLYR	Strong	Biomarker	[5589]
TPPP	OTCFMSUF	Strong	Biomarker	[546]
TPPP3	OTU8VUIG	Strong	Biomarker	[3789]
TRA2A	OT5NHOO3	Strong	Biomarker	[5590]
TRA2B	OTZYQW52	Strong	Altered Expression	[5591]
TRADD	OTBOSJHO	Strong	Biomarker	[5592]
TRAF3	OT5TQBGV	Strong	Biomarker	[5593]
TRAF4	OTJLRVMC	Strong	Biomarker	[5594]
TRAM2	OTSFG0ST	Strong	Altered Expression	[5595]
TRAPPC4	OT3THRCA	Strong	Biomarker	[5596]
TRAT1	OTMPUNPD	Strong	Biomarker	[5597]
TRDMT1	OTAYQ8ZF	Strong	Biomarker	[5598]
TREH	OTJE0NOY	Strong	Biomarker	[745]
TRIAP1	OTEAUJXN	Strong	Altered Expression	[5599]
TRIB1	OTPEO17G	Strong	Biomarker	[5600]
TRIB2	OTHSX3MX	Strong	Biomarker	[5601]
TRIM11	OTMD6IM2	Strong	Biomarker	[5602]
TRIM14	OTLQKUG0	Strong	Altered Expression	[5603]
TRIM15	OTNYAKP6	Strong	Biomarker	[5604]
TRIM16	OTLRXYOZ	Strong	Biomarker	[2319]
TRIM21	OTA4UJCF	Strong	Genetic Variation	[5605]
TRIM25	OT35SG1R	Strong	Biomarker	[2162]
TRIM29	OT2DNESG	Strong	Biomarker	[5606]
TRIM32	OTJOV0PG	Strong	Biomarker	[5607]
TRIM36	OT37JQ8Y	Strong	Biomarker	[5608]
TRIM44	OT0B1T2B	Strong	Altered Expression	[5609]
TRIM45	OTFDQT4E	Strong	Biomarker	[5610]
TRIM50	OTXA2IXF	Strong	Biomarker	[5611]
TRIM58	OT7OIIRH	Strong	Biomarker	[5612]
TRIM62	OT15YO6N	Strong	Biomarker	[5613]
TRIM63	OTUSWA74	Strong	Biomarker	[5614]
TRIM67	OTXRZN27	Strong	Biomarker	[5615]
TRIM7	OT1A26OW	Strong	Biomarker	[5616]
TRIM71	OTH8UB6H	Strong	Altered Expression	[5617]
TRIM72	OTFAFXPC	Strong	Altered Expression	[5618]
TRIP11	OT4FJEAR	Strong	Altered Expression	[5619]
TRIP13	OTFM3TI9	Strong	Altered Expression	[5620]
TRIP4	OTA8OASA	Strong	Altered Expression	[5621]
TRIT1	OTCU9FS5	Strong	Biomarker	[5622]
TRMT12	OTCN4IQZ	Strong	Altered Expression	[5623]
TRO	OTRZQMU8	Strong	Biomarker	[5624]
TROAP	OTC8CE0R	Strong	Altered Expression	[764]
TRPS1	OT7XPPEL	Strong	Biomarker	[5625]
TRPV5	OTWF4L0U	Strong	Altered Expression	[5626]
TRRAP	OT68OI2Y	Strong	Genetic Variation	[4100]
TSACC	OT3QW6PH	Strong	Biomarker	[4197]
TSC22D1	OTN4GFWD	Strong	Altered Expression	[5627]
TSC22D4	OTNMQGZS	Strong	Altered Expression	[5627]
TSHZ2	OTZWBXXY	Strong	Biomarker	[5628]
TSHZ3	OTAN7RY5	Strong	Biomarker	[5628]
TSKS	OT5LZ6GG	Strong	Altered Expression	[5629]
TSN	OTOFAQ2Z	Strong	Biomarker	[5630]
TSPAN12	OTF9I3CX	Strong	Genetic Variation	[5384]
TSPAN13	OTCS9BZY	Strong	Altered Expression	[4613]
TSPAN15	OTNQXXIG	Strong	Biomarker	[5631]
TSPAN17	OTXYUBMQ	Strong	Altered Expression	[5632]
TSPAN31	OT8WQ83R	Strong	Biomarker	[4525]
TSPAN33	OTH6C0WU	Strong	Altered Expression	[2252]
TSPY1	OTPY57X4	Strong	Genetic Variation	[5633]
TSPY3	OTQK3AKI	Strong	Genetic Variation	[5633]
TSPYL2	OTGGW2EF	Strong	Biomarker	[5634]
TSPYL5	OT7QEI2X	Strong	Biomarker	[5635]
TSSK6	OT1OYTXA	Strong	Genetic Variation	[5636]
TTBK2	OT90YSM5	Strong	Altered Expression	[5637]
TTC12	OTDB24YV	Strong	Biomarker	[5638]
TTC28	OTFOOYC3	Strong	Genetic Variation	[5639]
TTC36	OT90ZLHE	Strong	Biomarker	[5640]
TTC4	OTAPMYXU	Strong	Biomarker	[5641]
TTL	OTSS1CK4	Strong	Genetic Variation	[5642]
TTLL12	OTJQ8RF4	Strong	Biomarker	[5643]
TTLL3	OT7JWXHA	Strong	Biomarker	[5644]
TTN	OT0LZ058	Strong	Biomarker	[5645]
AASS	OTYCN07T	Definitive	Genetic Variation	[5646]
ABHD2	OTCRUOCS	Definitive	Altered Expression	[5647]
ACOT11	OTGPB0SM	Definitive	Biomarker	[2249]
ACSL6	OT0TT8P8	Definitive	Biomarker	[5648]
ACSM3	OT0AE1IV	Definitive	Posttranslational Modification	[5649]
ACTN1	OTUCLNXH	Definitive	Biomarker	[5650]
ACTR10	OTRF3E58	Definitive	Altered Expression	[5651]
ACTR3B	OTNEC9UT	Definitive	Altered Expression	[5651]
ACTR3C	OTLAWZPC	Definitive	Altered Expression	[5651]
ADAM11	OTPTVW5W	Definitive	Genetic Variation	[5652]
ADAM12	OTZKOTDB	Definitive	Altered Expression	[5653]
ADAM22	OT452ZDC	Definitive	Biomarker	[5654]
ADAR	OTQNOHR8	Definitive	Altered Expression	[5655]
ADCY3	OTGOQM6B	Definitive	Altered Expression	[5656]
ADD3	OTDRSHAZ	Definitive	Biomarker	[5657]
ADPRH	OTLJ5511	Definitive	Biomarker	[5658]
AIG1	OTJB2UTH	Definitive	Biomarker	[5659]
AMPD3	OT5SP1KJ	Definitive	Biomarker	[5660]
ANKDD1A	OTPNBHZS	Definitive	Biomarker	[5661]
ANKRD17	OTQ3DYEP	Definitive	Altered Expression	[5662]
ANKRD33	OTPY8R95	Definitive	Biomarker	[5663]
AP5M1	OTDLWEBL	Definitive	Altered Expression	[5664]
APOBEC2	OT4CCS0Q	Definitive	Altered Expression	[5665]
APOC1	OTA58CED	Definitive	Altered Expression	[5666]
APTX	OTPAS5G8	Definitive	Altered Expression	[5667]
ARAP3	OTUWZTH7	Definitive	Altered Expression	[5668]
ARHGAP21	OT6XY8Y9	Definitive	Biomarker	[5669]
ARHGAP27	OT8BSRPC	Definitive	Biomarker	[5670]
ARHGAP30	OTESZLFG	Definitive	Biomarker	[5671]
ARHGAP44	OTHJUCO1	Definitive	Biomarker	[5672]
ARID3B	OTUP9MS4	Definitive	Biomarker	[5673]
ARL4D	OTG5I3KU	Definitive	Biomarker	[5674]
ARMC8	OTNAXGM7	Definitive	Biomarker	[5675]
ARPC2	OTSOKOMY	Definitive	Biomarker	[5676]
ATF1	OT251CI0	Definitive	Biomarker	[5677]
ATP4B	OTIP2EYJ	Definitive	Posttranslational Modification	[5678]
ATP5F1C	OTV5GZK5	Definitive	Genetic Variation	[5679]
ATP6V0D1	OT9GU2NW	Definitive	Biomarker	[5680]
AVEN	OTGIN5YK	Definitive	Biomarker	[5681]
BAG1	OTRQNIA4	Definitive	Biomarker	[2360]
BAG6	OT4Z0S2U	Definitive	Biomarker	[1434]
BAIAP2	OT1KKMYZ	Definitive	Biomarker	[5682]
BASP1	OTF4VS5G	Definitive	Altered Expression	[5683]
BCAM	OTHZOPSD	Definitive	Altered Expression	[5684]
BCAN	OTPVY3ZR	Definitive	Biomarker	[5685]
BCL9L	OTTWI90E	Definitive	Altered Expression	[5686]
BEST1	OTWHE1ZC	Definitive	Biomarker	[5687]
BFAR	OTTBG0V7	Definitive	Biomarker	[5688]
BPIFA2	OTLFSDZD	Definitive	Altered Expression	[5689]
BRD8	OTIKS3PC	Definitive	Biomarker	[164]
BTN3A2	OT3DIBU3	Definitive	Altered Expression	[5690]
C18orf54	OT4WJKTF	Definitive	Genetic Variation	[5691]
C2CD3	OTC52E7V	Definitive	Biomarker	[5692]
C6orf58	OTT2T3DU	Definitive	Biomarker	[5693]
CADM3	OTSGOMWB	Definitive	Biomarker	[5694]
CAMK1	OTRN55RE	Definitive	Biomarker	[5695]
CAPN5	OTQ8QM7K	Definitive	Biomarker	[5696]
CBLL1	OTZUQBYX	Definitive	Altered Expression	[5697]
CCL4L2	OTDBSXOU	Definitive	Biomarker	[5698]
CCM2	OT2I5DOW	Definitive	Biomarker	[5699]
CCT4	OT5D452X	Definitive	Biomarker	[5700]
CD1D	OT3ROU4J	Definitive	Biomarker	[5701]
CDC42BPB	OTO6NT7Q	Definitive	Biomarker	[5702]
CDC42EP3	OTUZ3U9Z	Definitive	Biomarker	[5703]
CDK5R2	OTNUTLPU	Definitive	Biomarker	[5680]
CEACAM8	OTLL9WWO	Definitive	Biomarker	[5704]
CELSR3	OT8P6QNJ	Definitive	Genetic Variation	[5705]
CETN2	OTJTTGS0	Definitive	Biomarker	[5706]
CHAC1	OTJGE772	Definitive	Biomarker	[5707]
CHCHD4	OTQ185UW	Definitive	Altered Expression	[5708]
CHD2	OTRKL6YC	Definitive	Genetic Variation	[4250]
CHGB	OT7SAQT2	Definitive	Biomarker	[5709]
CHRNA3	OTCZQY1U	Definitive	Genetic Variation	[5710]
CHRNA6	OTT6W86V	Definitive	Biomarker	[5711]
CHTF18	OTQK3FI4	Definitive	Genetic Variation	[5712]
CLDN17	OTQCEYBY	Definitive	Altered Expression	[5713]
CMTM6	OT70T27A	Definitive	Altered Expression	[5714]
CMTM7	OTI7Q2JW	Definitive	Biomarker	[5715]
CNOT2	OT98OJ42	Definitive	Altered Expression	[5716]
CNTNAP2	OT48T2ZP	Definitive	Biomarker	[5717]
COL4A1	OTL6D1YE	Definitive	Biomarker	[5718]
COPZ2	OTM5W0BK	Definitive	Biomarker	[5719]
CORO7	OTG7MEAJ	Definitive	Biomarker	[5720]
CPN2	OTYOYP14	Definitive	Biomarker	[1470]
CPQ	OTTNZNLD	Definitive	Biomarker	[5721]
CRCP	OT4K9BT7	Definitive	Biomarker	[5722]
CRTC3	OTVIGVUW	Definitive	Biomarker	[5723]
CRYL1	OT0SJSJM	Definitive	Biomarker	[5724]
CTC1	OTRJY7QD	Definitive	Biomarker	[5725]
CYB561D2	OT1ZXC66	Definitive	Biomarker	[5726]
CYB5D2	OTX10KKR	Definitive	Biomarker	[5727]
DCAF13	OTQQ0QXT	Definitive	Biomarker	[5728]
DCBLD2	OTB71I02	Definitive	Biomarker	[5729]
DCUN1D3	OTG20VWE	Definitive	Biomarker	[5730]
DDX21	OTV73GMZ	Definitive	Biomarker	[5731]
DEPP1	OTB36PHJ	Definitive	Altered Expression	[5732]
DKK4	OTWCCVF6	Definitive	Biomarker	[5733]
DLX3	OTARP5SQ	Definitive	Biomarker	[5734]
DNALI1	OTTB3L8N	Definitive	Altered Expression	[5735]
DOC2B	OTRUMZ8C	Definitive	Altered Expression	[5736]
DPP3	OTUIVL1C	Definitive	Genetic Variation	[5737]
DPPA2	OT8Y55RY	Definitive	Biomarker	[5738]
DST	OTHZBM4X	Definitive	Biomarker	[5739]
E4F1	OTL5ESAC	Definitive	Biomarker	[5740]
ECSCR	OT9L72MD	Definitive	Altered Expression	[5741]
ELAVL3	OTI2VI8B	Definitive	Biomarker	[5742]
ELMO1	OTY2ORXK	Definitive	Biomarker	[5743]
ELOVL4	OT2M9W26	Definitive	Biomarker	[5744]
ELSPBP1	OT79E7DW	Definitive	Altered Expression	[5745]
EMCN	OTS03CZC	Definitive	Biomarker	[5746]
ERH	OTJDWX99	Definitive	Altered Expression	[5747]
ESS2	OTZ08VCZ	Definitive	Biomarker	[5748]
ESX1	OTZUPU2C	Definitive	Genetic Variation	[5749]
ETV2	OTP5URZ8	Definitive	Altered Expression	[5750]
FOXA3	OTRGT2OT	Definitive	Altered Expression	[5751]
FRMD3	OT0CD2GG	Definitive	Biomarker	[5752]
FRS2	OTDMD800	Definitive	Genetic Variation	[2971]
FUZ	OTC427QQ	Definitive	Biomarker	[5753]
G0S2	OT8FL49L	Definitive	Biomarker	[5754]
GAGE4	OTPB5C0O	Definitive	Altered Expression	[3907]
GAGE5	OTFI6OVS	Definitive	Altered Expression	[3907]
GALR3	OTXU6PKO	Definitive	Biomarker	[5755]
GARS1	OT5B6R9Y	Definitive	Altered Expression	[5756]
GBA2	OTOZXG5D	Definitive	Biomarker	[5757]
GBP2	OTVU4G07	Definitive	Biomarker	[5758]
GDF9	OTNTVKVU	Definitive	Biomarker	[5759]
GLRA2	OTDQ0KW7	Definitive	Biomarker	[5760]
GLYR1	OTY0VAVL	Definitive	Altered Expression	[5761]
GMFB	OTR1JN1D	Definitive	Altered Expression	[5762]
GNAI2	OTTLGRGH	Definitive	Biomarker	[5763]
GNS	OTNFKYGB	Definitive	Biomarker	[5764]
GTF2H5	OTRL219S	Definitive	Altered Expression	[5765]
GYPA	OTABU4YV	Definitive	Biomarker	[5766]
GZMK	OT6O7PCT	Definitive	Biomarker	[5767]
H1-2	OT0AVI4M	Definitive	Altered Expression	[5768]
H2AC18	OTCE5JC7	Definitive	Altered Expression	[5769]
H2AC20	OTEIVLM1	Definitive	Altered Expression	[5769]
HACD4	OT85HPZE	Definitive	Biomarker	[5770]
HAPLN2	OT0G3KEQ	Definitive	Biomarker	[5771]
HAPLN4	OTZQOG9A	Definitive	Biomarker	[5771]
HARS1	OTHOEOTS	Definitive	Biomarker	[5772]
HDLBP	OTKDEEYX	Definitive	Biomarker	[5773]
HECA	OTWG3P6C	Definitive	Biomarker	[5774]
HEPH	OTZ2F15Z	Definitive	Genetic Variation	[5775]
HIRA	OTON40EJ	Definitive	Biomarker	[5776]
HIVEP3	OTM3QT3L	Definitive	Biomarker	[5777]
HMGN4	OTD7GPRL	Definitive	Biomarker	[5778]
HNRNPA0	OTCP792K	Definitive	Genetic Variation	[5779]
HNRNPD	OT5UO1FA	Definitive	Altered Expression	[5780]
HOOK3	OT0OE8SX	Definitive	Altered Expression	[5781]
HPX	OT14T7Q1	Definitive	Biomarker	[5782]
HS3ST1	OT5DVN9P	Definitive	Biomarker	[5783]
HSD3B7	OT2Y9IW4	Definitive	Biomarker	[5784]
HSPA6	OTH4S7WB	Definitive	Altered Expression	[5785]
IER3	OTZJI5FZ	Definitive	Biomarker	[5786]
IFI16	OT4SPU0U	Definitive	Altered Expression	[5787]
IFIT5	OTYTSO77	Definitive	Biomarker	[5788]
IFITM2	OTAT6TI6	Definitive	Altered Expression	[5789]
IFNL2	OT4BMJF7	Definitive	Biomarker	[5790]
IKZF1	OTCW1FKL	Definitive	Altered Expression	[5791]
IL20RA	OTSIVBVS	Definitive	Biomarker	[5792]
INTS6	OT6GDV46	Definitive	Biomarker	[5793]
INTS7	OT7ZG99E	Definitive	Altered Expression	[5794]
INTU	OTXB13E6	Definitive	Altered Expression	[5795]
IQGAP2	OTX2UA7P	Definitive	Biomarker	[5796]
IQGAP3	OT4RZV2M	Definitive	Biomarker	[5797]
IRF4	OT1DHQ1P	Definitive	Biomarker	[5798]
IRX4	OT0TV6WK	Definitive	Biomarker	[5799]
ISX	OTULQRWA	Definitive	Altered Expression	[5800]
ITGB4	OT28UK84	Definitive	Biomarker	[5801]
ITPRID2	OTO3JDX5	Definitive	Biomarker	[5802]
IZUMO1R	OT7AUX7O	Definitive	Biomarker	[5803]
JDP2	OTW35WKX	Definitive	Altered Expression	[5804]
KALRN	OT8WRCBH	Definitive	Biomarker	[5805]
KCNIP3	OTCQPEM4	Definitive	Altered Expression	[5806]
KCTD12	OTPYKT4Z	Definitive	Biomarker	[5807]
KDM6A	OTZM3MJJ	Definitive	Genetic Variation	[5808]
KIF3B	OT0HJREB	Definitive	Biomarker	[5809]
KIF3C	OTTXKIWA	Definitive	Biomarker	[5810]
KRR1	OTCMJ3K3	Definitive	Altered Expression	[5811]
KRT14	OTUVZ1DW	Definitive	Altered Expression	[5812]
KRT81	OTMKIK2S	Definitive	Biomarker	[5813]
KSR2	OTSMUL59	Definitive	Altered Expression	[5814]
LAMB1	OT6J9LJR	Definitive	Biomarker	[5815]
LAMTOR5	OTER0U8L	Definitive	Biomarker	[5816]
LDOC1	OTWZH4O9	Definitive	Altered Expression	[5817]
LGALS13	OTEV3DD7	Definitive	Biomarker	[5818]
LGALS9C	OTZXGYKC	Definitive	Biomarker	[5819]
LIX1	OT1CPNCC	Definitive	Biomarker	[5820]
LRAT	OTB7CJKY	Definitive	Biomarker	[5821]
LRRFIP1	OTN7XAUD	Definitive	Genetic Variation	[5822]
LSAMP	OTYXVQX2	Definitive	Biomarker	[5823]
LURAP1	OTJ1EZDJ	Definitive	Biomarker	[5824]
MAGEA9	OTWGX2SD	Definitive	Biomarker	[5825]
MARCHF7	OTG9SF10	Definitive	Biomarker	[5826]
MARK4	OT6Z2TGV	Definitive	Altered Expression	[5827]
MAST1	OTEYFN5O	Definitive	Altered Expression	[5828]
MATN2	OTVDR68G	Definitive	Altered Expression	[5829]
MCM5	OTAHLB62	Definitive	Biomarker	[5830]
MCU	OTQZAYWQ	Definitive	Biomarker	[5831]
MED12	OTQZ4D2X	Definitive	Genetic Variation	[5832]
MEP1A	OTY2Z48T	Definitive	Biomarker	[5833]
METTL14	OT6TPQMH	Definitive	Biomarker	[5834]
MGA	OTTLB216	Definitive	Biomarker	[5835]
MICAL2	OT04OQQJ	Definitive	Biomarker	[5836]
MIXL1	OT584VOQ	Definitive	Biomarker	[5837]
MLF1	OTC5BKHU	Definitive	Biomarker	[5838]
MLIP	OTMT7AII	Definitive	Biomarker	[5839]
MOAP1	OTVF3LUG	Definitive	Biomarker	[5840]
MPPED2	OT7XLMJ6	Definitive	Biomarker	[5841]
MPRIP	OT5FV5NS	Definitive	Biomarker	[5842]
MRAS	OTNCVCQW	Definitive	Biomarker	[5843]
MROH8	OTM9AB8Z	Definitive	Biomarker	[5844]
MRPL19	OTRBKF6R	Definitive	Biomarker	[5845]
MSL2	OTVPQYBG	Definitive	Altered Expression	[5846]
MTMR14	OTUUEY6Q	Definitive	Biomarker	[5847]
MUC19	OTM06UGV	Definitive	Altered Expression	[5848]
MX1	OT6X8G5T	Definitive	Altered Expression	[5849]
MYBPC1	OTRPN93S	Definitive	Altered Expression	[5850]
MYCBP2	OTHODA1F	Definitive	Biomarker	[5851]
MYH10	OTXN2WXS	Definitive	Biomarker	[5852]
MYO1G	OTOCFS3Q	Definitive	Altered Expression	[5853]
MYO6	OTJQYRC7	Definitive	Altered Expression	[5854]
NCAN	OT8OO6ZE	Definitive	Altered Expression	[5855]
NCOA7	OT2CNBOG	Definitive	Genetic Variation	[5856]
NDN	OTYBYJ82	Definitive	Biomarker	[5857]
NEFL	OTQESJV4	Definitive	Biomarker	[5858]
NELFE	OTL4E94L	Definitive	Altered Expression	[5859]
NFKBIE	OTLAYEL9	Definitive	Biomarker	[5860]
NKAIN2	OTI4H30Z	Definitive	Genetic Variation	[5861]
NKTR	OTIADJNW	Definitive	Biomarker	[5862]
NME3	OT0CA0GF	Definitive	Altered Expression	[5863]
NOCT	OTVSYP2D	Definitive	Biomarker	[5864]
NOVA2	OTQ2X3Q4	Definitive	Altered Expression	[5865]
NPNT	OTFZAO1G	Definitive	Biomarker	[5866]
NRSN1	OT1KKXC8	Definitive	Altered Expression	[5867]
NUMBL	OTWMTMMH	Definitive	Biomarker	[5868]
OLFML3	OTDN45FN	Definitive	Biomarker	[5869]
OPTC	OTCASGO0	Definitive	Biomarker	[2427]
OPTN	OT2UXWH9	Definitive	Biomarker	[4526]
OR10A4	OTYYB8SY	Definitive	Biomarker	[5870]
ORC1	OTHWU8IJ	Definitive	Biomarker	[5871]
OTUD1	OTE6O5XB	Definitive	Biomarker	[5872]
PACS1	OT9TMQL3	Definitive	Biomarker	[5873]
PADI2	OTT40K94	Definitive	Biomarker	[5874]
PAPLN	OTCJD85N	Definitive	Biomarker	[1519]
PAX9	OT25J0F7	Definitive	Altered Expression	[5875]
PCK2	OTJ8LX4N	Definitive	Biomarker	[5876]
PCNP	OTJUQ122	Definitive	Altered Expression	[5877]
PGAM2	OT9BE03I	Definitive	Biomarker	[5878]
PGAM5	OT6Q5M0C	Definitive	Biomarker	[5879]
PHF10	OTWDR4EX	Definitive	Biomarker	[5880]
PHIP	OTZY806Z	Definitive	Altered Expression	[5881]
PHOX2A	OTVS3R2X	Definitive	Biomarker	[5882]
PIF1	OTUHKKVP	Definitive	Biomarker	[5883]
PIP5KL1	OT6ZJFEC	Definitive	Biomarker	[5884]
PKD1	OT5ALRZ5	Definitive	Biomarker	[5885]
PKHD1L1	OTREFCAA	Definitive	Altered Expression	[5886]
PLD5	OTEVPYNY	Definitive	Biomarker	[5887]
PLPP5	OTHT51D6	Definitive	Altered Expression	[5888]
POLM	OT0SRIP4	Definitive	Altered Expression	[5889]
POU4F2	OT6SW5H0	Definitive	Altered Expression	[5890]
PPM1F	OTU0MVR7	Definitive	Altered Expression	[5891]
PPP1R10	OT7GE3BN	Definitive	Biomarker	[5892]
PPT2	OTD5VJ9A	Definitive	Biomarker	[5893]
PRAM1	OTZN3DWD	Definitive	Genetic Variation	[5894]
PRC1	OTHD0XS0	Definitive	Biomarker	[1458]
PROCR	OTRHED17	Definitive	Biomarker	[5895]
PRSS3	OTN3S5YB	Definitive	Altered Expression	[5896]
PSG5	OTHTU98X	Definitive	Biomarker	[5897]
PSMD8	OTY6X27P	Definitive	Altered Expression	[5898]
PSME4	OTDGF53O	Definitive	Biomarker	[5899]
PSPC1	OTYS6WQ8	Definitive	Altered Expression	[5900]
PSPN	OT54LLZJ	Definitive	Altered Expression	[5689]
PTBP2	OTF4S7NE	Definitive	Biomarker	[5901]
PYCARD	OT67RON3	Definitive	Biomarker	[5902]
RAB11B	OT6GI23M	Definitive	Biomarker	[5903]
RAD51D	OTKOU5XN	Definitive	Biomarker	[5805]
RALYL	OT232N7Q	Definitive	Biomarker	[5904]
RAMAC	OTAFAKPR	Definitive	Biomarker	[5905]
RBM5	OTCBWHHV	Definitive	Altered Expression	[5906]
RBM8A	OT5SR6G0	Definitive	Biomarker	[5907]
RC3H1	OTCU6CYA	Definitive	Altered Expression	[5908]
RCAN3	OTTS3CQA	Definitive	Biomarker	[5909]
REEP6	OTY4FPO8	Definitive	Altered Expression	[5910]
REXO1	OTZT6RAW	Definitive	Posttranslational Modification	[5911]
RGS1	OTGXJYMG	Definitive	Biomarker	[1638]
RHOH	OT1J9SEB	Definitive	Biomarker	[5912]
RIDA	OTW4098I	Definitive	Altered Expression	[5689]
RMI1	OT1ZVTFL	Definitive	Biomarker	[5913]
RPE	OT0XT3JU	Definitive	Biomarker	[5914]
RPL13A	OTME3VXN	Definitive	Altered Expression	[2353]
RPLP2	OT2YBK3W	Definitive	Biomarker	[5915]
RPRD1A	OTXTV6FU	Definitive	Biomarker	[5916]
RRAS	OTBBF28C	Definitive	Biomarker	[5917]
SAG	OTDNS3ZQ	Definitive	Altered Expression	[5918]
SAMD14	OTLDQW51	Definitive	Genetic Variation	[5919]
SCARA3	OT46I38Y	Definitive	Biomarker	[5920]
SDHC	OTC8G2MX	Definitive	Biomarker	[5921]
SEMA3G	OTBLVF8V	Definitive	Biomarker	[5922]
SERPINA9	OT0OIZH1	Definitive	Altered Expression	[5923]
SESN3	OTJRY1Y5	Definitive	Biomarker	[5924]
SETD1A	OTVVWRIC	Definitive	Biomarker	[5925]
SEZ6L	OT5Z9CUA	Definitive	Altered Expression	[5926]
SFTPA2	OT6SFOMU	Definitive	Biomarker	[5246]
SH3KBP1	OTIUA60B	Definitive	Biomarker	[3885]
SHC2	OTTWMRNQ	Definitive	Biomarker	[5927]
SIGLEC10	OTD1WDQL	Definitive	Altered Expression	[5928]
SIGLEC5	OTYC440J	Definitive	Biomarker	[5929]
SLAMF1	OTBTT3ZQ	Definitive	Genetic Variation	[5930]
SLC46A3	OTEMDLPS	Definitive	Biomarker	[5931]
SLITRK1	OT1QQ7FR	Definitive	Genetic Variation	[5932]
SLTM	OT0VRZA6	Definitive	Altered Expression	[5933]
SMAD5	OTQNSVCQ	Definitive	Posttranslational Modification	[5934]
SMG9	OT172Y2R	Definitive	Biomarker	[5935]
SMYD5	OTE5VET6	Definitive	Biomarker	[5936]
SNRNP70	OTP52YZ3	Definitive	Genetic Variation	[5937]
SNRPE	OT18J6E8	Definitive	Biomarker	[5938]
SOX14	OTPEKVOM	Definitive	Altered Expression	[5939]
SOX30	OTGT38E3	Definitive	Altered Expression	[5940]
SP100	OTN8SD5W	Definitive	Biomarker	[5941]
SP140	OTQZHFMT	Definitive	Altered Expression	[5942]
SP3	OTYDQZ1T	Definitive	Biomarker	[5943]
SPRYD7	OT6FTW9Z	Definitive	Altered Expression	[5944]
SPTLC2	OTBTMH1Z	Definitive	Biomarker	[5945]
SPTY2D1	OT1RY99Z	Definitive	Biomarker	[5945]
SRF	OTW18FQN	Definitive	Genetic Variation	[4120]
ST6GALNAC5	OTH91ETM	Definitive	Altered Expression	[5946]
ST8SIA3	OTG9MXV9	Definitive	Altered Expression	[5947]
STIP1	OT7TXLOX	Definitive	Biomarker	[5948]
STN1	OT8UWRA3	Definitive	Biomarker	[5949]
STRN	OTLOZL5I	Definitive	Altered Expression	[5950]
STXBP3	OTTTYMAQ	Definitive	Altered Expression	[5689]
SUSD4	OTWCJTT3	Definitive	Altered Expression	[5951]
SV2C	OTIH108W	Definitive	Biomarker	[238]
SYT13	OTG94RJ4	Definitive	Biomarker	[5952]
SYTL1	OTP0R3S5	Definitive	Genetic Variation	[5953]
SZRD1	OTJMEJWT	Definitive	Biomarker	[5954]
TAB3	OT1ECMDL	Definitive	Biomarker	[5955]
TAL2	OTSK1E88	Definitive	Altered Expression	[5956]
TBC1D1	OTI9V7B0	Definitive	Biomarker	[5957]
TBC1D16	OTPR3C6A	Definitive	Posttranslational Modification	[5958]
TBC1D7	OT1ALJ63	Definitive	Altered Expression	[5959]
TBCC	OTBF0X8R	Definitive	Altered Expression	[5960]
TBPL2	OTDEC1KO	Definitive	Altered Expression	[5961]
TCERG1L	OTSBSCLF	Definitive	Biomarker	[5962]
TFAP2C	OTUDIW05	Definitive	Biomarker	[5963]
TFAP2E	OTA4B1SG	Definitive	Biomarker	[5964]
TGFBRAP1	OT80QNR5	Definitive	Altered Expression	[5965]
TGIF1	OTN9VHAG	Definitive	Biomarker	[5966]
THEM4	OTSIZU8Y	Definitive	Biomarker	[5967]
TIMM17A	OTVFRL8G	Definitive	Altered Expression	[5968]
TM2D3	OT6MS96W	Definitive	Genetic Variation	[5969]
TM4SF1	OTY0ECQN	Definitive	Altered Expression	[5970]
TM4SF4	OTRI8EHN	Definitive	Biomarker	[5971]
TM9SF3	OTBISJZQ	Definitive	Altered Expression	[5972]
TMED2	OTBLO7RW	Definitive	Altered Expression	[5867]
TMED5	OT70W1J8	Definitive	Altered Expression	[5735]
TMEM135	OT63ZT3X	Definitive	Genetic Variation	[5973]
TMF1	OT7JY7UF	Definitive	Altered Expression	[5974]
TMIGD2	OTWWAHTV	Definitive	Biomarker	[5975]
TMPRSS11B	OT2852G1	Definitive	Biomarker	[5976]
TMSB4Y	OT1BMJ6B	Definitive	Biomarker	[5977]
TNPO2	OTGHFQAV	Definitive	Biomarker	[5978]
TOX4	OTSOXQFN	Definitive	Altered Expression	[5979]
TPM1	OTD73X6R	Definitive	Altered Expression	[5980]
TPSB2	OTN769MT	Definitive	Genetic Variation	[1399]
TRABD	OTCFGFJH	Definitive	Biomarker	[5981]
TRAF1	OTTLM5RU	Definitive	Altered Expression	[5982]
TRAF3IP2	OTLLZERL	Definitive	Biomarker	[4326]
TRAF3IP3	OTNG0L8X	Definitive	Altered Expression	[5983]
TRAIP	OTMPT9Y2	Definitive	Genetic Variation	[5822]
TRARG1	OTQ1R3JD	Definitive	Biomarker	[5984]
TRIM8	OTS6JFR0	Definitive	Biomarker	[5985]
TRIP6	OTIPA4ZR	Definitive	Biomarker	[4368]
TTLL1	OTCE097J	Definitive	Altered Expression	[5986]

References

• [1] ClinicalTrials.gov (NCT03981796) A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer (RUBY). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT04596150) Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer. U.S. National Institutes of Health.
• [3] ClinicalTrials.gov (NCT02663297) Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
• [4] ClinicalTrials.gov (NCT03797391) A Dose Escalation Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors. U.S. National Institutes of Health.
• [5] ClinicalTrials.gov (NCT03602157) Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and NHL
• [6] ClinicalTrials.gov (NCT02369029) BAY1238097, First in Man. U.S. National Institutes of Health.
• [7] ClinicalTrials.gov (NCT02952248) A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours. U.S. National Institutes of Health.
• [8] ClinicalTrials.gov (NCT03972150) A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer. U.S. National Institutes of Health.
• [9] ClinicalTrials.gov (NCT01794104) Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas. U.S. National Institutes of Health.
• [10] ClinicalTrials.gov (NCT02720068) Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001). U.S. National Institutes of Health.
• [11] ClinicalTrials.gov (NCT04167137) Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Subjects. U.S. National Institutes of Health.
• [12] VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Sep;27(9):987-1004.
• [13] Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment.J Clin Endocrinol Metab. 2020 Jan 1;105(1):26-42. doi: 10.1210/clinem/dgz014.
• [14] ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.Clin Sci (Lond). 2019 Jan 11;133(1):83-99. doi: 10.1042/CS20180906. Print 2019 Jan 15.
• [15] ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer.Gastric Cancer. 2019 Mar;22(2):287-301. doi: 10.1007/s10120-018-0866-2. Epub 2018 Aug 13.
• [16] Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers.Br J Cancer. 2007 Jan 29;96(2):383-90. doi: 10.1038/sj.bjc.6603555.
• [17] Silencing LPAAT inhibits tumor growth of cisplatin-resistant human osteosarcoma in vivo and in vitro.Int J Oncol. 2017 Feb;50(2):535-544. doi: 10.3892/ijo.2016.3820. Epub 2016 Dec 28.
• [18] D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.Prostate. 2005 Sep 1;64(4):387-400. doi: 10.1002/pros.20250.
• [19] Vascular adhesion protein-1 as indicator of breast cancer tumor aggressiveness and invasiveness.APMIS. 2018 Sep;126(9):755-761. doi: 10.1111/apm.12885.
• [20] Tumor-specific targeting of a cell line with natural killer cell activity by asialoglycoprotein receptor gene transfer.Cancer Immunol Immunother. 2001 Dec;50(10):549-56. doi: 10.1007/s00262-001-0236-4.
• [21] SLC1A3 contributes to L-asparaginase resistance in solid tumors.EMBO J. 2019 Oct 4;38(21):e102147. doi: 10.15252/embj.2019102147. Epub 2019 Sep 16.
• [22] ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.Proc Natl Acad Sci U S A. 2002 May 14;99(10):6919-24. doi: 10.1073/pnas.102025999. Epub 2002 Apr 30.
• [23] Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors.Endocr J. 2011;58(4):297-303. doi: 10.1507/endocrj.k10e-389. Epub 2011 Mar 4.
• [24] Multistage Ultraviolet Photodissociation Mass Spectrometry To Characterize Single Amino Acid Variants of Human Mitochondrial BCAT2.Anal Chem. 2018 Aug 21;90(16):9904-9911. doi: 10.1021/acs.analchem.8b02099. Epub 2018 Aug 1.
• [25] Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/-catenin signaling pathway.J Orthop Res. 2019 Jul;37(7):1638-1648. doi: 10.1002/jor.24244. Epub 2019 Mar 28.
• [26] BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells.Sci Rep. 2018 Dec 4;8(1):17608. doi: 10.1038/s41598-018-35710-y.
• [27] Downregulation of BTLA on NKT Cells Promotes Tumor Immune Control in a Mouse Model of Mammary Carcinoma.Int J Mol Sci. 2018 Mar 7;19(3):752. doi: 10.3390/ijms19030752.
• [28] Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.J Cell Mol Med. 2019 May;23(5):3097-3107. doi: 10.1111/jcmm.13959. Epub 2019 Mar 1.
• [29] Silencing of carbonic anhydrase I enhances the malignant potential of exosomes secreted by prostatic tumour cells.J Cell Mol Med. 2019 May;23(5):3641-3655. doi: 10.1111/jcmm.14265. Epub 2019 Mar 27.
• [30] Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer.Clin Cancer Res. 2014 Aug 1;20(15):3962-73. doi: 10.1158/1078-0432.CCR-13-1378. Epub 2014 Jun 10.
• [31] Expression of epithelial-mesenchymal transition regulators TWIST, SLUG and SNAIL in follicular thyroid tumours may relate to widely invasive, poorly differentiated and distant metastasis.Histopathology. 2019 Apr;74(5):780-791. doi: 10.1111/his.13778. Epub 2019 Mar 10.
• [32] CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer.Nat Commun. 2019 Jun 4;10(1):2450. doi: 10.1038/s41467-019-10424-5.
• [33] High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal, and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents.J Clin Endocrinol Metab. 1999 Jan;84(1):233-9. doi: 10.1210/jcem.84.1.5400.
• [34] Intratumoral IFN- gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression.Cancer Gene Ther. 2019 Sep;26(9-10):334-343. doi: 10.1038/s41417-018-0059-5. Epub 2018 Nov 12.
• [35] PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer.Sci Rep. 2017 Feb 8;7:42319. doi: 10.1038/srep42319.
• [36] Rapid obtention of stable, bioluminescent tumor cell lines using a tCD2-luciferase chimeric construct.BMC Biotechnol. 2011 Mar 24;11:26. doi: 10.1186/1472-6750-11-26.
• [37] CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia. Oncotarget. 2018 Jan 11;9(44):27574-27584.
• [38] Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency.Cancer Immunol Res. 2019 Dec;7(12):2013-2024. doi: 10.1158/2326-6066.CIR-19-0121. Epub 2019 Oct 15.
• [39] CD96 Is an Immune Checkpoint That Regulates CD8(+) T-cell Antitumor Function.Cancer Immunol Res. 2019 Apr;7(4):559-571. doi: 10.1158/2326-6066.CIR-18-0637. Epub 2019 Mar 20.
• [40] Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.Cell Cycle. 2019 Feb;18(3):346-358. doi: 10.1080/15384101.2019.1568748. Epub 2019 Jan 22.
• [41] Gene fusions PAFAH1B1-USP6 and RUNX2-USP6 in aneurysmal bone cysts identified by next generation sequencing.Cancer Genet. 2017 Apr;212-213:13-18. doi: 10.1016/j.cancergen.2017.03.007. Epub 2017 Mar 24.
• [42] Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy.Oncogene. 2017 Feb 2;36(5):667-677. doi: 10.1038/onc.2016.237. Epub 2016 Jul 4.
• [43] Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma.Nat Commun. 2019 Jul 2;10(1):2910. doi: 10.1038/s41467-019-10993-5.
• [44] Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.Histochem Cell Biol. 2019 Oct;152(4):281-291. doi: 10.1007/s00418-019-01794-4. Epub 2019 Jul 27.
• [45] Compromising the constitutive p16(INK4a) expression sensitizes human neuroblastoma cells to Hsp90 inhibition and promotes premature senescence.J Cell Biochem. 2020 Apr;121(4):2770-2781. doi: 10.1002/jcb.29493. Epub 2019 Nov 6.
• [46] CDKL1 promotes tumor proliferation and invasion in colorectal cancer.Onco Targets Ther. 2017 Mar 16;10:1613-1624. doi: 10.2147/OTT.S133014. eCollection 2017.
• [47] Ceramide kinase promotes tumor cell survival and mammary tumor recurrence.Cancer Res. 2014 Nov 1;74(21):6352-63. doi: 10.1158/0008-5472.CAN-14-1292. Epub 2014 Aug 27.
• [48] Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma.Am J Pathol. 2017 May;187(5):1186-1197. doi: 10.1016/j.ajpath.2017.01.006. Epub 2017 Mar 17.
• [49] CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3.Oncogene. 2019 Jun;38(23):4560-4573. doi: 10.1038/s41388-019-0739-0. Epub 2019 Feb 12.
• [50] Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma.Cancer Res. 1988 Aug 1;48(15):4307-11.
• [51] Biomarkers in the diagnosis of pleural diseases: a 2018 update.Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808660. doi: 10.1177/1753466618808660.
• [52] Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy. J Clin Invest. 2018 May 1;128(5):1971-1984.
• [53] Cationic Polymeric Nanoparticle Delivering CCR2 siRNA to Inflammatory Monocytes for Tumor Microenvironment Modification and Cancer Therapy.Mol Pharm. 2018 Sep 4;15(9):3642-3653. doi: 10.1021/acs.molpharmaceut.7b00997. Epub 2018 Jan 26.
• [54] Overexpression of Contactin 1 promotes growth, migration and invasion in Hs578T breast cancer cells.BMC Cell Biol. 2018 Apr 19;19(1):5. doi: 10.1186/s12860-018-0154-3.
• [55] The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis.Pathol Res Pract. 2018 Apr;214(4):513-520. doi: 10.1016/j.prp.2018.02.015. Epub 2018 Feb 21.
• [56] The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.Leukemia. 2017 Nov;31(11):2365-2375. doi: 10.1038/leu.2017.93. Epub 2017 Mar 23.
• [57] SRC signaling is crucial in the growth of synovial sarcoma cells.Cancer Res. 2013 Apr 15;73(8):2518-28. doi: 10.1158/0008-5472.CAN-12-3023. Epub 2013 Apr 11.
• [58] Impact of Polymorphisms in Casein Kinase 1 Epsilon and Environmental Factors in Oral Cancer Susceptibility.J Cancer. 2019 Aug 28;10(21):5065-5069. doi: 10.7150/jca.34592. eCollection 2019.
• [59] Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.Pancreatology. 2019 Oct;19(7):951-956. doi: 10.1016/j.pan.2019.09.009. Epub 2019 Sep 20.
• [60] Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.Int J Nanomedicine. 2017 Jun 6;12:4299-4322. doi: 10.2147/IJN.S136766. eCollection 2017.
• [61] Expression of AIE-75 PDZ-domain protein induces G2/M cell cycle arrest in human colorectal adenocarcinoma SW480 cells.Cancer Lett. 2004 Aug 10;211(2):209-18. doi: 10.1016/j.canlet.2004.02.005.
• [62] Heterogeneity of chromatin modifications in testicular spermatocytic seminoma point toward an epigenetically unstable phenotype.Cancer Genet. 2012 Sep;205(9):425-31. doi: 10.1016/j.cancergen.2012.05.003. Epub 2012 Jul 21.
• [63] Second generation sequencing of the mesothelioma tumor genome.PLoS One. 2010 May 13;5(5):e10612. doi: 10.1371/journal.pone.0010612.
• [64] Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.Oncol Rep. 2004 Jun;11(6):1257-63.
• [65] Human Dynactin-Associated Protein Transforms NIH3T3 Cells to Generate Highly Vascularized Tumors with Weak Cell-Cell Interaction.PLoS One. 2015 Aug 18;10(8):e0135836. doi: 10.1371/journal.pone.0135836. eCollection 2015.
• [66] Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.Cancer Lett. 2019 Jun 1;451:100-109. doi: 10.1016/j.canlet.2019.02.046. Epub 2019 Mar 6.
• [67] Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors.J Control Release. 2016 Oct 10;239:82-91. doi: 10.1016/j.jconrel.2016.08.019. Epub 2016 Aug 23.
• [68] The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment.Oxid Med Cell Longev. 2017;2017:6098107. doi: 10.1155/2017/6098107. Epub 2017 Nov 26.
• [69] KRAS Oncoprotein Expression Is Regulated by a Self-Governing eIF5A-PEAK1 Feed-Forward Regulatory Loop.Cancer Res. 2018 Mar 15;78(6):1444-1456. doi: 10.1158/0008-5472.CAN-17-2873. Epub 2018 Jan 10.
• [70] Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18.Cancer Res Treat. 2018 Jan;50(1):71-87. doi: 10.4143/crt.2017.013. Epub 2017 Feb 24.
• [71] Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors.Front Pharmacol. 2017 Feb 15;8:54. doi: 10.3389/fphar.2017.00054. eCollection 2017.
• [72] GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3.Int J Biol Sci. 2019 Sep 7;15(12):2522-2537. doi: 10.7150/ijbs.35563. eCollection 2019.
• [73] MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.Mol Cell Biochem. 2018 Feb;439(1-2):95-104. doi: 10.1007/s11010-017-3139-1. Epub 2017 Aug 9.
• [74] Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression.Cell Death Dis. 2017 Oct 12;8(10):e3122. doi: 10.1038/cddis.2017.507.
• [75] Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.Int J Oncol. 2017 Apr;50(4):1191-1200. doi: 10.3892/ijo.2017.3883. Epub 2017 Feb 20.
• [76] EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival.Front Oncol. 2019 Jan 29;9:26. doi: 10.3389/fonc.2019.00026. eCollection 2019.
• [77] In-vitro cytocompatibility of dental resin monomers on osteoblast-like cells.J Dent. 2017 Oct;65:76-82. doi: 10.1016/j.jdent.2017.07.008. Epub 2017 Jul 12.
• [78] Novel target for peptide-based imaging and treatment of brain tumors.Mol Cancer Ther. 2014 Apr;13(4):996-1007. doi: 10.1158/1535-7163.MCT-13-0684. Epub 2014 Feb 3.
• [79] Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.Front Immunol. 2019 Apr 11;10:704. doi: 10.3389/fimmu.2019.00704. eCollection 2019.
• [80] Characterization of farnesyl diphosphate farnesyl transferase 1 (FDFT1) expression in cancer.Per Med. 2019 Jan;16(1):51-65. doi: 10.2217/pme-2016-0058. Epub 2018 Nov 23.
• [81] Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer.J Natl Cancer Inst. 2019 Jan 1;111(1):52-59. doi: 10.1093/jnci/djy125.
• [82] Fibroblast growth factor-10 and epithelial-mesenchymal transition in colorectal cancer.EXCLI J. 2019 Jul 17;18:530-539. doi: 10.17179/excli2018-1784. eCollection 2019.
• [83] Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.J Cell Biol. 2018 Apr 2;217(4):1335-1351. doi: 10.1083/jcb.201708064. Epub 2018 Feb 6.
• [84] Gene expression of fructosamine 3 kinase in patients with colorectal cancer.Oncology. 2007;73(1-2):72-5. doi: 10.1159/000120631. Epub 2008 Mar 12.
• [85] Mitotic deletions of 11p15.5 in two different tumors indicate that the CALCA locus is distal to the PTH locus.Cytogenet Cell Genet. 1989;50(2-3):155-7. doi: 10.1159/000132748.
• [86] RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.Mol Cancer. 2019 Mar 28;18(1):46. doi: 10.1186/s12943-019-1004-4.
• [87] Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.Genes Chromosomes Cancer. 2010 Mar;49(3):270-81. doi: 10.1002/gcc.20738.
• [88] The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2019 Mar;27(3):300-305.
• [89] Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy.Mol Imaging Biol. 2019 Apr;21(2):375-381. doi: 10.1007/s11307-018-1247-2.
• [90] Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression.Lab Invest. 2001 Jul;81(7):1039-48. doi: 10.1038/labinvest.3780315.
• [91] Adult-onset hyperinsulinaemic hypoglycaemia in clinical practice: diagnosis, aetiology and management.Endocr Connect. 2017 Oct;6(7):540-548. doi: 10.1530/EC-17-0076. Epub 2017 Aug 7.
• [92] Prognostic significance of the expression of GFR1, GFR3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma.BMC Cancer. 2013 Jan 26;13:34. doi: 10.1186/1471-2407-13-34.
• [93] The growth inhibitory effects of vitamins K and their actions on gene expression.Hepatology. 1995 Sep;22(3):876-82.
• [94] Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys(3)]-GHRP-6.Endocrine. 2019 May;64(2):393-405. doi: 10.1007/s12020-018-1796-9. Epub 2018 Nov 2.
• [95] Effects of small interfering RNA interference of connexin 37 on subcutaneous gastric tumours in mice.Mol Med Rep. 2014 Dec;10(6):2955-60. doi: 10.3892/mmr.2014.2609. Epub 2014 Oct 8.
• [96] Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines.J Cell Biol. 1992 Sep;118(5):1213-21. doi: 10.1083/jcb.118.5.1213.
• [97] Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice.Hum Gene Ther. 2001 Jan 20;12(2):193-204. doi: 10.1089/104303401750061258.
• [98] Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line.Cancer Res. 1985 Sep;45(9):4322-9.
• [99] Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia.Mol Med. 1995 Jan;1(2):161-71.
• [100] XCL1/Glypican-3 Fusion Gene Immunization Generates Potent Antitumor Cellular Immunity and Enhances Anti-PD-1 Efficacy.Cancer Immunol Res. 2020 Jan;8(1):81-93. doi: 10.1158/2326-6066.CIR-19-0210. Epub 2019 Oct 30.
• [101] G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.Int J Cancer. 2018 Jan 1;142(1):121-132. doi: 10.1002/ijc.31030. Epub 2017 Sep 21.
• [102] Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-B signaling pathway.Mol Cancer. 2017 Mar 14;16(1):61. doi: 10.1186/s12943-017-0627-6.
• [103] GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.Cell Death Dis. 2016 Jul 14;7(7):e2294. doi: 10.1038/cddis.2016.169.
• [104] Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics.Endocrinology. 2019 May 1;160(5):1275-1288. doi: 10.1210/en.2019-00213.
• [105] Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.J Biol Chem. 2017 Mar 10;292(10):4326-4335. doi: 10.1074/jbc.M117.779868. Epub 2017 Feb 6.
• [106] Genetic and Functional Analysis of GRIN2A in Tumor Samples.Methods Mol Biol. 2017;1677:93-116. doi: 10.1007/978-1-4939-7321-7_3.
• [107] High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma.Pathol Res Pract. 2018 Feb;214(2):228-232. doi: 10.1016/j.prp.2017.11.013. Epub 2017 Nov 20.
• [108] GRK5 promotes tumor progression in renal cell carcinoma.Neoplasma. 2019 Feb 6;66(2):261-270. doi: 10.4149/neo_2018_180621N409.
• [109] Melanoma-associated GRM3 variants dysregulate melanosome trafficking and cAMP signaling.Pigment Cell Melanoma Res. 2018 Jan;31(1):115-119. doi: 10.1111/pcmr.12610. Epub 2017 Oct 23.
• [110] Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy.Cancer Res. 2018 Feb 1;78(3):706-717. doi: 10.1158/0008-5472.CAN-17-0491. Epub 2017 Oct 20.
• [111] Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells.Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118523. doi: 10.1016/j.bbamcr.2019.118523. Epub 2019 Aug 8.
• [112] Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.J Enzyme Inhib Med Chem. 2017 Dec;32(1):1274-1281. doi: 10.1080/14756366.2017.1380638.
• [113] Up-regulation of GTPBP4 in colorectal carcinoma is responsible for tumor metastasis.Biochem Biophys Res Commun. 2016 Nov 4;480(1):48-54. doi: 10.1016/j.bbrc.2016.10.010. Epub 2016 Oct 5.
• [114] Inhibition of Hematopoietic Cell Kinase Activity Suppresses Myeloid Cell-Mediated Colon Cancer Progression.Cancer Cell. 2017 Apr 10;31(4):563-575.e5. doi: 10.1016/j.ccell.2017.03.006.
• [115] Identification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screening.Int J Oncol. 2016 Jul;49(1):225-34. doi: 10.3892/ijo.2016.3532. Epub 2016 May 18.
• [116] In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma.Oncotarget. 2018 Jan 9;9(6):6952-6967. doi: 10.18632/oncotarget.24084. eCollection 2018 Jan 23.
• [117] Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.Invest Ophthalmol Vis Sci. 2015 Jan 15;56(3):1447-58. doi: 10.1167/iovs.14-15250.
• [118] miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.J Cell Physiol. 2020 Mar;235(3):2631-2642. doi: 10.1002/jcp.29167. Epub 2019 Sep 11.
• [119] Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.Sci Rep. 2019 Nov 27;9(1):17663. doi: 10.1038/s41598-019-54184-0.
• [120] The Role of Hepsin in Endometrial Carcinoma.Appl Immunohistochem Mol Morphol. 2017 Oct;25(9):624-631. doi: 10.1097/PAI.0000000000000352.
• [121] Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells.Int J Mol Sci. 2019 Apr 26;20(9):2069. doi: 10.3390/ijms20092069.
• [122] PTEN-5-HT2C coupling: a new target for treating drug addiction.Prog Brain Res. 2008;172:407-20. doi: 10.1016/S0079-6123(08)00920-5.
• [123] Ion channels expression and function are strongly modified in solid tumors and vascular malformations.J Transl Med. 2016 Oct 4;14(1):285. doi: 10.1186/s12967-016-1038-y.
• [124] Indoleamine 2,3-dioxygenase 2 depletion suppresses tumor growth in a mouse model of Lewis lung carcinoma.Cancer Sci. 2019 Oct;110(10):3061-3067. doi: 10.1111/cas.14179. Epub 2019 Sep 25.
• [125] Synergy with interferon-lambda 3 and sorafenib suppresses hepatocellular carcinoma proliferation.Biomed Pharmacother. 2017 Apr;88:395-402. doi: 10.1016/j.biopha.2017.01.077. Epub 2017 Jan 22.
• [126] Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma.Oncotarget. 2016 May 10;7(19):27889-98. doi: 10.18632/oncotarget.8556.
• [127] MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.Cell Death Dis. 2017 Jun 22;8(6):e2890. doi: 10.1038/cddis.2017.291.
• [128] IFN-gamma and IL-12B polymorphisms in women with cervical intraepithellial neoplasia caused by human papillomavirus.Mol Biol Rep. 2012 Jul;39(7):7627-34. doi: 10.1007/s11033-012-1597-9. Epub 2012 Feb 12.
• [129] A high ratio of IL-12R2-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer.Oral Oncol. 2017 Nov;74:148-156. doi: 10.1016/j.oraloncology.2017.10.006. Epub 2017 Oct 16.
• [130] IL-16 rs4778889 polymorphism contribution to the development of renal cell cancer in a Chinese population.Genet Mol Res. 2016 Jun 10;15(2). doi: 10.4238/gmr.15027553.
• [131] High-grade ovarian serous carcinomas: Significant correlation of histologic patterns with IMP3 and E-Cadherin predicting disease recurrence and survival.Ann Diagn Pathol. 2019 Jun;40:30-39. doi: 10.1016/j.anndiagpath.2019.02.013. Epub 2019 Feb 28.
• [132] Over-expression of IMPDH2 is associated with tumor progression and poor prognosis in hepatocellular carcinoma.Am J Cancer Res. 2018 Aug 1;8(8):1604-1614. eCollection 2018.
• [133] Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells.Clin Cancer Res. 2020 Apr 1;26(7):1700-1711. doi: 10.1158/1078-0432.CCR-19-2202. Epub 2019 Dec 12.
• [134] Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.Endocrine. 2019 Jun;64(3):575-583. doi: 10.1007/s12020-019-01845-9. Epub 2019 Jan 30.
• [135] A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription.J Exp Med. 1999 Dec 20;190(12):1793-800. doi: 10.1084/jem.190.12.1793.
• [136] Cancer-associated Fibroblast-promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma.Clin Cancer Res. 2019 Mar 15;25(6):1989-2000. doi: 10.1158/1078-0432.CCR-18-0773. Epub 2018 Nov 21.
• [137] Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding.Cancer Res. 2017 Nov 15;77(22):6190-6201. doi: 10.1158/0008-5472.CAN-17-1388. Epub 2017 Oct 11.
• [138] KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma.Tumour Biol. 2015 Feb;36(2):1251-9. doi: 10.1007/s13277-014-2746-7. Epub 2014 Oct 26.
• [139] GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A.Sci Rep. 2019 Dec 17;9(1):19277. doi: 10.1038/s41598-019-55683-w.
• [140] Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression.Oncotarget. 2017 Jul 19;8(47):81737-81753. doi: 10.18632/oncotarget.19387. eCollection 2017 Oct 10.
• [141] The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.Gastroenterology. 2019 Dec;157(6):1646-1659.e11. doi: 10.1053/j.gastro.2019.08.018. Epub 2019 Aug 20.
• [142] Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc.Cancers (Basel). 2019 Nov 13;11(11):1785. doi: 10.3390/cancers11111785.
• [143] A novel KDM5A/MPC-1 signaling pathway promotes pancreatic cancer progression via redirecting mitochondrial pyruvate metabolism.Oncogene. 2020 Jan;39(5):1140-1151. doi: 10.1038/s41388-019-1051-8. Epub 2019 Oct 22.
• [144] KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation.J Cell Physiol. 2019 Sep;234(9):16517-16525. doi: 10.1002/jcp.28322. Epub 2019 Feb 25.
• [145] Mangiferin functionalized radioactive gold nanoparticles (MGF-(198)AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy.Dalton Trans. 2017 Oct 31;46(42):14561-14571. doi: 10.1039/c7dt00383h.
• [146] PKK suppresses tumor growth and is decreased in squamous cell carcinoma of the skin.J Invest Dermatol. 2015 Mar;135(3):869-876. doi: 10.1038/jid.2014.428. Epub 2014 Oct 6.
• [147] High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.J Clin Endocrinol Metab. 2015 Jun;100(6):E890-9. doi: 10.1210/jc.2014-4053. Epub 2015 Apr 13.
• [148] American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.Ann Diagn Pathol. 2020 Feb;44:151419. doi: 10.1016/j.anndiagpath.2019.151419. Epub 2019 Nov 15.
• [149] Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.Glycobiology. 2013 Dec;23(12):1477-90. doi: 10.1093/glycob/cwt075. Epub 2013 Sep 13.
• [150] Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.Cancer Lett. 2019 Apr 28;448:182-196. doi: 10.1016/j.canlet.2019.01.035. Epub 2019 Feb 1.
• [151] Identification of genes with universally upregulated or downregulated expressions in colorectal cancer.J Gastroenterol Hepatol. 2019 May;34(5):880-889. doi: 10.1111/jgh.14529. Epub 2018 Dec 11.
• [152] Lysophosphatidic Acid Receptor 4 Activation Augments Drug Delivery in Tumors by Tightening Endothelial Cell-Cell Contact.Cell Rep. 2017 Aug 29;20(9):2072-2086. doi: 10.1016/j.celrep.2017.07.080.
• [153] LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.Dig Dis Sci. 2020 Feb;65(2):500-508. doi: 10.1007/s10620-019-05806-0. Epub 2019 Sep 5.
• [154] Evidence that TNF- induces proliferation in colorectal cancer cells and resveratrol can down-modulate it.Exp Biol Med (Maywood). 2019 Jan;244(1):1-12. doi: 10.1177/1535370218824538. Epub 2019 Jan 19.
• [155] Mediatory role of BLT2 in the proliferation of KRAS mutant colorectal cancer cells.Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):329-336. doi: 10.1016/j.bbamcr.2018.12.006. Epub 2018 Dec 13.
• [156] Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells.Cell Rep. 2018 Dec 26;25(13):3674-3692.e10. doi: 10.1016/j.celrep.2018.11.103.
• [157] Docosahexaenoic Acid Monoglyceride Increases Carboplatin Activity in Lung Cancer Models by Targeting EGFR.Anticancer Res. 2017 Nov;37(11):6015-6023. doi: 10.21873/anticanres.12048.
• [158] cDNA and protein characterization of human MAGE-10.Int J Cancer. 1999 Sep 9;82(6):901-7. doi: 10.1002/(sici)1097-0215(19990909)82:6<901::aid-ijc21>3.0.co;2-x.
• [159] Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma. J Clin Endocrinol Metab. 2012 Aug;97(8):2773-81. doi: 10.1210/jc.2012-1557. Epub 2012 May 8.
• [160] Dual BRAF/MEK therapy in BRAF V600E-mutated primary brain tumors: a case series showing dramatic clinical and radiographic responses and a reduction in cutaneous toxicity.J Neurosurg. 2019 Nov 1;133(6):1704-1709. doi: 10.3171/2019.8.JNS19643.
• [161] Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.Biochem Biophys Res Commun. 2017 Jan 29;483(1):10-16. doi: 10.1016/j.bbrc.2017.01.023. Epub 2017 Jan 7.
• [162] MAP4K3 modulates cell death via the post-transcriptional regulation of BH3-only proteins.Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):11978-83. doi: 10.1073/pnas.0900608106. Epub 2009 Jul 8.
• [163] Role of JNK in tumor development.Cell Cycle. 2003 May-Jun;2(3):199-201.
• [164] A SMAP in the face for cancer.J Clin Invest. 2017 Jun 1;127(6):2048-2050. doi: 10.1172/JCI94763. Epub 2017 May 15.
• [165] The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.J Biol Chem. 2018 Mar 23;293(12):4334-4349. doi: 10.1074/jbc.RA117.000333. Epub 2018 Feb 6.
• [166] Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4680-4687. doi: 10.26355/eurrev_201906_18049.
• [167] The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death.Mol Cell. 2005 Jun 10;18(6):637-50. doi: 10.1016/j.molcel.2005.05.010.
• [168] Cell-based assay of MGAT2-driven diacylglycerol synthesis for profiling inhibitors: use of a stable isotope-labeled substrate and high-resolution LC/MS.J Lipid Res. 2015 Mar;56(3):747-753. doi: 10.1194/jlr.D055020. Epub 2015 Jan 18.
• [169] Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis.Nat Commun. 2012;3:978. doi: 10.1038/ncomms1981.
• [170] MT4-MMP: The GPI-Anchored Membrane-Type Matrix Metalloprotease with Multiple Functions in Diseases.Int J Mol Sci. 2019 Jan 16;20(2):354. doi: 10.3390/ijms20020354.
• [171] Expression of MMP-10, MMP-21, MMP-26, and MMP-28 in Merkel cell carcinoma.Virchows Arch. 2009 Dec;455(6):495-503. doi: 10.1007/s00428-009-0856-1. Epub 2009 Nov 17.
• [172] Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.Cell. 2019 Feb 7;176(4):757-774.e23. doi: 10.1016/j.cell.2018.12.038. Epub 2019 Jan 31.
• [173] Defective IL-23/IL-17 Axis Protects p47phox-/- Mice from Colon Cancer.Front Immunol. 2017 Jan 27;8:44. doi: 10.3389/fimmu.2017.00044. eCollection 2017.
• [174] Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells.J Am Chem Soc. 2019 Feb 27;141(8):3613-3622. doi: 10.1021/jacs.8b12872. Epub 2019 Feb 13.
• [175] NOD1 and NOD2 of the innate immune system is differently expressed in human clear cell renal cell carcinoma, corresponding healthy renal tissue, its vasculature and primary isolated renal tubular epithelial cells.J Cancer Res Clin Oncol. 2019 Jun;145(6):1405-1416. doi: 10.1007/s00432-019-02901-7. Epub 2019 Mar 22.
• [176] Expression profiles of long noncoding RNAs associated with the NSUN2 gene in HepG2 cells.Mol Med Rep. 2019 Apr;19(4):2999-3008. doi: 10.3892/mmr.2019.9984. Epub 2019 Feb 25.
• [177] C-type natriuretic peptide and its precursor: potential markers in human prostate cancer.Biomark Med. 2015;9(4):319-26. doi: 10.2217/bmm.14.74.
• [178] Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomas.Histol Histopathol. 2017 Aug;32(8):825-834. doi: 10.14670/HH-11-852. Epub 2016 Dec 7.
• [179] The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.Cancer Res. 2015 Oct 15;75(20):4265-71. doi: 10.1158/0008-5472.CAN-15-0649. Epub 2015 Aug 20.
• [180] Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.Am J Pathol. 2016 Nov;186(11):3040-3053. doi: 10.1016/j.ajpath.2016.07.019. Epub 2016 Oct 12.
• [181] MiR-204 inhibits hepatocellular cancer drug resistance and metastasis through targeting NUAK1.Biochem Cell Biol. 2019 Oct;97(5):563-570. doi: 10.1139/bcb-2018-0354. Epub 2019 Feb 26.
• [182] Pro-oncogenic action of LOX-1 and its splice variant LOX-14 in breast cancer phenotypes.Cell Death Dis. 2019 Jan 18;10(2):53. doi: 10.1038/s41419-018-1279-1.
• [183] Expression of Oxytocin Receptors in Canine Mammary Tumours.J Comp Pathol. 2019 Jul;170:26-33. doi: 10.1016/j.jcpa.2019.05.005. Epub 2019 Jun 12.
• [184] Stimulation of DC-CIK with PADI4 Protein Can Significantly Elevate the Therapeutic Efficiency in Esophageal Cancer.J Immunol Res. 2019 Mar 3;2019:6587570. doi: 10.1155/2019/6587570. eCollection 2019.
• [185] Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models.Cancer Discov. 2019 Jan;9(1):96-113. doi: 10.1158/2159-8290.CD-18-0065. Epub 2018 Oct 25.
• [186] Serum Exosomal Long Noncoding RNA pcsk2-2:1 As A Potential Novel Diagnostic Biomarker For Gastric Cancer.Onco Targets Ther. 2019 Nov 25;12:10035-10041. doi: 10.2147/OTT.S229033. eCollection 2019.
• [187] Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.J Clin Endocrinol Metab. 2011 Jul;96(7):E1206-11. doi: 10.1210/jc.2010-2143. Epub 2011 May 11.
• [188] Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth.Oncogene. 2019 Feb;38(7):1106-1120. doi: 10.1038/s41388-018-0499-2. Epub 2018 Sep 12.
• [189] PDZ-containing 1 acts as a suppressor of pancreatic cancer by regulating PTEN phosphorylation.Oncotarget. 2017 Aug 24;8(42):72893-72909. doi: 10.18632/oncotarget.20552. eCollection 2017 Sep 22.
• [190] Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.Am J Surg Pathol. 2007 Aug;31(8):1196-202. doi: 10.1097/PAS.0b013e3180335f65.
• [191] Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.Semin Cancer Biol. 2019 Jun;56:116-127. doi: 10.1016/j.semcancer.2017.11.002. Epub 2017 Nov 2.
• [192] PLEKHA5 regulates tumor growth in metastatic melanoma.Cancer. 2020 Mar 1;126(5):1016-1030. doi: 10.1002/cncr.32611. Epub 2019 Nov 26.
• [193] Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.Neoplasia. 2018 Mar;20(3):244-255. doi: 10.1016/j.neo.2018.01.004. Epub 2018 Feb 12.
• [194] Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma.Aging (Albany NY). 2019 Aug 25;11(16):6503-6521. doi: 10.18632/aging.102206. Epub 2019 Aug 25.
• [195] Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes.Jpn J Cancer Res. 2001 Jul;92(7):762-7. doi: 10.1111/j.1349-7006.2001.tb01159.x.
• [196] Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?.Cancer Lett. 2013 Jun 10;333(2):133-46. doi: 10.1016/j.canlet.2013.01.045. Epub 2013 Jan 31.
• [197] Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles.Small. 2018 Nov;14(45):e1802886. doi: 10.1002/smll.201802886. Epub 2018 Oct 7.
• [198] Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors.Horm Cancer. 2015 Dec;6(5-6):225-36. doi: 10.1007/s12672-015-0236-z.
• [199] PKR2 and -catenin genes regulates pancreatic cancer chemosensitivity.Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):48-54.
• [200] High FcR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody Therapy.J Immunol. 2018 Dec 15;201(12):3741-3749. doi: 10.4049/jimmunol.1800700. Epub 2018 Nov 5.
• [201] Inhibition of PRL-2CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth.J Biol Chem. 2016 May 13;291(20):10716-25. doi: 10.1074/jbc.M115.705863. Epub 2016 Mar 11.
• [202] Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2.Sci Rep. 2019 Feb 28;9(1):2990. doi: 10.1038/s41598-019-39643-y.
• [203] Protein dynamics analysis reveals that missense mutations in cancer-related genes appear frequently on hinge-neighboring residues.Proteins. 2019 Jun;87(6):512-519. doi: 10.1002/prot.25673. Epub 2019 Mar 6.
• [204] A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS).Sci Rep. 2019 May 14;9(1):7390. doi: 10.1038/s41598-019-43222-6.
• [205] Whole exome sequencing of rare aggressive breast cancer histologies.Breast Cancer Res Treat. 2016 Feb;156(1):21-32. doi: 10.1007/s10549-016-3718-y. Epub 2016 Feb 23.
• [206] Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-1/H-Ras signaling pathway.J Cell Physiol. 2020 Mar;235(3):2506-2520. doi: 10.1002/jcp.29155. Epub 2019 Sep 11.
• [207] RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.Cell Prolif. 2018 Dec;51(6):e12508. doi: 10.1111/cpr.12508. Epub 2018 Aug 7.
• [208] RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression. Cancer Res. 2017 Aug 15;77(16):4247-4257.
• [209] Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.Oncol Rep. 2020 Jan;43(1):41-54. doi: 10.3892/or.2019.7389. Epub 2019 Oct 25.
• [210] miR-652 Promotes Tumor Proliferation and Metastasis by Targeting RORA in Endometrial Cancer.Mol Cancer Res. 2018 Dec;16(12):1927-1939. doi: 10.1158/1541-7786.MCR-18-0267. Epub 2018 Aug 9.
• [211] High nuclear MSK1 is associated with longer survival in breast cancer patients.J Cancer Res Clin Oncol. 2018 Mar;144(3):509-517. doi: 10.1007/s00432-018-2579-7. Epub 2018 Jan 11.
• [212] Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.Clin Transl Oncol. 2019 Sep;21(9):1240-1249. doi: 10.1007/s12094-019-02049-3. Epub 2019 Feb 2.
• [213] Liver lipid metabolism disruption in cancer cachexia is aggravated by cla supplementation -induced inflammation.Clin Nutr. 2019 Oct;38(5):2219-2230. doi: 10.1016/j.clnu.2018.09.023. Epub 2018 Sep 25.
• [214] A Preliminary Study of the Effect of Semaphorin 3A and Acitretin on the Proliferation, Migration, and Apoptosis of HaCaT Cells.Indian J Dermatol. 2019 May-Jun;64(3):250. doi: 10.4103/ijd.IJD_179_18.
• [215] SENP1 Interacts with HIF1 to Regulate Glycolysis of Prostatic Carcinoma Cells.Int J Biol Sci. 2019 Jan 1;15(2):395-403. doi: 10.7150/ijbs.27256. eCollection 2019.
• [216] Essential role of SH3GL1 in interleukin-6(IL-6)- and vascular endothelial growth factor (VEGF)-triggered p130(cas)-mediated proliferation and migration of osteosarcoma cells.Hum Cell. 2017 Oct;30(4):300-310. doi: 10.1007/s13577-017-0178-6. Epub 2017 Jul 12.
• [217] SHCBP1 is a novel target and exhibits tumorpromoting effects in gastric cancer.Oncol Rep. 2019 Mar;41(3):1649-1657. doi: 10.3892/or.2018.6952. Epub 2018 Dec 21.
• [218] Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy.Front Oncol. 2019 Jan 22;9:18. doi: 10.3389/fonc.2019.00018. eCollection 2019.
• [219] Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression.Methods Mol Biol. 2017;1513:83-100. doi: 10.1007/978-1-4939-6539-7_7.
• [220] Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.Biomed Pharmacother. 2017 Feb;86:502-513. doi: 10.1016/j.biopha.2016.12.056. Epub 2016 Dec 23.
• [221] Device-assisted intravesical therapy for non-muscle invasive bladder cancer.Transl Androl Urol. 2019 Feb;8(1):94-100. doi: 10.21037/tau.2018.09.09.
• [222] Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.Cancer Res Treat. 2020 Jan;52(1):31-40. doi: 10.4143/crt.2018.624. Epub 2019 Apr 30.
• [223] Abundance of the Organic Anion-transporting Polypeptide OATP4A1 in Early-Stage Colorectal Cancer Patients: Association With Disease Relapse.Appl Immunohistochem Mol Morphol. 2019 Mar;27(3):185-194. doi: 10.1097/PAI.0000000000000557.
• [224] Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue.Gene. 2003 Oct 2;315:87-94. doi: 10.1016/s0378-1119(03)00715-7.
• [225] Pharmacological DNA demethylation restores SMAD1 expression and tumor suppressive signaling in diffuse large B-cell lymphoma.Blood Adv. 2019 Oct 22;3(20):3020-3032. doi: 10.1182/bloodadvances.2019000210.
• [226] Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway.Int J Cancer. 2005 Nov 10;117(3):340-8. doi: 10.1002/ijc.21238.
• [227] Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.Cell Death Dis. 2019 Mar 18;10(4):261. doi: 10.1038/s41419-019-1497-1.
• [228] The Emerging Role of Sperm-Associated Antigen 6 Gene in the Microtubule Function of Cells and Cancer.Mol Ther Oncolytics. 2019 Sep 10;15:101-107. doi: 10.1016/j.omto.2019.08.011. eCollection 2019 Dec 20.
• [229] A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.J Cell Biochem. 2020 Jan;121(1):743-754. doi: 10.1002/jcb.29320. Epub 2019 Sep 3.
• [230] Combination of bacteriolytic therapy with magnetic field for Ehrlich tumour treatment.Gen Physiol Biophys. 2017 Jul;36(3):259-271. doi: 10.4149/gpb_2016051. Epub 2017 May 4.
• [231] Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.PLoS One. 2014 Oct 30;9(10):e111545. doi: 10.1371/journal.pone.0111545. eCollection 2014.
• [232] Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling.Semin Cancer Biol. 2020 May;62:108-115. doi: 10.1016/j.semcancer.2019.07.004. Epub 2019 Jul 4.
• [233] Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma.APMIS. 2020 Apr;128(4):287-297. doi: 10.1111/apm.13023. Epub 2020 Jan 29.
• [234] Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas.J Cell Biochem. 2019 Jul;120(7):11172-11189. doi: 10.1002/jcb.28393. Epub 2019 Feb 3.
• [235] STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K/AKT/mTOR Pathway.Neuroendocrinology. 2020;110(3-4):307-320. doi: 10.1159/000501829. Epub 2019 Jul 2.
• [236] Prognoses of superficial soft tissue sarcoma: The importance of fascia-tumor relationship on MRI.Eur J Surg Oncol. 2020 Feb;46(2):282-287. doi: 10.1016/j.ejso.2019.10.003. Epub 2019 Oct 5.
• [237] Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):246-257. doi: 10.1016/j.bbcan.2017.05.003. Epub 2017 May 13.
• [238] Synaptic vesicle protein 2 (SV2) isoforms.Asian Pac J Cancer Prev. 2012;13(10):5063-7. doi: 10.7314/apjcp.2012.13.10.5063.
• [239] T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma.Exp Mol Med. 2018 Jan 5;50(1):e420. doi: 10.1038/emm.2017.166.
• [240] Low Transforming Growth Factor-3 Expression Predicts Tumor Malignancy in Meningiomas.World Neurosurg. 2019 May;125:e353-e360. doi: 10.1016/j.wneu.2019.01.077. Epub 2019 Jan 28.
• [241] Thyroid hormone receptors/THR genes in human cancer.Cancer Lett. 2003 Mar 31;192(2):121-32. doi: 10.1016/s0304-3835(02)00614-6.
• [242] Toll-like Receptor-6 Signaling Prevents Inflammation and Impacts Composition of the Microbiota During Inflammation-Induced Colorectal Cancer.Cancer Prev Res (Phila). 2020 Jan;13(1):25-40. doi: 10.1158/1940-6207.CAPR-19-0286. Epub 2019 Nov 26.
• [243] p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus.J Clin Invest. 2019 Nov 1;129(11):4875-4884. doi: 10.1172/JCI128626.
• [244] The insulin-like growth factor binding protein-3 and its death receptor in pancreatic ductal adenocarcinoma poor prognosis.J Cell Physiol. 2019 Dec;234(12):23537-23546. doi: 10.1002/jcp.28922. Epub 2019 Jun 4.
• [245] Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.Cancer Sci. 2018 Aug;109(8):2469-2478. doi: 10.1111/cas.13665. Epub 2018 Jul 20.
• [246] Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.Oncotarget. 2017 Sep 20;8(48):84112-84122. doi: 10.18632/oncotarget.21109. eCollection 2017 Oct 13.
• [247] 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer.Cancer Immunol Immunother. 2017 Apr;66(4):415-426. doi: 10.1007/s00262-016-1917-3. Epub 2016 Oct 18.
• [248] Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.Ann Surg Oncol. 2009 Feb;16(2):487-98. doi: 10.1245/s10434-008-0251-1. Epub 2008 Dec 3.
• [249] TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells.J Cancer Res Clin Oncol. 2019 Jun;145(6):1509-1519. doi: 10.1007/s00432-019-02921-3. Epub 2019 Apr 23.
• [250] Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci.Leukemia. 2003 Apr;17(4):738-45. doi: 10.1038/sj.leu.2402884.
• [251] Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the G alpha q, G alpha 11, G alpha s, or thyrotropin-releasing hormone receptor genes.J Clin Endocrinol Metab. 1996 Mar;81(3):1134-40. doi: 10.1210/jcem.81.3.8772588.
• [252] Natural product-drug conjugates for modulation of TRPV1-expressing tumors.Bioorg Med Chem. 2019 Jun 15;27(12):2531-2536. doi: 10.1016/j.bmc.2019.03.025. Epub 2019 Mar 13.
• [253] A TRPV2 interactome-based signature for prognosis in glioblastoma patients.Oncotarget. 2018 Apr 6;9(26):18400-18409. doi: 10.18632/oncotarget.24843. eCollection 2018 Apr 6.
• [254] Transthyretin Stimulates Tumor Growth through Regulation of Tumor, Immune, and Endothelial Cells.J Immunol. 2019 Feb 1;202(3):991-1002. doi: 10.4049/jimmunol.1800736. Epub 2018 Dec 19.
• [255] Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning.J Pineal Res. 2019 Nov;67(4):e12607. doi: 10.1111/jpi.12607. Epub 2019 Sep 13.
• [256] Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.Med Sci Monit. 2018 May 26;24:3496-3505. doi: 10.12659/MSM.908075.
• [257] USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization.Mol Cells. 2019 Jan 31;42(1):17-27. doi: 10.14348/molcells.2018.0329. Epub 2019 Jan 2.
• [258] miR-3928v is induced by HBx via NF-B/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.J Exp Clin Cancer Res. 2018 Jan 29;37(1):14. doi: 10.1186/s13046-018-0681-y.
• [259] Mechanism of VIPR1 gene regulating human lung adenocarcinoma H1299 cells.Med Oncol. 2019 Sep 27;36(11):91. doi: 10.1007/s12032-019-1312-y.
• [260] WWP2 Is One Promising Novel Oncogene.Pathol Oncol Res. 2019 Apr;25(2):443-446. doi: 10.1007/s12253-018-0506-5. Epub 2018 Nov 10.
• [261] Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.
• [262] Differential gene signatures in rat mammary tumors induced by DMBA and those induced by fractionated gamma radiation.Radiat Res. 2008 Nov;170(5):579-90. doi: 10.1667/RR1106.1.
• [263] Predictors of readmission and reoperation in patients with colorectal cancer.Support Care Cancer. 2020 May;28(5):2339-2350. doi: 10.1007/s00520-019-05050-2. Epub 2019 Sep 4.
• [264] PARG regulates the proliferation and differentiation of DCs and Tcells via PARP/NFB in tumour metastases of colon carcinoma.Oncol Rep. 2019 May;41(5):2657-2666. doi: 10.3892/or.2019.7051. Epub 2019 Mar 7.
• [265] Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.Clin Cancer Res. 2006 Dec 15;12(24):7284-93. doi: 10.1158/1078-0432.CCR-06-1567.
• [266] Cystathionine -synthase regulates mitochondrial morphogenesis in ovarian cancer.FASEB J. 2018 Aug;32(8):4145-4157. doi: 10.1096/fj.201701095R. Epub 2018 Mar 1.
• [267] Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib.J Cancer Res Clin Oncol. 2017 Jun;143(6):961-970. doi: 10.1007/s00432-017-2365-y. Epub 2017 Mar 4.
• [268] Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.Genes Chromosomes Cancer. 2016 Aug;55(8):661-73. doi: 10.1002/gcc.22368. Epub 2016 May 24.
• [269] The eIF2-alpha kinase HRI: a potential target beyond the red blood cell.Expert Opin Ther Targets. 2017 Dec;21(12):1171-1177. doi: 10.1080/14728222.2017.1397133. Epub 2017 Oct 30.
• [270] FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.Oncogene. 2019 Jun;38(26):5265-5280. doi: 10.1038/s41388-019-0791-9. Epub 2019 Mar 26.
• [271] Uncovering the heterogeneous genetic variations in two insulin-expressing tumors in a patient with MEN1.Oncol Lett. 2018 May;15(5):7123-7131. doi: 10.3892/ol.2018.8184. Epub 2018 Mar 6.
• [272] HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer.Sci Rep. 2019 Sep 2;9(1):12628. doi: 10.1038/s41598-019-48992-7.
• [273] Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.BMC Cancer. 2019 Jul 15;19(1):696. doi: 10.1186/s12885-019-5901-0.
• [274] Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma.PLoS One. 2011;6(12):e27399. doi: 10.1371/journal.pone.0027399. Epub 2011 Dec 13.
• [275] PRAK is essential for ras-induced senescence and tumor suppression.Cell. 2007 Jan 26;128(2):295-308. doi: 10.1016/j.cell.2006.11.050.
• [276] Methionine sulfoxide reductase B1 regulates proliferation and invasion by affecting mitogen-activated protein kinase pathway and epithelial-mesenchymal transition in u2os cells.Biochem Biophys Res Commun. 2018 Feb 12;496(3):806-813. doi: 10.1016/j.bbrc.2018.01.151. Epub 2018 Feb 1.
• [277] The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia.Front Oncol. 2018 Aug 6;8:299. doi: 10.3389/fonc.2018.00299. eCollection 2018.
• [278] Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors.Oncogene. 2008 Sep 18;27(42):5624-34. doi: 10.1038/onc.2008.177. Epub 2008 Jun 2.
• [279] The proton-coupled oligopeptide transporters PEPT2, PHT1 and PHT2 mediate the uptake of carnosine in glioblastoma cells.Amino Acids. 2019 Jul;51(7):999-1008. doi: 10.1007/s00726-019-02739-w. Epub 2019 May 9.
• [280] Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma.Histol Histopathol. 2009 Aug;24(8):971-7. doi: 10.14670/HH-24.971.
• [281] TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.Oncogene. 2009 Dec 10;28(49):4353-63. doi: 10.1038/onc.2009.289.
• [282] p100 functions as a metastasis activator and is targeted by tumor suppressing microRNA-320a in lung cancer.Thorac Cancer. 2018 Jan;9(1):152-158. doi: 10.1111/1759-7714.12564. Epub 2017 Nov 21.
• [283] ISG15 as a novel tumor biomarker for drug sensitivity.Mol Cancer Ther. 2008 Jun;7(6):1430-9. doi: 10.1158/1535-7163.MCT-07-2345.
• [284] ZNF224 is a transcriptional repressor of AXL in chronic myeloid leukemia cells.Biochimie. 2018 Nov;154:127-131. doi: 10.1016/j.biochi.2018.08.011. Epub 2018 Aug 31.
• [285] Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma.Mol Cancer Ther. 2019 Nov;18(11):2085-2096. doi: 10.1158/1535-7163.MCT-18-1181. Epub 2019 Jul 24.
• [286] Depletion of Lipid Efflux Pump ABCG1 Triggers the Intracellular Accumulation of Extracellular Vesicles and Reduces Aggregation and Tumorigenesis of Metastatic Cancer Cells.Front Oncol. 2018 Oct 10;8:376. doi: 10.3389/fonc.2018.00376. eCollection 2018.
• [287] LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.Mol Carcinog. 2019 Feb;58(2):279-292. doi: 10.1002/mc.22926. Epub 2018 Oct 31.
• [288] Promotion of Tumor Growth by ADAMTS4 in Colorectal Cancer: Focused on Macrophages.Cell Physiol Biochem. 2018;46(4):1693-1703. doi: 10.1159/000489245. Epub 2018 Apr 20.
• [289] Signaling pathways activated by PACAP in MCF-7 breast cancer cells.Cell Signal. 2018 Oct;50:37-47. doi: 10.1016/j.cellsig.2018.06.009. Epub 2018 Jun 20.
• [290] Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers.BMC Genomics. 2014;15 Suppl 3(Suppl 3):S1. doi: 10.1186/1471-2164-15-S3-S1. Epub 2014 May 6.
• [291] Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer.Tumour Biol. 2015 Jul;36(7):5627-34. doi: 10.1007/s13277-015-3235-3. Epub 2015 Feb 15.
• [292] Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors.J Virol. 2011 Dec;85(24):13114-23. doi: 10.1128/JVI.05759-11. Epub 2011 Sep 28.
• [293] The value of pretreatment serum butyrylcholinesterase level as anovel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy.Strahlenther Onkol. 2019 May;195(5):430-440. doi: 10.1007/s00066-019-01430-z. Epub 2019 Feb 8.
• [294] The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.BMC Cancer. 2018 Apr 4;18(1):382. doi: 10.1186/s12885-018-4260-6.
• [295] Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.Oncogene. 2019 Jun;38(24):4685-4699. doi: 10.1038/s41388-019-0756-z. Epub 2019 Feb 22.
• [296] Bone Morphogenetic Protein 1 Targeting COL1A1 and COL1A2 to Regulate the Epithelial-Mesenchymal Transition Process of Colon Cancer SW620 Cells.J Nanosci Nanotechnol. 2020 Mar 1;20(3):1366-1374. doi: 10.1166/jnn.2020.17362.
• [297] Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth.Biochem Pharmacol. 2019 Aug;166:70-81. doi: 10.1016/j.bcp.2019.05.010. Epub 2019 May 7.
• [298] Clinical significance of aberrant cyclin-dependent kinase-like 2 methylation in hepatocellular carcinoma.Gene. 2019 Jan 30;683:35-40. doi: 10.1016/j.gene.2018.10.009. Epub 2018 Oct 5.
• [299] Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.Nat Med. 2019 Nov;25(11):1783-1795. doi: 10.1038/s41591-019-0612-2. Epub 2019 Nov 7.
• [300] Cdc2-like kinase 2 is a key regulator of the cell cycle via FOXO3a/p27 in glioblastoma.Oncotarget. 2016 May 3;7(18):26793-805. doi: 10.18632/oncotarget.8471.
• [301] MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.Cancer Lett. 2019 Nov 28;465:12-23. doi: 10.1016/j.canlet.2019.08.016. Epub 2019 Aug 29.
• [302] Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma.Cancer Lett. 2019 Aug 28;458:113-122. doi: 10.1016/j.canlet.2019.05.023. Epub 2019 May 22.
• [303] CSE1L participates in regulating cell mitosis in human seminoma.Cell Prolif. 2019 Mar;52(2):e12549. doi: 10.1111/cpr.12549. Epub 2018 Nov 28.
• [304] The Relationship Between Cytokine Production, CSF2RA, and IL1R2 Expression in Mammary Adenocarcinoma, Tumor Histopathological Parameters, and Lymph Node Metastasis.Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819883626. doi: 10.1177/1533033819883626.
• [305] Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival.Med Sci Monit. 2018 Mar 23;24:1701-1711. doi: 10.12659/msm.909128.
• [306] Therapeutic targeting of casein kinase 1 in breast cancer.Sci Transl Med. 2015 Dec 16;7(318):318ra202. doi: 10.1126/scitranslmed.aac8773.
• [307] Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.Blood. 2019 Jan 31;133(5):446-456. doi: 10.1182/blood-2018-04-845420. Epub 2018 Nov 6.
• [308] Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.Biochem J. 2018 Jan 31;475(2):531-545. doi: 10.1042/BCJ20170597.
• [309] Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.Cancer Res. 2006 Apr 15;66(8):4516-24. doi: 10.1158/0008-5472.CAN-05-3796.
• [310] AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma.Clin Cancer Res. 2016 Apr 15;22(8):1989-99. doi: 10.1158/1078-0432.CCR-15-1542. Epub 2015 Nov 20.
• [311] PAR2 deficiency enhances myeloid cell-mediated immunosuppression and promotes colitis-associated tumorigenesis.Cancer Lett. 2020 Jan 28;469:437-446. doi: 10.1016/j.canlet.2019.11.015. Epub 2019 Nov 14.
• [312] Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.Biomater Sci. 2019 Apr 23;7(5):2023-2036. doi: 10.1039/c9bm00139e.
• [313] Prognostic value of follistatin-like 3 in human invasive breast cancer.Oncotarget. 2017 Jun 27;8(26):42189-42197. doi: 10.18632/oncotarget.15026.
• [314] Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.Cancer Res. 1997 Sep 1;57(17):3772-8.
• [315] A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors.Epigenetics. 2014 Aug;9(8):1163-71. doi: 10.4161/epi.29628. Epub 2014 Jul 8.
• [316] Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis.Sci Rep. 2019 Dec 16;9(1):19150. doi: 10.1038/s41598-019-55702-w.
• [317] New observation of sialuria prompts detection of liver tumor in previously reported patient.Mol Genet Metab. 2016 Jun;118(2):92-9. doi: 10.1016/j.ymgme.2016.04.004. Epub 2016 Apr 16.
• [318] G Protein subunit 7 loss contributes to progression of clear cell renal cell carcinoma.J Cell Physiol. 2019 Nov;234(11):20002-20012. doi: 10.1002/jcp.28597. Epub 2019 Apr 3.
• [319] GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.Oncotarget. 2017 Apr 25;8(17):28826-28839. doi: 10.18632/oncotarget.16259.
• [320] MiR-210 Is Overexpressed in Tumor-infiltrating Plasma Cells in Triple-negative Breast Cancer.J Histochem Cytochem. 2020 Jan;68(1):25-32. doi: 10.1369/0022155419892965. Epub 2019 Dec 1.
• [321] Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.Horm Cancer. 2018 Feb;9(1):40-54. doi: 10.1007/s12672-017-0311-8. Epub 2017 Oct 4.
• [322] The Infiltration of ICOS(+) Cells in Nasopharyngeal Carcinoma is Beneficial for Improved Prognosis.Pathol Oncol Res. 2020 Jan;26(1):365-370. doi: 10.1007/s12253-018-0509-2. Epub 2018 Oct 25.
• [323] Expression of B7-H2 on CD8(+) T cells in colorectal cancer microenvironment and its clinical significance.Int Immunopharmacol. 2018 Mar;56:128-134. doi: 10.1016/j.intimp.2018.01.018. Epub 2018 Feb 2.
• [324] Activin A Signaling Regulates IL13R2 Expression to Promote Breast Cancer Metastasis.Front Oncol. 2019 Feb 5;9:32. doi: 10.3389/fonc.2019.00032. eCollection 2019.
• [325] Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma.Neoplasia. 2009 Apr;11(4):388-96. doi: 10.1593/neo.81582.
• [326] Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness.ACS Chem Biol. 2014 Jun 20;9(6):1340-50. doi: 10.1021/cb5001907. Epub 2014 Apr 28.
• [327] Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.Biomed Pharmacother. 2018 Nov;107:382-389. doi: 10.1016/j.biopha.2018.07.118. Epub 2018 Aug 9.
• [328] Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.J Hematol Oncol. 2014 Oct 10;7:76. doi: 10.1186/s13045-014-0076-2.
• [329] KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.Biomed Pharmacother. 2018 Dec;108:766-773. doi: 10.1016/j.biopha.2018.09.036. Epub 2018 Sep 22.
• [330] Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer.Cancers (Basel). 2019 Aug 12;11(8):1154. doi: 10.3390/cancers11081154.
• [331] Karyopherin 1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.Biomed Pharmacother. 2019 Dec;120:109127. doi: 10.1016/j.biopha.2019.109127. Epub 2019 Oct 17.
• [332] Extracellular pH mapping of liver cancer on a clinical 3T MRI scanner.Magn Reson Med. 2020 May;83(5):1553-1564. doi: 10.1002/mrm.28035. Epub 2019 Nov 5.
• [333] LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.FASEB J. 2018 May;32(5):2422-2437. doi: 10.1096/fj.201700897R. Epub 2017 Dec 21.
• [334] ILT3.Fc-CD166 Interaction Induces Inactivation of p70 S6 Kinase and Inhibits Tumor Cell Growth.J Immunol. 2018 Feb 1;200(3):1207-1219. doi: 10.4049/jimmunol.1700553. Epub 2017 Dec 20.
• [335] Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.Sci Transl Med. 2017 Apr 12;9(385):eaak9679. doi: 10.1126/scitranslmed.aak9679.
• [336] MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.Gastroenterology. 2017 Oct;153(4):1120-1132.e15. doi: 10.1053/j.gastro.2016.12.036. Epub 2017 Feb 27.
• [337] Mesencephalic Astrocyte-Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin-Related Modifier (SUMO)ylation-Related Suppression of NF-B/Snail Signaling Pathway and Epithelial-Mesenchymal Transition.Hepatology. 2020 Apr;71(4):1262-1278. doi: 10.1002/hep.30917. Epub 2020 Jan 26.
• [338] Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.J Hematol Oncol. 2017 Feb 28;10(1):59. doi: 10.1186/s13045-017-0424-0.
• [339] High expression of integrin 6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.Cancer Med. 2016 Aug;5(8):2000-11. doi: 10.1002/cam4.756. Epub 2016 May 17.
• [340] SPIONs embedded in polyamino acid nanogels to synergistically treat tumor microenvironment and breast cancer cells.Int J Pharm. 2019 Jan 30;555:207-219. doi: 10.1016/j.ijpharm.2018.11.046. Epub 2018 Nov 17.
• [341] Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNF/Myostatin Axis.Alcohol Clin Exp Res. 2020 Jan;44(1):66-77. doi: 10.1111/acer.14221. Epub 2019 Nov 11.
• [342] MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells.Oncol Rep. 2019 Nov;42(5):1915-1923. doi: 10.3892/or.2019.7292. Epub 2019 Aug 23.
• [343] MicroRNA (miR)-597-5p Inhibits Colon Cancer Cell Migration and Invasion by Targeting FOS-Like Antigen 2 (FOSL2).Front Oncol. 2019 Jun 12;9:495. doi: 10.3389/fonc.2019.00495. eCollection 2019.
• [344] The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape.Nature. 2019 Sep;573(7773):281-286. doi: 10.1038/s41586-019-1534-3. Epub 2019 Sep 4.
• [345] Quantitative proteomic analysis of mitochondrial proteins differentially expressed between small cell lung cancer cells and normal human bronchial epithelial cells.Thorac Cancer. 2018 Nov;9(11):1366-1375. doi: 10.1111/1759-7714.12839. Epub 2018 Sep 9.
• [346] Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy.J Control Release. 2020 Jan 10;317:43-56. doi: 10.1016/j.jconrel.2019.11.011. Epub 2019 Nov 20.
• [347] Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.Nat Commun. 2019 Mar 1;10(1):991. doi: 10.1038/s41467-019-08921-8.
• [348] Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.Cancer Res. 2017 Jan 1;77(1):142-152. doi: 10.1158/0008-5472.CAN-15-3032. Epub 2016 Oct 28.
• [349] S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.Asian Pac J Cancer Prev. 2015;16(7):2883-7. doi: 10.7314/apjcp.2015.16.7.2883.
• [350] PRDX4 and Its Roles in Various Cancers.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819864313. doi: 10.1177/1533033819864313.
• [351] Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.Aging (Albany NY). 2019 Jun 6;11(11):3601-3623. doi: 10.18632/aging.102000.
• [352] RIP2 promotes glioma cell growth by regulating TRAF3 and activating the NFB and p38 signaling pathways.Oncol Rep. 2018 Jun;39(6):2915-2923. doi: 10.3892/or.2018.6397. Epub 2018 Apr 23.
• [353] Selective Targeting and Eradication of LGR5(+) Cancer Stem Cells Using RSPO-Conjugated Doxorubicin Liposomes.Mol Cancer Ther. 2018 Jul;17(7):1475-1485. doi: 10.1158/1535-7163.MCT-17-0694. Epub 2018 Apr 25.
• [354] R-spondin3 promotes the tumor growth of choriocarcinoma JEG-3 cells.Am J Physiol Cell Physiol. 2020 Mar 1;318(3):C664-C674. doi: 10.1152/ajpcell.00295.2019. Epub 2019 Dec 18.
• [355] Exogenous Melatonin Up-Regulates Expression of CD62L by Lymphocytes in Aged Mice under Inflammatory and Non-Inflammatory Conditions.Immunol Invest. 2019 Aug;48(6):632-643. doi: 10.1080/08820139.2019.1586918. Epub 2019 Mar 19.
• [356] Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis.Cancer Cell. 2019 Jun 10;35(6):916-931.e9. doi: 10.1016/j.ccell.2019.05.002.
• [357] Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-B/MMP-7 signaling pathway.Cell Death Dis. 2017 Mar 23;8(3):e2691. doi: 10.1038/cddis.2017.118.
• [358] Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapy.Oncol Lett. 2017 Oct;14(4):4158-4166. doi: 10.3892/ol.2017.6724. Epub 2017 Aug 4.
• [359] Overexpression of Uric Acid Transporter SLC2A9 Inhibits Proliferation of Hepatocellular Carcinoma Cells.Oncol Res. 2019 May 7;27(5):533-540. doi: 10.3727/096504018X15199489058224. Epub 2018 Mar 9.
• [360] SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8412-7.
• [361] Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer. Yonsei Med J. 2017 Jan;58(1):27-34.
• [362] Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma.BMC Cancer. 2014 May 7;14:324. doi: 10.1186/1471-2407-14-324.
• [363] A Positive Feedback Loop of SLP2 Activates MAPK Signaling Pathway to Promote Gastric Cancer Progression.Theranostics. 2018 Nov 10;8(20):5744-5757. doi: 10.7150/thno.28898. eCollection 2018.
• [364] TLR5 is a new reporter for triple-negative breast cancer indicated by radioimmunoimaging and fluorescent staining.J Cell Mol Med. 2019 Dec;23(12):8305-8313. doi: 10.1111/jcmm.14707. Epub 2019 Oct 1.
• [365] Neutrophil TLR4 and PKR are targets of breast cancer cell glycosaminoglycans and effectors of glycosaminoglycan-induced APRIL secretion.Oncogenesis. 2018 Jun 15;7(6):45. doi: 10.1038/s41389-018-0058-2.
• [366] LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression.Oncogene. 2019 Oct;38(44):7017-7034. doi: 10.1038/s41388-019-0923-2. Epub 2019 Aug 13.
• [367] Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance.Cancer Cell. 2018 Jun 11;33(6):985-1003.e7. doi: 10.1016/j.ccell.2018.05.001. Epub 2018 May 24.
• [368] UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.Am J Cancer Res. 2019 Sep 1;9(9):1970-1981. eCollection 2019.
• [369] Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy.Cell Death Dis. 2019 Mar 28;10(4):285. doi: 10.1038/s41419-019-1512-6.
• [370] Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.Endocr J. 2020 Feb 28;67(2):177-184. doi: 10.1507/endocrj.EJ19-0239. Epub 2019 Oct 30.
• [371] Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.Int J Cancer. 2018 Mar 15;142(6):1230-1243. doi: 10.1002/ijc.31129. Epub 2017 Nov 7.
• [372] Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca(2+)-NFAT1 Axis.Theranostics. 2019 Jan 1;9(1):34-47. doi: 10.7150/thno.29407. eCollection 2019.
• [373] Expression of flTF and asTF splice variants in various cell strains and tissues.Mol Med Rep. 2019 Mar;19(3):2077-2086. doi: 10.3892/mmr.2019.9843. Epub 2019 Jan 10.
• [374] RMP promotes the proliferation and radioresistance of esophageal carcinoma.J Cancer. 2019 Jun 9;10(16):3698-3705. doi: 10.7150/jca.32680. eCollection 2019.
• [375] Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer.Biosci Rep. 2018 Feb 21;38(1):BSR20171428. doi: 10.1042/BSR20171428. Print 2018 Feb 28.
• [376] Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer.Sci Rep. 2019 Feb 19;9(1):2245. doi: 10.1038/s41598-019-38667-8.
• [377] High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors.Cancer Sci. 2009 Dec;100(12):2383-9. doi: 10.1111/j.1349-7006.2009.01347.x. Epub 2009 Sep 4.
• [378] Potential protein markers for breast cancer recurrence: a retrospective cohort study.Cancer Causes Control. 2019 Jan;30(1):41-51. doi: 10.1007/s10552-018-1099-8. Epub 2018 Nov 28.
• [379] An Adult Drosophila Glioma Model for Studying Pathometabolic Pathways of Gliomagenesis.Mol Neurobiol. 2019 Jun;56(6):4589-4599. doi: 10.1007/s12035-018-1392-2. Epub 2018 Oct 24.
• [380] Radioprotective activity of glutathione on cognitive ability in X-ray radiated tumor-bearing mice.Neurol Res. 2018 Sep;40(9):758-766. doi: 10.1080/01616412.2018.1476080. Epub 2018 May 30.
• [381] Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry.Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):690-700. doi: 10.1158/1055-9965.EPI-18-0955.
• [382] The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target.Drug Resist Updat. 2016 Nov;29:47-53. doi: 10.1016/j.drup.2016.09.003. Epub 2016 Sep 21.
• [383] Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer.Med Oncol. 2013 Jun;30(2):552. doi: 10.1007/s12032-013-0552-5. Epub 2013 Apr 2.
• [384] RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma.Onco Targets Ther. 2019 Feb 28;12:1691-1703. doi: 10.2147/OTT.S197844. eCollection 2019.
• [385] The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.EBioMedicine. 2019 Nov;49:55-71. doi: 10.1016/j.ebiom.2019.10.039. Epub 2019 Nov 1.
• [386] BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.J Exp Clin Cancer Res. 2018 Aug 30;37(1):209. doi: 10.1186/s13046-018-0885-1.
• [387] Development of Adenosine Deaminase-Specific IgY Antibodies: Diagnostic and Inhibitory Application.Appl Biochem Biotechnol. 2018 Apr;184(4):1358-1374. doi: 10.1007/s12010-017-2626-x. Epub 2017 Oct 17.
• [388] ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.BMC Cancer. 2009 Mar 6;9:80. doi: 10.1186/1471-2407-9-80.
• [389] von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience.Semin Hematol. 2004 Jan;41(1):75-82. doi: 10.1053/j.seminhematol.2003.10.008.
• [390] PACAP and PAC1 receptor expression in pancreatic ductal carcinoma.Oncol Lett. 2019 Dec;18(6):5725-5730. doi: 10.3892/ol.2019.10971. Epub 2019 Oct 8.
• [391] 5'-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth.J Biol Chem. 2019 Apr 5;294(14):5456-5465. doi: 10.1074/jbc.RA118.006761. Epub 2019 Feb 12.
• [392] Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts.Oncogene. 2020 Feb;39(9):1914-1930. doi: 10.1038/s41388-019-1112-z. Epub 2019 Nov 21.
• [393] Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2721-32. doi: 10.1161/ATVBAHA.112.300185. Epub 2012 Aug 23.
• [394] Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma.Int J Mol Sci. 2019 Mar 14;20(6):1286. doi: 10.3390/ijms20061286.
• [395] A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.Neoplasia. 2017 Jul;19(7):530-536. doi: 10.1016/j.neo.2017.02.004. Epub 2017 Jun 3.
• [396] Adenosine receptor 2B activity promotes autonomous growth, migration as well as vascularization of head and neck squamous cell carcinoma cells.Int J Cancer. 2020 Jul 1;147(1):202-217. doi: 10.1002/ijc.32835. Epub 2020 Jan 9.
• [397] Cryo-EM structure of oxysterol-bound human Smoothened coupled to a heterotrimeric G(i).Nature. 2019 Jul;571(7764):279-283. doi: 10.1038/s41586-019-1286-0. Epub 2019 Jun 5.
• [398] Prognostic significance of - and 2-adrenoceptor gene expression in breast cancer patients.Br J Clin Pharmacol. 2019 Sep;85(9):2143-2154. doi: 10.1111/bcp.14030. Epub 2019 Jul 31.
• [399] 3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P(2) modulation.Oncogene. 2020 Jan;39(2):368-384. doi: 10.1038/s41388-019-0993-1. Epub 2019 Sep 2.
• [400] Association of RAGE gene four single nucleotide polymorphisms with the risk, invasion, metastasis and overall survival of gastric cancer in Chinese.J Cancer. 2019 Jan 1;10(2):504-509. doi: 10.7150/jca.26583. eCollection 2019.
• [401] AGK Unleashes CD8(+) T Cell Glycolysis to Combat Tumor Growth.Cell Metab. 2019 Aug 6;30(2):233-234. doi: 10.1016/j.cmet.2019.07.008.
• [402] Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter.PLoS Pathog. 2018 Dec 17;14(12):e1007441. doi: 10.1371/journal.ppat.1007441. eCollection 2018 Dec.
• [403] A Novel mTORC1/2 Inhibitor (MTI-31) Inhibits Tumor Growth, Epithelial-Mesenchymal Transition, Metastases, and Improves Antitumor Immunity in Preclinical Models of Lung Cancer.Clin Cancer Res. 2019 Jun 15;25(12):3630-3642. doi: 10.1158/1078-0432.CCR-18-2548. Epub 2019 Feb 22.
• [404] Hyperoside exerts potent anticancer activity in skin cancer.Front Biosci (Landmark Ed). 2020 Jan 1;25(3):463-479. doi: 10.2741/4814.
• [405] Design, synthesis, and biological evaluation of quinazoline derivatives as dual HDAC1 and HDAC6 inhibitors for the treatment of cancer.Chem Biol Drug Des. 2019 Mar;93(3):232-241. doi: 10.1111/cbdd.13405. Epub 2018 Oct 28.
• [406] Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.Int J Cancer. 2019 May 15;144(10):2465-2477. doi: 10.1002/ijc.31954. Epub 2019 Jan 30.
• [407] The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB.Biomed Pharmacother. 2019 Apr;112:108653. doi: 10.1016/j.biopha.2019.108653. Epub 2019 Feb 20.
• [408] M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma.J Cell Biochem. 2020 Apr;121(4):2828-2838. doi: 10.1002/jcb.29514. Epub 2019 Nov 6.
• [409] Reference gene selection for head and neck squamous cell carcinoma gene expression studies.BMC Mol Biol. 2009 Aug 3;10:78. doi: 10.1186/1471-2199-10-78.
• [410] Transcriptome analysis and prognosis of ALDH isoforms in human cancer.Sci Rep. 2018 Feb 9;8(1):2713. doi: 10.1038/s41598-018-21123-4.
• [411] ALKBH5 Holds Prognostic Values and Inhibits the Metastasis of Colon Cancer.Pathol Oncol Res. 2020 Jul;26(3):1615-1623. doi: 10.1007/s12253-019-00737-7. Epub 2019 Sep 10.
• [412] ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway.Nat Cell Biol. 2019 May;21(5):579-591. doi: 10.1038/s41556-019-0305-6. Epub 2019 Apr 8.
• [413] Up-regulation of 15-lipoxygenase enzymes and products in functional and non-functional pituitary adenomas.Lipids Health Dis. 2019 Jul 9;18(1):152. doi: 10.1186/s12944-019-1089-1.
• [414] Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer.Br J Cancer. 2017 Jan 17;116(2):227-236. doi: 10.1038/bjc.2016.402. Epub 2016 Dec 22.
• [415] Polyamine synthesis enzyme AMD1 is closely associated with tumorigenesis and prognosis of human gastric cancers.Carcinogenesis. 2020 Apr 22;41(2):214-222. doi: 10.1093/carcin/bgz098.
• [416] Novel homozygous mutation in a colombian patient with persistent mllerian duct syndrome: expanded phenotype.Int Braz J Urol. 2019 Sep-Oct;45(5):1064-1070. doi: 10.1590/S1677-5538.IBJU.2018.0808.
• [417] Angiomotin-p130 inhibits -catenin stability by competing with Axin for binding to tankyrase in breast cancer.Cell Death Dis. 2019 Feb 21;10(3):179. doi: 10.1038/s41419-019-1427-2.
• [418] AMY2A: a possible tumor-suppressor gene of 1p21.1 loss in gastric carcinoma.Int J Oncol. 2010 Jun;36(6):1429-35.
• [419] Antiproliferative and antiangiogenic effect of Amblyomma sculptum (Acari: Ixodidae) crude saliva in endothelial cells in vitro.Biomed Pharmacother. 2019 Feb;110:353-361. doi: 10.1016/j.biopha.2018.11.107. Epub 2018 Dec 5.
• [420] Angiotensin 1-7 formation in breast tissue is attenuated in breast cancer - a study on the metabolism of angiotensinogen in breast cancer cell lines.J Physiol Pharmacol. 2019 Aug;70(4). doi: 10.26402/jpp.2019.4.02. Epub 2019 Oct 19.
• [421] Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.J Cancer Res Clin Oncol. 2020 Jan;146(1):245-259. doi: 10.1007/s00432-019-03055-2. Epub 2019 Oct 15.
• [422] ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.Cancer Med. 2015 May;4(5):759-69. doi: 10.1002/cam4.418. Epub 2015 Jan 30.
• [423] ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.Cancer Lett. 2017 Dec 1;410:191-200. doi: 10.1016/j.canlet.2017.09.038. Epub 2017 Sep 29.
• [424] Promotive effects of capillary morphogenetic protein 2 on glioma cell invasion and the molecular mechanism.Folia Neuropathol. 2019;57(1):6-15. doi: 10.5114/fn.2019.83826.
• [425] Frequent Alteration of Annexin A9 and A10 in HPV-Negative Head and Neck Squamous Cell Carcinomas: Correlation with the Histopathological Differentiation Grade.J Clin Med. 2019 Feb 10;8(2):229. doi: 10.3390/jcm8020229.
• [426] Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.Cancer Lett. 2016 Oct 1;380(2):375-383. doi: 10.1016/j.canlet.2016.07.003. Epub 2016 Jul 12.
• [427] Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.Oncogene. 2020 Oct;39(40):6265-6285. doi: 10.1038/s41388-019-0902-7. Epub 2019 Aug 5.
• [428] Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study.EBioMedicine. 2019 Jan;39:265-271. doi: 10.1016/j.ebiom.2018.11.034. Epub 2018 Nov 22.
• [429] Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.Oncotarget. 2017 Jun 6;8(23):37250-37262. doi: 10.18632/oncotarget.16763.
• [430] Deletion of chromosome 3p is an early event in malignant progression of cervical cancer.Anticancer Res. 1998 Mar-Apr;18(2A):707-12.
• [431] Tumor apelin immunoreactivity is correlated with body mass index in ovarian high grade serous carcinoma.Biotech Histochem. 2020 Jan;95(1):27-36. doi: 10.1080/10520295.2019.1627419. Epub 2019 Jul 2.
• [432] Apelin and apelin receptor expression in renal cell carcinoma.Br J Cancer. 2019 Mar;120(6):633-639. doi: 10.1038/s41416-019-0396-7. Epub 2019 Feb 20.
• [433] HPV33+HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.Oral Oncol. 2020 Jan;100:104488. doi: 10.1016/j.oraloncology.2019.104488. Epub 2019 Dec 10.
• [434] Moderate sensitivity of mouse mammary tumour virus to inhibition by human APOBEC3G.J Gen Virol. 2017 Sep;98(9):2362-2367. doi: 10.1099/jgv.0.000897. Epub 2017 Aug 18.
• [435] In vivo modulation of angiogenesis by beta 2 glycoprotein I.J Autoimmun. 2010 Nov;35(3):232-40. doi: 10.1016/j.jaut.2010.06.013. Epub 2010 Jul 24.
• [436] miR-373-3p promotes lung adenocarcinoma cell proliferation via APP.Oncol Lett. 2018 Jan;15(1):1046-1050. doi: 10.3892/ol.2017.7372. Epub 2017 Nov 8.
• [437] Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression.Anticancer Agents Med Chem. 2019;19(2):236-247. doi: 10.2174/1871520618666181015142810.
• [438] Mitochondrial arginase-2 is a cellautonomous regulator of CD8+ T cell function and antitumor efficacy.JCI Insight. 2019 Nov 21;4(24):e132975. doi: 10.1172/jci.insight.132975.
• [439] Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line.Cell Cycle. 2008 Oct;7(19):3074-82. doi: 10.4161/cc.7.19.6777. Epub 2008 Oct 12.
• [440] ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia.Cancer Res. 2020 Mar 1;80(5):988-998. doi: 10.1158/0008-5472.CAN-19-1471. Epub 2019 Dec 10.
• [441] -Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer.Mol Cancer Ther. 2019 Apr;18(4):801-811. doi: 10.1158/1535-7163.MCT-18-1167. Epub 2019 Feb 20.
• [442] Down-regulation of ASIC1 suppressed gastric cancer via inhibiting autophagy.Gene. 2017 Apr 15;608:79-85. doi: 10.1016/j.gene.2017.01.014. Epub 2017 Jan 19.
• [443] Clinical impact of aspartyl aminopeptidase expression and activity in colorectal cancer.Transl Res. 2013 Nov;162(5):297-308. doi: 10.1016/j.trsl.2013.07.010. Epub 2013 Aug 13.
• [444] Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation. Cancer Lett. 2018 Aug 10;429:1-10.
• [445] ATF3 and JDP2 deficiency in cancer associated fibroblasts promotes tumor growth via SDF-1 transcription.Oncogene. 2019 May;38(20):3812-3823. doi: 10.1038/s41388-019-0692-y. Epub 2019 Jan 22.
• [446] Plumbagin induces autophagy and apoptosis of SMMC-7721 cells in vitro and in vivo.J Cell Biochem. 2019 Jun;120(6):9820-9830. doi: 10.1002/jcb.28262. Epub 2018 Dec 9.
• [447] Negative regulation of AMPK1 by PIM2 promotes aerobic glycolysis and tumorigenesis in endometrial cancer.Oncogene. 2019 Sep;38(38):6537-6549. doi: 10.1038/s41388-019-0898-z. Epub 2019 Jul 29.
• [448] Carbonic anhydrase 2 inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.Carcinogenesis. 2018 Apr 5;39(4):562-570. doi: 10.1093/carcin/bgx148.
• [449] Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.PLoS One. 2018 May 3;13(5):e0196858. doi: 10.1371/journal.pone.0196858. eCollection 2018.
• [450] Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity.Biochem J. 2019 Dec 19;476(24):3705-3719. doi: 10.1042/BCJ20190591.
• [451] The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models.Mol Cancer Ther. 2020 Jan;19(1):26-38. doi: 10.1158/1535-7163.MCT-19-0019. Epub 2019 Oct 3.
• [452] Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.Tumour Biol. 2015 Sep;36(10):8201-6. doi: 10.1007/s13277-015-3546-4. Epub 2015 May 21.
• [453] Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer.Cancer Res Treat. 2019 Apr;51(2):438-450. doi: 10.4143/crt.2018.040. Epub 2018 Jun 1.
• [454] Overexpression of the zinc-2-glycoprotein accelerates apoptosis and inhibits growth via the mTOR/PTEN signaling pathway in gastric carcinoma cells.Life Sci. 2020 Jan 1;240:117117. doi: 10.1016/j.lfs.2019.117117. Epub 2019 Nov 29.
• [455] Identification of a novel aspartic-like protease differentially expressed in human breast cancer cell lines.Biochim Biophys Acta. 2000 Jun 15;1501(2-3):125-37. doi: 10.1016/s0925-4439(00)00014-4.
• [456] Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism.Nature. 2019 Apr;568(7751):254-258. doi: 10.1038/s41586-019-1005-x. Epub 2019 Mar 6.
• [457] Targeted OMA1 therapies for cancer.Int J Cancer. 2019 Nov 1;145(9):2330-2341. doi: 10.1002/ijc.32177. Epub 2019 Feb 21.
• [458] Paradoxical Puma Prohibits Pyruvate Pumps to Prime Pathology.Cancer Cell. 2019 Feb 11;35(2):163-165. doi: 10.1016/j.ccell.2019.01.016.
• [459] Loss of BCAT1 Expression is a Sensitive Marker for IDH-Mutant Diffuse Glioma.Neurosurgery. 2019 Sep 1;85(3):335-342. doi: 10.1093/neuros/nyy338.
• [460] BCL11A enhances stemness and promotes progression by activating Wnt/-catenin signaling in breast cancer.Cancer Manag Res. 2019 Apr 11;11:2997-3007. doi: 10.2147/CMAR.S199368. eCollection 2019.
• [461] MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.J Cell Physiol. 2018 Dec;233(12):9447-9457. doi: 10.1002/jcp.26833. Epub 2018 Aug 22.
• [462] Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome.Curr Cancer Drug Targets. 2019;19(3):210-221. doi: 10.2174/1568009618666180706165845.
• [463] A novel BLK-induced tumor model.Tumour Biol. 2017 Jul;39(7):1010428317714196. doi: 10.1177/1010428317714196.
• [464] BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis.Oncogene. 2019 Nov;38(48):7281-7293. doi: 10.1038/s41388-019-0943-y. Epub 2019 Aug 15.
• [465] Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.Oncogene. 2020 Jan;39(5):987-1003. doi: 10.1038/s41388-019-1047-4. Epub 2019 Oct 7.
• [466] Downregulation of bone morphogenetic protein receptor 2 promotes the development of neuroblastoma.Biochem Biophys Res Commun. 2017 Jan 29;483(1):609-616. doi: 10.1016/j.bbrc.2016.12.095. Epub 2016 Dec 18.
• [467] BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK/STAT3 signaling pathway.Cancer Cell Int. 2019 May 17;19:133. doi: 10.1186/s12935-019-0847-5. eCollection 2019.
• [468] Hypoxia-Activated Anticancer Prodrug for Bioimaging, Tracking Drug Release, and Anticancer Application.Bioconjug Chem. 2018 Oct 17;29(10):3332-3343. doi: 10.1021/acs.bioconjchem.8b00511. Epub 2018 Sep 14.
• [469] Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.J Surg Oncol. 2019 Nov;120(6):976-984. doi: 10.1002/jso.25681. Epub 2019 Aug 26.
• [470] miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein.Sci Rep. 2018 Mar 14;8(1):4482. doi: 10.1038/s41598-018-22767-y.
• [471] Expression and clinical value of PD-L1 which is regulated by BRD4 in tongue squamous cell carcinoma.J Cell Biochem. 2020 Feb;121(2):1855-1869. doi: 10.1002/jcb.29420. Epub 2019 Oct 21.
• [472] Bromodomaincontaining protein7 sensitizes breast cancer cells to paclitaxel by activating Bcl2antagonist/killer protein.Oncol Rep. 2019 Mar;41(3):1487-1496. doi: 10.3892/or.2018.6951. Epub 2018 Dec 21.
• [473] Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment.Nat Commun. 2019 Feb 13;10(1):733. doi: 10.1038/s41467-019-08554-x.
• [474] miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.J Cell Physiol. 2019 Jun;234(6):9816-9825. doi: 10.1002/jcp.27670. Epub 2018 Nov 27.
• [475] Putative Tumor Suppressor Genes EGR1 and BRSK1 Are Mutated in Gastric and Colorectal Cancers.Oncology. 2016;91(5):289-294. doi: 10.1159/000450616. Epub 2016 Sep 28.
• [476] The treatment effects and the underlying mechanism of B cell translocation gene 1 on the oncogenesis of brain glioma.J Cell Biochem. 2019 Aug;120(8):13310-13320. doi: 10.1002/jcb.28605. Epub 2019 Mar 27.
• [477] Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma.Mol Cancer Ther. 2020 Feb;19(2):384-396. doi: 10.1158/1535-7163.MCT-19-0135. Epub 2019 Oct 3.
• [478] Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.J Immunother Cancer. 2019 Apr 26;7(1):114. doi: 10.1186/s40425-019-0587-z.
• [479] Complement Activation via a C3a Receptor Pathway Alters CD4(+) T Lymphocytes and Mediates Lung Cancer Progression.Cancer Res. 2018 Jan 1;78(1):143-156. doi: 10.1158/0008-5472.CAN-17-0240. Epub 2017 Nov 8.
• [480] Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.Br J Haematol. 2003 Jan;120(1):44-52. doi: 10.1046/j.1365-2141.2003.03948.x.
• [481] Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment.Cell Commun Signal. 2019 Dec 17;17(1):169. doi: 10.1186/s12964-019-0478-4.
• [482] JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.Gastroenterology. 2018 Apr;154(5):1480-1493. doi: 10.1053/j.gastro.2017.12.004. Epub 2017 Dec 14.
• [483] Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor.Front Oncol. 2019 Apr 26;9:307. doi: 10.3389/fonc.2019.00307. eCollection 2019.
• [484] Genetic polymorphisms in caveolin-1 associate with breast cancer risk in Chinese Han population.Oncotarget. 2017 Oct 6;8(53):91654-91661. doi: 10.18632/oncotarget.21560. eCollection 2017 Oct 31.
• [485] Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma.BMC Cancer. 2015 Apr 1;15:209. doi: 10.1186/s12885-015-1216-y.
• [486] Assessing the utility of in vitro microtubule assays for studying mechanisms of peripheral neuropathy with the microtubule inhibitor class of cancer chemotherapy.Chem Biol Interact. 2020 Jan 5;315:108906. doi: 10.1016/j.cbi.2019.108906. Epub 2019 Nov 21.
• [487] Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles.Onco Targets Ther. 2017 Jun 29;10:3225-3232. doi: 10.2147/OTT.S135764. eCollection 2017.
• [488] CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.Gastroenterology. 2014 Sep;147(3):637-45. doi: 10.1053/j.gastro.2014.05.009. Epub 2014 May 21.
• [489] Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.Oncotarget. 2017 Apr 18;8(16):26755-26770. doi: 10.18632/oncotarget.15815.
• [490] Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer.Oncol Rep. 2020 Jan;43(1):121-132. doi: 10.3892/or.2019.7396. Epub 2019 Oct 31.
• [491] Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.J Thorac Oncol. 2016 Jan;11(1):94-107. doi: 10.1016/j.jtho.2015.09.004.
• [492] Modulation of the activity of certain genes involved in tumor cell metabolism in the presence of the cytotoxic peptides defensin and cathelicidin LL37.Exp Ther Med. 2019 Dec;18(6):5033-5040. doi: 10.3892/etm.2019.8117. Epub 2019 Oct 21.
• [493] Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.Int J Biol Sci. 2019 Jan 6;15(1):127-137. doi: 10.7150/ijbs.28834. eCollection 2019.
• [494] CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity.Nat Commun. 2018 Feb 12;9(1):631. doi: 10.1038/s41467-018-03031-3.
• [495] Papilloma-pseudovirus eradicates intestinal tumours and triples the lifespan of Apc(Min/+) mice.Nat Commun. 2017 Apr 11;8:15004. doi: 10.1038/ncomms15004.
• [496] Caspase-10, matrix metalloproteinase-9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma.Oncol Lett. 2018 Aug;16(2):2039-2045. doi: 10.3892/ol.2018.8845. Epub 2018 May 30.
• [497] Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancer.Oncotarget. 2018 Apr 10;9(27):19356-19367. doi: 10.18632/oncotarget.25049. eCollection 2018 Apr 10.
• [498] Coding Microsatellite Frameshift Mutations Accumulate in Atherosclerotic Carotid Artery Lesions: Evaluation of 26 Cases and Literature Review.Mol Med. 2015 Jun 9;21(1):479-86. doi: 10.2119/molmed.2014.00258.
• [499] Proteomic characterization of EL4 lymphoma-derived tumors upon chemotherapy treatment reveals potential roles for lysosomes and caspase-6 during tumor cell death in vivo.Proteomics. 2017 Jun;17(12). doi: 10.1002/pmic.201700060.
• [500] Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer.Life Sci. 2019 Jun 15;227:145-152. doi: 10.1016/j.lfs.2019.04.047. Epub 2019 Apr 19.
• [501] A near-infrared laser and H(2)O(2) activated bio-nanoreactor for enhanced photodynamic therapy of hypoxic tumors.Biomater Sci. 2020 Feb 7;8(3):858-870. doi: 10.1039/c9bm01126a. Epub 2019 Dec 6.
• [502] MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.Oncotarget. 2016 Dec 13;7(50):82338-82353. doi: 10.18632/oncotarget.11001.
• [503] Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.J Exp Clin Cancer Res. 2018 Oct 30;37(1):264. doi: 10.1186/s13046-018-0942-9.
• [504] The complex CBX7-PRMT1 has a critical role in regulating E-cadherin gene expression and cell migration.Biochim Biophys Acta Gene Regul Mech. 2019 Apr;1862(4):509-521. doi: 10.1016/j.bbagrm.2019.02.006. Epub 2019 Feb 28.
• [505] Long noncoding RNA LINC00958 promotes the oral squamous cell carcinoma by sponging miR-185-5p/YWHAZ.Life Sci. 2020 Feb 1;242:116782. doi: 10.1016/j.lfs.2019.116782. Epub 2019 Aug 20.
• [506] Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer.Mol Cancer Ther. 2020 Jan;19(1):63-74. doi: 10.1158/1535-7163.MCT-19-0386. Epub 2019 Sep 23.
• [507] Adiposederived mesenchymal stem cells exhibit tumor tropism and promote tumorsphere formation of breast cancer cells.Oncol Rep. 2019 Apr;41(4):2126-2136. doi: 10.3892/or.2019.7018. Epub 2019 Feb 15.
• [508] Long noncoding RNA TPT1-AS1 downregulates the microRNA-770-5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation.J Cell Physiol. 2020 Apr;235(4):3679-3689. doi: 10.1002/jcp.29262. Epub 2019 Oct 21.
• [509] MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2.Cell Mol Biol Lett. 2019 Feb 5;24:4. doi: 10.1186/s11658-018-0129-6. eCollection 2019.
• [510] Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysis.Cancer Cell Int. 2019 Jun 10;19:158. doi: 10.1186/s12935-019-0865-3. eCollection 2019.
• [511] An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer.Gynecol Oncol. 2020 Jan;156(1):222-232. doi: 10.1016/j.ygyno.2019.10.011. Epub 2019 Dec 7.
• [512] CCR4 Expression in Tumor-Infiltrating Regulatory T Cells in Patients with Squamous Cell Carcinoma of the Lung: A Prognostic Factor for Relapse and Survival.Cancer Invest. 2019;37(3):163-173. doi: 10.1080/07357907.2019.1582848. Epub 2019 Mar 25.
• [513] Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.Cancer Res. 2018 Sep 15;78(18):5340-5348. doi: 10.1158/0008-5472.CAN-18-1119. Epub 2018 Jul 19.
• [514] Chemotactic Cues for NOTCH1-Dependent Leukemia.Front Immunol. 2018 Apr 3;9:633. doi: 10.3389/fimmu.2018.00633. eCollection 2018.
• [515] Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Clin Cancer Res. 2020 Mar 15;26(6):1420-1431.
• [516] The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway.Biol Res. 2018 May 30;51(1):14. doi: 10.1186/s40659-018-0163-x.
• [517] Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.Am J Pathol. 2011 Jul;179(1):436-51. doi: 10.1016/j.ajpath.2011.03.011. Epub 2011 May 18.
• [518] Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma.Oncogene. 2015 Jan 2;34(1):94-103. doi: 10.1038/onc.2013.523. Epub 2013 Dec 9.
• [519] Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review).Mol Med Rep. 2019 Aug;20(2):1488-1498. doi: 10.3892/mmr.2019.10429. Epub 2019 Jun 26.
• [520] (89)Zr-Cobalamin PET Tracer: Synthesis, Cellular Uptake, and Use for Tumor Imaging.ACS Omega. 2017 Oct 31;2(10):6314-6320. doi: 10.1021/acsomega.7b01180. Epub 2017 Oct 2.
• [521] Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors. Curr Opin Hematol. 2018 Mar;25(2):136-145.
• [522] CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis.FASEB J. 2019 Feb;33(2):1860-1872. doi: 10.1096/fj.201800985R. Epub 2018 Sep 12.
• [523] NKG2D ligands in glioma stem-like cells: expression in situ and in vitro.Histochem Cell Biol. 2018 Mar;149(3):219-233. doi: 10.1007/s00418-018-1633-5. Epub 2018 Jan 22.
• [524] CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.Cancer Cell. 2019 Mar 18;35(3):473-488.e6. doi: 10.1016/j.ccell.2019.02.006.
• [525] Polymorphism in the CD5 gene promoter in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.Am J Clin Pathol. 2005 May;123(5):646-50.
• [526] Alemtuzumab in the treatment of chronic lymphocytic lymphoma.Expert Rev Anticancer Ther. 2008 Apr;8(4):525-33. doi: 10.1586/14737140.8.4.525.
• [527] Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors.Onco Targets Ther. 2019 Jun 18;12:4703-4712. doi: 10.2147/OTT.S195182. eCollection 2019.
• [528] Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.Oncotarget. 2016 Nov 26;8(32):52225-52236. doi: 10.18632/oncotarget.13660. eCollection 2017 Aug 8.
• [529] Molecular Mechanism of Anti-Cancer Activity of the Nano-Drug C-PC/CMC-CD59sp NPs in Cervical Cancer.J Cancer. 2019 Jan 1;10(1):92-104. doi: 10.7150/jca.27462. eCollection 2019.
• [530] Citrobacter rodentium Induces Tissue-Resident Memory CD4(+) T Cells.Infect Immun. 2019 Jun 20;87(7):e00295-19. doi: 10.1128/IAI.00295-19. Print 2019 Jul.
• [531] Promoter polymorphisms in TGFB1 and IL10 genes influence tumor dendritic cells infiltration, development and prognosis of colorectal cancer.J Gene Med. 2018 Feb;20(2-3):e3005. doi: 10.1002/jgm.3005. Epub 2018 Mar 5.
• [532] Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.Leukemia. 2018 Sep;32(9):1932-1947. doi: 10.1038/s41375-018-0062-8. Epub 2018 Feb 22.
• [533] The TLR3 Agonist Inhibit Drug Efflux and Sequentially Consolidates Low-Dose Cisplatin-Based Chemoimmunotherapy while Reducing Side Effects.Mol Cancer Ther. 2017 Jun;16(6):1068-1079. doi: 10.1158/1535-7163.MCT-16-0454. Epub 2017 Jan 30.
• [534] CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells.Cancer Cell Int. 2018 Jul 9;18:96. doi: 10.1186/s12935-018-0587-y. eCollection 2018.
• [535] D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo.Peptides. 2018 Mar;101:17-24. doi: 10.1016/j.peptides.2017.12.016. Epub 2017 Dec 19.
• [536] CDC25B and CDC25C overexpression in nonmelanoma skin cancer suppresses cell death.Mol Carcinog. 2019 Sep;58(9):1691-1700. doi: 10.1002/mc.23075. Epub 2019 Jun 24.
• [537] Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression.Sci Rep. 2019 Feb 4;9(1):1335. doi: 10.1038/s41598-019-38579-7.
• [538] Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.Oncogene. 2003 Dec 11;22(57):9165-75. doi: 10.1038/sj.onc.1207179.
• [539] Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer.Cancer Res. 2018 Apr 15;78(8):2096-2114. doi: 10.1158/0008-5472.CAN-17-2870. Epub 2018 Jan 30.
• [540] Overexpression of CDC7 in malignant salivary gland tumors correlates with tumor differentiation.Braz J Otorhinolaryngol. 2019 Mar-Apr;85(2):144-149. doi: 10.1016/j.bjorl.2017.11.004. Epub 2017 Dec 26.
• [541] Tumor endothelial cell-derived cadherin-2 promotes angiogenesis and has prognostic significance for lung adenocarcinoma.Mol Cancer. 2019 Mar 4;18(1):34. doi: 10.1186/s12943-019-0987-1.
• [542] KLF4-Mediated CDH3 Upregulation Suppresses Human Hepatoma Cell Growth and Migration via GSK-3 Signaling.Int J Biol Sci. 2019 Mar 10;15(5):953-961. doi: 10.7150/ijbs.30857. eCollection 2019.
• [543] A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells.Biomacromolecules. 2018 Jul 9;19(7):2957-2968. doi: 10.1021/acs.biomac.8b00511. Epub 2018 Apr 16.
• [544] CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.Cell Physiol Biochem. 2018;47(6):2602-2612. doi: 10.1159/000491656. Epub 2018 Jul 11.
• [545] Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3/cyclinD1 signaling pathway.Oncol Rep. 2019 May;41(5):2739-2752. doi: 10.3892/or.2019.7042. Epub 2019 Mar 5.
• [546] Whole lesion histogram analysis of meningiomas derived from ADC values. Correlation with several cellularity parameters, proliferation index KI 67, nucleic content, and membrane permeability.Magn Reson Imaging. 2018 Sep;51:158-162. doi: 10.1016/j.mri.2018.05.009. Epub 2018 May 18.
• [547] Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.J Cell Mol Med. 2020 Jan;24(1):1087-1098. doi: 10.1111/jcmm.14841. Epub 2019 Nov 21.
• [548] A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.Cancer Genet. 2019 Nov;239:54-61. doi: 10.1016/j.cancergen.2019.09.005. Epub 2019 Sep 18.
• [549] Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms.Ann Surg Oncol. 2018 Oct;25(11):3358-3364. doi: 10.1245/s10434-018-6675-3. Epub 2018 Jul 27.
• [550] Proliferation of aneuploid cells induced by CENP-E depletion is counteracted by the p14(ARF) tumor suppressor.Mol Genet Genomics. 2019 Feb;294(1):149-158. doi: 10.1007/s00438-018-1495-5. Epub 2018 Sep 27.
• [551] Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs.J Med Chem. 2019 Apr 11;62(7):3524-3538. doi: 10.1021/acs.jmedchem.8b02009. Epub 2019 Mar 29.
• [552] In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis.Toxicol Appl Pharmacol. 2017 Jul 15;327:1-12. doi: 10.1016/j.taap.2017.04.022. Epub 2017 Apr 22.
• [553] Molecular Docking and Molecular Dynamics (MD) Simulation of Human Anti-Complement Factor H (CFH) Antibody Ab42 and CFH Polypeptide.Int J Mol Sci. 2019 May 25;20(10):2568. doi: 10.3390/ijms20102568.
• [554] Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3127-3132.
• [555] FLIP as a therapeutic target in cancer.FEBS J. 2018 Nov;285(22):4104-4123. doi: 10.1111/febs.14523. Epub 2018 Jun 27.
• [556] Role of ion channels in gastrointestinal cancer.World J Gastroenterol. 2019 Oct 14;25(38):5732-5772. doi: 10.3748/wjg.v25.i38.5732.
• [557] Significance of human chorionic gonadotropin as a predictor of resistance to standard chemo-radiotherapy for pure germinoma.Neurosurg Rev. 2018 Apr;41(2):557-565. doi: 10.1007/s10143-017-0891-3. Epub 2017 Aug 18.
• [558] Oncogenic role of rab escort protein 1 through EGFR and STAT3 pathway.Cell Death Dis. 2017 Feb 23;8(2):e2621. doi: 10.1038/cddis.2017.50.
• [559] Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia.Mol Cancer. 2014 Apr 3;13:77. doi: 10.1186/1476-4598-13-77.
• [560] Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma.Hum Vaccin Immunother. 2020 Mar 3;16(3):636-644. doi: 10.1080/21645515.2019.1665960. Epub 2019 Oct 21.
• [561] Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.Oncotarget. 2016 Jan 5;7(1):459-72. doi: 10.18632/oncotarget.6314.
• [562] Anti-tumoral activity of the human-specific duplicated form of 7-nicotinic receptor subunit in tobacco-induced lung cancer progression.Lung Cancer. 2019 Feb;128:134-144. doi: 10.1016/j.lungcan.2018.12.029. Epub 2018 Dec 28.
• [563] Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer.PLoS One. 2018 Dec 13;13(12):e0208982. doi: 10.1371/journal.pone.0208982. eCollection 2018.
• [564] IKK Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization.Comput Struct Biotechnol J. 2019 Feb 7;17:251-262. doi: 10.1016/j.csbj.2019.02.003. eCollection 2019.
• [565] Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma.Blood Adv. 2019 Apr 9;3(7):995-1002. doi: 10.1182/bloodadvances.2018028456.
• [566] High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy.Int J Med Sci. 2018 Jul 30;15(11):1171-1178. doi: 10.7150/ijms.26685. eCollection 2018.
• [567] Overexpression of chloride channel-3 (ClC-3) is associated with human cervical carcinoma development and prognosis.Cancer Cell Int. 2019 Jan 8;19:8. doi: 10.1186/s12935-018-0721-x. eCollection 2019.
• [568] Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults.Cancer Sci. 2019 Apr;110(4):1352-1363. doi: 10.1111/cas.13967.
• [569] Estrogen receptor inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.J Exp Clin Cancer Res. 2019 Aug 14;38(1):354. doi: 10.1186/s13046-019-1359-9.
• [570] CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia. Blood Adv. 2018 Jul 24;2(14):1738-1749.
• [571] Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection.Cancer Immunol Immunother. 2019 Aug;68(8):1223-1233. doi: 10.1007/s00262-019-02355-3. Epub 2019 Jun 14.
• [572] Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity.Front Oncol. 2019 Mar 13;9:135. doi: 10.3389/fonc.2019.00135. eCollection 2019.
• [573] Overexpression of CLN3 contributes to tumour progression and predicts poor prognosis in hepatocellular carcinoma.Surg Oncol. 2019 Mar;28:180-189. doi: 10.1016/j.suronc.2018.12.003. Epub 2018 Dec 20.
• [574] Monocarboxylate transporters in cancer.Mol Metab. 2020 Mar;33:48-66. doi: 10.1016/j.molmet.2019.07.006. Epub 2019 Jul 27.
• [575] CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.Theranostics. 2019 Sep 19;9(22):6719-6733. doi: 10.7150/thno.34857. eCollection 2019.
• [576] Impact of systemic inflammation on gastric cancer outcomes.PLoS One. 2017 Mar 30;12(3):e0174085. doi: 10.1371/journal.pone.0174085. eCollection 2017.
• [577] The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?.Front Pharmacol. 2019 Apr 5;10:339. doi: 10.3389/fphar.2019.00339. eCollection 2019.
• [578] WIN55,212-2 induces caspase-independent apoptosis on human glioblastoma cells by regulating HSP70, p53 and Cathepsin D. Toxicol In Vitro. 2019 Jun;57:233-243. doi: 10.1016/j.tiv.2019.02.009. Epub 2019 Feb 15.
• [579] Expression of the IL-6 family cytokines in human brain tumors.Int J Oncol. 2001 Sep;19(3):495-9. doi: 10.3892/ijo.19.3.495.
• [580] Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma.World J Urol. 2019 Nov;37(11):2297-2302. doi: 10.1007/s00345-019-02682-1. Epub 2019 Feb 28.
• [581] CoA Synthase (COASY) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer.Cancer Res. 2020 Jan 15;80(2):334-346. doi: 10.1158/0008-5472.CAN-19-1161. Epub 2019 Nov 8.
• [582] COL6A3-derived endotrophin links reciprocal interactions among hepatic cells in the pathology of chronic liver disease.J Pathol. 2019 Jan;247(1):99-109. doi: 10.1002/path.5172. Epub 2018 Nov 27.
• [583] Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients.DNA Cell Biol. 2012 Aug;31(8):1412-7. doi: 10.1089/dna.2012.1672. Epub 2012 May 11.
• [584] Prognostic factors of facial nerve function after vestibular schwannoma removal via translabyrinthine approach.Acta Otolaryngol. 2019 Jun;139(6):541-546. doi: 10.1080/00016489.2019.1592223. Epub 2019 Apr 16.
• [585] IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.Curr Probl Cancer. 2018 Mar-Apr;42(2):215-230. doi: 10.1016/j.currproblcancer.2018.01.009. Epub 2018 Jan 10.
• [586] Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study.Gene. 2019 Mar 10;688:107-118. doi: 10.1016/j.gene.2018.11.082. Epub 2018 Dec 5.
• [587] CaT1 expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun. 2001 Apr 6;282(3):729-34.
• [588] Molecular biology of human T cell leukemia virus.Semin Diagn Pathol. 2020 Mar;37(2):104-109. doi: 10.1053/j.semdp.2019.04.003. Epub 2019 Apr 16.
• [589] Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-1 signaling pathways.Acta Pharmacol Sin. 2020 Jan;41(1):82-92. doi: 10.1038/s41401-019-0271-3. Epub 2019 Aug 1.
• [590] Ectopic Corticotropin-Releasing Hormone-Secreting Pancreatic Neuroendocrine Tumor: Excellent Response of Liver Metastases to Peptide Receptor Radionuclide Therapy as Demonstrated by 68Ga-DOTATOC and 18F-FDG PET/CT Imaging.Clin Nucl Med. 2020 Feb;45(2):e125-e127. doi: 10.1097/RLU.0000000000002834.
• [591] Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma.Oncol Lett. 2018 Sep;16(3):3681-3689. doi: 10.3892/ol.2018.9073. Epub 2018 Jul 4.
• [592] Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes.Oncotarget. 2017 Jul 18;8(29):46891-46899. doi: 10.18632/oncotarget.16781.
• [593] CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.Int J Cancer. 2018 Jan 15;142(2):334-346. doi: 10.1002/ijc.31064. Epub 2017 Oct 12.
• [594] MR Imaging of the Extracranial Facial Nerve with the CISS Sequence.AJNR Am J Neuroradiol. 2019 Nov;40(11):1954-1959. doi: 10.3174/ajnr.A6261. Epub 2019 Oct 17.
• [595] The expression of clock genes cry1 and cry2 in human colorectal cancer and tumor adjacent tissues correlates differently dependent on tumor location.Neoplasma. 2018 Nov 15;65(6):986-992. doi: 10.4149/neo_2018_180122N47. Epub 2018 Jun 18.
• [596] Expression of CRYAB with the angiogenesis and poor prognosis for human gastric cancer.Medicine (Baltimore). 2019 Nov;98(45):e17799. doi: 10.1097/MD.0000000000017799.
• [597] Tumor-Specific Expansion of Oxidative Stress by Glutathione Depletion and Use of a Fenton Nanoagent for Enhanced Chemodynamic Therapy.ACS Appl Mater Interfaces. 2019 Aug 28;11(34):30551-30565. doi: 10.1021/acsami.9b09323. Epub 2019 Aug 14.
• [598] Citrate synthase expression affects tumor phenotype and drug resistance in human ovarian carcinoma.PLoS One. 2014 Dec 29;9(12):e115708. doi: 10.1371/journal.pone.0115708. eCollection 2014.
• [599] Lentivirus-mediated down-regulation of CK2 inhibits proliferation and induces apoptosis of malignant lymphoma and leukemia cells.Biochem Cell Biol. 2018 Dec;96(6):786-796. doi: 10.1139/bcb-2017-0345. Epub 2018 May 17.
• [600] Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells.Adv Mater. 2019 Jun;31(23):e1900192. doi: 10.1002/adma.201900192. Epub 2019 Mar 27.
• [601] Targeting CTCFL/BORIS for the immunotherapy of cancer. Cancer Immunol Immunother. 2018 Dec;67(12):1955-1965.
• [602] Dysregulation of cystathionine -lyase promotes prostate cancer progression and metastasis.EMBO Rep. 2019 Oct 4;20(10):e45986. doi: 10.15252/embr.201845986. Epub 2019 Aug 29.
• [603] pH-Driven Targeting Nanoprobe with Dual-Responsive Drug Release for Persistent Luminescence Imaging and Chemotherapy of Tumor.Anal Chem. 2020 Jan 7;92(1):1179-1188. doi: 10.1021/acs.analchem.9b04318. Epub 2019 Dec 24.
• [604] Cathepsin F Knockdown Induces Proliferation and Inhibits Apoptosis in Gastric Cancer Cells.Oncol Res. 2018 Jan 19;26(1):83-93. doi: 10.3727/096504017X14928634401204. Epub 2017 Apr 25.
• [605] Neutrophil Cathepsin G and Tumor Cell RAGE Facilitate Neutrophil Anti-Tumor Cytotoxicity.Oncoimmunology. 2019 Jun 11;8(9):e1624129. doi: 10.1080/2162402X.2019.1624129. eCollection 2019.
• [606] The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.JAMA Oncol. 2017 Feb 1;3(2):244-255. doi: 10.1001/jamaoncol.2016.1790.
• [607] Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC.J Exp Clin Cancer Res. 2019 Feb 7;38(1):61. doi: 10.1186/s13046-019-1054-x.
• [608] Regulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation.Cell Death Differ. 2019 May;26(5):812-825. doi: 10.1038/s41418-018-0153-0. Epub 2018 Jul 13.
• [609] Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes.Cancer Invest. 2012 Jun;30(5):398-403. doi: 10.3109/07357907.2012.672608. Epub 2012 Mar 27.
• [610] Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.BMC Cancer. 2018 Jan 6;18(1):46. doi: 10.1186/s12885-017-3907-z.
• [611] Cullin7 promotes epithelialmesenchymal transition of esophageal carcinoma via the ERKSNAI2 signaling pathway.Mol Med Rep. 2018 Apr;17(4):5362-5367. doi: 10.3892/mmr.2018.8503. Epub 2018 Jan 26.
• [612] Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics.Int J Cancer. 2020 May 15;146(10):2784-2796. doi: 10.1002/ijc.32637. Epub 2019 Sep 5.
• [613] Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti-PD-1 inhibitor.Int J Cancer. 2019 Mar 1;144(5):1170-1179. doi: 10.1002/ijc.31923. Epub 2018 Nov 12.
• [614] PGC-1 activator-induced fatty acid oxidation in tumor-infiltrating CTLs enhances effects of PD-1 blockade therapy in lung cancer.Tumori. 2020 Feb;106(1):55-63. doi: 10.1177/0300891619868287. Epub 2019 Aug 27.
• [615] The evaluation of the distribution of CD133, CXCR1 and the tumor associated macrophages in different molecular subtypes of breast cancer.Histol Histopathol. 2020 Jan;35(1):83-96. doi: 10.14670/HH-18-139. Epub 2019 Jun 28.
• [616] CXCL13/CXCR5 signaling axis in cancer.Life Sci. 2019 Jun 15;227:175-186. doi: 10.1016/j.lfs.2019.04.053. Epub 2019 Apr 23.
• [617] CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4(+) T-Cell-Dependent Control of Senescence.Gastroenterology. 2019 May;156(6):1877-1889.e4. doi: 10.1053/j.gastro.2019.01.247. Epub 2019 Jan 30.
• [618] CXXC5 suppresses hepatocellular carcinoma by promoting TGF--induced cell cycle arrest and apoptosis. J Mol Cell Biol. 2018 Feb 1;10(1):48-59.
• [619] Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.Endocrine. 2017 Dec;58(3):503-512. doi: 10.1007/s12020-017-1295-4. Epub 2017 Apr 12.
• [620] Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.Hypertension. 2019 Apr;73(4):885-892. doi: 10.1161/HYPERTENSIONAHA.118.12070.
• [621] Prevalence and Clinical Outcome of CYP21A2 Gene Mutations in Patients with Nonfunctional Adrenal Incidentalomas.Horm Metab Res. 2015 Aug;47(9):662-7. doi: 10.1055/s-0035-1549911. Epub 2015 May 13.
• [622] Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma.J Thorac Oncol. 2017 Feb;12(2):269-280. doi: 10.1016/j.jtho.2016.10.010. Epub 2016 Oct 26.
• [623] Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice.Cancer Immunol Res. 2016 Nov;4(11):917-926. doi: 10.1158/2326-6066.CIR-15-0038. Epub 2016 Sep 16.
• [624] Downregulation of CYP2A6 and CYP2C8 in Tumor Tissues Is Linked to Worse Overall Survival and Recurrence-Free Survival from Hepatocellular Carcinoma.Biomed Res Int. 2018 Jul 25;2018:5859415. doi: 10.1155/2018/5859415. eCollection 2018.
• [625] The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.Cancer Med. 2018 Apr;7(4):966-980. doi: 10.1002/cam4.1299. Epub 2018 Feb 26.
• [626] Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.Phytomedicine. 2018 Jan 15;39:137-145. doi: 10.1016/j.phymed.2017.12.026. Epub 2017 Dec 26.
• [627] Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A-mediated drug hepatotoxicity.Br J Pharmacol. 2020 Apr;177(7):1538-1555. doi: 10.1111/bph.14916. Epub 2020 Jan 29.
• [628] Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer.Oncol Lett. 2019 Apr;17(4):3890-3898. doi: 10.3892/ol.2019.10043. Epub 2019 Feb 14.
• [629] Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma.EMBO Mol Med. 2020 Jan 9;12(1):e10924. doi: 10.15252/emmm.201910924. Epub 2019 Nov 28.
• [630] Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients.Int J Cancer. 2011 Jul 1;129(1):9-22. doi: 10.1002/ijc.25648. Epub 2010 Nov 9.
• [631] CYSLTR2-mutant Cutaneous Melanocytic Neoplasms Frequently Simulate "Pigmented Epithelioid Melanocytoma," Expanding the Morphologic Spectrum of Blue Tumors: A Clinicopathologic Study of 7 Cases.Am J Surg Pathol. 2019 Oct;43(10):1368-1376. doi: 10.1097/PAS.0000000000001299.
• [632] Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.Sci Rep. 2013 Sep 30;3:2792. doi: 10.1038/srep02792.
• [633] D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.Cancer Gene Ther. 2012 Jan;19(1):1-18. doi: 10.1038/cgt.2011.59. Epub 2011 Sep 16.
• [634] Preclinical Pharmacokinetics and Dosimetry Studies of (124)I/(131)I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models.J Nucl Med. 2019 Oct;60(10):1414-1420. doi: 10.2967/jnumed.118.225409. Epub 2019 Mar 29.
• [635] Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients.Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1052-1062. doi: 10.1016/j.ijrobp.2018.04.064. Epub 2018 May 4.
• [636] VHL Dependent Expression of REDD1 and PDK3 Proteins in Clear-cell Renal Cell Carcinoma.J Med Biochem. 2018 Jan 1;37(1):31-38. doi: 10.1515/jomb-2017-0030. eCollection 2018 Jan.
• [637] Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.J Virol. 2020 Jan 31;94(4):e01812-19. doi: 10.1128/JVI.01812-19. Print 2020 Jan 31.
• [638] Recombinant Oncolytic Vaccinia Viruses Expressing Human -Defensin 2 Enhance Anti-tumor Immunity.Mol Ther Oncolytics. 2019 Apr 4;13:49-57. doi: 10.1016/j.omto.2019.03.010. eCollection 2019 Jun 28.
• [639] High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer.Front Oncol. 2019 Apr 12;9:262. doi: 10.3389/fonc.2019.00262. eCollection 2019.
• [640] DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals.Oncogene. 2020 Feb;39(7):1557-1571. doi: 10.1038/s41388-019-1085-y. Epub 2019 Nov 4.
• [641] DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.Onco Targets Ther. 2017 Sep 14;10:4579-4589. doi: 10.2147/OTT.S142979. eCollection 2017.
• [642] Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.BMC Cancer. 2018 Apr 13;18(1):418. doi: 10.1186/s12885-018-4333-6.
• [643] DGAT1 Inhibitor Suppresses Prostate Tumor Growth and Migration by Regulating Intracellular Lipids and Non-Centrosomal MTOC Protein GM130.Sci Rep. 2019 Feb 28;9(1):3035. doi: 10.1038/s41598-019-39537-z.
• [644] DGK Plays Crucial Roles in the Proliferation and Tumorigenicity of Human glioblastoma.Int J Biol Sci. 2019 Jul 20;15(9):1872-1881. doi: 10.7150/ijbs.35193. eCollection 2019.
• [645] Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reporting.J Med Imaging Radiat Oncol. 2019 Aug;63(4):487-494. doi: 10.1111/1754-9485.12878. Epub 2019 Apr 5.
• [646] DHFR/TYMS are positive regulators of glioma cell growth and modulate chemo-sensitivity to temozolomide.Eur J Pharmacol. 2019 Nov 15;863:172665. doi: 10.1016/j.ejphar.2019.172665. Epub 2019 Sep 19.
• [647] Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells.Cell Metab. 2019 Feb 5;29(2):399-416.e10. doi: 10.1016/j.cmet.2018.10.014. Epub 2018 Nov 15.
• [648] Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer.Theranostics. 2019 Jul 9;9(17):4909-4922. doi: 10.7150/thno.33758. eCollection 2019.
• [649] DICER1-Related Embryonal Rhabdomyosarcoma of the Uterine Corpus in a Prepubertal Girl.J Pediatr Adolesc Gynecol. 2020 Apr;33(2):173-176. doi: 10.1016/j.jpag.2019.12.002. Epub 2019 Dec 12.
• [650] Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease.J Endocrinol. 2011 Jun;209(3):283-97. doi: 10.1530/JOE-10-0481. Epub 2011 Mar 17.
• [651] Dickkopf-1 (DKK1) promotes tumor growth via Akt-phosphorylation and independently of Wnt-axis in Barrett's associated esophageal adenocarcinoma.Am J Cancer Res. 2019 Feb 1;9(2):330-346. eCollection 2019.
• [652] Comprehensive Analysis of the Canonical and Non-canonical Wnt Signaling Pathways in Gastric Cancer.Dig Dis Sci. 2019 Oct;64(10):2830-2842. doi: 10.1007/s10620-019-05606-6. Epub 2019 Apr 17.
• [653] DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.Int J Oncol. 2019 Mar;54(3):1021-1032. doi: 10.3892/ijo.2018.4667. Epub 2018 Dec 14.
• [654] Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor Tcell immunity.J Immunother Cancer. 2019 Apr 2;7(1):95. doi: 10.1186/s40425-019-0566-4.
• [655] DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail.Cancer Sci. 2019 May;110(5):1599-1608. doi: 10.1111/cas.13997. Epub 2019 Apr 13.
• [656] Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma.Nat Commun. 2018 Dec 21;9(1):5410. doi: 10.1038/s41467-018-07578-z.
• [657] Dual-Therapeutics-Loaded Mesoporous Silica Nanoparticles Applied for Breast Tumor Therapy.ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46497-46503. doi: 10.1021/acsami.9b16270. Epub 2019 Dec 3.
• [658] DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.Mod Pathol. 2020 Apr;33(4):648-656. doi: 10.1038/s41379-019-0398-2. Epub 2019 Nov 1.
• [659] Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors.J Immunol Res. 2019 Feb 11;2019:6705949. doi: 10.1155/2019/6705949. eCollection 2019.
• [660] Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.Cancer Res. 2019 Sep 15;79(18):4689-4702. doi: 10.1158/0008-5472.CAN-19-0492. Epub 2019 Jul 16.
• [661] Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer.Am J Transl Res. 2019 Feb 15;11(2):1145-1153. eCollection 2019.
• [662] Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer.Br J Cancer. 2013 Aug 6;109(3):694-703. doi: 10.1038/bjc.2013.363. Epub 2013 Jul 9.
• [663] N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1DR activation.Toxicol Appl Pharmacol. 2019 Dec 1;384:114789. doi: 10.1016/j.taap.2019.114789. Epub 2019 Oct 25.
• [664] Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary.Pituitary. 2019 Feb;22(1):70-78. doi: 10.1007/s11102-018-00935-7.
• [665] Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.FEBS Open Bio. 2019 Feb 21;9(4):693-706. doi: 10.1002/2211-5463.12600. eCollection 2019 Apr.
• [666] Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells.Onco Targets Ther. 2018 Mar 21;11:1601-1616. doi: 10.2147/OTT.S147453. eCollection 2018.
• [667] Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.Clin Cancer Res. 2019 Jul 1;25(13):4117-4127. doi: 10.1158/1078-0432.CCR-18-3224. Epub 2019 Apr 1.
• [668] DUSP3/VHR: A Druggable Dual Phosphatase for Human Diseases.Rev Physiol Biochem Pharmacol. 2019;176:1-35. doi: 10.1007/112_2018_12.
• [669] Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.Cancer Med. 2018 Feb;7(2):420-432. doi: 10.1002/cam4.1284. Epub 2018 Jan 17.
• [670] MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway.Cancer Cell Int. 2019 Mar 18;19:61. doi: 10.1186/s12935-019-0776-3. eCollection 2019.
• [671] The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.Sci Rep. 2019 Apr 25;9(1):6539. doi: 10.1038/s41598-019-42990-5.
• [672] Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.Hum Pathol. 2017 Aug;66:48-58. doi: 10.1016/j.humpath.2017.02.033. Epub 2017 May 26.
• [673] miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.Breast Cancer. 2020 Jan;27(1):147-158. doi: 10.1007/s12282-019-01002-0. Epub 2019 Aug 13.
• [674] miR?10?p regulates cell growth and affects cisplatin sensitivity in human ovarian cancer cells via targeting E2F3.Mol Med Rep. 2019 Jun;19(6):4946-4954. doi: 10.3892/mmr.2019.10129. Epub 2019 Apr 4.
• [675] Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.Breast Cancer Res. 2009;11(3):R34. doi: 10.1186/bcr2319. Epub 2009 Jun 15.
• [676] Standardization of volumetric modulated arc therapy-based frameless stereotactic technique using a multidimensional ensemble-aided knowledge-based planning.Med Phys. 2019 May;46(5):1953-1962. doi: 10.1002/mp.13470. Epub 2019 Apr 8.
• [677] Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.BMC Cancer. 2019 Jul 2;19(1):649. doi: 10.1186/s12885-019-5873-0.
• [678] EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.Oncogene. 2019 Mar;38(12):2123-2134. doi: 10.1038/s41388-018-0565-9. Epub 2018 Nov 19.
• [679] EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/-catenin signaling.J Cell Biochem. 2018 Dec;119(12):10327-10337. doi: 10.1002/jcb.27375. Epub 2018 Aug 20.
• [680] PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-B activity.Life Sci. 2020 Feb 1;242:117167. doi: 10.1016/j.lfs.2019.117167. Epub 2019 Dec 12.
• [681] Identification, Characterization, and Regulatory Mechanisms of a Novel EGR1 Splicing Isoform.Int J Mol Sci. 2019 Mar 28;20(7):1548. doi: 10.3390/ijms20071548.
• [682] Critical review of renal tubule karyomegaly in non-clinical safety evaluation studies and its significance for human risk assessment.Crit Rev Toxicol. 2018 Aug;48(7):575-595. doi: 10.1080/10408444.2018.1503641. Epub 2018 Oct 2.
• [683] HSF2 regulates aerobic glycolysis by suppression of FBP1 in hepatocellular carcinoma.Am J Cancer Res. 2019 Aug 1;9(8):1607-1621. eCollection 2019.
• [684] 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.Cancer Res. 2019 Apr 1;79(7):1438-1450. doi: 10.1158/0008-5472.CAN-18-1220. Epub 2019 Mar 20.
• [685] The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.Mol Cancer Res. 2018 Apr;16(4):682-695. doi: 10.1158/1541-7786.MCR-17-0696. Epub 2018 Feb 16.
• [686] Eukaryotic translation initiation factor 5A2 is highly expressed in prostate cancer and predicts poor prognosis.Exp Ther Med. 2019 May;17(5):3741-3747. doi: 10.3892/etm.2019.7331. Epub 2019 Mar 1.
• [687] A cationic polymeric prodrug with chemotherapeutic self-sensibilization co-delivering MMP-9 shRNA plasmid for a combined therapy to nasopharyngeal carcinoma.Drug Deliv. 2019 Dec;26(1):1280-1291. doi: 10.1080/10717544.2019.1698674.
• [688] PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3).Endocr Relat Cancer. 2020 Mar;27(3):R67-R77. doi: 10.1530/ERC-19-0400.
• [689] The significance of ENAH in carcinogenesis and prognosis in gastric cancer.Oncotarget. 2017 Aug 2;8(42):72466-72479. doi: 10.18632/oncotarget.19801. eCollection 2017 Sep 22.
• [690] Proteomics Based Identification of Autotaxin As An Anti-Hepatitis B Virus Factor and a Promoter of Hepatoma Cell Invasion and Migration.Cell Physiol Biochem. 2018;45(2):744-760. doi: 10.1159/000487166. Epub 2018 Feb 1.
• [691] The Oncogenic Functions of MASTL Kinase.Front Cell Dev Biol. 2018 Nov 23;6:162. doi: 10.3389/fcell.2018.00162. eCollection 2018.
• [692] Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation.Cell Rep. 2019 Apr 2;27(1):269-281.e4. doi: 10.1016/j.celrep.2019.03.008.
• [693] EphA3 inhibits migration and invasion of esophageal cancer cells by activating the mesenchymalepithelial transition process.Int J Oncol. 2019 Feb;54(2):722-732. doi: 10.3892/ijo.2018.4639. Epub 2018 Nov 21.
• [694] EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties.FASEB J. 2019 Apr;33(4):4851-4865. doi: 10.1096/fj.201701561RRRR. Epub 2019 Jan 8.
• [695] Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.Cancer Sci. 2019 Nov;110(11):3486-3496. doi: 10.1111/cas.14187. Epub 2019 Sep 20.
• [696] EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.Med Sci Monit. 2018 Oct 9;24:7213-7222. doi: 10.12659/MSM.910909.
• [697] ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.Nature. 2017 Jun 29;546(7660):671-675. doi: 10.1038/nature22820. Epub 2017 Jun 14.
• [698] Expression of inositol-requiring enzyme 1 is downregulated in azoxymethane/dextran sulfate sodium-induced mouse colonic tumors.Exp Ther Med. 2019 Apr;17(4):3181-3188. doi: 10.3892/etm.2019.7317. Epub 2019 Feb 26.
• [699] The enhanced expression of estrogen-related receptor in human bladder cancer tissues and the effects of estrogen-related receptor knockdown on bladder cancer cells.J Cell Biochem. 2019 Aug;120(8):13841-13852. doi: 10.1002/jcb.28657. Epub 2019 Apr 11.
• [700] Estrogen receptor dependent regulation of estrogen related receptor and its role in cell cycle in breast cancer.BMC Cancer. 2018 May 30;18(1):607. doi: 10.1186/s12885-018-4528-x.
• [701] ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma.J Clin Lab Anal. 2019 Jul;33(6):e22899. doi: 10.1002/jcla.22899. Epub 2019 Apr 19.
• [702] Differential expression of Ets-1 in breast cancer among North Indian population.J Cell Biochem. 2019 Sep;120(9):14552-14561. doi: 10.1002/jcb.28716. Epub 2019 Apr 23.
• [703] Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2.Nucleic Acids Res. 2017 May 5;45(8):4452-4462. doi: 10.1093/nar/gkx039.
• [704] Audiologic Natural History of Small Volume Cochleovestibular Schwannomas in Neurofibromatosis Type 2.Otol Neurotol. 2018 Mar;39(3):357-364. doi: 10.1097/MAO.0000000000001690.
• [705] Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 / pathways.Mol Carcinog. 2019 Jul;58(7):1181-1193. doi: 10.1002/mc.23001. Epub 2019 Mar 4.
• [706] The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.PLoS One. 2018 Feb 26;13(2):e0193477. doi: 10.1371/journal.pone.0193477. eCollection 2018.
• [707] RNA Sequencing revealed differentially expressed genes functionally associated with immunity and tumor suppression during latent phase infection of a vv?MDV in chickens.Sci Rep. 2019 Oct 2;9(1):14182. doi: 10.1038/s41598-019-50561-x.
• [708] Is disease progression a contraindication for the strategy of portal vein embolization followed by hepatectomy for hepatocellular carcinoma?.Surgery. 2019 Apr;165(4):696-702. doi: 10.1016/j.surg.2018.10.023. Epub 2018 Nov 19.
• [709] Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma.Cancers (Basel). 2019 Dec 11;11(12):1992. doi: 10.3390/cancers11121992.
• [710] Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma.Hum Pathol. 2017 Apr;62:134-140. doi: 10.1016/j.humpath.2017.01.009. Epub 2017 Feb 8.
• [711] A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.J Cancer Res Clin Oncol. 2013 Jun;139(6):1015-23. doi: 10.1007/s00432-013-1417-1. Epub 2013 Mar 15.
• [712] Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer.Clin Chim Acta. 2017 Jan;464:148-154. doi: 10.1016/j.cca.2016.11.032. Epub 2016 Nov 21.
• [713] Delta-6-desaturase inhibitor enhances radiation therapy in glioblastoma in vitro and in vivo.Cancer Manag Res. 2018 Dec 7;10:6779-6790. doi: 10.2147/CMAR.S185601. eCollection 2018.
• [714] Sanguinarine exhibits antitumor activity via up-regulation of Fas-associated factor 1 in non-small cell lung cancer.J Biochem Mol Toxicol. 2017 Aug;31(8). doi: 10.1002/jbt.21914. Epub 2017 Mar 14.
• [715] LDLR-mediated lipidome-transcriptome reprogramming in cisplatin insensitivity.Endocr Relat Cancer. 2020 Feb;27(2):81-95. doi: 10.1530/ERC-19-0095.
• [716] Molecular features of pleomorphic xanthoastrocytoma.Hum Pathol. 2019 Apr;86:38-48. doi: 10.1016/j.humpath.2018.08.038. Epub 2018 Nov 26.
• [717] Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.BMC Cancer. 2019 Mar 29;19(1):284. doi: 10.1186/s12885-019-5462-2.
• [718] Type I fatty acid synthase trapped in the octanoyl-bound state.Protein Sci. 2020 Feb;29(2):589-605. doi: 10.1002/pro.3797.
• [719] LINC01436, regulating miR-585 and FBXO11, is an oncogenic lncRNA in the progression of gastric cancer.Cell Biol Int. 2020 Mar;44(3):882-893. doi: 10.1002/cbin.11287. Epub 2020 Jan 8.
• [720] CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy.Oncoimmunology. 2017 Oct 12;7(1):e1380142. doi: 10.1080/2162402X.2017.1380142. eCollection 2017.
• [721] Tumor immunity and autoimmunity induced by immunization with homologous DNA.J Clin Invest. 1998 Sep 15;102(6):1258-64. doi: 10.1172/JCI4004.
• [722] Smoldering mantle cell lymphoma.J Exp Clin Cancer Res. 2017 Dec 15;36(1):185. doi: 10.1186/s13046-017-0652-8.
• [723] Contribution of Fc receptor IIB to creating a suppressive tumor microenvironment in a mouse model.Cancer Immunol Immunother. 2019 Nov;68(11):1769-1778. doi: 10.1007/s00262-019-02413-w. Epub 2019 Oct 15.
• [724] Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting.Molecules. 2019 Jan 29;24(3):478. doi: 10.3390/molecules24030478.
• [725] Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment.Front Immunol. 2018 Sep 28;9:2259. doi: 10.3389/fimmu.2018.02259. eCollection 2018.
• [726] Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.Photochem Photobiol. 2019 Jul;95(4):1052-1059. doi: 10.1111/php.13091. Epub 2019 Mar 15.
• [727] G protein-coupled receptor 40 expression in human melanoma - correlation with tumour thickness, AJCC stage and survival.J Eur Acad Dermatol Venereol. 2020 Feb;34(2):285-292. doi: 10.1111/jdv.15924. Epub 2019 Oct 31.
• [728] Oncoprotective Effects of Short-Chain Fatty Acids on Uterine Cervical Neoplasia.Nutr Cancer. 2019;71(2):312-319. doi: 10.1080/01635581.2019.1578388. Epub 2019 Mar 5.
• [729] Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades.Biochem Biophys Res Commun. 2019 May 21;513(1):1-7. doi: 10.1016/j.bbrc.2019.02.015. Epub 2019 Mar 31.
• [730] FGF21 Levels in Pheochromocytoma/Functional Paraganglioma.Cancers (Basel). 2019 Apr 5;11(4):485. doi: 10.3390/cancers11040485.
• [731] Krppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.Oncogene. 2009 Oct 22;28(42):3702-13. doi: 10.1038/onc.2009.235. Epub 2009 Aug 10.
• [732] FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation.Nat Commun. 2019 Jan 25;10(1):448. doi: 10.1038/s41467-018-08271-x.
• [733] Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cancer.Theranostics. 2019 Apr 13;9(9):2727-2738. doi: 10.7150/thno.31225. eCollection 2019.
• [734] Diet-induced unresolved ER stress hinders KRAS-driven lung tumorigenesis.Cell Metab. 2015 Jan 6;21(1):117-25. doi: 10.1016/j.cmet.2014.11.020. Epub 2014 Dec 18.
• [735] Bifunctional Elastin-like Polypeptide Nanoparticles Bind Rapamycin and Integrins and Suppress Tumor Growth in Vivo.Bioconjug Chem. 2017 Nov 15;28(11):2715-2728. doi: 10.1021/acs.bioconjchem.7b00469. Epub 2017 Oct 12.
• [736] TRAF2 and FKBP51 as possible markers for identification of suitable melanoma tumors for tumor necrosis factor- inhibition.Melanoma Res. 2019 Apr;29(2):145-150. doi: 10.1097/CMR.0000000000000553.
• [737] Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.Clin Cancer Res. 2019 Jan 15;25(2):710-723. doi: 10.1158/1078-0432.CCR-18-0704. Epub 2018 Oct 15.
• [738] An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis.J Vis Exp. 2019 Feb 8;(144). doi: 10.3791/58713.
• [739] Expression of activator protein-1 (AP-1) family members in breast cancer.BMC Cancer. 2013 Sep 28;13:441. doi: 10.1186/1471-2407-13-441.
• [740] C/EBP Regulates FOXC1 to Modulate Tumor Growth by Interacting with PPAR in Hepatocellular Carcinoma.Curr Cancer Drug Targets. 2020;20(1):59-66. doi: 10.2174/1568009619666190912161003.
• [741] The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):491-503. doi: 10.21873/cgp.20152.
• [742] The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.Mol Med Rep. 2016 Jul;14(1):254-62. doi: 10.3892/mmr.2016.5261. Epub 2016 May 12.
• [743] Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.J Clin Lab Anal. 2020 Jan;34(1):e23031. doi: 10.1002/jcla.23031. Epub 2019 Nov 12.
• [744] Expression profiles of Annexin A1, formylated peptide receptors and cyclooxigenase-2 in gastroesophageal inflammations and neoplasias.Pathol Res Pract. 2018 Feb;214(2):181-186. doi: 10.1016/j.prp.2017.12.003. Epub 2017 Dec 7.
• [745] Reversion of tumor hepatocytes to normal hepatocytes during liver tumor regression in an oncogene-expressing transgenic zebrafish model.Dis Model Mech. 2019 Oct 17;12(10):dmm039578. doi: 10.1242/dmm.039578.
• [746] The challenge of determining the impact of FUT3 tumor-associated polymorphism rs2306969 (-6951 C> T) in invasive breast cancer cells.Mol Biol Rep. 2019 Jun;46(3):3531-3536. doi: 10.1007/s11033-019-04780-0. Epub 2019 Mar 30.
• [747] Expression of bladder cancer-associated glycans in murine tumor cell lines.Oncol Lett. 2019 Mar;17(3):3141-3150. doi: 10.3892/ol.2019.9995. Epub 2019 Jan 31.
• [748] Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?.Lung Cancer. 2018 Feb;116:30-37. doi: 10.1016/j.lungcan.2017.12.009. Epub 2017 Dec 15.
• [749] Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation.J Exp Clin Cancer Res. 2019 Apr 12;38(1):160. doi: 10.1186/s13046-019-1164-5.
• [750] Modulating native GABA(A) receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death.J Neurooncol. 2019 May;142(3):411-422. doi: 10.1007/s11060-019-03115-0. Epub 2019 Feb 6.
• [751] GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner.Gut. 2019 Nov;68(11):1994-2006. doi: 10.1136/gutjnl-2018-317479. Epub 2019 Mar 2.
• [752] Clinical Heterogeneity in Patients with Glutamate Decarboxylase Antibody.Neuroimmunomodulation. 2019;26(5):234-238. doi: 10.1159/000502695. Epub 2019 Oct 29.
• [753] TFAP2C increases cell proliferation by downregulating GADD45B and PMAIP1 in non-small cell lung cancer cells.Biol Res. 2019 Jul 11;52(1):35. doi: 10.1186/s40659-019-0244-5.
• [754] Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.Cancer Biomark. 2018;22(3):417-426. doi: 10.3233/CBM-170995.
• [755] Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells.PLoS One. 2018 Feb 20;13(2):e0193275. doi: 10.1371/journal.pone.0193275. eCollection 2018.
• [756] Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.J Cell Mol Med. 2019 Dec;23(12):7974-7984. doi: 10.1111/jcmm.14460. Epub 2019 Sep 30.
• [757] Diagnostic and prognostic value of the detection of hTERT mRNA in renal tumors.Urol Oncol. 2019 Oct;37(10):749-757. doi: 10.1016/j.urolonc.2019.03.011. Epub 2019 Apr 8.
• [758] Stromal Gas6 promotes the progression of premalignant mammary cells.Oncogene. 2019 Apr;38(14):2437-2450. doi: 10.1038/s41388-018-0593-5. Epub 2018 Dec 7.
• [759] Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways.Hum Cell. 2020 Jan;33(1):175-184. doi: 10.1007/s13577-019-00284-y. Epub 2019 Nov 28.
• [760] Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.Neuro Oncol. 2018 Jul 5;20(8):1055-1067. doi: 10.1093/neuonc/noy012.
• [761] Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity.PLoS One. 2014 May 6;9(5):e96466. doi: 10.1371/journal.pone.0096466. eCollection 2014.
• [762] Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors.J Clin Invest. 2014 Jul;124(7):3061-74. doi: 10.1172/JCI72399. Epub 2014 Jun 9.
• [763] Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.Gastroenterology. 2019 Oct;157(4):1067-1080.e9. doi: 10.1053/j.gastro.2019.06.023. Epub 2019 Jun 21.
• [764] The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma.J Cancer. 2019 Jan 29;10(4):957-967. doi: 10.7150/jca.26666. eCollection 2019.
• [765] -Glutamyl transferase 7 is a novel regulator of glioblastoma growth. BMC Cancer. 2015 Apr 7;15:225.
• [766] Growth hormone receptor promotes osteosarcoma cell growth and metastases.FEBS Open Bio. 2020 Jan;10(1):127-134. doi: 10.1002/2211-5463.12761. Epub 2019 Dec 18.
• [767] Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15879-84. doi: 10.1073/pnas.0907843106. Epub 2009 Aug 27.
• [768] Characterization of (111)In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors.Sci Rep. 2018 Feb 13;8(1):2948. doi: 10.1038/s41598-018-21259-3.
• [769] Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors.Surgery. 2013 Dec;154(6):1206-13; discussion 1214. doi: 10.1016/j.surg.2013.04.052.
• [770] Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivo.Exp Eye Res. 2011 Apr;92(4):251-9. doi: 10.1016/j.exer.2011.02.003. Epub 2011 Feb 12.
• [771] Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma.J Exp Clin Cancer Res. 2019 Apr 4;38(1):145. doi: 10.1186/s13046-019-1142-y.
• [772] Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation.Oncogene. 2019 Feb;38(6):822-837. doi: 10.1038/s41388-018-0471-1. Epub 2018 Sep 3.
• [773] (11)C-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma.Cancers (Basel). 2019 Jun 19;11(6):847. doi: 10.3390/cancers11060847.
• [774] Quantitative validation of GJC1 promoter hypermethylation in benign and malignant colorectal tumors.Endocr Relat Cancer. 2011 Oct 27;18(6):C31-4. doi: 10.1530/ERC-11-0204. Print 2011 Oct.
• [775] Characterization of Senescence of Human Adipose-Derived Stem Cells After Long-Term Expansion.Adv Exp Med Biol. 2019;1084:109-128. doi: 10.1007/5584_2018_235.
• [776] FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/-catenin pathway.J Cell Physiol. 2019 Aug;234(10):17739-17748. doi: 10.1002/jcp.28399. Epub 2019 Feb 22.
• [777] [(68)Ga]Ga-NOTA-MAL-Cys(39)-exendin-4, a potential GLP-1R targeted PET tracer for the detection of insulinoma.Nucl Med Biol. 2019 Jul-Aug;74-75:19-24. doi: 10.1016/j.nucmedbio.2019.08.002. Epub 2019 Aug 16.
• [778] GLP-2 receptors in human disease: high expression in gastrointestinal stromal tumors and Crohn's disease.Mol Cell Endocrinol. 2012 Nov 25;364(1-2):46-53. doi: 10.1016/j.mce.2012.08.008. Epub 2012 Aug 19.
• [779] Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth.Oncogenesis. 2019 Feb 26;8(3):20. doi: 10.1038/s41389-019-0129-z.
• [780] GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.Gastroenterology. 2019 Jun;156(8):2297-2312. doi: 10.1053/j.gastro.2019.02.040. Epub 2019 Mar 2.
• [781] Synthesis and Evaluation of (18)F-Labeled Peptide for Gonadotropin-Releasing Hormone Receptor Imaging.Contrast Media Mol Imaging. 2019 Mar 7;2019:5635269. doi: 10.1155/2019/5635269. eCollection 2019.
• [782] 177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition.Endocr Relat Cancer. 2019 Apr 1;26(4):437-449. doi: 10.1530/ERC-18-0509. Epub 2019 Feb 1.
• [783] Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor.World J Gastroenterol. 2019 Nov 7;25(41):6248-6257. doi: 10.3748/wjg.v25.i41.6248.
• [784] Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in mice.Blood. 2019 Jun 20;133(25):2696-2706. doi: 10.1182/blood.2018877043. Epub 2019 Apr 5.
• [785] Smoking as an Independent Risk Factor for Hepatocellular Carcinoma Due to the 7-Nachr Modulating the JAK2/STAT3 Signaling Axis.J Clin Med. 2019 Sep 5;8(9):1391. doi: 10.3390/jcm8091391.
• [786] GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile.Cell Stem Cell. 2019 Aug 1;25(2):241-257.e8. doi: 10.1016/j.stem.2019.06.004. Epub 2019 Jul 11.
• [787] GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency.Horm Metab Res. 2016 Jun;48(6):389-93. doi: 10.1055/s-0042-100733. Epub 2016 Jan 21.
• [788] GPR137 is a promising novel bio-marker for the prognosis of bladder cancer patients.Medicine (Baltimore). 2019 Aug;98(35):e16576. doi: 10.1097/MD.0000000000016576.
• [789] On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment.Exp Cell Res. 2013 Jul 15;319(12):1828-1838. doi: 10.1016/j.yexcr.2013.03.025. Epub 2013 Mar 26.
• [790] t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.Blood. 2012 Nov 8;120(19):3949-57. doi: 10.1182/blood-2011-11-389908. Epub 2012 Sep 10.
• [791] ZnR/GPR39 upregulation of K(+)/Cl(-)-cotransporter 3 in tamoxifen resistant breast cancer cells.Cell Calcium. 2019 Jul;81:12-20. doi: 10.1016/j.ceca.2019.05.005. Epub 2019 May 22.
• [792] Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.Gastroenterology. 2020 Feb;158(3):638-651.e8. doi: 10.1053/j.gastro.2019.10.009. Epub 2019 Oct 14.
• [793] GRM4 inhibits the proliferation, migration, and invasion of human osteosarcoma cells through interaction with CBX4.Biosci Biotechnol Biochem. 2020 Feb;84(2):279-289. doi: 10.1080/09168451.2019.1673147. Epub 2019 Oct 4.
• [794] Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial-mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signaling.Mol Carcinog. 2019 Jul;58(7):1314-1323. doi: 10.1002/mc.23014. Epub 2019 Apr 11.
• [795] GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.Tumour Biol. 2017 Jun;39(6):1010428317704364. doi: 10.1177/1010428317704364.
• [796] Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: colocalization with N-methyl-D-aspartic acid receptor.Acta Neuropathol. 2001 Apr;101(4):383-92. doi: 10.1007/s004010000296.
• [797] Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma.BMC Cancer. 2011 Jun 5;11:220. doi: 10.1186/1471-2407-11-220.
• [798] Nuclear-receptor-mediated telomere insertion leads to genome instability in ALT cancers.Cell. 2015 Feb 26;160(5):913-927. doi: 10.1016/j.cell.2015.01.044.
• [799] G-protein-coupled receptor kinase 2 safeguards epithelial phenotype in head and neck squamous cell carcinomas.Int J Cancer. 2020 Jul 1;147(1):218-229. doi: 10.1002/ijc.32838. Epub 2020 Jan 7.
• [800] Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model.Oncogenesis. 2019 Oct 7;8(10):56. doi: 10.1038/s41389-019-0169-4.
• [801] Inhibition of metabotropic glutamate receptor 5 facilitates hypoxia-induced glioma cell death.Brain Res. 2019 Feb 1;1704:241-248. doi: 10.1016/j.brainres.2018.10.021. Epub 2018 Oct 19.
• [802] An endogenous and ectopic expression of metabotropic glutamate receptor 8 (mGluR8) inhibits proliferation and increases chemosensitivity of human neuroblastoma and glioma cells.Cancer Lett. 2018 Sep 28;432:1-16. doi: 10.1016/j.canlet.2018.06.004. Epub 2018 Jun 6.
• [803] Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future.Gut Liver. 2020 Mar 15;14(2):153-167. doi: 10.5009/gnl18490.
• [804] Omega-3 Fatty Acids Responsive Proteins and Reduction in Breast Density in Obese Postmenopausal Women.J Proteome Res. 2019 Sep 6;18(9):3461-3469. doi: 10.1021/acs.jproteome.9b00356. Epub 2019 Aug 14.
• [805] Downregulation of Glutathione S-transferase A1 suppressed tumor growth and induced cell apoptosis in A549 cell line.Oncol Lett. 2018 Jul;16(1):467-474. doi: 10.3892/ol.2018.8608. Epub 2018 May 2.
• [806] Design, synthesis, and biological evaluation of target water-soluble hydroxamic acid-based HDACi derivatives as prodrugs.Chem Biol Drug Des. 2019 Oct;94(4):1760-1767. doi: 10.1111/cbdd.13577. Epub 2019 Jun 19.
• [807] A human seminoma xenograft model with regional lymph node metastasis.J Urol. 1999 Jan;161(1):342-8.
• [808] Direct and straightforward access to substituted alkyl selenols as novel carbonic anhydrase inhibitors.Eur J Med Chem. 2020 Jan 1;185:111811. doi: 10.1016/j.ejmech.2019.111811. Epub 2019 Oct 30.
• [809] YY1 negatively regulates the XAF1 gene expression in prostate cancer.Biochem Biophys Res Commun. 2019 Jan 15;508(3):973-979. doi: 10.1016/j.bbrc.2018.12.056. Epub 2018 Dec 11.
• [810] 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis.Cell Death Dis. 2019 Jul 8;10(7):525. doi: 10.1038/s41419-019-1756-1.
• [811] HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway.Cancers (Basel). 2019 Nov 7;11(11):1747. doi: 10.3390/cancers11111747.
• [812] Evaluation of [(11)C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma.Nucl Med Biol. 2019 Jul-Aug;74-75:1-11. doi: 10.1016/j.nucmedbio.2019.05.004. Epub 2019 May 29.
• [813] HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells.Mol Oncol. 2019 Aug;13(8):1651-1668. doi: 10.1002/1878-0261.12503. Epub 2019 Jun 27.
• [814] METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.Gut. 2020 Jul;69(7):1193-1205. doi: 10.1136/gutjnl-2019-319639. Epub 2019 Oct 3.
• [815] HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase.Traffic. 2017 Jun;18(6):378-391. doi: 10.1111/tra.12482. Epub 2017 May 2.
• [816] Palmitoylation of proteins in cancer.Biochem Soc Trans. 2017 Apr 15;45(2):409-416. doi: 10.1042/BST20160233.
• [817] HIPK2 role in the tumor-host interaction: Impact on fibroblasts transdifferentiation CAF-like.IUBMB Life. 2019 Dec;71(12):2055-2061. doi: 10.1002/iub.2144. Epub 2019 Aug 15.
• [818] PGC1 Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression.Front Oncol. 2019 Apr 17;9:290. doi: 10.3389/fonc.2019.00290. eCollection 2019.
• [819] HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome. Hum Pathol. 2019 Feb;84:133-141.
• [820] Cholesterol depletion sensitizes gallbladder cancer to cisplatin by impairing DNA damage response.Cell Cycle. 2019 Dec;18(23):3337-3350. doi: 10.1080/15384101.2019.1676581. Epub 2019 Oct 10.
• [821] Inhibiting PI3K with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors.Clin Cancer Res. 2017 Dec 15;23(24):7584-7595. doi: 10.1158/1078-0432.CCR-17-0676. Epub 2017 Oct 2.
• [822] HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.Pathol Res Pract. 2019 Aug;215(8):152464. doi: 10.1016/j.prp.2019.152464. Epub 2019 May 22.
• [823] A Near-Infrared Probe Tracks and Treats Lung Tumor Initiating Cells by Targeting HMOX2.J Am Chem Soc. 2019 Sep 18;141(37):14673-14686. doi: 10.1021/jacs.9b06068. Epub 2019 Sep 4.
• [824] Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma.Oncogene. 2019 Jun;38(25):4915-4931. doi: 10.1038/s41388-019-0764-z. Epub 2019 Mar 11.
• [825] Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.Thorac Cancer. 2018 Jul;9(7):836-846. doi: 10.1111/1759-7714.12758. Epub 2018 May 14.
• [826] Association of leukocyte DNA methylation changes with dietary folate and alcohol intake in the EPIC study.Clin Epigenetics. 2019 Apr 2;11(1):57. doi: 10.1186/s13148-019-0637-x.
• [827] microRNA-144-3p suppresses human neuroblastoma cell proliferation by targeting HOXA7.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):716-723. doi: 10.26355/eurrev_201901_16885.
• [828] Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer.Signal Transduct Target Ther. 2019 Nov 29;4:51. doi: 10.1038/s41392-019-0086-1. eCollection 2019.
• [829] A Phase I-II Study Using Rexin-G Tumor-Targeted Retrovector Encoding a Dominant-Negative Cyclin G1 Inhibitor for Advanced Pancreatic Cancer.Mol Ther Oncolytics. 2018 Dec 14;12:56-67. doi: 10.1016/j.omto.2018.12.005. eCollection 2019 Mar 29.
• [830] Small hepatitis delta antigen selectively binds to target mRNA in hepatic cells: a potential mechanism by which hepatitis D virus downregulates glutathione S-transferase P1 and induces liver injury and hepatocarcinogenesis.Biochem Cell Biol. 2019 Apr;97(2):130-139. doi: 10.1139/bcb-2017-0321. Epub 2018 Aug 28.
• [831] The histidine-rich calcium binding protein (HRC) promotes tumor metastasis in hepatocellular carcinoma and is upregulated by SATB1. Oncotarget. 2015 Mar 30;6(9):6811-24.
• [832] Differential expression of neurogenes among breast cancer subtypes identifies high risk patients.Oncotarget. 2016 Feb 2;7(5):5313-26. doi: 10.18632/oncotarget.6543.
• [833] Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.Eur J Cancer. 2018 Mar;91:125-135. doi: 10.1016/j.ejca.2017.12.003.
• [834] Loss of 11HSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinoma.Oncotarget. 2016 Jan 12;7(2):2038-53. doi: 10.18632/oncotarget.6661.
• [835] Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.Elife. 2017 Feb 13;6:e20183. doi: 10.7554/eLife.20183.
• [836] 17hydroxysteroid dehydrogenase4 induces liver cancer proliferationassociated genes via STAT3 activation.Oncol Rep. 2019 Mar;41(3):2009-2019. doi: 10.3892/or.2019.6981. Epub 2019 Jan 23.
• [837] Heat shock factor 1 in cancer-associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma.Cancer Sci. 2019 May;110(5):1790-1803. doi: 10.1111/cas.13991. Epub 2019 Apr 11.
• [838] Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma.PLoS One. 2019 Apr 23;14(4):e0215765. doi: 10.1371/journal.pone.0215765. eCollection 2019.
• [839] Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses.PLoS One. 2019 Jan 31;14(1):e0211490. doi: 10.1371/journal.pone.0211490. eCollection 2019.
• [840] HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K/Akt/NF-B signaling pathway.Oncol Lett. 2018 Mar;15(3):3883-3889. doi: 10.3892/ol.2018.7800. Epub 2018 Jan 16.
• [841] Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1629-1639. doi: 10.1016/j.bbadis.2017.04.021. Epub 2017 Apr 26.
• [842] 5-Hydroxytryptamine1a receptors on tumour cells induce immune evasion in lung adenocarcinoma patients with depression via autophagy/pSTAT3.Eur J Cancer. 2019 Jun;114:8-24. doi: 10.1016/j.ejca.2019.03.017. Epub 2019 Apr 19.
• [843] Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers.Pathol Oncol Res. 2020 Jul;26(3):1539-1547. doi: 10.1007/s12253-019-00734-w. Epub 2019 Sep 2.
• [844] Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.Gastroenterology. 2017 Jul;153(1):277-291.e19. doi: 10.1053/j.gastro.2017.03.008. Epub 2017 Mar 15.
• [845] Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5... Endocr Relat Cancer. 2009 Mar;16(1):281-90.
• [846] Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.Endocr Relat Cancer. 2008 Dec;15(4):1025-34. doi: 10.1677/ERC-08-0085. Epub 2008 Aug 15.
• [847] HtrA1 as a promising tissue marker in cancer: a meta-analysis.BMC Cancer. 2018 Feb 6;18(1):143. doi: 10.1186/s12885-018-4041-2.
• [848] Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C- inhibitor as a potential prostate carcinoma therapeutic.Anticancer Drugs. 2019 Jan;30(1):65-71. doi: 10.1097/CAD.0000000000000694.
• [849] The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.Cancer. 2008 Feb 1;112(3):552-61. doi: 10.1002/cncr.23196.
• [850] Iduronate-2-Sulfatase-Regulated Dermatan Sulfate Levels Potentiate the Invasion of Breast Cancer Epithelia through Collagen Matrix.J Clin Med. 2019 Sep 30;8(10):1562. doi: 10.3390/jcm8101562.
• [851] Antithyroid cancer effects of human neural stem cells expressing therapeutic genes on anaplastic thyroid cancer cells.J Cell Biochem. 2020 Feb;121(2):1586-1598. doi: 10.1002/jcb.29393. Epub 2019 Sep 12.
• [852] White adipose tissue IFN- expression and signalling along the progression of rodent cancer cachexia.Cytokine. 2017 Jan;89:122-126. doi: 10.1016/j.cyto.2016.02.015. Epub 2016 Mar 14.
• [853] Clinical Significance of Serum Type III Interferons in Patients with Gastric Cancer.J Interferon Cytokine Res. 2019 Mar;39(3):155-163. doi: 10.1089/jir.2018.0119. Epub 2019 Jan 23.
• [854] PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.Oncogene. 2019 Jun;38(23):4590-4604. doi: 10.1038/s41388-019-0743-4. Epub 2019 Feb 11.
• [855] IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling.Cell Commun Signal. 2018 Sep 19;16(1):61. doi: 10.1186/s12964-018-0273-7.
• [856] IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes.Oncol Rep. 2019 Feb;41(2):1189-1197. doi: 10.3892/or.2018.6872. Epub 2018 Nov 19.
• [857] The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma.Oncoimmunology. 2018 Aug 1;7(10):e1486356. doi: 10.1080/2162402X.2018.1486356. eCollection 2018.
• [858] Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth.EMBO Mol Med. 2019 Apr;11(4):e9539. doi: 10.15252/emmm.201809539.
• [859] BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation.Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):8065-8070. doi: 10.1073/pnas.1704173114. Epub 2017 Jul 11.
• [860] Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.J Hepatol. 2019 Mar;70(3):449-457. doi: 10.1016/j.jhep.2018.10.040. Epub 2018 Nov 9.
• [861] IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma.PLoS One. 2018 Apr 5;13(4):e0193565. doi: 10.1371/journal.pone.0193565. eCollection 2018.
• [862] IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses.Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):599-608. doi: 10.1073/pnas.1814642116. Epub 2018 Dec 26.
• [863] Interleukin-17F Has Anti-Tumor Effects in Oral Tongue Cancer.Cancers (Basel). 2019 May 11;11(5):650. doi: 10.3390/cancers11050650.
• [864] Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.Clin Cancer Res. 2019 May 1;25(9):2769-2782. doi: 10.1158/1078-0432.CCR-18-2202. Epub 2019 Jan 22.
• [865] CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells.Cancer Res. 2019 Feb 1;79(3):663-675. doi: 10.1158/0008-5472.CAN-18-1078. Epub 2018 Dec 4.
• [866] Decreased ST2 expression is associated with gastric cancer progression and pathogenesis.Oncol Lett. 2019 Jun;17(6):5761-5767. doi: 10.3892/ol.2019.10223. Epub 2019 Apr 5.
• [867] Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma.Sci Rep. 2017 Dec 14;7(1):17609. doi: 10.1038/s41598-017-17054-1.
• [868] Adoptive Transfer of Interleukin-21-stimulated Human CD8+ T Memory Stem Cells Efficiently Inhibits Tumor Growth.J Immunother. 2018 Jul/Aug;41(6):274-283. doi: 10.1097/CJI.0000000000000229.
• [869] IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.Int J Oncol. 2019 Jan;54(1):7-16. doi: 10.3892/ijo.2018.4612. Epub 2018 Oct 31.
• [870] Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer.Mol Oncol. 2020 Jan;14(1):211-224. doi: 10.1002/1878-0261.12598. Epub 2019 Dec 4.
• [871] Aberrant expression of IL-23/IL-23R in patients with breast cancer and its clinical significance.Mol Med Rep. 2018 Mar;17(3):4639-4644. doi: 10.3892/mmr.2018.8427. Epub 2018 Jan 12.
• [872] Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.J Exp Clin Cancer Res. 2019 Jul 11;38(1):303. doi: 10.1186/s13046-019-1271-3.
• [873] Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.Fam Cancer. 2018 Oct;17(4):577-585. doi: 10.1007/s10689-017-0060-4.
• [874] Functional analysis of Cullin 3 E3 ligases in tumorigenesis. Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):11-28.
• [875] IL-32 expression indicates unfavorable prognosis in patients with colon cancer.Oncol Lett. 2019 May;17(5):4655-4660. doi: 10.3892/ol.2019.10136. Epub 2019 Mar 12.
• [876] Interleukin-33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development.Int J Cancer. 2020 Mar 1;146(5):1421-1434. doi: 10.1002/ijc.32779. Epub 2019 Dec 5.
• [877] Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.Eur Urol. 2019 May;75(5):752-763. doi: 10.1016/j.eururo.2018.09.030. Epub 2018 Oct 4.
• [878] IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the -catenin pathway.Oncogene. 2018 Mar;37(9):1175-1191. doi: 10.1038/s41388-017-0034-x. Epub 2017 Dec 14.
• [879] Omega-3 fatty acids decrease prostate cancer progression associated with an anti-tumor immune response in eugonadal and castrated mice.Prostate. 2019 Jan;79(1):9-20. doi: 10.1002/pros.23706. Epub 2018 Aug 2.
• [880] NLS-Cholic Acid Conjugation to IL-5R-Specific Antibody Improves Cellular Accumulation and In Vivo Tumor-Targeting Properties in a Bladder Cancer Model.Bioconjug Chem. 2018 Apr 18;29(4):1352-1363. doi: 10.1021/acs.bioconjchem.8b00077. Epub 2018 Mar 1.
• [881] Lineage-negative lymphoma with a helper innate lymphoid cell phenotype.Virchows Arch. 2020 Feb;476(2):285-293. doi: 10.1007/s00428-019-02658-x. Epub 2019 Sep 14.
• [882] Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC).EBioMedicine. 2019 Jan;39:207-214. doi: 10.1016/j.ebiom.2018.11.036. Epub 2018 Nov 22.
• [883] Inflammation-nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma.Int J Clin Oncol. 2019 Jul;24(7):825-835. doi: 10.1007/s10147-019-01402-4. Epub 2019 Apr 24.
• [884] IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3.Cancer Cell. 2016 May 9;29(5):684-696. doi: 10.1016/j.ccell.2016.03.014. Epub 2016 Apr 14.
• [885] Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia.Leukemia. 2020 Jan;34(1):100-114. doi: 10.1038/s41375-019-0507-8. Epub 2019 Jun 13.
• [886] Selective Editing of Herpes Simplex Virus 1 Enables Interferon Induction and Viral Replication That Destroy Malignant Cells.J Virol. 2019 Jan 4;93(2):e01761-18. doi: 10.1128/JVI.01761-18. Print 2019 Jan 15.
• [887] MicroRNA?66 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.Int J Oncol. 2019 Jan;54(1):315-325. doi: 10.3892/ijo.2018.4615. Epub 2018 Nov 1.
• [888] Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells.Oncogene. 2019 Jun;38(23):4480-4495. doi: 10.1038/s41388-019-0731-8. Epub 2019 Feb 14.
• [889] Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma.Oncoimmunology. 2018 Aug 6;7(10):e1490855. doi: 10.1080/2162402X.2018.1490855. eCollection 2018.
• [890] Integrin 11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.Cancer Sci. 2020 Jan;111(1):200-208. doi: 10.1111/cas.14257. Epub 2019 Dec 18.
• [891] Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway.J Exp Clin Cancer Res. 2019 Dec 9;38(1):485. doi: 10.1186/s13046-019-1496-1.
• [892] Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours.J Cell Mol Med. 2018 Apr;22(4):2220-2230. doi: 10.1111/jcmm.13502. Epub 2018 Jan 29.
• [893] NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription.Neoplasia. 2019 Mar;21(3):311-321. doi: 10.1016/j.neo.2019.01.006. Epub 2019 Feb 15.
• [894] Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin 3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery.Theranostics. 2019 Jan 1;9(1):265-278. doi: 10.7150/thno.27246. eCollection 2019.
• [895] (6) -integrin serves as a novel serum tumor marker for colorectal carcinoma.Int J Cancer. 2019 Aug 1;145(3):678-685. doi: 10.1002/ijc.32137. Epub 2019 Jan 29.
• [896] Alteration in metastasis potential and gene expression in human lung cancer cell lines by ITGB8 silencing.Anat Rec (Hoboken). 2012 Sep;295(9):1446-54. doi: 10.1002/ar.22521. Epub 2012 Jul 2.
• [897] In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.Mol Pharm. 2019 Mar 4;16(3):1156-1166. doi: 10.1021/acs.molpharmaceut.8b01131. Epub 2019 Feb 20.
• [898] Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma.J Hepatol. 2014 Nov;61(5):1064-72. doi: 10.1016/j.jhep.2014.05.027. Epub 2014 May 23.
• [899] PTEN counteracts FBXL2 to promote IP3R3- and Ca(2+)-mediated apoptosis limiting tumour growth.Nature. 2017 Jun 22;546(7659):554-558. doi: 10.1038/nature22965. Epub 2017 Jun 14.
• [900] Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy.Biochem Biophys Res Commun. 2019 Dec 3;520(2):250-256. doi: 10.1016/j.bbrc.2019.09.118. Epub 2019 Oct 5.
• [901] The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.Hepatology. 2020 Mar;71(3):929-942. doi: 10.1002/hep.30863. Epub 2019 Nov 6.
• [902] Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed -catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.Virchows Arch. 2017 Jul;471(1):31-47. doi: 10.1007/s00428-017-2130-2. Epub 2017 Apr 27.
• [903] JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.Leukemia. 2019 Jun;33(6):1400-1410. doi: 10.1038/s41375-018-0354-z. Epub 2019 Jan 8.
• [904] KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.Cancer Res. 2015 Sep 15;75(18):3936-45. doi: 10.1158/0008-5472.CAN-14-3702. Epub 2015 Jul 24.
• [905] Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1 interaction with cofactors p300/CBP.Clin Cancer Res. 2012 Dec 15;18(24):6623-33. doi: 10.1158/1078-0432.CCR-12-0861. Epub 2012 Aug 24.
• [906] Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.Mol Cancer Res. 2016 Jan;14(1):26-34. doi: 10.1158/1541-7786.MCR-15-0343. Epub 2015 Nov 16.
• [907] Role of KCNB1 in the prognosis of gliomas and autophagy modulation.Sci Rep. 2017 Feb 8;7(1):14. doi: 10.1038/s41598-017-00045-7.
• [908] HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.J Exp Clin Cancer Res. 2019 Jul 22;38(1):324. doi: 10.1186/s13046-019-1284-y.
• [909] Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics.Genes Dev. 2012 Aug 15;26(16):1780-96. doi: 10.1101/gad.193789.112. Epub 2012 Aug 1.
• [910] Genetics of aldosterone-producing adenomas with pathogenic KCNJ5 variants.Endocr Relat Cancer. 2019 Apr 1;26(4):463-470. doi: 10.1530/ERC-18-0364. Epub 2019 Feb 1.
• [911] Calcium-activated potassium channels as potential early markers of human cervical cancer.Oncol Lett. 2018 May;15(5):7249-7254. doi: 10.3892/ol.2018.8187. Epub 2018 Mar 7.
• [912] A novel role for estrogen-induced signaling in the colorectal cancer gender bias.Ir J Med Sci. 2019 May;188(2):389-395. doi: 10.1007/s11845-018-1867-1. Epub 2018 Jul 17.
• [913] Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.Sci Signal. 2019 Feb 5;12(567):eaau2922. doi: 10.1126/scisignal.aau2922.
• [914] Lysine demethylase2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelialmesenchymal transition.Oncol Rep. 2019 Feb;41(2):917-927. doi: 10.3892/or.2018.6888. Epub 2018 Nov 27.
• [915] JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR?91?p.Mol Med Rep. 2019 Apr;19(4):2489-2496. doi: 10.3892/mmr.2019.9916. Epub 2019 Jan 31.
• [916] Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.Mod Pathol. 2019 May;32(5):701-709. doi: 10.1038/s41379-018-0185-5. Epub 2019 Jan 8.
• [917] Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.Oncol Rep. 2019 May;41(5):2667-2678. doi: 10.3892/or.2019.7067. Epub 2019 Mar 14.
• [918] Ketohexokinase is involved in fructose utilization and promotes tumor progression in glioma.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1298-1306. doi: 10.1016/j.bbrc.2018.07.040. Epub 2018 Jul 19.
• [919] Identification of KIF11 As a Novel Target in Meningioma.Cancers (Basel). 2019 Apr 15;11(4):545. doi: 10.3390/cancers11040545.
• [920] Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes.Oncol Lett. 2018 Apr;15(4):5497-5504. doi: 10.3892/ol.2018.8062. Epub 2018 Feb 15.
• [921] Cells deficient for Krppel-like factor 4 exhibit mitochondrial dysfunction and impaired mitophagy.Eur J Cell Biol. 2020 Jan;99(1):151061. doi: 10.1016/j.ejcb.2019.151061. Epub 2019 Dec 5.
• [922] Identification of potential key genes and high-frequency mutant genes in prostate cancer by using RNA-Seq data.Oncol Lett. 2018 Apr;15(4):4550-4556. doi: 10.3892/ol.2018.7846. Epub 2018 Jan 24.
• [923] Identification and characterization of novel fusion genes in prostate cancer by targeted RNA capture and next-generation sequencing.Acta Biochim Biophys Sin (Shanghai). 2018 Nov 1;50(11):1166-1172. doi: 10.1093/abbs/gmy112.
• [924] Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein.Oncotarget. 2019 Oct 22;10(58):6062-6078. doi: 10.18632/oncotarget.27153. eCollection 2019 Oct 22.
• [925] Expression of kallikrein-related peptidase 7 is decreased in prostate cancer.Asian J Androl. 2015 Jan-Feb;17(1):106-10. doi: 10.4103/1008-682X.137613.
• [926] Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.PLoS One. 2018 Jan 29;13(1):e0190447. doi: 10.1371/journal.pone.0190447. eCollection 2018.
• [927] Bortezomib sensitizes multiple myeloma to NK cells via ER-stress-induced suppression of HLA-E and upregulation of DR5.Oncoimmunology. 2018 Nov 2;8(2):e1534664. doi: 10.1080/2162402X.2018.1534664. eCollection 2019.
• [928] Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.Oncotarget. 2019 Feb 15;10(14):1399-1406. doi: 10.18632/oncotarget.26659. eCollection 2019 Feb 15.
• [929] Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma.Sci Rep. 2019 Aug 21;9(1):12150. doi: 10.1038/s41598-019-48635-x.
• [930] Prognostic impact of SET domain-containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection.Oncol Lett. 2018 Sep;16(3):3665-3673. doi: 10.3892/ol.2018.9083. Epub 2018 Jul 5.
• [931] Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia.Mod Pathol. 2019 May;32(5):717-724. doi: 10.1038/s41379-018-0177-5. Epub 2018 Nov 15.
• [932] Monomeric and Dimeric (68)Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs).J Med Chem. 2018 Mar 8;61(5):2062-2074. doi: 10.1021/acs.jmedchem.7b01856. Epub 2018 Feb 22.
• [933] Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer.PLoS One. 2018 Mar 29;13(3):e0194998. doi: 10.1371/journal.pone.0194998. eCollection 2018.
• [934] Expression of the checkpoint receptors LAG-3, TIM-3 and VISTA in peripheral T cell lymphomas.J Clin Pathol. 2020 Apr;73(4):197-203. doi: 10.1136/jclinpath-2019-206117. Epub 2019 Oct 31.
• [935] Leukocyteassociated immunoglobulinlike receptor1 promotes tumorigenesis in RCC.Oncol Rep. 2019 Feb;41(2):1293-1303. doi: 10.3892/or.2018.6875. Epub 2018 Nov 20.
• [936] Spontaneous "pneumo-apoplexy" as a presentation of pituitary adenoma.Clin Imaging. 2019 Nov-Dec;58:152-155. doi: 10.1016/j.clinimag.2019.07.005. Epub 2019 Jul 23.
• [937] CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.J Cancer Res Clin Oncol. 2019 May;145(5):1179-1190. doi: 10.1007/s00432-019-02865-8. Epub 2019 Feb 18.
• [938] Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.Cancer Res. 2003 Feb 1;63(3):723-7.
• [939] The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer.Nucleic Acids Res. 2016 Feb 18;44(3):1227-46. doi: 10.1093/nar/gkv1515. Epub 2015 Dec 29.
• [940] LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.J Mol Neurosci. 2019 May;68(1):38-48. doi: 10.1007/s12031-019-1262-z. Epub 2019 Feb 15.
• [941] IL6 Shapes an Inflammatory Microenvironment and Triggers the Development of Unique Types of Cancer in End-stage Kidney.Anticancer Res. 2019 Apr;39(4):1869-1874. doi: 10.21873/anticanres.13294.
• [942] Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication.Mol Carcinog. 2019 Mar;58(3):376-387. doi: 10.1002/mc.22935. Epub 2018 Nov 28.
• [943] The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cells.Ther Adv Med Oncol. 2019 Jul 10;11:1758835919855859. doi: 10.1177/1758835919855859. eCollection 2019.
• [944] Leptin induces muscle wasting in a zebrafish kras-driven hepatocellular carcinoma (HCC) model.Dis Model Mech. 2019 Feb 27;12(2):dmm038240. doi: 10.1242/dmm.038240.
• [945] USP17 Suppresses Tumorigenesis and Tumor Growth through Deubiquitinating AEP.Int J Biol Sci. 2019 Jan 29;15(4):738-748. doi: 10.7150/ijbs.30106. eCollection 2019.
• [946] The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.PLoS One. 2013 Aug 9;8(8):e71791. doi: 10.1371/journal.pone.0071791. eCollection 2013.
• [947] Leukemia inhibitory factor inhibits the proliferation of gastric cancer by inducing G1-phase arrest.J Cell Physiol. 2019 Apr;234(4):3613-3620. doi: 10.1002/jcp.27083. Epub 2018 Nov 22.
• [948] TGF promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.Oncogene. 2019 May;38(20):3794-3811. doi: 10.1038/s41388-019-0703-z. Epub 2019 Jan 28.
• [949] Inhibition of circular RNA CDR1as increases chemosensitivity of 5-FU-resistant BC cells through up-regulating miR-7.J Cell Mol Med. 2019 May;23(5):3166-3177. doi: 10.1111/jcmm.14171. Epub 2019 Mar 18.
• [950] Structural and Functional Basis for LILRB Immune Checkpoint Receptor Recognition of HLA-G Isoforms.J Immunol. 2019 Dec 15;203(12):3386-3394. doi: 10.4049/jimmunol.1900562. Epub 2019 Nov 6.
• [951] Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.Cancer Res. 2020 Jan 1;80(1):69-78. doi: 10.1158/0008-5472.CAN-19-1237. Epub 2019 Oct 22.
• [952] Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target.Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3603-8. doi: 10.1073/pnas.1521251113. Epub 2016 Mar 15.
• [953] Deficiency in hormone-sensitive lipase accelerates the development of pancreatic cancer in conditional KrasG12D mice.BMC Cancer. 2018 Aug 7;18(1):797. doi: 10.1186/s12885-018-4713-y.
• [954] In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants.BMC Genomics. 2017 May 15;18(1):381. doi: 10.1186/s12864-017-3750-2.
• [955] Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.EMBO J. 2018 Jul 13;37(14):e98783. doi: 10.15252/embj.201798783. Epub 2018 Jun 7.
• [956] Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma.Virchows Arch. 2020 Mar;476(3):367-372. doi: 10.1007/s00428-019-02636-3. Epub 2019 Aug 3.
• [957] Pim-1 inhibitor SMI-4a suppresses tumor growth in non-small cell lung cancer via PI3K/AKT/mTOR pathway. Onco Targets Ther. 2019 Apr 23;12:3043-3050.
• [958] 2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth.J Med Chem. 2020 Mar 12;63(5):2308-2324. doi: 10.1021/acs.jmedchem.9b01112. Epub 2019 Sep 4.
• [959] Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.Mol Cancer Res. 2015 Jan;13(1):174-85. doi: 10.1158/1541-7786.MCR-14-0263. Epub 2014 Aug 26.
• [960] Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.Mol Diagn Ther. 2019 Feb;23(1):127-138. doi: 10.1007/s40291-019-00384-3.
• [961] Enhanced Fatty Acid Scavenging and Glycerophospholipid Metabolism Accompany Melanocyte Neoplasia Progression in Zebrafish.Cancer Res. 2019 May 1;79(9):2136-2151. doi: 10.1158/0008-5472.CAN-18-2409. Epub 2019 Mar 12.
• [962] In Vivo Imaging of Small Molecular Weight Peptides for Targeted Renal Drug Delivery: A Study in Normal and Polycystic Kidney Diseased Mice.J Pharmacol Exp Ther. 2019 Sep;370(3):786-795. doi: 10.1124/jpet.119.257022. Epub 2019 Apr 1.
• [963] DKK2 imparts tumor immunity evasion through -catenin-independent suppression of cytotoxic immune-cell activation.Nat Med. 2018 Mar;24(3):262-270. doi: 10.1038/nm.4496. Epub 2018 Feb 12.
• [964] Garlic-derived compound S-allylmercaptocysteine inhibits hepatocarcinogenesis through targeting LRP6/Wnt pathway.Acta Pharm Sin B. 2018 Jul;8(4):575-586. doi: 10.1016/j.apsb.2017.10.003. Epub 2017 Nov 10.
• [965] Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors.Cell Immunol. 2018 Oct;332:129-133. doi: 10.1016/j.cellimm.2018.07.011. Epub 2018 Jul 30.
• [966] Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.PLoS One. 2016 Feb 23;11(2):e0149628. doi: 10.1371/journal.pone.0149628. eCollection 2016.
• [967] Glucose transporter 1-mediated vascular translocation of nanomedicines enhances accumulation and efficacy in solid tumors.J Control Release. 2019 May 10;301:28-41. doi: 10.1016/j.jconrel.2019.02.021. Epub 2019 Mar 4.
• [968] The Tumor-Immune Response Is Not Compromised by Mesenchymal Stromal Cells in Humanized Mice.J Immunol. 2019 Nov 15;203(10):2735-2745. doi: 10.4049/jimmunol.1900807. Epub 2019 Oct 2.
• [969] Diagnostic utility of CD205 in breast cancer: Simultaneous detection of myoepithelial cells and dendritic cells in breast tissue by CD205.Histol Histopathol. 2020 May;35(5):481-488. doi: 10.14670/HH-18-164. Epub 2019 Sep 16.
• [970] RB/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation.Oncotarget. 2016 Mar 1;7(9):9832-43. doi: 10.18632/oncotarget.6954.
• [971] Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells.Mar Drugs. 2019 Apr 6;17(4):215. doi: 10.3390/md17040215.
• [972] Gastroesophageal junction Paneth cell carcinoma with extensive cystic and secretory features - case report and literature review.Diagn Pathol. 2019 Jan 8;14(1):1. doi: 10.1186/s13000-018-0775-z.
• [973] Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.BMC Cancer. 2018 Dec 29;18(1):1298. doi: 10.1186/s12885-018-5183-y.
• [974] Squamous cell carcinoma of the rectum: Practice trends and patient survival.Cancer Med. 2018 Dec;7(12):6093-6103. doi: 10.1002/cam4.1893. Epub 2018 Nov 20.
• [975] Epigenetic Coactivation of MAGEA6 and CT-GABRA3 Defines Orientation of a Segmental Duplication in the Human X Chromosome.Cytogenet Genome Res. 2019;159(1):12-18. doi: 10.1159/000502933. Epub 2019 Oct 9.
• [976] MEK5 overexpression is associated with the occurrence and development of colorectal cancer.BMC Cancer. 2016 May 9;16:302. doi: 10.1186/s12885-016-2327-9.
• [977] MAP3K1 rs889312 genotypes influence survival outcomes of Chinese gastric cancer patients who received adjuvant chemotherapy based on platinum and fluorouracil regimes.Onco Targets Ther. 2019 Aug 22;12:6843-6855. doi: 10.2147/OTT.S205438. eCollection 2019.
• [978] MiR-199a-5p suppresses non-small cell lung cancer via targeting MAP3K11.J Cancer. 2019 Jun 2;10(11):2472-2479. doi: 10.7150/jca.29426. eCollection 2019.
• [979] The Prognostic Role of the Non-Canonical Nuclear Factor-Kappa B Pathway in Renal Cell Carcinoma Patients.Urol Int. 2018;101(2):190-196. doi: 10.1159/000489816. Epub 2018 Aug 8.
• [980] The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models.Mol Cancer Ther. 2012 Sep;11(9):1999-2009. doi: 10.1158/1535-7163.MCT-12-0017. Epub 2012 Jul 2.
• [981] Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.Oncogene. 2019 Apr;38(15):2860-2875. doi: 10.1038/s41388-018-0618-0. Epub 2018 Dec 14.
• [982] miR?05 inhibits cell growth and EMT by targeting MAP3K3 through the AKTNFB pathway in NSCLC cells.Int J Mol Med. 2019 Mar;43(3):1203-1216. doi: 10.3892/ijmm.2018.4041. Epub 2018 Dec 31.
• [983] The Elevated ASK1 Expression Inhibits Proliferation and Invasion in Gastric Cancer HGC-27 Cells.Anat Rec (Hoboken). 2018 Nov;301(11):1815-1819. doi: 10.1002/ar.23906. Epub 2018 Oct 15.
• [984] Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genet. 2014 Oct 23;10(10):e1004669. doi: 10.1371/journal.pgen.1004669. eCollection 2014 Oct.
• [985] Endothelial Cell Killing by TAK1 Inhibition: A Novel Anti-angiogenic Strategy in Cancer Therapy.Dev Cell. 2019 Jan 28;48(2):127-128. doi: 10.1016/j.devcel.2019.01.011.
• [986] Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas.Nat Med. 2019 Apr;25(4):597-602. doi: 10.1038/s41591-019-0373-y. Epub 2019 Mar 4.
• [987] Expression of Syk and MAP4 proteins in ovarian cancer.J Cancer Res Clin Oncol. 2019 Apr;145(4):909-919. doi: 10.1007/s00432-019-02856-9. Epub 2019 Feb 8.
• [988] Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance.PLoS One. 2019 Mar 26;14(3):e0212670. doi: 10.1371/journal.pone.0212670. eCollection 2019.
• [989] Sanguinarine inhibits the proliferation of BGC-823 gastric cancer cells via regulating miR-96-5p/miR-29c-3p and the MAPK/JNK signaling pathway.J Nat Med. 2019 Sep;73(4):777-788. doi: 10.1007/s11418-019-01330-7. Epub 2019 Jun 26.
• [990] Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11.Biosci Rep. 2019 Jul 25;39(7):BSR20181794. doi: 10.1042/BSR20181794. Print 2019 Jul 31.
• [991] Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response.Exp Mol Med. 2019 Feb 21;51(2):1-20. doi: 10.1038/s12276-019-0209-3.
• [992] JNK2 silencing and caspase-9 activation by hyperosmotic polymer inhibits tumor progression.Int J Biol Macromol. 2018 Dec;120(Pt B):2215-2224. doi: 10.1016/j.ijbiomac.2018.07.019. Epub 2018 Jul 10.
• [993] The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.Mol Cell. 2019 Feb 21;73(4):830-844.e12. doi: 10.1016/j.molcel.2018.12.001. Epub 2019 Jan 10.
• [994] MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability.J Exp Clin Cancer Res. 2019 Apr 25;38(1):175. doi: 10.1186/s13046-019-1167-2.
• [995] Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer.Med Sci Monit. 2019 Jan 9;25:279-287. doi: 10.12659/MSM.913558.
• [996] Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.BMC Cancer. 2017 Feb 7;17(1):113. doi: 10.1186/s12885-017-3081-3.
• [997] Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high-resolution magic angle spinning (1) H NMR spectroscopy.NMR Biomed. 2018 Feb;31(2). doi: 10.1002/nbm.3862. Epub 2017 Dec 5.
• [998] PARTICLE - The RNA podium for genomic silencers.J Cell Physiol. 2019 Nov;234(11):19464-19470. doi: 10.1002/jcp.28739. Epub 2019 May 6.
• [999] Conditional knockout of TOG results in CNS hypomyelination.Glia. 2017 Mar;65(3):489-501. doi: 10.1002/glia.23106. Epub 2017 Jan 7.
• [1000] Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy.Mol Neurobiol. 2018 Feb;55(2):1396-1404. doi: 10.1007/s12035-017-0414-9. Epub 2017 Feb 1.
• [1001] The role of CD146 in serous ovarian carcinoma.J BUON. 2019 May-Jun;24(3):1009-1019.
• [1002] MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.BMC Cancer. 2018 Feb 20;18(1):200. doi: 10.1186/s12885-018-4056-8.
• [1003] Assessment of Proliferative Index Between the Tumor Margin, Center of Tumor, and the Invasive Tumor Front of Oral Squamous Cell Carcinoma With the Help of Mcm-2: An Immunohistochemical Study.Appl Immunohistochem Mol Morphol. 2020 Jan;28(1):30-35. doi: 10.1097/PAI.0000000000000709.
• [1004] Downregulated MCOLN1 Attenuates The Progression Of Non-Small-Cell Lung Cancer By Inhibiting Lysosome-Autophagy.Cancer Manag Res. 2019 Sep 23;11:8607-8617. doi: 10.2147/CMAR.S216538. eCollection 2019.
• [1005] MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors.Neuro Oncol. 2020 Jan 11;22(1):58-69. doi: 10.1093/neuonc/noz151.
• [1006] Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma.Mol Cancer Ther. 2019 Feb;18(2):278-288. doi: 10.1158/1535-7163.MCT-18-0456. Epub 2018 Nov 27.
• [1007] Suppression of glioblastoma growth and angiogenesis through molecular targeting of methionine aminopeptidase-2.J Neurooncol. 2018 Jan;136(2):243-254. doi: 10.1007/s11060-017-2663-x. Epub 2017 Nov 8.
• [1008] The significance of tumor cells-derived MFG-E8 in tumor growth of angiosarcoma.J Dermatol Sci. 2019 Oct;96(1):18-25. doi: 10.1016/j.jdermsci.2019.08.005. Epub 2019 Aug 16.
• [1009] Bioactivity and chemical characterization of Opuntia macrorhiza Engelm. seed oil: potential food and pharmaceutical applications.Food Funct. 2017 Aug 1;8(8):2739-2747. doi: 10.1039/c7fo00731k. Epub 2017 Jul 26.
• [1010] MGAT1 is a novel transcriptional target of Wnt/-catenin signaling pathway.BMC Cancer. 2018 Jan 8;18(1):60. doi: 10.1186/s12885-017-3960-7.
• [1011] MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma.Front Oncol. 2019 Jan 29;9:29. doi: 10.3389/fonc.2019.00029. eCollection 2019.
• [1012] ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin 31 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.Gastroenterology. 2020 Feb;158(3):679-692.e1. doi: 10.1053/j.gastro.2019.10.038. Epub 2019 Nov 9.
• [1013] Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP.Oncol Lett. 2019 Aug;18(2):1189-1198. doi: 10.3892/ol.2019.10443. Epub 2019 Jun 6.
• [1014] Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors.Bioorg Med Chem. 2019 Apr 1;27(7):1211-1225. doi: 10.1016/j.bmc.2019.02.007. Epub 2019 Feb 2.
• [1015] Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.Nucleic Acids Res. 2018 Nov 30;46(21):11396-11404. doi: 10.1093/nar/gky921.
• [1016] The density of mast cells c-Kit(+) and tryptase(+) correlates with each other and with angiogenesis in pancreatic cancer patients.Oncotarget. 2017 Jul 31;8(41):70463-70471. doi: 10.18632/oncotarget.19716. eCollection 2017 Sep 19.
• [1017] The Yin and Yang of YY1 in tumor growth and suppression.Int J Cancer. 2018 Aug 1;143(3):460-465. doi: 10.1002/ijc.31255. Epub 2018 Jan 31.
• [1018] MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.Oncotarget. 2017 Aug 7;8(42):72197-72204. doi: 10.18632/oncotarget.20060. eCollection 2017 Sep 22.
• [1019] Effects of dexmedetomidine on glioma cells in the presence or absence of cisplatin.J Cell Biochem. 2020 Jan;121(1):723-734. doi: 10.1002/jcb.29318. Epub 2019 Aug 26.
• [1020] Engineered clearing agents for the selective depletion of antigen-specific antibodies.Nat Commun. 2017 May 31;8:15314. doi: 10.1038/ncomms15314.
• [1021] CD110 promotes pancreatic cancer progression and its expression is correlated with poor prognosis.J Cancer Res Clin Oncol. 2019 May;145(5):1147-1164. doi: 10.1007/s00432-019-02860-z. Epub 2019 Feb 15.
• [1022] TGF1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.J Pathol. 2012 Apr;226(5):775-83. doi: 10.1002/path.3958. Epub 2011 Dec 8.
• [1023] MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.Life Sci. 2017 Nov 1;188:87-95. doi: 10.1016/j.lfs.2017.08.018. Epub 2017 Sep 1.
• [1024] Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers.Cancer Biol Med. 2019 May;16(2):319-330. doi: 10.20892/j.issn.2095-3941.2018.0384.
• [1025] Correlation between maximum standardized uptake values on FDG-PET and microenvironmental factors in patients with clinical stage IA radiologic pure-solid lung adenocarcinoma.Lung Cancer. 2019 Oct;136:57-64. doi: 10.1016/j.lungcan.2019.08.003. Epub 2019 Aug 9.
• [1026] MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages.Oncogene. 2019 Jul;38(28):5599-5611. doi: 10.1038/s41388-019-0811-9. Epub 2019 Apr 9.
• [1027] Molecular response of 4T1-induced mouse mammary tumours and healthy tissues to zinc treatment.Int J Oncol. 2015 Apr;46(4):1810-8. doi: 10.3892/ijo.2015.2883. Epub 2015 Feb 9.
• [1028] Melatonin regulates the aging mouse hippocampal homeostasis via the sirtuin1-FOXO1 pathway.EXCLI J. 2017 Mar 23;16:340-353. doi: 10.17179/excli2016-852. eCollection 2017.
• [1029] Characterizing amide proton transfer imaging in haemorrhage brain lesions using 3T MRI.Eur Radiol. 2017 Apr;27(4):1577-1584. doi: 10.1007/s00330-016-4477-1. Epub 2016 Jul 6.
• [1030] Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.Carcinogenesis. 2009 Aug;30(8):1452-8. doi: 10.1093/carcin/bgp137. Epub 2009 Jun 11.
• [1031] Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.Exp Cell Res. 2019 Jul 1;380(1):9-19. doi: 10.1016/j.yexcr.2019.03.039. Epub 2019 Apr 2.
• [1032] MYLK promotes hepatocellular carcinoma progression through regulating cytoskeleton to enhance epithelial-mesenchymal transition.Clin Exp Med. 2018 Nov;18(4):523-533. doi: 10.1007/s10238-018-0509-2. Epub 2018 May 31.
• [1033] Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents.J Biol Chem. 2019 Jun 21;294(25):10006-10017. doi: 10.1074/jbc.RA119.007664. Epub 2019 May 17.
• [1034] Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.Oncotarget. 2017 Feb 7;8(6):9323-9338. doi: 10.18632/oncotarget.14067.
• [1035] FOXO1 functions in the regulation of nicotinamide phosphoribosyltransferase (Nampt) expression.Biochem Biophys Res Commun. 2019 Apr 2;511(2):398-403. doi: 10.1016/j.bbrc.2019.02.069. Epub 2019 Feb 21.
• [1036] Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.Cell Signal. 2017 Aug;36:67-78. doi: 10.1016/j.cellsig.2017.04.020. Epub 2017 Apr 25.
• [1037] Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.Chin Med J (Engl). 2018 Jan 5;131(1):16-24. doi: 10.4103/0366-6999.221262.
• [1038] Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer.Cancer Sci. 2019 Jan;110(1):458-467. doi: 10.1111/cas.13865. Epub 2018 Dec 10.
• [1039] Increased Nek1 expression in renal cell carcinoma cells is associated with decreased sensitivity to DNA-damaging treatment.Oncotarget. 2014 Jun 30;5(12):4283-94. doi: 10.18632/oncotarget.2005.
• [1040] NEK2 promotes proliferation, migration and tumor growth of gastric cancer cells via regulating KDM5B/H3K4me3.Am J Cancer Res. 2019 Nov 1;9(11):2364-2378. eCollection 2019.
• [1041] Overexpression of NIMA-related kinase 6 (NEK6) contributes to malignant growth and dismal prognosis in Human Breast Cancer.Pathol Res Pract. 2018 Oct;214(10):1648-1654. doi: 10.1016/j.prp.2018.07.030. Epub 2018 Jul 27.
• [1042] Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.Mol Oncol. 2017 Aug;11(8):1065-1077. doi: 10.1002/1878-0261.12074. Epub 2017 May 30.
• [1043] Survival kinase genes present prognostic significance in glioblastoma.Oncotarget. 2016 Apr 12;7(15):20140-51. doi: 10.18632/oncotarget.7917.
• [1044] Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels.Anticancer Drugs. 2019 Jun;30(5):441-450. doi: 10.1097/CAD.0000000000000767.
• [1045] Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma.Cancers (Basel). 2019 Aug 2;11(8):1102. doi: 10.3390/cancers11081102.
• [1046] Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.Int J Cancer. 2020 May 1;146(9):2576-2587. doi: 10.1002/ijc.32690. Epub 2019 Oct 31.
• [1047] Circulating mRNA signature as a marker for high-risk prostate cancer.Carcinogenesis. 2020 Apr 22;41(2):139-145. doi: 10.1093/carcin/bgz129.
• [1048] Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.Immunogenetics. 2019 Mar;71(3):273-282. doi: 10.1007/s00251-019-01106-z. Epub 2019 Jan 31.
• [1049] Modified round block technique for peripherally located early cancer breast, a technique that fits for all quadrants.Breast J. 2020 Mar;26(3):414-419. doi: 10.1111/tbj.13485. Epub 2019 Aug 25.
• [1050] NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells.J Hematol Oncol. 2018 Feb 26;11(1):28. doi: 10.1186/s13045-018-0573-9.
• [1051] Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma.Cancer Manag Res. 2019 Aug 15;11:7739-7749. doi: 10.2147/CMAR.S207801. eCollection 2019.
• [1052] Downregulation of Notch4 - a prognostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma.Braz J Otorhinolaryngol. 2019 Jan-Feb;85(1):11-16. doi: 10.1016/j.bjorl.2017.09.005. Epub 2017 Oct 31.
• [1053] Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo.Biomaterials. 2019 Mar;197:41-50. doi: 10.1016/j.biomaterials.2019.01.001. Epub 2019 Jan 4.
• [1054] Dual effects of human adipose tissue-derived mesenchymal stem cells in human lung adenocarcinoma A549 xenografts and colorectal adenocarcinoma HT-29 xenografts in mice.Oncol Rep. 2015 Oct;34(4):1733-44. doi: 10.3892/or.2015.4185. Epub 2015 Aug 7.
• [1055] Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma.Cancer Gene Ther. 2019 Jul;26(7-8):195-207. doi: 10.1038/s41417-018-0057-7. Epub 2018 Nov 23.
• [1056] Microsatellite instability and loss of heterozygosity in primary breast tumours.Tumour Biol. 1997;18(3):157-66. doi: 10.1159/000218026.
• [1057] XPC beyond nucleotide excision repair and skin cancers.Mutat Res Rev Mutat Res. 2019 Oct-Dec;782:108286. doi: 10.1016/j.mrrev.2019.108286. Epub 2019 Jul 8.
• [1058] LXR-mediated downregulation of EGFR suppress colorectal cancer cell proliferation.J Cell Biochem. 2019 Oct;120(10):17391-17404. doi: 10.1002/jcb.29003. Epub 2019 May 19.
• [1059] Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation.Hepatol Int. 2018 May;12(3):254-261. doi: 10.1007/s12072-018-9860-3. Epub 2018 Apr 12.
• [1060] A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancer.EBioMedicine. 2019 Feb;40:375-381. doi: 10.1016/j.ebiom.2018.12.060. Epub 2019 Jan 8.
• [1061] Deciphering CD4(+) T cell specificity using novel MHC-TCR chimeric receptors.Nat Immunol. 2019 May;20(5):652-662. doi: 10.1038/s41590-019-0335-z. Epub 2019 Mar 11.
• [1062] Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells.Microvasc Res. 2020 Mar;128:103934. doi: 10.1016/j.mvr.2019.103934. Epub 2019 Oct 23.
• [1063] Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.J Neurooncol. 2020 Jan;146(1):25-39. doi: 10.1007/s11060-019-03349-y. Epub 2019 Nov 21.
• [1064] Nr5a2 promotes tumor growth and metastasis of gastric cancer AGS cells by Wnt/beta-catenin signaling.Onco Targets Ther. 2019 Apr 17;12:2891-2902. doi: 10.2147/OTT.S201228. eCollection 2019.
• [1065] Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.PLoS One. 2014 Apr 11;9(4):e94606. doi: 10.1371/journal.pone.0094606. eCollection 2014.
• [1066] Characterization of the expression of the hypoxia-induced genes neuritin, TXNIP and IGFBP3 in cancer.FEBS Lett. 2006 Jun 12;580(14):3395-400. doi: 10.1016/j.febslet.2006.05.011. Epub 2006 May 11.
• [1067] Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.Clin Cancer Res. 2011 Apr 1;17(7):1741-52. doi: 10.1158/1078-0432.CCR-10-1890. Epub 2011 Feb 24.
• [1068] Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma Progression.Cancer Res. 2020 Feb 15;80(4):747-756. doi: 10.1158/0008-5472.CAN-18-1590. Epub 2019 Dec 5.
• [1069] Screening for NTRK-rearranged Tumors Using Immunohistochemistry: Comparison of 2 Different pan-TRK Clones in Melanoma Samples.Appl Immunohistochem Mol Morphol. 2020 Mar;28(3):194-196. doi: 10.1097/PAI.0000000000000708.
• [1070] Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.Cell Stem Cell. 2018 Apr 5;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011.
• [1071] A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.Nat Commun. 2018 Aug 29;9(1):3510. doi: 10.1038/s41467-018-05939-2.
• [1072] NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.Int J Cancer. 2019 Aug 1;145(3):662-670. doi: 10.1002/ijc.32134. Epub 2019 Feb 4.
• [1073] Prospective oncotarget for gynecological cancer: Opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.Int Immunopharmacol. 2019 Oct;75:105723. doi: 10.1016/j.intimp.2019.105723. Epub 2019 Aug 9.
• [1074] Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.Int J Cancer. 2020 Mar 1;146(5):1346-1358. doi: 10.1002/ijc.32535. Epub 2019 Jul 9.
• [1075] Design of a Novel PEGylated Liposomal Vector for Systemic Delivery of siRNA to Solid Tumors.Biol Pharm Bull. 2019;42(6):996-1003. doi: 10.1248/bpb.b19-00032.
• [1076] A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain.J Pain. 2018 Jun;19(6):612-625. doi: 10.1016/j.jpain.2018.01.002. Epub 2018 Jan 31.
• [1077] Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis.Front Oncol. 2019 Apr 5;9:235. doi: 10.3389/fonc.2019.00235. eCollection 2019.
• [1078] Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats.Front Pharmacol. 2018 May 15;9:509. doi: 10.3389/fphar.2018.00509. eCollection 2018.
• [1079] M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis.Cytokine. 2019 Jun;118:130-143. doi: 10.1016/j.cyto.2018.03.032. Epub 2018 Apr 3.
• [1080] Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.Nat Neurosci. 2016 Jun;19(6):798-806. doi: 10.1038/nn.4295. Epub 2016 Apr 25.
• [1081] Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma.Oncol Lett. 2019 Jun;17(6):5030-5038. doi: 10.3892/ol.2019.10174. Epub 2019 Mar 21.
• [1082] Extracellular vesicles in cancer immune responses: roles of purinergic receptors.Semin Immunopathol. 2018 Sep;40(5):465-475. doi: 10.1007/s00281-018-0706-9. Epub 2018 Sep 12.
• [1083] Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade.Acta Neuropathol Commun. 2017 Jan 10;5(1):4. doi: 10.1186/s40478-016-0405-5.
• [1084] SP174, NRAS Q61R Mutant-Specific Antibody, Cross-Reacts With KRAS Q61R Mutant Protein in Colorectal Carcinoma.Arch Pathol Lab Med. 2017 Apr;141(4):564-568. doi: 10.5858/arpa.2016-0147-OA. Epub 2017 Feb 28.
• [1085] Extracellular ATP and Purinergic P2Y(2) Receptor Signaling Promote Liver Tumorigenesis in Mice by Exacerbating DNA Damage.Cancer Res. 2020 Feb 15;80(4):699-708. doi: 10.1158/0008-5472.CAN-19-1909. Epub 2019 Dec 10.
• [1086] High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.J Clin Lab Anal. 2020 Mar;34(3):e23107. doi: 10.1002/jcla.23107. Epub 2019 Nov 29.
• [1087] Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression.J Int Med Res. 2011;39(2):533-40. doi: 10.1177/147323001103900222.
• [1088] Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency.Sci Transl Med. 2017 Mar 8;9(380):eaag0339. doi: 10.1126/scitranslmed.aag0339. Epub 2017 Mar 8.
• [1089] Elucidation of in vitro cellular steps induced by antitumor treatment with plasma-activated medium.Sci Rep. 2019 Mar 19;9(1):4866. doi: 10.1038/s41598-019-41408-6.
• [1090] Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14573-14582. doi: 10.1073/pnas.1908547116. Epub 2019 Jul 2.
• [1091] PARP3 controls TGF and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.Oncotarget. 2016 Sep 27;7(39):64109-64123. doi: 10.18632/oncotarget.11627.
• [1092] PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.Leukemia. 2019 Aug;33(8):1895-1909. doi: 10.1038/s41375-019-0430-z. Epub 2019 Mar 6.
• [1093] Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.PLoS One. 2018 Oct 4;13(10):e0204866. doi: 10.1371/journal.pone.0204866. eCollection 2018.
• [1094] Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.Eur J Pharm Sci. 2016 Sep 20;92:39-48. doi: 10.1016/j.ejps.2016.06.020. Epub 2016 Jun 26.
• [1095] Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer.Arch Med Sci. 2019 May;15(3):559-569. doi: 10.5114/aoms.2019.84732. Epub 2019 Apr 30.
• [1096] Gene therapy for colorectal cancer using adenovirus-mediated full-length antibody, cetuximab.Oncotarget. 2016 May 10;7(19):28262-72. doi: 10.18632/oncotarget.8596.
• [1097] Phosphodiesterase sequence variants may predispose to prostate cancer.Endocr Relat Cancer. 2015 Aug;22(4):519-30. doi: 10.1530/ERC-15-0134. Epub 2015 May 15.
• [1098] Rare inactivating PDE11A variants associated with testicular germ cell tumors.Endocr Relat Cancer. 2015 Dec;22(6):909-17. doi: 10.1530/ERC-15-0034.
• [1099] Targeting tumor cells based on Phosphodiesterase 3A expression.Exp Cell Res. 2017 Dec 15;361(2):308-315. doi: 10.1016/j.yexcr.2017.10.032. Epub 2017 Oct 26.
• [1100] Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells.Cancer Med. 2013 Feb;2(1):40-9. doi: 10.1002/cam4.56. Epub 2013 Feb 3.
• [1101] Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer.Biochem Biophys Res Commun. 2019 Jan 15;508(3):825-831. doi: 10.1016/j.bbrc.2018.12.004. Epub 2018 Dec 7.
• [1102] Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.Oncol Rep. 2014 Jul;32(1):250-60. doi: 10.3892/or.2014.3176. Epub 2014 May 15.
• [1103] Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.Cancer Lett. 2018 Sep 28;432:237-250. doi: 10.1016/j.canlet.2018.04.035. Epub 2018 Apr 28.
• [1104] OncoRep: an n-of-1 reporting tool to support genome-guided treatment for breast cancer patients using RNA-sequencing.BMC Med Genomics. 2015 May 21;8:24. doi: 10.1186/s12920-015-0095-z.
• [1105] Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.J Hepatol. 2019 Apr;70(4):700-709. doi: 10.1016/j.jhep.2018.12.004. Epub 2018 Dec 14.
• [1106] Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase.Int J Cancer. 2019 Feb 15;144(4):674-686. doi: 10.1002/ijc.31812. Epub 2018 Oct 4.
• [1107] PDK2 induces cisplatin-resistance in lung adenocarcinoma via transcriptional regulation of CNNM3.J Drug Target. 2019 Apr;27(4):460-465. doi: 10.1080/1061186X.2018.1550648. Epub 2018 Dec 4.
• [1108] Expression of PDK-1 and DMBT1 in the thyroid carcinoma and its clinicopathological significance.Oncol Lett. 2019 Sep;18(3):2819-2824. doi: 10.3892/ol.2019.10639. Epub 2019 Jul 18.
• [1109] Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.Hum Pathol. 2019 May;87:103-114. doi: 10.1016/j.humpath.2018.11.032. Epub 2019 Feb 2.
• [1110] Expression of phosphatidylethanolamine N-methyltransferase in human hepatocellular carcinomas.Oncology. 2003;65(2):152-8. doi: 10.1159/000072341.
• [1111] PEPD is a pivotal regulator of p53 tumor suppressor.Nat Commun. 2017 Dec 12;8(1):2052. doi: 10.1038/s41467-017-02097-9.
• [1112] Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer.Cancer Lett. 2019 Feb 28;443:1-12. doi: 10.1016/j.canlet.2018.11.017. Epub 2018 Nov 24.
• [1113] A mouse model of luciferase-transfected stromal cells of giant cell tumor of bone.Connect Tissue Res. 2015 Nov;56(6):493-503. doi: 10.3109/03008207.2015.1075519. Epub 2015 Sep 1.
• [1114] Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.Maturitas. 2019 May;123:1-8. doi: 10.1016/j.maturitas.2019.01.015. Epub 2019 Jan 31.
• [1115] PHF8 Plays an Oncogene Function in Hepatocellular Carcinoma Formation.Oncol Res. 2019 May 7;27(5):613-621. doi: 10.3727/096504018X15410353669149. Epub 2019 Feb 14.
• [1116] Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. Nat Commun. 2016 Dec 23;7:13755.
• [1117] Overexpression of phosphatidylinositol 4-kinase type III is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.BMC Cancer. 2014 Jan 6;14:7. doi: 10.1186/1471-2407-14-7.
• [1118] In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models.Mol Cancer Ther. 2016 Jul;15(7):1568-79. doi: 10.1158/1535-7163.MCT-15-0871. Epub 2016 Apr 19.
• [1119] Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer.Pharmacol Ther. 2020 Mar;207:107454. doi: 10.1016/j.pharmthera.2019.107454. Epub 2019 Dec 11.
• [1120] Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.Oncogene. 2020 Jan;39(3):720-721. doi: 10.1038/s41388-019-0982-4.
• [1121] The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.J Pediatr Surg. 2019 Jun;54(6):1206-1213. doi: 10.1016/j.jpedsurg.2019.02.029. Epub 2019 Feb 28.
• [1122] Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/-catenin oncogenic pathways.Mol Carcinog. 2019 Aug;58(8):1450-1464. doi: 10.1002/mc.23027. Epub 2019 Apr 26.
• [1123] Targeted suppression of AR-V7 using PIP5K1 inhibitor overcomes enzalutamide resistance in prostate cancer cells.Oncotarget. 2016 Sep 27;7(39):63065-63081. doi: 10.18632/oncotarget.11757.
• [1124] PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis.J Clin Invest. 2016 Feb;126(2):681-94. doi: 10.1172/JCI83587. Epub 2016 Jan 19.
• [1125] PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway.Mol Cancer. 2018 Jan 24;17(1):13. doi: 10.1186/s12943-017-0747-z.
• [1126] Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER/ERBB-elicited signaling in lung and prostate cancer cells.Int J Oncol. 2017 Jun;50(6):2113-2122. doi: 10.3892/ijo.2017.3964. Epub 2017 Apr 19.
• [1127] Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2 Activatable Fluorophore.Sci Rep. 2019 Apr 16;9(1):6122. doi: 10.1038/s41598-019-41626-y.
• [1128] Diagnostic marker signature for esophageal cancer from transcriptome analysis.Tumour Biol. 2016 May;37(5):6349-58. doi: 10.1007/s13277-015-4400-4. Epub 2015 Dec 2.
• [1129] Characterising the Subsite Specificity of Urokinase-Type Plasminogen Activator and Tissue-Type Plasminogen Activator using a Sequence-Defined Peptide Aldehyde Library.Chembiochem. 2019 Jan 2;20(1):46-50. doi: 10.1002/cbic.201800395. Epub 2018 Oct 24.
• [1130] MicroRNA-124 inhibits colorectal cancer cell proliferation and suppresses tumor growth by interacting with PLCB1 and regulating Wnt/-catenin signaling pathway.Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):121-136. doi: 10.26355/eurrev_201901_16756.
• [1131] Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment.Oncogene. 2019 Feb;38(8):1309-1323. doi: 10.1038/s41388-018-0527-2. Epub 2018 Oct 10.
• [1132] Differential expression of lipid metabolism-related proteins in different breast cancer subtypes.PLoS One. 2015 Mar 9;10(3):e0119473. doi: 10.1371/journal.pone.0119473. eCollection 2015.
• [1133] Tumor PD-L1 Induction by Resveratrol/Piceatannol May Function as a Search, Enhance, and Engage ("SEE") Signal to Facilitate the Elimination of "Cold, Non-Responsive" Low PD-L1-Expressing Tumors by PD-L1 Blockade.Int J Mol Sci. 2019 Nov 27;20(23):5969. doi: 10.3390/ijms20235969.
• [1134] Assessment of biological parameters in head and neck cancer based on in vivo distribution of (18)F-FDG-FLT-FMISO-PET/CT images.Tumori. 2020 Feb;106(1):33-38. doi: 10.1177/0300891619868012. Epub 2019 Aug 26.
• [1135] Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas.Int J Mol Sci. 2018 Oct 26;19(11):3353. doi: 10.3390/ijms19113353.
• [1136] Lipoprotein lipase and phospholipid transfer protein overexpression in human glioma cells and their effect on cell growth, apoptosis, and migration.Acta Biochim Biophys Sin (Shanghai). 2017 Jan;49(1):62-73. doi: 10.1093/abbs/gmw117. Epub 2016 Nov 17.
• [1137] Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.Drug Deliv. 2018 Nov;25(1):1394-1402. doi: 10.1080/10717544.2018.1480672.
• [1138] The mismatch repair gene hPMS1 (human postmeiotic segregation1) is down regulated in oral squamous cell carcinoma.Gene. 2013 Jul 15;524(1):28-34. doi: 10.1016/j.gene.2013.04.030. Epub 2013 Apr 20.
• [1139] Adrenergic differentiation and Ret expression in rat pheochromocytomas.Endocr Pathol. 2008 Spring;19(1):9-16. doi: 10.1007/s12022-008-9019-1.
• [1140] Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.Curr Pharm Des. 2017 Nov 8:10.2174/1381612823666171109101851. doi: 10.2174/1381612823666171109101851. Online ahead of print.
• [1141] Impact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder.Oncol Rep. 2015 Oct;34(4):1667-74. doi: 10.3892/or.2015.4151. Epub 2015 Jul 24.
• [1142] Vascular PPAR/ Promotes Tumor Angiogenesis and Progression.Cells. 2019 Dec 12;8(12):1623. doi: 10.3390/cells8121623.
• [1143] Diffuse large B cell lymphoma-derived extracellular vesicles educate macrophages to promote tumours progression by increasing PGC-1.Scand J Immunol. 2020 Feb;91(2):e12841. doi: 10.1111/sji.12841. Epub 2019 Dec 13.
• [1144] High expression level of peptidylprolyl isomerase A is correlated with poor prognosis of liver hepatocellular carcinoma.Oncol Lett. 2019 Nov;18(5):4691-4702. doi: 10.3892/ol.2019.10846. Epub 2019 Sep 10.
• [1145] Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients.Eur J Drug Metab Pharmacokinet. 2020 Apr;45(2):297-304. doi: 10.1007/s13318-019-00595-3.
• [1146] Metformin Inhibit Lung Cancer Cell Growth and Invasion in Vitro as Well as Tumor Formation in Vivo Partially by Activating PP2A.Med Sci Monit. 2019 Jan 29;25:836-846. doi: 10.12659/MSM.912059.
• [1147] PPP2R5A: A multirole protein phosphatase subunit in regulating cancer development.Cancer Lett. 2018 Feb 1;414:222-229. doi: 10.1016/j.canlet.2017.11.024. Epub 2017 Nov 23.
• [1148] Quantitative Proteomic Analysis and Evaluation of the Potential Prognostic Biomarkers in Cholangiocarcinoma.J Cancer. 2019 Jul 5;10(17):3985-3999. doi: 10.7150/jca.29354. eCollection 2019.
• [1149] Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.Int J Oncol. 2017 Jul;51(1):39-48. doi: 10.3892/ijo.2017.3997. Epub 2017 May 16.
• [1150] PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.Cancer Discov. 2019 Feb;9(2):220-229. doi: 10.1158/2159-8290.CD-18-0706. Epub 2018 Nov 15.
• [1151] Pancreatic polypeptide-related tumors.Peptides. 2002 Feb;23(2):339-48. doi: 10.1016/s0196-9781(01)00606-4.
• [1152] Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder.Virchows Arch. 2020 Apr;476(4):535-542. doi: 10.1007/s00428-019-02661-2. Epub 2019 Sep 2.
• [1153] PRG4 expression in myxoid liposarcoma maintains tumor cell growth through suppression of an antitumor cytokine IL-24.Biochem Biophys Res Commun. 2017 Mar 25;485(1):209-214. doi: 10.1016/j.bbrc.2017.02.055. Epub 2017 Feb 10.
• [1154] Deciphering molecular consequences of the proprotein convertase 1/3 inhibition in macrophages for application in anti-tumour immunotherapy.J Biotechnol. 2018 Sep 20;282:80-85. doi: 10.1016/j.jbiotec.2018.07.002. Epub 2018 Jul 7.
• [1155] Knockdown of PKC expression inhibits growth, induces apoptosis and decreases invasiveness of human glioma cells partially through Stat3.J Mol Neurosci. 2015 Jan;55(1):21-31. doi: 10.1007/s12031-014-0341-4. Epub 2014 Jun 4.
• [1156] The Enigmatic Protein Kinase C-eta.Cancers (Basel). 2019 Feb 13;11(2):214. doi: 10.3390/cancers11020214.
• [1157] Role and mechanism of circ-PRKCI in hepatocellular carcinoma.World J Gastroenterol. 2019 Apr 28;25(16):1964-1974. doi: 10.3748/wjg.v25.i16.1964.
• [1158] Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes.Mod Pathol. 2020 Jan;33(1):65-73. doi: 10.1038/s41379-019-0351-4. Epub 2019 Sep 6.
• [1159] Cancer risk from low dose radiation in Ptch1(+)(/)(-) mice with inactive DNA repair systems: Therapeutic implications for medulloblastoma.DNA Repair (Amst). 2019 Feb;74:70-79. doi: 10.1016/j.dnarep.2018.12.003. Epub 2018 Dec 16.
• [1160] Association of prolactin receptor (PRLR) variants with prolactinomas.Hum Mol Genet. 2019 Mar 15;28(6):1023-1037. doi: 10.1093/hmg/ddy396.
• [1161] Selective PRMT5 Inhibitors Suppress Human CD8(+) T Cells by Upregulation of p53 and Impairment of the AKT Pathway Similar to the Tumor Metabolite MTA. Mol Cancer Ther. 2020 Feb;19(2):409-419. doi: 10.1158/1535-7163.MCT-19-0189. Epub 2019 Nov 11.
• [1162] A reliable method to determine which candidate chemotherapeutic drugs effectively inhibit tumor growth in patient-derived xenografts (PDX) in single mouse trials.Cancer Chemother Pharmacol. 2019 Dec;84(6):1167-1178. doi: 10.1007/s00280-019-03942-y. Epub 2019 Sep 12.
• [1163] PRSS8 suppresses colorectal carcinogenesis and metastasis.Oncogene. 2019 Jan;38(4):497-517. doi: 10.1038/s41388-018-0453-3. Epub 2018 Aug 16.
• [1164] Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer.Scand J Gastroenterol. 2019 Feb;54(2):246-251. doi: 10.1080/00365521.2019.1574360. Epub 2019 Mar 17.
• [1165] [(89)Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model.Mol Imaging Biol. 2020 Apr;22(2):367-376. doi: 10.1007/s11307-019-01386-7.
• [1166] TRAF6 promotes TGF-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGF type I receptor.Cell Cycle. 2015;14(4):554-65. doi: 10.4161/15384101.2014.990302.
• [1167] Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma.Eur J Haematol. 2017 Jan;98(1):52-56. doi: 10.1111/ejh.12784. Epub 2016 Jul 12.
• [1168] Heat shock protein induced TCR gammadelta gene rearrangements in patients with oral cancer.Oral Oncol. 2005 Feb;41(2):175-82. doi: 10.1016/j.oraloncology.2004.08.007.
• [1169] Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers.Cancer Res Treat. 2019 Jan;51(1):80-89. doi: 10.4143/crt.2017.500. Epub 2018 Feb 26.
• [1170] Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating -catenin/c-Myc signaling in human hepatocellular carcinoma.Cancer Lett. 2019 Feb 28;443:34-46. doi: 10.1016/j.canlet.2018.11.030. Epub 2018 Nov 29.
• [1171] Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death.Front Oncol. 2018 Feb 5;8:10. doi: 10.3389/fonc.2018.00010. eCollection 2018.
• [1172] Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.Cancer Lett. 2019 May 1;449:31-44. doi: 10.1016/j.canlet.2019.01.041. Epub 2019 Feb 10.
• [1173] Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review).Int J Mol Med. 2018 Sep;42(3):1203-1214. doi: 10.3892/ijmm.2018.3744. Epub 2018 Jun 26.
• [1174] Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.Clin Cancer Res. 2015 Nov 15;21(22):5151-63. doi: 10.1158/1078-0432.CCR-15-0505. Epub 2015 Jun 30.
• [1175] Decreased expression of PTH1R is a poor prognosis in hepatocellular carcinoma.Cancer Biomark. 2018 Feb 14;21(3):723-730. doi: 10.3233/CBM-170823.
• [1176] BRK phosphorylates SMAD4 for proteasomal degradation and inhibits tumor suppressor FRK to control SNAIL, SLUG, and metastatic potential.Sci Adv. 2019 Oct 23;5(10):eaaw3113. doi: 10.1126/sciadv.aaw3113. eCollection 2019 Oct.
• [1177] Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours.Cell Prolif. 2019 Jan;52(1):e12511. doi: 10.1111/cpr.12511. Epub 2018 Oct 12.
• [1178] MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.Mol Med Rep. 2014 Sep;10(3):1426-32. doi: 10.3892/mmr.2014.2335. Epub 2014 Jun 16.
• [1179] miR-146b Regulates Cell Proliferation and Apoptosis in Gastric Cancer by Targeting PTP1B.Dig Dis Sci. 2020 Feb;65(2):457-463. doi: 10.1007/s10620-019-05771-8. Epub 2019 Aug 22.
• [1180] A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth.Sci Rep. 2019 Jul 29;9(1):10917. doi: 10.1038/s41598-019-46680-0.
• [1181] PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7033-7042. doi: 10.1073/pnas.1819534116. Epub 2019 Mar 20.
• [1182] PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumours.EMBO J. 2020 Jan 15;39(2):e103637. doi: 10.15252/embj.2019103637. Epub 2019 Dec 5.
• [1183] Meta-analysis of association between Arg326Gln (rs1503185) and Gln276Pro (rs1566734) polymorphisms of PTPRJ gene and cancer risk.J Appl Genet. 2019 Feb;60(1):57-62. doi: 10.1007/s13353-019-00481-3. Epub 2019 Jan 19.
• [1184] A novel PTPRZ1-ETV1 fusion in gliomas.Brain Pathol. 2020 Mar;30(2):226-234. doi: 10.1111/bpa.12776. Epub 2019 Aug 27.
• [1185] Peptide tyrosine-tyrosine combined with its receptors exhibits an anti-cancer potential in pancreatic cancer MiaPaCa-2 cell.Chin Med J (Engl). 2014;127(24):4235-42.
• [1186] The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.Gynecol Oncol. 2014 May;133(2):382-7. doi: 10.1016/j.ygyno.2013.12.012. Epub 2013 Dec 14.
• [1187] Role of miR-520b in non-small cell lung cancer.Exp Ther Med. 2018 Nov;16(5):3987-3995. doi: 10.3892/etm.2018.6732. Epub 2018 Sep 12.
• [1188] Tumor-Derived Extracellular Vesicles Breach the Intact Blood-Brain Barrier via Transcytosis.ACS Nano. 2019 Dec 24;13(12):13853-13865. doi: 10.1021/acsnano.9b04397. Epub 2019 Sep 10.
• [1189] A bidirectional effect of Rac1 inhibition-Protects radiation-induced intestinal injury while inhibits tumor.Life Sci. 2020 Jan 1;240:117105. doi: 10.1016/j.lfs.2019.117105. Epub 2019 Nov 28.
• [1190] Silencing of Rac3 inhibits proliferation and induces apoptosis of human lung cancer cells.Asian Pac J Cancer Prev. 2015;16(7):3061-5. doi: 10.7314/apjcp.2015.16.7.3061.
• [1191] cAMP regulated EPAC1 supports microvascular density, angiogenic and metastatic properties in a model of triple negative breast cancer.Carcinogenesis. 2018 Oct 8;39(10):1245-1253. doi: 10.1093/carcin/bgy090.
• [1192] Selective Agonists of Nuclear Retinoic Acid Receptor Gamma Inhibit Growth of HCS-2/8 Chondrosarcoma Cells.J Orthop Res. 2020 May;38(5):1045-1051. doi: 10.1002/jor.24555. Epub 2019 Dec 19.
• [1193] RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC).Biomed Pharmacother. 2019 Oct;118:109250. doi: 10.1016/j.biopha.2019.109250. Epub 2019 Aug 13.
• [1194] Down-regulation of retinol binding protein 5 is associated with aggressive tumor features in hepatocellular carcinoma.J Cancer Res Clin Oncol. 2007 Dec;133(12):929-36. doi: 10.1007/s00432-007-0230-0. Epub 2007 May 12.
• [1195] Autophagy Controls CSL/RBPJ Stability through a p62/SQSTM1-Dependent Mechanism.Cell Rep. 2018 Sep 18;24(12):3108-3114.e4. doi: 10.1016/j.celrep.2018.08.043.
• [1196] Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.Oncol Rep. 2018 Mar;39(3):1099-1111. doi: 10.3892/or.2018.6214. Epub 2018 Jan 12.
• [1197] A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/-catenin signaling.Int J Cancer. 2020 May 15;146(10):2877-2890. doi: 10.1002/ijc.32728. Epub 2019 Nov 23.
• [1198] The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.Leuk Res. 2017 Mar;54:30-38. doi: 10.1016/j.leukres.2017.01.001. Epub 2017 Jan 9.
• [1199] A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas.Genes Chromosomes Cancer. 2008 Sep;47(9):766-80. doi: 10.1002/gcc.20578.
• [1200] Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression.Sci Rep. 2018 Nov 22;8(1):17259. doi: 10.1038/s41598-018-35332-4.
• [1201] High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer.Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):397-407. doi: 10.1158/1055-9965.EPI-10-0514. Epub 2010 Dec 6.
• [1202] The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion.Curr Cancer Drug Targets. 2008 Aug;8(5):404-13. doi: 10.2174/156800908785133141.
• [1203] Glucosylated nanomicelles target glucose-avid pediatric patient-derived sarcomas.J Control Release. 2018 Apr 28;276:59-71. doi: 10.1016/j.jconrel.2018.02.034. Epub 2018 Feb 28.
• [1204] RHO GTPases in cancer: known facts, open questions, and therapeutic challenges.Biochem Soc Trans. 2018 Jun 19;46(3):741-760. doi: 10.1042/BST20170531. Epub 2018 Jun 5.
• [1205] Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer.Cancer Discov. 2020 Feb;10(2):288-305. doi: 10.1158/2159-8290.CD-19-0811. Epub 2019 Nov 26.
• [1206] The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.EMBO Mol Med. 2017 Feb;9(2):238-250. doi: 10.15252/emmm.201606646.
• [1207] PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.Carcinogenesis. 2018 Mar 8;39(3):418-428. doi: 10.1093/carcin/bgx120.
• [1208] Mutated Rnf43 Aggravates Helicobacter Pylori-Induced Gastric Pathology.Cancers (Basel). 2019 Mar 16;11(3):372. doi: 10.3390/cancers11030372.
• [1209] RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer.Clin Cancer Res. 2018 Mar 15;24(6):1473-1485. doi: 10.1158/1078-0432.CCR-17-2133. Epub 2017 Dec 29.
• [1210] Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein.Mol Cell Biol. 2015 Jul;35(14):2464-78. doi: 10.1128/MCB.00300-15.
• [1211] 2-APB and CBD-Mediated Targeting of Charged Cytotoxic Compounds Into Tumor Cells Suggests the Involvement of TRPV2 Channels.Front Pharmacol. 2019 Oct 15;10:1198. doi: 10.3389/fphar.2019.01198. eCollection 2019.
• [1212] Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature.Int J Med Sci. 2019 Jan 1;16(1):115-124. doi: 10.7150/ijms.28735. eCollection 2019.
• [1213] FLI1 Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer.Clin Cancer Res. 2019 Feb 15;25(4):1302-1317. doi: 10.1158/1078-0432.CCR-18-1447. Epub 2018 Nov 14.
• [1214] Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas.J Oral Pathol Med. 2018 Feb;47(2):121-127. doi: 10.1111/jop.12651. Epub 2017 Nov 7.
• [1215] Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis.Oncotarget. 2017 Apr 4;8(14):23978-23995. doi: 10.18632/oncotarget.15074.
• [1216] Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery.PLoS One. 2013 Jun 25;8(6):e66927. doi: 10.1371/journal.pone.0066927. Print 2013.
• [1217] RSK1 promotes murine breast cancer growth and metastasis.Folia Histochem Cytobiol. 2018;56(1):11-20. doi: 10.5603/FHC.a2018.0001. Epub 2018 Mar 2.
• [1218] RSK activation via ERK modulates human colon cancer cells response to PTHrP.J Mol Endocrinol. 2017 Jul;59(1):13-27. doi: 10.1530/JME-16-0216. Epub 2017 Apr 6.
• [1219] RSK4 inhibits breast cancer cell proliferation and invasion invitro, and is correlated with estrogen receptor upregulation in breast cancer.Oncol Rep. 2019 Dec;42(6):2777-2787. doi: 10.3892/or.2019.7328. Epub 2019 Sep 20.
• [1220] Genetic variants in the mTOR pathway and breast cancer risk in African American women.Carcinogenesis. 2016 Jan;37(1):49-55. doi: 10.1093/carcin/bgv160. Epub 2015 Nov 16.
• [1221] Tumor suppressive activity of PIWI-interacting RNA in human fibrosarcoma mediated through repression of RRM2.Mol Carcinog. 2019 Mar;58(3):344-357. doi: 10.1002/mc.22932. Epub 2018 Nov 25.
• [1222] Association of CAA and TATC Insertion/Deletion Genetic Polymorphisms in RTN4 3'-UTR with Hepatocellular Carcinoma Risk.Pathol Oncol Res. 2018 Jan;24(1):31-34. doi: 10.1007/s12253-017-0204-8. Epub 2017 Jan 31.
• [1223] Gadofosveset-enhanced MRI as simple surrogate parameter for real-time evaluation of the initial tumour vessel infarction by retargeted tissue factor tTF-NGR.Oncol Lett. 2019 Jan;17(1):270-280. doi: 10.3892/ol.2018.9638. Epub 2018 Oct 29.
• [1224] RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells via KLF4-mediated transactivation of P57.Haematologica. 2019 Aug;104(8):1597-1607. doi: 10.3324/haematol.2018.192773. Epub 2019 Feb 21.
• [1225] Expression of LDL-A module of relaxin receptor in prostate cancer cells inhibits tumorigenesis.Int J Oncol. 2011 Dec;39(6):1559-65. doi: 10.3892/ijo.2011.1159. Epub 2011 Aug 12.
• [1226] Expression and clinical significance of retinoid X receptor in esophageal carcinoma.Ann Diagn Pathol. 2018 Jun;34:110-115. doi: 10.1016/j.anndiagpath.2018.03.003. Epub 2018 Mar 28.
• [1227] Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.Br J Cancer. 2019 Oct;121(9):776-785. doi: 10.1038/s41416-019-0589-0. Epub 2019 Sep 27.
• [1228] Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate. Exp Ther Med. 2017 Jun;13(6):2812-2818.
• [1229] Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer.Cell Death Dis. 2019 Jan 18;10(2):50. doi: 10.1038/s41419-018-1298-y.
• [1230] Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.Oncogene. 2019 Aug;38(33):6095-6108. doi: 10.1038/s41388-019-0862-y. Epub 2019 Jul 9.
• [1231] The immune modulation of Clara cell-10 in human peripheral monocytes and dendritic cells.Int J Mol Med. 2010 Sep;26(3):415-23.
• [1232] Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy.Oncologist. 2019 Mar;24(3):293-300. doi: 10.1634/theoncologist.2018-0387. Epub 2019 Jan 2.
• [1233] Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.Mod Pathol. 2011 May;24(5):638-45. doi: 10.1038/modpathol.2010.230. Epub 2011 Jan 14.
• [1234] Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma.Oncotarget. 2017 Jul 10;8(35):59086-59102. doi: 10.18632/oncotarget.19175. eCollection 2017 Aug 29.
• [1235] Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT.Blood. 2018 Apr 19;131(16):1846-1857. doi: 10.1182/blood-2017-09-805879. Epub 2018 Jan 8.
• [1236] Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.Arterioscler Thromb Vasc Biol. 2018 May;38(5):1202-1215. doi: 10.1161/ATVBAHA.117.310506. Epub 2018 Mar 15.
• [1237] Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model.Haematologica. 2020 Jan 31;105(2):457-467. doi: 10.3324/haematol.2018.212266. Print 2020.
• [1238] Expression of septin 2 and association with clinicopathological parameters in colorectal cancer.Oncol Lett. 2019 Sep;18(3):2376-2383. doi: 10.3892/ol.2019.10528. Epub 2019 Jun 26.
• [1239] Tumor cell-specific Serpin A1 expression in vulvar squamous cell carcinoma.Arch Gynecol Obstet. 2019 May;299(5):1345-1351. doi: 10.1007/s00404-018-5015-y. Epub 2019 Jan 4.
• [1240] Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.Cancer Sci. 2019 May;110(5):1552-1563. doi: 10.1111/cas.13986. Epub 2019 Apr 15.
• [1241] Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.PLoS One. 2019 Apr 19;14(4):e0215089. doi: 10.1371/journal.pone.0215089. eCollection 2019.
• [1242] "Equivocal" high-risk HPV DNA tests performed on ThinPrep specimens after ASC-US diagnoses are associated with an increased incidence of CIN3: a cytologic/histologic review of 315 cases.J Low Genit Tract Dis. 2014 Oct;18(4):291-7. doi: 10.1097/LGT.0000000000000018.
• [1243] Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.Urol Oncol. 2018 Aug;36(8):366.e1-366.e9. doi: 10.1016/j.urolonc.2018.05.021. Epub 2018 Jun 19.
• [1244] The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research.J Cancer Res Clin Oncol. 2018 Dec;144(12):2319-2328. doi: 10.1007/s00432-018-2739-9. Epub 2018 Aug 20.
• [1245] Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients.EBioMedicine. 2018 Nov;37:134-143. doi: 10.1016/j.ebiom.2018.10.036. Epub 2018 Oct 22.
• [1246] Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.Blood. 2019 Jun 20;133(25):2682-2695. doi: 10.1182/blood-2018-10-880690. Epub 2019 Apr 1.
• [1247] Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.Int J Biochem Cell Biol. 2019 Apr;109:23-32. doi: 10.1016/j.biocel.2019.01.016. Epub 2019 Jan 30.
• [1248] Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer.Front Oncol. 2019 Jul 9;9:542. doi: 10.3389/fonc.2019.00542. eCollection 2019.
• [1249] Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway.Cytotechnology. 2018 Feb;70(1):439-448. doi: 10.1007/s10616-017-0160-x. Epub 2017 Nov 6.
• [1250] ER-mitochondria interactions: Both strength and weakness within cancer cells.Biochim Biophys Acta Mol Cell Res. 2019 Apr;1866(4):650-662. doi: 10.1016/j.bbamcr.2019.01.009. Epub 2019 Jan 19.
• [1251] Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model.Mol Carcinog. 2016 May;55(5):600-10. doi: 10.1002/mc.22306. Epub 2015 Mar 14.
• [1252] Altered expression of sphingosine-1-phosphate metabolizing enzymes in oral cancer correlate with clinicopathological attributes. Cancer Invest. 2017 Feb 7;35(2):139-141.
• [1253] Molecular correlates of cerebellar mutism syndrome in medulloblastoma.Neuro Oncol. 2020 Feb 20;22(2):290-297. doi: 10.1093/neuonc/noz158.
• [1254] Imaging Sigma-1 Receptor (S1R) Expression Using Iodine-124-Labeled 1-(4-Iodophenyl)-3-(2-adamantyl)guanidine ([(124)I]IPAG).Mol Imaging Biol. 2020 Apr;22(2):358-366. doi: 10.1007/s11307-019-01369-8.
• [1255] Tumor mutational load predicts survival after immunotherapy across multiple cancer types.Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038/s41588-018-0312-8. Epub 2019 Jan 14.
• [1256] Downregulated Salt-inducible Kinase 3 Expression Promotes Chemoresistance in Serous Ovarian Cancer via the ATP-binding Cassette Protein ABCG2.J Cancer. 2019 Oct 15;10(24):6025-6036. doi: 10.7150/jca.34886. eCollection 2019.
• [1257] RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP- on Monocytes/Macrophages.Transl Oncol. 2019 Apr;12(4):626-632. doi: 10.1016/j.tranon.2018.12.001. Epub 2019 Feb 6.
• [1258] QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives.J Biomol Struct Dyn. 2020 Feb;38(2):354-363. doi: 10.1080/07391102.2019.1574603. Epub 2019 Feb 21.
• [1259] The prognostic role of Skp2 and the tumor suppressor protein p27 in colorectal cancer.J BUON. 2017 Sep-Oct;22(5):1122-1130.
• [1260] SLAMF6 as a Regulator of Exhausted CD8(+) T Cells in Cancer.Cancer Immunol Res. 2019 Sep;7(9):1485-1496. doi: 10.1158/2326-6066.CIR-18-0664. Epub 2019 Jul 17.
• [1261] Low DMT1 Expression Associates With IncreasedOxidative Phosphorylation and EarlyRecurrence in Hepatocellular Carcinoma.J Surg Res. 2019 Feb;234:343-352. doi: 10.1016/j.jss.2018.11.008.
• [1262] SPAK mediates KCC3-enhanced cervical cancer tumorigenesis.FEBS J. 2014 May;281(10):2353-65. doi: 10.1111/febs.12787. Epub 2014 Apr 7.
• [1263] Response to immunohistochemical markers' conversion after neoadjuvant chemotherapy in breast cancer patients: association between imaging and histopathologic analysis.Clin Transl Oncol. 2020 Jan;22(1):91-102. doi: 10.1007/s12094-019-02112-z. Epub 2019 Apr 20.
• [1264] Serum AKR1B10 predicts the risk of hepatocellular carcinoma - A retrospective single-center study.Gastroenterol Hepatol. 2019 Dec;42(10):614-621. doi: 10.1016/j.gastrohep.2019.06.007. Epub 2019 Sep 5.
• [1265] Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?.Q J Nucl Med Mol Imaging. 2017 Dec;61(4):447-455. doi: 10.23736/S1824-4785.17.02803-5. Epub 2015 Apr 17.
• [1266] Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.Mol Cancer Res. 2004 Aug;2(8):477-87.
• [1267] Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach.Metabolites. 2019 Mar 13;9(3):50. doi: 10.3390/metabo9030050.
• [1268] Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib. Br J Pharmacol. 2019 Mar;176(6):787-800.
• [1269] Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.Dig Dis Sci. 2011 Oct;56(10):3072-7. doi: 10.1007/s10620-011-1686-y. Epub 2011 Mar 30.
• [1270] Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes. Sci Rep. 2016 Jul 20;6:29930.
• [1271] The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models.Cancers (Basel). 2019 Mar 13;11(3):359. doi: 10.3390/cancers11030359.
• [1272] Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience.Medicine (Baltimore). 2019 Nov;98(47):e18020. doi: 10.1097/MD.0000000000018020.
• [1273] High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.Dis Markers. 2019 Apr 4;2019:5702026. doi: 10.1155/2019/5702026. eCollection 2019.
• [1274] Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state. Br J Pharmacol. 2018 Nov;175(22):4209-4217.
• [1275] Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.Br J Cancer. 2018 Apr;118(7):947-954. doi: 10.1038/s41416-018-0004-2. Epub 2018 Mar 8.
• [1276] Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer.FEBS Lett. 2020 Mar;594(6):1021-1035. doi: 10.1002/1873-3468.13686. Epub 2019 Nov 29.
• [1277] Expressions of IGF-1, ERK, GLUT4, IRS-1 in metabolic syndrome complicated with colorectal cancer and their associations with the clinical characteristics of CRC.Cancer Biomark. 2018;21(4):883-891. doi: 10.3233/CBM-170942.
• [1278] Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.J Cell Biochem. 2019 Jun;120(6):10205-10214. doi: 10.1002/jcb.28305. Epub 2018 Dec 28.
• [1279] Expression of reactive species related genes is associated with patient survival in luminal B breast cancer.Free Radic Biol Med. 2018 May 20;120:170-180. doi: 10.1016/j.freeradbiomed.2018.03.011. Epub 2018 Mar 12.
• [1280] Liver-directed gene therapy for murine glycogen storage disease type Ib.Hum Mol Genet. 2017 Nov 15;26(22):4395-4405. doi: 10.1093/hmg/ddx325.
• [1281] Direct comparison of 2amino[3?1C]isobutyric acid and 2amino[11C]methylisobutyric acid uptake in eight lung cancer xenograft models.Int J Oncol. 2018 Dec;53(6):2737-2744. doi: 10.3892/ijo.2018.4596. Epub 2018 Oct 16.
• [1282] Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.Mol Cancer Res. 2003 Sep;1(11):826-35.
• [1283] Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells.Cancer Res. 2016 Nov 1;76(21):6193-6204. doi: 10.1158/0008-5472.CAN-15-3502. Epub 2016 Sep 20.
• [1284] Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma.Cell. 2019 Oct 31;179(4):829-845.e20. doi: 10.1016/j.cell.2019.10.003.
• [1285] The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer.Mol Cancer Ther. 2016 Nov;15(11):2679-2687. doi: 10.1158/1535-7163.MCT-16-0225. Epub 2016 Aug 22.
• [1286] Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications.Int Braz J Urol. 2019 Jan-Feb;45(1):169-178. doi: 10.1590/S1677-5538.IBJU.2018.0271.
• [1287] Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma.Biomed Res Int. 2015;2015:593572. doi: 10.1155/2015/593572. Epub 2015 May 27.
• [1288] Low-Protein Diet Induces IRE1-Dependent Anticancer Immunosurveillance.Cell Metab. 2018 Apr 3;27(4):828-842.e7. doi: 10.1016/j.cmet.2018.02.009.
• [1289] Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma.Cancer Res. 2020 Feb 1;80(3):499-509. doi: 10.1158/0008-5472.CAN-19-1577. Epub 2019 Nov 13.
• [1290] Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.Ann Nucl Med. 2019 Jun;33(6):394-403. doi: 10.1007/s12149-019-01346-9. Epub 2019 Feb 28.
• [1291] Sodium/calcium exchanger is involved in apoptosis induced by H(2)S in tumor cells through decreased levels of intracellular pH.Nitric Oxide. 2019 Jun 1;87:1-9. doi: 10.1016/j.niox.2019.02.011. Epub 2019 Mar 5.
• [1292] Cutaneous pH landscape as a facilitator of melanoma initiation and progression.Acta Physiol (Oxf). 2019 Jan;225(1):e13105. doi: 10.1111/apha.13105. Epub 2018 Jun 17.
• [1293] OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy.Br J Cancer. 2015 Mar 3;112(5):857-65. doi: 10.1038/bjc.2015.5. Epub 2015 Jan 22.
• [1294] Role of OATP transporters in steroid uptake by prostate cancer cells in vivo.Prostate Cancer Prostatic Dis. 2017 Mar;20(1):20-27. doi: 10.1038/pcan.2016.42. Epub 2016 Sep 20.
• [1295] Organic anion-transporting polypeptide 1B3 as a dual reporter gene for fluorescence and magnetic resonance imaging.FASEB J. 2018 Mar;32(3):1705-1715. doi: 10.1096/fj.201700767R. Epub 2018 Jan 3.
• [1296] High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy.Oncotarget. 2018 Feb 8;9(18):14207-14218. doi: 10.18632/oncotarget.24453. eCollection 2018 Mar 6.
• [1297] SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.Clin Epigenetics. 2019 Jul 9;11(1):99. doi: 10.1186/s13148-019-0693-2.
• [1298] Loss of BRG1 (SMARCA4) Immunoexpression in a Pediatric Non-Central Nervous System Tumor Cohort.Pediatr Dev Pathol. 2020 Mar-Apr;23(2):132-138. doi: 10.1177/1093526619869154. Epub 2019 Aug 12.
• [1299] Identification of new hypoxia-regulated epithelial-mesenchymal transition marker genes labeled by H3K4 acetylation.Genes Chromosomes Cancer. 2020 Feb;59(2):73-83. doi: 10.1002/gcc.22802. Epub 2019 Sep 3.
• [1300] Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.Oncol Lett. 2019 Apr;17(4):3851-3861. doi: 10.3892/ol.2019.10054. Epub 2019 Feb 19.
• [1301] Overexpression of SMYD3 in Ovarian Cancer is Associated with Ovarian Cancer Proliferation and Apoptosis via Methylating H3K4 and H4K20.J Cancer. 2019 Jul 8;10(17):4072-4084. doi: 10.7150/jca.29861. eCollection 2019.
• [1302] Rapid Contour-based Segmentation for (18)F-FDG PET Imaging of Lung Tumors by Using ITK-SNAP: Comparison to Expert-based Segmentation.Radiology. 2018 Jul;288(1):277-284. doi: 10.1148/radiol.2018171756. Epub 2018 Apr 3.
• [1303] Multi-slice spiral CT evaluation of breast cancer chemotherapy and correlation between CT results and breast cancerspecific gene 1.J BUON. 2018 Mar-Apr;23(2):378-383.
• [1304] Intracellular mechanisms underlying lipid accumulation (white opaque substance) in gastric epithelial neoplasms: A pilot study of expression profiles of lipid-metabolism-associated genes.J Gastroenterol Hepatol. 2016 Apr;31(4):776-81. doi: 10.1111/jgh.13216.
• [1305] Imaging Features of Succinate Dehydrogenase-deficient Pheochromocytoma-Paraganglioma Syndromes.Radiographics. 2019 Sep-Oct;39(5):1393-1410. doi: 10.1148/rg.2019180151.
• [1306] ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.Neuro Oncol. 2013 Aug;15(8):990-1007. doi: 10.1093/neuonc/not039. Epub 2013 Apr 10.
• [1307] Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.JCI Insight. 2019 Apr 9;5(9):e125543. doi: 10.1172/jci.insight.125543.
• [1308] SOX5 predicts poor prognosis in lung adenocarcinoma and promotes tumor metastasis through epithelial-mesenchymal transition.Oncotarget. 2017 Nov 6;9(13):10891-10904. doi: 10.18632/oncotarget.22443. eCollection 2018 Feb 16.
• [1309] Specific protein 1, c-Abl and ERK1/2 form a regulatory loop.J Cell Sci. 2019 Jan 2;132(1):jcs222380. doi: 10.1242/jcs.222380.
• [1310] Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.Anticancer Res. 2019 Feb;39(2):663-670. doi: 10.21873/anticanres.13161.
• [1311] Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.Oncogene. 2019 Feb;38(8):1151-1165. doi: 10.1038/s41388-018-0504-9. Epub 2018 Sep 24.
• [1312] Hericium erinaceus isolectins recognize mucin-type O-glycans as tumor-associated carbohydrate antigens on the surface of K562 human leukemia cells.Int J Biol Macromol. 2018 Dec;120(Pt A):1093-1102. doi: 10.1016/j.ijbiomac.2018.08.115. Epub 2018 Aug 24.
• [1313] EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.Oncogene. 2017 Feb 9;36(6):766-776. doi: 10.1038/onc.2016.244. Epub 2016 Jul 4.
• [1314] Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.Sci Transl Med. 2018 Apr 18;10(437):eaap9840. doi: 10.1126/scitranslmed.aap9840.
• [1315] SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity.Cell Death Dis. 2019 Sep 11;10(9):672. doi: 10.1038/s41419-019-1884-7.
• [1316] Serine/arginine protein-specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53.FEBS J. 2019 May;286(9):1668-1682. doi: 10.1111/febs.14778. Epub 2019 Mar 1.
• [1317] Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.Gastroenterology. 2020 Feb;158(3):583-597.e1. doi: 10.1053/j.gastro.2019.10.040. Epub 2019 Nov 9.
• [1318] SSRP1 promotes colorectal cancer progression and is negatively regulated by miR-28-5p.J Cell Mol Med. 2019 May;23(5):3118-3129. doi: 10.1111/jcmm.14134. Epub 2019 Feb 14.
• [1319] Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas.Hum Pathol. 2019 Apr;86:66-75. doi: 10.1016/j.humpath.2018.11.020. Epub 2018 Dec 8.
• [1320] Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.Mol Cell Endocrinol. 2019 Mar 1;483:31-38. doi: 10.1016/j.mce.2018.12.022. Epub 2019 Jan 3.
• [1321] A nanometer-sized protease inhibitor for precise cancer diagnosis and treatment.J Mater Chem B. 2020 Jan 22;8(3):504-514. doi: 10.1039/c9tb02081k.
• [1322] Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.Cell Prolif. 2018 Dec;51(6):e12507. doi: 10.1111/cpr.12507. Epub 2018 Aug 13.
• [1323] Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8(+) T-cell Response against Immunosuppressive Tumors.Clin Cancer Res. 2019 Jun 1;25(11):3289-3303. doi: 10.1158/1078-0432.CCR-18-3016. Epub 2019 Feb 12.
• [1324] QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-B signalling.J Cell Mol Med. 2019 Oct;23(10):6578-6594. doi: 10.1111/jcmm.14481. Epub 2019 Aug 26.
• [1325] Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth.J Neurooncol. 2019 May;143(1):35-47. doi: 10.1007/s11060-019-03143-w. Epub 2019 Apr 16.
• [1326] Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer.Mol Cell Endocrinol. 2020 Feb 15;502:110659. doi: 10.1016/j.mce.2019.110659. Epub 2019 Dec 7.
• [1327] Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.Biosci Rep. 2019 Apr 26;39(4):BSR20182057. doi: 10.1042/BSR20182057. Print 2019 Apr 30.
• [1328] A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model.Anticancer Res. 2009 Mar;29(3):843-50.
• [1329] Serine Threonine Kinase 17A Maintains the Epithelial State in Colorectal Cancer Cells.Mol Cancer Res. 2019 Apr;17(4):882-894. doi: 10.1158/1541-7786.MCR-18-0990. Epub 2019 Jan 17.
• [1330] NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.J Exp Clin Cancer Res. 2019 Apr 12;38(1):158. doi: 10.1186/s13046-019-1145-8.
• [1331] Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.Oncotarget. 2016 Sep 20;7(38):61366-61377. doi: 10.18632/oncotarget.11351.
• [1332] EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.Front Immunol. 2018 Oct 16;9:2400. doi: 10.3389/fimmu.2018.02400. eCollection 2018.
• [1333] Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level.IUBMB Life. 2018 Feb;70(2):120-128. doi: 10.1002/iub.1707. Epub 2017 Dec 28.
• [1334] Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.EMBO J. 2020 Jan 2;39(1):e102406. doi: 10.15252/embj.2019102406. Epub 2019 Nov 29.
• [1335] TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment.Nucleic Acids Res. 2019 Apr 23;47(7):3365-3382. doi: 10.1093/nar/gkz041.
• [1336] Activating Structural Alterations in MAPK Genes Are Distinct Genetic Drivers in a Unique Subgroup Of Spitzoid Neoplasms.Am J Surg Pathol. 2019 Apr;43(4):538-548. doi: 10.1097/PAS.0000000000001213.
• [1337] Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.Clin Cancer Res. 2019 Feb 15;25(4):1174-1184. doi: 10.1158/1078-0432.CCR-18-1047. Epub 2018 Oct 17.
• [1338] Upregulation of HRD1 promotes cell migration and invasion in colon cancer.Mol Cell Biochem. 2019 Apr;454(1-2):1-9. doi: 10.1007/s11010-018-3447-0. Epub 2018 Oct 10.
• [1339] IL-13R2 mediates PNR-induced migration and metastasis in ER-negative breast cancer.Oncogene. 2015 Mar 19;34(12):1596-607. doi: 10.1038/onc.2014.53. Epub 2014 Apr 21.
• [1340] TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.Cell Death Dis. 2018 Jan 22;9(2):72. doi: 10.1038/s41419-017-0112-6.
• [1341] Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.BMJ Open. 2017 Nov 12;7(11):e017075. doi: 10.1136/bmjopen-2017-017075.
• [1342] Up- and downregulation of mature miR-1587 function by modulating its G-quadruplex structure and using small molecules.Int J Biol Macromol. 2019 Jan;121:127-134. doi: 10.1016/j.ijbiomac.2018.10.017. Epub 2018 Oct 3.
• [1343] Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3 Pathway.Mol Cancer Ther. 2019 Dec;18(12):2457-2468. doi: 10.1158/1535-7163.MCT-19-0261. Epub 2019 Sep 5.
• [1344] TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells.FASEB J. 2019 Jul;33(7):7822-7832. doi: 10.1096/fj.201801936RRR. Epub 2019 Mar 26.
• [1345] Discovery of EBI-1051: A novel and orally efficacious MEK inhibitor with benzofuran scaffold.Bioorg Med Chem. 2018 Feb 1;26(3):581-589. doi: 10.1016/j.bmc.2017.12.019. Epub 2017 Dec 20.
• [1346] Transducin ()-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.Oncogene. 2017 Mar 30;36(13):1873-1886. doi: 10.1038/onc.2016.352. Epub 2016 Oct 3.
• [1347] The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival.Ann Nucl Med. 2019 Sep;33(9):681-688. doi: 10.1007/s12149-019-01376-3. Epub 2019 Jun 13.
• [1348] Thromboxane A2 receptor promotes tumor growth through an autoregulatory feedback pathway.J Mol Cell Biol. 2013 Dec;5(6):380-90. doi: 10.1093/jmcb/mjt038. Epub 2013 Oct 9.
• [1349] The Impact of High-mobility Group Box Mutation of T-cell Factor 4 on Its Genomic Binding Pattern in Non-small Cell Lung Cancer.Transl Oncol. 2020 Jan;13(1):79-85. doi: 10.1016/j.tranon.2019.09.012. Epub 2019 Dec 2.
• [1350] Unique mutational profile associated with a loss of TDG expression in the rectal cancer of a patient with a constitutional PMS2 deficiency.DNA Repair (Amst). 2012 Jul 1;11(7):616-23. doi: 10.1016/j.dnarep.2012.04.004. Epub 2012 May 17.
• [1351] CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.J Pathol. 2018 Jul;245(3):297-310. doi: 10.1002/path.5083. Epub 2018 May 9.
• [1352] Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway.Oncogene. 2011 Sep 1;30(35):3802-12. doi: 10.1038/onc.2011.94. Epub 2011 Apr 11.
• [1353] Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma.Theranostics. 2017 Sep 21;7(17):4099-4117. doi: 10.7150/thno.20730. eCollection 2017.
• [1354] Angiopoietin-1 and Angiopoietin-2 Inhibitors: Clinical Development.Curr Oncol Rep. 2019 Feb 26;21(3):22. doi: 10.1007/s11912-019-0771-9.
• [1355] Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.Int J Oncol. 2013 Aug;43(2):513-20. doi: 10.3892/ijo.2013.1975. Epub 2013 Jun 5.
• [1356] Retrospective study of small pet tumors treated with Artemisia annua and iron.Int J Oncol. 2020 Jan;56(1):123-138. doi: 10.3892/ijo.2019.4921. Epub 2019 Nov 25.
• [1357] The miR-26a/AP-2/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.Theranostics. 2019 Jul 28;9(19):5497-5516. doi: 10.7150/thno.33800. eCollection 2019.
• [1358] HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor.Biomacromolecules. 2019 Oct 14;20(10):3855-3863. doi: 10.1021/acs.biomac.9b00947. Epub 2019 Sep 30.
• [1359] An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication.J Immunother. 2020 Feb/Mar;43(2):48-52. doi: 10.1097/CJI.0000000000000304.
• [1360] Is cancer a pure growth curve or does it follow a kinetics of dynamical structural transformation?.BMC Cancer. 2017 Mar 7;17(1):174. doi: 10.1186/s12885-017-3159-y.
• [1361] NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats.Brain Res. 2019 Sep 15;1719:124-132. doi: 10.1016/j.brainres.2019.05.040. Epub 2019 May 30.
• [1362] Thrombomodulin (TM) in tumor cell differentiation and periphery blood immune microenvironment in oral squamous cell carcinoma.Clin Immunol. 2018 Jun;191:27-33. doi: 10.1016/j.clim.2018.02.011. Epub 2018 Mar 18.
• [1363] Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma.Eur J Cancer. 1999 Apr;35(4):641-6. doi: 10.1016/s0959-8049(98)00419-5.
• [1364] Thyroid Hormone Receptor Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.Thyroid. 2020 Jan;30(1):116-132. doi: 10.1089/thy.2019.0175. Epub 2019 Dec 30.
• [1365] Endothelial Tie1-mediated angiogenesis and vascular abnormalization promote tumor progression and metastasis.J Clin Invest. 2018 Feb 1;128(2):834-845. doi: 10.1172/JCI94674. Epub 2018 Jan 22.
• [1366] Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer.Dis Markers. 2019 Jan 10;2019:5160565. doi: 10.1155/2019/5160565. eCollection 2019.
• [1367] Dual effects for lovastatin in anaplastic thyroid cancer: the pivotal effect of transketolase (TKT) on lovastatin and tumor proliferation.J Investig Med. 2018 Jun;66(5):1-9. doi: 10.1136/jim-2017-000634. Epub 2018 Mar 2.
• [1368] Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma.Cancer Biomark. 2020;27(1):129-137. doi: 10.3233/CBM-190414.
• [1369] Metastatic lymph node ratio as a prognostic indicator in patients with stage IV colon cancer undergoing resection.J Cancer. 2019 Jun 2;10(11):2534-2540. doi: 10.7150/jca.29216. eCollection 2019.
• [1370] Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis.Sci Rep. 2019 Mar 1;9(1):3299. doi: 10.1038/s41598-019-40032-8.
• [1371] Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation.Biomaterials. 2019 Jan;190-191:111-120. doi: 10.1016/j.biomaterials.2018.10.031. Epub 2018 Oct 25.
• [1372] Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.BMC Cancer. 2019 May 20;19(1):473. doi: 10.1186/s12885-019-5700-7.
• [1373] A novel method for isolation of histones from serum and its implications in therapeutics and prognosis of solid tumours.Clin Epigenetics. 2017 Mar 29;9:30. doi: 10.1186/s13148-017-0330-x. eCollection 2017.
• [1374] Expression of enteropeptidase in differentiated enterocytes, goblet cells, and the tumor cells in human duodenum.Am J Physiol Gastrointest Liver Physiol. 2003 Dec;285(6):G1235-41. doi: 10.1152/ajpgi.00198.2003. Epub 2003 Aug 7.
• [1375] Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma.Appl Immunohistochem Mol Morphol. 2017 Aug;25(7):481-488. doi: 10.1097/PAI.0000000000000324.
• [1376] Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.Sci Rep. 2017 Aug 22;7(1):9031. doi: 10.1038/s41598-017-09539-w.
• [1377] The RANKL-RANK Axis: A Bone to Thymus Round Trip.Front Immunol. 2019 Mar 29;10:629. doi: 10.3389/fimmu.2019.00629. eCollection 2019.
• [1378] Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.J Neurooncol. 2018 Jun;138(2):241-250. doi: 10.1007/s11060-018-2799-3. Epub 2018 Feb 16.
• [1379] Humoral primary immunodeficiency diseases: clinical overview and chest high-resolution computed tomography (HRCT) features in the adult population.Clin Radiol. 2017 Jul;72(7):534-542. doi: 10.1016/j.crad.2017.03.018. Epub 2017 Apr 19.
• [1380] Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LTR is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients.J Clin Med. 2019 May 24;8(5):741. doi: 10.3390/jcm8050741.
• [1381] Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism.J Immunother Cancer. 2019 Nov 20;7(1):311. doi: 10.1186/s40425-019-0786-7.
• [1382] Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.Cell Death Dis. 2019 Feb 8;10(2):115. doi: 10.1038/s41419-019-1391-x.
• [1383] Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas.Anticancer Res. 2019 May;39(5):2299-2306. doi: 10.21873/anticanres.13346.
• [1384] The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation.J Immunother Cancer. 2019 Apr 11;7(1):103. doi: 10.1186/s40425-019-0570-8.
• [1385] Fn14TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog.Cancer Lett. 2017 Aug 1;400:99-109. doi: 10.1016/j.canlet.2017.04.026. Epub 2017 Apr 25.
• [1386] The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).J Pathol. 2017 Feb;241(3):420-433. doi: 10.1002/path.4852. Epub 2016 Dec 29.
• [1387] EnLIGHTenment of tumor vessel normalization and immunotherapy in glioblastoma.J Pathol. 2018 Sep;246(1):3-6. doi: 10.1002/path.5103. Epub 2018 Jul 5.
• [1388] TNIK inhibition abrogates colorectal cancer stemness.Nat Commun. 2016 Aug 26;7:12586. doi: 10.1038/ncomms12586.
• [1389] High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells.Mol Cancer Res. 2011 Jun;9(6):724-32. doi: 10.1158/1541-7786.MCR-10-0436. Epub 2011 May 2.
• [1390] Research Progress of the Functional Role of ACK1 in Breast Cancer.Biomed Res Int. 2019 Oct 20;2019:1018034. doi: 10.1155/2019/1018034. eCollection 2019.
• [1391] Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors.J Med Chem. 2019 Apr 11;62(7):3407-3427. doi: 10.1021/acs.jmedchem.8b01888. Epub 2019 Apr 1.
• [1392] Interleukin-18 expression in oral squamous cell carcinoma: its role in tumor cell migration and invasion, and growth of tumor cell xenografts.FEBS Open Bio. 2018 Oct 31;8(12):1953-1963. doi: 10.1002/2211-5463.12532. eCollection 2018 Dec.
• [1393] Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes.Lung Cancer. 2005 Jan;47(1):17-29. doi: 10.1016/j.lungcan.2004.05.016.
• [1394] The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear -Catenin.Mol Cancer Ther. 2019 Jul;18(7):1217-1229. doi: 10.1158/1535-7163.MCT-18-0709. Epub 2019 Apr 30.
• [1395] Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene.BMC Cancer. 2019 Jun 13;19(1):573. doi: 10.1186/s12885-019-5788-9.
• [1396] Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models.PLoS One. 2019 Feb 26;14(2):e0206309. doi: 10.1371/journal.pone.0206309. eCollection 2019.
• [1397] Generation of a Transgenic BALB/c Mouse Line With Selective Expression of Human Mesothelin in Thyroid Gland: Application in Mesothelin-targeted Immunotherapy.J Immunother. 2019 May;42(4):119-125. doi: 10.1097/CJI.0000000000000263.
• [1398] Tripeptidyl peptidase II in human oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2013 Jan;139(1):123-30. doi: 10.1007/s00432-012-1307-y. Epub 2012 Sep 18.
• [1399] Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer.Oncotarget. 2019 Jan 15;10(5):561-572. doi: 10.18632/oncotarget.26529. eCollection 2019 Jan 15.
• [1400] Exosome-mediated uptake of mast cell tryptase into the nucleus of melanoma cells: a novel axis for regulating tumor cell proliferation and gene expression.Cell Death Dis. 2019 Sep 10;10(9):659. doi: 10.1038/s41419-019-1879-4.
• [1401] Identification of a Specific Translational Machinery via TCTP-EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA).Mol Cell Proteomics. 2019 Feb;18(2):245-262. doi: 10.1074/mcp.RA118.001014. Epub 2018 Oct 31.
• [1402] Single Antibody Detection of T-Cell Receptor Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance.Cytometry B Clin Cytom. 2020 Jan;98(1):99-107. doi: 10.1002/cyto.b.21782. Epub 2019 Apr 11.
• [1403] Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.Hepatology. 2019 Jul;70(1):198-214. doi: 10.1002/hep.30593. Epub 2019 Apr 12.
• [1404] TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/-catenin pathway.Oncogenesis. 2019 Jan 25;8(2):9. doi: 10.1038/s41389-018-0115-x.
• [1405] Gsp mutation in acromegaly and its influence on TRH-induced paradoxical GH response.Clin Endocrinol (Oxf). 2014 May;80(5):714-9. doi: 10.1111/cen.12336. Epub 2013 Oct 23.
• [1406] TRIM28 haploinsufficiency predisposes to Wilms tumor.Int J Cancer. 2019 Aug 15;145(4):941-951. doi: 10.1002/ijc.32167. Epub 2019 Feb 14.
• [1407] Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.Gene. 2019 May 25;698:50-60. doi: 10.1016/j.gene.2019.02.044. Epub 2019 Feb 27.
• [1408] Expression of the transient receptor potential channel c3 correlates with a favorable prognosis in patients with adenocarcinoma of the lung.Ann Surg Oncol. 2011 Nov;18(12):3377-83. doi: 10.1245/s10434-011-1798-9. Epub 2011 May 21.
• [1409] Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.PLoS One. 2015 Jun 22;10(6):e0127498. doi: 10.1371/journal.pone.0127498. eCollection 2015.
• [1410] Nociceptive transient receptor potential canonical 7(TRPC7) mediates aging-associated tumorigenesis induced by ultraviolet B.Aging Cell. 2020 Jan;19(1):e13075. doi: 10.1111/acel.13075. Epub 2019 Nov 21.
• [1411] Targeting Transient Receptor Potential Channels by MicroRNAs Drives Tumor Development and Progression.Adv Exp Med Biol. 2020;1131:605-623. doi: 10.1007/978-3-030-12457-1_24.
• [1412] TRPM2 ion channel promotes gastric cancer migration, invasion and tumor growth through the AKT signaling pathway.Sci Rep. 2019 Mar 12;9(1):4182. doi: 10.1038/s41598-019-40330-1.
• [1413] TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells.Mol Oncol. 2019 Nov;13(11):2393-2405. doi: 10.1002/1878-0261.12566. Epub 2019 Sep 12.
• [1414] TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.Cancer Biomark. 2019;26(4):451-460. doi: 10.3233/CBM-190666.
• [1415] Regulation of TRPM8 channel activity by Src-mediated tyrosine phosphorylation.J Cell Physiol. 2020 Jun;235(6):5192-5203. doi: 10.1002/jcp.29397. Epub 2019 Nov 14.
• [1416] Mechanosensitive TRPV4 channels stabilize VE-cadherin junctions to regulate tumor vascular integrity and metastasis.Cancer Lett. 2019 Feb 1;442:15-20. doi: 10.1016/j.canlet.2018.07.042. Epub 2018 Oct 27.
• [1417] Structural bases of TRP channel TRPV6 allosteric modulation by 2-APB.Nat Commun. 2018 Jun 25;9(1):2465. doi: 10.1038/s41467-018-04828-y.
• [1418] Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth.Clin Cancer Res. 2019 Jan 1;25(1):414-425. doi: 10.1158/1078-0432.CCR-18-0663. Epub 2018 Oct 12.
• [1419] The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer.J Immunother Cancer. 2019 Feb 13;7(1):45. doi: 10.1186/s40425-019-0521-4.
• [1420] TSPAN7 promotes the migration and proliferation of lung cancer cells via epithelial-to-mesenchymal transition.Onco Targets Ther. 2018 Dec 13;11:8815-8822. doi: 10.2147/OTT.S167902. eCollection 2018.
• [1421] Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer.Int J Cancer. 2017 Nov 15;141(10):2121-2130. doi: 10.1002/ijc.30893. Epub 2017 Jul 31.
• [1422] Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP.Oncogene. 2019 Mar;38(11):1892-1904. doi: 10.1038/s41388-018-0534-3. Epub 2018 Nov 2.
• [1423] Oncogenic role of TYRO3 receptor tyrosine kinase in the progression of pancreatic cancer.Cancer Lett. 2020 Feb 1;470:149-160. doi: 10.1016/j.canlet.2019.11.028. Epub 2019 Nov 23.
• [1424] 17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.PLoS One. 2018 Feb 26;13(2):e0191264. doi: 10.1371/journal.pone.0191264. eCollection 2018.
• [1425] Structural Basis for the Activation of the Deubiquitinase Calypso by the Polycomb Protein ASX.Structure. 2019 Mar 5;27(3):528-536.e4. doi: 10.1016/j.str.2018.11.013. Epub 2019 Jan 10.
• [1426] UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.Mol Med Rep. 2019 Aug;20(2):1212-1220. doi: 10.3892/mmr.2019.10322. Epub 2019 Jun 3.
• [1427] UCP2 promotes proliferation and chemoresistance through regulating the NF-B/-catenin axis and mitochondrial ROS in gallbladder cancer.Biochem Pharmacol. 2020 Feb;172:113745. doi: 10.1016/j.bcp.2019.113745. Epub 2019 Dec 5.
• [1428] USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors.Mol Cell. 2018 Dec 20;72(6):925-941.e4. doi: 10.1016/j.molcel.2018.10.045.
• [1429] Amplification of USP13 drives non-small cell lung cancer progression mediated by AKT/MAPK signaling.Biomed Pharmacother. 2019 Jun;114:108831. doi: 10.1016/j.biopha.2019.108831. Epub 2019 Apr 12.
• [1430] Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: Therapeutic implication.Life Sci. 2019 Dec 15;239:116875. doi: 10.1016/j.lfs.2019.116875. Epub 2019 Oct 30.
• [1431] Deubiquitinating enzyme USP20 is a positive regulator of Claspin and suppresses the malignant characteristics of gastric cancer cells.Int J Oncol. 2017 Apr;50(4):1136-1146. doi: 10.3892/ijo.2017.3904. Epub 2017 Mar 8.
• [1432] Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation.Mol Cancer Res. 2017 Aug;15(8):1073-1084. doi: 10.1158/1541-7786.MCR-16-0424. Epub 2017 May 8.
• [1433] miR-125a suppresses malignancy of multiple myeloma by reducing the deubiquitinase USP5.J Cell Biochem. 2020 Jan;121(1):642-650. doi: 10.1002/jcb.29309. Epub 2019 Aug 26.
• [1434] HLA-B-associated transcript 3 (Bat3) stabilizes and activates p53 in a HAUSP-dependent manner.J Mol Cell Biol. 2020 Feb 20;12(2):99-112. doi: 10.1093/jmcb/mjz102.
• [1435] Cyclooxygenase-2-Mediated Up-Regulation of Mitochondrial Transcription Factor A Mitigates the Radio-Sensitivity of Cancer Cells.Int J Mol Sci. 2019 Mar 11;20(5):1218. doi: 10.3390/ijms20051218.
• [1436] Cafestol, a coffee diterpene, inhibits urotensin II-induced interleukin-8 expression in human umbilical vein endothelial cells.Eur J Pharmacol. 2018 Feb 5;820:106-112. doi: 10.1016/j.ejphar.2017.12.030. Epub 2017 Dec 12.
• [1437] HLA-G 3' untranslated region polymorphic sites associated with increased HLA-G production are more frequent in patients exhibiting differentiated thyroid tumours.Clin Endocrinol (Oxf). 2017 Apr;86(4):597-605. doi: 10.1111/cen.13289. Epub 2017 Jan 10.
• [1438] MFF Regulation of Mitochondrial Cell Death Is a Therapeutic Target in Cancer.Cancer Res. 2019 Dec 15;79(24):6215-6226. doi: 10.1158/0008-5472.CAN-19-1982. Epub 2019 Oct 3.
• [1439] VDAC2 enables BAX to mediate apoptosis and limit tumor development.Nat Commun. 2018 Nov 26;9(1):4976. doi: 10.1038/s41467-018-07309-4.
• [1440] Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway.Cancer Sci. 2019 Jan;110(1):235-244. doi: 10.1111/cas.13861. Epub 2018 Dec 4.
• [1441] Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.Nat Med. 2019 Jan;25(1):130-140. doi: 10.1038/s41591-018-0262-9. Epub 2018 Dec 3.
• [1442] HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.Hepatology. 2020 May;71(5):1678-1695. doi: 10.1002/hep.30947. Epub 2020 Jan 26.
• [1443] Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors.Gastric Cancer. 2020 Jan;23(1):39-51. doi: 10.1007/s10120-019-00977-1. Epub 2019 Jun 13.
• [1444] p65/miR-23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma.Cancer Med. 2020 Jan;9(2):711-723. doi: 10.1002/cam4.2611. Epub 2019 Nov 25.
• [1445] The Expression of Checkpoint and DNA Repair Genes in Head and Neck Cancer as Possible Predictive Factors.Pathol Oncol Res. 2017 Apr;23(2):253-264. doi: 10.1007/s12253-016-0088-z. Epub 2016 Jul 13.
• [1446] Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway.Science. 2019 May 17;364(6441):eaau0159. doi: 10.1126/science.aau0159.
• [1447] Targeted knock-in mice expressing the oxidase-fixed form of xanthine oxidoreductase favor tumor growth.Nat Commun. 2019 Oct 28;10(1):4904. doi: 10.1038/s41467-019-12565-z.
• [1448] Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial.Int J Cancer. 2019 Dec 1;145(11):3163-3172. doi: 10.1002/ijc.32417. Epub 2019 May 31.
• [1449] XPNPEP2 is associated with lymph node metastasis in prostate cancer patients.Sci Rep. 2019 Jul 11;9(1):10078. doi: 10.1038/s41598-019-45245-5.
• [1450] Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.Clin Cancer Res. 2020 Jan 1;26(1):54-60. doi: 10.1158/1078-0432.CCR-19-2169. Epub 2019 Oct 21.
• [1451] Ku80 promotes melanoma growth and regulates antitumor effect of melatonin by targeting HIF1- dependent PDK-1 signaling pathway.Redox Biol. 2019 Jul;25:101197. doi: 10.1016/j.redox.2019.101197. Epub 2019 Apr 20.
• [1452] MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1.J Cell Biochem. 2020 Jan;121(1):482-488. doi: 10.1002/jcb.29231. Epub 2019 Jul 16.
• [1453] Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma.Oncogene. 2015 Sep 24;34(39):5095-104. doi: 10.1038/onc.2014.438. Epub 2015 Jan 19.
• [1454] Attenuation correction in 4D-PET using a single-phase attenuation map and rigidity-adaptive deformable registration.Med Phys. 2017 Feb;44(2):522-532. doi: 10.1002/mp.12063. Epub 2017 Feb 3.
• [1455] An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.Oncogenesis. 2019 Feb 19;8(3):13. doi: 10.1038/s41389-019-0125-3.
• [1456] RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling.Cancer Res. 2020 Jan 15;80(2):219-233. doi: 10.1158/0008-5472.CAN-18-2796. Epub 2019 Sep 24.
• [1457] ZNF217 is overexpressed and enhances cell migration and invasion in colorectal carcinoma.Asian Pac J Cancer Prev. 2015;16(6):2459-63. doi: 10.7314/apjcp.2015.16.6.2459.
• [1458] ZWINT is the next potential target for lung cancer therapy.J Cancer Res Clin Oncol. 2019 Mar;145(3):661-673. doi: 10.1007/s00432-018-2823-1. Epub 2019 Jan 14.
• [1459] In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.Cancer Immunol Immunother. 2012 Oct;61(10):1617-26. doi: 10.1007/s00262-012-1219-3. Epub 2012 Feb 19.
• [1460] Aquaporin-1 inhibition reduces metastatic formation in a mouse model of melanoma.J Cell Mol Med. 2018 Feb;22(2):904-912. doi: 10.1111/jcmm.13378. Epub 2017 Oct 17.
• [1461] Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.Cell Oncol (Dordr). 2017 Aug;40(4):389-399. doi: 10.1007/s13402-017-0329-5. Epub 2017 Jun 19.
• [1462] A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes.PLoS One. 2008 May 21;3(5):e2207. doi: 10.1371/journal.pone.0002207.
• [1463] ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation.Int J Oncol. 2020 Jan;56(1):219-231. doi: 10.3892/ijo.2019.4913. Epub 2019 Nov 14.
• [1464] C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.FASEB J. 2019 Oct;33(10):11060-11071. doi: 10.1096/fj.201800980RR. Epub 2019 Jul 12.
• [1465] A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors.Pharm Res. 2019 Nov 4;36(12):176. doi: 10.1007/s11095-019-2714-4.
• [1466] Therapeutic Effect of pHLIP-mediated CEACAM6 Gene Silencing in Lung Adenocarcinoma.Sci Rep. 2019 Sep 2;9(1):11607. doi: 10.1038/s41598-019-48104-5.
• [1467] Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.Oncogene. 2013 Jul 11;32(28):3329-38. doi: 10.1038/onc.2012.344. Epub 2012 Sep 3.
• [1468] Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma.Transl Oncol. 2018 Jun;11(3):691-699. doi: 10.1016/j.tranon.2018.03.005. Epub 2018 Apr 6.
• [1469] Carboxypeptidase M in apoptosis, adipogenesis and cancer.Clin Chim Acta. 2013 Jan 16;415:306-16. doi: 10.1016/j.cca.2012.11.012. Epub 2012 Nov 21.
• [1470] Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation.Cell Metab. 2019 Aug 6;30(2):274-289.e5. doi: 10.1016/j.cmet.2019.04.004. Epub 2019 May 2.
• [1471] Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1 by Chemical Proteomics.PLoS One. 2016 Mar 31;11(3):e0152934. doi: 10.1371/journal.pone.0152934. eCollection 2016.
• [1472] Novel insights into the molecular mechanisms governing Mdm2 ubiquitination and destruction.Oncotarget. 2010 Nov;1(7):685-690. doi: 10.18632/oncotarget.202.
• [1473] Expression of sulfotransferases and sulfatases in human breast cancer: impact on resveratrol metabolism.Cancer Lett. 2010 Mar 28;289(2):237-45. doi: 10.1016/j.canlet.2009.08.020. Epub 2009 Sep 10.
• [1474] Delta-like 1 homologue promotes tumorigenesis and epithelial-mesenchymal transition of ovarian high-grade serous carcinoma through activation of Notch signaling.Oncogene. 2019 Apr;38(17):3201-3215. doi: 10.1038/s41388-018-0658-5. Epub 2019 Jan 9.
• [1475] CD26/DPP4 - a potential biomarker and target for cancer therapy.Pharmacol Ther. 2019 Jun;198:135-159. doi: 10.1016/j.pharmthera.2019.02.015. Epub 2019 Feb 26.
• [1476] Targeting Endothelin-1 Receptor/-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach.Front Endocrinol (Lausanne). 2019 Sep 4;10:609. doi: 10.3389/fendo.2019.00609. eCollection 2019.
• [1477] Immune response evoked by tumor-associated NADH oxidase (tNOX) confers potential inhibitory effect on lung carcinoma in a mouse model.Am J Cancer Res. 2019 Apr 1;9(4):740-751. eCollection 2019.
• [1478] Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.BMC Cancer. 2014 Nov 18;14:841. doi: 10.1186/1471-2407-14-841.
• [1479] Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.Hum Pathol. 2018 Nov;81:9-17. doi: 10.1016/j.humpath.2018.04.018. Epub 2018 May 1.
• [1480] Serum CD95L Level Correlates with Tumor Immune Infiltration and Is a Positive Prognostic Marker for Advanced High-Grade Serous Ovarian Cancer.Mol Cancer Res. 2019 Dec;17(12):2537-2548. doi: 10.1158/1541-7786.MCR-19-0449. Epub 2019 Sep 19.
• [1481] Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.Nucl Med Biol. 2011 May;38(4):509-15. doi: 10.1016/j.nucmedbio.2010.11.003. Epub 2011 Mar 1.
• [1482] Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.Gynecol Oncol. 2019 May;153(2):405-415. doi: 10.1016/j.ygyno.2019.01.020. Epub 2019 Feb 20.
• [1483] The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma.Mol Oncol. 2019 Apr;13(4):757-780. doi: 10.1002/1878-0261.12425. Epub 2019 Jan 19.
• [1484] Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.Cancer Med. 2019 Aug;8(9):4189-4199. doi: 10.1002/cam4.2345. Epub 2019 Jun 17.
• [1485] Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition.Nat Commun. 2019 Apr 10;10(1):1665. doi: 10.1038/s41467-019-09295-7.
• [1486] The role of GDF15 in bone metastasis of lung adenocarcinoma cells.Oncol Rep. 2019 Apr;41(4):2379-2388. doi: 10.3892/or.2019.7024. Epub 2019 Feb 21.
• [1487] TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.J Cell Biochem. 2018 Feb;119(2):1791-1803. doi: 10.1002/jcb.26340. Epub 2017 Sep 11.
• [1488] GLRX inhibition enhances the effects of geftinib in EGFR-TKI-resistant NSCLC cells through FoxM1 signaling pathway.J Cancer Res Clin Oncol. 2019 Apr;145(4):861-872. doi: 10.1007/s00432-019-02845-y. Epub 2019 Jan 19.
• [1489] GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway.J Exp Clin Cancer Res. 2019 May 22;38(1):214. doi: 10.1186/s13046-019-1218-8.
• [1490] Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia.Leukemia. 2019 Dec;33(12):2805-2816. doi: 10.1038/s41375-019-0491-z. Epub 2019 May 24.
• [1491] Selected Case From the Arkadi M. Rywlin International Pathology Slide Seminar: Atypical Thymoma With Rhabdomyomatous Differentiation.Adv Anat Pathol. 2019 Jan;26(1):64-68. doi: 10.1097/PAP.0000000000000218.
• [1492] Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation.J Neurooncol. 2008 Jun;88(2):121-33. doi: 10.1007/s11060-008-9552-2.
• [1493] Glutamate receptors in pediatric tumors of the central nervous system.Cancer Biol Ther. 2010 Mar 15;9(6):455-68. doi: 10.4161/cbt.9.6.10898. Epub 2010 Mar 9.
• [1494] Abnormal expression of HAX? is associated with cellular proliferation and migration in human hypopharyngeal squamous cell carcinoma.Mol Med Rep. 2017 Oct;16(4):4664-4670. doi: 10.3892/mmr.2017.7155. Epub 2017 Aug 3.
• [1495] Pharmacological and transcriptional inhibition of the G9a histone methyltransferase suppresses proliferation and modulates redox homeostasis in human microvascular endothelial cells.Pharmacol Res. 2018 Feb;128:252-263. doi: 10.1016/j.phrs.2017.10.014. Epub 2017 Nov 4.
• [1496] DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma.Oncotarget. 2017 May 16;8(20):33100-33109. doi: 10.18632/oncotarget.16528.
• [1497] Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients.Proteomics Clin Appl. 2013 Jun;7(5-6):403-15. doi: 10.1002/prca.201100103. Epub 2013 May 17.
• [1498] Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer.Mol Carcinog. 2019 Mar;58(3):358-365. doi: 10.1002/mc.22933. Epub 2018 Dec 5.
• [1499] Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis.Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):20725-9. doi: 10.1073/pnas.1108462109. Epub 2011 Dec 5.
• [1500] Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.PLoS One. 2019 Feb 27;14(2):e0212968. doi: 10.1371/journal.pone.0212968. eCollection 2019.
• [1501] LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.Cell Death Dis. 2018 Mar 12;9(3):393. doi: 10.1038/s41419-018-0443-y.
• [1502] Tumor Microenvironmental pH and Enzyme Dual Responsive Polymer-Liposomes for Synergistic Treatment of Cancer Immuno-Chemotherapy.Biomacromolecules. 2019 Feb 11;20(2):882-892. doi: 10.1021/acs.biomac.8b01510. Epub 2019 Jan 18.
• [1503] Mitotic arrest deficient-like 1 is correlated with poor prognosis in small-cell lung cancer after surgical resection.Tumour Biol. 2016 Apr;37(4):4393-8. doi: 10.1007/s13277-015-4302-5. Epub 2015 Oct 24.
• [1504] Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer.Br J Cancer. 2018 May;118(11):1442-1452. doi: 10.1038/s41416-018-0078-x. Epub 2018 Apr 26.
• [1505] Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma.J Cancer. 2019 Feb 26;10(6):1580-1592. doi: 10.7150/jca.27352. eCollection 2019.
• [1506] Platelet-Facilitated Photothermal Therapy of Head and Neck Squamous Cell Carcinoma.Angew Chem Int Ed Engl. 2018 Jan 22;57(4):986-991. doi: 10.1002/anie.201709457. Epub 2017 Dec 20.
• [1507] Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.Cancer Res. 2017 Jul 15;77(14):3857-3869. doi: 10.1158/0008-5472.CAN-16-3079. Epub 2017 May 15.
• [1508] NLRP3 deletion inhibits inflammation-driven mouse lung tumorigenesis induced by benzo(a)pyrene and lipopolysaccharide.Respir Res. 2019 Jan 29;20(1):20. doi: 10.1186/s12931-019-0983-4.
• [1509] Number of positive lymph nodes better predicts survival for oral cavity cancer.J Surg Oncol. 2019 May;119(6):675-682. doi: 10.1002/jso.25386. Epub 2019 Jan 23.
• [1510] Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.Oncogene. 2019 Mar;38(12):2108-2122. doi: 10.1038/s41388-018-0566-8. Epub 2018 Nov 19.
• [1511] -Ketoglutarate links p53 to cell fate during tumour suppression.Nature. 2019 Sep;573(7775):595-599. doi: 10.1038/s41586-019-1577-5. Epub 2019 Sep 18.
• [1512] Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.Clin Cancer Res. 2018 Apr 15;24(8):1987-2001. doi: 10.1158/1078-0432.CCR-17-2776. Epub 2018 Jan 31.
• [1513] Therapeutic silencing of KRAS using systemically delivered siRNAs.Mol Cancer Ther. 2014 Dec;13(12):2876-85. doi: 10.1158/1535-7163.MCT-14-0074. Epub 2014 Oct 3.
• [1514] Role of PFKFB3 and CD163 in Oral Squamous Cell Carcinoma Angiogenesis.Curr Med Sci. 2019 Jun;39(3):410-414. doi: 10.1007/s11596-019-2051-1. Epub 2019 Jun 17.
• [1515] A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.Drug Deliv Transl Res. 2019 Feb;9(1):37-52. doi: 10.1007/s13346-018-0575-8.
• [1516] uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.Oncotarget. 2017 Feb 28;8(9):15407-15419. doi: 10.18632/oncotarget.14282.
• [1517] Rare compound heterozygous variants in PNKP identified by whole exome sequencing in a German patient with ataxia-oculomotor apraxia 4 and pilocytic astrocytoma.Clin Genet. 2018 Jul;94(1):185-186. doi: 10.1111/cge.13216. Epub 2018 Mar 2.
• [1518] Combined effects of FLT3 and NF-B selective inhibitors on acute myeloid leukemia in vivo.J Biochem Mol Toxicol. 2012 Jan;26(1):35-43. doi: 10.1002/jbt.20411. Epub 2011 Sep 16.
• [1519] Novel hyaluronic acid-modified temperature-sensitive nanoparticles for synergistic chemo-photothermal therapy.Carbohydr Polym. 2019 Jun 15;214:221-233. doi: 10.1016/j.carbpol.2019.03.043. Epub 2019 Mar 14.
• [1520] Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.BMC Cancer. 2010 Nov 24;10:646. doi: 10.1186/1471-2407-10-646.
• [1521] Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines.Oncogene. 2009 Sep 3;28(35):3121-31. doi: 10.1038/onc.2009.168. Epub 2009 Jun 22.
• [1522] PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.Cell Oncol (Dordr). 2020 Feb;43(1):51-62. doi: 10.1007/s13402-019-00435-1. Epub 2019 Sep 13.
• [1523] Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.Cancer Sci. 2012 Jun;103(6):1038-44. doi: 10.1111/j.1349-7006.2012.02261.x. Epub 2012 Apr 17.
• [1524] RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia.Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2189-94. doi: 10.1073/pnas.0911646107. Epub 2009 Dec 28.
• [1525] Prognostic role of RECK in pathological outcome-dependent buccal mucosa squamous cell carcinoma.Oral Dis. 2020 Jan;26(1):62-71. doi: 10.1111/odi.13214. Epub 2019 Nov 15.
• [1526] CX-F9, a novel RSK2 inhibitor, suppresses cutaneous melanoma cells proliferation and metastasis through regulating autophagy.Biochem Pharmacol. 2019 Oct;168:14-25. doi: 10.1016/j.bcp.2019.06.014. Epub 2019 Jun 14.
• [1527] S100A6/miR193a regulates the proliferation, invasion, migration and angiogenesis of lung cancer cells through the P53 acetylation.Am J Transl Res. 2019 Aug 15;11(8):4634-4649. eCollection 2019.
• [1528] SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals.Cancer Cell Int. 2019 Apr 18;19:103. doi: 10.1186/s12935-019-0809-y. eCollection 2019.
• [1529] Upregulated genes at 2q24 gains as candidate oncogenes in hepatoblastomas.Future Oncol. 2014 Dec;10(15):2449-57. doi: 10.2217/fon.14.149.
• [1530] Lung Adenocarcinoma Syndecan-2 Potentiates Cell Invasiveness.Am J Respir Cell Mol Biol. 2019 Jun;60(6):659-666. doi: 10.1165/rcmb.2018-0118OC.
• [1531] Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.J Nucl Med. 2018 Mar;59(3):494-501. doi: 10.2967/jnumed.117.196279. Epub 2017 Nov 16.
• [1532] Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase.Oncogene. 2019 Jun;38(24):4788-4803. doi: 10.1038/s41388-019-0758-x. Epub 2019 Feb 28.
• [1533] Siglec-15: An Attractive Immunotherapy Target.Cancer Discov. 2020 Jan;10(1):7-8. doi: 10.1158/2159-8290.CD-NB2019-136. Epub 2019 Dec 5.
• [1534] Calcium intake and ion transporter genetic polymorphisms interact in human colorectal neoplasia risk in a 2-phase study.J Nutr. 2014 Nov;144(11):1734-41. doi: 10.3945/jn.114.196709. Epub 2014 Aug 27.
• [1535] Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.J Am Coll Surg. 2019 Sep;229(3):305-315. doi: 10.1016/j.jamcollsurg.2019.04.018. Epub 2019 Apr 26.
• [1536] Update on pediatric cancer predisposition syndromes.Pediatr Blood Cancer. 2013 Aug;60(8):1247-52. doi: 10.1002/pbc.24555. Epub 2013 Apr 26.
• [1537] Ste20-like kinase, SLK, a novel mediator of podocyte integrity.Am J Physiol Renal Physiol. 2018 Jul 1;315(1):F186-F198. doi: 10.1152/ajprenal.00238.2017. Epub 2017 Nov 29.
• [1538] Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors.J Clin Endocrinol Metab. 2019 Jun 1;104(6):2083-2093. doi: 10.1210/jc.2018-01931.
• [1539] Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden.J Thorac Oncol. 2019 Nov;14(11):2009-2018. doi: 10.1016/j.jtho.2019.07.017. Epub 2019 Jul 30.
• [1540] Inhibition of TDP43-Mediated SNHG12-miR-195-SOX5 Feedback Loop Impeded Malignant Biological Behaviors of Glioma Cells.Mol Ther Nucleic Acids. 2018 Mar 2;10:142-158. doi: 10.1016/j.omtn.2017.12.001. Epub 2017 Dec 8.
• [1541] Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotean on invivo tumor models.Eur J Med Chem. 2019 Jan 1;161:581-593. doi: 10.1016/j.ejmech.2018.10.055. Epub 2018 Oct 28.
• [1542] Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature.Virchows Arch. 2020 Apr;476(4):609-614. doi: 10.1007/s00428-019-02691-w. Epub 2019 Dec 5.
• [1543] Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells.Biochem Biophys Res Commun. 2014 Mar 28;446(1):85-90. doi: 10.1016/j.bbrc.2014.02.076. Epub 2014 Feb 25.
• [1544] Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.Cancer Res. 2010 Jan 1;70(1):418-27. doi: 10.1158/0008-5472.CAN-09-2654. Epub 2009 Dec 22.
• [1545] Inhibition of proteasome deubiquitinating activity as a new cancer therapy.Nat Med. 2011 Nov 6;17(12):1636-40. doi: 10.1038/nm.2536.
• [1546] Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers.Br J Cancer. 2013 Oct 15;109(8):2286-94. doi: 10.1038/bjc.2013.574. Epub 2013 Sep 17.
• [1547] The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI.Cell Rep. 2017 Sep 5;20(10):2468-2479. doi: 10.1016/j.celrep.2017.08.048.
• [1548] Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.Cancer Med. 2020 Jan;9(2):700-710. doi: 10.1002/cam4.2650. Epub 2019 Nov 23.
• [1549] VKORC1 haplotypes influence the performance characteristics of PIVKAII for screening of hepatocellular carcinoma.Clin Chem Lab Med. 2010 Oct;48(10):1475-9. doi: 10.1515/CCLM.2010.275. Epub 2010 Jun 25.
• [1550] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer.Cancer Immunol Immunother. 2020 Jan;69(1):33-42. doi: 10.1007/s00262-019-02434-5. Epub 2019 Nov 28.
• [1551] Comparative analysis of 14-3-3 isoform expression and epigenetic alterations in colorectal cancer.BMC Cancer. 2015 Oct 30;15:826. doi: 10.1186/s12885-015-1856-y.
• [1552] ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.J Natl Cancer Inst. 2014 Jun 23;106(7):dju149. doi: 10.1093/jnci/dju149. Print 2014 Jul.
• [1553] Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.Cancer Med. 2019 Apr;8(4):1755-1764. doi: 10.1002/cam4.2049. Epub 2019 Mar 7.
• [1554] The retinamide VNLG-152 inhibits f-AR/AR-V7 and MNK-eIF4E signaling pathways to suppress EMT and castration-resistant prostate cancer xenograft growth.FEBS J. 2018 Mar;285(6):1051-1063. doi: 10.1111/febs.14383. Epub 2018 Feb 3.
• [1555] Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma.Oral Oncol. 2003 Feb;39(2):163-9. doi: 10.1016/s1368-8375(02)00064-7.
• [1556] Altered microRNA Expression Profiles and Regulation of INK4A/CDKN2A Tumor Suppressor Genes in Canine Breast Cancer Models.J Cell Biochem. 2015 Dec;116(12):2956-69. doi: 10.1002/jcb.25243.
• [1557] The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer.Int J Cancer. 2019 May 1;144(9):2320-2329. doi: 10.1002/ijc.32045. Epub 2019 Jan 11.
• [1558] Molecular pathogenesis of transplacentally induced mouse lung tumors.Exp Lung Res. 1998 Jul-Aug;24(4):557-77. doi: 10.3109/01902149809087386.
• [1559] SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer.Cancer Cell Int. 2019 Feb 14;19:33. doi: 10.1186/s12935-019-0746-9. eCollection 2019.
• [1560] Pretreating Mesenchymal Stem Cells with Cancer Conditioned-Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells.Adv Healthc Mater. 2019 May;8(10):e1801589. doi: 10.1002/adhm.201801589. Epub 2019 Apr 9.
• [1561] TGF--induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.Carcinogenesis. 2016 Nov 1;37(11):1041-1051. doi: 10.1093/carcin/bgw093.
• [1562] Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.PLoS One. 2017 Oct 24;12(10):e0186567. doi: 10.1371/journal.pone.0186567. eCollection 2017.
• [1563] Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.Drug Resist Updat. 2015 May;20:39-70. doi: 10.1016/j.drup.2015.05.003. Epub 2015 May 22.
• [1564] Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice.J Virol. 2004 Feb;78(3):1333-43. doi: 10.1128/jvi.78.3.1333-1343.2004.
• [1565] Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.Cancer Biol Ther. 2011 Aug 15;12(4):297-303. doi: 10.4161/cbt.12.4.16356. Epub 2011 Aug 15.
• [1566] Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibition and bax-associated mitochondrial apoptosis.Aging (Albany NY). 2019 May 8;11(9):2681-2698. doi: 10.18632/aging.101940.
• [1567] Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.J Natl Cancer Inst. 2013 Oct 2;105(19):1463-73. doi: 10.1093/jnci/djt241. Epub 2013 Sep 19.
• [1568] ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.Oncotarget. 2017 May 26;8(43):74106-74118. doi: 10.18632/oncotarget.18266. eCollection 2017 Sep 26.
• [1569] Cross-Kingdom Gene regulation via miRNAs of Hypericum perforatum (St. John's wort) flower dietetically absorbed: An in silico approach to define potential biomarkers for prostate cancer.Comput Biol Chem. 2019 Jun;80:16-22. doi: 10.1016/j.compbiolchem.2019.02.010. Epub 2019 Feb 28.
• [1570] Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression.Cancer Lett. 2015 Jan 28;356(2 Pt B):837-45. doi: 10.1016/j.canlet.2014.10.032. Epub 2014 Oct 31.
• [1571] Modification of ASC1 by UFM1 is crucial for ER transactivation and breast cancer development.Mol Cell. 2014 Oct 23;56(2):261-274. doi: 10.1016/j.molcel.2014.08.007. Epub 2014 Sep 11.
• [1572] Point mutation of K-ras gene codon 12 in biliary tract tumors.Gastroenterology. 1994 Oct;107(4):1147-53. doi: 10.1016/0016-5085(94)90240-2.
• [1573] Calculating the Tumor Volumes in Vestibular Schwannomas: Are the ABC/2 and Volumetric Methods Comparable?.Otol Neurotol. 2017 Jul;38(6):889-894. doi: 10.1097/MAO.0000000000001423.
• [1574] Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling.Arch Surg. 2008 Sep;143(9):841-6; discussion 846. doi: 10.1001/archsurg.143.9.841.
• [1575] ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells.Endocrinology. 2008 Oct;149(10):4912-20. doi: 10.1210/en.2008-0351. Epub 2008 Jun 26.
• [1576] NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.J Cell Physiol. 2019 Feb;234(2):1630-1642. doi: 10.1002/jcp.27033. Epub 2018 Aug 29.
• [1577] GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer.Cancer Sci. 2007 Oct;98(10):1625-32. doi: 10.1111/j.1349-7006.2007.00578.x. Epub 2007 Aug 16.
• [1578] Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells. Mol Pharmacol. 2010 Jun;77(6):912-21. doi: 10.1124/mol.109.062836. Epub 2010 Mar 1.
• [1579] Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis. Theranostics. 2017 Feb 26;7(4):1036-1046.
• [1580] Overexpression of riboflavin transporter 2 contributes toward progression and invasion of glioma.Neuroreport. 2016 Oct 19;27(15):1167-73. doi: 10.1097/WNR.0000000000000674.
• [1581] Organellar (Na+, K+)/H+ exchanger NHE7 regulates cell adhesion, invasion and anchorage-independent growth of breast cancer MDA-MB-231 cells.Oncol Rep. 2012 Feb;27(2):311-7. doi: 10.3892/or.2011.1542. Epub 2011 Nov 9.
• [1582] Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy.Cancer Lett. 2015 Jan 28;356(2 Pt B):517-24. doi: 10.1016/j.canlet.2014.09.025. Epub 2014 Oct 6.
• [1583] Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor.Biol Pharm Bull. 2007 Jun;30(6):1144-6. doi: 10.1248/bpb.30.1144.
• [1584] Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay.Mol Cell. 2019 Sep 5;75(5):967-981.e9. doi: 10.1016/j.molcel.2019.06.001. Epub 2019 Jul 9.
• [1585] Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide.J Drug Target. 2018 Jun-Jul;26(5-6):466-473. doi: 10.1080/1061186X.2018.1433678. Epub 2018 Feb 8.
• [1586] Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinoma.Surg Oncol. 2017 Jun;26(2):178-187. doi: 10.1016/j.suronc.2017.03.004. Epub 2017 Mar 14.
• [1587] The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.Mol Cancer Ther. 2017 Jun;16(6):1021-1030. doi: 10.1158/1535-7163.MCT-16-0511. Epub 2017 Mar 6.
• [1588] Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.J Neurooncol. 2005 Sep;74(2):113-21. doi: 10.1007/s11060-004-6152-7.
• [1589] Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.PLoS Med. 2007 Apr;4(4):e122. doi: 10.1371/journal.pmed.0040122.
• [1590] Investigating in vitro and in vivo v6 integrin receptor-targeting liposomal alendronate for combinatory T cell immunotherapy.J Control Release. 2017 Jun 28;256:141-152. doi: 10.1016/j.jconrel.2017.04.025. Epub 2017 Apr 18.
• [1591] Downregulation of Annexin A11 (ANXA11) Inhibits Cell Proliferation, Invasion, and Migration via the AKT/GSK-3 Pathway in Gastric Cancer.Med Sci Monit. 2018 Jan 7;24:149-160. doi: 10.12659/msm.905372.
• [1592] Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder.Urology. 2006 Apr;67(4):756-61. doi: 10.1016/j.urology.2005.10.053. Epub 2006 Mar 29.
• [1593] H?myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma.Curr Cancer Drug Targets. 2011 Oct;11(8):966-75. doi: 10.2174/156800911797264752.
• [1594] Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.Acta Neuropathol Commun. 2018 Jun 11;6(1):49. doi: 10.1186/s40478-018-0544-y.
• [1595] High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.Hum Pathol. 2019 Feb;84:62-70. doi: 10.1016/j.humpath.2018.09.002. Epub 2018 Sep 18.
• [1596] Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):387-393. doi: 10.21873/cgp.20097.
• [1597] Placental site trophoblastic tumor and epithelioid trophoblastic tumor: Clinical and pathological features, prognostic variables and treatment strategy.Gynecol Oncol. 2019 Jun;153(3):684-693. doi: 10.1016/j.ygyno.2019.03.011. Epub 2019 Apr 30.
• [1598] The mitochondrial carrier SLC25A10 regulates cancer cell growth.Oncotarget. 2015 Apr 20;6(11):9271-83. doi: 10.18632/oncotarget.3375.
• [1599] Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation.EBioMedicine. 2019 Feb;40:184-197. doi: 10.1016/j.ebiom.2019.01.036. Epub 2019 Jan 25.
• [1600] Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting.Cell Metab. 2018 Nov 6;28(5):706-720.e6. doi: 10.1016/j.cmet.2018.07.021. Epub 2018 Aug 16.
• [1601] Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer.Sci Rep. 2016 Dec 7;6:38415. doi: 10.1038/srep38415.
• [1602] Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p.J Cell Mol Med. 2020 Jan;24(1):799-813. doi: 10.1111/jcmm.14791. Epub 2019 Nov 16.
• [1603] GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1941-1948. doi: 10.1016/j.bbrc.2018.07.139. Epub 2018 Jul 30.
• [1604] Polyamine synthesis as a target of MYC oncogenes.J Biol Chem. 2018 Nov 30;293(48):18757-18769. doi: 10.1074/jbc.TM118.003336. Epub 2018 Nov 7.
• [1605] Hypermethylation of adenomatosis polyposis coli-2 and its tumor suppressor role in retinoblastoma.Curr Eye Res. 2015 Jul;40(7):719-28. doi: 10.3109/02713683.2014.954673. Epub 2014 Sep 10.
• [1606] Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.Pathol Res Pract. 2011 Jun 15;207(6):377-82. doi: 10.1016/j.prp.2011.03.007. Epub 2011 May 31.
• [1607] Iron metabolism gene expression and prognostic features of hepatocellular carcinoma.J Cell Biochem. 2018 Nov;119(11):9178-9204. doi: 10.1002/jcb.27184. Epub 2018 Aug 4.
• [1608] Adenine Nucleotide Translocase 2 as an Enzyme Related to [(18)F] FDG Accumulation in Various Cancers.Mol Imaging Biol. 2019 Aug;21(4):722-730. doi: 10.1007/s11307-018-1268-x.
• [1609] A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance.Mol Cancer Res. 2017 Apr;15(4):382-394. doi: 10.1158/1541-7786.MCR-16-0234. Epub 2017 Jan 20.
• [1610] Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.J Gastroenterol. 2016 May;51(5):447-57. doi: 10.1007/s00535-015-1121-9. Epub 2015 Sep 11.
• [1611] Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity.BMC Cancer. 2014 Jun 4;14:401. doi: 10.1186/1471-2407-14-401.
• [1612] The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.Cancer Chemother Pharmacol. 2013 Sep;72(3):669-82. doi: 10.1007/s00280-013-2246-2. Epub 2013 Aug 11.
• [1613] Co-expression network analysis of differentially expressed genes associated with metastasis in prolactin pituitary tumors.Mol Med Rep. 2014 Jul;10(1):113-8. doi: 10.3892/mmr.2014.2152. Epub 2014 Apr 15.
• [1614] Inhibition of hepatic gluconeogenesis and enhanced glucose uptake contribute to the development of hypoglycemia in mice bearing interleukin-1beta- secreting tumor.Endocrinology. 2004 Nov;145(11):5150-6. doi: 10.1210/en.2004-0323. Epub 2004 Aug 5.
• [1615] GLUT5 increases fructose utilization in ovarian cancer.Onco Targets Ther. 2019 Jul 8;12:5425-5436. doi: 10.2147/OTT.S205522. eCollection 2019.
• [1616] ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells.Cancer Lett. 2011 May 1;304(1):41-51. doi: 10.1016/j.canlet.2011.01.027. Epub 2011 Feb 25.
• [1617] Coordinative unsaturated Cu(I) entities are crucial intermediates governing cell internalization of copper. A combined experimental ESI-MS and DFT study.Metallomics. 2019 Nov 1;11(11):1800-1804. doi: 10.1039/c9mt00236g. Epub 2019 Oct 28.
• [1618] Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression.Leuk Res. 2017 Jul;58:39-42. doi: 10.1016/j.leukres.2017.04.002. Epub 2017 Apr 4.
• [1619] mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient.Cell. 2017 Oct 19;171(3):642-654.e12. doi: 10.1016/j.cell.2017.09.046.
• [1620] SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms. Biochem J. 2016 May 1;473(9):1113-24.
• [1621] Association between ZIP10 gene expression and tumor aggressiveness in renal cell carcinoma.Gene. 2014 Nov 15;552(1):195-8. doi: 10.1016/j.gene.2014.09.010. Epub 2014 Sep 6.
• [1622] Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.Tumour Biol. 2015 Sep;36(10):7431-7. doi: 10.1007/s13277-015-3459-2. Epub 2015 Apr 23.
• [1623] Knockdown of Zinc Transporter ZIP5 by RNA Interference Inhibits Esophageal Cancer Growth In Vivo.Oncol Res. 2016;24(3):205-14. doi: 10.3727/096504016X14648701447896.
• [1624] Positional mapping and candidate gene analysis of the mouse Ccs3 locus that regulates differential susceptibility to carcinogen-induced colorectal cancer.PLoS One. 2013;8(3):e58733. doi: 10.1371/journal.pone.0058733. Epub 2013 Mar 14.
• [1625] NUP160-SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma.Cancer Res. 2015 Nov 1;75(21):4458-65. doi: 10.1158/0008-5472.CAN-15-0418.
• [1626] SLC44A1-PRKCA fusion in papillary and rosette-forming glioneuronal tumors.J Clin Neurosci. 2016 Jan;23:73-75. doi: 10.1016/j.jocn.2015.04.021. Epub 2015 Aug 7.
• [1627] A partial gene deletion of SLC45A2 causes oculocutaneous albinism in Doberman pinscher dogs.PLoS One. 2014 Mar 19;9(3):e92127. doi: 10.1371/journal.pone.0092127. eCollection 2014.
• [1628] High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer. PLoS One. 2017 Nov 1;12(11):e0187385.
• [1629] Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.Haematologica. 2018 Jun;103(6):1065-1072. doi: 10.3324/haematol.2017.175687. Epub 2017 Nov 30.
• [1630] Tannic acid inhibits electrogenic Na+/HCO3- co-transporter activity in embryonic neural stem cell-derived radial glial-like cells.Neuroreport. 2020 Jan 8;31(1):57-63. doi: 10.1097/WNR.0000000000001372.
• [1631] Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8789-98. doi: 10.1158/1078-0432.CCR-05-0674.
• [1632] Protease activated receptor 2 mediates tryptase-induced cell migration through MYO10 in colorectal cancer.Am J Cancer Res. 2019 Sep 1;9(9):1995-2006. eCollection 2019.
• [1633] Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.Int J Oncol. 2019 May;54(5):1613-1624. doi: 10.3892/ijo.2019.4749. Epub 2019 Mar 14.
• [1634] Pan-cancer analysis of the metabolic reaction network.Metab Eng. 2020 Jan;57:51-62. doi: 10.1016/j.ymben.2019.09.006. Epub 2019 Sep 14.
• [1635] Targeting Taurine Transporter (TauT) for Cancer Immunotherapy of p53 Mutation Mediated Cancers - Molecular Basis and Preclinical Implication.Adv Exp Med Biol. 2019;1155:543-553. doi: 10.1007/978-981-13-8023-5_50.
• [1636] The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.Mol Cells. 2017 Oct;40(10):761-772. doi: 10.14348/molcells.2017.0104. Epub 2017 Oct 17.
• [1637] NHE5 regulates growth factor signaling, integrin trafficking, and degradation in glioma cells.Clin Exp Metastasis. 2019 Dec;36(6):527-538. doi: 10.1007/s10585-019-10001-6. Epub 2019 Oct 8.
• [1638] Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India.Mutat Res. 2010 Feb;696(2):130-8. doi: 10.1016/j.mrgentox.2010.01.001. Epub 2010 Jan 18.
• [1639] Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma.Exp Mol Pathol. 2013 Aug;95(1):62-7. doi: 10.1016/j.yexmp.2013.05.001. Epub 2013 May 16.
• [1640] The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine.Int J Oncol. 2011 May;38(5):1421-5. doi: 10.3892/ijo.2011.914. Epub 2011 Jan 20.
• [1641] Isolation and characterization of the anticancer gene organic cation transporter like-3 (ORCTL3).Adv Exp Med Biol. 2014;818:213-27. doi: 10.1007/978-1-4471-6458-6_11.
• [1642] NGAL and NGALR are frequently overexpressed in human gliomas and are associated with clinical prognosis.J Neurooncol. 2011 Aug;104(1):119-27. doi: 10.1007/s11060-010-0486-0. Epub 2010 Dec 24.
• [1643] L-Carnitine-Mediated Tumor Cell Protection and Poor Patient Survival Associated with OCTN2 Overexpression in Glioblastoma Multiforme.Clin Cancer Res. 2019 May 1;25(9):2874-2886. doi: 10.1158/1078-0432.CCR-18-2380. Epub 2019 Jan 22.
• [1644] Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.Oncogene. 2020 Mar;39(10):2055-2068. doi: 10.1038/s41388-019-1128-4. Epub 2019 Dec 4.
• [1645] Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification.Int J Oncol. 2014 Nov;45(5):1829-36. doi: 10.3892/ijo.2014.2605. Epub 2014 Aug 18.
• [1646] Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation.Am J Pathol. 2011 Mar;178(3):1395-402. doi: 10.1016/j.ajpath.2010.12.011.
• [1647] Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer.Biomolecules. 2019 Mar 14;9(3):103. doi: 10.3390/biom9030103.
• [1648] Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.Clin Cancer Res. 2005 May 15;11(10):3758-65. doi: 10.1158/1078-0432.CCR-04-1848.
• [1649] Profiling cytochrome P450 family 4 gene expression in human hepatocellular carcinoma.Mol Med Rep. 2018 Dec;18(6):4865-4876. doi: 10.3892/mmr.2018.9526. Epub 2018 Oct 1.
• [1650] Androgen receptor overexpression in prostate cancer in type 2 diabetes.Mol Metab. 2018 Feb;8:158-166. doi: 10.1016/j.molmet.2017.11.013. Epub 2017 Dec 5.
• [1651] Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells.Oncotarget. 2018 Aug 17;9(64):32331-32345. doi: 10.18632/oncotarget.25965. eCollection 2018 Aug 17.
• [1652] Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT.Intern Emerg Med. 2017 Apr;12(3):333-339. doi: 10.1007/s11739-017-1610-3. Epub 2017 Feb 2.
• [1653] Activity of thymidylate synthetase, thymidine kinase and galactokinase in primary and xenografted human colorectal cancers in relation to their chromosomal patterns.Int J Cancer. 1991 Mar 12;47(5):670-4. doi: 10.1002/ijc.2910470507.
• [1654] GDP-mannose-4,6-dehydratase (GMDS) deficiency renders colon cancer cells resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor- and CD95-mediated apoptosis by inhibiting complex II formation.J Biol Chem. 2011 Dec 16;286(50):43123-33. doi: 10.1074/jbc.M111.262741. Epub 2011 Oct 25.
• [1655] Glyoxalase 2 drives tumorigenesis in human prostate cells in a mechanism involving androgen receptor and p53-p21 axis.Mol Carcinog. 2017 Sep;56(9):2112-2126. doi: 10.1002/mc.22668. Epub 2017 May 15.
• [1656] Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia.Int J Biol Sci. 2019 Mar 1;15(4):882-894. doi: 10.7150/ijbs.30290. eCollection 2019.
• [1657] 17 Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.Gynecol Oncol. 2012 Dec;127(3):587-94. doi: 10.1016/j.ygyno.2012.08.010. Epub 2012 Aug 17.
• [1658] Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer.Clin Chim Acta. 2020 Apr;503:203-209. doi: 10.1016/j.cca.2019.11.032. Epub 2019 Nov 30.
• [1659] Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic Tumors.Radiology. 2019 Jan;290(1):116-124. doi: 10.1148/radiol.2018180687. Epub 2018 Oct 9.
• [1660] Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.PLoS Biol. 2018 Oct 18;16(10):e2006483. doi: 10.1371/journal.pbio.2006483. eCollection 2018 Oct.
• [1661] High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.Genes Chromosomes Cancer. 2003 Nov;38(3):215-25. doi: 10.1002/gcc.10273.
• [1662] Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats.Int J Biochem Cell Biol. 2014 Aug;53:186-94. doi: 10.1016/j.biocel.2014.05.017. Epub 2014 May 20.
• [1663] Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice.Leukemia. 2001 Jan;15(1):141-7. doi: 10.1038/sj.leu.2401997.
• [1664] UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.Breast Cancer Res. 2004;6(5):R488-98. doi: 10.1186/bcr818. Epub 2004 Jun 29.
• [1665] Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.J Cell Mol Med. 2019 Nov;23(11):7438-7448. doi: 10.1111/jcmm.14612. Epub 2019 Sep 9.
• [1666] Expression of Indoleamine 2, 3-dioxygenase 1 (IDO1) and Tryptophanyl-tRNA Synthetase (WARS) in Gastric Cancer Molecular Subtypes.Appl Immunohistochem Mol Morphol. 2020 May/Jun;28(5):360-368. doi: 10.1097/PAI.0000000000000761.
• [1667] Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: implications for lymphomagenesis.Leuk Lymphoma. 2006 Aug;47(8):1523-34. doi: 10.1080/10428190600612909.
• [1668] Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples.Basic Clin Pharmacol Toxicol. 2007 Apr;100(4):240-8. doi: 10.1111/j.1742-7843.2006.00023.x.
• [1669] Investigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models.PLoS One. 2017 Feb 9;12(2):e0171871. doi: 10.1371/journal.pone.0171871. eCollection 2017.
• [1670] Combined SEP and anti-PD-L1 antibody produces a synergistic antitumor effect in B16-F10 melanoma-bearing mice.Sci Rep. 2018 Jan 9;8(1):217. doi: 10.1038/s41598-017-18641-y.
• [1671] AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy.Oncol Lett. 2019 Jan;17(1):773-780. doi: 10.3892/ol.2018.9705. Epub 2018 Nov 15.
• [1672] Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells.Cancer Lett. 2008 Dec 8;272(1):160-6. doi: 10.1016/j.canlet.2008.07.013. Epub 2008 Aug 26.
• [1673] NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.Mol Cell Proteomics. 2015 Nov;14(11):2988-99. doi: 10.1074/mcp.M115.050385. Epub 2015 Sep 8.
• [1674] Dihomo--linolenic acid inhibits growth of xenograft tumors in mice bearing human pancreatic cancer cells (BxPC-3) transfected with delta-5-desaturase shRNA.Redox Biol. 2019 Jan;20:236-246. doi: 10.1016/j.redox.2018.10.001. Epub 2018 Oct 15.
• [1675] Dopamine-induced SULT1A3/4 promotes EMT and cancer stemness in hepatocellular carcinoma.Tumour Biol. 2017 Oct;39(10):1010428317719272. doi: 10.1177/1010428317719272.
• [1676] Overexpressed ACP5 has prognostic value in colorectal cancer and promotes cell proliferation and tumorigenesis via FAK/PI3K/AKT signaling pathway.Am J Cancer Res. 2019 Jan 1;9(1):22-35. eCollection 2019.
• [1677] The Effect of Underlying Liver Disease on Perioperative Outcomes Following Craniotomy for Tumor: An American College of Surgeons National Quality Improvement Program Analysis.World Neurosurg. 2018 Jul;115:e85-e96. doi: 10.1016/j.wneu.2018.03.183. Epub 2018 Apr 3.
• [1678] Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer.Pharmacogenomics. 2014 Feb;15(3):329-37. doi: 10.2217/pgs.13.237.
• [1679] Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells.BMC Cancer. 2014 May 28;14:377. doi: 10.1186/1471-2407-14-377.
• [1680] Prognostic and therapeutic potential of Adenylate kinase 2 in lung adenocarcinoma.Sci Rep. 2019 Nov 28;9(1):17757. doi: 10.1038/s41598-019-53594-4.
• [1681] The Diagnostic Significance of Serum Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in Prostate Cancer Patients.Anticancer Res. 2017 Sep;37(9):4961-4965. doi: 10.21873/anticanres.11906.
• [1682] Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma.Onco Targets Ther. 2019 Jan 24;12:815-823. doi: 10.2147/OTT.S165647. eCollection 2019.
• [1683] Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2, and rab11a expression.World J Gastroenterol. 2004 Jun 15;10(12):1716-21. doi: 10.3748/wjg.v10.i12.1716.
• [1684] ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer.Cancers (Basel). 2019 Oct 14;11(10):1553. doi: 10.3390/cancers11101553.
• [1685] Effects of long-term ethanol consumption and Aldh1b1 depletion on intestinal tumourigenesis in mice.J Pathol. 2017 Apr;241(5):649-660. doi: 10.1002/path.4869. Epub 2017 Mar 7.
• [1686] Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib.Mol Oncol. 2019 May;13(5):1311-1331. doi: 10.1002/1878-0261.12488. Epub 2019 Apr 15.
• [1687] Melatonergic system-based two-gene index is prognostic in human gliomas.J Pineal Res. 2016 Jan;60(1):84-94. doi: 10.1111/jpi.12293. Epub 2015 Nov 20.
• [1688] Asparagine bioavailability governs metastasis in a model of breast cancer.Nature. 2018 Feb 15;554(7692):378-381. doi: 10.1038/nature25465. Epub 2018 Feb 7.
• [1689] MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.J Cell Physiol. 2019 Aug;234(8):13128-13136. doi: 10.1002/jcp.27983. Epub 2018 Dec 13.
• [1690] Effective targeting of RNA polymerase I in treatment-resistant prostate cancer.Prostate. 2019 Dec;79(16):1837-1851. doi: 10.1002/pros.23909. Epub 2019 Sep 16.
• [1691] Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity.Pharmacogenet Genomics. 2008 Jul;18(7):621-31. doi: 10.1097/FPC.0b013e328301a869.
• [1692] Expression of Topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancer.Cancer Biol Ther. 2018 Mar 4;19(3):153-159. doi: 10.1080/15384047.2017.1414754. Epub 2018 Jan 16.
• [1693] CHAC2, downregulated in gastric and colorectal cancers, acted as a tumor suppressor inducing apoptosis and autophagy through unfolded protein response.Cell Death Dis. 2017 Aug 24;8(8):e3009. doi: 10.1038/cddis.2017.405.
• [1694] Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.Mol Oncol. 2017 Oct;11(10):1348-1360. doi: 10.1002/1878-0261.12104. Epub 2017 Jul 21.
• [1695] Human 3-hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations.Cancer Med. 2016 Jul;5(7):1405-15. doi: 10.1002/cam4.708. Epub 2016 May 3.
• [1696] Foot-and-mouth disease virus induces lysosomal degradation of NME1 to impair p53-regulated interferon-inducible antiviral genes expression.Cell Death Dis. 2018 Aug 29;9(9):885. doi: 10.1038/s41419-018-0940-z.
• [1697] Role of CYB5A in pancreatic cancer prognosis and autophagy modulation.J Natl Cancer Inst. 2014 Jan;106(1):djt346. doi: 10.1093/jnci/djt346. Epub 2013 Dec 3.
• [1698] Host CYP27A1 expression is essential for ovarian cancer progression.Endocr Relat Cancer. 2019 Jul;26(7):659-675. doi: 10.1530/ERC-18-0572.
• [1699] Chronic moderate ethanol intake differentially regulates vitamin D hydroxylases gene expression in kidneys and xenografted breast cancer cells in female mice.J Steroid Biochem Mol Biol. 2017 Oct;173:148-156. doi: 10.1016/j.jsbmb.2016.09.011. Epub 2016 Sep 14.
• [1700] Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).J Med Chem. 2018 Sep 13;61(17):7767-7784. doi: 10.1021/acs.jmedchem.8b00743. Epub 2018 Aug 23.
• [1701] Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes.Pharmacol Rep. 2019 Dec;71(6):1001-1005. doi: 10.1016/j.pharep.2019.08.005. Epub 2019 Aug 14.
• [1702] The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors.Cancer. 2010 Dec 1;116(23):5358-64. doi: 10.1002/cncr.25508. Epub 2010 Aug 16.
• [1703] Cytochrome P450 4A11 expression in tumor cells: A favorable prognostic factor for hepatocellular carcinoma patients.J Gastroenterol Hepatol. 2019 Jan;34(1):224-233. doi: 10.1111/jgh.14406. Epub 2018 Aug 29.
• [1704] Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.APMIS. 2019 Apr;127(4):170-180. doi: 10.1111/apm.12939.
• [1705] The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.Br J Cancer. 2017 Jun 6;116(12):1612-1620. doi: 10.1038/bjc.2017.135. Epub 2017 May 30.
• [1706] CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response.Oncotarget. 2017 Jun 13;8(24):38530-38540. doi: 10.18632/oncotarget.15869.
• [1707] Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinoma.Cell Mol Biol Lett. 2006;11(2):230-41. doi: 10.2478/s11658-006-0022-6.
• [1708] The retinal dehydrogenase/reductase retSDR1/DHRS3 gene is activated by p53 and p63 but not by mutants derived from tumors or EEC/ADULT malformation syndromes.Cell Cycle. 2010 Jun 1;9(11):2177-88. doi: 10.4161/cc.9.11.11844. Epub 2010 Jun 1.
• [1709] DHRS7 (SDR34C1) - A new player in the regulation of androgen receptor function by inactivation of 5-dihydrotestosterone?.J Steroid Biochem Mol Biol. 2017 Jul;171:288-295. doi: 10.1016/j.jsbmb.2017.04.013. Epub 2017 Apr 27.
• [1710] Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma.Pathology. 2018 Oct;50(6):642-647. doi: 10.1016/j.pathol.2018.06.002. Epub 2018 Aug 24.
• [1711] Energizing the search to target LKB1-mutant tumors.Cancer Discov. 2013 Aug;3(8):843-5. doi: 10.1158/2159-8290.CD-13-0296.
• [1712] Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.Investig Clin Urol. 2019 Nov;60(6):425-431. doi: 10.4111/icu.2019.60.6.425. Epub 2019 Oct 1.
• [1713] Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.Breast Cancer Res. 2004;6(3):R252-63. doi: 10.1186/bcr784. Epub 2004 Mar 26.
• [1714] Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.Oncotarget. 2016 Apr 12;7(15):20166-79. doi: 10.18632/oncotarget.7737.
• [1715] Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich's ataxia.Dis Model Mech. 2012 Nov;5(6):860-9. doi: 10.1242/dmm.009829. Epub 2012 Jun 26.
• [1716] -Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.Gynecol Oncol. 2018 Apr;149(1):163-172. doi: 10.1016/j.ygyno.2018.01.023. Epub 2018 Feb 9.
• [1717] Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity.Oncogene. 2019 Dec;38(50):7504-7520. doi: 10.1038/s41388-019-0967-3. Epub 2019 Aug 23.
• [1718] Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer.Semin Cell Dev Biol. 2020 Feb;98:34-43. doi: 10.1016/j.semcdb.2019.05.012. Epub 2019 May 22.
• [1719] A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.Cancer Med. 2020 Jan;9(1):104-115. doi: 10.1002/cam4.2606. Epub 2019 Nov 12.
• [1720] Glutathione-s-transferase A 4 (GSTA4) suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting AKT pathway.Am J Transl Res. 2017 Feb 15;9(2):301-315. eCollection 2017.
• [1721] GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.Oncogene. 2009 Nov 19;28(46):4126-32. doi: 10.1038/onc.2009.262. Epub 2009 Aug 31.
• [1722] Glutathione S-transferase omega 2 regulates cell growth and the expression of E-cadherin via post-transcriptional down-regulation of -catenin in human esophageal squamous cells.Carcinogenesis. 2020 Jul 14;41(7):875-886. doi: 10.1093/carcin/bgz189.
• [1723] GSTZ1-1 downregulates Wnt/-catenin signalling in hepatocellular carcinoma cells.FEBS Open Bio. 2020 Jan;10(1):6-17. doi: 10.1002/2211-5463.12769. Epub 2019 Dec 10.
• [1724] Hint1 expression inhibits proliferation and promotes radiosensitivity of human SGC7901 gastric cancer cells.Oncol Lett. 2018 Aug;16(2):2135-2142. doi: 10.3892/ol.2018.8900. Epub 2018 Jun 5.
• [1725] 15-Keto prostaglandin E(2) induces heme oxygenase-1 expression through activation of Nrf2 in human colon epithelial CCD 841 CoN cells.Arch Biochem Biophys. 2020 Jan 15;679:108162. doi: 10.1016/j.abb.2019.108162. Epub 2019 Dec 24.
• [1726] Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer.Mol Cancer Ther. 2016 Jan;15(1):48-59. doi: 10.1158/1535-7163.MCT-15-0527. Epub 2015 Nov 19.
• [1727] Targetable T-type Calcium Channels Drive Glioblastoma.Cancer Res. 2017 Jul 1;77(13):3479-3490. doi: 10.1158/0008-5472.CAN-16-2347. Epub 2017 May 16.
• [1728] Germline polymorphisms associated with impaired survival outcomes and somatic tumor alterations in advanced prostate cancer.Prostate Cancer Prostatic Dis. 2020 Jun;23(2):316-323. doi: 10.1038/s41391-019-0188-4. Epub 2019 Nov 19.
• [1729] Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.Mod Pathol. 2017 Dec;30(12):1760-1772. doi: 10.1038/modpathol.2017.60. Epub 2017 Aug 4.
• [1730] Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.Dig Liver Dis. 2017 Jan;49(1):98-102. doi: 10.1016/j.dld.2016.10.007. Epub 2016 Oct 20.
• [1731] TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells.Prostate. 2015 Jul 1;75(10):1020-33. doi: 10.1002/pros.22983. Epub 2015 Apr 2.
• [1732] MAT2B promotes proliferation and inhibits apoptosis in osteosarcoma by targeting epidermal growth factor receptor and proliferating cell nuclear antigen.Int J Oncol. 2019 Jun;54(6):2019-2029. doi: 10.3892/ijo.2019.4764. Epub 2019 Mar 27.
• [1733] Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.Biomed Pharmacother. 2020 Jan;121:109562. doi: 10.1016/j.biopha.2019.109562. Epub 2019 Nov 7.
• [1734] Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.J Clin Endocrinol Metab. 2001 Apr;86(4):1801-5. doi: 10.1210/jcem.86.4.7419.
• [1735] Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation. Cancer Discov. 2013 Jan;3(1):96-111. doi: 10.1158/2159-8290.CD-12-0031. Epub 2012 Nov 2.
• [1736] MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma.Sci Rep. 2019 Aug 23;9(1):12301. doi: 10.1038/s41598-019-48846-2.
• [1737] Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies.Mol Biol Rep. 2012 Feb;39(2):805-16. doi: 10.1007/s11033-011-0802-6. Epub 2011 May 6.
• [1738] Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior.Breast Cancer Res Treat. 2019 Apr;174(3):649-659. doi: 10.1007/s10549-018-05089-5. Epub 2019 Jan 4.
• [1739] GSK-3-regulated N-acetyltransferase 10 is involved in colorectal cancer invasion.Clin Cancer Res. 2014 Sep 1;20(17):4717-29. doi: 10.1158/1078-0432.CCR-13-3477. Epub 2014 Jun 30.
• [1740] The -NAD(+) salvage pathway and PKC-mediated signaling influence localized PARP-1 activity and CTCF Poly(ADP)ribosylation.Oncotarget. 2017 Aug 3;8(39):64698-64713. doi: 10.18632/oncotarget.19841. eCollection 2017 Sep 12.
• [1741] Downregulated SIRT6 and upregulated NMNAT2 are associated with the presence, depth and stage of colorectal cancer.Oncol Lett. 2018 Nov;16(5):5829-5837. doi: 10.3892/ol.2018.9400. Epub 2018 Sep 5.
• [1742] Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts.Nature. 2019 May;569(7758):723-728. doi: 10.1038/s41586-019-1173-8. Epub 2019 May 1.
• [1743] Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity.Nanoscale. 2018 May 17;10(19):9311-9319. doi: 10.1039/c8nr01376d.
• [1744] The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer.Br J Cancer. 2009 May 19;100(10):1687-96. doi: 10.1038/sj.bjc.6605042.
• [1745] COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway.Aging (Albany NY). 2019 Oct 17;11(20):8845-8859. doi: 10.18632/aging.102300. Epub 2019 Oct 17.
• [1746] In Vivo Validation of PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target.Clin Cancer Res. 2017 Nov 1;23(21):6555-6566. doi: 10.1158/1078-0432.CCR-17-0700. Epub 2017 Aug 8.
• [1747] Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin.Nanomedicine. 2018 Jun;14(4):1395-1405. doi: 10.1016/j.nano.2018.03.005. Epub 2018 Apr 7.
• [1748] PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27(Kip1) axis.J Exp Clin Cancer Res. 2019 Feb 4;38(1):50. doi: 10.1186/s13046-019-1029-y.
• [1749] Phosphoethanolamine Accumulation Protects Cancer Cells under Glutamine Starvation through Downregulation of PCYT2.Cell Rep. 2019 Oct 1;29(1):89-103.e7. doi: 10.1016/j.celrep.2019.08.087.
• [1750] Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration.Int J Mol Med. 2016 Apr;37(4):998-1004. doi: 10.3892/ijmm.2016.2500. Epub 2016 Feb 23.
• [1751] Lipid phosphate phosphatase-1 expression in cancer cells attenuates tumor growth and metastasis in mice.J Lipid Res. 2014 Nov;55(11):2389-400. doi: 10.1194/jlr.M053462. Epub 2014 Sep 10.
• [1752] Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer.Cell Death Dis. 2018 Mar 12;9(3):392. doi: 10.1038/s41419-018-0395-2.
• [1753] The role of paraoxonase in cancer.Semin Cancer Biol. 2019 Jun;56:72-86. doi: 10.1016/j.semcancer.2017.11.013. Epub 2017 Nov 21.
• [1754] PRKCSH contributes to tumorigenesis by selective boosting of IRE1 signaling pathway.Nat Commun. 2019 Jul 18;10(1):3185. doi: 10.1038/s41467-019-11019-w.
• [1755] Proline Metabolism in Cell Regulation and Cancer Biology: Recent Advances and Hypotheses.Antioxid Redox Signal. 2019 Feb 1;30(4):635-649. doi: 10.1089/ars.2017.7350. Epub 2017 Nov 15.
• [1756] Spermidine/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness.Oncogene. 2019 Oct;38(41):6794-6800. doi: 10.1038/s41388-019-0917-0. Epub 2019 Aug 9.
• [1757] Spermine oxidase is upregulated and promotes tumor growth in hepatocellular carcinoma.Hepatol Res. 2018 Nov;48(12):967-977. doi: 10.1111/hepr.13206. Epub 2018 Jul 27.
• [1758] Basigin-mediated redistribution of CD98 promotes cell spreading and tumorigenicity in hepatocellular carcinoma.J Exp Clin Cancer Res. 2015 Oct 6;34:110. doi: 10.1186/s13046-015-0226-6.
• [1759] Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue.Int J Oncol. 2005 Apr;26(4):1079-85.
• [1760] SULT1E1 inhibits cell proliferation and invasion by activating PPAR in breast cancer.J Cancer. 2018 Feb 28;9(6):1078-1087. doi: 10.7150/jca.23596. eCollection 2018.
• [1761] TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection.Dig Liver Dis. 2020 Jun;52(6):668-676. doi: 10.1016/j.dld.2019.10.010. Epub 2019 Dec 9.
• [1762] Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.Mol Carcinog. 2019 Apr;58(4):603-615. doi: 10.1002/mc.22954. Epub 2019 Jan 22.
• [1763] Targeting UDP--D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration.Oncogene. 2018 May;37(20):2615-2629. doi: 10.1038/s41388-018-0138-y. Epub 2018 Feb 26.
• [1764] Increased UGT1A3 and UGT1A7 expression is associated with pancreatic cancer.Asian Pac J Cancer Prev. 2015;16(4):1651-5. doi: 10.7314/apjcp.2015.16.4.1651.
• [1765] Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.PLoS One. 2015 May 26;10(5):e0127524. doi: 10.1371/journal.pone.0127524. eCollection 2015.
• [1766] Genetic polymorphisms in UDP-glucuronosyltransferase 1A6 and 1A7 and the risk for benign Warthin's tumors of the parotid gland.Head Neck. 2016 Apr;38 Suppl 1:E717-23. doi: 10.1002/hed.24077. Epub 2015 Jul 29.
• [1767] The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer Progression.Eur Urol. 2016 Apr;69(4):601-609. doi: 10.1016/j.eururo.2015.06.054. Epub 2015 Jul 26.
• [1768] Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor.Oncotarget. 2017 Apr 25;8(17):29138-29150. doi: 10.18632/oncotarget.16251.
• [1769] Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.Clin Cancer Res. 2000 Aug;6(8):3166-71.
• [1770] Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.Int J Cancer. 2019 Feb 15;144(4):897-908. doi: 10.1002/ijc.31792. Epub 2018 Sep 27.
• [1771] Overexpressed tryptophanyl-tRNA synthetase, an angiostatic protein, enhances oral cancer cell invasiveness.Oncotarget. 2015 Sep 8;6(26):21979-92. doi: 10.18632/oncotarget.4273.
• [1772] (18)F-Labeled Pyrido[3,4-d]pyrimidine as an Effective Probe for Imaging of L858R Mutant Epidermal Growth Factor Receptor.ACS Med Chem Lett. 2017 Mar 20;8(4):418-422. doi: 10.1021/acsmedchemlett.6b00520. eCollection 2017 Apr 13.
• [1773] Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.Cell Death Dis. 2019 Nov 7;10(11):854. doi: 10.1038/s41419-019-2082-3.
• [1774] ,-carotene 15,15'-monooxygenase and its substrate -carotene modulate migration and invasion in colorectal carcinoma cells.Am J Clin Nutr. 2013 Aug;98(2):413-22. doi: 10.3945/ajcn.113.060996. Epub 2013 Jun 26.
• [1775] Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.Anticancer Agents Med Chem. 2017;17(2):250-264. doi: 10.2174/1871520616666161013145853.
• [1776] Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma.Oncogenesis. 2019 Feb 26;8(3):18. doi: 10.1038/s41389-019-0128-0.
• [1777] Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype.Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18628-33. doi: 10.1073/pnas.1010171107. Epub 2010 Oct 11.
• [1778] Identification of novel HMGA2 fusion sequences in lipoma: evidence that deletion of let-7 miRNA consensus binding site 1 in the HMGA2 3' UTR is not critical for HMGA2 transcriptional upregulation.Genes Chromosomes Cancer. 2009 Aug;48(8):673-8. doi: 10.1002/gcc.20674.
• [1779] Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13.
• [1780] Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.World J Surg Oncol. 2018 Jan 18;16(1):11. doi: 10.1186/s12957-018-1316-7.
• [1781] A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice.Melanoma Res. 2012 Jun;22(3):225-35. doi: 10.1097/CMR.0b013e32835312fd.
• [1782] Oncogenic role of ABHD5 in endometrial cancer.Cancer Manag Res. 2019 Mar 14;11:2139-2150. doi: 10.2147/CMAR.S188648. eCollection 2019.
• [1783] Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.Cancer Immunol Res. 2017 Oct;5(10):839-846. doi: 10.1158/2326-6066.CIR-17-0192. Epub 2017 Sep 13.
• [1784] A novel RET rearrangement (ACBD5/RET) by pericentric inversion, inv(10)(p12.1;q11.2), in papillary thyroid cancer from an atomic bomb survivor exposed to high-dose radiation.Oncol Rep. 2014 Nov;32(5):1809-14. doi: 10.3892/or.2014.3449. Epub 2014 Aug 29.
• [1785] Loss of atypical chemokine receptor 4 facilitates C-C motif chemokine ligand 21-mediated tumor growth and invasion in nasopharyngeal carcinoma.Exp Ther Med. 2019 Jan;17(1):613-620. doi: 10.3892/etm.2018.7007. Epub 2018 Nov 23.
• [1786] Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma.Oncogene. 2005 Jun 9;24(25):4155-61. doi: 10.1038/sj.onc.1208578.
• [1787] ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma.Oncogene. 2019 Mar;38(12):2056-2075. doi: 10.1038/s41388-018-0543-2. Epub 2018 Nov 6.
• [1788] Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers.Neoplasia. 2017 Apr;19(4):279-287. doi: 10.1016/j.neo.2017.01.005. Epub 2017 Mar 8.
• [1789] Comprehensive Analysis of Genome Rearrangements in Eight Human Malignant Tumor Tissues.PLoS One. 2016 Jul 8;11(7):e0158995. doi: 10.1371/journal.pone.0158995. eCollection 2016.
• [1790] Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells.Oncotarget. 2014 Mar 15;5(5):1253-64. doi: 10.18632/oncotarget.1690.
• [1791] The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation.Mol Cancer Res. 2014 Feb;12(2):228-38. doi: 10.1158/1541-7786.MCR-13-0195. Epub 2013 Nov 1.
• [1792] Correlation of five secretory proteins with the nasopharyngeal carcinoma metastasis and the clinical applications.Oncotarget. 2017 Apr 25;8(17):29383-29394. doi: 10.18632/oncotarget.14725.
• [1793] The Transactivation Domains of the p53 Protein.Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):a026047. doi: 10.1101/cshperspect.a026047.
• [1794] Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.BMC Cancer. 2019 Apr 5;19(1):322. doi: 10.1186/s12885-019-5537-0.
• [1795] Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.Dig Dis Sci. 2017 Mar;62(3):626-632. doi: 10.1007/s10620-017-4460-y. Epub 2017 Jan 23.
• [1796] Paradoxical expression of AHCYL1 affecting ovarian carcinogenesis between chickens and women.Exp Biol Med (Maywood). 2012 Jul;237(7):758-67. doi: 10.1258/ebm.2012.011433. Epub 2012 Jul 23.
• [1797] Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.Prostate. 2017 Jun;77(9):1000-1011. doi: 10.1002/pros.23356. Epub 2017 Apr 19.
• [1798] Silencing of A-Kinase Anchor Protein 4 (AKAP4) Inhibits Proliferation and Progression of Thyroid Cancer.Oncol Res. 2017 Jul 5;25(6):873-878. doi: 10.3727/096504016X14783701102564. Epub 2016 Nov 8.
• [1799] AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-B signaling pathways.Oncotarget. 2016 Oct 18;8(48):83469-83479. doi: 10.18632/oncotarget.12726. eCollection 2017 Oct 13.
• [1800] ALG2 regulates glioblastoma cell proliferation, migration and tumorigenicity.Biochem Biophys Res Commun. 2017 Apr 29;486(2):300-306. doi: 10.1016/j.bbrc.2017.03.032. Epub 2017 Mar 12.
• [1801] Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.Dig Dis Sci. 2019 Jun;64(6):1503-1513. doi: 10.1007/s10620-018-5452-2. Epub 2019 Jan 14.
• [1802] An Alpha-kinase 2 Gene Variant Disrupts Filamentous Actin Localization in the Surface Cells of Colorectal Cancer Spheroids.Anticancer Res. 2017 Jul;37(7):3855-3862. doi: 10.21873/anticanres.11765.
• [1803] Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma.Sci Rep. 2017 Jan 5;7:40187. doi: 10.1038/srep40187.
• [1804] AMPH-1 is a tumor suppressor of lung cancer by inhibiting Ras-Raf-MEK-ERK signal pathway.Lasers Med Sci. 2019 Apr;34(3):473-478. doi: 10.1007/s10103-018-2616-4. Epub 2018 Aug 24.
• [1805] ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.Pathol Res Pract. 2019 Aug;215(8):152454. doi: 10.1016/j.prp.2019.152454. Epub 2019 May 23.
• [1806] Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth.Hepatology. 2018 Nov;68(5):1833-1850. doi: 10.1002/hep.30030. Epub 2018 Sep 19.
• [1807] High expression of the ANKRD49 protein is associated with progression and poor prognosis of gastric cancer.Cancer Biomark. 2018;22(4):649-656. doi: 10.3233/CBM-171074.
• [1808] Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.Mol Cell Proteomics. 2017 Mar;16(3):407-427. doi: 10.1074/mcp.M116.062273. Epub 2017 Jan 4.
• [1809] ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy.Cancer Immunol Immunother. 2019 Oct;68(10):1597-1603. doi: 10.1007/s00262-019-02392-y. Epub 2019 Sep 14.
• [1810] Molecular genetics of meningiomas.Neurosurg Focus. 2005 Nov 15;19(5):E9. doi: 10.3171/foc.2005.19.5.10.
• [1811] Circulating methylated MINT2 promoter DNA is a potential poor prognostic factor in gastric cancer.Dig Dis Sci. 2014 Jun;59(6):1160-8. doi: 10.1007/s10620-013-3007-0. Epub 2014 Jan 3.
• [1812] Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1.Nucleic Acids Res. 2019 Feb 20;47(3):1255-1267. doi: 10.1093/nar/gky1207.
• [1813] Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.PLoS One. 2017 Mar 16;12(3):e0171453. doi: 10.1371/journal.pone.0171453. eCollection 2017.
• [1814] Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets.Clin Cancer Res. 2003 Jun;9(6):1995-2004.
• [1815] Altered endosome biogenesis in prostate cancer has biomarker potential.Mol Cancer Res. 2014 Dec;12(12):1851-62. doi: 10.1158/1541-7786.MCR-14-0074. Epub 2014 Jul 30.
• [1816] YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis.Cell Rep. 2017 May 23;19(8):1495-1502. doi: 10.1016/j.celrep.2017.04.075.
• [1817] Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray.J Dent Res. 2002 Aug;81(8):525-30. doi: 10.1177/154405910208100805.
• [1818] Rho guanine nucleotide exchange factor ARHGEF10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma.Oncogene. 2020 Jan;39(2):308-321. doi: 10.1038/s41388-019-0985-1. Epub 2019 Sep 2.
• [1819] ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis.Genes Dev. 2017 Dec 1;31(23-24):2343-2360. doi: 10.1101/gad.302646.117. Epub 2018 Jan 11.
• [1820] RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis.Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1552-1561. doi: 10.1016/j.bbadis.2018.02.013. Epub 2018 Feb 23.
• [1821] Armadillo repeat containing 12 promotes neuroblastoma progression through interaction with retinoblastoma binding protein 4.Nat Commun. 2018 Jul 19;9(1):2829. doi: 10.1038/s41467-018-05286-2.
• [1822] ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation.Am J Cancer Res. 2018 Jan 1;8(1):132-143. eCollection 2018.
• [1823] In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma.Cancer Discov. 2020 Feb;10(2):270-287. doi: 10.1158/2159-8290.CD-19-0780. Epub 2019 Nov 19.
• [1824] Anti-silencing function 1B histone chaperone promotes cell proliferation and migration via activation of the AKT pathway in clear cell renal cell carcinoma.Biochem Biophys Res Commun. 2019 Mar 26;511(1):165-172. doi: 10.1016/j.bbrc.2019.02.060. Epub 2019 Feb 15.
• [1825] Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1.J Endocrinol Invest. 2003 Oct;26(10):957-65. doi: 10.1007/BF03348192.
• [1826] Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India.Arch Med Res. 2011 Feb;42(2):122-7. doi: 10.1016/j.arcmed.2011.03.001.
• [1827] Replication of genetic susceptibility loci for testicular germ cell cancer in the Croatian population.Carcinogenesis. 2012 Aug;33(8):1548-52. doi: 10.1093/carcin/bgs218. Epub 2012 Jun 27.
• [1828] Potentially functional variants of autophagy-related genes are associated with the efficacy and toxicity of radiotherapy in patients with nasopharyngeal carcinoma.Mol Genet Genomic Med. 2019 Dec;7(12):e1030. doi: 10.1002/mgg3.1030. Epub 2019 Nov 6.
• [1829] ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis and reduced cellular bioenergetics.Cell Death Differ. 2020 Jun;27(6):1965-1980. doi: 10.1038/s41418-019-0476-5. Epub 2019 Dec 16.
• [1830] TMEM74 promotes tumor cell survival by inducing autophagy via interactions with ATG16L1 and ATG9A.Cell Death Dis. 2017 Aug 31;8(8):e3031. doi: 10.1038/cddis.2017.370.
• [1831] Lipoxin-Induced Phenotypic Changes in CD115(+)LY6C(hi) Monocytes TAM Precursors Inhibits Tumor Development.Front Oncol. 2019 Jun 19;9:540. doi: 10.3389/fonc.2019.00540. eCollection 2019.
• [1832] ATP11B mediates platinum resistance in ovarian cancer.J Clin Invest. 2013 May;123(5):2119-30. doi: 10.1172/JCI65425. Epub 2013 Apr 15.
• [1833] A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer.Breast Cancer Res Treat. 2019 Jul;176(2):271-289. doi: 10.1007/s10549-019-05174-3. Epub 2019 Apr 20.
• [1834] Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.Epigenetics. 2016 Mar 3;11(3):237-46. doi: 10.1080/15592294.2016.1154246. Epub 2016 Mar 1.
• [1835] Primary small cell carcinoma of the stomach: a case report with an immunohistochemical and molecular genetic analysis.Int J Clin Exp Pathol. 2013;6(3):524-30. Epub 2013 Feb 15.
• [1836] The effects of PTBP3 silencing on the proliferation and differentiation of MKN45 human gastric cancer cells.Life Sci. 2014 Sep 26;114(1):29-35. doi: 10.1016/j.lfs.2014.07.038. Epub 2014 Aug 10.
• [1837] Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.EBioMedicine. 2019 Sep;47:44-57. doi: 10.1016/j.ebiom.2019.08.013. Epub 2019 Aug 10.
• [1838] Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity.J Hematol Oncol. 2018 Apr 4;11(1):50. doi: 10.1186/s13045-018-0595-3.
• [1839] Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.Gastroenterology. 2017 Apr;152(5):1161-1173.e1. doi: 10.1053/j.gastro.2016.12.002. Epub 2016 Dec 10.
• [1840] MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.Tumour Biol. 2016 Oct;37(10):14249-14257. doi: 10.1007/s13277-016-5270-0. Epub 2016 Aug 29.
• [1841] The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing.Mod Pathol. 2016 Apr;29(4):359-69. doi: 10.1038/modpathol.2016.37. Epub 2016 Feb 19.
• [1842] A novel gene expression signature for bone metastasis in breast carcinomas.Breast Cancer Res Treat. 2016 Apr;156(2):249-59. doi: 10.1007/s10549-016-3741-z. Epub 2016 Mar 10.
• [1843] Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer.Cancer Lett. 2002 Nov 28;185(2):219-23. doi: 10.1016/s0304-3835(02)00286-0.
• [1844] Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.Cancer Biomark. 2019;25(2):141-149. doi: 10.3233/CBM-181772.
• [1845] Mitochondrial -Carotene 9',10' Oxygenase Modulates Prostate Cancer Growth via NF-B Inhibition: A Lycopene-Independent Function.Mol Cancer Res. 2016 Oct;14(10):966-975. doi: 10.1158/1541-7786.MCR-16-0075. Epub 2016 Jul 12.
• [1846] Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.PLoS One. 2015 May 1;10(5):e0125281. doi: 10.1371/journal.pone.0125281. eCollection 2015.
• [1847] LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-B activity in nasopharyngeal carcinoma.Oncogene. 2019 Jun;38(25):5062-5075. doi: 10.1038/s41388-019-0778-6. Epub 2019 Mar 18.
• [1848] TFIIB-related factor 2 is associated with poor prognosis of nonsmall cell lung cancer patients through promoting tumor epithelial-mesenchymal transition.Biomed Res Int. 2014;2014:530786. doi: 10.1155/2014/530786. Epub 2014 Mar 17.
• [1849] Brick1 is an essential regulator of actin cytoskeleton required for embryonic development and cell transformation.Cancer Res. 2010 Nov 15;70(22):9349-59. doi: 10.1158/0008-5472.CAN-09-4491. Epub 2010 Sep 22.
• [1850] Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.Oncotarget. 2018 Apr 27;9(32):22785-22801. doi: 10.18632/oncotarget.25237. eCollection 2018 Apr 27.
• [1851] Blood vessel epicardial substance reduces LRP6 receptor and cytoplasmic -catenin levels to modulate Wnt signaling and intestinal homeostasis.Carcinogenesis. 2019 Sep 18;40(9):1086-1098. doi: 10.1093/carcin/bgz007.
• [1852] Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation.Oncotarget. 2017 Oct 19;8(69):113662-113672. doi: 10.18632/oncotarget.21939. eCollection 2017 Dec 26.
• [1853] Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.Anticancer Res. 1992 Mar-Apr;12(2):297-304.
• [1854] Ctrp4, a new adipokine, promotes the differentiation of osteoblasts.Biochem Biophys Res Commun. 2019 Apr 30;512(2):224-229. doi: 10.1016/j.bbrc.2019.03.053. Epub 2019 Mar 15.
• [1855] Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies.Inorg Chem. 2017 Aug 21;56(16):9860-9868. doi: 10.1021/acs.inorgchem.7b01368. Epub 2017 Aug 2.
• [1856] Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.Oncogene. 2018 Jan 4;37(1):75-85. doi: 10.1038/onc.2017.312. Epub 2017 Sep 4.
• [1857] Regulation of complement classical pathway by association of C4b-binding protein to the surfaces of SK-OV-3 and Caov-3 ovarian adenocarcinoma cells.J Immunol. 2001 Jul 15;167(2):935-9. doi: 10.4049/jimmunol.167.2.935.
• [1858] Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?.Eur J Surg Oncol. 2020 Apr;46(4 Pt A):504-510. doi: 10.1016/j.ejso.2019.10.043. Epub 2019 Nov 1.
• [1859] Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.Aliment Pharmacol Ther. 2019 May;49(10):1260-1273. doi: 10.1111/apt.15253. Epub 2019 Apr 15.
• [1860] RETRACTED: Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors.Lung Cancer. 2011 Mar;71(3):283-90. doi: 10.1016/j.lungcan.2010.06.005.
• [1861] Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice.Oncogene. 2005 Jun 2;24(24):3896-905. doi: 10.1038/sj.onc.1208553.
• [1862] Calnexin Impairs the Antitumor Immunity of CD4(+) and CD8(+) T Cells.Cancer Immunol Res. 2019 Jan;7(1):123-135. doi: 10.1158/2326-6066.CIR-18-0124. Epub 2018 Nov 6.
• [1863] Intravenous and intratumoral injection of Pluronic P94: The effect of administration route on biodistribution and tumor retention.Nanomedicine. 2017 Oct;13(7):2179-2188. doi: 10.1016/j.nano.2017.04.015. Epub 2017 May 20.
• [1864] Prognostic value of CAPZA1 overexpression in gastric cancer.Int J Oncol. 2013 May;42(5):1569-77. doi: 10.3892/ijo.2013.1867. Epub 2013 Mar 27.
• [1865] Identification of an amplified gene cluster in glioma including two novel amplified genes isolated by exon trapping.Hum Genet. 1997 Dec;101(2):190-7. doi: 10.1007/s004390050612.
• [1866] Self-Templated Stepwise Synthesis of Monodispersed Nanoscale Metalated Covalent Organic Polymers for In Vivo Bioimaging and Photothermal Therapy.Chem Asian J. 2017 Sep 5;12(17):2183-2188. doi: 10.1002/asia.201700796. Epub 2017 Aug 2.
• [1867] ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma.PLoS Biol. 2011 Sep;9(9):e1001156. doi: 10.1371/journal.pbio.1001156. Epub 2011 Sep 20.
• [1868] A systematic analysis reveals gene expression alteration of serum deprivation response (SDPR) gene is significantly associated with the survival of patients with cancer.Oncol Rep. 2019 Sep;42(3):1161-1172. doi: 10.3892/or.2019.7212. Epub 2019 Jun 26.
• [1869] Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.Ann Hematol. 2018 Oct;97(10):1775-1783. doi: 10.1007/s00277-018-3389-3. Epub 2018 Jun 5.
• [1870] Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?.BMC Cancer. 2004 Jul 9;4:31. doi: 10.1186/1471-2407-4-31.
• [1871] Overexpression of a novel osteopetrosis-related gene CCDC154 suppresses cell proliferation by inducing G2/M arrest.Cell Cycle. 2012 Sep 1;11(17):3270-9. doi: 10.4161/cc.21642. Epub 2012 Aug 16.
• [1872] Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion.Mol Med Rep. 2018 Jan;17(1):465-473. doi: 10.3892/mmr.2017.7860. Epub 2017 Oct 24.
• [1873] Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration.Br J Cancer. 1995 Sep;72(3):708-14. doi: 10.1038/bjc.1995.398.
• [1874] Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer.J Cell Physiol. 2020 Jan;235(1):394-407. doi: 10.1002/jcp.28980. Epub 2019 Jun 21.
• [1875] Cyclin T1 overexpression induces malignant transformation and tumor growth.Cell Cycle. 2010 Aug 1;9(15):3119-26. doi: 10.4161/cc.9.15.12526.
• [1876] Copper Chaperone for Superoxide Dismutase Promotes Breast Cancer Cell Proliferation and Migration via ROS-Mediated MAPK/ERK Signaling.Front Pharmacol. 2019 Apr 5;10:356. doi: 10.3389/fphar.2019.00356. eCollection 2019.
• [1877] Inhibition of cytosolic chaperonin CCT-1 expression depletes proliferation of colorectal carcinoma in vitro.J Surg Oncol. 2010 Oct 1;102(5):419-23. doi: 10.1002/jso.21625.
• [1878] Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors.Clin Cancer Res. 2017 Feb 15;23(4):1025-1035. doi: 10.1158/1078-0432.CCR-16-1658. Epub 2017 Jan 10.
• [1879] Cyclin D1 gene amplification and p16 gene deletion in patients with esophageal carcinosarcoma.Diagn Mol Pathol. 1998 Oct;7(5):253-9. doi: 10.1097/00019606-199810000-00004.
• [1880] In melanoma changes of immature and mature dendritic cell expression correlate with tumor thickness:an immunohistochemical study.Int J Immunopathol Pharmacol. 2007 Apr-Jun;20(2):325-33. doi: 10.1177/039463200702000212.
• [1881] Paragangliomas of the head and neck region show complete loss of heterozygosity at 11q22-q23 in chief cells and the flow-sorted DNA aneuploid fraction.Hum Pathol. 1998 Oct;29(10):1045-9. doi: 10.1016/s0046-8177(98)90411-7.
• [1882] Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.J Cutan Pathol. 2016 Oct;43(10):884-91. doi: 10.1111/cup.12746. Epub 2016 Jun 29.
• [1883] Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma.Esophagus. 2019 Oct;16(4):333-344. doi: 10.1007/s10388-019-00669-w. Epub 2019 Apr 9.
• [1884] Exclusion of Leu1 and Leu2 genes as tumor suppressor genes in 13q14.3-deleted B-CLL.Leukemia. 1999 Oct;13(10):1630-2. doi: 10.1038/sj.leu.2401525.
• [1885] High expression of CDH3 predicts a good prognosis for colon adenocarcinoma patients.Exp Ther Med. 2019 Jul;18(1):841-847. doi: 10.3892/etm.2019.7638. Epub 2019 Jun 3.
• [1886] CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.Oncogene. 2018 Jul;37(27):3617-3630. doi: 10.1038/s41388-018-0231-2. Epub 2018 Apr 3.
• [1887] Cadherin Related Family Member 2 Acts As A Tumor Suppressor By Inactivating AKT In Human Hepatocellular Carcinoma.J Cancer. 2019 Jan 29;10(4):864-873. doi: 10.7150/jca.27663. eCollection 2019.
• [1888] A nonsense mutant of the hepatitis B virus large S protein antagonizes multiple tumor suppressor pathways through c-Jun activation domain-binding protein1.PLoS One. 2019 Mar 14;14(3):e0208665. doi: 10.1371/journal.pone.0208665. eCollection 2019.
• [1889] Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).Invest New Drugs. 2017 Feb;35(1):11-25. doi: 10.1007/s10637-016-0398-8. Epub 2016 Oct 25.
• [1890] The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.Cell Mol Biol (Noisy-le-grand). 1998 May;44(3):493-504.
• [1891] HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis.Aging (Albany NY). 2019 Sep 16;11(18):7473-7491. doi: 10.18632/aging.102254. Epub 2019 Sep 16.
• [1892] The Ciliopathy-Associated Cep104 Protein Interacts with Tubulin and Nek1 Kinase.Structure. 2017 Jan 3;25(1):146-156. doi: 10.1016/j.str.2016.11.014. Epub 2016 Dec 22.
• [1893] CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma.Int J Biochem Cell Biol. 2017 Sep;90:1-8. doi: 10.1016/j.biocel.2017.07.001. Epub 2017 Jul 8.
• [1894] Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma.Nat Genet. 2015 May;47(5):486-95. doi: 10.1038/ng.3275. Epub 2015 Apr 13.
• [1895] Discovery of Centrosomal Protein 70 as an Important Player in the Development and Progression of Breast Cancer.Am J Pathol. 2017 Mar;187(3):679-688. doi: 10.1016/j.ajpath.2016.11.005. Epub 2017 Jan 5.
• [1896] Clinicopathologic significance of S100A4 expression in osteosarcoma.Eur Rev Med Pharmacol Sci. 2014;18(6):833-9.
• [1897] INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform.Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1053-8. doi: 10.1073/pnas.1418203112. Epub 2014 Dec 30.
• [1898] Cofilin-2 Acts as a Marker for Predicting Radiotherapy Response and Is a Potential Therapeutic Target in Nasopharyngeal Carcinoma.Med Sci Monit. 2018 Apr 17;24:2317-2329. doi: 10.12659/msm.909832.
• [1899] Human chorionic gonadotropin beta subunit genes CGB1 and CGB2 are transcriptionally active in ovarian cancer.Int J Mol Sci. 2013 Jun 17;14(6):12650-60. doi: 10.3390/ijms140612650.
• [1900] Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group).Am J Surg Pathol. 1996 Oct;20(10):1182-9. doi: 10.1097/00000478-199610000-00002.
• [1901] Knockdown of CHCHD2 inhibits migration and angiogenesis of human renal cell carcinoma: A potential molecular marker for treatment of RCC.Oncol Lett. 2019 Jan;17(1):765-772. doi: 10.3892/ol.2018.9686. Epub 2018 Nov 12.
• [1902] Chmp1A acts as a tumor suppressor gene that inhibits proliferation of renal cell carcinoma.Cancer Lett. 2012 Jun 28;319(2):190-196. doi: 10.1016/j.canlet.2012.01.010. Epub 2012 Jan 17.
• [1903] The IKK/NF-B signalingpathway requires Morgana to drive breast cancer metastasis.Nat Commun. 2017 Nov 21;8(1):1636. doi: 10.1038/s41467-017-01829-1.
• [1904] Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.Cancer Genet Cytogenet. 2007 Jul 15;176(2):100-6. doi: 10.1016/j.cancergencyto.2007.04.003.
• [1905] Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.Diagn Pathol. 2015 Sep 17;10:169. doi: 10.1186/s13000-015-0403-0.
• [1906] Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma.Cancer Manag Res. 2019 Jul 24;11:6959-6969. doi: 10.2147/CMAR.S211389. eCollection 2019.
• [1907] NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14676-81. doi: 10.1073/pnas.1313198110. Epub 2013 Aug 19.
• [1908] CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation.J Cancer Res Clin Oncol. 2016 Jan;142(1):225-37. doi: 10.1007/s00432-015-2011-5. Epub 2015 Aug 5.
• [1909] Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma.Ann Diagn Pathol. 2015 Aug;19(4):193-7. doi: 10.1016/j.anndiagpath.2015.03.007. Epub 2015 Apr 14.
• [1910] TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas.Oncotarget. 2018 Dec 25;9(101):37564-37580. doi: 10.18632/oncotarget.26500. eCollection 2018 Dec 25.
• [1911] Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12.Int J Colorectal Dis. 2007 Jun;22(6):651-9. doi: 10.1007/s00384-006-0197-3. Epub 2006 Oct 18.
• [1912] High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma.PLoS One. 2013 Jun 26;8(6):e64709. doi: 10.1371/journal.pone.0064709. Print 2013.
• [1913] Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization.Cancer Genet Cytogenet. 1998 Jun;103(2):110-6. doi: 10.1016/s0165-4608(97)00410-x.
• [1914] A novel protein CMTM1-v5 specifically induced human lymphoma cells apoptosis in vitro and in vivo.Exp Cell Res. 2019 Dec 1;385(1):111623. doi: 10.1016/j.yexcr.2019.111623. Epub 2019 Sep 19.
• [1915] CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(9):915-924. doi: 10.1093/abbs/gmz084.
• [1916] Loss of calponin h1 confers anoikis resistance and tumor progression in the development of high-grade serous carcinoma originating from the fallopian tube epithelium.Oncotarget. 2017 May 19;8(37):61133-61145. doi: 10.18632/oncotarget.18024. eCollection 2017 Sep 22.
• [1917] CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.Oncogene. 2019 Apr;38(14):2580-2594. doi: 10.1038/s41388-018-0603-7. Epub 2018 Dec 10.
• [1918] p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.Genes Dev. 2003 Feb 15;17(4):476-87. doi: 10.1101/gad.1040003.
• [1919] Primary anaplastic large cell lymphoma of the small intestine.Am J Clin Pathol. 1999 Nov;112(5):696-701. doi: 10.1093/ajcp/112.5.696.
• [1920] Bioinformatics approach reveals systematic mechanism underlying lung adenocarcinoma.Tumori. 2015 May-Jun;101(3):281-6. doi: 10.5301/tj.5000278. Epub 2015 May 21.
• [1921] Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling.Ann Oncol. 2017 Sep 1;28(9):2160-2168. doi: 10.1093/annonc/mdx293.
• [1922] Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours.Hum Mol Genet. 1995 Jan;4(1):99-108. doi: 10.1093/hmg/4.1.99.
• [1923] Reactive stroma component COL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth.Oncotarget. 2015 Jun 10;6(16):14488-96. doi: 10.18632/oncotarget.3697.
• [1924] Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human.Cancer Gene Ther. 2020 Apr;27(3-4):216-225. doi: 10.1038/s41417-019-0087-9. Epub 2019 Feb 21.
• [1925] HCaRG, a novel calcium-regulated gene coding for a nuclear protein, is potentially involved in the regulation of cell proliferation.J Biol Chem. 2000 Oct 13;275(41):32234-43. doi: 10.1074/jbc.M001352200.
• [1926] Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.Int J Oncol. 2019 Apr;54(4):1195-1208. doi: 10.3892/ijo.2019.4717. Epub 2019 Feb 18.
• [1927] Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia.BMC Cancer. 2016 Apr 14;16:271. doi: 10.1186/s12885-016-2303-4.
• [1928] Increased expression of genes encoding mitochondrial proteins in papillary thyroid carcinomas.Thyroid. 2003 Jul;13(7):613-20. doi: 10.1089/105072503322239943.
• [1929] Rearrangement involving chromosomes 1 and 8 in a retroperitoneal lipoma.Cancer Genet Cytogenet. 2002 Mar;133(2):156-9. doi: 10.1016/s0165-4608(01)00573-8.
• [1930] SARI inhibits angiogenesis and tumour growth of human colon cancer through directly targeting ceruloplasmin.Nat Commun. 2016 Jun 29;7:11996. doi: 10.1038/ncomms11996.
• [1931] LncRNA SUMO1P3 promotes proliferation and inhibits apoptosis in colorectal cancer by epigenetically silencing CPEB3.Biochem Biophys Res Commun. 2019 Apr 2;511(2):239-245. doi: 10.1016/j.bbrc.2019.02.006. Epub 2019 Feb 22.
• [1932] Downregulated cytoplasmic polyadenylation element-binding protein-4 is associated with the carcinogenesis of head and neck squamous cell carcinoma.Oncol Lett. 2018 Mar;15(3):3226-3232. doi: 10.3892/ol.2017.7661. Epub 2017 Dec 20.
• [1933] Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer.Sci Rep. 2017 Jun 20;7(1):3896. doi: 10.1038/s41598-017-04248-w.
• [1934] Effects of carnitine palmitoyltransferases on cancer cellular senescence.J Cell Physiol. 2019 Feb;234(2):1707-1719. doi: 10.1002/jcp.27042. Epub 2018 Aug 2.
• [1935] Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer.Oncol Rep. 2016 Apr;35(4):1967-78. doi: 10.3892/or.2016.4579. Epub 2016 Jan 20.
• [1936] A cellular repressor of E1A-stimulated genes that inhibits activation by E2F.Mol Cell Biol. 1998 Sep;18(9):5032-41. doi: 10.1128/MCB.18.9.5032.
• [1937] Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.J Exp Clin Cancer Res. 2019 Mar 8;38(1):120. doi: 10.1186/s13046-019-1117-z.
• [1938] Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.Blood. 2012 Jun 14;119(24):5795-806. doi: 10.1182/blood-2011-12-396150. Epub 2012 Apr 17.
• [1939] Growth response of human colorectal tumour cell lines to treatment with afatinib (BIBW2992), an irreversible erbB family blocker, and its association with expression of HER family members.Int J Oncol. 2011 Aug;39(2):483-91. doi: 10.3892/ijo.2011.1054. Epub 2011 May 25.
• [1940] Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.Cancer Res. 2002 Mar 1;62(5):1256-60.
• [1941] UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis.Cancer Cell. 2016 Nov 14;30(5):694-707. doi: 10.1016/j.ccell.2016.10.004. Epub 2016 Oct 27.
• [1942] Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).Oncogene. 2013 May 23;32(21):2631-9. doi: 10.1038/onc.2012.286. Epub 2012 Jul 9.
• [1943] Serological detection of cutaneous T-cell lymphoma-associated antigens.Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):629-34. doi: 10.1073/pnas.98.2.629. Epub 2001 Jan 9.
• [1944] Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro.J Cancer Res Clin Oncol. 2016 Apr;142(4):723-32. doi: 10.1007/s00432-015-2070-7. Epub 2015 Nov 21.
• [1945] The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.J Exp Clin Cancer Res. 2018 Jan 30;37(1):15. doi: 10.1186/s13046-018-0679-5.
• [1946] An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors.Mol Ther. 2013 Nov;21(11):2008-18. doi: 10.1038/mt.2013.153. Epub 2013 Jul 2.
• [1947] Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.Proc Natl Acad Sci U S A. 1990 Sep;87(17):6791-4. doi: 10.1073/pnas.87.17.6791.
• [1948] CUL1 Knockdown Attenuates the Adhesion, Invasion, and Migration of Triple-Negative Breast Cancer Cells via Inhibition of Epithelial-Mesenchymal Transition.Pathol Oncol Res. 2020 Apr;26(2):1153-1163. doi: 10.1007/s12253-019-00681-6. Epub 2019 Jun 7.
• [1949] hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.Br J Cancer. 2015 Mar 17;112(6):1076-87. doi: 10.1038/bjc.2015.28.
• [1950] Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis of CYP2D6, SREBP2 and NAGA.Int J Cancer. 2000 Sep 15;87(6):798-802. doi: 10.1002/1097-0215(20000915)87:6<798::aid-ijc6>3.0.co;2-x.
• [1951] Changes in Brain Metastasis During Radiosurgical Planning.Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):727-733. doi: 10.1016/j.ijrobp.2018.06.021. Epub 2018 Jun 25.
• [1952] Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.BMC Cancer. 2007 Apr 18;7:66. doi: 10.1186/1471-2407-7-66.
• [1953] The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters.Anticancer Res. 2012 Feb;32(2):671-4.
• [1954] Functional interaction between tumor suppressor menin and activator of S-phase kinase.Cancer Res. 2004 Sep 15;64(18):6791-6. doi: 10.1158/0008-5472.CAN-04-0724.
• [1955] Parallel Signaling through IRE1 and PERK Regulates Pancreatic Neuroendocrine Tumor Growth and Survival.Cancer Res. 2019 Dec 15;79(24):6190-6203. doi: 10.1158/0008-5472.CAN-19-1116. Epub 2019 Oct 31.
• [1956] Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer.World J Gastroenterol. 2018 Sep 14;24(34):3898-3907. doi: 10.3748/wjg.v24.i34.3898.
• [1957] Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice.PLoS One. 2017 Apr 27;12(4):e0176075. doi: 10.1371/journal.pone.0176075. eCollection 2017.
• [1958] Novel DDX41 variants in Thai patients with myeloid neoplasms.Int J Hematol. 2020 Feb;111(2):241-246. doi: 10.1007/s12185-019-02770-3. Epub 2019 Nov 11.
• [1959] Knockdown of DDX46 Inhibits the Invasion and Tumorigenesis in Osteosarcoma Cells.Oncol Res. 2017 Mar 13;25(3):417-425. doi: 10.3727/096504016X14747253292210. Epub 2016 Sep 30.
• [1960] Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.Cancer Sci. 2019 Oct;110(10):3132-3144. doi: 10.1111/cas.14163. Epub 2019 Aug 29.
• [1961] Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.Cell Growth Differ. 1992 Aug;3(8):541-8.
• [1962] Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition.BMC Cancer. 2017 Jul 17;17(1):487. doi: 10.1186/s12885-017-3472-5.
• [1963] The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma.Br J Haematol. 2015 Apr;169(1):57-70. doi: 10.1111/bjh.13256. Epub 2014 Dec 17.
• [1964] Differential expression of DLG1 as a common trait in different human diseases: an encouraging issue in molecular pathology.Biol Chem. 2019 May 27;400(6):699-710. doi: 10.1515/hsz-2018-0350.
• [1965] Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array.World J Gastroenterol. 2002 Aug;8(4):580-5. doi: 10.3748/wjg.v8.i4.580.
• [1966] Therapeutic efficacy of combined vaccination against tumor pericyte-associated antigens DLK1 and DLK2 in mice.Oncoimmunology. 2017 Feb 10;6(3):e1290035. doi: 10.1080/2162402X.2017.1290035. eCollection 2017.
• [1967] Dermokine as a novel biomarker for early-stage colorectal cancer.J Gastroenterol. 2010 Dec;45(12):1201-11. doi: 10.1007/s00535-010-0279-4. Epub 2010 Jul 21.
• [1968] Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells.Oncotarget. 2018 Sep 4;9(69):33215-33231. doi: 10.18632/oncotarget.26061. eCollection 2018 Sep 4.
• [1969] KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis.Oncogene. 2020 Jan;39(2):249-261. doi: 10.1038/s41388-019-0978-0. Epub 2019 Sep 2.
• [1970] HSP40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-TCF3-MMP9 axis signaling.Theranostics. 2018 Jun 13;8(14):3841-3855. doi: 10.7150/thno.25784. eCollection 2018.
• [1971] The endoplasmic reticulum co-chaperone ERdj3/DNAJB11 promotes hepatocellular carcinoma progression through suppressing AATZ degradation.Future Oncol. 2018 Dec;14(29):3001-3013. doi: 10.2217/fon-2018-0401. Epub 2018 Jul 11.
• [1972] Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23.Int J Oncol. 2003 Oct;23(4):1219-24.
• [1973] Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.Exp Mol Pathol. 2015 Jun;98(3):338-45. doi: 10.1016/j.yexmp.2015.03.029. Epub 2015 Mar 21.
• [1974] Effect of radical prostatectomy on levels of cancer related epitopes in circulating macrophages of patients with clinically localized prostate cancer.Prostate. 2017 Sep;77(12):1251-1258. doi: 10.1002/pros.23384. Epub 2017 Jul 20.
• [1975] LSD and genetic damage.Science. 1971 Apr 30;172(3982):431-40. doi: 10.1126/science.172.3982.431.
• [1976] Dppa3 is a marker of pluripotency and has a human homologue that is expressed in germ cell tumours.Cytogenet Genome Res. 2003;101(3-4):261-5. doi: 10.1159/000074346.
• [1977] Irinotecan pharmacokinetic and pharmacogenomic alterations induced by methylselenocysteine in human head and neck xenograft tumors. Mol Cancer Ther. 2005 May;4(5):843-54.
• [1978] Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.Hum Pathol. 2018 Nov;81:113-120. doi: 10.1016/j.humpath.2018.06.032. Epub 2018 Jul 3.
• [1979] Dysbindin promotes progression of pancreatic ductal adenocarcinoma via direct activation of PI3K.J Mol Cell Biol. 2017 Dec 1;9(6):504-515. doi: 10.1093/jmcb/mjx043.
• [1980] Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress.Sci Rep. 2018 Sep 17;8(1):13904. doi: 10.1038/s41598-018-32272-x.
• [1981] Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells.J Zhejiang Univ Sci B. 2017 Jan.;18(1):27-36. doi: 10.1631/jzus.B1600205.
• [1982] High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.Cancer Manag Res. 2018 Nov 20;10:6003-6014. doi: 10.2147/CMAR.S185459. eCollection 2018.
• [1983] EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.EBioMedicine. 2019 Nov;49:189-201. doi: 10.1016/j.ebiom.2019.10.030. Epub 2019 Oct 26.
• [1984] SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination.J Exp Clin Cancer Res. 2019 Feb 13;38(1):76. doi: 10.1186/s13046-019-1069-3.
• [1985] eIF4B is a convergent target and critical effector of oncogenic Pim and PI3K/Akt/mTOR signaling pathways in Abl transformants.Oncotarget. 2016 Mar 1;7(9):10073-89. doi: 10.18632/oncotarget.7164.
• [1986] Ets protein Elf-1 bidirectionally suppresses transcriptional activities of the tumor suppressor Tsc2 gene and the repair-related Nth1 gene.Mol Carcinog. 2003 Jul;37(3):122-9. doi: 10.1002/mc.10123.
• [1987] The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer.Prostate. 2020 Feb;80(2):198-208. doi: 10.1002/pros.23932. Epub 2019 Dec 3.
• [1988] Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer.Oncogene. 2018 Feb 8;37(6):710-721. doi: 10.1038/onc.2017.385. Epub 2017 Oct 23.
• [1989] T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients.Br J Radiol. 2018 Jan;91(1081):20170617. doi: 10.1259/bjr.20170617. Epub 2017 Nov 21.
• [1990] Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.PLoS One. 2015 Jul 15;10(7):e0126566. doi: 10.1371/journal.pone.0126566. eCollection 2015.
• [1991] Developmental transcription factor EN1--a novel biomarker in human salivary gland adenoid cystic carcinoma.Cancer. 2012 Mar 1;118(5):1288-92. doi: 10.1002/cncr.26412. Epub 2011 Jul 28.
• [1992] ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth.Mol Cell. 2016 May 19;62(4):558-71. doi: 10.1016/j.molcel.2016.03.030. Epub 2016 Apr 28.
• [1993] The Ras-related gene ERAS is involved in human and murine breast cancer.Sci Rep. 2018 Aug 29;8(1):13038. doi: 10.1038/s41598-018-31326-4.
• [1994] Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.Breast Cancer Res Treat. 2003 May;79(2):175-85. doi: 10.1023/a:1023929504884.
• [1995] Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.Thyroid. 2005 Apr;15(4):326-35. doi: 10.1089/thy.2005.15.326.
• [1996] Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer.Oral Oncol. 2017 Apr;67:70-76. doi: 10.1016/j.oraloncology.2017.02.003. Epub 2017 Feb 14.
• [1997] The Cellular Response to Oxidatively Induced DNA Damage and Polymorphism of Some DNA Repair Genes Associated with Clinicopathological Features of Bladder Cancer.Oxid Med Cell Longev. 2016;2016:5710403. doi: 10.1155/2016/5710403. Epub 2015 Nov 16.
• [1998] Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways.J Pathol. 2000 Jul;191(3):257-63. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH631>3.0.CO;2-2.
• [1999] Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamouscell carcinoma.Biochimie. 2019 Aug;163:84-93. doi: 10.1016/j.biochi.2019.05.016. Epub 2019 May 31.
• [2000] ESCO2 knockdown inhibits cell proliferation and induces apoptosis in human gastric cancer cells.Biochem Biophys Res Commun. 2018 Feb 5;496(2):475-481. doi: 10.1016/j.bbrc.2018.01.048. Epub 2018 Jan 9.
• [2001] Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1521-6. doi: 10.1073/pnas.032678499. Epub 2002 Jan 29.
• [2002] cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene.Genomics. 1991 Mar;9(3):446-60. doi: 10.1016/0888-7543(91)90410-g.
• [2003] Structure, chromosomal location, and expression profile of EXTR1 and EXTR2, new members of the multiple exostoses gene family.Biochem Biophys Res Commun. 1998 Feb 4;243(1):61-6. doi: 10.1006/bbrc.1997.8062.
• [2004] A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation.BMC Genet. 2001;2:9. doi: 10.1186/1471-2156-2-9. Epub 2001 Jun 29.
• [2005] Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.PLoS One. 2018 Mar 29;13(3):e0193427. doi: 10.1371/journal.pone.0193427. eCollection 2018.
• [2006] FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFB pathway.BMC Cancer. 2019 Jul 10;19(1):679. doi: 10.1186/s12885-019-5898-4.
• [2007] Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1).J Biol Chem. 2018 Jul 20;293(29):11401-11414. doi: 10.1074/jbc.RA118.003616. Epub 2018 Jun 5.
• [2008] Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.Cancer Biomark. 2019;26(3):367-373. doi: 10.3233/CBM-190520.
• [2009] Acute megakaryoblastic leukemia.Leuk Lymphoma. 1995;18 Suppl 1:69-73. doi: 10.3109/10428199509075307.
• [2010] FATE1 antagonizes calcium- and drug-induced apoptosis by uncoupling ER and mitochondria.EMBO Rep. 2016 Sep;17(9):1264-80. doi: 10.15252/embr.201541504. Epub 2016 Jul 11.
• [2011] Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination.J Exp Med. 2017 Jan;214(1):245-267. doi: 10.1084/jem.20151673. Epub 2016 Dec 6.
• [2012] FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.J Exp Clin Cancer Res. 2019 Feb 26;38(1):101. doi: 10.1186/s13046-019-1058-6.
• [2013] FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway.Cancers (Basel). 2019 Jun 17;11(6):836. doi: 10.3390/cancers11060836.
• [2014] Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8.J Biol Chem. 2015 May 22;290(21):13017-27. doi: 10.1074/jbc.M115.650903. Epub 2015 Apr 7.
• [2015] CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Szary syndrome patients.J Invest Dermatol. 2014 Jan;134(1):229-236. doi: 10.1038/jid.2013.279. Epub 2013 Jun 21.
• [2016] 1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia.Clin Exp Med. 2019 May;19(2):261-267. doi: 10.1007/s10238-019-00551-0. Epub 2019 Mar 15.
• [2017] Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing.Oncotarget. 2017 Mar 7;8(10):16463-16472. doi: 10.18632/oncotarget.14864.
• [2018] Distinct expression profiles and functions of Kindlins in breast cancer.J Exp Clin Cancer Res. 2018 Nov 26;37(1):281. doi: 10.1186/s13046-018-0955-4.
• [2019] FGD1 as a central regulator of extracellular matrix remodelling--lessons from faciogenital dysplasia.J Cell Sci. 2012 Jul 15;125(Pt 14):3265-70. doi: 10.1242/jcs.093419. Epub 2012 Aug 1.
• [2020] FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.Breast Cancer Res Treat. 2017 Apr;162(2):243-253. doi: 10.1007/s10549-017-4125-8. Epub 2017 Jan 25.
• [2021] Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma.J Pathol. 2016 Nov;240(3):329-340. doi: 10.1002/path.4781.
• [2022] High-yield of biologically active recombinant human fibroblast growth factor-16 in E. coli and its mechanism of proliferation in NCL-H460 cells.Prep Biochem Biotechnol. 2017 Aug 9;47(7):720-729. doi: 10.1080/10826068.2017.1315599. Epub 2017 Apr 14.
• [2023] Human hst-2 (FGF-6) oncogene: cDNA cloning and characterization.Oncogene. 1992 Feb;7(2):303-9.
• [2024] FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth.Exp Cell Res. 2017 Jan 1;350(1):267-278. doi: 10.1016/j.yexcr.2016.12.004. Epub 2016 Dec 2.
• [2025] A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.Cancer Genet. 2017 Oct;216-217:91-99. doi: 10.1016/j.cancergen.2017.07.007. Epub 2017 Aug 3.
• [2026] Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.Lab Invest. 1999 Dec;79(12):1573-82.
• [2027] High expression of FMNL3 associates with cancer cell migration, invasion, and unfavorable prognosis in tongue squamous cell carcinoma.J Oral Pathol Med. 2019 Jul;48(6):459-467. doi: 10.1111/jop.12857. Epub 2019 Apr 25.
• [2028] Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.PLoS One. 2017 Aug 21;12(8):e0182973. doi: 10.1371/journal.pone.0182973. eCollection 2017.
• [2029] IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.Nucleic Acids Res. 2019 Jan 10;47(1):375-390. doi: 10.1093/nar/gky1012.
• [2030] Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.Gene. 2020 Jan 5;722:144057. doi: 10.1016/j.gene.2019.144057. Epub 2019 Aug 17.
• [2031] Long non-coding RNA MIR205HG function as a ceRNA to accelerate tumor growth and progression via sponging miR-122-5p in cervical cancer.Biochem Biophys Res Commun. 2019 Jun 18;514(1):78-85. doi: 10.1016/j.bbrc.2019.04.102. Epub 2019 Apr 22.
• [2032] Frequently rearranged in advanced Tcell lymphomas? demonstrates oncogenic properties in prostate cancer.Mol Med Rep. 2016 Oct;14(4):3551-8. doi: 10.3892/mmr.2016.5704. Epub 2016 Sep 5.
• [2033] Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization.Cell Death Dis. 2019 Feb 27;10(3):204. doi: 10.1038/s41419-018-1248-8.
• [2034] Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.J Cancer. 2019 Jan 29;10(5):1237-1251. doi: 10.7150/jca.28662. eCollection 2019.
• [2035] Increased expression levels of ppGalNAc-T13 in lung cancers: Significance in the prognostic diagnosis.Int J Oncol. 2016 Oct;49(4):1369-76. doi: 10.3892/ijo.2016.3638. Epub 2016 Jul 29.
• [2036] The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer.FEBS Lett. 2019 Oct;593(19):2751-2761. doi: 10.1002/1873-3468.13532. Epub 2019 Jul 21.
• [2037] GALNT7, a target of miR-494, participates in the oncogenesis of nasopharyngeal carcinoma.Tumour Biol. 2016 Apr;37(4):4559-67. doi: 10.1007/s13277-015-4281-6. Epub 2015 Oct 27.
• [2038] Molecular approach to common causes of female infertility.Best Pract Res Clin Obstet Gynaecol. 2002 Oct;16(5):685-702. doi: 10.1053/beog.2002.0317.
• [2039] Does TP53 mutation promote ovarian cancer metastasis to omentum by regulating lipid metabolism?.Med Hypotheses. 2013 Oct;81(4):515-20. doi: 10.1016/j.mehy.2013.06.009. Epub 2013 Jul 20.
• [2040] MicroRNA-128 contributes to the progression of gastric carcinoma through GAREM-mediated MAPK signaling activation.Biochem Biophys Res Commun. 2018 Sep 26;504(1):295-301. doi: 10.1016/j.bbrc.2018.08.177. Epub 2018 Aug 31.
• [2041] FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression.Clin Cancer Res. 2018 Feb 15;24(4):916-926. doi: 10.1158/1078-0432.CCR-17-1347. Epub 2017 Dec 7.
• [2042] Knockdown of GATAD2A suppresses cell proliferation in thyroid cancer invitro.Oncol Rep. 2017 Apr;37(4):2147-2152. doi: 10.3892/or.2017.5436. Epub 2017 Feb 10.
• [2043] Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration.Genome Biol. 2002 Jun 25;3(7):RESEARCH0035. doi: 10.1186/gb-2002-3-7-research0035. Epub 2002 Jun 25.
• [2044] Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.Cell Physiol Biochem. 2018;50(3):987-1004. doi: 10.1159/000494482. Epub 2018 Oct 24.
• [2045] Overexpression of TWA1 predicts poor prognosis in patients with gastric cancer.Pathol Res Pract. 2019 Nov;215(11):152594. doi: 10.1016/j.prp.2019.152594. Epub 2019 Aug 16.
• [2046] The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42.Theranostics. 2019 Oct 21;9(26):8294-8311. doi: 10.7150/thno.36256. eCollection 2019.
• [2047] Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity.Int J Oncol. 2014 Oct;45(4):1583-93. doi: 10.3892/ijo.2014.2538. Epub 2014 Jul 8.
• [2048] NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.Oncotarget. 2017 Jun 21;8(40):66815-66832. doi: 10.18632/oncotarget.18609. eCollection 2017 Sep 15.
• [2049] Widening Spectrum of Cellular and Subcellular Expression of Human GLUD1 and GLUD2 Glutamate Dehydrogenases Suggests Novel Functions.Neurochem Res. 2017 Jan;42(1):92-107. doi: 10.1007/s11064-016-1986-x. Epub 2016 Jul 16.
• [2050] Lack of expression of the proteins GMPR2 and PPAR are associated with the basal phenotype and patient outcome in breast cancer.Breast Cancer Res Treat. 2013 Jan;137(1):127-37. doi: 10.1007/s10549-012-2302-3. Epub 2012 Dec 4.
• [2051] GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses.Cell Signal. 2015 May;27(5):899-907. doi: 10.1016/j.cellsig.2015.02.001. Epub 2015 Feb 17.
• [2052] Transforming growth factor- promotes aggressiveness and invasion of clear cell renal cell carcinoma.Oncotarget. 2016 Jun 14;7(24):35917-35931. doi: 10.18632/oncotarget.9177.
• [2053] Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells.J Clin Endocrinol Metab. 2009 May;94(5):1761-7. doi: 10.1210/jc.2008-1741. Epub 2009 Feb 3.
• [2054] Small non-coding RNA landscape is modified by GPAT2 silencing in MDA-MB-231 cells.Oncotarget. 2018 Jun 15;9(46):28141-28154. doi: 10.18632/oncotarget.25582. eCollection 2018 Jun 15.
• [2055] Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression.PLoS One. 2015 Feb 18;10(2):e0117758. doi: 10.1371/journal.pone.0117758. eCollection 2015.
• [2056] Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.J Cell Physiol. 2020 Apr;235(4):3425-3437. doi: 10.1002/jcp.29232. Epub 2019 Sep 25.
• [2057] GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis.J Biol Chem. 2018 Mar 16;293(11):3949-3964. doi: 10.1074/jbc.RA117.001103. Epub 2018 Jan 24.
• [2058] A label-free nanostructured plasmonic biosensor based on Blu-ray discs with integrated microfluidics for sensitive biodetection.Biosens Bioelectron. 2017 Oct 15;96:260-267. doi: 10.1016/j.bios.2017.05.020. Epub 2017 May 10.
• [2059] GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFR2 in colorectal cancer.Cancer Sci. 2020 Feb;111(2):343-355. doi: 10.1111/cas.14248. Epub 2019 Dec 27.
• [2060] Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription.J Mol Med (Berl). 2001 Jun;79(5-6):314-20. doi: 10.1007/s001090100211.
• [2061] The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells.Oncotarget. 2017 Jan 31;8(5):8189-8205. doi: 10.18632/oncotarget.14138.
• [2062] Characterization of a novel human cell-cycle-regulated homologue of Drosophila dlg1.Genomics. 2001 Sep;77(1-2):5-7. doi: 10.1006/geno.2001.6570.
• [2063] RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.J Neurooncol. 2019 Jan;141(1):95-102. doi: 10.1007/s11060-018-03010-0. Epub 2018 Oct 23.
• [2064] Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.Clin Epigenetics. 2018 Mar 2;10:30. doi: 10.1186/s13148-018-0458-3. eCollection 2018.
• [2065] Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.Cancer Res. 2008 Jan 15;68(2):483-91. doi: 10.1158/0008-5472.CAN-07-2140.
• [2066] A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.Protein Cell. 2019 Aug;10(8):595-605. doi: 10.1007/s13238-019-0607-2. Epub 2019 Feb 1.
• [2067] Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma.Pediatr Blood Cancer. 2017 May;64(5):10.1002/pbc.26318. doi: 10.1002/pbc.26318. Epub 2016 Oct 27.
• [2068] Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.Oncotarget. 2016 Aug 30;7(35):56013-56029. doi: 10.18632/oncotarget.10820.
• [2069] The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China.Onco Targets Ther. 2018 Oct 25;11:7459-7469. doi: 10.2147/OTT.S166878. eCollection 2018.
• [2070] Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.Breast Cancer Res. 2015 Jan 9;17(1):3. doi: 10.1186/s13058-014-0508-5.
• [2071] Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients.Mod Pathol. 2017 Dec;30(12):1666-1676. doi: 10.1038/modpathol.2017.89. Epub 2017 Aug 4.
• [2072] HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma.Cancer Manag Res. 2019 Apr 1;11:2605-2616. doi: 10.2147/CMAR.S197855. eCollection 2019.
• [2073] High expression of HMBOX1 contributes to poor prognosis of gastric cancer by promoting cell proliferation and migration.Biomed Pharmacother. 2019 Jul;115:108867. doi: 10.1016/j.biopha.2019.108867. Epub 2019 Apr 18.
• [2074] Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Large Established Tumors.Sci Rep. 2017 Oct 27;7(1):14186. doi: 10.1038/s41598-017-14655-8.
• [2075] hnRNP L-dependent protection of normal mRNAs from NMD subverts quality control in B cell lymphoma.EMBO J. 2019 Feb 1;38(3):e99128. doi: 10.15252/embj.201899128. Epub 2018 Dec 7.
• [2076] HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress.Cancer Res. 2018 Nov 1;78(21):6196-6208. doi: 10.1158/0008-5472.CAN-18-1377. Epub 2018 Sep 5.
• [2077] HORMAD2 methylation-mediated epigenetic regulation of gene expression in thyroid cancer.J Cell Mol Med. 2018 Oct;22(10):4640-4652. doi: 10.1111/jcmm.13680. Epub 2018 Jul 24.
• [2078] miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma.BMC Nephrol. 2019 Apr 11;20(1):127. doi: 10.1186/s12882-019-1322-1.
• [2079] The role of HOXB2 and HOXB3 in acute myeloid leukemia.Biochem Biophys Res Commun. 2015 Nov 27;467(4):742-7. doi: 10.1016/j.bbrc.2015.10.071. Epub 2015 Oct 22.
• [2080] Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.J Cell Biochem. 2019 Aug;120(8):13717-13725. doi: 10.1002/jcb.28644. Epub 2019 Apr 2.
• [2081] HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.Tumour Biol. 2016 Nov;37(11):15087-15096. doi: 10.1007/s13277-016-5356-8. Epub 2016 Sep 22.
• [2082] Testis-specific human small heat shock protein HSPB9 is a cancer/testis antigen, and potentially interacts with the dynein subunit TCTEL1.Eur J Cell Biol. 2004 Aug;83(7):337-45. doi: 10.1078/0171-9335-00396.
• [2083] HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness.Cell Stress Chaperones. 2009 May;14(3):301-10. doi: 10.1007/s12192-008-0085-6. Epub 2008 Nov 6.
• [2084] Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.Gynecol Oncol. 2005 Aug;98(2):193-202. doi: 10.1016/j.ygyno.2005.02.031.
• [2085] Central nervous system lesions in von Hippel-Lindau syndrome.J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):898-901. doi: 10.1136/jnnp.55.10.898.
• [2086] Alterations of repeated sequences in 5' upstream and coding regions in colorectal tumors from patients with hereditary nonpolyposis colorectal cancer and Turcot syndrome.Oncogene. 2001 Aug 23;20(37):5215-8. doi: 10.1038/sj.onc.1204578.
• [2087] ICAM-2 confers a non-metastatic phenotype in neuroblastoma cells by interaction with -actinin.Oncogene. 2015 Mar 19;34(12):1553-62. doi: 10.1038/onc.2014.87. Epub 2014 Apr 7.
• [2088] Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.Biomed Pharmacother. 2018 Mar;99:169-175. doi: 10.1016/j.biopha.2018.01.048. Epub 2018 Jan 11.
• [2089] Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.Mol Oncol. 2017 Apr;11(4):337-357. doi: 10.1002/1878-0261.12028. Epub 2017 Mar 2.
• [2090] IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.BMC Cancer. 2018 May 30;18(1):609. doi: 10.1186/s12885-018-4529-9.
• [2091] IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.Oncogene. 2019 Apr;38(17):3232-3247. doi: 10.1038/s41388-018-0662-9. Epub 2019 Jan 9.
• [2092] Effects of the overexpression of IFITM5 and IFITM5 c.-14C>T mutation on human osteosarcoma cells.Oncol Lett. 2017 Jan;13(1):111-118. doi: 10.3892/ol.2016.5426. Epub 2016 Nov 23.
• [2093] Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.Clin Cancer Res. 2001 Sep;7(9):2840-53.
• [2094] Expression of neighbor of Punc E11 in hepatocarcinogenesis induced by diethylnitrosamine.Oncol Rep. 2014 Sep;32(3):1043-9. doi: 10.3892/or.2014.3285. Epub 2014 Jun 23.
• [2095] Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.Int J Cancer. 2014 Mar 15;134(6):1408-21. doi: 10.1002/ijc.28458. Epub 2013 Oct 8.
• [2096] Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway.Oncotarget. 2017 Dec 7;9(19):14803-14814. doi: 10.18632/oncotarget.22976. eCollection 2018 Mar 13.
• [2097] Interleukin-38 in colorectal cancer: a potential role in precision medicine.Cancer Immunol Immunother. 2020 Jan;69(1):69-79. doi: 10.1007/s00262-019-02440-7. Epub 2019 Nov 30.
• [2098] Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.J BUON. 2019 Jan-Feb;24(1):215-220.
• [2099] NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer.Dig Dis Sci. 2014 Jun;59(6):1169-79. doi: 10.1007/s10620-014-3168-5. Epub 2014 May 6.
• [2100] Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.RNA. 2019 May;25(5):630-644. doi: 10.1261/rna.068619.118. Epub 2019 Feb 22.
• [2101] Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinoma.J Am Acad Dermatol. 2020 Apr;82(4):846-853. doi: 10.1016/j.jaad.2019.08.027. Epub 2019 Aug 19.
• [2102] Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration.Oncogene. 2015 Jul;34(28):3711-27. doi: 10.1038/onc.2014.303. Epub 2014 Sep 22.
• [2103] Correlation between gene expression of IGF-1R pathway markers and cetuximab benefit in metastatic colorectal cancer.Clin Cancer Res. 2012 Feb 15;18(4):1156-66. doi: 10.1158/1078-0432.CCR-11-1135. Epub 2012 Jan 31.
• [2104] Fine map of the Gct1 spontaneous ovarian granulosa cell tumor locus.Mamm Genome. 2013 Feb;24(1-2):63-71. doi: 10.1007/s00335-012-9439-6. Epub 2012 Nov 18.
• [2105] Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.Oncogene. 2019 Apr;38(15):2814-2829. doi: 10.1038/s41388-018-0624-2. Epub 2018 Dec 13.
• [2106] Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer.Elife. 2018 Oct 25;7:e37925. doi: 10.7554/eLife.37925.
• [2107] Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients.J Mol Histol. 2018 Feb;49(1):39-49. doi: 10.1007/s10735-017-9745-0. Epub 2017 Nov 28.
• [2108] Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster.Am J Pathol. 2010 Nov;177(5):2609-21. doi: 10.2353/ajpath.2010.100130. Epub 2010 Sep 16.
• [2109] Regulation of OLC1 protein expression by the anaphase-promoting complex.Oncol Lett. 2019 Mar;17(3):2639-2646. doi: 10.3892/ol.2019.9881. Epub 2019 Jan 2.
• [2110] Integrin-10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.Cancer Discov. 2016 Oct;6(10):1148-1165. doi: 10.1158/2159-8290.CD-15-1481. Epub 2016 Aug 30.
• [2111] Blockade of integrin 3 attenuates human pancreatic cancer via inhibition of EGFR signalling.Sci Rep. 2019 Feb 26;9(1):2793. doi: 10.1038/s41598-019-39628-x.
• [2112] Integrin 7 is overexpressed and correlates with higher pathological grade, increased T stage, advanced TNM stage as well as worse survival in clear cell renal cell carcinoma patients: A retrospective study.J Clin Lab Anal. 2020 Jan;34(1):e23034. doi: 10.1002/jcla.23034. Epub 2019 Nov 11.
• [2113] Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.Vaccine. 2012 May 21;30(24):3519-25. doi: 10.1016/j.vaccine.2012.03.075. Epub 2012 Apr 6.
• [2114] Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma.Am J Surg Pathol. 2017 Aug;41(8):1045-1052. doi: 10.1097/PAS.0000000000000852.
• [2115] Silencing Intersectin 1 Slows Orthotopic Neuroblastoma Growth in Mice.J Pediatr Hematol Oncol. 2017 Nov;39(8):e413-e418. doi: 10.1097/MPH.0000000000000931.
• [2116] Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma.Cancer Res. 2013 Sep 1;73(17):5371-80. doi: 10.1158/0008-5472.CAN-12-4707. Epub 2013 Jul 1.
• [2117] JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.Cancer Res. 2017 Oct 1;77(19):5287-5300. doi: 10.1158/0008-5472.CAN-17-0229. Epub 2017 Aug 3.
• [2118] Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.Clin Cancer Res. 2004 May 15;10(10):3291-300. doi: 10.1158/1078-0432.CCR-03-0409.
• [2119] HN1L-mediated transcriptional axis AP-2/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.Cell Death Differ. 2019 Nov;26(11):2268-2283. doi: 10.1038/s41418-019-0301-1. Epub 2019 Feb 18.
• [2120] A novel HIF1AN substrate KANK3 plays a tumor-suppressive role in hepatocellular carcinoma.Cell Biol Int. 2018 Mar;42(3):303-312. doi: 10.1002/cbin.10895. Epub 2017 Nov 15.
• [2121] Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region.Tumour Biol. 2010 Jan;31(1):33-45. doi: 10.1007/s13277-009-0005-0. Epub 2009 Dec 18.
• [2122] Histone Demethylase JMJD2D Interacts With -Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.Gastroenterology. 2019 Mar;156(4):1112-1126. doi: 10.1053/j.gastro.2018.11.036. Epub 2018 Nov 23.
• [2123] KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male.J Cell Biochem. 2019 Aug;120(8):12247-12258. doi: 10.1002/jcb.27308. Epub 2019 Mar 12.
• [2124] Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line.Cancer Gene Ther. 2001 Jun;8(6):459-68. doi: 10.1038/sj.cgt.7700326.
• [2125] KIF15 plays a role in promoting the tumorigenicity of melanoma.Exp Eye Res. 2019 Aug;185:107598. doi: 10.1016/j.exer.2019.02.014. Epub 2019 Feb 21.
• [2126] KLF10 as a Tumor Suppressor Gene and Its TGF- Signaling.Cancers (Basel). 2018 May 25;10(6):161. doi: 10.3390/cancers10060161.
• [2127] The level of Krppel-like factor 8 expression predicts prognosis and metastasis in various carcinomas.Medicine (Baltimore). 2019 May;98(18):e15519. doi: 10.1097/MD.0000000000015519.
• [2128] Krppel-like factor 9 promotes neuroblastoma differentiation via targeting the sonic hedgehog signaling pathway.Pediatr Blood Cancer. 2020 Mar;67(3):e28108. doi: 10.1002/pbc.28108. Epub 2019 Nov 29.
• [2129] Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma.PLoS One. 2016 Mar 31;11(3):e0152820. doi: 10.1371/journal.pone.0152820. eCollection 2016.
• [2130] Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer.Br J Surg. 2017 Dec;104(13):1847-1856. doi: 10.1002/bjs.10628. Epub 2017 Oct 17.
• [2131] Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.Oncoimmunology. 2018 Jan 29;7(5):e1423184. doi: 10.1080/2162402X.2017.1423184. eCollection 2018.
• [2132] Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.Eur J Immunol. 2013 May;43(5):1133-41. doi: 10.1002/eji.201243117.
• [2133] Genomic profiling in high hyperdiploid acute myeloid leukemia: a retrospective study of 19 cases.Cancer Genet. 2011 Sep;204(9):516-21. doi: 10.1016/j.cancergen.2011.09.002.
• [2134] Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer.Cancer Res. 2018 Jan 15;78(2):475-488. doi: 10.1158/0008-5472.CAN-17-2415. Epub 2017 Nov 27.
• [2135] Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk.PLoS One. 2013;8(1):e53768. doi: 10.1371/journal.pone.0053768. Epub 2013 Jan 16.
• [2136] Exome sequencing reveals recurrent germ line variants in patients with familial Waldenstrm macroglobulinemia.Blood. 2016 May 26;127(21):2598-606. doi: 10.1182/blood-2015-11-680199. Epub 2016 Feb 22.
• [2137] miR?15 promotes epithelial to mesenchymal transition and proliferation by regulating LEFTY2 in endometrial cancer.Int J Mol Med. 2018 Sep;42(3):1229-1236. doi: 10.3892/ijmm.2018.3703. Epub 2018 May 22.
• [2138] LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.J Cell Biochem. 2019 Sep;120(9):15190-15201. doi: 10.1002/jcb.28783. Epub 2019 Apr 25.
• [2139] LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.Exp Mol Pathol. 2020 Feb;112:104333. doi: 10.1016/j.yexmp.2019.104333. Epub 2019 Nov 6.
• [2140] HCCR-1 is a Novel Prognostic Indicator for Gastric Cancer and Promotes Cell Proliferation.J Cancer. 2019 Jun 9;10(15):3533-3542. doi: 10.7150/jca.22462. eCollection 2019.
• [2141] Galectin-7 in Epithelial Homeostasis and Carcinomas.Int J Mol Sci. 2017 Dec 19;18(12):2760. doi: 10.3390/ijms18122760.
• [2142] Targeted nanoparticle-mediated LHPP for melanoma treatment.Int J Nanomedicine. 2019 May 10;14:3455-3468. doi: 10.2147/IJN.S196374. eCollection 2019.
• [2143] EWSR1 genetic rearrangements in salivary gland tumors: a specific and very common feature of hyalinizing clear cell carcinoma.Am J Surg Pathol. 2013 Apr;37(4):571-8. doi: 10.1097/PAS.0b013e3182772a15.
• [2144] LIMD1 phosphorylation in mitosis is required for mitotic progression and its tumor-suppressing activity.FEBS J. 2019 Mar;286(5):963-974. doi: 10.1111/febs.14743. Epub 2019 Jan 16.
• [2145] LIMS1 Promotes Pancreatic Cancer Cell Survival under Oxygen-Glucose Deprivation Conditions by Enhancing HIF1A Protein Translation.Clin Cancer Res. 2019 Jul 1;25(13):4091-4103. doi: 10.1158/1078-0432.CCR-18-3533. Epub 2019 Jan 24.
• [2146] Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET.J Exp Med. 2019 Jun 3;216(6):1377-1395. doi: 10.1084/jem.20181394. Epub 2019 Apr 23.
• [2147] Identification of LMX1B as a novel oncogene in human ovarian cancer.Oncogene. 2014 Aug 14;33(33):4226-35. doi: 10.1038/onc.2013.375. Epub 2013 Sep 23.
• [2148] Deregulated expression of LRBA facilitates cancer cell growth.Oncogene. 2004 May 20;23(23):4089-97. doi: 10.1038/sj.onc.1207567.
• [2149] The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma.Front Oncol. 2019 Jun 6;9:447. doi: 10.3389/fonc.2019.00447. eCollection 2019.
• [2150] Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.Cancer Lett. 2018 Dec 1;438:165-173. doi: 10.1016/j.canlet.2018.09.022. Epub 2018 Sep 15.
• [2151] Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization.Hum Genet. 2001 Feb;108(2):98-104. doi: 10.1007/s004390000450.
• [2152] Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).Cancer. 2017 Dec 1;123(23):4653-4662. doi: 10.1002/cncr.30920. Epub 2017 Aug 7.
• [2153] Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.J Clin Endocrinol Metab. 2000 Jul;85(7):2537-42. doi: 10.1210/jcem.85.7.6683.
• [2154] MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.Nutrients. 2019 Sep 4;11(9):2096. doi: 10.3390/nu11092096.
• [2155] LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL? and TNF?"Xu J. Zhang W
• [2156] Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer.Onco Targets Ther. 2018 Mar 5;11:1215-1222. doi: 10.2147/OTT.S157914. eCollection 2018.
• [2157] Coordinated regulation of p31(Comet) and Mad2 expression is required for cellular proliferation.Cell Cycle. 2013 Dec 15;12(24):3824-32. doi: 10.4161/cc.26811. Epub 2013 Oct 15.
• [2158] Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.Cancer Lett. 2016 Feb 28;371(2):143-50. doi: 10.1016/j.canlet.2015.11.012. Epub 2015 Nov 30.
• [2159] Attenuation of MAMLD1 Expression Suppresses the Growth and Migratory Properties of Gonadotroph Pituitary Adenomas.Pathol Oncol Res. 2020 Apr;26(2):937-946. doi: 10.1007/s12253-019-00615-2. Epub 2019 Mar 25.
• [2160] Transforming Growth Factor TGF Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas.PLoS One. 2015 Nov 16;10(11):e0143150. doi: 10.1371/journal.pone.0143150. eCollection 2015.
• [2161] Differential expression of delta-like gene and protein in neuroblastoma, ganglioneuroblastoma and ganglioneuroma.Mod Pathol. 2005 May;18(5):656-62. doi: 10.1038/modpathol.3800335.
• [2162] The MAP3K13-TRIM25-FBXW7 axis affects c-Myc protein stability and tumor development.Cell Death Differ. 2020 Feb;27(2):420-433. doi: 10.1038/s41418-019-0363-0. Epub 2019 Jun 11.
• [2163] MAP9 Loss Triggers Chromosomal Instability, Initiates Colorectal Tumorigenesis, and Is Associated with Poor Survival of Patients with Colorectal Cancer.Clin Cancer Res. 2020 Feb 1;26(3):746-757. doi: 10.1158/1078-0432.CCR-19-1611. Epub 2019 Oct 29.
• [2164] Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis.Breast Cancer Res Treat. 2019 Feb;173(3):573-583. doi: 10.1007/s10549-018-5026-1. Epub 2018 Oct 27.
• [2165] Altered expression of claudin-1, claudin-7, and tricellulin regardless of human papilloma virus infection in human tonsillar squamous cell carcinoma.Acta Otolaryngol. 2011 Aug;131(8):861-8. doi: 10.3109/00016489.2011.562537. Epub 2011 Apr 11.
• [2166] MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/-catenin signaling.Mol Cancer. 2018 Aug 1;17(1):111. doi: 10.1186/s12943-018-0848-3.
• [2167] Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.J Innate Immun. 2014;6(3):293-305. doi: 10.1159/000355126. Epub 2013 Oct 29.
• [2168] Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer.Biomark Med. 2019 Apr;13(6):427-436. doi: 10.2217/bmm-2018-0475. Epub 2019 Mar 21.
• [2169] Genomic organization of a novel glycosylphosphatidylinositol MAM gene expressed in human tissues and tumors.Oncogene. 2002 May 2;21(19):3089-94. doi: 10.1038/sj.onc.1205383.
• [2170] MDGA2 is a novel tumour suppressor cooperating with DMAP1 in gastric cancer and is associated with disease outcome.Gut. 2016 Oct;65(10):1619-31. doi: 10.1136/gutjnl-2015-309276. Epub 2015 Jul 23.
• [2171] MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma.Cancer Lett. 2014 May 28;347(1):75-8. doi: 10.1016/j.canlet.2014.01.030. Epub 2014 Feb 11.
• [2172] Silencing of MED27 inhibits adrenal cortical carcinogenesis by targeting the Wnt/-catenin signaling pathway and the epithelial-mesenchymal transition process.Biol Chem. 2018 May 24;399(6):593-602. doi: 10.1515/hsz-2017-0304.
• [2173] Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastoma.Mol Carcinog. 2017 Apr;56(4):1290-1301. doi: 10.1002/mc.22591. Epub 2016 Nov 29.
• [2174] Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors.J Exp Clin Cancer Res. 2010 Nov 16;29(1):147. doi: 10.1186/1756-9966-29-147.
• [2175] Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer.Exp Ther Med. 2017 Oct;14(4):2789-2794. doi: 10.3892/etm.2017.4887. Epub 2017 Aug 4.
• [2176] Regulation of Proliferation by a Mitochondrial Potassium Channel in Pancreatic Ductal Adenocarcinoma Cells.Front Oncol. 2017 Sep 29;7:239. doi: 10.3389/fonc.2017.00239. eCollection 2017.
• [2177] A common genetic variation of melanoma inhibitory activity-2 labels a subtype of pancreatic adenocarcinoma with high endoplasmic reticulum stress levels.Sci Rep. 2015 Feb 6;5:8109. doi: 10.1038/srep08109.
• [2178] Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-kB pathway.J Cell Mol Med. 2012 May;16(5):1134-45. doi: 10.1111/j.1582-4934.2011.01388.x.
• [2179] Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.Dev Cell. 2017 Jun 5;41(5):467-480.e3. doi: 10.1016/j.devcel.2017.05.005.
• [2180] Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8838-43. doi: 10.1073/pnas.1320769111. Epub 2014 May 29.
• [2181] Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers.Sci Rep. 2016 Jan 4;6:18669. doi: 10.1038/srep18669.
• [2182] The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity, progression-free and overall survival in advanced epithelial ovarian cancer.Gynecol Oncol. 2013 Aug;130(2):377-82. doi: 10.1016/j.ygyno.2013.04.054. Epub 2013 Apr 28.
• [2183] Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma.Oncogene. 1995 Apr 20;10(8):1521-8.
• [2184] A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization.Cancer Genet Cytogenet. 2000 Aug;121(1):9-16. doi: 10.1016/s0165-4608(99)00247-2.
• [2185] MORF4L1 suppresses cell proliferation, migration and invasion by increasing p21 and E-cadherin expression in nasopharyngeal carcinoma.Oncol Lett. 2019 Jan;17(1):294-302. doi: 10.3892/ol.2018.9588. Epub 2018 Oct 16.
• [2186] Newly characterized motile sperm domain-containing protein 2 promotes human breast cancer metastasis.Int J Cancer. 2019 Jan 1;144(1):125-135. doi: 10.1002/ijc.31665. Epub 2018 Oct 29.
• [2187] Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma.Sci Rep. 2017 Sep 8;7(1):11026. doi: 10.1038/s41598-017-11389-5.
• [2188] M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways.J Cell Biochem. 2020 Mar;121(3):2330-2342. doi: 10.1002/jcb.29456. Epub 2019 Nov 6.
• [2189] Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study.Lancet Oncol. 2015 May;16(5):541-9. doi: 10.1016/S1470-2045(15)70106-3. Epub 2015 Apr 1.
• [2190] Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.J Clin Invest. 1993 May;91(5):2194-206. doi: 10.1172/JCI116446.
• [2191] Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma.Oncogene. 2011 Nov 17;30(46):4666-77. doi: 10.1038/onc.2011.180. Epub 2011 May 23.
• [2192] Registration error of the liver CT using deformable image registration of MIM Maestro and Velocity AI.BMC Med Imaging. 2017 May 4;17(1):30. doi: 10.1186/s12880-017-0202-z.
• [2193] Long Noncoding RNA MRPL39 Inhibits Gastric Cancer Proliferation and Progression by Directly Targeting miR-130.Genet Test Mol Biomarkers. 2018 Nov;22(11):656-663. doi: 10.1089/gtmb.2018.0151.
• [2194] Transcriptional profiling of human mammary carcinoma cell lines reveals PKW, a new tumor-specific gene.Anticancer Res. 2000 Jul-Aug;20(4):2255-64.
• [2195] Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer.Oncol Lett. 2019 Jul;18(1):465-471. doi: 10.3892/ol.2019.10318. Epub 2019 May 6.
• [2196] MTBP inhibits migration and metastasis of hepatocellular carcinoma.Clin Exp Metastasis. 2015 Apr;32(4):301-11. doi: 10.1007/s10585-015-9706-5. Epub 2015 Mar 11.
• [2197] Hybrid QM/MM vs Pure MM Molecular Dynamics for Evaluating Water Distribution within p21(N-ras) and the Resulting GTP Electronic Density.J Phys Chem B. 2019 May 9;123(18):3935-3944. doi: 10.1021/acs.jpcb.9b02660. Epub 2019 Apr 25.
• [2198] PTEN: its deregulation and tumorigenesis.Biol Pharm Bull. 2007 Sep;30(9):1624-7. doi: 10.1248/bpb.30.1624.
• [2199] Two novel mucin genes down-regulated in colorectal cancer identified by differential display.Cancer Res. 1999 Aug 15;59(16):4083-9.
• [2200] High expression of diffuse panbronchiolitis critical region 1 gene promotes cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma.Biochem Biophys Res Commun. 2018 Jan 8;495(2):1908-1914. doi: 10.1016/j.bbrc.2017.12.031. Epub 2017 Dec 11.
• [2201] Net1 and Myeov: computationally identified mediators of gastric cancer.Br J Cancer. 2006 Apr 24;94(8):1204-12. doi: 10.1038/sj.bjc.6603054.
• [2202] Expression of members of the myf gene family in human rhabdomyosarcomas.Br J Cancer. 1991 Dec;64(6):1039-42. doi: 10.1038/bjc.1991.461.
• [2203] MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development.J Exp Clin Cancer Res. 2018 Feb 13;37(1):28. doi: 10.1186/s13046-018-0693-7.
• [2204] Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis.Oncogenesis. 2019 Mar 8;8(3):21. doi: 10.1038/s41389-019-0130-6.
• [2205] TTID: A novel gene at 5q31 encoding a protein with titin-like features.Genomics. 1999 Sep 1;60(2):226-33. doi: 10.1006/geno.1999.5912.
• [2206] Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2.PLoS Genet. 2013;9(2):e1003298. doi: 10.1371/journal.pgen.1003298. Epub 2013 Feb 7.
• [2207] Metabolic Syndrome, as Defined Based on Parameters Including Visceral Fat Area, Predicts Complications After Surgery for Rectal Cancer.Obes Surg. 2020 Jan;30(1):319-326. doi: 10.1007/s11695-019-04163-1.
• [2208] NASP antagonize chromatin accessibility through maintaining histone H3K9me1 in hepatocellular carcinoma.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3438-3448. doi: 10.1016/j.bbadis.2018.07.033. Epub 2018 Aug 1.
• [2209] Long Non-coding RNA LINC01420 Contributes to Pancreatic Cancer Progression Through Targeting KRAS Proto-oncogene.Dig Dis Sci. 2020 Apr;65(4):1042-1052. doi: 10.1007/s10620-019-05829-7. Epub 2019 Sep 27.
• [2210] Tumor expression studies indicate that HEM-1 is unlikely to be the active factor in oncogenic osteomalacia.Bone. 1998 Dec;23(6):549-53. doi: 10.1016/s8756-3282(98)00136-7.
• [2211] Hepatocellular Carcinoma Outcome Is Predicted by Expression of Neuronal Calcium Sensor 1.Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1091-1100. doi: 10.1158/1055-9965.EPI-18-0167. Epub 2018 May 22.
• [2212] The role of genes co-amplified with nicastrin in breast invasive carcinoma.Breast Cancer Res Treat. 2014 Jan;143(2):393-401. doi: 10.1007/s10549-013-2805-6. Epub 2013 Dec 13.
• [2213] Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas.Genes Chromosomes Cancer. 2002 Nov;35(3):256-60. doi: 10.1002/gcc.10118.
• [2214] Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization.Br J Cancer. 2001 Nov 2;85(9):1372-82. doi: 10.1054/bjoc.2001.2074.
• [2215] Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through suppressing TGF--induced EMT.J Cell Biochem. 2019 Aug;120(8):13651-13657. doi: 10.1002/jcb.28638. Epub 2019 Apr 4.
• [2216] Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.Cancer Res. 2006 Aug 15;66(16):8017-25. doi: 10.1158/0008-5472.CAN-05-4490.
• [2217] New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome.Cancer Sci. 2020 Jan;111(1):6-14. doi: 10.1111/cas.14244. Epub 2019 Dec 14.
• [2218] Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?.Clin Exp Metastasis. 2010 Aug;27(6):371-87. doi: 10.1007/s10585-010-9307-2. Epub 2010 Feb 24.
• [2219] Stress and interferon signalling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1.Br J Cancer. 2018 Dec;119(12):1538-1551. doi: 10.1038/s41416-018-0265-9. Epub 2018 Nov 2.
• [2220] LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.Cancer Res. 2005 Jun 1;65(11):4587-97. doi: 10.1158/0008-5472.CAN-04-4630.
• [2221] Hypermethylation of NF-B-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.Dig Dis Sci. 2018 Mar;63(3):676-686. doi: 10.1007/s10620-018-4929-3. Epub 2018 Jan 20.
• [2222] Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.Nat Commun. 2016 Jun 14;7:11889. doi: 10.1038/ncomms11889.
• [2223] Inhibition of miR31 and miR92a as Oncological Biomarkers in RKO Colon Cancer Cells Treated with Kaempferol-3-O-Glycoside Isolated from Black Bean.J Med Food. 2020 Jan;23(1):50-55. doi: 10.1089/jmf.2019.0059. Epub 2019 Aug 23.
• [2224] Increased expression of N-myristoyltransferase in gallbladder carcinomas.Cancer. 2000 May 1;88(9):1992-9.
• [2225] FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth.Breast Cancer Res. 2015 Mar 28;17:47. doi: 10.1186/s13058-015-0551-x.
• [2226] NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/-catenin signaling pathway.Braz J Med Biol Res. 2018 Nov 23;52(1):e7952. doi: 10.1590/1414-431X20187952.
• [2227] HSPC111 governs breast cancer growth by regulating ribosomal biogenesis.Mol Cancer Res. 2014 Apr;12(4):583-94. doi: 10.1158/1541-7786.MCR-13-0168. Epub 2014 Jan 14.
• [2228] NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1 and p27(Kip1) expression in malignant melanoma and other human tumors.Mol Carcinog. 2017 Dec;56(12):2643-2662. doi: 10.1002/mc.22708. Epub 2017 Aug 30.
• [2229] Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.Mol Cancer Ther. 2010 Jan;9(1):33-45. doi: 10.1158/1535-7163.MCT-09-0486. Epub 2010 Jan 6.
• [2230] Genes affected by mouse mammary tumor virus (MMTV) proviral insertions in mouse mammary tumors are deregulated or mutated in primary human mammary tumors.Oncotarget. 2012 Nov;3(11):1320-34. doi: 10.18632/oncotarget.682.
• [2231] The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression.Nat Commun. 2019 Mar 4;10(1):1034. doi: 10.1038/s41467-019-08618-y.
• [2232] The neurotrophic factor neurturin contributes toward an aggressive cancer cell phenotype, neuropathic pain and neuronal plasticity in pancreatic cancer.Carcinogenesis. 2014 Jan;35(1):103-13. doi: 10.1093/carcin/bgt312. Epub 2013 Sep 25.
• [2233] The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.Cell Death Dis. 2017 Nov 16;8(11):e3169. doi: 10.1038/cddis.2017.521.
• [2234] Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):613-621. doi: 10.26355/eurrev_201901_16875.
• [2235] Epigenetic deregulations of Wnt/-catenin and transforming growth factor beta-Smad pathways in esophageal cancer: Outcome of DNA methylation.J Cancer Res Ther. 2019 Jan-Mar;15(1):192-203. doi: 10.4103/jcrt.JCRT_634_17.
• [2236] Differential Redox Regulation of Ca?Signaling and Viability in Normal and Malignant Prostate Cells.Biophys J. 2015 Oct 6;109(7):1410-9. doi: 10.1016/j.bpj.2015.08.006.
• [2237] Trial watch: Peptide-based vaccines in anticancer therapy.Oncoimmunology. 2018 Sep 6;7(12):e1511506. doi: 10.1080/2162402X.2018.1511506. eCollection 2018.
• [2238] Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas.J Vis Exp. 2019 Feb 28;(144). doi: 10.3791/56880.
• [2239] The role of OXCT1 in the pathogenesis of cancer as a rate-limiting enzyme of ketone body metabolism.Life Sci. 2017 Aug 15;183:110-115. doi: 10.1016/j.lfs.2017.07.003. Epub 2017 Jul 4.
• [2240] Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.J Transl Med. 2017 Jun 29;15(1):149. doi: 10.1186/s12967-017-1248-y.
• [2241] Collagen prolyl hydroxylase 3 has a tumor suppressive activity in human lung cancer.Exp Cell Res. 2018 Feb 1;363(1):121-128. doi: 10.1016/j.yexcr.2017.12.020. Epub 2017 Dec 23.
• [2242] P3H4 affects renal carcinoma through up-regulating miR-1/133a.Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5180-5186. doi: 10.26355/eurrev_201808_15714.
• [2243] Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival.ACS Chem Biol. 2015 Apr 17;10(4):925-32. doi: 10.1021/cb500893q. Epub 2015 Jan 20.
• [2244] Panx3 links body mass index and tumorigenesis in a genetically heterogeneous mouse model of carcinogen-induced cancer.Genome Med. 2016 Aug 9;8(1):83. doi: 10.1186/s13073-016-0334-8.
• [2245] PARP12 (ARTD12) suppresses hepatocellular carcinoma metastasis through interacting with FHL2 and regulating its stability.Cell Death Dis. 2018 Aug 28;9(9):856. doi: 10.1038/s41419-018-0906-1.
• [2246] PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.Prostate. 2018 May;78(7):547-559. doi: 10.1002/pros.23499. Epub 2018 Mar 9.
• [2247] PCBP2 promotes the development of glioma by regulating FHL3/TGF-/Smad signaling pathway.J Cell Physiol. 2020 Apr;235(4):3280-3291. doi: 10.1002/jcp.29104. Epub 2019 Nov 6.
• [2248] The Inhibitory Signaling Receptor Protocadherin-18 Regulates Tumor-Infiltrating CD8(+) T-cell Function.Cancer Immunol Res. 2017 Oct;5(10):920-928. doi: 10.1158/2326-6066.CIR-17-0187. Epub 2017 Sep 5.
• [2249] Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers.Clin Cancer Res. 2011 Sep 1;17(17):5582-92. doi: 10.1158/1078-0432.CCR-10-2659. Epub 2011 Jul 25.
• [2250] PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer.Cell Death Dis. 2018 Jan 18;9(2):27. doi: 10.1038/s41419-017-0189-y.
• [2251] Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma.Nat Commun. 2018 Dec 14;9(1):5331. doi: 10.1038/s41467-018-07580-5.
• [2252] Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo.J Med Chem. 2019 Mar 14;62(5):2708-2719. doi: 10.1021/acs.jmedchem.8b02036. Epub 2019 Feb 28.
• [2253] Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.Neuro Oncol. 2017 Feb 1;19(2):219-228. doi: 10.1093/neuonc/now160.
• [2254] Cancer-associated oxidoreductase ERO1- promotes immune escape through up-regulation of PD-L1 in human breast cancer.Oncotarget. 2017 Apr 11;8(15):24706-24718. doi: 10.18632/oncotarget.14960.
• [2255] The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect.Biochem Biophys Res Commun. 2018 Sep 18;503(4):2749-2757. doi: 10.1016/j.bbrc.2018.08.035. Epub 2018 Aug 6.
• [2256] PDLIM2 Is a Marker of Adhesion and -Catenin Activity in Triple-Negative Breast Cancer.Cancer Res. 2019 May 15;79(10):2619-2633. doi: 10.1158/0008-5472.CAN-18-2787. Epub 2019 Mar 18.
• [2257] Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.Blood. 2015 Nov 26;126(22):2484-90. doi: 10.1182/blood-2015-04-641100. Epub 2015 Oct 22.
• [2258] Glucuronorhamnoxylan from Capsosiphon fulvescens inhibits the growth of HT-29 human colon cancer cells in vitro and in vivo via induction of apoptotic cell death.Int J Biol Macromol. 2019 Mar 1;124:1060-1068. doi: 10.1016/j.ijbiomac.2018.12.001. Epub 2018 Dec 3.
• [2259] PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer.J Exp Clin Cancer Res. 2019 Nov 12;38(1):463. doi: 10.1186/s13046-019-1466-7.
• [2260] Comprehensive genome sequence analysis of a breast cancer amplicon.Genome Res. 2001 Jun;11(6):1034-42. doi: 10.1101/gr.gr1743r.
• [2261] Differential gene expression profiles and identification of the genes relevant to clinicopathologic factors in colorectal cancer selected by cDNA array method in combination with principal component analysis.Int J Oncol. 2003 Jul;23(1):49-59.
• [2262] 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia.J Biol Chem. 2004 Dec 17;279(51):53562-70. doi: 10.1074/jbc.M406096200. Epub 2004 Oct 5.
• [2263] Synthesis and biological evaluation of anthraquinone derivatives as allosteric phosphoglycerate mutase 1 inhibitors for cancer treatment.Eur J Med Chem. 2019 Apr 15;168:45-57. doi: 10.1016/j.ejmech.2019.01.085. Epub 2019 Feb 8.
• [2264] Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.Dig Dis Sci. 2018 Jul;63(7):1835-1850. doi: 10.1007/s10620-018-5081-9. Epub 2018 Apr 25.
• [2265] Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesis.Sci Rep. 2018 Sep 21;8(1):14161. doi: 10.1038/s41598-018-32256-x.
• [2266] Genetic and Methylation-Induced Loss of miR-181a2/181b2 within chr9q33.3 Facilitates Tumor Growth of Cervical Cancer through the PIK3R3/Akt/FoxO Signaling Pathway.Clin Cancer Res. 2017 Jan 15;23(2):575-586. doi: 10.1158/1078-0432.CCR-16-0303. Epub 2016 Aug 8.
• [2267] Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.J Exp Clin Cancer Res. 2019 Sep 5;38(1):390. doi: 10.1186/s13046-019-1379-5.
• [2268] Expression of PIWIL3 in primary and metastatic melanoma.J Cancer Res Clin Oncol. 2017 Mar;143(3):433-437. doi: 10.1007/s00432-016-2305-2. Epub 2016 Nov 17.
• [2269] Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.Pathol Res Pract. 2019 Jul;215(7):152438. doi: 10.1016/j.prp.2019.152438. Epub 2019 May 13.
• [2270] Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis.Mol Cancer Res. 2010 Mar;8(3):295-308. doi: 10.1158/1541-7786.MCR-09-0502. Epub 2010 Feb 23.
• [2271] Secreted phospholipases Aare differentially expressed and epigenetically silenced in human breast cancer cells.Biochem Biophys Res Commun. 2014 Feb 28;445(1):230-5. doi: 10.1016/j.bbrc.2014.01.182. Epub 2014 Feb 6.
• [2272] Molecular interaction between K-Ras and H-REV107 in the Ras signaling pathway.Biochem Biophys Res Commun. 2017 Sep 16;491(2):257-264. doi: 10.1016/j.bbrc.2017.07.120. Epub 2017 Jul 22.
• [2273] RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade.Leukemia. 2020 Apr;34(4):1017-1026. doi: 10.1038/s41375-019-0639-x. Epub 2019 Nov 18.
• [2274] A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.World Neurosurg. 2019 Mar;123:e45-e59. doi: 10.1016/j.wneu.2018.11.021. Epub 2018 Nov 15.
• [2275] GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma.Cell Rep. 2018 Feb 27;22(9):2455-2468. doi: 10.1016/j.celrep.2018.01.081.
• [2276] An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and Tumors.Cancer Res. 2019 Jun 15;79(12):3100-3111. doi: 10.1158/0008-5472.CAN-18-2372. Epub 2019 Apr 30.
• [2277] A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.Jpn J Cancer Res. 2001 Dec;92(12):1342-51. doi: 10.1111/j.1349-7006.2001.tb02159.x.
• [2278] (131)I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma.Nanoscale Res Lett. 2017 Dec;12(1):365. doi: 10.1186/s11671-017-2140-7. Epub 2017 May 19.
• [2279] Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death.Breast Cancer Res. 2015 Jan 15;17(1):6. doi: 10.1186/s13058-014-0506-7.
• [2280] The prognostic role of clinical, morphological and molecular markers in oral squamous cell tumors.Neoplasma. 2005;52(2):95-102.
• [2281] Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222.Mol Ther. 2015 Dec;23(12):1899-911. doi: 10.1038/mt.2015.170. Epub 2015 Sep 15.
• [2282] Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells.Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11948-53. doi: 10.1073/pnas.0914143107. Epub 2010 Jun 14.
• [2283] Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.Gynecol Oncol. 2020 Jan;156(1):194-202. doi: 10.1016/j.ygyno.2019.10.028. Epub 2019 Nov 19.
• [2284] The role of double-strand break repair, translesion synthesis, and interstrand crosslinks in colorectal cancer progression-clinicopathological data and survival.J Surg Oncol. 2020 Apr;121(5):906-916. doi: 10.1002/jso.25737. Epub 2019 Oct 25.
• [2285] Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.Eur J Cancer. 2013 May;49(7):1725-40. doi: 10.1016/j.ejca.2012.12.002. Epub 2013 Jan 5.
• [2286] Protein phosphatase 1, regulatory subunit 15B is a survival factor for ER-positive breast cancer.Int J Cancer. 2013 Jun 1;132(11):2714-9. doi: 10.1002/ijc.27945. Epub 2012 Dec 27.
• [2287] IPP5, a novel inhibitor of protein phosphatase 1, suppresses tumor growth and progression of cervical carcinoma cells by inducing G2/M arrest.Cancer Genet. 2012 Sep;205(9):442-52. doi: 10.1016/j.cancergen.2012.06.002.
• [2288] The selective inhibition of protein phosphatase-1 results in mitotic catastrophe and impaired tumor growth.J Cell Sci. 2015 Dec 15;128(24):4526-37. doi: 10.1242/jcs.175588. Epub 2015 Nov 5.
• [2289] The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.Sci Transl Med. 2016 Dec 14;8(369):369ra177. doi: 10.1126/scitranslmed.aai9188.
• [2290] Gene expression profiling identifies WNT7A as a possible candidate gene for decreased cancer risk in fragile X syndrome patients.Arch Med Res. 2010 Feb;41(2):110-118.e2. doi: 10.1016/j.arcmed.2010.03.001.
• [2291] Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer.Int J Oncol. 2012 Jun;40(6):1865-80. doi: 10.3892/ijo.2012.1371. Epub 2012 Feb 14.
• [2292] Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome.Leukemia. 2003 Jul;17(7):1313-23. doi: 10.1038/sj.leu.2402969.
• [2293] Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers.Biochim Biophys Acta. 2014 Jun;1839(6):476-92. doi: 10.1016/j.bbagrm.2014.04.010. Epub 2014 Apr 18.
• [2294] GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.Sci Rep. 2015 Nov 18;5:16214. doi: 10.1038/srep16214.
• [2295] PRPF8 defects cause missplicing in myeloid malignancies.Leukemia. 2015 Jan;29(1):126-36. doi: 10.1038/leu.2014.144. Epub 2014 Apr 30.
• [2296] PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia.Leukemia. 2019 May;33(5):1184-1194. doi: 10.1038/s41375-018-0340-5. Epub 2018 Dec 20.
• [2297] Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/-catenin signaling pathway.Pathol Res Pract. 2019 Oct;215(10):152593. doi: 10.1016/j.prp.2019.152593. Epub 2019 Aug 11.
• [2298] Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP.Cancer Invest. 2012 Oct;30(8):583-92. doi: 10.3109/07357907.2012.716467. Epub 2012 Aug 21.
• [2299] The epigenome of testicular germ cell tumors.APMIS. 2007 Oct;115(10):1147-60. doi: 10.1111/j.1600-0463.2007.apm_660.xml.x.
• [2300] Testes-specific protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer.Oncol Lett. 2018 Jun;15(6):8796-8804. doi: 10.3892/ol.2018.8387. Epub 2018 Mar 29.
• [2301] MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.Cancer Res. 2016 Aug 15;76(16):4872-86. doi: 10.1158/0008-5472.CAN-15-1664. Epub 2016 May 24.
• [2302] Toll-like receptor 4 mediates the antitumor host response induced by Ganoderma atrum polysaccharide.J Agric Food Chem. 2015 Jan 21;63(2):517-25. doi: 10.1021/jf5041096. Epub 2015 Jan 9.
• [2303] Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation.Cancers (Basel). 2019 Apr 12;11(4):527. doi: 10.3390/cancers11040527.
• [2304] Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer.Cancer Sci. 2019 Jul;110(7):2258-2272. doi: 10.1111/cas.14031. Epub 2019 May 23.
• [2305] Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.Tumour Biol. 2017 Mar;39(3):1010428317691427. doi: 10.1177/1010428317691427.
• [2306] PUF60 accelerates the progression of breast cancer through downregulation of PTEN expression.Cancer Manag Res. 2019 Jan 17;11:821-830. doi: 10.2147/CMAR.S180242. eCollection 2019.
• [2307] The Pur protein family: clues to function from recent studies on cancer and AIDS.Anticancer Res. 2003 May-Jun;23(3A):2093-100.
• [2308] Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical, and genetic features.Virchows Arch. 2008 Feb;452(2):193-200. doi: 10.1007/s00428-007-0541-1. Epub 2007 Dec 8.
• [2309] Perspective on allogeneic melanoma lysates in active specific immunotherapy.Semin Oncol. 1998 Dec;25(6):623-35.
• [2310] RCP induces Slug expression and cancer cell invasion by stabilizing 1 integrin.Oncogene. 2017 Feb 23;36(8):1102-1111. doi: 10.1038/onc.2016.277. Epub 2016 Aug 15.
• [2311] RAB31 Targeted by MiR-30c-2-3p Regulates the GLI1 Signaling Pathway, Affecting Gastric Cancer Cell Proliferation and Apoptosis.Front Oncol. 2018 Nov 26;8:554. doi: 10.3389/fonc.2018.00554. eCollection 2018.
• [2312] Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6974-80. eCollection 2015.
• [2313] Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.Am J Pathol. 2001 Apr;158(4):1355-62. doi: 10.1016/S0002-9440(10)64086-2.
• [2314] Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.ACS Appl Mater Interfaces. 2017 Jan 25;9(3):2093-2103. doi: 10.1021/acsami.6b12647. Epub 2017 Jan 12.
• [2315] Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma.Cancer Manag Res. 2018 Nov 9;10:5559-5572. doi: 10.2147/CMAR.S182996. eCollection 2018.
• [2316] EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer.Mol Cancer Ther. 2019 Apr;18(4):845-855. doi: 10.1158/1535-7163.MCT-18-0539. Epub 2019 Mar 1.
• [2317] Near-genomewide RNAi screening for regulators of BRAF(V600E) -induced senescence identifies RASEF, a gene epigenetically silenced in melanoma.Pigment Cell Melanoma Res. 2014 Jul;27(4):640-52. doi: 10.1111/pcmr.12248. Epub 2014 May 14.
• [2318] RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-B pathway.Cancer Biol Ther. 2019;20(4):435-443. doi: 10.1080/15384047.2018.1529117. Epub 2018 Oct 25.
• [2319] RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.J Genet Genomics. 2019 Oct 20;46(10):477-488. doi: 10.1016/j.jgg.2019.10.004. Epub 2019 Nov 14.
• [2320] RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma.Cell Death Dis. 2016 Sep 1;7(9):e2352. doi: 10.1038/cddis.2016.252.
• [2321] RNA-binding protein RBM6 as a tumor suppressor gene represses the growth and progression in laryngocarcinoma.Gene. 2019 May 20;697:26-34. doi: 10.1016/j.gene.2019.02.025. Epub 2019 Feb 15.
• [2322] Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.Am J Cancer Res. 2017 Nov 1;7(11):2169-2179. eCollection 2017.
• [2323] Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.Mol Oncol. 2020 Feb;14(2):373-386. doi: 10.1002/1878-0261.12593. Epub 2019 Dec 19.
• [2324] Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression.Cell Death Dis. 2017 Sep 7;8(9):e3033. doi: 10.1038/cddis.2017.424.
• [2325] Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.Oncotarget. 2015 Mar 20;6(8):5903-17. doi: 10.18632/oncotarget.3464.
• [2326] FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.Hum Pathol. 2019 May;87:1-10. doi: 10.1016/j.humpath.2018.11.033. Epub 2019 Feb 20.
• [2327] Genome-wide transcript profiling reveals novel breast cancer-associated intronic sense RNAs.PLoS One. 2015 Mar 23;10(3):e0120296. doi: 10.1371/journal.pone.0120296. eCollection 2015.
• [2328] Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro.Int J Oncol. 2019 Jan;54(1):188-198. doi: 10.3892/ijo.2018.4611. Epub 2018 Oct 30.
• [2329] Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.PLoS One. 2014 Jan 27;9(1):e87455. doi: 10.1371/journal.pone.0087455. eCollection 2014.
• [2330] RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells.Sci Rep. 2018 Jan 12;8(1):653. doi: 10.1038/s41598-017-18851-4.
• [2331] Silencing RhoA inhibits migration and invasion through Wnt/-catenin pathway and growth through cell cycle regulation in human tongue cancer.Acta Biochim Biophys Sin (Shanghai). 2014 Aug;46(8):682-90. doi: 10.1093/abbs/gmu051.
• [2332] The RHOV gene is overexpressed in human non-small cell lung cancer.Cancer Genet. 2013 Nov;206(11):393-7. doi: 10.1016/j.cancergen.2013.10.006. Epub 2013 Nov 5.
• [2333] Rearrangement of the p53 gene in human osteogenic sarcomas.Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716-9. doi: 10.1073/pnas.84.21.7716.
• [2334] The human homologue of the Drosophila tailless gene (TLX): characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21.Genomics. 1998 May 15;50(1):34-43. doi: 10.1006/geno.1998.5270.
• [2335] HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.Oncotarget. 2016 Feb 9;7(6):6727-47. doi: 10.18632/oncotarget.6797.
• [2336] Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8(+) T Cells and Histone Acetyltransferases.Cancer Immunol Res. 2017 Apr;5(4):300-311. doi: 10.1158/2326-6066.CIR-16-0234. Epub 2017 Feb 21.
• [2337] KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST.PLoS One. 2015 Jun 23;10(6):e0130149. doi: 10.1371/journal.pone.0130149. eCollection 2015.
• [2338] Promoter methylation of RNF180 is associated with H.pylori infection and serves as a marker for gastric cancer and atrophic gastritis.Oncotarget. 2016 Apr 26;7(17):24800-9. doi: 10.18632/oncotarget.8523.
• [2339] Overexpression of RNF187 induces cell EMT and apoptosis resistance in NSCLC.J Cell Physiol. 2019 Aug;234(8):14161-14169. doi: 10.1002/jcp.28111. Epub 2019 Jan 9.
• [2340] An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention.BMC Bioinformatics. 2005 Dec 1;6 Suppl 4(Suppl 4):S7. doi: 10.1186/1471-2105-6-S4-S7.
• [2341] Degradation of AMPK-1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation.Mol Oncol. 2017 Dec;11(12):1806-1825. doi: 10.1002/1878-0261.12151. Epub 2017 Nov 16.
• [2342] The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8.EMBO J. 2019 Oct 4;38(21):e102361. doi: 10.15252/embj.2019102361. Epub 2019 Oct 15.
• [2343] Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.Thyroid. 2019 Apr;29(4):530-539. doi: 10.1089/thy.2018.0687. Epub 2019 Feb 13.
• [2344] Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation.Cancer Lett. 2013 Jan 1;328(1):168-75. doi: 10.1016/j.canlet.2012.08.015. Epub 2012 Aug 17.
• [2345] Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling.Int J Cancer. 2015 Jul 1;137(1):104-15. doi: 10.1002/ijc.29361. Epub 2014 Dec 12.
• [2346] Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations.Am J Pathol. 1999 May;154(5):1335-43. doi: 10.1016/S0002-9440(10)65387-4.
• [2347] Molecular analysis in combination with iodine staining may contribute to the risk prediction of esophageal squamous cell carcinoma.J Cancer Res Clin Oncol. 2008 Mar;134(3):307-15. doi: 10.1007/s00432-007-0269-y. Epub 2007 Aug 14.
• [2348] siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer.PLoS One. 2011;6(7):e22672. doi: 10.1371/journal.pone.0022672. Epub 2011 Jul 22.
• [2349] Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.Am J Pathol. 2001 Jun;158(6):1955-9. doi: 10.1016/S0002-9440(10)64665-2.
• [2350] The uS8, uS4, eS31, and uL14 Ribosomal Protein Genes Are Dysregulated in Nasopharyngeal Carcinoma Cell Lines.Biomed Res Int. 2017;2017:4876954. doi: 10.1155/2017/4876954. Epub 2017 Jul 16.
• [2351] Role of RPL39 in Metaplastic Breast Cancer.J Natl Cancer Inst. 2016 Dec 31;109(6):djw292. doi: 10.1093/jnci/djw292. Print 2017 Jun.
• [2352] The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.Oncotarget. 2017 Feb 28;8(9):14462-14478. doi: 10.18632/oncotarget.14895.
• [2353] Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells.J Steroid Biochem Mol Biol. 2011 Jul;125(3-5):219-25. doi: 10.1016/j.jsbmb.2011.03.005. Epub 2011 Mar 21.
• [2354] Rig is a novel Ras-related protein and potential neural tumor suppressor.Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9876-81. doi: 10.1073/pnas.142193799. Epub 2002 Jul 9.
• [2355] Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.Clin Cancer Res. 2016 Nov 1;22(21):5383-5393. doi: 10.1158/1078-0432.CCR-16-0609. Epub 2016 Jun 7.
• [2356] Potential lncRNA diagnostic biomarkers for early gastric cancer.Mol Med Rep. 2017 Dec;16(6):9545-9552. doi: 10.3892/mmr.2017.7770. Epub 2017 Oct 12.
• [2357] RSRC1 suppresses gastric cancer cell proliferation and migration by regulating PTEN expression.Mol Med Rep. 2019 Aug;20(2):1747-1753. doi: 10.3892/mmr.2019.10409. Epub 2019 Jun 21.
• [2358] Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.Genome Res. 2011 Jan;21(1):56-67. doi: 10.1101/gr.110684.110. Epub 2010 Oct 29.
• [2359] Dedifferentiated chondrosarcoma with t(9;22)(q34;q11-12).Genes Chromosomes Cancer. 1994 Feb;9(2):136-40. doi: 10.1002/gcc.2870090210.
• [2360] A commensal strain of Staphylococcus epidermidis protects against skin neoplasia.Sci Adv. 2018 Feb 28;4(2):eaao4502. doi: 10.1126/sciadv.aao4502. eCollection 2018 Feb.
• [2361] Re-expression of Selected Epigenetically Silenced Candidate Tumor Suppressor Genes in Cervical Cancer by TET2-directed Demethylation.Mol Ther. 2016 Mar;24(3):536-47. doi: 10.1038/mt.2015.226. Epub 2015 Dec 21.
• [2362] Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.Nat Commun. 2019 Nov 7;10(1):5051. doi: 10.1038/s41467-019-12960-6.
• [2363] Peptide P11 suppresses the growth of human thyroid carcinoma by inhibiting the PI3K/AKT/mTOR signaling pathway.Mol Biol Rep. 2019 Jun;46(3):2665-2678. doi: 10.1007/s11033-019-04698-7. Epub 2019 Apr 26.
• [2364] An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.Radiat Res. 2014 Aug;182(2):191-200. doi: 10.1667/RR13594.1. Epub 2014 Jun 27.
• [2365] Scavenger Receptor A1 Prevents Metastasis of Non-Small Cell Lung Cancer via Suppression of Macrophage Serum Amyloid A1.Cancer Res. 2017 Apr 1;77(7):1586-1598. doi: 10.1158/0008-5472.CAN-16-1569. Epub 2017 Feb 15.
• [2366] SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma.Oncotarget. 2018 Jan 9;9(7):7567-7581. doi: 10.18632/oncotarget.24085. eCollection 2018 Jan 26.
• [2367] Evaluation of lipophilins as determinants of tumor cell response to estramustine.J Pharmacol Exp Ther. 2005 Dec;315(3):1158-62. doi: 10.1124/jpet.105.090860. Epub 2005 Aug 24.
• [2368] Sex comb on midleg like-2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors.Exp Ther Med. 2017 Aug;14(2):1749-1755. doi: 10.3892/etm.2017.4677. Epub 2017 Jun 26.
• [2369] Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosis.Dis Markers. 2015;2015:230703. doi: 10.1155/2015/230703. Epub 2015 Feb 26.
• [2370] Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.Neoplasia. 2016 Jan;18(1):49-59. doi: 10.1016/j.neo.2015.11.013.
• [2371] Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.EBioMedicine. 2018 Nov;37:47-55. doi: 10.1016/j.ebiom.2018.10.002. Epub 2018 Oct 6.
• [2372] Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma.Lab Invest. 1996 Apr;74(4):809-18.
• [2373] Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.Oncotarget. 2018 Feb 3;9(17):13407-13422. doi: 10.18632/oncotarget.24388. eCollection 2018 Mar 2.
• [2374] The -isoform of BCCIP promotes ADP release from the RAD51 presynaptic filament and enhances homologous DNA pairing.Nucleic Acids Res. 2017 Jan 25;45(2):711-725. doi: 10.1093/nar/gkw877. Epub 2016 Sep 30.
• [2375] Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.Clin Exp Metastasis. 2019 Jun;36(3):225-241. doi: 10.1007/s10585-019-09964-3. Epub 2019 Mar 27.
• [2376] Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study.Curr Pharm Biotechnol. 2019;20(9):727-732. doi: 10.2174/1389201020666190619145655.
• [2377] Sema4A Responds to Hypoxia and Is Involved in Breast Cancer Progression.Biol Pharm Bull. 2018 Dec 1;41(12):1791-1796. doi: 10.1248/bpb.b18-00423. Epub 2018 Sep 28.
• [2378] The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells.Cancer Res. 2009 Feb 15;69(4):1485-93. doi: 10.1158/0008-5472.CAN-08-3659. Epub 2009 Jan 27.
• [2379] SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.Oncotarget. 2016 Mar 1;7(9):10117-32. doi: 10.18632/oncotarget.6956.
• [2380] Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.Transl Oncol. 2019 Jan;12(1):84-95. doi: 10.1016/j.tranon.2018.09.011. Epub 2018 Oct 1.
• [2381] SETMAR isoforms in glioblastoma: A matter of protein stability.Oncotarget. 2017 Feb 7;8(6):9835-9848. doi: 10.18632/oncotarget.14218.
• [2382] Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.J Clin Endocrinol Metab. 2010 Mar;95(3):1458-62. doi: 10.1210/jc.2009-2040. Epub 2010 Jan 15.
• [2383] SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma.BMB Rep. 2018 Feb;51(2):57-58. doi: 10.5483/bmbrep.2018.51.2.021.
• [2384] The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma.Vaccine. 2002 Jan 31;20(9-10):1400-11. doi: 10.1016/s0264-410x(01)00464-9.
• [2385] A locus on chromosome 8 controlling tumor regionality-a new type of tumor diversity in the mouse lung.Int J Cancer. 2010 Jun 1;126(11):2603-13. doi: 10.1002/ijc.24983.
• [2386] Development and Biological Analysis of a Novel Orthotopic Peritoneal Dissemination Mouse Model Generated Using a Pancreatic Ductal Adenocarcinoma Cell Line.Pancreas. 2019 Mar;48(3):315-322. doi: 10.1097/MPA.0000000000001253.
• [2387] Sphingomyelin Synthase 1 (SMS1) Downregulation Is Associated With Sphingolipid Reprogramming and a Worse Prognosis in Melanoma.Front Pharmacol. 2019 Apr 30;10:443. doi: 10.3389/fphar.2019.00443. eCollection 2019.
• [2388] SH2B1 promotes epithelial-mesenchymal transition through the IRS1/-catenin signaling axis in lung adenocarcinoma.Mol Carcinog. 2018 May;57(5):640-652. doi: 10.1002/mc.22788. Epub 2018 Feb 20.
• [2389] The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors.Sci Rep. 2019 May 17;9(1):7548. doi: 10.1038/s41598-019-44039-z.
• [2390] Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability.Cancer Res. 2019 Feb 15;79(4):747-759. doi: 10.1158/0008-5472.CAN-18-1754. Epub 2018 Dec 20.
• [2391] IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity.Nature. 2017 Nov 2;551(7678):110-114. doi: 10.1038/nature24293. Epub 2017 Oct 25.
• [2392] Dynamic relationship between SIPA1 gene and protein expression and the development of gastric cancer.Genet Mol Res. 2017 Mar 16;16(1). doi: 10.4238/gmr16019271.
• [2393] Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: A real world single center study.Eur J Surg Oncol. 2020 Apr;46(4 Pt A):548-559. doi: 10.1016/j.ejso.2019.10.026. Epub 2019 Oct 24.
• [2394] Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.J Magn Reson Imaging. 2020 Feb;51(2):615-626. doi: 10.1002/jmri.26865. Epub 2019 Jul 16.
• [2395] Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer.Oncotarget. 2018 Jan 24;9(14):11734-11751. doi: 10.18632/oncotarget.24312. eCollection 2018 Feb 20.
• [2396] Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells.Stem Cells. 2016 Apr;34(4):832-46. doi: 10.1002/stem.2284. Epub 2016 Jan 19.
• [2397] Silencing of Synuclein- inhibits human cervical cancer through the AKT signaling pathway.Cell Mol Biol Lett. 2019 Jul 10;24:49. doi: 10.1186/s11658-019-0172-y. eCollection 2019.
• [2398] SNX10 (sorting nexin 10) inhibits colorectal cancer initiation and progression by controlling autophagic degradation of SRC.Autophagy. 2020 Apr;16(4):735-749. doi: 10.1080/15548627.2019.1632122. Epub 2019 Jul 4.
• [2399] MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression.Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):992-1001. doi: 10.26355/eurrev_201902_16986.
• [2400] Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.Neuro Oncol. 2019 Feb 14;21(2):222-233. doi: 10.1093/neuonc/noy105.
• [2401] Over-expression of SOX8 predicts poor prognosis in colorectal cancer: A retrospective study.Medicine (Baltimore). 2019 Jul;98(27):e16237. doi: 10.1097/MD.0000000000016237.
• [2402] KLF14 potentiates oxidative adaptation via modulating HO-1 signaling in castrate-resistant prostate cancer.Endocr Relat Cancer. 2019 Jan 1;26(1):181-195. doi: 10.1530/ERC-18-0383.
• [2403] Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103(+) dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity.J Extracell Vesicles. 2019 Sep 28;8(1):1670893. doi: 10.1080/20013078.2019.1670893. eCollection 2019.
• [2404] Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).Breast Cancer Res Treat. 2012 Apr;132(3):1049-62. doi: 10.1007/s10549-011-1895-2. Epub 2011 Dec 25.
• [2405] SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor.Cancer Res. 2017 Jan 15;77(2):579-589. doi: 10.1158/0008-5472.CAN-16-1281. Epub 2016 Sep 26.
• [2406] Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis.Biosci Rep. 2019 Jun 4;39(6):BSR20181339. doi: 10.1042/BSR20181339. Print 2019 Jun 28.
• [2407] Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.PLoS One. 2019 Mar 11;14(3):e0213411. doi: 10.1371/journal.pone.0213411. eCollection 2019.
• [2408] A tumor suppressor role for srGAP3 in mammary epithelial cells.Oncogene. 2013 Oct;32(40):4854-60. doi: 10.1038/onc.2012.489. Epub 2012 Oct 29.
• [2409] Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.Gastric Cancer. 2016 Oct;19(4):1066-1079. doi: 10.1007/s10120-015-0566-0. Epub 2015 Nov 18.
• [2410] SRRM4 gene expression correlates with neuroendocrine prostate cancer.Prostate. 2019 Jan;79(1):96-104. doi: 10.1002/pros.23715. Epub 2018 Aug 28.
• [2411] Overexpression of signal sequence receptor predicts poor survival in patients with hepatocellular carcinoma.Hum Pathol. 2018 Nov;81:47-54. doi: 10.1016/j.humpath.2018.06.014. Epub 2018 Jun 23.
• [2412] A critical role for the neural zinc factor ST18 in pancreatic -cell apoptosis.J Biol Chem. 2014 Mar 21;289(12):8413-9. doi: 10.1074/jbc.M114.554915. Epub 2014 Feb 7.
• [2413] An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor.Cancer Discov. 2014 Mar;4(3):304-17. doi: 10.1158/2159-8290.CD-13-0287. Epub 2014 Feb 11.
• [2414] Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.Nat Med. 2016 Sep;22(9):1056-61. doi: 10.1038/nm.4155. Epub 2016 Aug 8.
• [2415] Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.Am J Pathol. 2003 Nov;163(5):1721-7. doi: 10.1016/S0002-9440(10)63530-4.
• [2416] High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.Haematologica. 2020 Jan 31;105(2):435-447. doi: 10.3324/haematol.2019.216986. Print 2020.
• [2417] Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry.Pigment Cell Melanoma Res. 2014 May;27(3):442-53. doi: 10.1111/pcmr.12222. Epub 2014 Mar 7.
• [2418] Drak2 is not required for tumor surveillance and suppression.Int Immunol. 2015 Mar;27(3):161-6. doi: 10.1093/intimm/dxu146. Epub 2015 Jan 7.
• [2419] Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.Cancer Res. 2009 Mar 15;69(6):2234-43. doi: 10.1158/0008-5472.CAN-08-3338. Epub 2009 Mar 3.
• [2420] Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF- in thyroid cancer cells.Oncol Rep. 2014 Jan;31(1):153-60. doi: 10.3892/or.2013.2833. Epub 2013 Nov 4.
• [2421] Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells.Gynecol Oncol. 2002 Jun;85(3):451-8. doi: 10.1006/gyno.2002.6644.
• [2422] Shiga-like toxin I exerts specific and potent anti-tumour efficacy against gastric cancer cell proliferation when driven by tumour-preferential Frizzled-7 promoter.Cell Prolif. 2019 May;52(3):e12607. doi: 10.1111/cpr.12607. Epub 2019 Apr 6.
• [2423] The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.Nephrol Dial Transplant. 2015 Jun;30(6):969-77. doi: 10.1093/ndt/gfv004. Epub 2015 Feb 17.
• [2424] Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence.Transl Oncol. 2017 Jun;10(3):385-395. doi: 10.1016/j.tranon.2017.03.002. Epub 2017 Apr 20.
• [2425] Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.Mol Cell Biol. 1984 Nov;4(11):2486-97. doi: 10.1128/mcb.4.11.2486-2497.1984.
• [2426] Pseudophosphatase STYX promotes tumor growth and metastasis by inhibiting FBXW7 function in colorectal cancer.Cancer Lett. 2019 Jul 10;454:53-65. doi: 10.1016/j.canlet.2019.04.014. Epub 2019 Apr 11.
• [2427] A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.Blood. 2010 Aug 12;116(6):900-8. doi: 10.1182/blood-2009-10-250209. Epub 2010 May 10.
• [2428] Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.Oncotarget. 2015 Oct 20;6(32):32841-55. doi: 10.18632/oncotarget.5301.
• [2429] A predicted protein, KIAA0247, is a cell cycle modulator in colorectal cancer cells under 5-FU treatment.J Transl Med. 2011 May 28;9:82. doi: 10.1186/1479-5876-9-82.
• [2430] Efficacy of a single intravesical treatment with Ad-IFN/Syn 3 is dependent on dose and urine IFN concentration obtained: implications for clinical investigation.Cancer Gene Ther. 2006 Feb;13(2):125-30. doi: 10.1038/sj.cgt.7700865.
• [2431] Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors.Peptides. 2016 Sep;83:8-15. doi: 10.1016/j.peptides.2016.07.004. Epub 2016 Jul 22.
• [2432] Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.Cancer Res. 2016 Oct 15;76(20):6095-6106. doi: 10.1158/0008-5472.CAN-16-0709. Epub 2016 Aug 28.
• [2433] Inhibition of integrin (V)(6) changes fibril thickness of stromal collagen in experimental carcinomas.Cell Commun Signal. 2018 Jul 2;16(1):36. doi: 10.1186/s12964-018-0249-7.
• [2434] Downregulation of TAP1 and TAP2 in early stage breast cancer.PLoS One. 2017 Nov 1;12(11):e0187323. doi: 10.1371/journal.pone.0187323. eCollection 2017.
• [2435] Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma.J Pathol. 1995 Apr;175(4):391-6. doi: 10.1002/path.1711750405.
• [2436] Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles.Clin Cancer Res. 2005 Nov 15;11(22):8114-21. doi: 10.1158/1078-0432.CCR-05-1410.
• [2437] A spontaneous sarcoma dependent on host tumor-specific immune lymphocytes.Bioessays. 1989 Dec;11(6):181-5. doi: 10.1002/bies.950110606.
• [2438] Immunopathologic characteristics of nasal polyps in adult Koreans: A single-center study.Am J Rhinol Allergy. 2017 May 1;31(3):168-173. doi: 10.2500/ajra.2017.31.4423.
• [2439] TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma.Acta Neuropathol. 2019 Apr;137(4):657-673. doi: 10.1007/s00401-019-01982-5. Epub 2019 Mar 4.
• [2440] C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling.Nat Commun. 2015 May 19;6:7122. doi: 10.1038/ncomms8122.
• [2441] A novel vascular-targeting peptide for gastric cancer delivers low-dose TNF to normalize the blood vessels and improve the anti-cancer efficiency of 5-fluorouracil.Peptides. 2017 Nov;97:54-63. doi: 10.1016/j.peptides.2017.09.020. Epub 2017 Sep 29.
• [2442] Identification of novel genes with somatic frameshift mutations within coding mononucleotide repeats in colorectal tumors with high microsatellite instability.Genes Chromosomes Cancer. 2003 Jan;36(1):48-56. doi: 10.1002/gcc.10141.
• [2443] Long non-coding RNA DILC suppresses bladder cancer cells progression.Gene. 2019 Aug 20;710:193-201. doi: 10.1016/j.gene.2019.06.009. Epub 2019 Jun 7.
• [2444] TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.PLoS One. 2018 Sep 20;13(9):e0203833. doi: 10.1371/journal.pone.0203833. eCollection 2018.
• [2445] Homeodomain Protein Transforming Growth Factor Beta-Induced Factor 2 Like, X-Linked Function in Colon Adenocarcinoma Cells.Asian Pac J Cancer Prev. 2017 Aug 27;18(18):2101-2108. doi: 10.22034/APJCP.2017.18.8.2101.
• [2446] The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer.PLoS One. 2019 Nov 8;14(11):e0224727. doi: 10.1371/journal.pone.0224727. eCollection 2019.
• [2447] Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study.J Cell Mol Med. 2020 Jan;24(1):139-148. doi: 10.1111/jcmm.14671. Epub 2019 Sep 30.
• [2448] TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.Oncotarget. 2016 Jan 19;7(3):2878-88. doi: 10.18632/oncotarget.6694.
• [2449] Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.Cell Cycle. 2018;17(18):2284-2295. doi: 10.1080/15384101.2018.1526601. Epub 2018 Oct 9.
• [2450] Clinicopathological significance of TM4SF5 expression in human hepatocellular carcinoma tissues.Oncol Lett. 2019 Jun;17(6):5187-5192. doi: 10.3892/ol.2019.10210. Epub 2019 Apr 3.
• [2451] Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity.Cancer Res. 2010 Apr 15;70(8):3062-70. doi: 10.1158/0008-5472.CAN-09-3856.
• [2452] Upregulation and biological function of transmembrane protein 119 in osteosarcoma.Exp Mol Med. 2017 May 12;49(5):e329. doi: 10.1038/emm.2017.41.
• [2453] Expression of transmembrane protein 41A is associated with metastasis via the modulation of Ecadherin in radically resected gastric cancer.Mol Med Rep. 2018 Sep;18(3):2963-2972. doi: 10.3892/mmr.2018.9241. Epub 2018 Jul 3.
• [2454] DNA methylation changes involved in the tumor increase in F2 males born to gestationally arsenite-exposed F1 male mice.Cancer Sci. 2019 Aug;110(8):2629-2642. doi: 10.1111/cas.14104. Epub 2019 Jul 25.
• [2455] TIPE1 promotes cervical cancer progression by repression of p53 acetylation and is associated with poor cervical cancer outcome.Carcinogenesis. 2019 Jun 10;40(4):592-599. doi: 10.1093/carcin/bgy163.
• [2456] The Expression and Possible Functions of Tenascin-W During Development and Disease.Front Cell Dev Biol. 2019 Apr 12;7:53. doi: 10.3389/fcell.2019.00053. eCollection 2019.
• [2457] hTERT is a critical determinant of telomerase activity in renal-cell carcinoma.Int J Cancer. 1998 Nov 23;78(5):539-43. doi: 10.1002/(sici)1097-0215(19981123)78:5<539::aid-ijc2>3.0.co;2-i.
• [2458] TNR/11q#1 trinucleotide (GCC)n repeat alleles and predisposition to acute and chronic leukemia.Ann Hum Genet. 2004 Jul;68(Pt 4):362-6. doi: 10.1046/j.1529-8817.2004.00101.x.
• [2459] Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.PLoS One. 2017 Apr 26;12(4):e0176167. doi: 10.1371/journal.pone.0176167. eCollection 2017.
• [2460] Sanguinarine inhibits the tumorigenesis of gastric cancer by regulating the TOX/DNA-PKcs/ KU70/80 pathway.Pathol Res Pract. 2019 Nov;215(11):152677. doi: 10.1016/j.prp.2019.152677. Epub 2019 Sep 27.
• [2461] Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.J Breast Cancer. 2019 Jun;22(2):172-184. doi: 10.4048/jbc.2019.22.e21.
• [2462] Genome-wide cDNA microarray analysis of gene-expression profiles involved in ovarian endometriosis.Int J Oncol. 2003 Mar;22(3):551-60.
• [2463] DSCP1, a novel TP53-inducible gene, is upregulated by strong genotoxic stresses and its overexpression inhibits tumor cell growth in vitro.Int J Oncol. 2004 Mar;24(3):513-20.
• [2464] Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1.Exp Ther Med. 2019 Sep;18(3):1653-1660. doi: 10.3892/etm.2019.7718. Epub 2019 Jul 1.
• [2465] Opposite effects of tumor protein D (TPD) 52 and TPD54 on oral squamous cell carcinoma cells.Int J Oncol. 2017 May;50(5):1634-1646. doi: 10.3892/ijo.2017.3929. Epub 2017 Mar 23.
• [2466] Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.Histopathology. 2019 Jul;75(1):54-62. doi: 10.1111/his.13845. Epub 2019 May 16.
• [2467] Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives.Cancer. 2000 Apr 15;88(8):1801-6.
• [2468] Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.Exp Mol Pathol. 2014 Dec;97(3):572-8. doi: 10.1016/j.yexmp.2014.10.011. Epub 2014 Oct 29.
• [2469] Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis.Circ Res. 2004 May 14;94(9):1186-94. doi: 10.1161/01.RES.0000126925.66005.39. Epub 2004 Apr 1.
• [2470] Tumor-specific macrophage targeting through recognition of retinoid X receptor beta.J Control Release. 2019 May 10;301:42-53. doi: 10.1016/j.jconrel.2019.03.009. Epub 2019 Mar 11.
• [2471] TRIM2 is a novel promoter of human colorectal cancer.Scand J Gastroenterol. 2019 Feb;54(2):210-218. doi: 10.1080/00365521.2019.1575463. Epub 2019 Mar 27.
• [2472] Targeting TRIM3 deletion-induced tumor-associated lymphangiogenesis prohibits lymphatic metastasis in esophageal squamous cell carcinoma.Oncogene. 2019 Apr;38(15):2736-2749. doi: 10.1038/s41388-018-0621-5. Epub 2018 Dec 12.
• [2473] Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.Oncotarget. 2015 Feb 10;6(4):2538-48. doi: 10.18632/oncotarget.2991.
• [2474] TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.J Exp Clin Cancer Res. 2019 Apr 12;38(1):159. doi: 10.1186/s13046-019-1143-x.
• [2475] TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling.Cancer Cell Int. 2019 Mar 14;19:57. doi: 10.1186/s12935-019-0775-4. eCollection 2019.
• [2476] Mechanisms promoting escape from mitotic stress-induced tumor cell death.Cancer Res. 2014 Jul 15;74(14):3857-69. doi: 10.1158/0008-5472.CAN-13-3398. Epub 2014 May 23.
• [2477] Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity.Nat Med. 2019 Sep;25(9):1428-1441. doi: 10.1038/s41591-019-0566-4. Epub 2019 Sep 9.
• [2478] A Patient With a Thyrotropin-Secreting Microadenoma and Resistance to Thyroid Hormone (P453T).J Clin Endocrinol Metab. 2015 Jul;100(7):2511-4. doi: 10.1210/jc.2014-3994. Epub 2015 Apr 13.
• [2479] Genome-wide copy number profiling using a 100K SNP array reveals novel disease-related genes BORIS and TSHZ1 in juvenile angiofibroma.Int J Oncol. 2011 Nov;39(5):1143-51. doi: 10.3892/ijo.2011.1166. Epub 2011 Aug 18.
• [2480] Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta.Am J Pathol. 2004 Aug;165(2):541-52. doi: 10.1016/s0002-9440(10)63319-6.
• [2481] MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2.Theranostics. 2018 Jan 1;8(2):486-504. doi: 10.7150/thno.22059. eCollection 2018.
• [2482] DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients.Oncogene. 2006 Oct 12;25(47):6319-24. doi: 10.1038/sj.onc.1209647. Epub 2006 May 8.
• [2483] G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer.BMC Cancer. 2019 Aug 14;19(1):810. doi: 10.1186/s12885-019-5998-1.
• [2484] Tumor immune evasion arises through loss of TNF sensitivity.Sci Immunol. 2018 May 18;3(23):eaar3451. doi: 10.1126/sciimmunol.aar3451.
• [2485] Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor properties.J Immunol. 2008 Jul 1;181(1):146-54. doi: 10.4049/jimmunol.181.1.146.
• [2486] Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer.BMC Cancer. 2006 Jan 23;6:16. doi: 10.1186/1471-2407-6-16.
• [2487] ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens.Int J Mol Sci. 2018 Mar 10;19(3):804. doi: 10.3390/ijms19030804.
• [2488] SIRT1 suppresses the migration and invasion of gastric cancer by regulating ARHGAP5 expression.Cell Death Dis. 2018 Sep 24;9(10):977. doi: 10.1038/s41419-018-1033-8.
• [2489] Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.Cell. 2008 May 16;133(4):727-41. doi: 10.1016/j.cell.2008.03.021.
• [2490] Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.BMC Cancer. 2018 Nov 22;18(1):1157. doi: 10.1186/s12885-018-5074-2.
• [2491] Current and evolving understanding of atypical chronic myeloid leukemia.Blood Rev. 2019 Jan;33:74-81. doi: 10.1016/j.blre.2018.07.004. Epub 2018 Jul 29.
• [2492] Future Liver Remnant Indocyanine Green Plasma Clearance Rate as a Predictor of Post-hepatectomy Liver Failure After Portal Vein Embolization.Cardiovasc Intervent Radiol. 2018 Dec;41(12):1877-1884. doi: 10.1007/s00270-018-2065-2. Epub 2018 Aug 21.
• [2493] MiR-32 promotes tumorigenesis of colorectal cancer by targeting BMP5.Biomed Pharmacother. 2018 Oct;106:1046-1051. doi: 10.1016/j.biopha.2018.07.050. Epub 2018 Jul 17.
• [2494] Contribution of the BOP1 gene, located on 8q24, to colorectal tumorigenesis.Genes Chromosomes Cancer. 2006 Sep;45(9):874-81. doi: 10.1002/gcc.20351.
• [2495] Cellular senescence bypass screen identifies new putative tumor suppressor genes.Oncogene. 2008 Mar 27;27(14):1961-70. doi: 10.1038/sj.onc.1210846. Epub 2007 Oct 29.
• [2496] Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.Cancer Res. 2007 Aug 1;67(15):7238-46. doi: 10.1158/0008-5472.CAN-07-0962.
• [2497] BAP18 coactivates androgen receptor action and promotes prostate cancer progression.Nucleic Acids Res. 2016 Sep 30;44(17):8112-28. doi: 10.1093/nar/gkw472. Epub 2016 May 25.
• [2498] Imup-1 and imup-2 overexpression in endometrial carcinoma in Korean and Japanese populations.Anticancer Res. 2008 Mar-Apr;28(2A):865-71.
• [2499] Disclosing the Interaction of Carbonic Anhydrase IX with Cullin-Associated NEDD8-Dissociated Protein 1 by Molecular Modeling and Integrated Binding Measurements.ACS Chem Biol. 2017 Jun 16;12(6):1460-1465. doi: 10.1021/acschembio.7b00055. Epub 2017 Apr 19.
• [2500] Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinoma.Oncology. 2006;70(3):168-72. doi: 10.1159/000094444. Epub 2006 Jul 7.
• [2501] Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.J Neurooncol. 2018 Jan;136(2):395-401. doi: 10.1007/s11060-017-2666-7. Epub 2017 Nov 20.
• [2502] Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.Sci Rep. 2017 Feb 9;7:42074. doi: 10.1038/srep42074.
• [2503] Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis.Front Pharmacol. 2019 Jan 9;9:1544. doi: 10.3389/fphar.2018.01544. eCollection 2018.
• [2504] Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.Int J Mol Sci. 2019 Aug 21;20(17):4087. doi: 10.3390/ijms20174087.
• [2505] Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma in Vitro and in Vivo.Int J Med Sci. 2018 Jan 1;15(1):69-76. doi: 10.7150/ijms.21113. eCollection 2018.
• [2506] COPS3 amplification and clinical outcome in osteosarcoma.Cancer. 2007 May 1;109(9):1870-6. doi: 10.1002/cncr.22595.
• [2507] Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer.Oncotarget. 2017 Mar 21;8(12):19645-19660. doi: 10.18632/oncotarget.14902.
• [2508] AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma.Cancer Gene Ther. 2020 May;27(5):356-367. doi: 10.1038/s41417-019-0108-8. Epub 2019 Jun 4.
• [2509] The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.Semin Cancer Biol. 2006 Oct;16(5):359-66. doi: 10.1016/j.semcancer.2006.07.002. Epub 2006 Jul 7.
• [2510] The helicase HAGE prevents interferon--induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.Cell Death Dis. 2014 Feb 13;5(2):e1061. doi: 10.1038/cddis.2014.29.
• [2511] The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.PLoS One. 2018 Jul 10;13(7):e0200488. doi: 10.1371/journal.pone.0200488. eCollection 2018.
• [2512] C-Src confers resistance to mitotic stress through inhibition DMAP1/Bub3 complex formation in pancreatic cancer.Mol Cancer. 2018 Dec 15;17(1):174. doi: 10.1186/s12943-018-0919-5.
• [2513] Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.Acta Neuropathol. 2018 Apr;135(4):569-579. doi: 10.1007/s00401-017-1802-y. Epub 2018 Jan 3.
• [2514] Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.Biomed Pharmacother. 2018 Oct;106:678-685. doi: 10.1016/j.biopha.2018.06.156. Epub 2018 Jul 11.
• [2515] Dissecting the non-canonical functions of telomerase.Cytogenet Genome Res. 2008;122(3-4):273-80. doi: 10.1159/000167813. Epub 2009 Jan 30.
• [2516] A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis.Cancer Res. 2005 Jul 1;65(13):5638-46. doi: 10.1158/0008-5472.CAN-05-0600.
• [2517] Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma.J Exp Med. 2019 Mar 4;216(3):656-673. doi: 10.1084/jem.20180749. Epub 2019 Feb 7.
• [2518] Regulation of ELL2 stability and polyubiquitination by EAF2 in prostate cancer cells.Prostate. 2018 Nov;78(15):1201-1212. doi: 10.1002/pros.23695. Epub 2018 Jul 15.
• [2519] Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling.Cancer Cell. 2006 Sep;10(3):179-90. doi: 10.1016/j.ccr.2006.08.008.
• [2520] An Immunosuppressive Role for Eya3 in TNBC.Cancer Discov. 2018 Aug;8(8):OF8. doi: 10.1158/2159-8290.CD-NB2018-072. Epub 2018 Jun 8.
• [2521] Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling.Breast Cancer Res Treat. 2018 Nov;172(2):353-362. doi: 10.1007/s10549-018-4933-5. Epub 2018 Aug 27.
• [2522] FAM163A, a positive regulator of ERK signaling pathway, interacts with 14-3-3 and promotes cell proliferation in squamous cell lung carcinoma.Onco Targets Ther. 2019 Aug 13;12:6393-6406. doi: 10.2147/OTT.S214731. eCollection 2019.
• [2523] Fam20C is under the control of sphingolipid signaling in human cell lines.FEBS J. 2017 Apr;284(8):1246-1257. doi: 10.1111/febs.14052. Epub 2017 Mar 22.
• [2524] Forkhead box B2 inhibits the malignant characteristics of the pancreatic cancer cell line Panc-1 in vitro.Genes Cells. 2019 Oct;24(10):674-681. doi: 10.1111/gtc.12717. Epub 2019 Oct 7.
• [2525] GALNT12 is not a major contributor of familial colorectal cancer type X.Hum Mutat. 2014 Jan;35(1):50-2. doi: 10.1002/humu.22454. Epub 2013 Oct 17.
• [2526] The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors.Front Immunol. 2018 Aug 22;9:1914. doi: 10.3389/fimmu.2018.01914. eCollection 2018.
• [2527] Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility.Cancer Res. 2008 Feb 1;68(3):639-44. doi: 10.1158/0008-5472.CAN-07-2632.
• [2528] Dysregulation of GIMAP genes in non-small cell lung cancer.Lung Cancer. 2008 Dec;62(3):287-94. doi: 10.1016/j.lungcan.2008.03.021. Epub 2008 May 6.
• [2529] GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.Oncogene. 2018 Mar;37(10):1340-1353. doi: 10.1038/s41388-017-0038-6. Epub 2017 Dec 19.
• [2530] Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.World J Urol. 2005 Sep;23(4):279-86. doi: 10.1007/s00345-005-0006-6. Epub 2005 Nov 8.
• [2531] Vascular marker expression during the development of various types of gynaecological malignancy.Tumour Biol. 2014 Nov;35(11):11229-35. doi: 10.1007/s13277-014-2447-2. Epub 2014 Aug 12.
• [2532] Target genes of the WNT/beta-catenin pathway in Wilms tumors.Genes Chromosomes Cancer. 2006 Jun;45(6):565-74. doi: 10.1002/gcc.20319.
• [2533] GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer.Oncol Lett. 2018 Mar;15(3):3133-3140. doi: 10.3892/ol.2017.7695. Epub 2017 Dec 27.
• [2534] Histone H1 defect in escort cells triggers germline tumor in Drosophila ovary.Dev Biol. 2017 Apr 1;424(1):40-49. doi: 10.1016/j.ydbio.2017.02.012. Epub 2017 Feb 21.
• [2535] Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.Dis Markers. 2018 Feb 25;2018:9369358. doi: 10.1155/2018/9369358. eCollection 2018.
• [2536] Divergent Hemogen genes of teleosts and mammals share conserved roles in erythropoiesis: analysis using transgenic and mutant zebrafish.Biol Open. 2018 Aug 28;7(8):bio035576. doi: 10.1242/bio.035576.
• [2537] Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.PLoS One. 2019 Feb 26;14(2):e0212978. doi: 10.1371/journal.pone.0212978. eCollection 2019.
• [2538] Genes in the HLA region indicative for head and neck squamous cell carcinoma.Mol Immunol. 2007 Feb;44(5):848-55. doi: 10.1016/j.molimm.2006.04.003. Epub 2006 Jun 5.
• [2539] Decreased IFIT2 Expression Promotes Gastric Cancer Progression and Predicts Poor Prognosis of the Patients.Cell Physiol Biochem. 2018;45(1):15-25. doi: 10.1159/000486219. Epub 2017 Dec 22.
• [2540] Anti-IL-10-mediated Enhancement of Antitumor Efficacy of a Dendritic Cell-targeting MIP3-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Interferons.J Immunother. 2018 May;41(4):181-189. doi: 10.1097/CJI.0000000000000212.
• [2541] Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen.Oncoimmunology. 2018 Feb 21;7(5):e1423173. doi: 10.1080/2162402X.2017.1423173. eCollection 2018.
• [2542] Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours.Tissue Antigens. 2007 Mar;69(3):220-6. doi: 10.1111/j.1399-0039.2006.00792.x.
• [2543] High SALM3 Expression in Tumor Cells and Fibroblasts Is Correlated with Poor Prognosis in Gastric Cancer Patients.Dis Markers. 2019 Apr 4;2019:8282414. doi: 10.1155/2019/8282414. eCollection 2019.
• [2544] N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma.Oncogene. 2008 Oct 9;27(46):6075-82. doi: 10.1038/onc.2008.200. Epub 2008 Jun 30.
• [2545] REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2.Cancer Sci. 2019 Mar;110(3):962-972. doi: 10.1111/cas.13946. Epub 2019 Feb 8.
• [2546] Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma.Hum Pathol. 2019 Apr;86:143-154. doi: 10.1016/j.humpath.2018.11.026. Epub 2018 Dec 9.
• [2547] SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.Oncogene. 2018 Feb 15;37(7):912-923. doi: 10.1038/onc.2017.393. Epub 2017 Oct 23.
• [2548] MEF2 plays a significant role in the tumor inhibitory mechanism of encapsulated RENCA cells via EGF receptor signaling in target tumor cells.BMC Cancer. 2018 Dec 4;18(1):1217. doi: 10.1186/s12885-018-5128-5.
• [2549] Extracellular gamma-synuclein promotes tumor cell motility by activating 1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.J Exp Clin Cancer Res. 2018 Jun 15;37(1):117. doi: 10.1186/s13046-018-0783-6.
• [2550] Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.BMC Cancer. 2009 Jun 16;9:188. doi: 10.1186/1471-2407-9-188.
• [2551] Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast Cancer.Mol Ther Nucleic Acids. 2018 Dec 7;13:399-406. doi: 10.1016/j.omtn.2018.09.014. Epub 2018 Sep 27.
• [2552] Aberrant high expression level of MORC2 is a common character in multiple cancers.Hum Pathol. 2018 Jun;76:58-67. doi: 10.1016/j.humpath.2018.03.011. Epub 2018 Mar 16.
• [2553] Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.Cancer Res. 2006 Jan 1;66(1):175-83. doi: 10.1158/0008-5472.CAN-05-1130.
• [2554] Mannose impairs tumour growth and enhances chemotherapy.Nature. 2018 Nov;563(7733):719-723. doi: 10.1038/s41586-018-0729-3. Epub 2018 Nov 21.
• [2555] Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13.World J Surg. 2008 May;32(5):873-81. doi: 10.1007/s00268-008-9521-0.
• [2556] Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.Mol Cancer. 2009 Sep 25;8:77. doi: 10.1186/1476-4598-8-77.
• [2557] A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue.Biol Chem. 2007 Mar;388(3):289-95. doi: 10.1515/BC.2007.032.
• [2558] ArfGAP family proteins in cell adhesion, migration and tumor invasion.Curr Opin Cell Biol. 2006 Oct;18(5):558-64. doi: 10.1016/j.ceb.2006.08.002. Epub 2006 Aug 9.
• [2559] A specific isoform of nonmuscle myosin II-C is required for cytokinesis in a tumor cell line.J Biol Chem. 2006 Aug 25;281(34):24662-70. doi: 10.1074/jbc.M604606200. Epub 2006 Jun 21.
• [2560] Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer.Int J Cancer. 2018 Oct 1;143(7):1706-1719. doi: 10.1002/ijc.31548. Epub 2018 May 7.
• [2561] Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis.Oncogene. 2008 Dec 11;27(58):7296-306. doi: 10.1038/onc.2008.332. Epub 2008 Sep 15.
• [2562] Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck.Proc Natl Acad Sci U S A. 2007 May 1;104(18):7540-5. doi: 10.1073/pnas.0610818104. Epub 2007 Apr 24.
• [2563] Targeted therapy of DNA tumor virus-associated cancers using virus-activated transcription factors.Mol Ther. 2006 May;13(5):899-909. doi: 10.1016/j.ymthe.2005.11.023. Epub 2006 Feb 3.
• [2564] Anti-cancer activities of Bharangin against breast cancer: Evidence for the role of NF-B and lncRNAs.Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2738-2749. doi: 10.1016/j.bbagen.2018.08.016. Epub 2018 Aug 24.
• [2565] Prussian blue nanoparticles: Synthesis, surface modification, and application in cancer treatment.Int J Pharm. 2018 Oct 5;549(1-2):31-49. doi: 10.1016/j.ijpharm.2018.07.055. Epub 2018 Jul 24.
• [2566] Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis.J Clin Endocrinol Metab. 2017 Feb 1;102(2):613-624. doi: 10.1210/jc.2016-1677.
• [2567] Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.Acta Neuropathol. 2006 Jan;111(1):29-38. doi: 10.1007/s00401-005-1085-6. Epub 2005 Nov 30.
• [2568] Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis.Cancer Sci. 2018 Jul;109(7):2221-2234. doi: 10.1111/cas.13633. Epub 2018 Jun 13.
• [2569] Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.Int J Gynecol Cancer. 2018 Feb;28(2):346-354. doi: 10.1097/IGC.0000000000001169.
• [2570] Protocadherin A3 is expressed in follicular lymphoma irrespective of BCL2 status and is associated with tumor cell growth.Mol Med Rep. 2016 Nov;14(5):4622-4628. doi: 10.3892/mmr.2016.5808. Epub 2016 Oct 5.
• [2571] NSPc1 is a cell growth regulator that acts as a transcriptional repressor of p21Waf1/Cip1 via the RARE element.Nucleic Acids Res. 2006;34(21):6158-69. doi: 10.1093/nar/gkl834. Epub 2006 Nov 6.
• [2572] Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.J Neurooncol. 2019 Jan;141(1):31-41. doi: 10.1007/s11060-018-03017-7. Epub 2018 Nov 3.
• [2573] Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).J Neuropathol Exp Neurol. 2019 Sep 1;78(9):865-870. doi: 10.1093/jnen/nlz067.
• [2574] A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.EBioMedicine. 2019 Jun;44:311-321. doi: 10.1016/j.ebiom.2019.05.003. Epub 2019 May 9.
• [2575] PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.J Exp Clin Cancer Res. 2019 Jun 10;38(1):247. doi: 10.1186/s13046-019-1250-8.
• [2576] Collagenase-Encapsulated pH-Responsive Nanoscale Coordination Polymers for Tumor Microenvironment Modulation and Enhanced Photodynamic Nanomedicine.ACS Appl Mater Interfaces. 2018 Dec 19;10(50):43493-43502. doi: 10.1021/acsami.8b17684. Epub 2018 Dec 5.
• [2577] IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis.J Immunol. 2017 Dec 1;199(11):3849-3857. doi: 10.4049/jimmunol.1601540. Epub 2017 Oct 25.
• [2578] Secondary Prevention of Retinoblastoma Revisited: Laser Photocoagulation of Invisible New Retinoblastoma.Ophthalmology. 2020 Jan;127(1):122-127. doi: 10.1016/j.ophtha.2019.08.011. Epub 2019 Aug 21.
• [2579] Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity.Cancer Gene Ther. 2006 Sep;13(9):873-85. doi: 10.1038/sj.cgt.7700956. Epub 2006 Apr 28.
• [2580] miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.Oncotarget. 2017 Jul 4;8(27):43897-43914. doi: 10.18632/oncotarget.14915.
• [2581] Expression analysis of proline rich 15 (Prr15) in mouse and human gastrointestinal tumors.Mol Carcinog. 2011 Jan;50(1):8-15. doi: 10.1002/mc.20692.
• [2582] Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.Pharmacol Res. 2007 Jun;55(6):487-97. doi: 10.1016/j.phrs.2007.04.015. Epub 2007 May 5.
• [2583] MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FR Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity.Mol Cancer Ther. 2018 Dec;17(12):2665-2675. doi: 10.1158/1535-7163.MCT-17-1215. Epub 2018 Sep 27.
• [2584] Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system.Oncotarget. 2018 Apr 10;9(27):18832-18843. doi: 10.18632/oncotarget.24777. eCollection 2018 Apr 10.
• [2585] Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105.Oncogene. 2006 Mar 2;25(9):1330-9. doi: 10.1038/sj.onc.1209167.
• [2586] A yeast two-hybrid system using Sp17 identified Ropporin as a novel cancer-testis antigen in hematologic malignancies.Int J Cancer. 2007 Oct 1;121(7):1507-11. doi: 10.1002/ijc.22842.
• [2587] Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.Br J Haematol. 2007 Nov;139(4):578-89. doi: 10.1111/j.1365-2141.2007.06833.x. Epub 2007 Oct 3.
• [2588] Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data.Clin Cancer Res. 2011 Feb 15;17(4):700-9. doi: 10.1158/1078-0432.CCR-10-1300. Epub 2011 Feb 8.
• [2589] Long noncoding RNA RUSC1-AS-N indicates poor prognosis and increases cell viability in hepatocellular carcinoma.Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):388-396. doi: 10.26355/eurrev_201801_14185.
• [2590] Gene expression in early stage cervical cancer.Gynecol Oncol. 2008 Mar;108(3):520-6. doi: 10.1016/j.ygyno.2007.11.024. Epub 2008 Jan 11.
• [2591] Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth.Oncogene. 2007 Jun 21;26(29):4319-28. doi: 10.1038/sj.onc.1210195. Epub 2007 Jan 29.
• [2592] SHARPIN Promotes Melanoma Progression viaRap1 Signaling Pathway.J Invest Dermatol. 2020 Feb;140(2):395-403.e6. doi: 10.1016/j.jid.2019.07.696. Epub 2019 Aug 8.
• [2593] Network Analysis Reveals A Signaling Regulatory Loop in the PIK3CA-mutated Breast Cancer Predicting Survival Outcome.Genomics Proteomics Bioinformatics. 2017 Apr;15(2):121-129. doi: 10.1016/j.gpb.2017.02.002. Epub 2017 Apr 7.
• [2594] Siglec-9 Regulates an Effector Memory CD8(+) T-cell Subset That Congregates in the Melanoma Tumor Microenvironment.Cancer Immunol Res. 2019 May;7(5):707-718. doi: 10.1158/2326-6066.CIR-18-0505. Epub 2019 Apr 15.
• [2595] SLIRP, a small SRA binding protein, is a nuclear receptor corepressor.Mol Cell. 2006 Jun 9;22(5):657-68. doi: 10.1016/j.molcel.2006.05.024.
• [2596] Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements.Cancer Res. 2018 Aug 1;78(15):4215-4228. doi: 10.1158/0008-5472.CAN-18-0595. Epub 2018 Jun 13.
• [2597] Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.J Nucl Med. 2007 Dec;48(12):2028-36. doi: 10.2967/jnumed.107.042622. Epub 2007 Nov 15.
• [2598] A novel multifunctional carbon aerogel-coated platform for osteosarcoma therapy and enhanced bone regeneration.J Mater Chem B. 2020 Jan 22;8(3):368-379. doi: 10.1039/c9tb02383f.
• [2599] Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer.Br J Cancer. 2013 Feb 19;108(3):597-601. doi: 10.1038/bjc.2012.507. Epub 2012 Nov 20.
• [2600] Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.Cancer Cell. 2019 Jul 8;36(1):17-34.e7. doi: 10.1016/j.ccell.2019.06.005.
• [2601] Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.Clin Epigenetics. 2019 Mar 27;11(1):54. doi: 10.1186/s13148-019-0651-z.
• [2602] High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer.Onco Targets Ther. 2018 May 28;11:3149-3157. doi: 10.2147/OTT.S158820. eCollection 2018.
• [2603] LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers.Oncotarget. 2018 Apr 27;9(32):22586-22604. doi: 10.18632/oncotarget.25187. eCollection 2018 Apr 27.
• [2604] Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.Gastroenterology. 2017 Jul;153(1):292-306.e2. doi: 10.1053/j.gastro.2017.03.050. Epub 2017 Apr 5.
• [2605] Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia.Immunol Lett. 2010 May 4;130(1-2):115-24. doi: 10.1016/j.imlet.2009.12.007. Epub 2009 Dec 11.
• [2606] Identification of prostate cancer antigens by automated high-throughput filter immunoscreening.J Immunol Methods. 2008 Jan 31;330(1-2):12-23. doi: 10.1016/j.jim.2007.10.011. Epub 2007 Nov 20.
• [2607] Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma.J Immunol. 2009 Jul 15;183(2):832-40. doi: 10.4049/jimmunol.0803298. Epub 2009 Jun 19.
• [2608] Evaluating the prognostic value and functional roles of transcription factor AP4 in colorectal cancer.Oncol Lett. 2018 May;15(5):7545-7554. doi: 10.3892/ol.2018.8290. Epub 2018 Mar 16.
• [2609] New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway.J Cell Physiol. 2018 Jan;233(1):79-87. doi: 10.1002/jcp.25853. Epub 2017 Apr 27.
• [2610] Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018).Lung Cancer. 2019 Jan;127:138-145. doi: 10.1016/j.lungcan.2018.11.034. Epub 2018 Nov 29.
• [2611] Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response.Mamm Genome. 2008 Apr;19(4):246-62. doi: 10.1007/s00335-008-9100-6. Epub 2008 Mar 15.
• [2612] New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors.Genes Chromosomes Cancer. 2008 May;47(5):386-95. doi: 10.1002/gcc.20544.
• [2613] Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.Mol Imaging Biol. 2013 Feb;15(1):68-78. doi: 10.1007/s11307-012-0558-y.
• [2614] TSPAN8 serves as a prognostic marker involving Akt/MAPK pathway in nasopharyngeal carcinoma.Ann Transl Med. 2019 Sep;7(18):470. doi: 10.21037/atm.2019.08.02.
• [2615] Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.Cell Commun Signal. 2019 Sep 18;17(1):120. doi: 10.1186/s12964-019-0410-y.
• [2616] ACADS acts as a potential methylation biomarker associated with the proliferation and metastasis of hepatocellular carcinomas.Aging (Albany NY). 2019 Oct 25;11(20):8825-8844. doi: 10.18632/aging.102292. Epub 2019 Oct 25.
• [2617] Clinical significance of ADAM29 promoting the invasion and growth of gastric cancer cells in vitro.Oncol Lett. 2018 Aug;16(2):1483-1490. doi: 10.3892/ol.2018.8838. Epub 2018 May 30.
• [2618] BAI3, CDX2 and VIL1: a panel of three antibodies to distinguish small cell from large cell neuroendocrine lung carcinomas.Histopathology. 2014 Mar;64(4):547-56. doi: 10.1111/his.12278. Epub 2013 Nov 25.
• [2619] AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment.Oncogenesis. 2018 May 25;7(5):43. doi: 10.1038/s41389-018-0053-7.
• [2620] AKAP3 correlates with triple negative status and disease free survival in breast cancer.BMC Cancer. 2015 Oct 12;15:681. doi: 10.1186/s12885-015-1668-0.
• [2621] Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway.Mol Cancer Res. 2015 Oct;13(10):1408-20. doi: 10.1158/1541-7786.MCR-15-0048. Epub 2015 Jun 16.
• [2622] Clinical Relevance of Gene Copy Number Variation in Metastatic Clear Cell Renal Cell Carcinoma.Clin Genitourin Cancer. 2018 Aug;16(4):e795-e805. doi: 10.1016/j.clgc.2018.02.013. Epub 2018 Feb 23.
• [2623] High expression of ALPPL2 is associated with poor prognosis in gastric cancer.Hum Pathol. 2019 Apr;86:49-56. doi: 10.1016/j.humpath.2018.11.019. Epub 2018 Nov 26.
• [2624] Sensitivity to TOP2 targeting chemotherapeutics is regulated by Oct1 and FILIP1L.PLoS One. 2012;7(8):e42921. doi: 10.1371/journal.pone.0042921. Epub 2012 Aug 10.
• [2625] One repressor to rule them all: ANCO1 links YAP and AIB1.EMBO Rep. 2020 Jan 7;21(1):e49647. doi: 10.15252/embr.201949647. Epub 2019 Dec 2.
• [2626] ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.J Exp Clin Cancer Res. 2019 Aug 8;38(1):347. doi: 10.1186/s13046-019-1340-7.
• [2627] Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2.Lab Invest. 2018 Jan;98(1):117-129. doi: 10.1038/labinvest.2017.106. Epub 2017 Oct 16.
• [2628] Expression of amyloid precursor-like protein 2 (APLP2) in glioblastoma is associated with patient prognosis.Folia Neuropathol. 2018;56(1):30-38. doi: 10.5114/fn.2018.74657.
• [2629] The eQTL-missense polymorphisms of APOBEC3H are associated with lung cancer risk in a Han Chinese population.Sci Rep. 2015 Oct 13;5:14969. doi: 10.1038/srep14969.
• [2630] p190 RhoGAP promotes contact inhibition in epithelial cells by repressing YAP activity.J Cell Biol. 2018 Sep 3;217(9):3183-3201. doi: 10.1083/jcb.201710058. Epub 2018 Jun 22.
• [2631] ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1/Rho GTPase signaling pathway.J Gastroenterol. 2018 Jan;53(1):71-83. doi: 10.1007/s00535-017-1329-y. Epub 2017 Mar 17.
• [2632] Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1885-93. doi: 10.1007/s00405-015-3703-9. Epub 2015 Jul 3.
• [2633] Effects of -caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.Int J Oncol. 2018 Oct;53(4):1613-1624. doi: 10.3892/ijo.2018.4506. Epub 2018 Jul 27.
• [2634] Integrative analysis of deep sequencing data identifies estrogen receptor early response genes and links ATAD3B to poor survival in breast cancer.PLoS Comput Biol. 2013;9(6):e1003100. doi: 10.1371/journal.pcbi.1003100. Epub 2013 Jun 20.
• [2635] Molecular Analysis by Gene Expression of Mitochondrial ATPase Subunits in Papillary Thyroid Cancer: Is ATP5E Transcript a Possible Early Tumor Marker?.Med Sci Monit. 2015 Jun 16;21:1745-51. doi: 10.12659/MSM.893597.
• [2636] ATP6L promotes metastasis of colorectal cancer by inducing epithelial-mesenchymal transition.Cancer Sci. 2020 Feb;111(2):477-488. doi: 10.1111/cas.14283. Epub 2020 Jan 6.
• [2637] Shiga toxin glycosphingolipid receptor expression and toxin susceptibility of human pancreatic ductal adenocarcinomas of differing origin and differentiation.Biol Chem. 2012 Aug;393(8):785-99. doi: 10.1515/hsz-2012-0165.
• [2638] Live Cell Imaging Supports a Key Role for Histone Deacetylase as a Molecular Target during Glioblastoma Malignancy Downgrade through Tumor Competence Modulation.J Oncol. 2019 Aug 8;2019:9043675. doi: 10.1155/2019/9043675. eCollection 2019.
• [2639] CD70 as a target for chimeric antigen receptor T cells in head and neck squamous cell carcinoma.Oral Oncol. 2018 Mar;78:145-150. doi: 10.1016/j.oraloncology.2018.01.024. Epub 2018 Feb 20.
• [2640] Correction: BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer.Oncotarget. 2019 May 3;10(33):3144. doi: 10.18632/oncotarget.26920. eCollection 2019 May 3.
• [2641] The photocytotoxicity effect of cationic sulfonated corrole towards lung cancer cells: in vitro and in vivo study.Lasers Med Sci. 2019 Sep;34(7):1353-1363. doi: 10.1007/s10103-019-02725-4. Epub 2019 Feb 2.
• [2642] Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells.Cell Cycle. 2012 Nov 1;11(21):3956-63. doi: 10.4161/cc.22136. Epub 2012 Sep 19.
• [2643] Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins.PLoS One. 2019 Apr 11;14(4):e0214758. doi: 10.1371/journal.pone.0214758. eCollection 2019.
• [2644] BMP8B Is a Tumor Suppressor Gene Regulated by Histone Acetylation in Gastric Cancer.J Cell Biochem. 2017 Apr;118(4):869-877. doi: 10.1002/jcb.25766. Epub 2016 Nov 10.
• [2645] Human basonuclin 2 up-regulates a cascade set of interferon-stimulated genes with anti-cancerous properties in a lung cancer model.Cancer Cell Int. 2017 Feb 6;17:18. doi: 10.1186/s12935-017-0394-x. eCollection 2017.
• [2646] Epigenetics mechanisms mediate the miR-125a/BRMS1 axis to regulate invasion and metastasis in gastric cancer.Onco Targets Ther. 2019 Sep 12;12:7513-7525. doi: 10.2147/OTT.S210376. eCollection 2019.
• [2647] BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway.J Cell Physiol. 2020 May;235(5):4834-4842. doi: 10.1002/jcp.29361. Epub 2019 Oct 23.
• [2648] Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors.BMC Cancer. 2018 May 23;18(1):584. doi: 10.1186/s12885-018-4493-4.
• [2649] CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1 axis to inhibit gastric tumorigenesis.Oncogene. 2018 Dec;37(50):6383-6398. doi: 10.1038/s41388-018-0402-1. Epub 2018 Jul 27.
• [2650] Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence.JCI Insight. 2018 Sep 6;3(17):e121225. doi: 10.1172/jci.insight.121225. eCollection 2018 Sep 6.
• [2651] Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.J Neuropathol Exp Neurol. 2007 Jun;66(6):505-16. doi: 10.1097/01.jnen.0000240475.35414.c3.
• [2652] Changes in the Distribution of Cocaine- and Amphetamine-Regulated Transcript-Containing Neural Structures in the Human Colon Affected by the Neoplastic Process.Int J Mol Sci. 2018 Jan 31;19(2):414. doi: 10.3390/ijms19020414.
• [2653] MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.PLoS One. 2015 Jun 18;10(6):e0130287. doi: 10.1371/journal.pone.0130287. eCollection 2015.
• [2654] Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.Cell Rep. 2019 Feb 12;26(7):1893-1905.e7. doi: 10.1016/j.celrep.2019.01.076.
• [2655] Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.Cancer Res. 2017 Jun 15;77(12):3144-3150. doi: 10.1158/0008-5472.CAN-16-0708. Epub 2017 Apr 20.
• [2656] Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.Cancer Res. 2016 Aug 1;76(15):4332-46. doi: 10.1158/0008-5472.CAN-15-1695. Epub 2016 Jun 20.
• [2657] PCBP1/HNRNP E1 Protects Chromosomal Integrity by Translational Regulation of CDC27.Mol Cancer Res. 2016 Jul;14(7):634-46. doi: 10.1158/1541-7786.MCR-16-0018. Epub 2016 Apr 21.
• [2658] MicroRNA-1297 inhibits proliferation and promotes apoptosis in gastric cancer cells by downregulating CDC6 expression.Anticancer Drugs. 2019 Sep;30(8):803-811. doi: 10.1097/CAD.0000000000000776.
• [2659] Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.Med Sci Monit. 2018 Oct 15;24:7357-7365. doi: 10.12659/MSM.910168.
• [2660] Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.J Thorac Oncol. 2015 Aug;10(8):1181-8. doi: 10.1097/JTO.0000000000000592.
• [2661] Tumor repressor gene chondroadherin oppose migration and proliferation in hepatocellular carcinoma and predicts a good survival.Oncotarget. 2017 Aug 2;8(36):60270-60279. doi: 10.18632/oncotarget.19811. eCollection 2017 Sep 1.
• [2662] CHAF1B promotes proliferation and reduces apoptosis in 95D lung cancer cells and predicts a poor prognosis in nonsmall cell lung cancer.Oncol Rep. 2019 Apr;41(4):2518-2528. doi: 10.3892/or.2019.6994. Epub 2019 Feb 1.
• [2663] CDKN1A-interacting zinc finger protein 1 is a novel biomarker for lung squamous cell carcinoma.Oncol Lett. 2018 Jan;15(1):183-188. doi: 10.3892/ol.2017.7282. Epub 2017 Oct 26.
• [2664] Extracellular metabolic energetics can promote cancer progression. Cell. 2015 Jan 29;160(3):393-406.
• [2665] Proteomic detection of a large amount of SCGF in the stroma of GISTs after imatinib therapy.J Transl Med. 2011 Sep 23;9:158. doi: 10.1186/1479-5876-9-158.
• [2666] Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res. 2005 Oct 15;11(20):7434-43. doi: 10.1158/1078-0432.CCR-04-0548.
• [2667] Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11.Hum Mol Genet. 1996 May;5(5):625-31. doi: 10.1093/hmg/5.5.625.
• [2668] Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma.Anticancer Res. 2016 Aug;36(8):4013-8.
• [2669] Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as tumour prognostic marker.Int J Mol Sci. 2012;13(9):11044-11062. doi: 10.3390/ijms130911044. Epub 2012 Sep 5.
• [2670] Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway.Bosn J Basic Med Sci. 2019 Feb 12;19(1):52-59. doi: 10.17305/bjbms.2018.3399.
• [2671] Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.Int J Gynecol Cancer. 2009 May;19(4):513-25. doi: 10.1111/IGC.0b013e3181a3cd38.
• [2672] TNF-receptor-1 adaptor protein FAN mediates TNF-induced B16 melanoma motility and invasion.Br J Cancer. 2013 Jul 23;109(2):422-32. doi: 10.1038/bjc.2013.242. Epub 2013 May 14.
• [2673] Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma.Cancer Manag Res. 2019 Feb 7;11:1263-1274. doi: 10.2147/CMAR.S188216. eCollection 2019.
• [2674] The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data.Medicine (Baltimore). 2018 Mar;97(10):e0091. doi: 10.1097/MD.0000000000010091.
• [2675] CSN6 promotes tumorigenesis of gastric cancer by ubiquitin-independent proteasomal degradation of p16(INK4a).Cancer Biol Med. 2019 Aug;16(3):514-529. doi: 10.20892/j.issn.2095-3941.2018.0410.
• [2676] Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease.J Clin Endocrinol Metab. 2014 Jul;99(7):E1173-82. doi: 10.1210/jc.2013-4140. Epub 2014 Mar 21.
• [2677] Promotion of Cancer Cell Proliferation by Cleaved and Secreted Luminal Domains of ER Stress Transducer BBF2H7.PLoS One. 2015 May 8;10(5):e0125982. doi: 10.1371/journal.pone.0125982. eCollection 2015.
• [2678] Intracellular Chloride Ion Channel Protein-1 Expression in Clear Cell Renal Cell Carcinoma.Cancer Genomics Proteomics. 2019 Jul-Aug;16(4):299-307. doi: 10.21873/cgp.20135.
• [2679] The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.Int J Mol Sci. 2019 Nov 18;20(22):5793. doi: 10.3390/ijms20225793.
• [2680] Overexpression and Nucleolar Localization of -Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma.J Neuropathol Exp Neurol. 2015 Jul;74(7):723-42. doi: 10.1097/NEN.0000000000000212.
• [2681] Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma.Tumour Biol. 2014 Apr;35(4):3755-63. doi: 10.1007/s13277-013-1497-1. Epub 2013 Dec 12.
• [2682] Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma.Neoplasma. 2018;65(2):292-295. doi: 10.4149/neo_2018_170318N194.
• [2683] Preclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapy.J Pharmacol Exp Ther. 2014 Jun;349(3):458-69. doi: 10.1124/jpet.114.214619. Epub 2014 Apr 2.
• [2684] Downregulation of DBN1 is related to vincristine resistance in colon cancer cells.J Cancer Res Ther. 2019 Jan-Mar;15(1):38-41. doi: 10.4103/0973-1482.192766.
• [2685] SCCRO promotes glioma formation and malignant progression in mice.Neoplasia. 2010 Jun;12(6):476-84. doi: 10.1593/neo.10202.
• [2686] MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer.Int J Biochem Cell Biol. 2018 Sep;102:59-70. doi: 10.1016/j.biocel.2018.06.007. Epub 2018 Jun 25.
• [2687] Human -defensin 1 update: Potential clinical applications of the restless warrior.Int J Biochem Cell Biol. 2018 Nov;104:133-137. doi: 10.1016/j.biocel.2018.09.007. Epub 2018 Sep 17.
• [2688] The downregulated long noncoding RNA DHRS4-AS1 is protumoral and associated with the prognosis of clear cell renal cell carcinoma.Onco Targets Ther. 2018 Sep 10;11:5631-5646. doi: 10.2147/OTT.S164984. eCollection 2018.
• [2689] Overexpression and clinical relevance of the RNA helicase DHX15 in hepatocellular carcinoma.Hum Pathol. 2019 Feb;84:213-220. doi: 10.1016/j.humpath.2018.10.006. Epub 2018 Oct 17.
• [2690] -TrCP-mediated ubiquitination and degradation of Dlg5 regulates hepatocellular carcinoma cell proliferation.Cancer Cell Int. 2019 Nov 15;19:298. doi: 10.1186/s12935-019-1029-1. eCollection 2019.
• [2691] The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer.BMC Cancer. 2012 Feb 29;12:79. doi: 10.1186/1471-2407-12-79.
• [2692] The metastasis gene NEDD9 product acts through integrin 3 and Src to promote mesenchymal motility and inhibit amoeboid motility.J Cell Sci. 2012 Apr 1;125(Pt 7):1814-26. doi: 10.1242/jcs.101444. Epub 2012 Feb 10.
• [2693] TGF-/Smad signaling through DOCK4 facilitates lung adenocarcinoma metastasis.Genes Dev. 2015 Feb 1;29(3):250-61. doi: 10.1101/gad.248963.114.
• [2694] Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.Clin Cancer Res. 2018 Oct 15;24(20):5123-5132. doi: 10.1158/1078-0432.CCR-18-0752. Epub 2018 Jun 26.
• [2695] Dysregulation of the miR-325-3p/DPAGT1 axis supports HBV-positive HCC chemoresistance.Biochem Biophys Res Commun. 2019 Nov 5;519(2):358-365. doi: 10.1016/j.bbrc.2019.08.116. Epub 2019 Sep 10.
• [2696] Serum starvation induces DRAM expression in liver cancer cells via histone modifications within its promoter locus.PLoS One. 2012;7(12):e50502. doi: 10.1371/journal.pone.0050502. Epub 2012 Dec 12.
• [2697] Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC.Oncotarget. 2017 Feb 28;8(9):15349-15363. doi: 10.18632/oncotarget.14856.
• [2698] High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.Int J Oncol. 2003 Apr;22(4):815-22.
• [2699] Fibulin-3 Has Anti-Tumorigenic Activities inCutaneous Squamous Cell Carcinoma.J Invest Dermatol. 2019 Aug;139(8):1798-1808.e5. doi: 10.1016/j.jid.2019.01.022. Epub 2019 Feb 6.
• [2700] Structural investigation of a C-terminal EphA2 receptor mutant: Does mutation affect the structure and interaction properties of the Sam domain?.Biochim Biophys Acta Proteins Proteom. 2017 Sep;1865(9):1095-1104. doi: 10.1016/j.bbapap.2017.06.003. Epub 2017 Jun 6.
• [2701] Euphorbia factor L2 inhibits TGF--induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3.Phytomedicine. 2019 Sep;62:152931. doi: 10.1016/j.phymed.2019.152931. Epub 2019 Apr 17.
• [2702] Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating 2AR signaling.J Exp Clin Cancer Res. 2019 Apr 25;38(1):174. doi: 10.1186/s13046-019-1162-7.
• [2703] A MYC-GCN2-eIF2 negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer.Nat Cell Biol. 2019 Nov;21(11):1413-1424. doi: 10.1038/s41556-019-0408-0. Epub 2019 Nov 4.
• [2704] EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.Cancer Manag Res. 2019 Aug 21;11:7877-7891. doi: 10.2147/CMAR.S207834. eCollection 2019.
• [2705] eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition.Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3877-82. doi: 10.1073/pnas.1216862110. Epub 2013 Feb 19.
• [2706] Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy.Oncotarget. 2019 Aug 13;10(48):4973-4986. doi: 10.18632/oncotarget.27132. eCollection 2019 Aug 13.
• [2707] ER membrane protein complex subunit 6 (EMC6) is a novel tumor suppressor in gastric cancer.BMB Rep. 2017 Aug;50(8):411-416. doi: 10.5483/bmbrep.2017.50.8.065.
• [2708] Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.Microvasc Res. 2000 Jul;60(1):70-80. doi: 10.1006/mvre.2000.2249.
• [2709] The function of EMSY in cancer development.Tumour Biol. 2014 Jun;35(6):5061-6. doi: 10.1007/s13277-013-1584-3. Epub 2014 Mar 9.
• [2710] Is Engrailed-2 (EN2) a truly promising biomarker in prostate cancer detection?.Biomarkers. 2020 Feb;25(1):34-39. doi: 10.1080/1354750X.2019.1690047. Epub 2019 Nov 14.
• [2711] Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma.Nat Commun. 2017 Sep 11;8(1):517. doi: 10.1038/s41467-017-00530-7.
• [2712] GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis.Cancer Genet Cytogenet. 2005 Oct 1;162(1):63-7. doi: 10.1016/j.cancergencyto.2005.02.009.
• [2713] PWP1 Mediates Nutrient-Dependent Growth Control through Nucleolar Regulation of Ribosomal Gene Expression.Dev Cell. 2017 Oct 23;43(2):240-252.e5. doi: 10.1016/j.devcel.2017.09.022.
• [2714] Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases.J Cancer Res Clin Oncol. 2013 Apr;139(4):533-42. doi: 10.1007/s00432-012-1356-2. Epub 2012 Dec 4.
• [2715] Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.J Neurooncol. 2001 Dec;55(3):149-58. doi: 10.1023/a:1013863630293.
• [2716] Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28.Cancer Immunol Immunother. 2006 Dec;55(12):1575-83. doi: 10.1007/s00262-006-0152-8. Epub 2006 Mar 14.
• [2717] Somatic loss of an EXT2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromas.Cancer Genet. 2015 Mar;208(3):62-7. doi: 10.1016/j.cancergen.2015.01.002. Epub 2015 Jan 16.
• [2718] Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines.Eur J Cancer. 2004 May;40(8):1255-61. doi: 10.1016/j.ejca.2004.01.013.
• [2719] Estrogen receptor- regulation of microRNA-590 targets FAM171A1-a modifier of breast cancer invasiveness.Oncogenesis. 2019 Jan 9;8(1):5. doi: 10.1038/s41389-018-0113-z.
• [2720] MiR-1827 functions as a tumor suppressor in lung adenocarcinoma by targeting MYC and FAM83F.J Cell Biochem. 2020 Feb;121(2):1675-1689. doi: 10.1002/jcb.29402. Epub 2019 Oct 8.
• [2721] FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.Oncotarget. 2016 Jun 28;7(26):39872-39884. doi: 10.18632/oncotarget.9524.
• [2722] Nutrient-induced FNIP degradation by SCF-TRCP regulates FLCN complex localization and promotes renal cancer progression.Oncotarget. 2017 Feb 7;8(6):9947-9960. doi: 10.18632/oncotarget.14221.
• [2723] miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/-catenin signaling in the development of gastric cancer.Cell Death Dis. 2017 Mar 30;8(3):e2714. doi: 10.1038/cddis.2017.134.
• [2724] Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis.Onco Targets Ther. 2018 Feb 27;11:1067-1075. doi: 10.2147/OTT.S157126. eCollection 2018.
• [2725] Formiminotransferase Cyclodeaminase Suppresses Hepatocellular Carcinoma by Modulating Cell Apoptosis, DNA Damage, and Phosphatidylinositol 3-Kinases (PI3K)/Akt Signaling Pathway.Med Sci Monit. 2019 Jun 16;25:4474-4484. doi: 10.12659/MSM.916202.
• [2726] Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.Oncol Rep. 2016 Aug;36(2):803-10. doi: 10.3892/or.2016.4885. Epub 2016 Jun 17.
• [2727] Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics.Sci Rep. 2018 Jun 4;8(1):8537. doi: 10.1038/s41598-018-26761-2.
• [2728] Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.Nat Cell Biol. 2015 May;17(5):678-88. doi: 10.1038/ncb3157. Epub 2015 Apr 20.
• [2729] GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.Cell Death Differ. 2020 Jun;27(6):1862-1877. doi: 10.1038/s41418-019-0466-7. Epub 2019 Dec 4.
• [2730] Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.Clin Sci (Lond). 2019 May 21;133(10):1167-1184. doi: 10.1042/CS20190145. Print 2019 May 31.
• [2731] GBX2, as a tumor promoter in lung adenocarcinoma, enhances cells viability, invasion and migration by regulating the AKT/ERK signaling pathway.J Gene Med. 2020 Feb;22(2):e3147. doi: 10.1002/jgm.3147. Epub 2019 Dec 20.
• [2732] Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.NMR Biomed. 2012 Sep;25(9):1033-42. doi: 10.1002/nbm.2766. Epub 2012 Jan 26.
• [2733] High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma.Oncotarget. 2017 Mar 21;8(12):19205-19217. doi: 10.18632/oncotarget.15164.
• [2734] Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency.Sci Rep. 2017 Sep 11;7(1):11137. doi: 10.1038/s41598-017-11605-2.
• [2735] GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma.Virchows Arch. 2020 Mar;476(3):475-481. doi: 10.1007/s00428-019-02673-y. Epub 2019 Nov 9.
• [2736] Long noncoding RNA lncGNAT1? inhibits gastric cancer cell proliferation and invasion through the Wnt/catenin pathway in Helicobacterpylori infection.Mol Med Rep. 2018 Oct;18(4):4009-4015. doi: 10.3892/mmr.2018.9405. Epub 2018 Aug 20.
• [2737] Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma.Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6623-E6631. doi: 10.1073/pnas.1706055114. Epub 2017 Jul 24.
• [2738] Stress-induced isoforms of MDM2 and MDM4 correlate with high-grade disease and an altered splicing network in pediatric rhabdomyosarcoma.Neoplasia. 2013 Sep;15(9):1049-63. doi: 10.1593/neo.13286.
• [2739] Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.Tumour Biol. 2017 Jun;39(6):1010428317701443. doi: 10.1177/1010428317701443.
• [2740] GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis.Oncotarget. 2017 Dec 15;8(70):115370-115383. doi: 10.18632/oncotarget.23265. eCollection 2017 Dec 29.
• [2741] Overexpression of G Protein-Coupled Receptor Kinase 6 (GRK6) Is Associated with Progression and Poor Prognosis of Papillary Thyroid Carcinoma.Med Sci Monit. 2018 May 28;24:3540-3548. doi: 10.12659/MSM.908176.
• [2742] Nuclear translocation of Hand-1 acts as a molecular switch to regulate vascular radiosensitivity in medulloblastoma tumors: the protein uPAR is a cytoplasmic sequestration factor for Hand-1.Mol Cancer Ther. 2014 May;13(5):1309-22. doi: 10.1158/1535-7163.MCT-13-0892. Epub 2014 Mar 12.
• [2743] Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.Exp Cell Res. 2019 Dec 1;385(1):111605. doi: 10.1016/j.yexcr.2019.111605. Epub 2019 Sep 4.
• [2744] Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer.Neoplasia. 2019 Oct;21(10):963-973. doi: 10.1016/j.neo.2019.07.001. Epub 2019 Aug 19.
• [2745] miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/-Catenin Axis.Theranostics. 2018 Nov 10;8(21):5801-5813. doi: 10.7150/thno.29380. eCollection 2018.
• [2746] Upregulation of Holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer.Oncol Lett. 2019 Dec;18(6):6697-6703. doi: 10.3892/ol.2019.11061. Epub 2019 Nov 5.
• [2747] Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4.Ann Neurol. 2017 Feb;81(2):193-198. doi: 10.1002/ana.24858. Epub 2017 Jan 27.
• [2748] A cancer-associated mutation inactivates a region of the high-mobility group protein HMG20b essential for cytokinesis.Cell Cycle. 2014;13(16):2554-63. doi: 10.4161/15384101.2014.942204.
• [2749] Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.Mol Cell. 2015 Aug 6;59(3):345-358. doi: 10.1016/j.molcel.2015.05.037. Epub 2015 Jul 2.
• [2750] Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells.Oncol Lett. 2019 Jan;17(1):1160-1166. doi: 10.3892/ol.2018.9668. Epub 2018 Nov 5.
• [2751] Expression of HNF4G and its potential functions in lung cancer.Oncotarget. 2017 Dec 4;9(26):18018-18028. doi: 10.18632/oncotarget.22933. eCollection 2018 Apr 6.
• [2752] MicroRNA-625 inhibits the progression of nonsmall cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/-catenin pathway.Int J Mol Med. 2019 Jul;44(1):346-356. doi: 10.3892/ijmm.2019.4203. Epub 2019 May 20.
• [2753] Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesis.Mol Cell Proteomics. 2014 Dec;13(12):3236-49. doi: 10.1074/mcp.M114.038232. Epub 2014 Aug 6.
• [2754] IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer.Sci Rep. 2019 Jul 17;9(1):10353. doi: 10.1038/s41598-019-46759-8.
• [2755] ILF2 promotes anchorage independence through direct regulation of PTEN.Oncol Lett. 2019 Aug;18(2):1689-1696. doi: 10.3892/ol.2019.10510. Epub 2019 Jun 21.
• [2756] C6orf106 accelerates pancreatic cancer cell invasion and proliferation via activating ERK signaling pathway.Mol Cell Biochem. 2019 Apr;454(1-2):87-95. doi: 10.1007/s11010-018-3455-0. Epub 2018 Oct 11.
• [2757] Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm.BMC Cancer. 2018 Jun 26;18(1):691. doi: 10.1186/s12885-018-4449-8.
• [2758] Nephrometry score correlated with tumor proliferative activity inT1 clear cell renal cell carcinoma.Urol Oncol. 2019 May;37(5):301.e19-301.e25. doi: 10.1016/j.urolonc.2019.02.005. Epub 2019 Feb 27.
• [2759] Development and Validation of Tumor-educated Blood Platelets Integrin Alpha 2b (ITGA2B) RNA for Diagnosis and Prognosis of Non-small-cell Lung Cancer through RNA-seq.Int J Biol Sci. 2019 Jul 24;15(9):1977-1992. doi: 10.7150/ijbs.36284. eCollection 2019.
• [2760] Livin promotes colon cancer progression by regulation of H2A.X(Y39ph) via JMJD6.Life Sci. 2019 Oct 1;234:116788. doi: 10.1016/j.lfs.2019.116788. Epub 2019 Aug 22.
• [2761] Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor.PLoS One. 2013 Aug 19;8(8):e73896. doi: 10.1371/journal.pone.0073896. eCollection 2013.
• [2762] The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies.Brain. 2019 Jun 1;142(6):1631-1643. doi: 10.1093/brain/awz094.
• [2763] Characterization of Kelch domain-containing protein 7B in breast tumours and breast cancer cell lines.Oncol Lett. 2019 Sep;18(3):2853-2860. doi: 10.3892/ol.2019.10672. Epub 2019 Jul 26.
• [2764] Enhanced metastatic potential in the MB49 urothelial carcinoma model.Sci Rep. 2019 May 15;9(1):7425. doi: 10.1038/s41598-019-43641-5.
• [2765] Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET.Ther Adv Endocrinol Metab. 2019 Jan 29;10:2042018818821296. doi: 10.1177/2042018818821296. eCollection 2019.
• [2766] Alazami syndrome: the first case of papillary thyroid carcinoma.J Hum Genet. 2020 Jan;65(2):133-141. doi: 10.1038/s10038-019-0682-5. Epub 2019 Oct 28.
• [2767] N-Acetylglucosaminyltransferase III (GnT-III) but not N-Acetylgalactosaminyltransferase-6 and 8 are Differentially Expressed in Invasive and In Situ Ductal Carcinoma of the Breast.Pathol Oncol Res. 2019 Apr;25(2):759-768. doi: 10.1007/s12253-019-00593-5. Epub 2019 Jan 28.
• [2768] Overexpression of LIMD2 promotes the progression of non-small cell lung cancer.Oncol Lett. 2019 Aug;18(2):2073-2081. doi: 10.3892/ol.2019.10473. Epub 2019 Jun 12.
• [2769] LMX1A inhibits C-Myc expression through ANGPTL4 to exert tumor suppressive role in gastric cancer.PLoS One. 2019 Sep 26;14(9):e0221640. doi: 10.1371/journal.pone.0221640. eCollection 2019.
• [2770] Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.Aging (Albany NY). 2019 Sep 18;11(18):7796-7804. doi: 10.18632/aging.102287. Epub 2019 Sep 18.
• [2771] Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17, and LPIN2 genes.Cancer Biol Ther. 2013 Sep;14(9):840-52. doi: 10.4161/cbt.25329. Epub 2013 Jul 26.
• [2772] LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis.Nat Commun. 2017 Apr 24;8:15059. doi: 10.1038/ncomms15059.
• [2773] Upregulation of FAM84B during prostate cancer progression.Oncotarget. 2017 Mar 21;8(12):19218-19235. doi: 10.18632/oncotarget.15168.
• [2774] CAPC negatively regulates NF-B activation and suppresses tumor growth and metastasis.Oncogene. 2012 Mar 29;31(13):1673-82. doi: 10.1038/onc.2011.355. Epub 2011 Aug 8.
• [2775] Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes.Front Immunol. 2017 Dec 11;8:1748. doi: 10.3389/fimmu.2017.01748. eCollection 2017.
• [2776] ORCA-010, a novel potency-enhanced oncolytic adenovirus, exerts strong antitumor activity in preclinical models.Hum Gene Ther. 2014 Oct;25(10):897-904. doi: 10.1089/hum.2013.229. Epub 2014 Sep 17.
• [2777] New Gene Profiling in Determination of Breast Cancer Recurrence and Prognosis in Iranian Women.Asian Pac J Cancer Prev. 2016;17(S3):155-60. doi: 10.7314/apjcp.2016.17.s3.155.
• [2778] MiR-129 regulates growth and invasion by targeting MAL2 in papillary thyroid carcinoma.Biomed Pharmacother. 2018 Sep;105:1072-1078. doi: 10.1016/j.biopha.2018.06.050. Epub 2018 Jun 19.
• [2779] MARCH5 overexpression contributes to tumor growth and metastasis and associates with poor survival in breast cancer.Cancer Manag Res. 2018 Dec 24;11:201-215. doi: 10.2147/CMAR.S190694. eCollection 2019.
• [2780] Reduced mRNA expression levels of MBD2 and MBD3 in gastric carcinogenesis.Tumour Biol. 2014 Apr;35(4):3447-53. doi: 10.1007/s13277-013-1455-y. Epub 2013 Dec 13.
• [2781] Expression of the dbl proto-oncogene in Ewing's sarcomas.Oncogene. 1989 Jul;4(7):897-900.
• [2782] A new member of the MCM protein family encoded by the human MCM8 gene, located contrapodal to GCD10 at chromosome band 20p12.3-13.Nucleic Acids Res. 2003 Jun 1;31(11):2915-25. doi: 10.1093/nar/gkg395.
• [2783] Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly.Int J Cancer. 2019 Oct 15;145(8):2070-2081. doi: 10.1002/ijc.32234. Epub 2019 Mar 21.
• [2784] Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila.Adv Exp Med Biol. 2019;1167:129-155. doi: 10.1007/978-3-030-23629-8_8.
• [2785] miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-, CCNJ, and MEGF9.PLoS One. 2013 Oct 3;8(10):e76247. doi: 10.1371/journal.pone.0076247. eCollection 2013.
• [2786] MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway.Onco Targets Ther. 2019 May 1;12:3285-3294. doi: 10.2147/OTT.S199667. eCollection 2019.
• [2787] MFSD2A expression predicts better prognosis in gastric cancer.Biochem Biophys Res Commun. 2018 Nov 2;505(3):699-704. doi: 10.1016/j.bbrc.2018.09.156. Epub 2018 Oct 3.
• [2788] Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):625-630. doi: 10.1073/pnas.1806851116. Epub 2018 Dec 26.
• [2789] CRISPR deletion of MIEN1 in breast cancer cells.PLoS One. 2018 Oct 4;13(10):e0204976. doi: 10.1371/journal.pone.0204976. eCollection 2018.
• [2790] Silencing of STRN4 suppresses the malignant characteristics of cancer cells.Cancer Sci. 2014 Dec;105(12):1526-32. doi: 10.1111/cas.12541. Epub 2014 Oct 23.
• [2791] Functional characterization of a candidate tumor suppressor gene, Mirror Image Polydactyly 1, in nasopharyngeal carcinoma.Int J Cancer. 2020 May 15;146(10):2891-2900. doi: 10.1002/ijc.32732. Epub 2019 Nov 1.
• [2792] Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition.Genet Med. 2019 Aug;21(8):1868-1873. doi: 10.1038/s41436-018-0405-x. Epub 2018 Dec 21.
• [2793] MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.Scand J Gastroenterol. 2018 Aug;53(8):964-971. doi: 10.1080/00365521.2018.1481521. Epub 2018 Aug 13.
• [2794] MPZL1 is highly expressed in advanced gallbladder carcinoma and promotes the aggressive behavior of human gallbladder carcinoma GBCSD cells.Mol Med Rep. 2019 Sep;20(3):2725-2733. doi: 10.3892/mmr.2019.10506. Epub 2019 Jul 18.
• [2795] Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.Oncol Rep. 2017 Dec;38(6):3489-3496. doi: 10.3892/or.2017.6046. Epub 2017 Oct 19.
• [2796] Early recognition of lung cancer by integrin targeted imaging in K-ras mouse model.Int J Cancer. 2015 Sep 1;137(5):1107-18. doi: 10.1002/ijc.29372. Epub 2015 Jan 14.
• [2797] Upregulation of miR-504-3p is associated with favorable prognosis of acute myeloid leukemia and may serve as a tumor suppressor by targeting MTHFD2.Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1203-1213. doi: 10.26355/eurrev_201902_17013.
• [2798] Morphine enhances renal cell carcinoma aggressiveness through promotes survivin level.Ren Fail. 2017 Nov;39(1):258-264. doi: 10.1080/0886022X.2016.1256322. Epub 2016 Nov 21.
• [2799] Myosin Va plays essential roles in maintaining normal mitosis, enhancing tumor cell motility and viability.Oncotarget. 2017 May 17;8(33):54654-54671. doi: 10.18632/oncotarget.17920. eCollection 2017 Aug 15.
• [2800] Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer.Mol Cell Probes. 2004 Feb;18(1):39-44. doi: 10.1016/j.mcp.2003.09.002.
• [2801] Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.Clin Exp Metastasis. 2014 Dec;31(8):869-79. doi: 10.1007/s10585-014-9676-z. Epub 2014 Sep 11.
• [2802] The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.Tumour Biol. 2014 May;35(5):4425-34. doi: 10.1007/s13277-013-1582-5. Epub 2014 Jan 10.
• [2803] NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.Cell Death Dis. 2019 May 8;10(5):369. doi: 10.1038/s41419-019-1603-4.
• [2804] Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells.Oncotarget. 2017 Dec 4;8(68):112942-112958. doi: 10.18632/oncotarget.22896. eCollection 2017 Dec 22.
• [2805] Cofactor of BRCA1: a novel transcription factor regulator in upper gastrointestinal adenocarcinomas.Cancer Res. 2006 Feb 1;66(3):1346-53. doi: 10.1158/0008-5472.CAN-05-3593.
• [2806] NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-B/Snail axis and predicts outcome of the patients.Cell Death Dis. 2019 Feb 15;10(3):162. doi: 10.1038/s41419-019-1388-5.
• [2807] Down regulation of differentiated embryonic chondrocytes 1 (DEC1) is involved in 8-methoxypsoralen-induced apoptosis in HepG2 cells. Toxicology. 2012 Nov 15;301(1-3):58-65. doi: 10.1016/j.tox.2012.06.022. Epub 2012 Jul 11.
• [2808] A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.Peptides. 2018 Mar;101:213-226. doi: 10.1016/j.peptides.2018.01.016. Epub 2018 Feb 2.
• [2809] MicroRNA-592 suppresses the malignant phenotypes of thyroid cancer by regulating lncRNA NEAT1 and downregulating NOVA1.Int J Mol Med. 2019 Sep;44(3):1172-1182. doi: 10.3892/ijmm.2019.4278. Epub 2019 Jul 16.
• [2810] NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.BMC Cancer. 2019 Jul 29;19(1):743. doi: 10.1186/s12885-019-5925-5.
• [2811] Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling.Acta Pharmacol Sin. 2019 Aug;40(8):1067-1075. doi: 10.1038/s41401-018-0199-z. Epub 2019 Jan 22.
• [2812] No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5cm.J Hepatol. 2018 Jun;68(6):1172-1180. doi: 10.1016/j.jhep.2018.01.014. Epub 2018 Feb 2.
• [2813] Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.BMC Cancer. 2013 May 7;13:227. doi: 10.1186/1471-2407-13-227.
• [2814] pH protective Y(1) receptor ligand functionalized antiphagocytosis BPLP-WPU micelles for enhanced tumor imaging and therapy with prolonged survival time.Biomaterials. 2018 Jul;170:70-81. doi: 10.1016/j.biomaterials.2018.04.002. Epub 2018 Apr 4.
• [2815] Identifying genes with tri-modal association with survival and tumor grade in cancer patients.BMC Bioinformatics. 2019 Jan 8;20(1):13. doi: 10.1186/s12859-018-2582-7.
• [2816] Oxysterol-Binding Protein-Related Protein 8 Inhibits Gastric Cancer Growth Through Induction of ER Stress, Inhibition of Wnt Signaling, and Activation of Apoptosis.Oncol Res. 2017 May 24;25(5):799-808. doi: 10.3727/096504016X14783691306605. Epub 2016 Nov 8.
• [2817] Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.Endocr Pathol. 2019 Mar;30(1):35-42. doi: 10.1007/s12022-018-9559-y.
• [2818] Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models.Oncotarget. 2017 Dec 26;9(4):5197-5207. doi: 10.18632/oncotarget.23708. eCollection 2018 Jan 12.
• [2819] k-RAS mutation and resistance to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer.J Cancer Res Ther. 2017;13(4):699-701. doi: 10.4103/jcrt.JCRT_468_17.
• [2820] Research Progress on PARP14 as a Drug Target.Front Pharmacol. 2019 Mar 5;10:172. doi: 10.3389/fphar.2019.00172. eCollection 2019.
• [2821] Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.Eur Urol. 2018 Mar;73(3):322-339. doi: 10.1016/j.eururo.2017.08.027. Epub 2017 Sep 18.
• [2822] Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.BMC Cancer. 2016 Nov 14;16(1):886. doi: 10.1186/s12885-016-2936-3.
• [2823] Absolute quantification of DNA methylation using microfluidic chip-based digital PCR.Biosens Bioelectron. 2017 Oct 15;96:339-344. doi: 10.1016/j.bios.2017.05.021. Epub 2017 May 12.
• [2824] Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.Mol Carcinog. 2019 Jan;58(1):135-143. doi: 10.1002/mc.22915. Epub 2018 Oct 5.
• [2825] PRISM: methylation pattern-based, reference-free inference of subclonal makeup.Bioinformatics. 2019 Jul 15;35(14):i520-i529. doi: 10.1093/bioinformatics/btz327.
• [2826] High expression of proenkephalin is associated with favorable outcomes in patients with gastrointestinal stromal tumors.Cancer Manag Res. 2019 Jul 17;11:6681-6690. doi: 10.2147/CMAR.S202044. eCollection 2019.
• [2827] Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.Genes Chromosomes Cancer. 2007 Jan;46(1):45-52. doi: 10.1002/gcc.20387.
• [2828] SPOC1, a novel PHD-finger protein: association with residual disease and survival in ovarian cancer.Int J Cancer. 2005 Sep 10;116(4):547-54. doi: 10.1002/ijc.20912.
• [2829] TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis.J Exp Clin Cancer Res. 2018 Aug 9;37(1):188. doi: 10.1186/s13046-018-0856-6.
• [2830] Protein interacting with C kinase 1 suppresses invasion and anchorage-independent growth of astrocytic tumor cells.Mol Biol Cell. 2015 Dec 15;26(25):4552-61. doi: 10.1091/mbc.E15-05-0270. Epub 2015 Oct 14.
• [2831] Phospholipase C1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/- catenin/MMP7 signalling.Oncotarget. 2017 Apr 25;8(17):29056-29066. doi: 10.18632/oncotarget.16072.
• [2832] The gene for a new brain specific RhoA exchange factor maps to the highly unstable chromosomal region 1p36.2-1p36.3.Oncogene. 2001 Nov 1;20(50):7307-17. doi: 10.1038/sj.onc.1204921.
• [2833] Aberrant activation of RPB1 is critical for cell overgrowth in acute myeloid leukemia.Exp Cell Res. 2019 Nov 15;384(2):111653. doi: 10.1016/j.yexcr.2019.111653. Epub 2019 Sep 28.
• [2834] Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.Gut. 2017 Apr;66(4):581-587. doi: 10.1136/gutjnl-2015-310612. Epub 2015 Dec 23.
• [2835] Cell-type specificity of -actin expression and its clinicopathological correlation in gastric adenocarcinoma.World J Gastroenterol. 2014 Sep 14;20(34):12202-11. doi: 10.3748/wjg.v20.i34.12202.
• [2836] POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.Genes Dev. 2018 Jul 1;32(13-14):915-928. doi: 10.1101/gad.314815.118. Epub 2018 Jun 26.
• [2837] LncRNA POU3F3 promotes cancer cell migration and invasion in nasopharyngeal carcinoma by up-regulating TGF-1.Biosci Rep. 2019 Jan 25;39(1):BSR20181632. doi: 10.1042/BSR20181632. Print 2019 Jan 31.
• [2838] Clinical significance and functional validation of inorganic pyrophosphatase in diffuse large B cell lymphoma in humans.Cytotechnology. 2018 Apr;70(2):641-649. doi: 10.1007/s10616-017-0165-5. Epub 2017 Dec 12.
• [2839] Myosin phosphatase and RhoA-activated kinase modulate arginine methylation by the regulation of protein arginine methyltransferase 5 in hepatocellular carcinoma cells.Sci Rep. 2017 Jan 11;7:40590. doi: 10.1038/srep40590.
• [2840] Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regression.J Immunol. 2013 Jun 15;190(12):6034-42. doi: 10.4049/jimmunol.1202830. Epub 2013 May 20.
• [2841] Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.Oncogene. 2016 May;35(21):2777-88. doi: 10.1038/onc.2015.341. Epub 2015 Sep 21.
• [2842] Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.Int J Cancer. 2003 Aug 20;106(2):244-51. doi: 10.1002/ijc.11208.
• [2843] Overexpression of PRDM5 promotes acute myeloid leukemia cell proliferation and migration by activating the JNK pathway.Cancer Med. 2019 Jul;8(8):3905-3917. doi: 10.1002/cam4.2261. Epub 2019 May 23.
• [2844] A proline/arginine-rich end leucine-rich repeat protein (PRELP) variant is uniquely expressed in chronic lymphocytic leukemia cells.PLoS One. 2013 Jun 24;8(6):e67601. doi: 10.1371/journal.pone.0067601. Print 2013.
• [2845] Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.Gastroenterology. 2006 Oct;131(4):1218-27. doi: 10.1053/j.gastro.2006.07.020. Epub 2006 Jul 24.
• [2846] EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.Biomed Pharmacother. 2019 Jan;109:762-769. doi: 10.1016/j.biopha.2018.10.125. Epub 2018 Nov 5.
• [2847] Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea.Mol Med Rep. 2018 Dec;18(6):5243-5255. doi: 10.3892/mmr.2018.9535. Epub 2018 Oct 8.
• [2848] Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival.Cancer. 2005 Dec 1;104(11):2417-29. doi: 10.1002/cncr.21538.
• [2849] An (18)F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with (18)F-JK-PSMA-7 During the First Year of Application.J Nucl Med. 2020 Feb;61(2):202-209. doi: 10.2967/jnumed.119.229542. Epub 2019 Jul 19.
• [2850] Suppression of protein tyrosine phosphatase N23 predisposes to breast tumorigenesis via activation of FYN kinase.Genes Dev. 2017 Oct 1;31(19):1939-1957. doi: 10.1101/gad.304261.117. Epub 2017 Oct 24.
• [2851] PTPS Facilitates Compartmentalized LTBP1 S-Nitrosylation and Promotes Tumor Growth under Hypoxia.Mol Cell. 2020 Jan 2;77(1):95-107.e5. doi: 10.1016/j.molcel.2019.09.018. Epub 2019 Oct 15.
• [2852] Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1/VEGF signaling.Thorac Cancer. 2020 Feb;11(2):379-388. doi: 10.1111/1759-7714.13278. Epub 2019 Dec 16.
• [2853] RAB18 promotes proliferation and metastasis in hepatocellular carcinoma.Am J Transl Res. 2019 Feb 15;11(2):1009-1019. eCollection 2019.
• [2854] Rab25 augments cancer cell invasiveness through a 1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.Exp Mol Med. 2018 Jan 26;50(1):e435. doi: 10.1038/emm.2017.248.
• [2855] Loss of Rab25 promotes the development of skin squamous cell carcinoma through the dysregulation of integrin trafficking.J Pathol. 2019 Oct;249(2):227-240. doi: 10.1002/path.5311. Epub 2019 Jul 18.
• [2856] RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas.Int J Cancer. 2006 Aug 15;119(4):801-6. doi: 10.1002/ijc.21912.
• [2857] High expression of RAB38 promotes malignant progression of pancreatic cancer.Mol Med Rep. 2019 Feb;19(2):909-918. doi: 10.3892/mmr.2018.9732. Epub 2018 Dec 10.
• [2858] Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.PLoS One. 2019 Jul 16;14(7):e0219317. doi: 10.1371/journal.pone.0219317. eCollection 2019.
• [2859] IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.Nature. 2015 Jan 29;517(7536):626-30. doi: 10.1038/nature13910. Epub 2014 Nov 17.
• [2860] Regulation of c-Raf Stability through the CTLH Complex.Int J Mol Sci. 2019 Feb 21;20(4):934. doi: 10.3390/ijms20040934.
• [2861] Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway.Sci Rep. 2017 Jun 9;7(1):3202. doi: 10.1038/s41598-017-03612-0.
• [2862] The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis.Genes Dev. 2019 Dec 1;33(23-24):1718-1738. doi: 10.1101/gad.328336.119. Epub 2019 Nov 14.
• [2863] Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma.Neoplasia. 2005 Jan;7(1):67-74. doi: 10.1593/neo.04370.
• [2864] REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.Oncogene. 2017 Jan 12;36(2):182-193. doi: 10.1038/onc.2016.187. Epub 2016 May 23.
• [2865] Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.Mol Cancer Ther. 2017 Jan;16(1):239-250. doi: 10.1158/1535-7163.MCT-16-0290. Epub 2016 Nov 11.
• [2866] RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment.J Exp Clin Cancer Res. 2019 Jan 10;38(1):15. doi: 10.1186/s13046-018-0986-x.
• [2867] Resistin effects on pancreatic cancer progression and chemoresistance are mediated through its receptors CAP1 and TLR4.J Cell Physiol. 2019 Jun;234(6):9457-9466. doi: 10.1002/jcp.27631. Epub 2018 Oct 14.
• [2868] Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.J Oral Pathol Med. 2010 Jul;39(6):470-6. doi: 10.1111/j.1600-0714.2009.00869.x. Epub 2010 Apr 13.
• [2869] Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT.Transl Oncol. 2017 Feb;10(1):1-9. doi: 10.1016/j.tranon.2016.10.004. Epub 2016 Nov 23.
• [2870] Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.Chin Med J (Engl). 2019 Jul 5;132(13):1572-1581. doi: 10.1097/CM9.0000000000000296.
• [2871] G-Protein Signaling Protein-17 (RGS17) Is Upregulated and Promotes Tumor Growth and Migration in Human Colorectal Carcinoma.Oncol Res. 2018 Jan 19;26(1):27-35. doi: 10.3727/096504017X14900515946914. Epub 2017 Mar 23.
• [2872] Magnetic Resonance Imaging-Guided Drug Delivery to Breast Cancer Stem-Like Cells.Adv Healthc Mater. 2018 Nov;7(21):e1800266. doi: 10.1002/adhm.201800266. Epub 2018 Aug 26.
• [2873] Knockdown of LncRNA RHPN1-AS1 Inhibits Cell Migration, Invasion and Proliferation in Head and Neck Squamous Cell Carcinoma.J Cancer. 2019 Jul 5;10(17):4000-4008. doi: 10.7150/jca.29029. eCollection 2019.
• [2874] Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.Cell Rep. 2015 Jun 9;11(9):1458-73. doi: 10.1016/j.celrep.2015.04.049. Epub 2015 May 28.
• [2875] Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients.Sci Rep. 2019 Sep 10;9(1):13008. doi: 10.1038/s41598-019-49477-3.
• [2876] Overexpression of PDZK1IP1, EEF1A2 and RPL41 genes in intrahepatic cholangiocarcinoma.Mol Med Rep. 2016 Jun;13(6):4786-90. doi: 10.3892/mmr.2016.5110. Epub 2016 Apr 12.
• [2877] Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.PLoS One. 2015 Oct 27;10(10):e0141334. doi: 10.1371/journal.pone.0141334. eCollection 2015.
• [2878] PIDDosome-independent tumor suppression by Caspase-2.Cell Death Differ. 2012 Oct;19(10):1722-32. doi: 10.1038/cdd.2012.54. Epub 2012 May 18.
• [2879] RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function.J Clin Endocrinol Metab. 2013 Mar;98(3):E446-54. doi: 10.1210/jc.2012-3180. Epub 2013 Feb 7.
• [2880] Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res. 2007 Mar 15;67(6):2617-25.
• [2881] Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma.Oncol Lett. 2019 Oct;18(4):3605-3612. doi: 10.3892/ol.2019.10732. Epub 2019 Aug 7.
• [2882] Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma.Oncotarget. 2017 Nov 27;8(65):109247-109257. doi: 10.18632/oncotarget.22665. eCollection 2017 Dec 12.
• [2883] Secretin receptor promotes the proliferation of endocrine tumor cells via the PI3K/AKT pathway.Mol Endocrinol. 2012 Aug;26(8):1394-405. doi: 10.1210/me.2012-1055. Epub 2012 Jun 12.
• [2884] Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.Cell Physiol Biochem. 2018;46(6):2517-2531. doi: 10.1159/000489658. Epub 2018 May 5.
• [2885] Overexpression of SENP3 in oral squamous cell carcinoma and its association with differentiation.Oncol Rep. 2013 May;29(5):1701-6. doi: 10.3892/or.2013.2318. Epub 2013 Mar 1.
• [2886] Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.Hum Gene Ther Clin Dev. 2017 Jun;28(2):80-86. doi: 10.1089/humc.2017.008. Epub 2017 Mar 23.
• [2887] Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors.Int J Cancer. 2020 May 1;146(9):2433-2441. doi: 10.1002/ijc.32569. Epub 2019 Jul 31.
• [2888] Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.Cancer Gene Ther. 2015 Dec;22(12):564-72. doi: 10.1038/cgt.2015.41. Epub 2015 Oct 23.
• [2889] A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.Int J Cancer. 2019 Nov 1;145(9):2535-2546. doi: 10.1002/ijc.32531. Epub 2019 Jul 8.
• [2890] Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth.Mol Oncol. 2018 Aug;12(8):1383-1397. doi: 10.1002/1878-0261.12332. Epub 2018 Jun 30.
• [2891] Loss of CD169(+) Subcapsular Macrophages during Metastatic Spread of Head and Neck Squamous Cell Carcinoma.Otolaryngol Head Neck Surg. 2019 Jul;161(1):67-73. doi: 10.1177/0194599819829741. Epub 2019 Feb 12.
• [2892] SIX4 activates Akt and promotes tumor angiogenesis.Exp Cell Res. 2019 Oct 1;383(1):111495. doi: 10.1016/j.yexcr.2019.111495. Epub 2019 Jul 10.
• [2893] SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.Cell Death Dis. 2019 Dec 5;10(12):929. doi: 10.1038/s41419-019-2163-3.
• [2894] Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15.Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):644-652. doi: 10.1158/1055-9965.EPI-17-0887. Epub 2018 Apr 12.
• [2895] A non-functional neoepitope specific CD8(+) T-cell response induced by tumor derived antigen exposure in vivo.Oncoimmunology. 2018 Dec 24;8(3):1553478. doi: 10.1080/2162402X.2018.1553478. eCollection 2019.
• [2896] SNRPA enhances tumour cell growth in gastric cancer through modulating NGF expression.Cell Prolif. 2018 Oct;51(5):e12484. doi: 10.1111/cpr.12484. Epub 2018 Jul 24.
• [2897] Sorting Nexin 5 Controls Head and Neck Squamous Cell Carcinoma Progression by Modulating FBW7.J Cancer. 2019 Jun 2;10(13):2942-2952. doi: 10.7150/jca.31055. eCollection 2019.
• [2898] Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients.J Cell Biochem. 2020 Feb;121(2):1552-1562. doi: 10.1002/jcb.29390. Epub 2019 Sep 12.
• [2899] SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.Mol Oncol. 2018 May;12(5):724-755. doi: 10.1002/1878-0261.12195. Epub 2018 Apr 16.
• [2900] Expression analysis of ST3GAL4 transcripts in cervical cancer cells.Mol Med Rep. 2018 Jul;18(1):617-621. doi: 10.3892/mmr.2018.8938. Epub 2018 Apr 27.
• [2901] STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.J Exp Clin Cancer Res. 2018 Jul 11;37(1):144. doi: 10.1186/s13046-018-0808-1.
• [2902] Serum FBLN1 and STK31 as biomarkers of colorectal cancer and their ability to noninvasively differentiate colorectal cancer from benign polyps.Clin Chim Acta. 2018 Aug;483:151-155. doi: 10.1016/j.cca.2018.04.038. Epub 2018 Apr 30.
• [2903] Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma.Clin Epigenetics. 2018 Oct 22;10(1):129. doi: 10.1186/s13148-018-0562-4.
• [2904] WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway.Br J Cancer. 2016 Jul 12;115(2):243-51. doi: 10.1038/bjc.2016.186. Epub 2016 Jun 23.
• [2905] Trichohyalin-like 1 protein, a member of fused S100 proteins, is expressed in normal and pathologic human skin.Biochem Biophys Res Commun. 2013 Mar 1;432(1):66-72. doi: 10.1016/j.bbrc.2013.01.084. Epub 2013 Jan 29.
• [2906] Clinical features of pulmonary embolism in patients with lung cancer: A meta-analysis.PLoS One. 2019 Sep 30;14(9):e0223230. doi: 10.1371/journal.pone.0223230. eCollection 2019.
• [2907] FAM46C suppresses gastric cancer by inhibition of Wnt/beta-catenin.Front Biosci (Landmark Ed). 2020 Jan 1;25(3):549-563. doi: 10.2741/4820.
• [2908] Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis.EMBO Mol Med. 2020 Jan 9;12(1):e10880. doi: 10.15252/emmm.201910880. Epub 2019 Nov 11.
• [2909] RETRACTED: Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway.Cancer Lett. 2018 Nov 1;436:119-128. doi: 10.1016/j.canlet.2018.08.012. Epub 2018 Aug 14.
• [2910] TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.Mol Carcinog. 2019 May;58(5):767-776. doi: 10.1002/mc.22969. Epub 2019 Jan 22.
• [2911] High expression of mitochondrial intermembrane chaperone TIMM9 represents a negative prognostic marker in gastric cancer.J Formos Med Assoc. 2017 Jun;116(6):476-483. doi: 10.1016/j.jfma.2016.08.007. Epub 2016 Oct 6.
• [2912] TIPIN depletion leads to apoptosis in breast cancer cells.Mol Oncol. 2015 Oct;9(8):1580-98. doi: 10.1016/j.molonc.2015.04.010. Epub 2015 May 9.
• [2913] Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer.J Med Chem. 2019 Mar 14;62(5):2651-2665. doi: 10.1021/acs.jmedchem.8b01957. Epub 2019 Mar 6.
• [2914] miR-508-5p acts as an anti-oncogene by targeting MESDC1 in hepatocellular carcinoma.Neoplasma. 2017;64(1):40-47. doi: 10.4149/neo_2017_105.
• [2915] Histone H2A.Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progression.Cancer Lett. 2012 Feb 1;315(1):38-47. doi: 10.1016/j.canlet.2011.10.003. Epub 2011 Oct 12.
• [2916] TMEM45B is a novel predictive biomarker for prostate cancer progression and metastasis.Neoplasma. 2018 Sep 19;65(5):815-821. doi: 10.4149/neo_2018_170822N551. Epub 2018 Sep 4.
• [2917] Tropomodulin 1 expression driven by NF-B enhances breast cancer growth.Cancer Res. 2015 Jan 1;75(1):62-72. doi: 10.1158/0008-5472.CAN-13-3455. Epub 2014 Nov 14.
• [2918] Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.Epigenetics. 2013 Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11.
• [2919] Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deactivating Akt pathway.Neoplasma. 2020 Mar;67(2):277-285. doi: 10.4149/neo_2019_190404N295. Epub 2019 Dec 17.
• [2920] Tyrosylprotein sulfotransferase 1 expression is negatively correlated with cMet and lymph node metastasis in human lung cancer.Mol Med Rep. 2015 Oct;12(4):5217-22. doi: 10.3892/mmr.2015.4096. Epub 2015 Jul 20.
• [2921] Elevated TRIM23 expression predicts poor prognosis in Chinese gastric cancer.Pathol Res Pract. 2018 Dec;214(12):2062-2068. doi: 10.1016/j.prp.2018.10.010. Epub 2018 Oct 19.
• [2922] Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells.J Cell Physiol. 2019 Aug;234(10):19019-19027. doi: 10.1002/jcp.28541. Epub 2019 Mar 29.
• [2923] TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling.Yonsei Med J. 2018 Jan;59(1):43-50. doi: 10.3349/ymj.2018.59.1.43.
• [2924] Expression of Nur77 induced by an n-butylidenephthalide derivative promotes apoptosis and inhibits cell growth in oral squamous cell carcinoma.Invest New Drugs. 2012 Feb;30(1):79-89. doi: 10.1007/s10637-010-9518-z. Epub 2010 Sep 1.
• [2925] TSGA10 overexpression inhibits angiogenesis of HUVECs: A HIF-2 biased perspective.Microvasc Res. 2020 Mar;128:103952. doi: 10.1016/j.mvr.2019.103952. Epub 2019 Nov 5.
• [2926] Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.J Exp Clin Cancer Res. 2019 Jun 11;38(1):248. doi: 10.1186/s13046-019-1200-5.
• [2927] Paraneoplastic pemphigus: a clinical, laboratorial, and therapeutic overview.An Bras Dermatol. 2019 Oct 17;94(4):388-398. doi: 10.1590/abd1806-4841.20199165. eCollection 2019.
• [2928] Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.Biomed Pharmacother. 2019 Apr;112:108632. doi: 10.1016/j.biopha.2019.108632. Epub 2019 Feb 20.
• [2929] AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.Int J Mol Sci. 2017 Jun 11;18(6):1251. doi: 10.3390/ijms18061251.
• [2930] The PI3K/AKT axis modulates AATF activity in Wilms' tumor cells.FEBS Open Bio. 2018 Sep 4;8(10):1615-1623. doi: 10.1002/2211-5463.12500. eCollection 2018 Oct.
• [2931] Promyelocytic leukemia zinc finger triggers ATP-binding cassette subfamily E member 1-mediated growth inhibition in breast cancer cells.Oncol Lett. 2018 Oct;16(4):4143-4150. doi: 10.3892/ol.2018.9207. Epub 2018 Jul 24.
• [2932] Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization.Mol Carcinog. 2019 Jul;58(7):1118-1133. doi: 10.1002/mc.22996. Epub 2019 Mar 4.
• [2933] Transcriptional regulation of the potential tumor suppressor ABI3 gene in thyroid carcinomas: interplay between methylation and NKX2-1 availability.Oncotarget. 2016 May 3;7(18):25960-70. doi: 10.18632/oncotarget.8416.
• [2934] Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression.Biochem Biophys Res Commun. 2009 Mar 20;380(4):807-12. doi: 10.1016/j.bbrc.2009.01.171. Epub 2009 Feb 4.
• [2935] A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer.J Clin Med. 2019 Oct 24;8(11):1772. doi: 10.3390/jcm8111772.
• [2936] Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy.Cancer Immunol Res. 2018 Feb;6(2):178-188. doi: 10.1158/2326-6066.CIR-17-0035. Epub 2017 Dec 7.
• [2937] Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening.J Med Screen. 2019 Mar;26(1):11-18. doi: 10.1177/0969141318785654. Epub 2018 Oct 3.
• [2938] Role of atypical chemokine receptor ACKR2 in experimental oral squamous cell carcinogenesis.Cytokine. 2019 Jun;118:160-167. doi: 10.1016/j.cyto.2018.03.001. Epub 2018 Mar 15.
• [2939] A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2(V617F) positive polycythemia vera: a case report.BMC Cancer. 2018 Mar 13;18(1):286. doi: 10.1186/s12885-018-4127-x.
• [2940] Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy.Clin Cancer Res. 2019 Oct 1;25(19):5890-5900. doi: 10.1158/1078-0432.CCR-18-3927. Epub 2019 Jul 8.
• [2941] Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation.Cancer Res. 2010 Oct 1;70(19):7652-61. doi: 10.1158/0008-5472.CAN-10-0840. Epub 2010 Sep 28.
• [2942] Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.Pediatr Dermatol. 2019 Jan;36(1):e23-e26. doi: 10.1111/pde.13728. Epub 2018 Dec 11.
• [2943] Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.Biochem Pharmacol. 2019 Jan;159:52-63. doi: 10.1016/j.bcp.2018.11.005. Epub 2018 Nov 9.
• [2944] Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion.Oncotarget. 2017 Feb 28;8(9):15014-15022. doi: 10.18632/oncotarget.14788.
• [2945] Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization.Cell Rep. 2015 Dec 1;13(9):2014-26. doi: 10.1016/j.celrep.2015.10.045. Epub 2015 Nov 19.
• [2946] Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression.Cancer Med. 2018 Apr;7(4):1240-1252. doi: 10.1002/cam4.1295. Epub 2018 Mar 1.
• [2947] High ASMA(+) Fibroblasts and Low Cytoplasmic HMGB1(+) Breast Cancer Cells Predict PoorPrognosis.Clin Breast Cancer. 2017 Oct;17(6):441-452.e2. doi: 10.1016/j.clbc.2017.04.007. Epub 2017 Apr 21.
• [2948] Actin-like protein 6A is a novel prognostic indicator promoting invasion and metastasis in osteosarcoma.Oncol Rep. 2017 Apr;37(4):2405-2417. doi: 10.3892/or.2017.5473. Epub 2017 Feb 23.
• [2949] Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma.Cancer Manag Res. 2018 Mar 19;10:503-511. doi: 10.2147/CMAR.S155453. eCollection 2018.
• [2950] Long Noncoding RNA CRYBG3 Blocks Cytokinesis by Directly Binding G-Actin.Cancer Res. 2018 Aug 15;78(16):4563-4572. doi: 10.1158/0008-5472.CAN-18-0988. Epub 2018 Jun 22.
• [2951] Differential aminoacylase expression in neuroblastoma.Int J Cancer. 2011 Sep 15;129(6):1322-30. doi: 10.1002/ijc.25798. Epub 2011 Apr 1.
• [2952] Associations between polymorphisms of the ACYP2 gene and Liver cancer risk: A case-control study and meta-analysis.Mol Genet Genomic Med. 2019 Jul;7(7):e00716. doi: 10.1002/mgg3.716. Epub 2019 May 23.
• [2953] Design, Synthesis, and Biological Evaluation of Polyaminocarboxylate Ligand-Based Theranostic Conjugates for Antibody-Targeted Cancer Therapy and Near-Infrared Optical Imaging.ChemMedChem. 2018 Dec 20;13(24):2606-2617. doi: 10.1002/cmdc.201800598. Epub 2018 Nov 26.
• [2954] A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18.
• [2955] The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1.J Cell Physiol. 2019 Mar;234(3):2460-2470. doi: 10.1002/jcp.26764. Epub 2018 Oct 14.
• [2956] Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer.Cancer Res. 2009 Jun 1;69(11):4926-34. doi: 10.1158/0008-5472.CAN-08-4155. Epub 2009 May 19.
• [2957] Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.BMC Cancer. 2018 Aug 6;18(1):796. doi: 10.1186/s12885-018-4701-2.
• [2958] Relationship Between ADAMTS8, ADAMTS18, and ADAMTS20 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) Expressions and Tumor Molecular Classification, Clinical Pathological Parameters, and Prognosis in Breast Invasive Ductal Carcinoma.Med Sci Monit. 2018 Jun 3;24:3726-3735. doi: 10.12659/MSM.907310.
• [2959] ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.Exp Mol Pathol. 2018 Apr;104(2):134-139. doi: 10.1016/j.yexmp.2018.02.004. Epub 2018 Feb 21.
• [2960] The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.J Cell Mol Med. 2018 Feb;22(2):1257-1271. doi: 10.1111/jcmm.13404. Epub 2017 Nov 29.
• [2961] ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and its mRNA is reduced in colon cancer.Int J Cancer. 2007 Oct 15;121(8):1710-6. doi: 10.1002/ijc.22882.
• [2962] ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2(Q607R).Cancer Cell Int. 2018 Dec 3;18:196. doi: 10.1186/s12935-018-0695-8. eCollection 2018.
• [2963] Aneuploidy: Cancer strength or vulnerability?.Int J Cancer. 2019 Jan 1;144(1):8-25. doi: 10.1002/ijc.31718. Epub 2018 Oct 31.
• [2964] Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.Ann Oncol. 2017 Jan 1;28(1):83-89. doi: 10.1093/annonc/mdw437.
• [2965] G-protein coupled receptor 124 (GPR124) in endothelial cells regulates vascular endothelial growth factor (VEGF)-induced tumor angiogenesis.Curr Mol Med. 2014 May;14(4):543-54. doi: 10.2174/1566524014666140414205943.
• [2966] BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.Cancer Cell. 2018 Jun 11;33(6):1004-1016.e5. doi: 10.1016/j.ccell.2018.05.006.
• [2967] Role of CD97 small isoform in human cervical carcinoma.Int J Exp Pathol. 2019 Feb;100(1):19-24. doi: 10.1111/iep.12303. Epub 2019 Mar 18.
• [2968] GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer.Breast Cancer Res Treat. 2018 Jul;170(2):279-292. doi: 10.1007/s10549-018-4751-9. Epub 2018 Mar 24.
• [2969] MiR-511-5p functions as a tumor suppressor and a predictive of prognosis in colorectal cancer by directly targeting GPR116.Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6119-6130. doi: 10.26355/eurrev_201907_18425.
• [2970] GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism.Mol Cancer Res. 2019 Nov;17(11):2196-2207. doi: 10.1158/1541-7786.MCR-19-0436. Epub 2019 Aug 23.
• [2971] Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.Nat Commun. 2019 Feb 12;10(1):720. doi: 10.1038/s41467-019-08576-5.
• [2972] ADGRL4/ELTD1 Silencing in Endothelial Cells Induces ACLY and SLC25A1 and Alters the Cellular Metabolic Profile.Metabolites. 2019 Nov 25;9(12):287. doi: 10.3390/metabo9120287.
• [2973] The methionine salvage pathway-involving ADI1 inhibits hepatoma growth by epigenetically altering genes expression via elevating S-adenosylmethionine.Cell Death Dis. 2019 Mar 11;10(3):240. doi: 10.1038/s41419-019-1486-4.
• [2974] Human renal adipose tissue induces the invasion and progression of renal cell carcinoma.Oncotarget. 2017 Oct 9;8(55):94223-94234. doi: 10.18632/oncotarget.21666. eCollection 2017 Nov 7.
• [2975] ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer.Clin Cancer Res. 2017 Jun 1;23(11):2769-2780. doi: 10.1158/1078-0432.CCR-16-1604. Epub 2016 Nov 30.
• [2976] Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.Clin Breast Cancer. 2020 Apr;20(2):131-144.e3. doi: 10.1016/j.clbc.2019.07.009. Epub 2019 Sep 3.
• [2977] Adenylosuccinate synthetase 1 gene is a novel target of deletion in lung adenocarcinoma.Mol Carcinog. 2009 Dec;48(12):1116-22. doi: 10.1002/mc.20563.
• [2978] MicroRNA 214 inhibits adipocyte enhancer-binding protein 1 activity and increases the sensitivity of chemotherapy in colorectal cancer.Oncol Lett. 2019 Jan;17(1):55-62. doi: 10.3892/ol.2018.9623. Epub 2018 Oct 26.
• [2979] Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.Oncol Res. 2019 Jun 21;27(6):653-661. doi: 10.3727/096504018X15420748671075. Epub 2019 Mar 4.
• [2980] XB130 deficiency enhances carcinogen-induced skin tumorigenesis.Carcinogenesis. 2019 Nov 25;40(11):1363-1375. doi: 10.1093/carcin/bgz042.
• [2981] Preclinical PET imaging of HIP/PAP using 1'-(18)F-fluoroethyl--D-lactose.Oncotarget. 2017 Sep 6;8(43):75162-75173. doi: 10.18632/oncotarget.20654. eCollection 2017 Sep 26.
• [2982] AFF3 upregulation mediates tamoxifen resistance in breast cancers.J Exp Clin Cancer Res. 2018 Oct 16;37(1):254. doi: 10.1186/s13046-018-0928-7.
• [2983] Identification of a sodium pump Na(+)/K(+) ATPase 1-targeted peptide for PET imaging of breast cancer.J Control Release. 2018 Jul 10;281:178-188. doi: 10.1016/j.jconrel.2018.05.019. Epub 2018 May 17.
• [2984] Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity.Cell Death Differ. 2016 Jan;23(1):52-63. doi: 10.1038/cdd.2015.66. Epub 2015 May 22.
• [2985] High expression of AGBL2 is a novel prognostic factor of adverse outcome in patients with ovarian carcinoma.Oncol Lett. 2019 Nov;18(5):4900-4906. doi: 10.3892/ol.2019.10829. Epub 2019 Sep 9.
• [2986] Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations.Clin Cancer Res. 2019 Jun 15;25(12):3548-3560. doi: 10.1158/1078-0432.CCR-18-3442. Epub 2019 Feb 19.
• [2987] Knockdown of AGGF1 inhibits the invasion and migration of gastric cancer via epithelial-mesenchymal transition through Wnt/-catenin pathway.Cancer Cell Int. 2019 Feb 27;19:41. doi: 10.1186/s12935-019-0765-6. eCollection 2019.
• [2988] Metabolic phenotype of bladder cancer.Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8.
• [2989] The stem cell E3-ligase Lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing.J Pathol. 2013 Feb;229(3):486-96. doi: 10.1002/path.4130.
• [2990] Detection of circulating microRNAs with Ago2 complexes to monitor the tumor dynamics of colorectal cancer patients during chemotherapy.Int J Cancer. 2019 May 1;144(9):2169-2180. doi: 10.1002/ijc.31960. Epub 2019 Jan 7.
• [2991] The effect of benzyl isothiocyanate and its computer-aided design derivants targeting alkylglycerone phosphate synthase on the inhibition of human glioma U87MG cell line.Tumour Biol. 2015 May;36(5):3499-509. doi: 10.1007/s13277-014-2986-6. Epub 2014 Dec 28.
• [2992] AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.PLoS One. 2015 Apr 15;10(4):e0122106. doi: 10.1371/journal.pone.0122106. eCollection 2015.
• [2993] The human adenovirus E4-ORF1 protein subverts discs large 1 to mediate membrane recruitment and dysregulation of phosphatidylinositol 3-kinase.PLoS Pathog. 2014 May 1;10(5):e1004102. doi: 10.1371/journal.ppat.1004102. eCollection 2014 May.
• [2994] Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme.Oncotarget. 2019 Jul 9;10(43):4449-4465. doi: 10.18632/oncotarget.27056. eCollection 2019 Jul 9.
• [2995] A Protective Role of Aryl Hydrocarbon Receptor Repressor in Inflammation and Tumor Growth.Cancers (Basel). 2019 Apr 27;11(5):589. doi: 10.3390/cancers11050589.
• [2996] Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.BMC Cancer. 2019 May 14;19(1):451. doi: 10.1186/s12885-019-5659-4.
• [2997] Low expression of AIM2 combined with high expression of pSTAT3 is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.Oncol Rep. 2019 Apr;41(4):2396-2408. doi: 10.3892/or.2019.7029. Epub 2019 Feb 25.
• [2998] Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.Biochem Pharmacol. 2014 Jun 15;89(4):477-89. doi: 10.1016/j.bcp.2014.04.014. Epub 2014 Apr 30.
• [2999] The ATPase hCINAP regulates 18S rRNA processing and is essential for embryogenesis and tumour growth.Nat Commun. 2016 Aug 1;7:12310. doi: 10.1038/ncomms12310.
• [3000] Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).BMC Cancer. 2018 Feb 12;18(1):174. doi: 10.1186/s12885-018-4021-6.
• [3001] A-kinase anchoring proteins 10 expression in relation to 2073A/G polymorphism and tumor progression in patients with colorectal cancer.Pathol Oncol Res. 2013 Jul;19(3):521-7. doi: 10.1007/s12253-013-9612-6. Epub 2013 Mar 7.
• [3002] Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer.Int J Oncol. 2018 Apr;52(4):1305-1316. doi: 10.3892/ijo.2018.4284. Epub 2018 Feb 23.
• [3003] Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen.Oncotarget. 2016 Jul 12;7(28):43412-43418. doi: 10.18632/oncotarget.9727.
• [3004] A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.J Clin Lab Anal. 2020 Feb;34(2):e23061. doi: 10.1002/jcla.23061. Epub 2019 Dec 11.
• [3005] Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.Cell Death Dis. 2019 Mar 18;10(4):262. doi: 10.1038/s41419-019-1506-4.
• [3006] PRAS40 signaling in tumor.Oncotarget. 2017 Apr 20;8(40):69076-69085. doi: 10.18632/oncotarget.17299. eCollection 2017 Sep 15.
• [3007] High expression of ALDH1A3 might independently influence poor progression-free and overall survival in patients with glioma via maintaining glucose uptake and lactate production.Cell Biol Int. 2020 Feb;44(2):569-582. doi: 10.1002/cbin.11257. Epub 2019 Nov 7.
• [3008] Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression.Chem Biol Interact. 2019 Apr 1;302:149-155. doi: 10.1016/j.cbi.2019.02.013. Epub 2019 Feb 20.
• [3009] Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.Breast Cancer Res. 2019 Jan 14;21(1):4. doi: 10.1186/s13058-018-1093-9.
• [3010] High expression of fructose-bisphosphate aldolaseA induces progression of renal cell carcinoma.Oncol Rep. 2018 Jun;39(6):2996-3006. doi: 10.3892/or.2018.6378. Epub 2018 Apr 18.
• [3011] Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.Mol Biol Rep. 2019 Jun;46(3):2693-2701. doi: 10.1007/s11033-019-04712-y. Epub 2019 Feb 25.
• [3012] Genome-wide bioinformatics analysis reveals CTCFL is upregulated in high-grade epithelial ovarian cancer.Oncol Lett. 2019 Oct;18(4):4030-4039. doi: 10.3892/ol.2019.10736. Epub 2019 Aug 8.
• [3013] ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression.Cancer Sci. 2013 Mar;104(3):321-7. doi: 10.1111/cas.12089. Epub 2013 Feb 14.
• [3014] Association of AlkB homolog 3 expression with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14117. Online ahead of print.
• [3015] Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.Cell Cycle. 2014;13(11):1798-810. doi: 10.4161/cc.28757. Epub 2014 Apr 14.
• [3016] ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients.Am J Pathol. 2019 Jan;189(1):190-199. doi: 10.1016/j.ajpath.2018.09.003. Epub 2018 Oct 11.
• [3017] Human Cart-1: structural organization, chromosomal localization, and functional analysis of a cartilage-specific homeodomain cDNA.DNA Cell Biol. 1996 Jul;15(7):531-41. doi: 10.1089/dna.1996.15.531.
• [3018] Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.PLoS One. 2019 Mar 15;14(3):e0209392. doi: 10.1371/journal.pone.0209392. eCollection 2019.
• [3019] Overexpression of Aristaless-Like Homeobox-4 Inhibits Proliferation, Invasion, and EMT in Hepatocellular Carcinoma Cells.Oncol Res. 2017 Jan 2;25(1):11-18. doi: 10.3727/096504016X14685034103833.
• [3020] Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1.Clin Cancer Res. 2017 Apr 15;23(8):1920-1928. doi: 10.1158/1078-0432.CCR-16-1741. Epub 2016 Nov 8.
• [3021] Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.Cancer Res. 2006 Feb 1;66(3):1464-72. doi: 10.1158/0008-5472.CAN-05-1913.
• [3022] AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation.Nat Cell Biol. 2015 Jan;17(1):20-30. doi: 10.1038/ncb3072. Epub 2014 Dec 1.
• [3023] Clinical, Pathologic, and Genetic Features of Wilms Tumors With WTX Gene Mutation.Pediatr Dev Pathol. 2017 Mar-Apr;20(2):105-111. doi: 10.1177/1093526616683881. Epub 2017 Jan 26.
• [3024] Mllerian inhibiting substance/anti-Mllerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria.Oncol Lett. 2019 Jan;17(1):532-538. doi: 10.3892/ol.2018.9565. Epub 2018 Oct 10.
• [3025] Loss of AMIGO2 causes dramatic damage to cardiac preservation after ischemic injury.Cardiol J. 2019;26(4):394-404. doi: 10.5603/CJ.a2018.0049. Epub 2018 May 2.
• [3026] Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia?.Expert Opin Investig Drugs. 2005 Aug;14(8):1063-6. doi: 10.1517/13543784.14.8.1063.
• [3027] Expression patterns of AMP-deaminase isozymes in human hepatocellular carcinoma (HCC).Mol Cell Biochem. 2008 Nov;318(1-2):1-5. doi: 10.1007/s11010-008-9773-x. Epub 2008 May 21.
• [3028] The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.Cancer Lett. 2015 Apr 28;360(1):68-75. doi: 10.1016/j.canlet.2015.02.004. Epub 2015 Feb 7.
• [3029] Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer.Sci Rep. 2018 May 9;8(1):7386. doi: 10.1038/s41598-018-25631-1.
• [3030] Angiopoietin-4 increases permeability of blood vessels and promotes lymphatic dilation.FASEB J. 2015 Sep;29(9):3668-77. doi: 10.1096/fj.14-268920. Epub 2015 May 14.
• [3031] Angiopoietin-like protein 1 inhibits epithelial to mesenchymal transition in colorectal cancer cells via suppress Slug expression.Cytotechnology. 2019 Feb;71(1):35-44. doi: 10.1007/s10616-018-0259-8. Epub 2019 Jan 4.
• [3032] Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity.Genes Dev. 2019 Dec 1;33(23-24):1641-1656. doi: 10.1101/gad.329417.119. Epub 2019 Nov 14.
• [3033] Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs.J Biol Chem. 2018 Jun 22;293(25):9570-9579. doi: 10.1074/jbc.RA117.000975. Epub 2018 Apr 25.
• [3034] LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ER pathway.Nat Commun. 2018 Oct 9;9(1):4180. doi: 10.1038/s41467-018-06309-8.
• [3035] ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.Sci Rep. 2017 Jun 30;7(1):4430. doi: 10.1038/s41598-017-04818-y.
• [3036] ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma.Cancer Genet. 2019 Oct;238:10-17. doi: 10.1016/j.cancergen.2019.07.002. Epub 2019 Jul 5.
• [3037] A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice.BMC Cancer. 2019 Sep 13;19(1):914. doi: 10.1186/s12885-019-6102-6.
• [3038] ANKRD9 is associated with tumor suppression as a substrate receptor subunit of ubiquitin ligase.Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3145-3153. doi: 10.1016/j.bbadis.2018.07.001. Epub 2018 Jul 3.
• [3039] Clinical relevance of cytoskeleton associated proteins for ovarian cancer.J Cancer Res Clin Oncol. 2018 Nov;144(11):2195-2205. doi: 10.1007/s00432-018-2710-9. Epub 2018 Aug 9.
• [3040] HARP111-136 enhances radiation-induced apoptosis of U87MG glioblastoma by induction of the proapoptotic protein CHOP.Int J Oncol. 2011 Jan;38(1):179-88.
• [3041] Multifunctional anti-angiogenic activity of the cyclic peroxide ANO-2 with antitumor activity.Int J Cancer. 2002 Jul 10;100(2):220-7. doi: 10.1002/ijc.10469.
• [3042] Whole exome sequencing links dental tumor to an autosomal-dominant mutation in ANO5 gene associated with gnathodiaphyseal dysplasia and muscle dystrophies.Sci Rep. 2016 May 24;6:26440. doi: 10.1038/srep26440.
• [3043] CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.Cancer Res. 2017 Mar 1;77(5):1097-1107. doi: 10.1158/0008-5472.CAN-16-0786. Epub 2016 Dec 6.
• [3044] Expression of pp32 gene family members in breast cancer.Breast Cancer Res Treat. 2001 Jul;68(1):65-73. doi: 10.1023/a:1017919507109.
• [3045] ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1.Mol Oncol. 2018 Jun;12(6):896-912. doi: 10.1002/1878-0261.12202. Epub 2018 Apr 18.
• [3046] The role of PIP5K1/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1 inhibitor.Oncogene. 2019 Jan;38(3):375-389. doi: 10.1038/s41388-018-0438-2. Epub 2018 Aug 13.
• [3047] Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.Cell Death Dis. 2018 Jan 26;9(2):126. doi: 10.1038/s41419-017-0143-z.
• [3048] The role of annexin A4 in cancer.Front Biosci (Landmark Ed). 2016 Jun 1;21(5):949-57. doi: 10.2741/4432.
• [3049] Annexin A7 is correlated with better clinical outcomes of patients with breast cancer.J Cell Biochem. 2018 Sep;119(9):7577-7584. doi: 10.1002/jcb.27087. Epub 2018 Jun 12.
• [3050] Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.Oncotarget. 2017 Feb 14;8(7):12158-12173. doi: 10.18632/oncotarget.14555.
• [3051] 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.Cancer Res. 2000 Oct 1;60(19):5371-5.
• [3052] Gene expression analyses of grade II gliomas and identification of rPTPbeta/zeta as a candidate oligodendroglioma marker.Neuro Oncol. 2008 Feb;10(1):2-9. doi: 10.1215/15228517-2007-041. Epub 2007 Nov 14.
• [3053] Concordant DNA methylation in synchronous colorectal carcinomas.Cancer Prev Res (Phila). 2009 Sep;2(9):814-22. doi: 10.1158/1940-6207.CAPR-09-0054. Epub 2009 Sep 8.
• [3054] Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells.J Biol Chem. 2011 May 27;286(21):18492-504. doi: 10.1074/jbc.M110.189811. Epub 2011 Mar 26.
• [3055] Silencing of SRA1 Regulates ER Expression and Attenuates the Growth of Stromal Cells in Ovarian Endometriosis.Reprod Sci. 2017 Jun;24(6):836-843. doi: 10.1177/1933719116670036. Epub 2016 Sep 30.
• [3056] APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner.Gynecol Oncol. 2017 Dec;147(3):663-671. doi: 10.1016/j.ygyno.2017.10.016. Epub 2017 Oct 24.
• [3057] The prognostic correlation between CD105 expression level in tumor tissue and peripheral blood and sunitinib administration in advanced hepatocellular carcinoma.Cancer Biol Ther. 2018;19(11):1006-1014. doi: 10.1080/15384047.2018.1470731. Epub 2018 Sep 5.
• [3058] API5 confers cancer stem cell-like properties through the FGF2-NANOG axis.Oncogenesis. 2017 Jan 16;6(1):e285. doi: 10.1038/oncsis.2016.87.
• [3059] APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.Oncotarget. 2016 Apr 19;7(16):21601-17. doi: 10.18632/oncotarget.7802.
• [3060] Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract.Endocr Relat Cancer. 2008 Jun;15(2):569-81. doi: 10.1677/ERC-07-0145. Epub 2008 Apr 22.
• [3061] Pancancer analysis identifies prognostic high-APOBEC1 expression level implicated in cancer in-frame insertions and deletions.Carcinogenesis. 2018 Mar 8;39(3):327-335. doi: 10.1093/carcin/bgy005.
• [3062] Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.BMC Med Genomics. 2019 Sep 18;12(1):131. doi: 10.1186/s12920-019-0579-3.
• [3063] Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling.Cancer Manag Res. 2019 Apr 30;11:3691-3701. doi: 10.2147/CMAR.S202799. eCollection 2019.
• [3064] Multifunctional protein APPL2 contributes to survival of human glioma cells.Mol Oncol. 2013 Feb;7(1):67-84. doi: 10.1016/j.molonc.2012.08.003. Epub 2012 Sep 5.
• [3065] Radiation-Induced Changes in Tumor Vessels and Microenvironment Contribute to Therapeutic Resistance in Glioblastoma.Front Oncol. 2019 Nov 15;9:1259. doi: 10.3389/fonc.2019.01259. eCollection 2019.
• [3066] Human colorectal cancer initiation is bidirectional, and cell growth, metabolic genes and transporter genes are early drivers of tumorigenesis.Cancer Lett. 2018 Sep 1;431:213-218. doi: 10.1016/j.canlet.2018.06.005. Epub 2018 Jun 6.
• [3067] The Caenorhabditis elegans NF2/Merlin Molecule NFM-1 Nonautonomously Regulates Neuroblast Migration and Interacts Genetically with the Guidance Cue SLT-1/Slit.Genetics. 2017 Feb;205(2):737-748. doi: 10.1534/genetics.116.191957. Epub 2016 Dec 2.
• [3068] Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity.J Cell Physiol. 2010 Jul;224(1):33-40. doi: 10.1002/jcp.22085.
• [3069] The Small GTPase ARF6 Activates PI3K in Melanoma to Induce a Prometastatic State.Cancer Res. 2019 Jun 1;79(11):2892-2908. doi: 10.1158/0008-5472.CAN-18-3026. Epub 2019 May 2.
• [3070] Involvement of small ArfGAP1 (SMAP1), a novel Arf6-specific GTPase-activating protein, in microsatellite instability oncogenesis.Oncogene. 2014 May 22;33(21):2758-67. doi: 10.1038/onc.2013.211. Epub 2013 Jun 10.
• [3071] RNA-Seq analysis of interferon inducible p204-mediated network in anti-tumor immunity.Sci Rep. 2018 Apr 24;8(1):6495. doi: 10.1038/s41598-018-24561-2.
• [3072] Biophysical characterization of the breast cancer-related BIG3-PHB2 interaction: Effect of non-conserved loop region of BIG3 on the structure and the interaction.Biochem Biophys Res Commun. 2019 Oct 8;518(1):183-189. doi: 10.1016/j.bbrc.2019.08.028. Epub 2019 Aug 14.
• [3073] DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.J Biol Chem. 2020 Jan 10;295(2):645-656. doi: 10.1074/jbc.RA119.011929. Epub 2019 Dec 5.
• [3074] CXCL12 promotes human ovarian cancer cell invasion through suppressing ARHGAP10 expression.Biochem Biophys Res Commun. 2019 Oct 20;518(3):416-422. doi: 10.1016/j.bbrc.2019.07.098. Epub 2019 Aug 22.
• [3075] ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer.Gene. 2019 Apr 15;692:9-16. doi: 10.1016/j.gene.2019.01.004. Epub 2019 Jan 11.
• [3076] Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.Br J Cancer. 2017 Oct 10;117(8):1176-1184. doi: 10.1038/bjc.2017.261. Epub 2017 Aug 22.
• [3077] SMURF1-mediated ubiquitination of ARHGAP26 promotes ovarian cancer cell invasion and migration.Exp Mol Med. 2019 Apr 19;51(4):1-12. doi: 10.1038/s12276-019-0236-0.
• [3078] Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy. Blood. 2009 Mar 19;113(12):2715-22. doi: 10.1182/blood-2008-05-158956. Epub 2008 Dec 18.
• [3079] ARHGAP6 regulates the proliferation, migration and invasion of lung cancer cells.Oncol Rep. 2019 Apr;41(4):2281-2888. doi: 10.3892/or.2019.7031. Epub 2019 Feb 25.
• [3080] Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer.J Cell Biochem. 2018 Sep;119(9):7747-7756. doi: 10.1002/jcb.27127. Epub 2018 Jun 15.
• [3081] Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer.Oncogene. 2019 Jul;38(28):5700-5724. doi: 10.1038/s41388-019-0823-5. Epub 2019 May 1.
• [3082] Prognostic value of Rho GDP dissociation inhibitors in patients with hepatocellular carcinoma following liver transplantation.Oncol Lett. 2017 Aug;14(2):1395-1402. doi: 10.3892/ol.2017.6333. Epub 2017 Jun 7.
• [3083] miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.Tumour Biol. 2012 Dec;33(6):1863-70. doi: 10.1007/s13277-012-0446-8. Epub 2012 Oct 16.
• [3084] PDZ-RhoGEF Is a Signaling Effector for TROY-Induced Glioblastoma Cell Invasion and Survival.Neoplasia. 2018 Oct;20(10):1045-1058. doi: 10.1016/j.neo.2018.08.008. Epub 2018 Sep 13.
• [3085] LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer.Oncogene. 2009 Nov 26;28(47):4189-200. doi: 10.1038/onc.2009.266. Epub 2009 Sep 7.
• [3086] SGEF Is Regulated via TWEAK/Fn14/NF-B Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide.Mol Cancer Res. 2016 Mar;14(3):302-12. doi: 10.1158/1541-7786.MCR-15-0183. Epub 2016 Jan 13.
• [3087] GEFT protein expression in digestive tract malignant tumors and its clinical significance.Oncol Lett. 2019 Nov;18(5):5577-5590. doi: 10.3892/ol.2019.10915. Epub 2019 Sep 24.
• [3088] ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.Lab Invest. 2018 May;98(5):670-681. doi: 10.1038/s41374-018-0022-y. Epub 2018 Jan 30.
• [3089] The tumor suppressor Sef is a scaffold for the classical NF-B/RELA:P50 signaling module.Cell Signal. 2019 Jul;59:110-121. doi: 10.1016/j.cellsig.2019.01.009. Epub 2019 Mar 9.
• [3090] Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.Am J Surg Pathol. 2018 Jun;42(6):750-760. doi: 10.1097/PAS.0000000000001042.
• [3091] Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.J Pathol. 2019 Apr;247(4):494-504. doi: 10.1002/path.5208. Epub 2019 Jan 16.
• [3092] Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.Int J Cancer. 2014 Aug 1;135(3):611-23. doi: 10.1002/ijc.28705. Epub 2014 Jan 13.
• [3093] Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.Hum Pathol. 2018 Mar;73:114-121. doi: 10.1016/j.humpath.2017.12.012. Epub 2017 Dec 27.
• [3094] Association between 5-reductase inhibitors therapy and incidence, cancer-specific mortality, and progression of prostate cancer: evidence from a meta-analysis.Asian J Androl. 2020 Sep-Oct;22(5):532-538. doi: 10.4103/aja.aja_112_19.
• [3095] MAPping the kinase landscape of macrophage activation.J Biol Chem. 2018 Jun 22;293(25):9910-9911. doi: 10.1074/jbc.H118.003380.
• [3096] Disruption of the ciliary GTPase Arl13b suppresses Sonic hedgehog overactivation and inhibits medulloblastoma formation.Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1570-1575. doi: 10.1073/pnas.1706977115. Epub 2018 Jan 29.
• [3097] A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report.BMC Med Genet. 2018 Mar 27;19(1):49. doi: 10.1186/s12881-018-0564-2.
• [3098] Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.Cancer Res. 2001 Nov 1;61(21):7900-7.
• [3099] Overexpression of ARNT2 is associated with decreased cell proliferation and better prognosis in gastric cancer.Mol Cell Biochem. 2019 Jan;450(1-2):97-103. doi: 10.1007/s11010-018-3376-y. Epub 2018 Jun 12.
• [3100] Aberrant expression of Arpin in human breast cancer and its clinical significance.J Cell Mol Med. 2016 Mar;20(3):450-8. doi: 10.1111/jcmm.12740. Epub 2015 Dec 9.
• [3101] Increased ARPP-19 expression is associated with hepatocellular carcinoma.Int J Mol Sci. 2014 Dec 24;16(1):178-92. doi: 10.3390/ijms16010178.
• [3102] Risk Factors for Fatal Pulmonary Hemorrhage following Concurrent Chemoradiotherapy in Stage 3B/C Squamous-Cell Lung Carcinoma Patients.J Oncol. 2018 Nov 1;2018:4518935. doi: 10.1155/2018/4518935. eCollection 2018.
• [3103] Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.Int J Gynecol Cancer. 2013 Jul;23(6):990-6. doi: 10.1097/IGC.0b013e31829783e3.
• [3104] Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.Oncotarget. 2016 Apr 12;7(15):19960-74. doi: 10.18632/oncotarget.6963.
• [3105] LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma.World J Gastroenterol. 2010 Apr 28;16(16):2046-54. doi: 10.3748/wjg.v16.i16.2046.
• [3106] Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-B signaling.Exp Cell Res. 2018 Apr 1;365(1):12-23. doi: 10.1016/j.yexcr.2018.02.008. Epub 2018 Feb 14.
• [3107] Acid Ceramidase: A Novel Therapeutic Target in Cancer.Curr Top Med Chem. 2019;19(17):1512-1520. doi: 10.2174/1568026619666190227222930.
• [3108] The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer.Cancer Immunol Res. 2018 Mar;6(3):358-369. doi: 10.1158/2326-6066.CIR-17-0518. Epub 2018 Jan 25.
• [3109] An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1-Positive Lung Adenocarcinomas.J Thorac Oncol. 2018 Nov;13(11):1676-1691. doi: 10.1016/j.jtho.2018.07.096. Epub 2018 Aug 16.
• [3110] Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models.PLoS One. 2019 Jan 25;14(1):e0210261. doi: 10.1371/journal.pone.0210261. eCollection 2019.
• [3111] Arterial spin-labeling is useful for the diagnosis of residual or recurrent meningiomas.Eur Radiol. 2018 Oct;28(10):4334-4342. doi: 10.1007/s00330-018-5404-4. Epub 2018 Apr 13.
• [3112] Rhodospirillum rubruml-asparaginase targets tumor growth by a dual mechanism involving telomerase inhibition.Biochem Biophys Res Commun. 2017 Oct 14;492(2):282-288. doi: 10.1016/j.bbrc.2017.08.078. Epub 2017 Aug 23.
• [3113] Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.Oncotarget. 2015 Apr 20;6(11):8663-75. doi: 10.18632/oncotarget.3536.
• [3114] Multifaceted Roles of Asporin in Cancer: Current Understanding.Front Oncol. 2019 Sep 24;9:948. doi: 10.3389/fonc.2019.00948. eCollection 2019.
• [3115] LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.Biomed Pharmacother. 2018 Jan;97:1645-1653. doi: 10.1016/j.biopha.2017.12.004. Epub 2017 Dec 8.
• [3116] Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.Oncotarget. 2015 Oct 6;6(30):30194-211. doi: 10.18632/oncotarget.4734.
• [3117] The role of ASXL1 in hematopoiesis and myeloid malignancies.Cell Mol Life Sci. 2019 Jul;76(13):2511-2523. doi: 10.1007/s00018-019-03084-7. Epub 2019 Mar 30.
• [3118] Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.Nat Commun. 2018 Oct 22;9(1):4385. doi: 10.1038/s41467-018-06854-2.
• [3119] ATAD3A on the Path to Cancer.Adv Exp Med Biol. 2019;1134:259-269. doi: 10.1007/978-3-030-12668-1_14.
• [3120] Elg1, a central player in genome stability.Mutat Res Rev Mutat Res. 2015 Jan-Mar;763:267-79. doi: 10.1016/j.mrrev.2014.11.007. Epub 2014 Nov 24.
• [3121] Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis.Oncogene. 2019 Feb;38(6):838-851. doi: 10.1038/s41388-018-0462-2. Epub 2018 Sep 3.
• [3122] ATF2 promotes urothelial cancer outgrowth via cooperation with androgen receptor signaling.Endocr Connect. 2018 Dec 1;7(12):1397-1408. doi: 10.1530/EC-18-0364.
• [3123] Genistein induces apoptosis in vitro and has antitumor activity against human leukemia HL-60 cancer cell xenograft growth in vivo.Environ Toxicol. 2019 Apr;34(4):443-456. doi: 10.1002/tox.22698. Epub 2019 Jan 7.
• [3124] Autophagic Flux Is Regulated by Interaction Between the C-terminal Domain of PATCHED1 and ATG101.Mol Cancer Res. 2018 May;16(5):909-919. doi: 10.1158/1541-7786.MCR-17-0597. Epub 2018 Feb 16.
• [3125] Inhibition of autophagy initiation potentiates chemosensitivity in mesothelioma.Mol Carcinog. 2018 Mar;57(3):319-332. doi: 10.1002/mc.22757. Epub 2017 Nov 14.
• [3126] ATG5 cancer mutations and alternative mRNA splicing reveal a conjugation switch that regulates ATG12-ATG5-ATG16L1 complex assembly and autophagy.Cell Discov. 2019 Aug 27;5:42. doi: 10.1038/s41421-019-0110-1. eCollection 2019.
• [3127] Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3.Oncotarget. 2017 May 9;8(19):31714-31725. doi: 10.18632/oncotarget.15955.
• [3128] Autophagy maintains tumour growth through circulating arginine.Nature. 2018 Nov;563(7732):569-573. doi: 10.1038/s41586-018-0697-7. Epub 2018 Nov 14.
• [3129] The Influence of Tumor Microenvironment on ATG4D Gene Expression in Colorectal Cancer Patients.Med Oncol. 2018 Oct 29;35(12):159. doi: 10.1007/s12032-018-1220-6.
• [3130] Expression analysis of NF-B interacting long noncoding RNAs in breast cancer.Exp Mol Pathol. 2020 Feb;112:104359. doi: 10.1016/j.yexmp.2019.104359. Epub 2019 Dec 14.
• [3131] ATMIN Is a Tumor Suppressor Gene in Lung Adenocarcinoma.Cancer Res. 2019 Oct 15;79(20):5159-5166. doi: 10.1158/0008-5472.CAN-19-0647. Epub 2019 Sep 3.
• [3132] Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma.J Cancer Res Clin Oncol. 2017 Jan;143(1):43-49. doi: 10.1007/s00432-016-2257-6. Epub 2016 Sep 13.
• [3133] Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice.Mol Nutr Food Res. 2015 Aug;59(8):1419-30. doi: 10.1002/mnfr.201500028. Epub 2015 Jun 26.
• [3134] Differential expression of PMCA2 mRNA isoforms in a cohort of Spanish patients with breast tumor types.Oncol Lett. 2018 Dec;16(6):6950-6959. doi: 10.3892/ol.2018.9540. Epub 2018 Oct 2.
• [3135] Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.Endocr Relat Cancer. 2015 Oct;22(5):735-44. doi: 10.1530/ERC-15-0321.
• [3136] Investigation of the association between ATP2B4 and ATP5B genes with colorectal cancer.Gene. 2014 May 1;540(2):178-82. doi: 10.1016/j.gene.2014.02.050. Epub 2014 Feb 26.
• [3137] Inhibition of microRNA?39 suppresses the development of human nonsmall cell lung cancer via the upregulation of tissue inhibitor of metalloproteinases 2.Mol Med Rep. 2018 Dec;18(6):4831-4838. doi: 10.3892/mmr.2018.9502. Epub 2018 Sep 20.
• [3138] Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance.J Clin Invest. 2018 Aug 31;128(9):4098-4114. doi: 10.1172/JCI96804. Epub 2018 Aug 20.
• [3139] Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking Infection.Clin Cancer Res. 2019 Nov 1;25(21):6283-6294. doi: 10.1158/1078-0432.CCR-18-1800. Epub 2019 May 23.
• [3140] Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2-mediated tumor progression.J Clin Invest. 2019 Feb 1;129(2):631-646. doi: 10.1172/JCI123027. Epub 2019 Jan 7.
• [3141] Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.Oncotarget. 2017 Jul 18;8(29):47675-47690. doi: 10.18632/oncotarget.17544.
• [3142] Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration.Clin Cancer Res. 2006 Nov 1;12(21):6331-6. doi: 10.1158/1078-0432.CCR-06-1296.
• [3143] Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma.Int J Hematol. 2020 Jan;111(1):75-83. doi: 10.1007/s12185-019-02766-z. Epub 2019 Nov 4.
• [3144] MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.Vascul Pharmacol. 2019 May;116:24-35. doi: 10.1016/j.vph.2017.07.002. Epub 2017 Jul 8.
• [3145] Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.Cancer Lett. 2019 Mar 1;444:127-135. doi: 10.1016/j.canlet.2018.12.009. Epub 2018 Dec 21.
• [3146] Changes in the microarchitecture of the pancreatic cancer stroma are linked to neutrophil-dependent reprogramming of stellate cells and reflected by diffusion-weighted magnetic resonance imaging.Theranostics. 2018 Jan 1;8(1):13-30. doi: 10.7150/thno.21089. eCollection 2018.
• [3147] High Expression B3GAT3 Is Related with Poor Prognosis of Liver Cancer.Open Med (Wars). 2019 Feb 26;14:251-258. doi: 10.1515/med-2019-0020. eCollection 2019.
• [3148] 12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.Cytokine. 2017 Aug;96:217-227. doi: 10.1016/j.cyto.2017.04.021. Epub 2017 Apr 28.
• [3149] Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.Int J Cancer. 2013 Dec 15;133(12):2824-33. doi: 10.1002/ijc.28322. Epub 2013 Aug 5.
• [3150] The Immunological Regulation Roles of Porcine -1, 4 Galactosyltransferase V (B4GALT5) in PRRSV Infection.Front Cell Infect Microbiol. 2018 Mar 1;8:48. doi: 10.3389/fcimb.2018.00048. eCollection 2018.
• [3151] B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.BMC Cancer. 2018 May 24;18(1):590. doi: 10.1186/s12885-018-4497-0.
• [3152] Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.Aging (Albany NY). 2018 Oct 12;10(10):2606-2623. doi: 10.18632/aging.101573.
• [3153] High levels of -glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.
• [3154] Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism.Oncogene. 2019 May;38(18):3325-3339. doi: 10.1038/s41388-018-0673-6. Epub 2019 Jan 11.
• [3155] BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function.Elife. 2015 Aug 13;4:e08401. doi: 10.7554/eLife.08401.
• [3156] Bcl? associated athanogene 4 promotes proliferation, migration and invasion of gastric cancer cells.Mol Med Rep. 2017 Oct;16(4):3753-3760. doi: 10.3892/mmr.2017.7073. Epub 2017 Jul 21.
• [3157] GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.Pharmacogenomics J. 2009 Jun;9(3):202-7. doi: 10.1038/tpj.2009.5. Epub 2009 Mar 10.
• [3158] BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design.Nat Chem Biol. 2019 Jul;15(7):672-680. doi: 10.1038/s41589-019-0294-6. Epub 2019 Jun 10.
• [3159] SMAR1 promotes immune escape of Tri-negative Breast Cancer through a mechanism involving T-bet/PD-1 Axis.Cell Mol Biol (Noisy-le-grand). 2018 Sep 30;64(12):70-75.
• [3160] Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.Thorac Cancer. 2018 Mar;9(3):390-399. doi: 10.1111/1759-7714.12593. Epub 2018 Jan 17.
• [3161] Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity.J Exp Med. 2019 Jun 3;216(6):1359-1376. doi: 10.1084/jem.20180660. Epub 2019 Apr 18.
• [3162] Bombesin induces angiogenesis and neuroblastoma growth.Cancer Lett. 2007 Aug 18;253(2):273-81. doi: 10.1016/j.canlet.2007.02.007. Epub 2007 Mar 26.
• [3163] MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer.Cell Death Dis. 2019 Feb 15;10(3):152. doi: 10.1038/s41419-019-1403-x.
• [3164] High Expression of BCCIP Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.Dig Dis Sci. 2017 Feb;62(2):387-395. doi: 10.1007/s10620-016-4382-0. Epub 2016 Dec 19.
• [3165] Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):285-92.
• [3166] BCLB, methylated in hepatocellular carcinoma, is a starvation stresssensor that induces apoptosis and autophagy through theAMPK-mTOR signaling cascade.Cancer Lett. 2017 Jun 1;395:63-71. doi: 10.1016/j.canlet.2017.02.030. Epub 2017 Mar 2.
• [3167] Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.Cell Oncol (Dordr). 2019 Jun;42(3):369-380. doi: 10.1007/s13402-019-00432-4. Epub 2019 Feb 20.
• [3168] Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5682-7. doi: 10.1073/pnas.1316700111. Epub 2014 Mar 31.
• [3169] BCL-3 promotes a cancer stem cell phenotype by enhancing -catenin signalling in colorectal tumour cells.Dis Model Mech. 2019 Mar 4;12(3):dmm037697. doi: 10.1242/dmm.037697.
• [3170] Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis.Theranostics. 2019 Oct 18;9(26):8182-8195. doi: 10.7150/thno.34983. eCollection 2019.
• [3171] Genipin as a novel chemical activator of EBV lytic cycle.J Microbiol. 2015 Feb;53(2):155-65. doi: 10.1007/s12275-015-4672-9. Epub 2015 Jan 28.
• [3172] The Tumor Suppressor BCL7B Functions in the Wnt Signaling Pathway.PLoS Genet. 2015 Jan 8;11(1):e1004921. doi: 10.1371/journal.pgen.1004921. eCollection 2015 Jan.
• [3173] Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models.Nat Commun. 2019 Feb 13;10(1):724. doi: 10.1038/s41467-018-08164-z.
• [3174] Bclaf1 promotes angiogenesis by regulating HIF-1 transcription in hepatocellular carcinoma.Oncogene. 2019 Mar;38(11):1845-1859. doi: 10.1038/s41388-018-0552-1. Epub 2018 Oct 26.
• [3175] High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.Brain Pathol. 2020 Jan;30(1):46-62. doi: 10.1111/bpa.12747. Epub 2019 Jun 10.
• [3176] MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1.Biomed Pharmacother. 2018 Jul;103:645-652. doi: 10.1016/j.biopha.2018.04.037. Epub 2018 Apr 24.
• [3177] Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention.Br J Cancer. 2020 Jan;122(1):102-110. doi: 10.1038/s41416-019-0638-8. Epub 2019 Dec 10.
• [3178] RNA polymerase III transcription in cancer: the BRF2 connection.Mol Cancer. 2011 Apr 25;10:47. doi: 10.1186/1476-4598-10-47.
• [3179] The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion.Sci Rep. 2018 Jan 18;8(1):1032. doi: 10.1038/s41598-018-19389-9.
• [3180] Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.Oncol Rep. 2018 Nov;40(5):2778-2787. doi: 10.3892/or.2018.6647. Epub 2018 Aug 17.
• [3181] BEX2 promotes tumor proliferation in colorectal cancer.Int J Biol Sci. 2017 Feb 12;13(3):286-294. doi: 10.7150/ijbs.15171. eCollection 2017.
• [3182] Induction of Bex genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells.Sci Rep. 2017 Feb 1;7:41420. doi: 10.1038/srep41420.
• [3183] Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma.J Exp Clin Cancer Res. 2016 Jun 13;35(1):92. doi: 10.1186/s13046-016-0355-6.
• [3184] Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance.Cancers (Basel). 2018 Aug 18;10(8):274. doi: 10.3390/cancers10080274.
• [3185] Interaction with SP1, but not binding to the E-box motifs, is responsible for BHLHE40/DEC1-induced transcriptional suppression of CLDN1 and cell invasion in MCF-7 cells.Mol Carcinog. 2018 Sep;57(9):1116-1129. doi: 10.1002/mc.22829. Epub 2018 May 2.
• [3186] MicroRNA-873 acts as a tumor suppressor in esophageal cancer by inhibiting differentiated embryonic chondrocyte expressed gene 2.Biomed Pharmacother. 2018 Sep;105:582-589. doi: 10.1016/j.biopha.2018.05.152. Epub 2018 Jun 8.
• [3187] Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.Tumour Biol. 2016 May;37(5):5911-7. doi: 10.1007/s13277-015-4443-6. Epub 2015 Nov 23.
• [3188] A splicing variant leads to complete loss of function of betaine-homocysteine methyltransferase (BHMT) gene in hepatocellular carcinoma.Int J Biochem Cell Biol. 2012 Feb;44(2):385-92. doi: 10.1016/j.biocel.2011.11.014. Epub 2011 Nov 26.
• [3189] High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.Oncol Lett. 2018 Nov;16(5):6749-6755. doi: 10.3892/ol.2018.9490. Epub 2018 Sep 24.
• [3190] Azidothymidine is effective against human multiple myeloma: a new use for an old drug?.Anticancer Agents Med Chem. 2013 Jan;13(1):186-92.
• [3191] BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes.Oncogene. 2008 Dec;27 Suppl 1(Suppl 1):S20-9. doi: 10.1038/onc.2009.40.
• [3192] Aristolochic acid I interferes with the expression of BLCAP tumor suppressor gene in human cells.Toxicol Lett. 2018 Jul;291:129-137. doi: 10.1016/j.toxlet.2018.03.032. Epub 2018 Apr 12.
• [3193] MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells.FEBS Lett. 2015 Mar 24;589(7):805-11. doi: 10.1016/j.febslet.2015.02.013. Epub 2015 Feb 26.
• [3194] Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p.Cancer Res. 2019 Oct 1;79(19):4882-4895. doi: 10.1158/0008-5472.CAN-18-3880. Epub 2019 Aug 13.
• [3195] NRAS-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3K.Cancer Res. 2018 Apr 15;78(8):2000-2013. doi: 10.1158/0008-5472.CAN-17-1737. Epub 2018 Feb 6.
• [3196] BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.J Exp Clin Cancer Res. 2019 Oct 28;38(1):428. doi: 10.1186/s13046-019-1435-1.
• [3197] Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.Cell Physiol Biochem. 2018;45(5):1759-1771. doi: 10.1159/000487784. Epub 2018 Feb 23.
• [3198] BMPR1B up-regulation via a miRNA binding site variation defines endometriosis susceptibility and CA125 levels.PLoS One. 2013 Dec 5;8(12):e80630. doi: 10.1371/journal.pone.0080630. eCollection 2013.
• [3199] Adenoid cystic carcinoma of head and neck: A retrospective clinical analysis of a single institution.Auris Nasus Larynx. 2018 Aug;45(4):831-837. doi: 10.1016/j.anl.2017.10.009. Epub 2018 Apr 10.
• [3200] Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood.Clin Epigenetics. 2019 Apr 5;11(1):59. doi: 10.1186/s13148-019-0650-0.
• [3201] Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma.Cancer Res. 2019 Oct 15;79(20):5218-5232. doi: 10.1158/0008-5472.CAN-19-0198. Epub 2019 Sep 5.
• [3202] BolA family member 2 enhances cell proliferation and predicts a poor prognosis in hepatocellular carcinoma with tumor hemorrhage.J Cancer. 2019 Jul 10;10(18):4293-4304. doi: 10.7150/jca.31829. eCollection 2019.
• [3203] Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression.Oncogene. 2019 Nov;38(47):7200-7215. doi: 10.1038/s41388-019-0914-3. Epub 2019 Sep 5.
• [3204] BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.Oncogene. 2020 Mar;39(11):2305-2327. doi: 10.1038/s41388-019-1125-7. Epub 2019 Dec 16.
• [3205] BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-/PI3K/AKT/mTOR signalling pathway.Cell Oncol (Dordr). 2020 Apr;43(2):223-235. doi: 10.1007/s13402-019-00482-8. Epub 2019 Nov 27.
• [3206] BRCC3 mutations in myeloid neoplasms.Haematologica. 2015 Aug;100(8):1051-7. doi: 10.3324/haematol.2014.111989. Epub 2015 May 22.
• [3207] Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer.Dis Markers. 2012;32(3):195-202. doi: 10.3233/DMA-2011-0877.
• [3208] FUP1, a gene associated with hepatocellular carcinoma, stimulates NIH3T3 cell proliferation and tumor formation in nude mice.Biochem Biophys Res Commun. 2001 Sep 7;286(5):1033-8. doi: 10.1006/bbrc.2001.5478.
• [3209] Oncological patients admitted to an intensive care unit. Analysis of predictors of in-hospital mortality.Med Intensiva (Engl Ed). 2018 Aug-Sep;42(6):346-353. doi: 10.1016/j.medin.2018.02.001. Epub 2018 Mar 15.
• [3210] Zwitterionic chitooligosaccharide-modified ink-blue titanium dioxide nanoparticles with inherent immune activation for enhanced photothermal therapy.Biomater Sci. 2019 Nov 19;7(12):5027-5034. doi: 10.1039/c9bm01170f.
• [3211] Basic transcription factor 3 expression silencing attenuates colon cancer cell proliferation and migration in vitro.Oncol Lett. 2019 Jan;17(1):113-118. doi: 10.3892/ol.2018.9613. Epub 2018 Oct 24.
• [3212] Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice.Endocr Relat Cancer. 2019 Jan 1;26(1):13-29. doi: 10.1530/ERC-18-0337.
• [3213] Oleuropein inhibits esophageal cancer through hypoxic suppression of BTG3 mRNA.Food Funct. 2019 Feb 20;10(2):978-985. doi: 10.1039/c8fo02223b.
• [3214] Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer.Biochem Biophys Res Commun. 2009 Sep 11;387(1):132-8. doi: 10.1016/j.bbrc.2009.06.140. Epub 2009 Jul 1.
• [3215] Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector T cells with antitumor activity.Oncoimmunology. 2017 Jan 6;6(3):e1278099. doi: 10.1080/2162402X.2016.1278099. eCollection 2017.
• [3216] BTN3A is a prognosis marker and a promising target for V9V2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC).Oncoimmunology. 2017 Sep 21;7(1):e1372080. doi: 10.1080/2162402X.2017.1372080. eCollection 2017.
• [3217] Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma.JAMA Ophthalmol. 2016 Oct 1;134(10):1125-1133. doi: 10.1001/jamaophthalmol.2016.2691.
• [3218] The -TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor.Nat Commun. 2017 Jan 16;8:14002. doi: 10.1038/ncomms14002.
• [3219] Melanoma genome evolution across species.BMC Genomics. 2017 Feb 7;18(1):136. doi: 10.1186/s12864-017-3518-8.
• [3220] Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome.Pigment Cell Melanoma Res. 2019 Jul;32(4):564-575. doi: 10.1111/pcmr.12767. Epub 2019 Feb 19.
• [3221] Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer.Nucleic Acids Res. 2018 Jun 20;46(11):5809-5821. doi: 10.1093/nar/gky214.
• [3222] Hypermethylation of normal mucosa of esophagus-specific 1 is associated with an unfavorable prognosis in patients with non-small cell lung cancer.Oncol Lett. 2018 Aug;16(2):2409-2415. doi: 10.3892/ol.2018.8915. Epub 2018 Jun 6.
• [3223] Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?.Crit Rev Oncol Hematol. 2019 Mar;135:66-75. doi: 10.1016/j.critrevonc.2019.01.016. Epub 2019 Jan 30.
• [3224] Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.BMC Cancer. 2018 Aug 16;18(1):827. doi: 10.1186/s12885-018-4708-8.
• [3225] Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.Int J Clin Exp Pathol. 2015 Mar 1;8(3):2590-602. eCollection 2015.
• [3226] C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.Nat Commun. 2016 Feb 1;7:10346. doi: 10.1038/ncomms10346.
• [3227] Corticotropin-releasing factor suppresses glioma progression by upregulation of long non-coding RNA-p21.Life Sci. 2019 Jan 1;216:92-100. doi: 10.1016/j.lfs.2018.07.003. Epub 2018 Jul 5.
• [3228] Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma.Int J Oncol. 2018 Jan;52(1):139-154. doi: 10.3892/ijo.2017.4199. Epub 2017 Nov 9.
• [3229] CD10(+)GPR77(+) Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness.Cell. 2018 Feb 8;172(4):841-856.e16. doi: 10.1016/j.cell.2018.01.009. Epub 2018 Jan 25.
• [3230] Low C6orf141 Expression is Significantly Associated with a Poor Prognosis in Patients with Oral Cancer.Sci Rep. 2019 Mar 14;9(1):4520. doi: 10.1038/s41598-019-41194-1.
• [3231] CA10 and CA11 negatively regulate neuronal activity-dependent growth of gliomas.Mol Oncol. 2019 May;13(5):1018-1032. doi: 10.1002/1878-0261.12445. Epub 2019 Mar 20.
• [3232] Cables1 Inhibits Proliferation and Induces Senescence by Angiotensin II via a p21-Dependent Pathway in Human Umbilical Vein Endothelial Cells.J Vasc Res. 2017;54(1):13-21. doi: 10.1159/000452409. Epub 2017 Jan 25.
• [3233] Interactions between calcium intake and polymorphisms in genes essential for calcium reabsorption and risk of colorectal neoplasia in a two-phase study.Mol Carcinog. 2017 Oct;56(10):2258-2266. doi: 10.1002/mc.22678. Epub 2017 Jun 15.
• [3234] Flower isoforms promote competitive growth incancer.Nature. 2019 Aug;572(7768):260-264. doi: 10.1038/s41586-019-1429-3. Epub 2019 Jul 24.
• [3235] Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model.Clin Cancer Res. 2011 May 1;17(9):2934-46. doi: 10.1158/1078-0432.CCR-10-1803. Epub 2011 Jan 17.
• [3236] CACYBP Enhances Cytoplasmic Retention of P27(Kip1) to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation.Theranostics. 2019 Oct 22;9(26):8392-8408. doi: 10.7150/thno.36838. eCollection 2019.
• [3237] CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.J Exp Clin Cancer Res. 2018 Mar 5;37(1):46. doi: 10.1186/s13046-018-0699-1.
• [3238] Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer.Oncol Lett. 2018 Feb;15(2):2401-2406. doi: 10.3892/ol.2017.7536. Epub 2017 Dec 6.
• [3239] Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.Int J Mol Med. 2006 Oct;18(4):547-57.
• [3240] Downregulation of Calbindin 1 by miR-454-3p Suppresses Cell Proliferation in Nonsmall Cell Lung Cancer In Vitro.Cancer Biother Radiopharm. 2019 Mar;34(2):119-127. doi: 10.1089/cbr.2018.2598. Epub 2019 Jan 14.
• [3241] Modulation of Calretinin Expression in Human Mesothelioma Cells Reveals the Implication of the FAK and Wnt Signaling Pathways in Conferring Chemoresistance towards Cisplatin.Int J Mol Sci. 2019 Oct 29;20(21):5391. doi: 10.3390/ijms20215391.
• [3242] Structural and functional annotation of human FAM26F: A multifaceted protein having a critical role in the immune system.Gene. 2017 Jan 15;597:66-75. doi: 10.1016/j.gene.2016.10.029. Epub 2016 Oct 23.
• [3243] Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.Biochem Biophys Res Commun. 2018 Jun 2;500(2):170-176. doi: 10.1016/j.bbrc.2018.04.016. Epub 2018 Apr 11.
• [3244] CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.Mol Oncol. 2008 Dec;2(4):327-39. doi: 10.1016/j.molonc.2008.09.004. Epub 2008 Oct 2.
• [3245] Functional Analyses of RUNX3 and CaMKIIN in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIIN and Dichotomous Roles for RUNX3 Transcript Variants.Int J Mol Sci. 2018 Jan 15;19(1):253. doi: 10.3390/ijms19010253.
• [3246] MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4).Cell Death Dis. 2019 Oct 17;10(11):789. doi: 10.1038/s41419-019-1923-4.
• [3247] Immunohistochemical correlates of recurrent genetic alterations in sarcomas.Genes Chromosomes Cancer. 2019 Feb;58(2):111-123. doi: 10.1002/gcc.22700. Epub 2018 Dec 19.
• [3248] CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.Pathol Oncol Res. 2020 Jan;26(1):273-279. doi: 10.1007/s12253-018-0450-4. Epub 2018 Jul 26.
• [3249] In Situ One-Pot Synthesis of MOF-Polydopamine Hybrid Nanogels with Enhanced Photothermal Effect for Targeted Cancer Therapy.Adv Sci (Weinh). 2018 Apr 14;5(6):1800287. doi: 10.1002/advs.201800287. eCollection 2018 Jun.
• [3250] Capn4 overexpression indicates poor prognosis of ovarian cancer patients.J Cancer. 2018 Jan 1;9(2):304-309. doi: 10.7150/jca.22004. eCollection 2018.
• [3251] Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex.Hepatology. 2014 Nov;60(5):1686-96. doi: 10.1002/hep.27243. Epub 2014 Sep 19.
• [3252] Expression of F-actin-capping protein subunit beta, CAPZB, is associated with cell growth and motility in epithelioid sarcoma.BMC Cancer. 2016 Mar 10;16:206. doi: 10.1186/s12885-016-2235-z.
• [3253] Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating -catenin signaling pathway.Onco Targets Ther. 2019 Aug 9;12:6309-6322. doi: 10.2147/OTT.S191502. eCollection 2019.
• [3254] Targeting the CBM complex causes T(reg) cells to prime tumours for immune checkpoint therapy.Nature. 2019 Jun;570(7759):112-116. doi: 10.1038/s41586-019-1215-2. Epub 2019 May 15.
• [3255] TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer.J Biol Chem. 2001 Aug 24;276(34):32220-9. doi: 10.1074/jbc.M100433200. Epub 2001 Jun 14.
• [3256] CARD9 prevents lung cancer development by suppressing the expansion of myeloid-derived suppressor cells and IDO production.Int J Cancer. 2019 Oct 15;145(8):2225-2237. doi: 10.1002/ijc.32355. Epub 2019 May 6.
• [3257] SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.J Neurooncol. 2019 May;142(3):423-434. doi: 10.1007/s11060-019-03126-x. Epub 2019 Mar 5.
• [3258] An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses.Radiother Oncol. 2019 Oct;139:23-27. doi: 10.1016/j.radonc.2019.03.028. Epub 2019 Apr 19.
• [3259] Blocking the Cleavage of Filamin A by Calpain Inhibitor Decreases Tumor Cell Growth.Anticancer Res. 2018 Apr;38(4):2079-2085. doi: 10.21873/anticanres.12447.
• [3260] The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma.Dis Markers. 2019 Aug 6;2019:1342161. doi: 10.1155/2019/1342161. eCollection 2019.
• [3261] The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.Theranostics. 2018 Feb 7;8(6):1540-1557. doi: 10.7150/thno.22952. eCollection 2018.
• [3262] Elevation of PRKCDBP, a novel transcriptional target of TNF-, and its downregulation by infliximab in patients with ulcerative colitis.Dig Dis Sci. 2014 Dec;59(12):2947-57. doi: 10.1007/s10620-014-3282-4. Epub 2014 Jul 23.
• [3263] The p85 isoform of the kinase S6K1 functions as a secreted oncoprotein to facilitate cell migration and tumor growth.Sci Signal. 2018 Mar 27;11(523):eaao1052. doi: 10.1126/scisignal.aao1052.
• [3264] Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.Am J Hematol. 2017 Jun;92(6):520-528. doi: 10.1002/ajh.24710. Epub 2017 Apr 6.
• [3265] Subcutaneous inoculation position affects the immune environment in CT26 carcinomas.Biochem Biophys Res Commun. 2019 Apr 30;512(2):244-249. doi: 10.1016/j.bbrc.2019.03.042. Epub 2019 Mar 14.
• [3266] Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase.Prostate. 2019 Jun;79(8):864-871. doi: 10.1002/pros.23793. Epub 2019 Apr 7.
• [3267] CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.Int J Biochem Cell Biol. 2018 Feb;95:1-8. doi: 10.1016/j.biocel.2017.12.006. Epub 2017 Dec 8.
• [3268] CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.Cancer Med. 2019 Jul;8(8):3981-3991. doi: 10.1002/cam4.2320. Epub 2019 May 31.
• [3269] CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.J Neurooncol. 2019 Oct;145(1):35-48. doi: 10.1007/s11060-019-03286-w. Epub 2019 Sep 9.
• [3270] CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma.Cancer Res. 2016 Dec 15;76(24):7277-7289. doi: 10.1158/0008-5472.CAN-16-2100. Epub 2016 Nov 18.
• [3271] Heterochromatin Protein 1 Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.Cancer Res. 2018 May 15;78(10):2691-2704. doi: 10.1158/0008-5472.CAN-17-3677. Epub 2018 Feb 27.
• [3272] CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer.Sci Rep. 2019 Jan 17;9(1):197. doi: 10.1038/s41598-018-36560-4.
• [3273] Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer.Front Oncol. 2019 Oct 1;9:986. doi: 10.3389/fonc.2019.00986. eCollection 2019.
• [3274] Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth.Nat Commun. 2018 Jun 25;9(1):2464. doi: 10.1038/s41467-018-04815-3.
• [3275] Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology.Mutat Res Rev Mutat Res. 2018 Apr-Jun;776:1-9. doi: 10.1016/j.mrrev.2018.03.004. Epub 2018 Mar 19.
• [3276] CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.J Exp Clin Cancer Res. 2019 Mar 18;38(1):131. doi: 10.1186/s13046-019-1137-8.
• [3277] Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.BMC Genomics. 2018 Jun 11;19(1):450. doi: 10.1186/s12864-018-4827-2.
• [3278] Expression of tumor related gene NAG6 in gastric cancer and restriction fragment length polymorphism analysis.World J Gastroenterol. 2004 May 1;10(9):1361-4. doi: 10.3748/wjg.v10.i9.1361.
• [3279] Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers.Nat Commun. 2014 Aug 7;5:4577. doi: 10.1038/ncomms5577.
• [3280] Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.Int J Hematol. 2019 Jun;109(6):744-750. doi: 10.1007/s12185-019-02595-0. Epub 2019 Jan 31.
• [3281] Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma.Oncogene. 2015 Aug 6;34(32):4238-47. doi: 10.1038/onc.2014.357. Epub 2014 Nov 10.
• [3282] Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells.Hum Pathol. 2016 Oct;56:64-73. doi: 10.1016/j.humpath.2016.06.001. Epub 2016 Jun 21.
• [3283] Dro1/Ccdc80 inactivation promotes AOM/DSS-induced colorectal carcinogenesis and aggravates colitis by DSS in mice.Carcinogenesis. 2018 Sep 21;39(9):1176-1184. doi: 10.1093/carcin/bgy077.
• [3284] KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis antigen in colon cancer.Int J Oncol. 2012 Nov;41(5):1820-6. doi: 10.3892/ijo.2012.1601. Epub 2012 Aug 22.
• [3285] Expression of Ccdc85C, a causative protein for murine hydrocephalus, in the mammary gland tumors of dogs.Histol Histopathol. 2017 Apr;32(4):397-403. doi: 10.14670/HH-11-806. Epub 2016 Jul 26.
• [3286] Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms.Genes Chromosomes Cancer. 2014 May;53(5):411-21. doi: 10.1002/gcc.22153.
• [3287] CCHCR1 is up-regulated in skin cancer and associated with EGFR expression.PLoS One. 2009 Jun 24;4(6):e6030. doi: 10.1371/journal.pone.0006030.
• [3288] Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate.Pathology. 2019 Oct;51(6):586-592. doi: 10.1016/j.pathol.2019.06.001. Epub 2019 Aug 21.
• [3289] CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis.Cell Death Dis. 2019 Oct 22;10(11):796. doi: 10.1038/s41419-019-1966-6.
• [3290] Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.Cancer Cell. 2019 Sep 16;36(3):250-267.e9. doi: 10.1016/j.ccell.2019.08.001.
• [3291] CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis.Oncotarget. 2017 Jan 17;8(3):5135-5148. doi: 10.18632/oncotarget.14095.
• [3292] 4T1 Mammary Carcinoma Colonization of Metastatic Niches Is Accelerated by Obesity.Front Oncol. 2019 Sep 20;9:685. doi: 10.3389/fonc.2019.00685. eCollection 2019.
• [3293] Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function.Front Immunol. 2019 Apr 26;10:877. doi: 10.3389/fimmu.2019.00877. eCollection 2019.
• [3294] CCL28-induced RAR expression inhibits oral squamous cell carcinoma bone invasion.J Clin Invest. 2019 Dec 2;129(12):5381-5399. doi: 10.1172/JCI125336.
• [3295] Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells.J Clin Med. 2019 Mar 13;8(3):354. doi: 10.3390/jcm8030354.
• [3296] Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.BMC Cancer. 2019 Mar 4;19(1):197. doi: 10.1186/s12885-019-5409-7.
• [3297] Imatinib independent aberrant methylation of NOV/CCN3 in chronic myelogenous leukemia patients: a mechanism upstream of BCR-ABL1 function?.Cell Commun Signal. 2019 Apr 23;17(1):38. doi: 10.1186/s12964-019-0350-6.
• [3298] Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of -catenin/TCF/LEF signalling.Cell Prolif. 2019 May;52(3):e12583. doi: 10.1111/cpr.12583. Epub 2019 Feb 22.
• [3299] Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associatedwith Poor Prognosis.Arch Med Res. 2019 Jan;50(1):10-17. doi: 10.1016/j.arcmed.2019.03.003. Epub 2019 Apr 4.
• [3300] Clinicopathologic Diversity of Undifferentiated Sarcoma With BCOR-CCNB3 Fusion: Analysis of 11 Cases With a Reappraisal of the Utility of Immunohistochemistry for BCOR and CCNB3.Am J Surg Pathol. 2017 Dec;41(12):1713-1721. doi: 10.1097/PAS.0000000000000934.
• [3301] Synergistic repression of thyroid hyperplasia by cyclin C and Pten.J Cell Sci. 2019 Aug 15;132(16):jcs230029. doi: 10.1242/jcs.230029.
• [3302] miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor.Asian Pac J Cancer Prev. 2015;16(11):4509-13. doi: 10.7314/apjcp.2015.16.11.4509.
• [3303] CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.Cancer Med. 2019 Jan;8(1):351-362. doi: 10.1002/cam4.1812. Epub 2018 Dec 18.
• [3304] Cyclin I mRNA expression correlates with kinase insert domain receptor expression in human epithelial ovarian cancer.Anticancer Res. 2015 Feb;35(2):1115-9.
• [3305] CCNJ detected by triple combination array analysis as a tumor-related gene of hepatocellular carcinoma.Int J Oncol. 2015 May;46(5):1963-70. doi: 10.3892/ijo.2015.2892. Epub 2015 Feb 11.
• [3306] Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma.Br J Cancer. 2006 Apr 10;94(7):1041-4. doi: 10.1038/sj.bjc.6603036.
• [3307] Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells.J Biol Chem. 2004 Mar 19;279(12):11639-48. doi: 10.1074/jbc.M312895200. Epub 2003 Dec 17.
• [3308] A Case Report of Adult Pineoblastoma Occurring in a Pregnant Woman.Anticancer Res. 2019 May;39(5):2627-2631. doi: 10.21873/anticanres.13386.
• [3309] Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.Oncol Lett. 2018 May;15(5):8172-8180. doi: 10.3892/ol.2018.8330. Epub 2018 Mar 23.
• [3310] Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients.Onco Targets Ther. 2019 Jan 29;12:921-932. doi: 10.2147/OTT.S180507. eCollection 2019.
• [3311] Biophysical and Structural Characterization of the Centriolar Protein Cep104 Interaction Network.J Biol Chem. 2016 Aug 26;291(35):18496-504. doi: 10.1074/jbc.M116.739771. Epub 2016 Jul 8.
• [3312] The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.Cell Death Dis. 2018 Feb 14;9(2):232. doi: 10.1038/s41419-018-0267-9.
• [3313] Heat shock proteins create a signature to predict the clinical outcome in breast cancer.Sci Rep. 2019 May 17;9(1):7507. doi: 10.1038/s41598-019-43556-1.
• [3314] Chaperonin containing TCP1 subunit 5 is a tumor associated antigen of non-small cell lung cancer.Oncotarget. 2017 Jul 18;8(38):64170-64179. doi: 10.18632/oncotarget.19369. eCollection 2017 Sep 8.
• [3315] Overexpression of CCT8 and its significance for tumor cell proliferation, migration and invasion in glioma.Pathol Res Pract. 2015 Oct;211(10):717-25. doi: 10.1016/j.prp.2015.04.012. Epub 2015 May 19.
• [3316] CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.Cancer Med. 2018 Aug;7(8):3763-3772. doi: 10.1002/cam4.1607. Epub 2018 Jul 18.
• [3317] High expression of soluble CD155 in estrogen receptor-negative breast cancer.Breast Cancer. 2020 Jan;27(1):92-99. doi: 10.1007/s12282-019-00999-8. Epub 2019 Aug 1.
• [3318] The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.Front Immunol. 2018 Nov 28;9:2809. doi: 10.3389/fimmu.2018.02809. eCollection 2018.
• [3319] Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.J Immunother Cancer. 2017 Mar 21;5:22. doi: 10.1186/s40425-017-0222-9. eCollection 2017.
• [3320] A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.Clin Cancer Res. 2019 Jul 15;25(14):4431-4442. doi: 10.1158/1078-0432.CCR-18-3032. Epub 2019 Apr 19.
• [3321] CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78).FASEB J. 2018 Jul;32(7):3878-3891. doi: 10.1096/fj.201700941RR. Epub 2018 Feb 20.
• [3322] The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma.Cell Oncol (Dordr). 2019 Dec;42(6):861-871. doi: 10.1007/s13402-019-00472-w. Epub 2019 Sep 7.
• [3323] Recent progress in LyP-1-based strategies for targeted imaging and therapy.Drug Deliv. 2019 Dec;26(1):363-375. doi: 10.1080/10717544.2019.1587047.
• [3324] Radioimmunoimaging of (125)I-labeled anti-CD93 monoclonal antibodies in a xenograft model of non-small cell lung cancer.Oncol Lett. 2019 Dec;18(6):6413-6422. doi: 10.3892/ol.2019.11036. Epub 2019 Nov 1.
• [3325] Targeting Tumor Vascular CD99 Inhibits Tumor Growth.Front Immunol. 2019 Apr 2;10:651. doi: 10.3389/fimmu.2019.00651. eCollection 2019.
• [3326] miR-449a: a potential therapeutic agent for cancer.Anticancer Drugs. 2017 Nov;28(10):1067-1078. doi: 10.1097/CAD.0000000000000555.
• [3327] CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer.Endocr Relat Cancer. 2011 Nov 28;18(6):731-42. doi: 10.1530/ERC-11-0181. Print 2011.
• [3328] Inhibition of Cdc42-intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth.Cancer Biol Ther. 2019;20(6):740-749. doi: 10.1080/15384047.2018.1564559. Epub 2019 Mar 8.
• [3329] Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.Int J Cancer. 2016 Jan 1;138(1):98-109. doi: 10.1002/ijc.29691. Epub 2015 Aug 28.
• [3330] Overexpression of circular RNA circ-CDC45 facilitates glioma cell progression by sponging miR-516b and miR-527 and predicts an adverse prognosis.J Cell Biochem. 2020 Jan;121(1):690-697. doi: 10.1002/jcb.29315. Epub 2019 Aug 12.
• [3331] CDC5L Promotes hTERT Expression and Colorectal Tumor Growth.Cell Physiol Biochem. 2017;41(6):2475-2488. doi: 10.1159/000475916. Epub 2017 May 4.
• [3332] CDCA3 is a potential prognostic marker that promotes cell proliferation in gastric cancer.Oncol Rep. 2019 Apr;41(4):2471-2481. doi: 10.3892/or.2019.7008. Epub 2019 Feb 12.
• [3333] Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.EBioMedicine. 2019 Aug;46:54-65. doi: 10.1016/j.ebiom.2019.07.030. Epub 2019 Jul 16.
• [3334] CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth.Haematologica. 2018 Oct;103(10):1669-1678. doi: 10.3324/haematol.2018.188961. Epub 2018 Jun 7.
• [3335] Cell division cycle associated 7 like predicts unfavorable prognosis and promotes invasion in glioma.Pathol Res Pract. 2019 Jan;215(1):50-56. doi: 10.1016/j.prp.2018.10.023. Epub 2018 Oct 24.
• [3336] Regulation of inside-out 1-integrin activation by CDCP1.Oncogene. 2018 May;37(21):2817-2836. doi: 10.1038/s41388-018-0142-2. Epub 2018 Mar 7.
• [3337] Alterations of type II classical cadherin, cadherin-10 (CDH10), is associated with pancreatic ductal adenocarcinomas.Genes Chromosomes Cancer. 2017 May;56(5):427-435. doi: 10.1002/gcc.22447. Epub 2017 Mar 7.
• [3338] Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.Pathol Oncol Res. 2018 Jan;24(1):35-43. doi: 10.1007/s12253-017-0194-6. Epub 2017 Feb 4.
• [3339] Genomic profile in gestational and non-gestational choriocarcinomas.Placenta. 2017 Feb;50:8-15. doi: 10.1016/j.placenta.2016.12.009. Epub 2016 Dec 7.
• [3340] Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.Oncogene. 2018 Feb 1;37(5):651-662. doi: 10.1038/onc.2017.372. Epub 2017 Oct 9.
• [3341] The strong propensity of Cadherin-23 for aggregation inhibits cell migration.Mol Oncol. 2019 May;13(5):1092-1109. doi: 10.1002/1878-0261.12469. Epub 2019 Mar 19.
• [3342] Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.Cancer Sci. 2009 Feb;100(2):261-8. doi: 10.1111/j.1349-7006.2008.01048.x.
• [3343] Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.Clin Epigenetics. 2016 Sep 13;8(1):96. doi: 10.1186/s13148-016-0263-9. eCollection 2016.
• [3344] Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression.Oncotarget. 2017 Aug 24;8(43):75076-75086. doi: 10.18632/oncotarget.20507. eCollection 2017 Sep 26.
• [3345] Downregulated CDK10 expression in gastric cancer: Association with tumor progression and poor prognosis.Mol Med Rep. 2018 May;17(5):6812-6818. doi: 10.3892/mmr.2018.8662. Epub 2018 Mar 1.
• [3346] Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma.Nat Genet. 1994 Jul;7(3):370-5. doi: 10.1038/ng0794-370.
• [3347] PCTAIRE1/CDK16/PCTK1 is overexpressed in cutaneous squamous cell carcinoma and regulates p27 stability and cell cycle.J Dermatol Sci. 2017 May;86(2):149-157. doi: 10.1016/j.jdermsci.2017.02.281. Epub 2017 Feb 22.
• [3348] An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate InVivo.Mol Ther Oncolytics. 2019 May 15;14:107-120. doi: 10.1016/j.omto.2019.05.001. eCollection 2019 Sep 27.
• [3349] Tumor suppressor activity of miR-451: Identification of CARF as a new target.Sci Rep. 2018 Jan 10;8(1):375. doi: 10.1038/s41598-017-18559-5.
• [3350] Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.Oncol Res. 2017 Nov 2;25(9):1431-1440. doi: 10.3727/096504017X14835311718295. Epub 2017 Jan 20.
• [3351] T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy.JCI Insight. 2017 Nov 2;2(21):e96173. doi: 10.1172/jci.insight.96173.
• [3352] Conditional survival of patients with gastric cancer who undergo curative resection: A multi-institutional analysis in China.Cancer. 2018 Mar 1;124(5):916-924. doi: 10.1002/cncr.31160. Epub 2017 Dec 4.
• [3353] Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition.Cell Res. 2019 Nov;29(11):895-910. doi: 10.1038/s41422-019-0229-5. Epub 2019 Sep 9.
• [3354] C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia.Leuk Res. 1997 Sep;21(9):833-9. doi: 10.1016/s0145-2126(97)00072-6.
• [3355] Dynamic susceptibility contrast parametric imaging using accelerated dual-contrast echo planar imaging with keyhole.J Magn Reson Imaging. 2019 Aug;50(2):628-640. doi: 10.1002/jmri.26639. Epub 2019 Jan 8.
• [3356] Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1.Gastroenterol Res Pract. 2019 Aug 14;2019:5290642. doi: 10.1155/2019/5290642. eCollection 2019.
• [3357] miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction.FASEB J. 2019 Jun;33(6):6933-6947. doi: 10.1096/fj.201802547R. Epub 2019 Mar 28.
• [3358] Pleotropic role of RNA binding protein CELF2 in autophagy induction.Mol Carcinog. 2019 Aug;58(8):1400-1409. doi: 10.1002/mc.23023. Epub 2019 Apr 24.
• [3359] RNA-binding protein CELF6 is cell cycle regulated and controls cancer cell proliferation by stabilizing p21.Cell Death Dis. 2019 Sep 18;10(10):688. doi: 10.1038/s41419-019-1927-0.
• [3360] Differential cellular localization of CELSR2 and ING4 and correlations with hormone receptor status in breast cancer.Histol Histopathol. 2018 Aug;33(8):835-842. doi: 10.14670/HH-11-979. Epub 2018 Feb 28.
• [3361] H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis.Biomed Pharmacother. 2020 Mar;123:109728. doi: 10.1016/j.biopha.2019.109728. Epub 2019 Dec 14.
• [3362] Essential role for centromeric factors following p53 loss and oncogenic transformation.Genes Dev. 2017 Mar 1;31(5):463-480. doi: 10.1101/gad.290924.116. Epub 2017 Mar 29.
• [3363] CENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer.J Cancer. 2017 Jul 15;8(12):2163-2172. doi: 10.7150/jca.19940. eCollection 2017.
• [3364] CENPI is overexpressed in colorectal cancer and regulates cell migration and invasion.Gene. 2018 Oct 20;674:80-86. doi: 10.1016/j.gene.2018.06.067. Epub 2018 Jun 21.
• [3365] Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1.Onco Targets Ther. 2019 Jan 29;12:869-882. doi: 10.2147/OTT.S190061. eCollection 2019.
• [3366] Expression of APITD1 is not related to copy number changes of chromosomal region 1p36 or the prognosis of uveal melanoma.Invest Ophthalmol Vis Sci. 2007 Nov;48(11):4919-23. doi: 10.1167/iovs.07-0061.
• [3367] Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2.Cancer Lett. 2020 Jul 10;482:102-111. doi: 10.1016/j.canlet.2019.11.003. Epub 2019 Nov 6.
• [3368] Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma.Epigenetics. 2013 Nov;8(11):1198-204. doi: 10.4161/epi.26266. Epub 2013 Sep 4.
• [3369] EI24, as a Component of Autophagy, Is Involved in Pancreatic Cell Proliferation.Front Oncol. 2019 Jul 23;9:652. doi: 10.3389/fonc.2019.00652. eCollection 2019.
• [3370] Low expression of centrosomal protein 78 (CEP78) is associated with poor prognosis of colorectal cancer patients.Chin J Cancer. 2016 Jun 29;35(1):62. doi: 10.1186/s40880-016-0121-3.
• [3371] Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions.Genome Res. 2008 Mar;18(3):370-9. doi: 10.1101/gr.7010208. Epub 2008 Jan 29.
• [3372] Concerted functions of HDAC1 and microRNA-574-5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells.EMBO Mol Med. 2012 Feb;4(2):78-92. doi: 10.1002/emmm.201100189. Epub 2011 Dec 19.
• [3373] High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer.J Cell Physiol. 2019 Aug;234(8):13001-13013. doi: 10.1002/jcp.27970. Epub 2018 Dec 7.
• [3374] Ceramide synthase 6 predicts the prognosis of human gastric cancer: It functions as an oncoprotein by dysregulating the SOCS2/JAK2/STAT3 pathway.Mol Carcinog. 2018 Dec;57(12):1675-1689. doi: 10.1002/mc.22888. Epub 2018 Aug 29.
• [3375] VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.Int J Cancer. 2020 Jan 15;146(2):496-509. doi: 10.1002/ijc.32429. Epub 2019 Jun 19.
• [3376] Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples.Nat Med. 2017 Mar;23(3):376-385. doi: 10.1038/nm.4279. Epub 2017 Feb 6.
• [3377] CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.Cell Cycle. 2018;17(12):1513-1523. doi: 10.1080/15384101.2018.1491236. Epub 2018 Jul 25.
• [3378] STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity.Cancer Lett. 2019 May 28;450:110-122. doi: 10.1016/j.canlet.2019.02.029. Epub 2019 Feb 18.
• [3379] CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.Gynecol Oncol. 2014 Apr;133(1):83-9. doi: 10.1016/j.ygyno.2013.12.006.
• [3380] Comparison of CDH1 Gene Hypermethylation Status in Blood and Serum among Gastric Cancer Patients.Pathol Oncol Res. 2020 Apr;26(2):1057-1062. doi: 10.1007/s12253-019-00658-5. Epub 2019 Apr 15.
• [3381] CHD1L promotes cell cycle progression and cell motility by up-regulating MDM2 in breast cancer.Am J Transl Res. 2019 Mar 15;11(3):1581-1592. eCollection 2019.
• [3382] rs187960998 polymorphism in miR-211 prevents development of human colon cancer by deregulation of 3'UTR in CHD5.Onco Targets Ther. 2019 Jan 3;12:405-412. doi: 10.2147/OTT.S180935. eCollection 2019.
• [3383] CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signature.Sci Rep. 2019 Mar 8;9(1):3952. doi: 10.1038/s41598-019-39564-w.
• [3384] Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.Gastroenterology. 2014 Feb;146(2):530-38.e5. doi: 10.1053/j.gastro.2013.10.060. Epub 2013 Nov 6.
• [3385] Decreased expression of chromodomain helicase DNA-binding protein 9 is a novel independent prognostic biomarker for colorectal cancer.Braz J Med Biol Res. 2018 Jul 23;51(9):e7588. doi: 10.1590/1414-431X20187588.
• [3386] M2 Macrophage Marker Chitinase 3-Like 2 (CHI3L2) Associates With Progression of Conventional Renal Cell Carcinoma.Anticancer Res. 2019 Dec;39(12):6939-6943. doi: 10.21873/anticanres.13915.
• [3387] Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).J Cancer Res Clin Oncol. 2019 Sep;145(9):2285-2292. doi: 10.1007/s00432-019-02989-x. Epub 2019 Aug 1.
• [3388] Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.Clin Cancer Res. 2011 Dec 15;17(24):7712-22. doi: 10.1158/1078-0432.CCR-11-0619. Epub 2011 Oct 20.
• [3389] Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.Histopathology. 2018 Jun;72(7):1156-1163. doi: 10.1111/his.13475. Epub 2018 Mar 9.
• [3390] Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis.Oncotarget. 2017 Feb 14;8(7):11489-11506. doi: 10.18632/oncotarget.14039.
• [3391] Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11) gene in a B-cell chronic lymphocytic leukemia with a t(12;14)(q23;q32).Oncogene. 2004 Sep 9;23(41):6991-6. doi: 10.1038/sj.onc.1207934.
• [3392] A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci.Am J Hum Genet. 1991 Dec;49(6):1189-96.
• [3393] CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer.Sci Rep. 2017 Sep 18;7(1):11802. doi: 10.1038/s41598-017-12306-6.
• [3394] Chondroitin sulfate synthase 1 expression is associated with malignant potential of soft tissue sarcomas with myxoid substance.Hum Pathol. 2016 Apr;50:15-23. doi: 10.1016/j.humpath.2015.11.005. Epub 2015 Nov 22.
• [3395] Combination therapy of hTERTR and FAM96A for hepatocellular carcinoma through enhancing apoptosis sensitivity.Exp Ther Med. 2018 Jan;15(1):641-648. doi: 10.3892/etm.2017.5505. Epub 2017 Nov 13.
• [3396] CIAPIN1 Targeted NHE1 and ERK1/2 to Suppress NSCLC Cells' Metastasis and Predicted Good Prognosis in NSCLC Patients Receiving Pulmonectomy.Oxid Med Cell Longev. 2019 Apr 9;2019:1970818. doi: 10.1155/2019/1970818. eCollection 2019.
• [3397] Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma.Oncotarget. 2017 Mar 21;8(12):19389-19402. doi: 10.18632/oncotarget.14288.
• [3398] Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults.Histopathology. 2020 Mar;76(4):509-520. doi: 10.1111/his.14023. Epub 2020 Feb 21.
• [3399] CINP is a novel cofactor of KLF5 required for its role in the promotion of cell proliferation, survival and tumor growth.Int J Cancer. 2019 Feb 1;144(3):582-594. doi: 10.1002/ijc.31908. Epub 2018 Oct 26.
• [3400] CDGSH Iron Sulfur Domain 2 Activates Proliferation and EMT of Pancreatic Cancer Cells via Wnt/-Catenin Pathway and Has Prognostic Value in Human Pancreatic Cancer.Oncol Res. 2017 Apr 14;25(4):605-615. doi: 10.3727/096504016X14767450526417. Epub 2016 Oct 26.
• [3401] Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome.Clin Cancer Res. 2008 Sep 1;14(17):5531-9. doi: 10.1158/1078-0432.CCR-08-0443.
• [3402] CITED1 contributes to the progression of papillary thyroid carcinoma via the Wnt/-catenin signaling pathway.Onco Targets Ther. 2019 Aug 21;12:6769-6777. doi: 10.2147/OTT.S215025. eCollection 2019.
• [3403] CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells.Oncol Lett. 2018 Jan;15(1):871-878. doi: 10.3892/ol.2017.7420. Epub 2017 Nov 15.
• [3404] Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.Biomed Pharmacother. 2018 Oct;106:1396-1403. doi: 10.1016/j.biopha.2018.07.104. Epub 2018 Jul 23.
• [3405] CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC.Clin Cancer Res. 2019 Jul 1;25(13):4141-4154. doi: 10.1158/1078-0432.CCR-18-3510. Epub 2019 Mar 27.
• [3406] Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma.Br J Cancer. 2006 Mar 13;94(5):698-709. doi: 10.1038/sj.bjc.6602986.
• [3407] Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression.Biochem Biophys Res Commun. 2019 Jan 1;508(1):275-281. doi: 10.1016/j.bbrc.2018.11.070. Epub 2018 Nov 26.
• [3408] Significance of CLASP2 expression in prognosis for muscle-invasive bladder cancer patients: A propensity score-based analysis.Urol Oncol. 2019 Oct;37(10):800-807. doi: 10.1016/j.urolonc.2019.05.003. Epub 2019 May 24.
• [3409] Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.J Exp Clin Cancer Res. 2018 Feb 20;37(1):34. doi: 10.1186/s13046-018-0692-8.
• [3410] Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer.Med Sci Monit. 2019 Jun 5;25:4176-4185. doi: 10.12659/MSM.914195.
• [3411] 65 YEARS OF THE DOUBLE HELIX: Classification of endocrine tumors in the age of integrated genomics.Endocr Relat Cancer. 2018 Aug;25(8):T171-T187. doi: 10.1530/ERC-18-0116.
• [3412] Snail-induced claudin-11 prompts collective migration for tumour progression.Nat Cell Biol. 2019 Feb;21(2):251-262. doi: 10.1038/s41556-018-0268-z. Epub 2019 Jan 21.
• [3413] The Cytoplasmic Expression Of CLDN12 Predicts An Unfavorable Prognosis And Promotes Proliferation And Migration Of Osteosarcoma.Cancer Manag Res. 2019 Nov 1;11:9339-9351. doi: 10.2147/CMAR.S229441. eCollection 2019.
• [3414] CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.Carcinogenesis. 2016 Jun;37(6):557-566. doi: 10.1093/carcin/bgw036. Epub 2016 Mar 31.
• [3415] Claudin-16/paracellin-1, cloning, expression, and its role in tight junction functions in cancer and endothelial cells.Methods Mol Biol. 2011;762:383-407. doi: 10.1007/978-1-61779-185-7_28.
• [3416] Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model.Carcinogenesis. 2018 Jan 12;39(1):47-55. doi: 10.1093/carcin/bgx097.
• [3417] Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.BMC Cancer. 2019 Jul 15;19(1):695. doi: 10.1186/s12885-019-5908-6.
• [3418] A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction.PLoS One. 2019 Sep 25;14(9):e0222331. doi: 10.1371/journal.pone.0222331. eCollection 2019.
• [3419] Tumor cells of non-hematopoietic and hematopoietic origins express activation-induced C-type lectin, the ligand for killer cell lectin-like receptor F1.Int Immunol. 2010 Sep;22(9):783-90. doi: 10.1093/intimm/dxq430. Epub 2010 Jul 26.
• [3420] Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B.Cancer Biol Ther. 2019;20(7):967-978. doi: 10.1080/15384047.2019.1591122. Epub 2019 Mar 20.
• [3421] Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.Cancer Res. 2019 Jan 1;79(1):159-170. doi: 10.1158/0008-5472.CAN-18-0981. Epub 2018 Sep 17.
• [3422] Platelet-rich plasma-induced feedback inhibition of activin A/follistatin signaling: A mechanism for tumor-low risk skin rejuvenation in irradiated rats.J Photochem Photobiol B. 2018 Mar;180:17-24. doi: 10.1016/j.jphotobiol.2018.01.024. Epub 2018 Feb 20.
• [3423] Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration.Oral Oncol. 2015 Dec;51(12):1120-5. doi: 10.1016/j.oraloncology.2015.09.010. Epub 2015 Oct 17.
• [3424] CLIC4 abrogation promotes epithelial-mesenchymal transition in gastric cancer.Carcinogenesis. 2020 Jul 10;41(6):841-849. doi: 10.1093/carcin/bgz156.
• [3425] Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions.Am J Surg Pathol. 2015 May;39(5):581-91. doi: 10.1097/PAS.0000000000000387.
• [3426] Disruption of the Molecular Circadian Clock and Cancer: An Epigenetic Link.Biochem Genet. 2020 Feb;58(1):189-209. doi: 10.1007/s10528-019-09938-w. Epub 2019 Sep 24.
• [3427] Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2019 Apr;145(4):851-859. doi: 10.1007/s00432-019-02843-0. Epub 2019 Jan 11.
• [3428] Claspin functions in cell homeostasis-A link to cancer?.DNA Repair (Amst). 2017 Nov;59:27-33. doi: 10.1016/j.dnarep.2017.09.002. Epub 2017 Sep 8.
• [3429] MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.Cell Biochem Funct. 2017 Mar;35(2):98-104. doi: 10.1002/cbf.3252. Epub 2017 Mar 5.
• [3430] Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma.J Cancer Res Clin Oncol. 2016 Sep;142(9):1947-53. doi: 10.1007/s00432-016-2207-3. Epub 2016 Jul 14.
• [3431] miR-135b-5p promotes gastric cancer progression by targeting CMTM3.Int J Oncol. 2018 Feb;52(2):589-598. doi: 10.3892/ijo.2017.4222. Epub 2017 Dec 11.
• [3432] CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling.Cancer Cell Int. 2017 Nov 29;17:113. doi: 10.1186/s12935-017-0485-8. eCollection 2017.
• [3433] Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.Tumour Biol. 2016 May;37(5):6217-25. doi: 10.1007/s13277-015-4508-6. Epub 2015 Nov 28.
• [3434] Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation.Mol Cancer. 2019 Nov 13;18(1):158. doi: 10.1186/s12943-019-1094-z.
• [3435] Underexpressed CNDP2 participates in gastric cancer growth inhibition through activating the MAPK signaling pathway.Mol Med. 2014 Mar 13;20(1):17-28. doi: 10.2119/molmed.2013.00102.
• [3436] Multi-dimensional immunoproteomics coupled with in vitro recapitulation of oncogenic NRAS(Q61R) identifies diagnostically relevant autoantibody biomarkers in thyroid neoplasia.Cancer Lett. 2019 Dec 28;467:96-106. doi: 10.1016/j.canlet.2019.07.013. Epub 2019 Jul 18.
• [3437] Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.Oncotarget. 2017 Jan 24;8(4):5924-5935. doi: 10.18632/oncotarget.12641.
• [3438] Post-transcriptional Control of Tumor Cell Autonomous Metastatic Potential by CCR4-NOT Deadenylase CNOT7.PLoS Genet. 2016 Jan 25;12(1):e1005820. doi: 10.1371/journal.pgen.1005820. eCollection 2016 Jan.
• [3439] Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.Cell Physiol Biochem. 2018;50(6):2017-2028. doi: 10.1159/000495048. Epub 2018 Nov 9.
• [3440] Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.Cancer Res. 2016 Sep 1;76(17):4948-58. doi: 10.1158/0008-5472.CAN-16-0902. Epub 2016 Jun 14.
• [3441] MiR-127 and miR-376a act as tumor suppressors by invivo targeting of COA1 and PDIA6 in giant cell tumor of bone.Cancer Lett. 2017 Nov 28;409:49-55. doi: 10.1016/j.canlet.2017.08.029. Epub 2017 Sep 1.
• [3442] Development of novel real-time RT-qPCR methodologies for quantification of the COL11A1 mRNA general and C transcripts and evaluation in non-small cell lung cancer specimens.J BUON. 2018 Nov-Dec;23(6):1699-1710.
• [3443] COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer.Mol Med Rep. 2019 Oct;20(4):3103-3112. doi: 10.3892/mmr.2019.10548. Epub 2019 Aug 1.
• [3444] Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.Oncogene. 2010 Apr 8;29(14):2104-17. doi: 10.1038/onc.2009.493. Epub 2010 Feb 15.
• [3445] Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis.Int J Clin Oncol. 2016 Apr;21(2):302-309. doi: 10.1007/s10147-015-0888-2. Epub 2015 Aug 21.
• [3446] The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma.Sci Rep. 2017 Aug 29;7(1):9846. doi: 10.1038/s41598-017-10134-2.
• [3447] Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study.Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):489-494. doi: 10.1097/PAI.0000000000000458.
• [3448] Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice.Technol Cancer Res Treat. 2016 Jun;15(3):498-508. doi: 10.1177/1533034615581977. Epub 2015 May 11.
• [3449] IFN- is required for cytotoxic T cell-dependent cancer genome immunoediting.Nat Commun. 2017 Feb 24;8:14607. doi: 10.1038/ncomms14607.
• [3450] Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells.Cell Death Differ. 2016 May;23(5):841-52. doi: 10.1038/cdd.2015.147. Epub 2015 Nov 20.
• [3451] Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis.Br J Cancer. 2019 Oct;121(8):699-709. doi: 10.1038/s41416-019-0571-x. Epub 2019 Sep 16.
• [3452] COMMD7 Regulates NF-B Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells.Mol Ther Oncolytics. 2018 Dec 14;12:112-123. doi: 10.1016/j.omto.2018.12.006. eCollection 2019 Mar 29.
• [3453] Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling.Matrix Biol. 2019 Aug;81:107-121. doi: 10.1016/j.matbio.2018.11.007. Epub 2018 Nov 28.
• [3454] COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.J Clin Invest. 2018 Apr 2;128(4):1442-1457. doi: 10.1172/JCI94840. Epub 2018 Mar 5.
• [3455] Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model.Genomics. 2010 Apr;95(4):210-6. doi: 10.1016/j.ygeno.2010.02.002. Epub 2010 Feb 11.
• [3456] Analysis of RNA expression of normal and cancer tissues reveals high correlation of COP9 gene expression with respiratory chain complex components. BMC Genomics. 2016 Dec 1;17(1):983.
• [3457] Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells.Cancer Lett. 2017 Dec 1;410:201-211. doi: 10.1016/j.canlet.2017.09.024. Epub 2017 Sep 23.
• [3458] Binding of coronin 1B to TRI negatively regulates the TGF1 signaling pathway.Biochem Biophys Res Commun. 2017 Aug 19;490(2):574-579. doi: 10.1016/j.bbrc.2017.06.080. Epub 2017 Jun 15.
• [3459] CRN2 binds to TIMP4 and MMP14 and promotes perivascular invasion of glioblastoma cells.Eur J Cell Biol. 2019 Dec;98(5-8):151046. doi: 10.1016/j.ejcb.2019.151046. Epub 2019 Oct 11.
• [3460] Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.Oncogene. 2011 Mar 24;30(12):1390-401. doi: 10.1038/onc.2010.525. Epub 2010 Dec 6.
• [3461] The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features.Lung Cancer. 2017 Jul;109:128-136. doi: 10.1016/j.lungcan.2017.05.006. Epub 2017 May 13.
• [3462] Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGF signaling.Oncogene. 2018 Jan 18;37(3):323-331. doi: 10.1038/onc.2017.342. Epub 2017 Sep 18.
• [3463] Identification of PCAG1 as a novel prostate cancer-associated gene.Mol Med Rep. 2013 Mar;7(3):755-60. doi: 10.3892/mmr.2012.1249. Epub 2012 Dec 24.
• [3464] Caffeine induces metformin anticancer effect on fibrosarcoma in hamsters.Eur Rev Med Pharmacol Sci. 2018 Apr;22(8):2461-2467. doi: 10.26355/eurrev_201804_14840.
• [3465] Biological Evaluation and Molecular Docking Studies of Dimethylpyridine Derivatives.Molecules. 2019 Mar 20;24(6):1093. doi: 10.3390/molecules24061093.
• [3466] Identification of COX5B as a novel biomarker in high-grade glioma patients.Onco Targets Ther. 2017 Nov 15;10:5463-5470. doi: 10.2147/OTT.S139243. eCollection 2017.
• [3467] Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.J Neurooncol. 2018 Jan;136(1):41-50. doi: 10.1007/s11060-017-2637-z. Epub 2017 Oct 27.
• [3468] microRNA-214 Governs Lung Cancer Growth and Metastasis by Targeting Carboxypeptidase-D.DNA Cell Biol. 2016 Nov;35(11):715-721. doi: 10.1089/dna.2016.3398. Epub 2016 Aug 5.
• [3469] Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.J Neurol Sci. 2016 Apr 15;363:80-3. doi: 10.1016/j.jns.2016.02.032. Epub 2016 Feb 16.
• [3470] Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.BMC Cancer. 2019 Jun 11;19(1):561. doi: 10.1186/s12885-019-5771-5.
• [3471] CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.Med Sci Monit. 2017 Nov 19;23:5504-5514. doi: 10.12659/msm.904720.
• [3472] CPSF3 is a promising prognostic biomarker and predicts recurrence of non-small cell lung cancer.Oncol Lett. 2019 Sep;18(3):2835-2844. doi: 10.3892/ol.2019.10659. Epub 2019 Jul 24.
• [3473] Cleavage and polyadenylation specific factor 4 targets NF-B/cyclooxygenase-2 signaling to promote lung cancer growth and progression.Cancer Lett. 2016 Oct 10;381(1):1-13. doi: 10.1016/j.canlet.2016.07.016. Epub 2016 Jul 20.
• [3474] Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells. J Biol Chem. 2019 Jun 14;294(24):9342-9357.
• [3475] Human papillomavirus seropositivity and risks of head and neck cancer.Int J Cancer. 2007 Feb 15;120(4):825-32. doi: 10.1002/ijc.22330.
• [3476] Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family.Sci Rep. 2018 Aug 2;8(1):11635. doi: 10.1038/s41598-018-29952-z.
• [3477] Overexpression of carboxypeptidase X M14 family member 2 predicts an unfavorable prognosis and promotes proliferation and migration of osteosarcoma.Diagn Pathol. 2019 Oct 24;14(1):118. doi: 10.1186/s13000-019-0887-0.
• [3478] A novel tumor targeting drug carrier for optical imaging and therapy.Theranostics. 2014 Mar 24;4(6):642-59. doi: 10.7150/thno.8527. eCollection 2014.
• [3479] CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.Mol Cancer. 2015 Jul 5;14:129. doi: 10.1186/s12943-015-0380-7.
• [3480] Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas.Diagn Pathol. 2018 Jan 22;13(1):9. doi: 10.1186/s13000-018-0686-z.
• [3481] KIAA1211 plays an oncogenic role in human non-small cell lung cancer.J Cancer. 2019 Oct 22;10(26):6747-6753. doi: 10.7150/jca.35951. eCollection 2019.
• [3482] Genetic heterogeneity in leiomyomas of deep soft tissue.Oncotarget. 2017 Jul 25;8(30):48769-48781. doi: 10.18632/oncotarget.17953.
• [3483] Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer.Cancer Biol Ther. 2017 Nov 2;18(11):904-915. doi: 10.1080/15384047.2017.1385678. Epub 2017 Oct 20.
• [3484] Crumbs3 is a critical factor that regulates invasion and metastasis of colon adenocarcinoma via the specific interaction with FGFR1.Int J Cancer. 2019 Nov 15;145(10):2740-2753. doi: 10.1002/ijc.32336. Epub 2019 Apr 29.
• [3485] CRCT1 regulated by microRNA-520g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.Tumour Biol. 2016 Jun;37(6):8271-9. doi: 10.1007/s13277-015-4730-2. Epub 2015 Dec 30.
• [3486] Knockdown of CREB3 activates endoplasmic reticulum stress and induces apoptosis in glioblastoma.Aging (Albany NY). 2019 Oct 13;11(19):8156-8168. doi: 10.18632/aging.102310. Epub 2019 Oct 13.
• [3487] CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy.BMC Cancer. 2018 Aug 13;18(1):813. doi: 10.1186/s12885-018-4724-8.
• [3488] MiR-17-92 cluster promotes hepatocarcinogenesis.Carcinogenesis. 2015 Oct;36(10):1213-22. doi: 10.1093/carcin/bgv112. Epub 2015 Aug 1.
• [3489] Intragenic antagonistic roles of protein and circRNA in tumorigenesis.Cell Res. 2019 Aug;29(8):628-640. doi: 10.1038/s41422-019-0192-1. Epub 2019 Jun 17.
• [3490] The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.Mol Cancer. 2013 Apr 9;12:28. doi: 10.1186/1476-4598-12-28.
• [3491] External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response.Int J Gynecol Cancer. 2020 Jan;30(1):67-73. doi: 10.1136/ijgc-2019-000561. Epub 2019 Nov 21.
• [3492] Lgl1 controls NG2 endocytic pathway to regulate oligodendrocyte differentiation and asymmetric cell division and gliomagenesis.Nat Commun. 2018 Aug 21;9(1):2862. doi: 10.1038/s41467-018-05099-3.
• [3493] The microRNA-200/Zeb1 axis regulates ECM-dependent 1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL.Sci Rep. 2016 Jan 5;6:18652. doi: 10.1038/srep18652.
• [3494] Phosphorylation of the N-terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48.Mol Carcinog. 2015 Nov;54(11):1283-91. doi: 10.1002/mc.22203. Epub 2014 Aug 23.
• [3495] Expression and potential mechanism of metabolism-related genes and CRLS1 in non-small cell lung cancer.Oncol Lett. 2018 Feb;15(2):2661-2668. doi: 10.3892/ol.2017.7591. Epub 2017 Dec 12.
• [3496] Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.J Thorac Cardiovasc Surg. 2014 May;147(5):1612-1618.e4. doi: 10.1016/j.jtcvs.2013.09.066. Epub 2013 Nov 19.
• [3497] The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.Hepatology. 2012 Nov;56(5):1770-81. doi: 10.1002/hep.25851. Epub 2012 Sep 17.
• [3498] NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in Medulloblastoma.Cancer Cell. 2018 Mar 12;33(3):435-449.e6. doi: 10.1016/j.ccell.2018.02.006.
• [3499] Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans.Anticancer Res. 2015 May;35(5):2565-70.
• [3500] LNC CRYBG3 inhibits tumor growth by inducing M phase arrest.J Cancer. 2019 Jun 2;10(12):2764-2770. doi: 10.7150/jca.31703. eCollection 2019.
• [3501] Dynamic Contrast-Enhanced Ultrasound of Gastric Cancer: Correlation with Perfusion CT and Histopathology.Korean J Radiol. 2019 May;20(5):781-790. doi: 10.3348/kjr.2018.0273.
• [3502] Placental genes and breast cancer: can the offspring's or father's genotypes predict mother's risk?.Epidemiology. 2003 Mar;14(2):251-3. doi: 10.1097/01.EDE.0000050696.19411.C0.
• [3503] Clinical significance of YAP1 activation in head and neck squamous cell carcinoma.Oncotarget. 2017 Nov 27;8(67):111130-111143. doi: 10.18632/oncotarget.22666. eCollection 2017 Dec 19.
• [3504] Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.Tumour Biol. 2014 May;35(5):4419-23. doi: 10.1007/s13277-013-1581-6. Epub 2014 Jan 10.
• [3505] Whole-genome profiling helps to classify phyllodes tumours of the breast.J Clin Pathol. 2016 Dec;69(12):1081-1087. doi: 10.1136/jclinpath-2016-203684. Epub 2016 May 20.
• [3506] CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma.Cancer Res. 2016 Aug 15;76(16):4720-4727. doi: 10.1158/0008-5472.CAN-15-3134. Epub 2016 Jun 20.
• [3507] Inhibition of Csn3 expression induces growth arrest and apoptosis of hepatocellular carcinoma cells.Cancer Chemother Pharmacol. 2012 May;69(5):1173-80. doi: 10.1007/s00280-011-1810-x. Epub 2012 Jan 12.
• [3508] Identification of AXUD1, a novel human gene induced by AXIN1 and its reduced expression in human carcinomas of the lung, liver, colon and kidney.Oncogene. 2001 Aug 16;20(36):5062-6. doi: 10.1038/sj.onc.1204603.
• [3509] Screening of tumor suppressor genes on 1q31.1-32.1 in Chinese patients with sporadic colorectal cancer.Chin Med J (Engl). 2008 Dec 20;121(24):2479-86.
• [3510] Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis.J Cell Physiol. 2019 Dec;234(12):22623-22634. doi: 10.1002/jcp.28828. Epub 2019 May 20.
• [3511] Expression of high molecular weight cysteine proteinase inhibitor in ovarian cancer tissues: regulation of cathepsin B expression by placental CPI.Biol Chem. 2003 Jul;384(7):1103-7. doi: 10.1515/BC.2003.123.
• [3512] Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents.Nephrol Dial Transplant. 2018 Mar 1;33(3):402-408. doi: 10.1093/ndt/gfx063.
• [3513] Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.J Biol Chem. 2015 Oct 30;290(44):26533-48. doi: 10.1074/jbc.M115.660175. Epub 2015 Sep 13.
• [3514] Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-B.Mol Cell Biol. 2016 May 31;36(12):1776-92. doi: 10.1128/MCB.00878-15. Print 2016 Jun 15.
• [3515] Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis B virusrelated hepatocellular carcinoma.Oncol Rep. 2019 Jul;42(1):189-201. doi: 10.3892/or.2019.7154. Epub 2019 May 9.
• [3516] Clinicopathological significance of cystatin A expression in progression of esophageal squamous cell carcinoma.Medicine (Baltimore). 2018 Apr;97(15):e0357. doi: 10.1097/MD.0000000000010357.
• [3517] Expression and epigenetic regulation of cystatin B in lung cancer and colorectal cancer.Pathol Res Pract. 2017 Dec;213(12):1568-1574. doi: 10.1016/j.prp.2017.06.007. Epub 2017 Jun 6.
• [3518] Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation.Cancer Res. 2016 Dec 15;76(24):7231-7241. doi: 10.1158/0008-5472.CAN-16-0844. Epub 2016 Oct 10.
• [3519] Potential for adaptive dose escalation in radiotherapy for patients with locally advanced non-small-cell lung cancer in a low mid income setting.Br J Radiol. 2017 Feb;90(1070):20140234. doi: 10.1259/bjr.20140234. Epub 2017 Jan 3.
• [3520] A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.Mol Cancer Ther. 2015 Mar;14(3):828-34. doi: 10.1158/1535-7163.MCT-14-0796. Epub 2015 Jan 6.
• [3521] Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.J Immunother Cancer. 2019 Aug 28;7(1):229. doi: 10.1186/s40425-019-0678-x.
• [3522] Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability.Front Endocrinol (Lausanne). 2018 Nov 30;9:706. doi: 10.3389/fendo.2018.00706. eCollection 2018.
• [3523] CTBP1/CYP19A1/estradiol axis together with adipose tissue impacts over prostate cancer growth associated to metabolic syndrome.Int J Cancer. 2019 Mar 1;144(5):1115-1127. doi: 10.1002/ijc.31773. Epub 2018 Oct 9.
• [3524] CtBP-a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma.Oncogenesis. 2019 Oct 4;8(10):55. doi: 10.1038/s41389-019-0163-x.
• [3525] CTHRC1 overexpression promotes cervical carcinoma progression by activating the Wnt/PCP signaling pathway.Oncol Rep. 2019 Mar;41(3):1531-1538. doi: 10.3892/or.2019.6963. Epub 2019 Jan 10.
• [3526] Identification of -N-catenin as a novel tumor suppressor in neuroblastoma.Oncotarget. 2019 Aug 20;10(49):5028-5040. doi: 10.18632/oncotarget.27096. eCollection 2019 Aug 20.
• [3527] CTNNA3 is a tumor suppressor in hepatocellular carcinomas and is inhibited by miR-425.Oncotarget. 2016 Feb 16;7(7):8078-89. doi: 10.18632/oncotarget.6978.
• [3528] -Catulin marks the invasion front of squamous cell carcinoma and is important for tumor cell metastasis.Mol Cancer Res. 2012 Jul;10(7):892-903. doi: 10.1158/1541-7786.MCR-12-0169. Epub 2012 May 30.
• [3529] p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer.Mol Carcinog. 2018 Jan;57(1):89-96. doi: 10.1002/mc.22734. Epub 2017 Sep 25.
• [3530] Instability of a dinucleotide repeat in the 3'-untranslated region (UTR) of the microsomal prostaglandin E synthase-1 (mPGES-1) gene in microsatellite instability-high (MSI-H) colorectal carcinoma.Mol Oncol. 2015 Aug;9(7):1252-8. doi: 10.1016/j.molonc.2015.01.009. Epub 2015 Mar 5.
• [3531] Identification of a novel CTR9 germline mutation in a family with Wilms tumor.Eur J Med Genet. 2018 May;61(5):294-299. doi: 10.1016/j.ejmg.2017.12.010. Epub 2017 Dec 29.
• [3532] Characterization of cathepsin X in colorectal cancer development and progression.Pathol Res Pract. 2014 Dec;210(12):822-9. doi: 10.1016/j.prp.2014.08.014. Epub 2014 Sep 18.
• [3533] An update of knowledge on cortactin as a metastatic driver and potential therapeutic target in oral squamous cell carcinoma.Oral Dis. 2019 May;25(4):949-971. doi: 10.1111/odi.12913. Epub 2018 Jul 6.
• [3534] Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.Cell. 2015 Jan 29;160(3):489-502. doi: 10.1016/j.cell.2015.01.001. Epub 2015 Jan 22.
• [3535] CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling.J Cancer. 2019 Apr 21;10(8):1800-1807. doi: 10.7150/jca.29889. eCollection 2019.
• [3536] High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.Cell Physiol Biochem. 2018;51(6):2829-2842. doi: 10.1159/000496013. Epub 2018 Dec 18.
• [3537] CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/-catenin signaling pathway.Cancer Med. 2019 May;8(5):2278-2287. doi: 10.1002/cam4.1960. Epub 2019 Mar 18.
• [3538] Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability.Oncogenesis. 2019 Jan 9;8(1):4. doi: 10.1038/s41389-018-0110-2.
• [3539] Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53.Oncogene. 2017 Sep 7;36(36):5212-5218. doi: 10.1038/onc.2017.141. Epub 2017 May 8.
• [3540] Establishment of a novel cancer cell line derived from vulvar carcinoma associated with lichen sclerosus exhibiting a fibroblast-dependent tumorigenic potential.Exp Cell Res. 2020 Jan 1;386(1):111684. doi: 10.1016/j.yexcr.2019.111684. Epub 2019 Oct 23.
• [3541] KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.Cancer Cell. 2019 Apr 15;35(4):559-572.e7. doi: 10.1016/j.ccell.2019.02.008. Epub 2019 Mar 21.
• [3542] Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus.Clin Cancer Res. 2017 Oct 1;23(19):5846-5857. doi: 10.1158/1078-0432.CCR-17-0285. Epub 2017 May 23.
• [3543] CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer.Oncotarget. 2016 May 24;7(21):31350-60. doi: 10.18632/oncotarget.8912.
• [3544] Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies.Head Neck. 2017 Aug;39(8):1621-1630. doi: 10.1002/hed.24803. Epub 2017 May 12.
• [3545] MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.Cell Physiol Biochem. 2017;41(5):1935-1946. doi: 10.1159/000472380. Epub 2017 Apr 7.
• [3546] Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms.Endocr Relat Cancer. 2019 Jan 1;26(1):1-12. doi: 10.1530/ERC-18-0120.
• [3547] Cytoglobin ameliorates the stemness of hepatocellular carcinoma via coupling oxidative-nitrosative stress signals.Mol Carcinog. 2019 Mar;58(3):334-343. doi: 10.1002/mc.22931. Epub 2018 Dec 4.
• [3548] Proviral insertions near cyclin D1 in mouse lymphomas: a parallel for BCL1 translocations in human B-cell neoplasms.Oncogene. 1992 Dec;7(12):2381-7.
• [3549] Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer. Toxicol Appl Pharmacol. 2012 Oct 1;264(1):73-83. doi: 10.1016/j.taap.2012.07.019. Epub 2012 Jul 25.
• [3550] ZFR promotes cell proliferation and tumor development in colorectal and liver cancers.Biochem Biophys Res Commun. 2019 Jun 11;513(4):1027-1034. doi: 10.1016/j.bbrc.2019.04.103. Epub 2019 Apr 19.
• [3551] Down-regulation of mitochondrial NADH and cytochrome b gene associated with high tumor stages in head and neck squamous cell carcinoma.Arch Oral Biol. 2019 Mar;99:107-112. doi: 10.1016/j.archoralbio.2019.01.005. Epub 2019 Jan 10.
• [3552] Cytohesin-3 is upregulated in hepatocellular carcinoma and contributes to tumor growth and vascular invasion.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2123-32. eCollection 2014.
• [3553] Protein Cytl1: its role in chondrogenesis, cartilage homeostasis, and disease.Cell Mol Life Sci. 2019 Sep;76(18):3515-3523. doi: 10.1007/s00018-019-03137-x. Epub 2019 May 14.
• [3554] Disabled-1 is down-regulated in clinical breast cancer and regulates cell apoptosis through NF-B/Bcl-2/caspase-9.J Cell Mol Med. 2019 Feb;23(2):1622-1627. doi: 10.1111/jcmm.14047. Epub 2018 Nov 28.
• [3555] Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.Adv Cancer Res. 2019;141:1-42. doi: 10.1016/bs.acr.2018.12.001. Epub 2019 Jan 16.
• [3556] Prospective validation of DACH2 as a novel biomarker for prediction of metastasis and prognosis in muscle-invasive urothelial carcinoma of the bladder.Biochem Biophys Res Commun. 2015 Apr 10;459(3):416-23. doi: 10.1016/j.bbrc.2015.02.119. Epub 2015 Mar 2.
• [3557] DACT1 overexpression inhibits proliferation, enhances apoptosis, and increases daunorubicin chemosensitivity in KG-1 cells.Tumour Biol. 2017 Oct;39(10):1010428317711089. doi: 10.1177/1010428317711089.
• [3558] Association between promoter hypermethylation of the DACT2 gene and tumor stages in breast cancer.J BUON. 2018 Mar-Apr;23(2):361-365.
• [3559] Elevated serum DAND5 is associated with metastasis and predicts poor prognosis in colorectal cancer.United European Gastroenterol J. 2017 Aug;5(5):725-734. doi: 10.1177/2050640616674838. Epub 2016 Oct 12.
• [3560] Symmetric dimeric bisbenzimidazoles DBP(n) reduce methylation of RARB and PTEN while significantly increase methylation of rRNA genes in MCF-7 cancer cells.PLoS One. 2018 Jan 12;13(1):e0189826. doi: 10.1371/journal.pone.0189826. eCollection 2018.
• [3561] Dbx2 exhibits a tumor-promoting function in hepatocellular carcinoma cell lines via regulating Shh-Gli1 signaling.World J Gastroenterol. 2019 Feb 28;25(8):923-940. doi: 10.3748/wjg.v25.i8.923.
• [3562] Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.J Nucl Med. 2017 Nov;58(11):1735-1742. doi: 10.2967/jnumed.117.193250. Epub 2017 Jul 13.
• [3563] Functional variants in DCAF4 associated with lung cancer risk in European populations.Carcinogenesis. 2017 May 1;38(5):541-551. doi: 10.1093/carcin/bgx033.
• [3564] NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.Oncotarget. 2017 Mar 28;8(13):21501-21515. doi: 10.18632/oncotarget.15308.
• [3565] Are tumoral factors responsible for host tissue wasting in cancer cachexia?.Future Oncol. 2010 Apr;6(4):503-13. doi: 10.2217/fon.10.20.
• [3566] Synthesis, Characterization, and Inducing Tumor Cell Apoptosis of Two Ru(II) Complexes Containing Guanidinium as Ligands.Anticancer Agents Med Chem. 2018;18(1):110-120. doi: 10.2174/1871520617666170419122056.
• [3567] Effects of miR?81a on the biological function of multiple myeloma.Oncol Rep. 2019 Jul;42(1):291-300. doi: 10.3892/or.2019.7160. Epub 2019 May 15.
• [3568] Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells.Oncoimmunology. 2018 Dec 5;8(3):1542917. doi: 10.1080/2162402X.2018.1542917. eCollection 2019.
• [3569] STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.J Hematol Oncol. 2015 Jun 11;8:66. doi: 10.1186/s13045-015-0160-2.
• [3570] Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.Oncogene. 2020 Feb;39(7):1429-1444. doi: 10.1038/s41388-019-1072-3. Epub 2019 Oct 28.
• [3571] Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells.Oncol Rep. 2017 Nov;38(5):3238-3244. doi: 10.3892/or.2017.5974. Epub 2017 Sep 20.
• [3572] Cullin-4ADNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis.J Biol Chem. 2011 Mar 4;286(9):6971-8. doi: 10.1074/jbc.M110.186494. Epub 2011 Jan 4.
• [3573] NER-factor DDB2 regulates HIF1 and hypoxia-response genes in HNSCC.Oncogene. 2020 Feb;39(8):1784-1796. doi: 10.1038/s41388-019-1105-y. Epub 2019 Nov 18.
• [3574] Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas.Clin Cancer Res. 2011 Apr 1;17(7):1828-38. doi: 10.1158/1078-0432.CCR-10-2066. Epub 2011 Feb 16.
• [3575] Combined Knockdown of D-dopachrome Tautomerase and Migration Inhibitory Factor Inhibits the Proliferation, Migration, and Invasion in Human Cervical Cancer.Int J Gynecol Cancer. 2017 May;27(4):634-642. doi: 10.1097/IGC.0000000000000951.
• [3576] Epigenetic down-regulated DDX10 promotes cell proliferation through Akt/NF-B pathway in ovarian cancer.Biochem Biophys Res Commun. 2016 Jan 22;469(4):1000-5. doi: 10.1016/j.bbrc.2015.12.069. Epub 2015 Dec 20.
• [3577] Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.BMC Cancer. 2018 Oct 22;18(1):1016. doi: 10.1186/s12885-018-4950-0.
• [3578] A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models.Elife. 2018 Mar 20;7:e34701. doi: 10.7554/eLife.34701.
• [3579] DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.Oncogene. 2018 May;37(22):3006-3021. doi: 10.1038/s41388-018-0196-1. Epub 2018 Mar 14.
• [3580] DDX39 acts as a suppressor of invasion for bladder cancer.Cancer Sci. 2012 Jul;103(7):1363-9. doi: 10.1111/j.1349-7006.2012.02298.x. Epub 2012 Jun 4.
• [3581] Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.Hum Mol Genet. 2019 Apr 15;28(8):1331-1342. doi: 10.1093/hmg/ddy444.
• [3582] Chaperone protein HSC70 regulates intercellular transfer of Y chromosome antigen DBY.J Clin Invest. 2019 Jun 17;129(7):2952-2963. doi: 10.1172/JCI123105. eCollection 2019 Jun 17.
• [3583] Ovarian Cancer Stem Cells: Unraveling a Germline Connection.Stem Cells Dev. 2017 Dec 15;26(24):1781-1803. doi: 10.1089/scd.2017.0153. Epub 2017 Nov 28.
• [3584] The DEAD-box RNA helicase 51 controls non-small cell lung cancer proliferation by regulating cell cycle progression via multiple pathways.Sci Rep. 2016 May 20;6:26108. doi: 10.1038/srep26108.
• [3585] Regulation of epithelial-mesenchymal transition and metastasis by TGF-, P-bodies, and autophagy.Oncotarget. 2017 Oct 17;8(61):103302-103314. doi: 10.18632/oncotarget.21871. eCollection 2017 Nov 28.
• [3586] Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma.Oncotarget. 2016 Dec 20;7(51):85097-85108. doi: 10.18632/oncotarget.13197.
• [3587] Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.Clin Cancer Res. 2001 Nov;7(11):3495-503.
• [3588] Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.Biomater Sci. 2020 Jan 21;8(2):694-701. doi: 10.1039/c9bm01640f.
• [3589] Oncogenic relevant defensins: expression pattern and proliferation characteristics of human tumor cell lines.Tumour Biol. 2016 Jun;37(6):7959-66. doi: 10.1007/s13277-015-4701-7. Epub 2015 Dec 28.
• [3590] Human -defensin 3 contains an oncolytic motif that binds PI(4,5)P2 to mediate tumour cell permeabilisation.Oncotarget. 2016 Jan 12;7(2):2054-69. doi: 10.18632/oncotarget.6520.
• [3591] Overexpression of human -defensin 2 promotes growth and invasion during esophageal carcinogenesis.Oncotarget. 2014 Nov 30;5(22):11333-44. doi: 10.18632/oncotarget.2416.
• [3592] Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.Gastric Cancer. 2015 Apr;18(2):288-96. doi: 10.1007/s10120-014-0372-0. Epub 2014 Apr 3.
• [3593] DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis.Exp Cell Res. 2019 Jun 1;379(1):48-54. doi: 10.1016/j.yexcr.2019.03.021. Epub 2019 Mar 14.
• [3594] Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth.Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20505-20510. doi: 10.1073/pnas.1904774116. Epub 2019 Sep 23.
• [3595] MicroRNA-181d is a tumor suppressor in human esophageal squamous cell carcinoma inversely regulating Derlin-1.Oncol Rep. 2016 Oct;36(4):2041-8. doi: 10.3892/or.2016.5028. Epub 2016 Aug 22.
• [3596] A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.Carcinogenesis. 2018 Mar 8;39(3):397-406. doi: 10.1093/carcin/bgy006.
• [3597] A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect.Nat Commun. 2014 Apr 3;5:3608. doi: 10.1038/ncomms4608.
• [3598] POST-TEXT III and IV Hepatoblastoma: Extended Hepatic Resection Avoids Liver Transplantation in Selected Cases.Ann Surg. 2017 Aug;266(2):318-323. doi: 10.1097/SLA.0000000000001936.
• [3599] Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.Rapid Commun Mass Spectrom. 2020 Apr;34 Suppl 1(Suppl 1):e8551. doi: 10.1002/rcm.8551. Epub 2019 Nov 6.
• [3600] Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma.Oncol Lett. 2019 Aug;18(2):1356-1364. doi: 10.3892/ol.2019.10421. Epub 2019 May 30.
• [3601] Diacylglycerol kinase predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma.Exp Cell Res. 2018 Dec 15;373(1-2):211-220. doi: 10.1016/j.yexcr.2018.11.001. Epub 2018 Nov 3.
• [3602] DGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.PLoS One. 2014 Sep 18;9(9):e104455. doi: 10.1371/journal.pone.0104455. eCollection 2014.
• [3603] The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma.EMBO Mol Med. 2019 Dec;11(12):e10849. doi: 10.15252/emmm.201910849. Epub 2019 Oct 21.
• [3604] Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer.Cell Commun Signal. 2018 Jan 8;16(1):3. doi: 10.1186/s12964-017-0213-y.
• [3605] Role of DHX33 in c-Myc-induced cancers.Carcinogenesis. 2017 Jun 1;38(6):649-660. doi: 10.1093/carcin/bgx041.
• [3606] Innate immune sensor laboratory of genetics and physiology 2 suppresses tumor cell growth and functions as a prognostic marker in neuroblastoma.Cancer Sci. 2018 Nov;109(11):3494-3502. doi: 10.1111/cas.13790. Epub 2018 Oct 4.
• [3607] Engineered Bacterial Bioreactor for Tumor Therapy via Fenton-Like Reaction with Localized H(2) O(2) Generation.Adv Mater. 2019 Apr;31(16):e1808278. doi: 10.1002/adma.201808278. Epub 2019 Feb 25.
• [3608] DIAPH2 alterations increase cellular motility and may contribute to the metastatic potential of laryngeal squamous cell carcinoma.Carcinogenesis. 2019 Oct 16;40(10):1251-1259. doi: 10.1093/carcin/bgz035.
• [3609] Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment.Cancer Biol Ther. 2014 Apr;15(4):409-18. doi: 10.4161/cbt.27627. Epub 2014 Jan 14.
• [3610] CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.Cell Oncol (Dordr). 2012 Aug;35(4):293-300. doi: 10.1007/s13402-012-0088-2. Epub 2012 Jun 19.
• [3611] Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity.Cell Rep. 2018 Aug 14;24(7):1790-1801. doi: 10.1016/j.celrep.2018.07.043.
• [3612] RNAa and Vector-Mediated Overexpression of DIRAS1 Suppresses Tumor Growth and Migration in Renal Cell Carcinoma.Mol Ther Nucleic Acids. 2018 Sep 7;12:845-853. doi: 10.1016/j.omtn.2018.07.019. Epub 2018 Aug 8.
• [3613] DIRAS3-Derived Peptide Inhibits Autophagy in Ovarian Cancer Cells by Binding to Beclin1.Cancers (Basel). 2019 Apr 18;11(4):557. doi: 10.3390/cancers11040557.
• [3614] Loss of Dis3l2 partially phenocopies Perlman syndrome in mice and results in up-regulation of Igf2 in nephron progenitor cells.Genes Dev. 2018 Jul 1;32(13-14):903-908. doi: 10.1101/gad.315804.118. Epub 2018 Jun 27.
• [3615] Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis.Tumour Biol. 2016 Oct;37(10):13607-13616. doi: 10.1007/s13277-016-5213-9. Epub 2016 Jul 28.
• [3616] Schwannoma-like tumor in the anterior cranial fossa immunonegative for Leu7 but immunopositive for Schwann/2E.Neuropathology. 2017 Jun;37(3):265-271. doi: 10.1111/neup.12357. Epub 2016 Dec 7.
• [3617] Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma.Oncogene. 2019 Jan;38(2):291-298. doi: 10.1038/s41388-018-0444-4. Epub 2018 Aug 9.
• [3618] GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth.Cancer Cell. 2018 Apr 9;33(4):736-751.e5. doi: 10.1016/j.ccell.2018.02.011. Epub 2018 Mar 29.
• [3619] In vitro study of anti-ER positive breast cancer effect and mechanism of 1,2,3,4-6-pentyl-O-galloyl-beta-d-glucose (PGG).Biomed Pharmacother. 2019 Mar;111:813-820. doi: 10.1016/j.biopha.2018.12.062. Epub 2019 Jan 4.
• [3620] Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.Am J Hum Genet. 2019 Apr 4;104(4):651-664. doi: 10.1016/j.ajhg.2019.02.017. Epub 2019 Mar 28.
• [3621] MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-/Smad4 signalling pathway by down-regulating DLX1.J Cell Mol Med. 2019 Sep;23(9):5934-5948. doi: 10.1111/jcmm.14402. Epub 2019 Jul 12.
• [3622] Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch.Oncotarget. 2016 Feb 16;7(7):7925-39. doi: 10.18632/oncotarget.6879.
• [3623] Beta protein 1 homeoprotein induces cell growth and estrogen-independent tumorigenesis by binding to the estrogen receptor in breast cancer.Oncotarget. 2016 Aug 16;7(33):53204-53216. doi: 10.18632/oncotarget.10633.
• [3624] The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.Oncotarget. 2017 Feb 28;8(9):14941-14956. doi: 10.18632/oncotarget.14784.
• [3625] LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis.Onco Targets Ther. 2019 May 22;12:3945-3954. doi: 10.2147/OTT.S196865. eCollection 2019.
• [3626] DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell.Cancer Lett. 2019 Jul 1;453:45-56. doi: 10.1016/j.canlet.2019.03.045. Epub 2019 Mar 27.
• [3627] Dissecting the Recombination Mediator Activity of BRCA2 Using Biochemical Methods.Methods Enzymol. 2018;600:479-511. doi: 10.1016/bs.mie.2017.11.018.
• [3628] Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1.Med Decis Making. 2019 Apr;39(3):217-227. doi: 10.1177/0272989X19827258. Epub 2019 Feb 25.
• [3629] Multiple roles of DNA2 nuclease/helicase in DNA metabolism, genome stability and human diseases.Nucleic Acids Res. 2020 Jan 10;48(1):16-35. doi: 10.1093/nar/gkz1101.
• [3630] Mutations in LRRC50 predispose zebrafish and humans to seminomas.PLoS Genet. 2013 Apr;9(4):e1003384. doi: 10.1371/journal.pgen.1003384. Epub 2013 Apr 11.
• [3631] Candidate susceptibility variants for esophageal squamous cell carcinoma.Genes Chromosomes Cancer. 2017 Jun;56(6):453-459. doi: 10.1002/gcc.22448. Epub 2017 Apr 3.
• [3632] HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.OMICS. 2017 May;21(5):257-265. doi: 10.1089/omi.2017.0016.
• [3633] DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.Oncol Res. 2018 Jan 19;26(1):45-58. doi: 10.3727/096504017X14926874596386. Epub 2017 May 4.
• [3634] HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells.Cancer Res. 2012 Jun 1;72(11):2844-54. doi: 10.1158/0008-5472.CAN-11-3062. Epub 2012 May 2.
• [3635] Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer. 2007 Apr 10;96(7):1062-71. doi: 10.1038/sj.bjc.6603672. Epub 2007 Mar 13.
• [3636] Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours.Int J Cancer. 2006 Jan 15;118(2):346-52. doi: 10.1002/ijc.21353.
• [3637] Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.Dis Markers. 2016;2016:5128720. doi: 10.1155/2016/5128720. Epub 2016 Oct 25.
• [3638] Small GTPase RBJ promotes cancer progression by mobilizing MDSCs via IL-6.Oncoimmunology. 2016 Dec 23;6(1):e1245265. doi: 10.1080/2162402X.2016.1245265. eCollection 2017.
• [3639] Colorectal carcinomas and PTEN/MMAC1 gene mutations.Clin Cancer Res. 2001 Dec;7(12):4049-53.
• [3640] MicroRNA-24 regulates the growth and chemosensitivity of the human colorectal cancer cells by targeting RNA-binding protein DND1.J BUON. 2019 Jul-Aug;24(4):1476-1481.
• [3641] Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.Clin Cancer Res. 2019 Jun 1;25(11):3404-3416. doi: 10.1158/1078-0432.CCR-18-2437. Epub 2019 Feb 22.
• [3642] Validation of R-2-[(18)F]Fluoropropionic Acid as a Potential Tracer for PET Imaging of Liver Cancer.Mol Imaging Biol. 2019 Dec;21(6):1127-1137. doi: 10.1007/s11307-019-01346-1.
• [3643] Linc01278 inhibits the development of papillary thyroid carcinoma by regulating miR-376c-3p/DNM3 axis.Cancer Manag Res. 2019 Sep 19;11:8557-8569. doi: 10.2147/CMAR.S217886. eCollection 2019.
• [3644] A novel sphingosine kinase inhibitor induces autophagy in tumor cells.J Pharmacol Exp Ther. 2010 May;333(2):454-64. doi: 10.1124/jpet.109.163337. Epub 2010 Feb 23.
• [3645] Smurf1 regulation of DAB2IP controls cell proliferation and migration.Oncotarget. 2016 May 3;7(18):26057-69. doi: 10.18632/oncotarget.8424.
• [3646] Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.Cell Prolif. 2019 Jul;52(4):e12614. doi: 10.1111/cpr.12614. Epub 2019 Apr 14.
• [3647] Overexpression of dedicator of cytokinesis 2 correlates with good prognosis in colorectal cancer associated with more prominent CD8(+) lymphocytes infiltration: a colorectal cancer analysis.J Cell Biochem. 2018 Nov;119(11):8962-8970. doi: 10.1002/jcb.27151. Epub 2018 Aug 4.
• [3648] Docking protein-1 promotes inflammatory macrophage signaling in gastric cancer.Oncoimmunology. 2019 Aug 21;8(11):e1649961. doi: 10.1080/2162402X.2019.1649961. eCollection 2019.
• [3649] Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.Oncol Lett. 2017 Nov;14(5):5386-5392. doi: 10.3892/ol.2017.6844. Epub 2017 Aug 28.
• [3650] The tumor suppressor OVCA1 is a short half-life protein degraded by the ubiquitin-proteasome pathway.Oncol Lett. 2019 Feb;17(2):2328-2334. doi: 10.3892/ol.2018.9852. Epub 2018 Dec 19.
• [3651] High developmental pluripotencyassociated 4 expression promotes cell proliferation and glycolysis, and predicts poor prognosis in nonsmallcell lung cancer.Mol Med Rep. 2019 Jul;20(1):445-454. doi: 10.3892/mmr.2019.10272. Epub 2019 May 22.
• [3652] Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma.Biomed Pharmacother. 2020 Mar;123:109766. doi: 10.1016/j.biopha.2019.109766. Epub 2019 Dec 14.
• [3653] 1,4-Dihydropyridine: A Dependable Heterocyclic Ring with the Promising and the Most Anticipable Therapeutic Effects.Mini Rev Med Chem. 2019;19(15):1219-1254. doi: 10.2174/1389557519666190425184749.
• [3654] p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells.Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):8370-8375. doi: 10.1073/pnas.1804243115. Epub 2018 Jul 30.
• [3655] DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53.J Exp Clin Cancer Res. 2019 Feb 12;38(1):72. doi: 10.1186/s13046-019-1068-4.
• [3656] Functional intronic variant of SLC5A10 affects DRG2 expression and survival outcomes of early-stage non-small-cell lung cancer.Cancer Sci. 2018 Dec;109(12):3902-3909. doi: 10.1111/cas.13814. Epub 2018 Nov 7.
• [3657] Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.Pathol Oncol Res. 2020 Apr;26(2):1235-1241. doi: 10.1007/s12253-019-00688-z. Epub 2019 Jun 27.
• [3658] Proteomics Identification and Validation of Desmocollin-1 and Catechol-O-Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis.Proteomics. 2019 Nov;19(21-22):e1900073. doi: 10.1002/pmic.201900073. Epub 2019 Oct 28.
• [3659] Desmocollin 3 has a tumor suppressive activity through inhibition of AKT pathway in colorectal cancer.Exp Cell Res. 2019 May 15;378(2):124-130. doi: 10.1016/j.yexcr.2019.03.015. Epub 2019 Mar 8.
• [3660] Effect of Upregulated DNA Replication and Sister Chromatid Cohesion 1 Expression on Proliferation and Prognosis in Hepatocellular Carcinoma.Chin Med J (Engl). 2018 Dec 5;131(23):2827-2835. doi: 10.4103/0366-6999.246076.
• [3661] DSE regulates the malignant characters of hepatocellular carcinoma cells by modulating CCL5/CCR1 axis.Am J Cancer Res. 2019 Feb 1;9(2):347-362. eCollection 2019.
• [3662] Structure-based Design of JOC-x, a Conjugatable Tumor Tight Junction Opener to Enhance Cancer Therapy.Sci Rep. 2019 Apr 16;9(1):6169. doi: 10.1038/s41598-019-42229-3.
• [3663] One-pot synthesis of SiO(2)-coated Gd(2)(WO(4))(3):Yb(3+)/Ho(3+) nanoparticles for simultaneous multi-imaging, temperature sensing and tumor inhibition.Dalton Trans. 2019 Jul 16;48(28):10537-10546. doi: 10.1039/c9dt01841g.
• [3664] Survey of dentin sialophosphoprotein and its cognate matrix metalloproteinase-20 in human cancers.Cancer Med. 2019 May;8(5):2167-2178. doi: 10.1002/cam4.2117. Epub 2019 Apr 1.
• [3665] NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.Cancer Res. 1992 Feb 15;52(4):797-802.
• [3666] DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.Mol Cancer. 2014 May 27;13:125. doi: 10.1186/1476-4598-13-125.
• [3667] DUOX1 Silencing in Mammary Cell Alters the Response to Genotoxic Stress.Oxid Med Cell Longev. 2018 Apr 19;2018:3570526. doi: 10.1155/2018/3570526. eCollection 2018.
• [3668] IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells.J Immunol. 2019 Nov 1;203(9):2532-2544. doi: 10.4049/jimmunol.1800469. Epub 2019 Sep 23.
• [3669] Identification of differentially expressed genes involved in the formation of multicellular tumor spheroids by HT-29 colon carcinoma cells.Mol Ther. 2007 Jan;15(1):94-102. doi: 10.1038/sj.mt.6300003.
• [3670] MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.J Cell Biochem. 2018 Jul;119(7):5143-5152. doi: 10.1002/jcb.26526. Epub 2018 Apr 17.
• [3671] VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers.Mol Cancer. 2010 May 28;9:128. doi: 10.1186/1476-4598-9-128.
• [3672] Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A.Sci Rep. 2017 Oct 6;7(1):12760. doi: 10.1038/s41598-017-13023-w.
• [3673] miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.Cell Death Dis. 2019 Dec 4;10(12):922. doi: 10.1038/s41419-019-2164-2.
• [3674] Different behaviour of DVL1, DVL2, DVL3 in astrocytoma malignancy grades and their association to TCF1 and LEF1 upregulation.J Cell Mol Med. 2019 Jan;23(1):641-655. doi: 10.1111/jcmm.13969. Epub 2018 Nov 23.
• [3675] Overexpression of Dishevelled-2 contributes to proliferation and migration of human esophageal squamous cell carcinoma.J Mol Histol. 2016 Jun;47(3):287-95. doi: 10.1007/s10735-016-9674-3. Epub 2016 Apr 15.
• [3676] Identification of driver genes regulating immune cell infiltration in cervical cancer by multiple omics integration.Biomed Pharmacother. 2019 Dec;120:109546. doi: 10.1016/j.biopha.2019.109546. Epub 2019 Oct 30.
• [3677] Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma.Eur J Histochem. 2019 Feb 18;63(1):2981. doi: 10.4081/ejh.2019.2981.
• [3678] ER(+) Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.Clin Cancer Res. 2018 Jun 1;24(11):2517-2529. doi: 10.1158/1078-0432.CCR-17-2904. Epub 2018 Mar 26.
• [3679] MicroRNA-32 inhibits the proliferation, migration and invasion of human colon cancer cell lines by targeting E2F transcription factor 5.Eur Rev Med Pharmacol Sci. 2019 May;23(10):4156-4163. doi: 10.26355/eurrev_201905_17918.
• [3680] E2F6 is essential for cell viability in breast cancer cells during replication stress.Turk J Biol. 2019 Oct 14;43(5):293-304. doi: 10.3906/biy-1905-6. eCollection 2019.
• [3681] microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.Br J Biomed Sci. 2019 Jan;76(1):17-23. doi: 10.1080/09674845.2018.1520066. Epub 2018 Oct 30.
• [3682] Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression.EMBO J. 2019 Oct 15;38(20):e101430. doi: 10.15252/embj.2018101430. Epub 2019 Sep 2.
• [3683] Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.Neoplasia. 2019 Aug;21(8):752-764. doi: 10.1016/j.neo.2019.05.005. Epub 2019 Jun 21.
• [3684] EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.Neoplasia. 2018 Apr;20(4):351-363. doi: 10.1016/j.neo.2018.01.011. Epub 2018 Mar 6.
• [3685] Immunization with HER2 extracellular subdomain proteins induces cellular response and tumor growth inhibition in mice.Immunotherapy. 2018 Mar 1;10(6):511-524. doi: 10.2217/imt-2017-0181.
• [3686] Enoyl-coenzyme A hydratase short chain 1 silencing attenuates the proliferation of hepatocellular carcinoma by inhibiting epidermal growth factor signaling in vitro and in vivo.Mol Med Rep. 2015 Jul;12(1):1421-8. doi: 10.3892/mmr.2015.3453. Epub 2015 Mar 9.
• [3687] Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis.Cancer Gene Ther. 2018 Oct;25(9-10):248-259. doi: 10.1038/s41417-018-0032-3. Epub 2018 Jul 9.
• [3688] The Ectodysplasin receptor EDAR acts as a tumor suppressor in melanoma by conditionally inducing cell death.Cell Death Differ. 2019 Mar;26(3):443-454. doi: 10.1038/s41418-018-0128-1. Epub 2018 May 31.
• [3689] Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer.Curr Pharm Biotechnol. 2019;20(6):483-488. doi: 10.2174/1389201020666190408112822.
• [3690] Epigenetic silencing of endothelin-3 in colorectal cancer.Int J Immunopathol Pharmacol. 2016 Jun;29(2):333-40. doi: 10.1177/0394632015600371. Epub 2015 Dec 18.
• [3691] Independent overexpression of the subunits of translation elongation factor complex eEF1H in human lung cancer.BMC Cancer. 2014 Dec 3;14:913. doi: 10.1186/1471-2407-14-913.
• [3692] EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling.J Exp Clin Cancer Res. 2018 Mar 6;37(1):50. doi: 10.1186/s13046-018-0715-5.
• [3693] Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.Oncotarget. 2017 Feb 14;8(7):11950-11962. doi: 10.18632/oncotarget.14447.
• [3694] FBLN-4 and BCRP genes as two prognostic markers are downregulated in breast cancer tissue.Cancer Biomark. 2017;19(1):51-55. doi: 10.3233/CBM-160335.
• [3695] Roles of EphA1/A2 and ephrin-A1 in cancer.Cancer Sci. 2019 Mar;110(3):841-848. doi: 10.1111/cas.13942. Epub 2019 Feb 15.
• [3696] First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.Int J Cancer. 2019 Oct 1;145(7):1798-1808. doi: 10.1002/ijc.32154. Epub 2019 Feb 23.
• [3697] UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma.Nat Commun. 2018 Jul 13;9(1):2720. doi: 10.1038/s41467-018-05084-w.
• [3698] Ligand-dependent EphB4 activation serves as an anchoring signal in glioma cells.Cancer Lett. 2019 May 1;449:56-65. doi: 10.1016/j.canlet.2019.02.021. Epub 2019 Feb 15.
• [3699] Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4.Oncotarget. 2017 Apr 4;8(14):23750-23759. doi: 10.18632/oncotarget.16077.
• [3700] A positive feedback loop between ZNF205-AS1 and EGR4 promotes non-small cell lung cancer growth.J Cell Mol Med. 2019 Feb;23(2):1495-1508. doi: 10.1111/jcmm.14056. Epub 2018 Dec 16.
• [3701] Effect of EH domain containing protein 2 on the biological behavior of clear cell renal cell carcinoma.Hum Exp Toxicol. 2019 Aug;38(8):927-937. doi: 10.1177/0960327119842241. Epub 2019 Apr 17.
• [3702] Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis.Carcinogenesis. 2014 Apr;35(4):877-85. doi: 10.1093/carcin/bgt399. Epub 2013 Dec 4.
• [3703] Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors.Oncotarget. 2017 Oct 31;8(63):106206-106221. doi: 10.18632/oncotarget.22175. eCollection 2017 Dec 5.
• [3704] Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.Thyroid. 2019 Mar;29(3):311-321. doi: 10.1089/thy.2018.0509.
• [3705] Regulation of interferon pathway in 2-methoxyestradiol-treated osteosarcoma cells.BMC Cancer. 2012 Mar 19;12:93. doi: 10.1186/1471-2407-12-93.
• [3706] Upregulated expression of eIF3C is associated with malignant behavior in renal cell carcinoma.Int J Oncol. 2019 Dec;55(6):1385-1395. doi: 10.3892/ijo.2019.4903. Epub 2019 Oct 21.
• [3707] The Bad, the Good and eIF3e/INT6.Front Biosci (Landmark Ed). 2017 Jan 1;22(1):1-20. doi: 10.2741/4469.
• [3708] eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.Oncotarget. 2016 Apr 5;7(14):18541-57. doi: 10.18632/oncotarget.8105.
• [3709] Eukaryotic translation initiation factor 3 subunit G (EIF3G) resensitized HCT116/5-Fu to 5-fluorouracil (5-Fu) via inhibition of MRP and MDR1.Onco Targets Ther. 2018 Aug 31;11:5315-5324. doi: 10.2147/OTT.S170854. eCollection 2018.
• [3710] Cancer Targeted Gene Therapy for Inhibition of Melanoma Lung Metastasis with eIF3i shRNA Loaded Liposomes.Mol Pharm. 2020 Jan 6;17(1):229-238. doi: 10.1021/acs.molpharmaceut.9b00943. Epub 2019 Dec 10.
• [3711] Generation of a tumor- and tissue-specific episomal non-viral vector system.BMC Biotechnol. 2013 Jun 4;13:49. doi: 10.1186/1472-6750-13-49.
• [3712] Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.Cancer Cell Int. 2019 Jun 4;19:155. doi: 10.1186/s12935-019-0867-1. eCollection 2019.
• [3713] Evaluation of prognostic usefulness of long noncoding RNA GAS5 and FAL1 in papillary thyroid carcinoma.J Cell Biochem. 2019 Jul;120(7):11471-11477. doi: 10.1002/jcb.28425. Epub 2019 Feb 11.
• [3714] Down-regulation of eIF4GII by miR-520c-3p represses diffuse large B cell lymphoma development.PLoS Genet. 2014 Jan 30;10(1):e1004105. doi: 10.1371/journal.pgen.1004105. eCollection 2014 Jan.
• [3715] Key contribution of eIF4H-mediated translational control in tumor promotion.Oncotarget. 2015 Nov 24;6(37):39924-40. doi: 10.18632/oncotarget.5442.
• [3716] Proteomic analysis of eIF-5A in lung adenocarcinomas.Proteomics. 2003 Apr;3(4):496-504. doi: 10.1002/pmic.200390063.
• [3717] Eukaryotic initiation factor 5B (eIF5B) regulates temozolomide-mediated apoptosis in brain tumour stem cells (BTSCs).Biochem Cell Biol. 2020 Dec;98(6):647-652. doi: 10.1139/bcb-2019-0329. Epub 2019 Oct 31.
• [3718] HE4 and eIF3a Expression Correlates with Surgical Outcome and Overall Survival in Ovarian Cancer Patients with Secondary Cytoreduction.J Cancer. 2018 Jun 14;9(14):2472-2479. doi: 10.7150/jca.25184. eCollection 2018.
• [3719] Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.J Neuroimmunol. 2016 Oct 15;299:70-78. doi: 10.1016/j.jneuroim.2016.09.002. Epub 2016 Sep 3.
• [3720] ChIP-on-chip analysis of thyroid hormone-regulated genes and their physiological significance.Oncotarget. 2016 Apr 19;7(16):22448-59. doi: 10.18632/oncotarget.7988.
• [3721] ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.Cancer Biol Ther. 2019;20(1):90-100. doi: 10.1080/15384047.2018.1507256. Epub 2018 Aug 27.
• [3722] Embryonic Fibroblasts Promote Antitumor Cytotoxic Effects of CD8(+) T Cells.Front Immunol. 2018 Apr 13;9:685. doi: 10.3389/fimmu.2018.00685. eCollection 2018.
• [3723] Overexpression of E74-Like Factor 5 (ELF5) Inhibits Migration and Invasion of Ovarian Cancer Cells.Med Sci Monit. 2019 Jan 30;25:856-865. doi: 10.12659/MSM.913058.
• [3724] ELL targets c-Myc for proteasomal degradation and suppresses tumour growth.Nat Commun. 2016 Mar 24;7:11057. doi: 10.1038/ncomms11057.
• [3725] ELMO3 predicts poor outcome in T1 laryngeal cancer.Clin Otolaryngol. 2017 Dec;42(6):1181-1186. doi: 10.1111/coa.12845. Epub 2017 Mar 13.
• [3726] Prognostic significance of venous invasion in node-negative head and neck squamous cell carcinoma.J Oral Pathol Med. 2020 Feb;49(2):150-155. doi: 10.1111/jop.12975. Epub 2019 Dec 1.
• [3727] Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer.BMC Cancer. 2017 Aug 29;17(1):589. doi: 10.1186/s12885-017-3554-4.
• [3728] Decreased expression levels of ELOVL6 indicate poor prognosis in hepatocellular carcinoma.Oncol Lett. 2019 Dec;18(6):6214-6220. doi: 10.3892/ol.2019.10974. Epub 2019 Oct 9.
• [3729] WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance.Cell Oncol. 2010 Jan 1;32(4):303-10. doi: 10.3233/CLO-2009-0503.
• [3730] Elongator promotes the migration and invasion of hepatocellular carcinoma cell by the phosphorylation of AKT.Int J Biol Sci. 2018 Apr 5;14(5):518-530. doi: 10.7150/ijbs.23511. eCollection 2018.
• [3731] Functional evidence for Eme1 as a marker of cisplatin resistance.Int J Cancer. 2009 Jun 15;124(12):2997-3001. doi: 10.1002/ijc.24268.
• [3732] Abrogation of EMILIN1-1 integrin interaction promotes experimental colitis and colon carcinogenesis.Matrix Biol. 2019 Oct;83:97-115. doi: 10.1016/j.matbio.2019.08.006. Epub 2019 Aug 31.
• [3733] The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth.Oncogene. 2018 Jun;37(25):3399-3414. doi: 10.1038/s41388-017-0107-x. Epub 2018 Feb 27.
• [3734] Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.Cell Physiol Biochem. 2018;47(1):428-439. doi: 10.1159/000489954. Epub 2018 May 18.
• [3735] Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy.Cancer Chemother Pharmacol. 2011 Sep;68(3):571-82. doi: 10.1007/s00280-010-1514-7. Epub 2010 Nov 26.
• [3736] p53, miR-34a and EMP1-Newly Identified Targets of TFF3 Signaling in Y79 Retinoblastoma Cells.Int J Mol Sci. 2019 Aug 24;20(17):4129. doi: 10.3390/ijms20174129.
• [3737] Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer.Clin Transl Oncol. 2019 Apr;21(4):433-442. doi: 10.1007/s12094-018-1941-1. Epub 2018 Sep 14.
• [3738] Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation.Int J Cancer. 2019 Jul 15;145(2):461-473. doi: 10.1002/ijc.32107. Epub 2019 Jan 20.
• [3739] miRNA-mRNA Associated With Survival in Endometrial Cancer.Front Genet. 2019 Aug 20;10:743. doi: 10.3389/fgene.2019.00743. eCollection 2019.
• [3740] Emx2 as a novel tool to suppress glioblastoma.Oncotarget. 2016 Jul 5;7(27):41005-41016. doi: 10.18632/oncotarget.9322.
• [3741] Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.J Neurooncol. 2014 Sep;119(2):307-15. doi: 10.1007/s11060-014-1479-1. Epub 2014 Jun 11.
• [3742] Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer.BMC Cancer. 2017 May 22;17(1):360. doi: 10.1186/s12885-017-3330-5.
• [3743] ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K/Akt and MAPK/ERK signaling pathways.J Cancer. 2019 Jul 5;10(17):3975-3984. doi: 10.7150/jca.30021. eCollection 2019.
• [3744] CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1.Cell Death Dis. 2019 Nov 25;10(12):885. doi: 10.1038/s41419-019-2127-7.
• [3745] rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.Int J Mol Sci. 2018 Aug 21;19(9):2473. doi: 10.3390/ijms19092473.
• [3746] Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.Int J Colorectal Dis. 2003 Jul;18(4):309-13. doi: 10.1007/s00384-002-0471-y. Epub 2003 Mar 4.
• [3747] The ENTPD5/mt-PCPH oncoprotein is a catalytically inactive member of the ectonucleoside triphosphate diphosphohydrolase family.Int J Oncol. 2013 Oct;43(4):1244-52. doi: 10.3892/ijo.2013.2052. Epub 2013 Aug 6.
• [3748] The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesis.Oncogene. 2013 Sep 26;32(39):4602-13. doi: 10.1038/onc.2012.485. Epub 2012 Oct 29.
• [3749] Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.J Immunother. 2018 Feb/Mar;41(2):53-63. doi: 10.1097/CJI.0000000000000206.
• [3750] Senescence-associated protein p400 is a prognostic marker in renal cell carcinoma.Oncol Rep. 2013 Nov;30(5):2245-53. doi: 10.3892/or.2013.2698. Epub 2013 Aug 26.
• [3751] miR-452 promotes the development of gastric cancer via targeting EPB41L3.Pathol Res Pract. 2020 Jan;216(1):152725. doi: 10.1016/j.prp.2019.152725. Epub 2019 Oct 31.
• [3752] Differential expression and functions of Ehm2 transcript variants in lung adenocarcinoma.Int J Oncol. 2019 May;54(5):1747-1758. doi: 10.3892/ijo.2019.4732. Epub 2019 Feb 27.
• [3753] Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.J Clin Invest. 2012 Dec;122(12):4424-38. doi: 10.1172/JCI64537. Epub 2012 Nov 26.
• [3754] Overexpression of Epsin3 enhances migration and invasion of glioma cells by inducing epithelialmesenchymal transition.Oncol Rep. 2018 Nov;40(5):3049-3059. doi: 10.3892/or.2018.6691. Epub 2018 Sep 10.
• [3755] EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.Oncotarget. 2016 Oct 25;7(43):69592-69605. doi: 10.18632/oncotarget.11870.
• [3756] Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling.Tumour Biol. 2017 Feb;39(2):1010428317691010. doi: 10.1177/1010428317691010.
• [3757] LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.J Cell Physiol. 2019 Mar;234(3):2880-2894. doi: 10.1002/jcp.27105. Epub 2018 Sep 10.
• [3758] Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer.Front Oncol. 2019 Feb 21;9:85. doi: 10.3389/fonc.2019.00085. eCollection 2019.
• [3759] ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.Gynecol Oncol. 2019 May;153(2):416-424. doi: 10.1016/j.ygyno.2019.02.014. Epub 2019 Feb 21.
• [3760] ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.Cancer Gene Ther. 2019 Sep;26(9-10):323-333. doi: 10.1038/s41417-018-0064-8. Epub 2018 Nov 21.
• [3761] ERGIC3, which is regulated by miR-203a, is a potential biomarker for non-small cell lung cancer.Cancer Sci. 2015 Oct;106(10):1463-73. doi: 10.1111/cas.12741. Epub 2015 Aug 10.
• [3762] MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.Cell Physiol Biochem. 2018;48(2):461-474. doi: 10.1159/000491777. Epub 2018 Jul 17.
• [3763] Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma.J Bone Oncol. 2019 Mar 19;16:100233. doi: 10.1016/j.jbo.2019.100233. eCollection 2019 Jun.
• [3764] A calcium-dependent phospholipase A2 (cPLA2) expression is regulated by MIG-6 during endometrial tumorigenesis.Biochem Biophys Res Commun. 2019 Mar 26;511(1):129-134. doi: 10.1016/j.bbrc.2019.02.034. Epub 2019 Feb 14.
• [3765] Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis.Cancer Immunol Res. 2018 Apr;6(4):378-388. doi: 10.1158/2326-6066.CIR-17-0489. Epub 2018 Feb 23.
• [3766] Role of endothelial cell-selective adhesion molecule in hematogeneous metastasis.Microvasc Res. 2010 Jul;80(1):133-41. doi: 10.1016/j.mvr.2010.02.006. Epub 2010 Feb 11.
• [3767] Esterase D assay in Brazilian retinoblastoma families.Am J Med Genet. 1989 Nov;34(3):391-6. doi: 10.1002/ajmg.1320340314.
• [3768] Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma.BMC Endocr Disord. 2019 Aug 27;19(1):90. doi: 10.1186/s12902-019-0418-8.
• [3769] Toxicity study of separase inhibitor-Sepin-1 in Sprague-Dawley rats.Pathol Res Pract. 2020 Jan;216(1):152730. doi: 10.1016/j.prp.2019.152730. Epub 2019 Nov 11.
• [3770] Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways.EMBO Rep. 2019 Feb;20(2):e46078. doi: 10.15252/embr.201846078. Epub 2019 Jan 21.
• [3771] Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.Oncogene. 2017 Nov 16;36(46):6446-6461. doi: 10.1038/onc.2017.246. Epub 2017 Jul 31.
• [3772] Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.Breast Cancer Res Treat. 2018 Jan;167(1):249-256. doi: 10.1007/s10549-017-4497-9. Epub 2017 Sep 14.
• [3773] AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis.J Clin Pathol. 2016 Mar;69(3):215-20. doi: 10.1136/jclinpath-2015-203042. Epub 2015 Aug 20.
• [3774] ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.Int J Cancer. 2019 Jul 1;145(1):179-191. doi: 10.1002/ijc.32071. Epub 2019 Jan 28.
• [3775] ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer. Sci Adv. 2018 Sep 12;4(9):eaar3938.
• [3776] Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.J Virol. 1995 Aug;69(8):5095-102. doi: 10.1128/JVI.69.8.5095-5102.1995.
• [3777] EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy.Oncol Rep. 2017 Oct;38(4):2251-2258. doi: 10.3892/or.2017.5862. Epub 2017 Aug 1.
• [3778] Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.Eur J Haematol. 2018 Sep;101(3):291-296. doi: 10.1111/ejh.13084. Epub 2018 Jul 12.
• [3779] Contribution of EVX1 in Aggressiveness of Esophageal Squamous Cell Carcinoma.Pathol Oncol Res. 2016 Apr;22(2):341-7. doi: 10.1007/s12253-015-0005-x. Epub 2015 Nov 9.
• [3780] Exo70 is an independent prognostic factor in colon cancer.Sci Rep. 2017 Jul 11;7(1):5039. doi: 10.1038/s41598-017-05308-x.
• [3781] EYA4 serves as a prognostic biomarker in hepatocellular carcinoma and suppresses tumour angiogenesis and metastasis.J Cell Mol Med. 2019 Jun;23(6):4208-4216. doi: 10.1111/jcmm.14309. Epub 2019 Apr 7.
• [3782] EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma.Neuro Oncol. 2019 Jul 11;21(7):878-889. doi: 10.1093/neuonc/noz058.
• [3783] Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer.EBioMedicine. 2019 Mar;41:256-267. doi: 10.1016/j.ebiom.2019.01.066. Epub 2019 Feb 7.
• [3784] FABP7 promotes cell proliferation and survival in colon cancer through MEK/ERK signaling pathway.Biomed Pharmacother. 2018 Dec;108:119-129. doi: 10.1016/j.biopha.2018.08.038. Epub 2018 Sep 13.
• [3785] Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.Oncotarget. 2016 Sep 20;7(38):61485-61499. doi: 10.18632/oncotarget.11370.
• [3786] miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.Cell Prolif. 2018 Feb;51(1):e12406. doi: 10.1111/cpr.12406. Epub 2017 Nov 12.
• [3787] Loss of HITS (FAM107B) expression in cancers of multiple organs: tissue microarray analysis.Int J Oncol. 2012 Oct;41(4):1347-57. doi: 10.3892/ijo.2012.1550. Epub 2012 Jul 10.
• [3788] FAM111B, a direct target of p53, promotes the malignant process of lung adenocarcinoma.Onco Targets Ther. 2019 Apr 17;12:2829-2842. doi: 10.2147/OTT.S190934. eCollection 2019.
• [3789] Inhibition of melanoma metastasis by dual-peptide PLGA NPS.Biopolymers. 2017 Sep;108(5). doi: 10.1002/bip.23029.
• [3790] FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X(L) cell survival genes.BMC Cancer. 2018 Jan 22;18(1):90. doi: 10.1186/s12885-017-3950-9.
• [3791] FAM53A Affects Breast Cancer Cell Proliferation, Migration, and Invasion in a p53-Dependent Manner.Front Oncol. 2019 Nov 14;9:1244. doi: 10.3389/fonc.2019.01244. eCollection 2019.
• [3792] Stromal micropapillary pattern predominant lung adenocarcinoma--a report of two cases.Diagn Pathol. 2011 Sep 29;6:92. doi: 10.1186/1746-1596-6-92.
• [3793] A lymphomagenic role for HIV beyond immune suppression?.Blood. 2016 Mar 17;127(11):1403-9. doi: 10.1182/blood-2015-11-681411. Epub 2016 Jan 14.
• [3794] Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis.Yonsei Med J. 2019 Jul;60(7):611-618. doi: 10.3349/ymj.2019.60.7.611.
• [3795] FAM98A promotes proliferation of non-small cell lung cancer cells via the P38-ATF2 signaling pathway.Cancer Manag Res. 2018 Jul 27;10:2269-2278. doi: 10.2147/CMAR.S163323. eCollection 2018.
• [3796] FAN1 interaction with ubiquitylated PCNA alleviates replication stress and preserves genomic integrity independently of BRCA2.Nat Commun. 2017 Oct 20;8(1):1073. doi: 10.1038/s41467-017-01074-6.
• [3797] Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance.PLoS One. 2014 Aug 7;9(8):e104125. doi: 10.1371/journal.pone.0104125. eCollection 2014.
• [3798] The genetics of FANCC and FANCG in familial pancreatic cancer.Cancer Biol Ther. 2004 Feb;3(2):167-9. doi: 10.4161/cbt.3.2.609. Epub 2004 Feb 1.
• [3799] A tumor suppressive DNA translocase named FANCM.Crit Rev Biochem Mol Biol. 2019 Feb;54(1):27-40. doi: 10.1080/10409238.2019.1568963. Epub 2019 Feb 4.
• [3800] Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.Gastroenterology. 2018 Apr;154(5):1421-1434. doi: 10.1053/j.gastro.2017.12.013. Epub 2017 Dec 21.
• [3801] FASTKD2 promotes cancer cell progression through upregulating Myc expression in pancreatic ductal adenocarcinoma.J Cell Biochem. 2020 Mar;121(3):2458-2466. doi: 10.1002/jcb.29468. Epub 2019 Nov 6.
• [3802] Np63 induces the expression of FAT2 and Slug to promote tumor invasion.Oncotarget. 2016 May 10;7(19):28592-611. doi: 10.18632/oncotarget.8696.
• [3803] FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.J Exp Clin Cancer Res. 2019 Mar 4;38(1):112. doi: 10.1186/s13046-019-1043-0.
• [3804] Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene.Hum Mol Genet. 1993 Apr;2(4):349-53. doi: 10.1093/hmg/2.4.349.
• [3805] Quantitative time-resolved chemoproteomics reveals that stable O-GlcNAc regulates box C/D snoRNP biogenesis.Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):E6749-E6758. doi: 10.1073/pnas.1702688114. Epub 2017 Jul 31.
• [3806] LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo.Environ Toxicol. 2019 Aug;34(8):958-967. doi: 10.1002/tox.22767. Epub 2019 May 21.
• [3807] Antitumor Potential of Fibulin-5 in Breast Cancer Cells Depends on Its RGD Cell Adhesion Motif.Cell Physiol Biochem. 2019;53(1):87-100. doi: 10.33594/000000123.
• [3808] Automated Identification of Optimal Portal Venous Phase Timing with Convolutional Neural Networks.Acad Radiol. 2020 Feb;27(2):e10-e18. doi: 10.1016/j.acra.2019.02.024. Epub 2019 May 28.
• [3809] Combining imaging and tumour biopsy improves the diagnosis of combined hepatocellular-cholangiocarcinoma.Liver Int. 2019 Dec;39(12):2386-2396. doi: 10.1111/liv.14261. Epub 2019 Oct 20.
• [3810] Grade progression in urothelial carcinoma can occur with high or low mutational homology: a first-step toward tumor-specific care in initial low-grade bladder cancer.Oncotarget. 2018 Jan 6;9(10):9415-9424. doi: 10.18632/oncotarget.24072. eCollection 2018 Feb 6.
• [3811] Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells.Mol Cancer. 2013 Sep 25;12(1):110. doi: 10.1186/1476-4598-12-110.
• [3812] Tiny Rare-Earth Fluoride Nanoparticles Activate Tumour Cell Growth via Electrical Polar Interactions.Nanoscale Res Lett. 2018 Nov 21;13(1):370. doi: 10.1186/s11671-018-2775-z.
• [3813] FBXL3 is regulated by miRNA-4735-3p and suppresses cell proliferation and migration in non-small cell lung cancer.Pathol Res Pract. 2019 Feb;215(2):358-365. doi: 10.1016/j.prp.2018.12.008. Epub 2018 Dec 11.
• [3814] F-box protein FBXO16 functions as a tumor suppressor by attenuating nuclear -catenin function.J Pathol. 2019 Jul;248(3):266-279. doi: 10.1002/path.5252. Epub 2019 Mar 8.
• [3815] FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.Respir Res. 2018 Oct 25;19(1):206. doi: 10.1186/s12931-018-0910-0.
• [3816] Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis.Nat Med. 2014 Dec;20(12):1401-9. doi: 10.1038/nm.3740. Epub 2014 Nov 24.
• [3817] TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.Oncotarget. 2017 Mar 14;8(11):18381-18398. doi: 10.18632/oncotarget.15110.
• [3818] The tumor suppressor FBXO31 preserves genomic integrity by regulating DNA replication and segregation through precise control of cyclin A levels.J Biol Chem. 2019 Oct 11;294(41):14879-14895. doi: 10.1074/jbc.RA118.007055. Epub 2019 Aug 14.
• [3819] Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-)/Smad4 Signalling Pathway.Med Sci Monit. 2018 Feb 21;24:1080-1088. doi: 10.12659/msm.908030.
• [3820] FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells.Nature. 2018 Dec;564(7734):130-135. doi: 10.1038/s41586-018-0756-0. Epub 2018 Nov 28.
• [3821] Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications.Dis Markers. 2016;2016:1987505. doi: 10.1155/2016/1987505. Epub 2016 Aug 18.
• [3822] The RNA-binding protein FXR1 modulates prostate cancer progression by regulating FBXO4.Funct Integr Genomics. 2019 May;19(3):487-496. doi: 10.1007/s10142-019-00661-8. Epub 2019 Feb 11.
• [3823] Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival.Cell Death Differ. 2014 Oct;21(10):1535-45. doi: 10.1038/cdd.2014.92. Epub 2014 Jul 4.
• [3824] Molecular cloning and characterization of FBXO47, a novel gene containing an F-box domain, located in the 17q12 band deleted in papillary renal cell carcinoma.Genes Chromosomes Cancer. 2005 May;43(1):83-94. doi: 10.1002/gcc.20170.
• [3825] The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.Mol Cell. 2009 Aug 28;35(4):442-53. doi: 10.1016/j.molcel.2009.06.030.
• [3826] FBXW10 promotes hepatocarcinogenesis in male patients and mice.Carcinogenesis. 2020 Jul 10;41(5):689-698. doi: 10.1093/carcin/bgz138.
• [3827] A novel peptide targets CD105 for tumour imaging invivo.Oncol Rep. 2018 Nov;40(5):2935-2943. doi: 10.3892/or.2018.6643. Epub 2018 Aug 14.
• [3828] FBXW12, a novel F box protein-encoding gene, is deleted or methylated in some cases of epithelial ovarian cancer.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10192-203. eCollection 2015.
• [3829] FBXW2 suppresses migration and invasion of lung cancer cells via promoting -catenin ubiquitylation and degradation.Nat Commun. 2019 Mar 27;10(1):1382. doi: 10.1038/s41467-019-09289-5.
• [3830] Ficolin-2 triggers antitumor effect by activating macrophages and CD8(+) T cells.Clin Immunol. 2017 Oct;183:145-157. doi: 10.1016/j.clim.2017.08.012. Epub 2017 Aug 26.
• [3831] Evaluation of CD307a expression patterns during normal B-cell maturation and in B-cell malignancies by flow cytometry.Cytometry B Clin Cytom. 2018 Jul;94(4):588-595. doi: 10.1002/cyto.b.21631. Epub 2018 Mar 9.
• [3832] IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification.Am J Clin Pathol. 2019 Feb 4;151(3):337-343. doi: 10.1093/ajcp/aqy144.
• [3833] Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement.JCI Insight. 2018 Dec 20;3(24):e120360. doi: 10.1172/jci.insight.120360.
• [3834] Adrenals Contribute to Growth of Castration-Resistant VCaP Prostate Cancer Xenografts.Am J Pathol. 2018 Dec;188(12):2890-2901. doi: 10.1016/j.ajpath.2018.07.029. Epub 2018 Sep 28.
• [3835] Identification of Flap endonuclease 1 as a potential core gene in hepatocellular carcinoma by integrated bioinformatics analysis.PeerJ. 2019 Sep 6;7:e7619. doi: 10.7717/peerj.7619. eCollection 2019.
• [3836] The Effect of FERMT1 Regulated by miR-24 on the Growth and Radiation Resistance of Esophageal Cancer.J Biomed Nanotechnol. 2019 Mar 1;15(3):621-631. doi: 10.1166/jbn.2019.2711.
• [3837] Kindlin-2 links mechano-environment to proline synthesis and tumor growth.Nat Commun. 2019 Feb 19;10(1):845. doi: 10.1038/s41467-019-08772-3.
• [3838] Identification of Fetuin-B as a member of a cystatin-like gene family on mouse chromosome 16 with tumor suppressor activity.Genome. 2004 Oct;47(5):931-46. doi: 10.1139/g04-043.
• [3839] Prostatic carcinoma with neuroendocrine differentiation harboring the EWSR1-FEV fusion transcript in a man with the WRN G327X germline mutation: A new variant of prostatic carcinoma or a member of the Ewing sarcoma family of tumors?.Pathol Res Pract. 2020 Feb;216(2):152758. doi: 10.1016/j.prp.2019.152758. Epub 2019 Nov 22.
• [3840] FEZF1 is an Independent Predictive Factor for Recurrence and Promotes Cell Proliferation and Migration in Cervical Cancer.J Cancer. 2018 Oct 10;9(21):3929-3938. doi: 10.7150/jca.26073. eCollection 2018.
• [3841] Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-B signaling pathway.Lab Invest. 2018 Sep;98(9):1225-1236. doi: 10.1038/s41374-018-0077-9. Epub 2018 Jun 20.
• [3842] FGD4 (Frabin) Overexpression in Pancreatic Neuroendocrine Neoplasms.Pancreas. 2019 Nov/Dec;48(10):1307-1311. doi: 10.1097/MPA.0000000000001422.
• [3843] Identification and Validation of Fibroblast Growth Factor 12 Gene as a Novel Potential Biomarker in Esophageal Cancer Using Cancer Genomic Datasets.OMICS. 2017 Oct;21(10):616-631. doi: 10.1089/omi.2017.0116.
• [3844] E2F1 Drives Breast Cancer Metastasis by Regulating the Target Gene FGF13 and Altering Cell Migration.Sci Rep. 2019 Jul 24;9(1):10718. doi: 10.1038/s41598-019-47218-0.
• [3845] Increased production of human fibroblast growth factor 17 in Escherichia coli and proliferative activity in NIH3T3 cells.Mol Med Rep. 2017 Jul;16(1):447-452. doi: 10.3892/mmr.2017.6575. Epub 2017 May 11.
• [3846] FGF5 promotes osteosarcoma cells proliferation via activating MAPK signaling pathway.Cancer Manag Res. 2019 Jul 10;11:6457-6466. doi: 10.2147/CMAR.S200234. eCollection 2019.
• [3847] FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.Pharmacol Res. 2020 Feb;152:104575. doi: 10.1016/j.phrs.2019.104575. Epub 2019 Dec 2.
• [3848] FGFRL1 Promotes Ovarian Cancer Progression by Crosstalk with Hedgehog Signaling.J Immunol Res. 2018 Feb 20;2018:7438608. doi: 10.1155/2018/7438608. eCollection 2018.
• [3849] Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.Cell. 2019 Jan 10;176(1-2):334-347.e12. doi: 10.1016/j.cell.2018.11.010. Epub 2018 Dec 20.
• [3850] Fumarate Metabolic Signature for the Detection of Reed Syndrome in Humans.Clin Cancer Res. 2020 Jan 15;26(2):391-396. doi: 10.1158/1078-0432.CCR-19-1729. Epub 2019 Oct 21.
• [3851] Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer.Oncotarget. 2016 Nov 1;7(44):72229-72241. doi: 10.18632/oncotarget.12664.
• [3852] Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma.PLoS One. 2013 Jul 29;8(7):e69660. doi: 10.1371/journal.pone.0069660. Print 2013.
• [3853] Identification of FKBP11 as a biomarker for hepatocellular carcinoma.Anticancer Res. 2013 Jun;33(6):2763-9.
• [3854] FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis.Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):845-54. doi: 10.1161/ATVBAHA.114.304539. Epub 2015 Mar 12.
• [3855] Tissue-engineered 3D melanoma model with blood and lymphatic capillaries for drug development.Sci Rep. 2018 Sep 4;8(1):13191. doi: 10.1038/s41598-018-31502-6.
• [3856] Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity.Nat Commun. 2019 Aug 21;10(1):3773. doi: 10.1038/s41467-019-11728-2.
• [3857] Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.Oncol Rep. 2017 Mar;37(3):1461-1468. doi: 10.3892/or.2017.5433. Epub 2017 Feb 7.
• [3858] FLOT1 promotes tumor development, induces epithelial-mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma.Thorac Cancer. 2019 Apr;10(4):909-917. doi: 10.1111/1759-7714.13027. Epub 2019 Mar 5.
• [3859] Flot2 targeted by miR-449 acts as a prognostic biomarker in glioma.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):250-255. doi: 10.1080/21691401.2018.1549062.
• [3860] Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.Sci Rep. 2017 Mar 21;7(1):272. doi: 10.1038/s41598-017-00424-0.
• [3861] Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer.J Clin Med. 2019 Sep 6;8(9):1400. doi: 10.3390/jcm8091400.
• [3862] MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2.J Gene Med. 2017 Jun;19(6-7). doi: 10.1002/jgm.2898.
• [3863] BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas.PLoS One. 2019 Apr 30;14(4):e0216043. doi: 10.1371/journal.pone.0216043. eCollection 2019.
• [3864] Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway.Oncotarget. 2016 Nov 15;7(46):75394-75406. doi: 10.18632/oncotarget.12215.
• [3865] Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.Biomed Pharmacother. 2017 Mar;87:405-411. doi: 10.1016/j.biopha.2016.12.100. Epub 2017 Jan 6.
• [3866] Investigation of the expression of irisin and some cachectic factors in mice with experimentally induced gastric cancer.QJM. 2016 Dec;109(12):785-790. doi: 10.1093/qjmed/hcw074. Epub 2016 Jun 1.
• [3867] FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas.Acta Neuropathol. 2020 Jan;139(1):175-192. doi: 10.1007/s00401-019-02067-z. Epub 2019 Aug 31.
• [3868] Expression of activator protein-1 in papillary thyroid carcinoma and its clinical significance.World J Surg Oncol. 2019 Jan 31;17(1):25. doi: 10.1186/s12957-019-1568-x.
• [3869] MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.J Cancer Res Clin Oncol. 2018 Dec;144(12):2351-2366. doi: 10.1007/s00432-018-2745-y. Epub 2018 Sep 17.
• [3870] Long noncoding RNA FOXD2AS1/miR?50?p/PFN2 axis regulates breast cancer malignancy and tumorigenesis.Int J Oncol. 2019 Mar;54(3):1043-1052. doi: 10.3892/ijo.2019.4671. Epub 2019 Jan 3.
• [3871] FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA.Mol Cell Endocrinol. 2019 Aug 1;493:110420. doi: 10.1016/j.mce.2019.03.010. Epub 2019 May 23.
• [3872] FOXF1 Defines the Core-Regulatory Circuitry in Gastrointestinal Stromal Tumor.Cancer Discov. 2018 Feb;8(2):234-251. doi: 10.1158/2159-8290.CD-17-0468. Epub 2017 Nov 21.
• [3873] Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL--Catenin Signaling Axis.Cancer Res. 2018 Apr 1;78(7):1643-1656. doi: 10.1158/0008-5472.CAN-17-2403. Epub 2018 Jan 26.
• [3874] Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.Neuropathol Appl Neurobiol. 2018 Feb;44(2):207-223. doi: 10.1111/nan.12447. Epub 2017 Nov 23.
• [3875] The link between FOXJ1 expression level in bladder carcinoma and tumor recurrence.Oncol Lett. 2018 Feb;15(2):1483-1486. doi: 10.3892/ol.2017.7504. Epub 2017 Nov 29.
• [3876] Germline Stem Cell Activity Is Sustained by SALL4-Dependent Silencing ofDistinct Tumor Suppressor Genes.Stem Cell Reports. 2017 Sep 12;9(3):956-971. doi: 10.1016/j.stemcr.2017.08.001. Epub 2017 Aug 31.
• [3877] Forkhead box N1 inhibits the progression of non-small cell lung cancer and serves as a tumor suppressor.Oncol Lett. 2018 May;15(5):7221-7230. doi: 10.3892/ol.2018.8210. Epub 2018 Mar 8.
• [3878] FOXN2 is downregulated in breast cancer and regulates migration, invasion, and epithelial- mesenchymal transition through regulation of SLUG.Cancer Manag Res. 2019 Jan 4;11:525-535. doi: 10.2147/CMAR.S176938. eCollection 2019.
• [3879] FOXN3 is downregulated in osteosarcoma and transcriptionally regulates SIRT6, and suppresses migration and invasion in osteosarcoma.Oncol Rep. 2019 Feb;41(2):1404-1414. doi: 10.3892/or.2018.6878. Epub 2018 Nov 21.
• [3880] Novel role of forkhead box O 4 transcription factor in cancer: Bringing out the good or the bad.Semin Cancer Biol. 2018 Jun;50:1-12. doi: 10.1016/j.semcancer.2018.04.007. Epub 2018 Apr 30.
• [3881] Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT.Oncol Lett. 2019 Apr;17(4):3944-3951. doi: 10.3892/ol.2019.10049. Epub 2019 Feb 19.
• [3882] FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer.Sci Rep. 2019 Mar 27;9(1):5281. doi: 10.1038/s41598-019-41717-w.
• [3883] FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma.Int J Mol Med. 2016 Nov;38(5):1443-1449. doi: 10.3892/ijmm.2016.2745. Epub 2016 Sep 21.
• [3884] FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression.FEBS Lett. 2012 Sep 21;586(19):3044-50. doi: 10.1016/j.febslet.2012.07.019. Epub 2012 Jul 27.
• [3885] Adaptor protein complex of FRS2 and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation.Cancer Sci. 2013 Mar;104(3):345-52. doi: 10.1111/cas.12086. Epub 2013 Feb 8.
• [3886] Mapping of Mcs30, a new mammary carcinoma susceptibility quantitative trait locus (QTL30) on rat chromosome 12: identification of fry as a candidate Mcs gene.PLoS One. 2013 Sep 2;8(9):e70930. doi: 10.1371/journal.pone.0070930. eCollection 2013.
• [3887] Selective Capture and Purification of MicroRNAs and Intracellular Proteins through Antisense-vectorized Magnetic Nanobeads.Sci Rep. 2019 Feb 14;9(1):2069. doi: 10.1038/s41598-019-39575-7.
• [3888] Follistatin-like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase-dependent apoptosis and regulating Bcl-2 family proteins.J Cell Mol Med. 2018 Dec;22(12):6190-6201. doi: 10.1111/jcmm.13906. Epub 2018 Sep 25.
• [3889] A novel method for quantification of beam's-eye-view tumor tracking performance.Med Phys. 2017 Nov;44(11):5650-5659. doi: 10.1002/mp.12572. Epub 2017 Oct 13.
• [3890] Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer.Oncotarget. 2017 Apr 18;8(16):27075-27092. doi: 10.18632/oncotarget.15635.
• [3891] FUN14 Domain-Containing 1-Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in Mice.Hepatology. 2019 Feb;69(2):604-621. doi: 10.1002/hep.30191. Epub 2019 Jan 7.
• [3892] Effects of ABO and FUT2 genetic transcription absence on ABH histo-blood group antigen expression in lung cancer patients.Asian Pac J Cancer Prev. 2011;12(12):3201-6.
• [3893] Fucosylated TGF- receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells.Br J Cancer. 2014 Jan 7;110(1):156-63. doi: 10.1038/bjc.2013.699. Epub 2013 Nov 19.
• [3894] -1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation.Int J Mol Med. 2018 Nov;42(5):2700-2708. doi: 10.3892/ijmm.2018.3850. Epub 2018 Aug 31.
• [3895] Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer.PLoS One. 2018 Jul 5;13(7):e0200315. doi: 10.1371/journal.pone.0200315. eCollection 2018.
• [3896] An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer.Mol Syst Biol. 2017 Dec 1;13(12):956. doi: 10.15252/msb.20177739.
• [3897] Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma.Cancer Sci. 2019 Apr;110(4):1169-1182. doi: 10.1111/cas.13949. Epub 2019 Mar 6.
• [3898] Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signaling.Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4548-4557. doi: 10.1073/pnas.1813802116. Epub 2019 Feb 21.
• [3899] MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8.Oncotarget. 2016 Jun 28;7(26):40644-40656. doi: 10.18632/oncotarget.9811.
• [3900] Methylation status of the promoter region of the human frizzled 9 gene in acute myeloid leukemia.Mol Med Rep. 2016 Aug;14(2):1339-44. doi: 10.3892/mmr.2016.5387. Epub 2016 Jun 10.
• [3901] Anaphase-Promoting Complex Adaptor FZR1/CDH1 Blocks BRAF Signaling Both by Targeting BRAF for Proteolytic Degradation and by Disrupting BRAF Dimerization.Cancer Discov. 2017 Apr;7(4):356-358. doi: 10.1158/2159-8290.CD-17-0172.
• [3902] Gab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.PLoS One. 2017 Mar 14;12(3):e0173473. doi: 10.1371/journal.pone.0173473. eCollection 2017.
• [3903] Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.Cancer Res. 2005 Jan 15;65(2):394-400.
• [3904] GABARAPL1 tumor suppressive function is independent of its conjugation to autophagosomes in MCF-7 breast cancer cells.Oncotarget. 2017 Jul 27;8(34):55998-56020. doi: 10.18632/oncotarget.19639. eCollection 2017 Aug 22.
• [3905] Chromium disrupts chromatin organization and CTCF access to its cognate sites in promoters of differentially expressed genes.Epigenetics. 2018;13(4):363-375. doi: 10.1080/15592294.2018.1454243. Epub 2018 May 3.
• [3906] Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.Oncol Rep. 2015 Jul;34(1):43-50. doi: 10.3892/or.2015.3990. Epub 2015 May 19.
• [3907] Relationship between GAGE-1/-2 expression, EBV infection and interferon-gamma expression in undifferentiated carcinoma of nasopharyngeal type.Anticancer Res. 2000 May-Jun;20(3A):1727-32.
• [3908] Binding of LINE-1 RNA to PSF transcriptionally promotes GAGE6 and regulates cell proliferation and tumor formation in vitro.Exp Ther Med. 2017 Aug;14(2):1685-1691. doi: 10.3892/etm.2017.4667. Epub 2017 Jun 26.
• [3909] Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.Clin Respir J. 2018 Jun;12(6):2020-2028. doi: 10.1111/crj.12769. Epub 2018 Feb 15.
• [3910] A Hypoxia-Inducible HIF1-GAL3ST1-Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell-Platelet Binding.Mol Cancer Res. 2019 Nov;17(11):2306-2317. doi: 10.1158/1541-7786.MCR-19-0461. Epub 2019 Aug 19.
• [3911] GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.Medicine (Baltimore). 2016 Apr;95(17):e3487. doi: 10.1097/MD.0000000000003487.
• [3912] Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.Cell Oncol (Dordr). 2018 Aug;41(4):379-393. doi: 10.1007/s13402-018-0375-7. Epub 2018 Mar 7.
• [3913] MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5133-5138. doi: 10.26355/eurrev_201906_18177.
• [3914] GALNT9 gene expression is a prognostic marker in neuroblastoma patients.Clin Chem. 2013 Jan;59(1):225-33. doi: 10.1373/clinchem.2012.192328. Epub 2012 Nov 7.
• [3915] Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth.Gene Ther. 2018 Sep;25(6):439-449. doi: 10.1038/s41434-018-0020-0. Epub 2018 Jun 25.
• [3916] Upregulation of the growth arrest-specific-2 in recurrent colorectal cancers, and its susceptibility to chemotherapy in a model cell system.Biochim Biophys Acta. 2016 Jul;1862(7):1345-53. doi: 10.1016/j.bbadis.2016.04.010. Epub 2016 Apr 13.
• [3917] Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via GAS7C and the N-WASP/FAK/F-actin pathway.Acta Biochim Biophys Sin (Shanghai). 2017 Jul 1;49(7):581-587. doi: 10.1093/abbs/gmx046.
• [3918] The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8.J Biol Chem. 2018 Nov 2;293(44):17154-17165. doi: 10.1074/jbc.RA118.003055. Epub 2018 Sep 18.
• [3919] Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.Int J Cancer. 2019 Oct 1;145(7):1860-1873. doi: 10.1002/ijc.32248. Epub 2019 Mar 28.
• [3920] GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription.Cancer Med. 2019 Sep;8(11):5242-5253. doi: 10.1002/cam4.2405. Epub 2019 Jul 8.
• [3921] Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity.Mol Cancer. 2019 Jun 20;18(1):108. doi: 10.1186/s12943-019-1027-x.
• [3922] Overexpression of GBP1 predicts poor prognosis and promotes tumor growth in human glioblastoma multiforme.Cancer Biomark. 2019;25(3):275-290. doi: 10.3233/CBM-171177.
• [3923] GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis.Biochem Biophys Res Commun. 2018 Jan 1;495(1):446-453. doi: 10.1016/j.bbrc.2017.11.050. Epub 2017 Nov 8.
• [3924] Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma.Histopathology. 2018 Jul;73(1):124-136. doi: 10.1111/his.13504. Epub 2018 Apr 17.
• [3925] Association of rs2282679 A>C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake.BMC Cancer. 2018 Feb 6;18(1):155. doi: 10.1186/s12885-018-4026-1.
• [3926] Expression of GCMB by intrathymic parathyroid hormone-secreting adenomas indicates their parathyroid cell origin.J Clin Endocrinol Metab. 2004 Jan;89(1):8-12. doi: 10.1210/jc.2003-030733.
• [3927] JC virus granule cell neuronopathy is associated with VP1 C terminus mutants.J Gen Virol. 2012 Jan;93(Pt 1):175-183. doi: 10.1099/vir.0.037440-0. Epub 2011 Sep 21.
• [3928] CCAT-1 promotes proliferation and inhibits apoptosis of cervical cancer cells via the Wnt signaling pathway.Oncotarget. 2017 Jul 10;8(40):68059-68070. doi: 10.18632/oncotarget.19155. eCollection 2017 Sep 15.
• [3929] Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.Clin Cancer Res. 2003 Oct 1;9(12):4553-61.
• [3930] GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7.Aging (Albany NY). 2019 May 31;11(10):3298-3314. doi: 10.18632/aging.101983.
• [3931] GDF11 exhibits tumor suppressive properties in hepatocellular carcinoma cells by restricting clonal expansion and invasion.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1540-1554. doi: 10.1016/j.bbadis.2019.03.003. Epub 2019 Mar 16.
• [3932] KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model.Clin Exp Metastasis. 2010 Dec;27(8):591-600. doi: 10.1007/s10585-010-9349-5. Epub 2010 Sep 16.
• [3933] Bioinformatics analysis of Rab GDP dissociation inhibitor beta and its expression in non-small cell lung cancer.Diagn Pathol. 2014 Nov 4;9:201. doi: 10.1186/s13000-014-0201-0.
• [3934] Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.Elife. 2017 Aug 29;6:e23649. doi: 10.7554/eLife.23649.
• [3935] Expression of TWIST1, Snail, Slug, and NF-B and methylation of the TWIST1 promoter in mammary phyllodes tumor.Tumour Biol. 2013 Feb;34(1):445-53. doi: 10.1007/s13277-012-0569-y. Epub 2012 Nov 14.
• [3936] GEN-1 immunotherapy for the treatment of ovarian cancer.Future Oncol. 2019 Feb;15(4):421-438. doi: 10.2217/fon-2018-0423. Epub 2018 Oct 16.
• [3937] Clinical Implications of Augmenter of Liver Regeneration in Cancer: A Systematic Review.Anticancer Res. 2017 Jul;37(7):3379-3383. doi: 10.21873/anticanres.11704.
• [3938] A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.Oncotarget. 2017 May 9;8(19):32212-32227. doi: 10.18632/oncotarget.12922.
• [3939] GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance.Int J Mol Sci. 2018 Apr 4;19(4):1078. doi: 10.3390/ijms19041078.
• [3940] GDNF family receptor alpha 2 promotes neuroblastoma cell proliferation by interacting with PTEN.Biochem Biophys Res Commun. 2019 Mar 12;510(3):339-344. doi: 10.1016/j.bbrc.2018.12.169. Epub 2019 Feb 2.
• [3941] Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis.J Thorac Oncol. 2019 Apr;14(4):656-671. doi: 10.1016/j.jtho.2018.12.004. Epub 2018 Dec 19.
• [3942] GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation.Breast Cancer Res Treat. 2019 Feb;174(1):65-78. doi: 10.1007/s10549-018-5052-z. Epub 2018 Nov 19.
• [3943] GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis.BMC Cancer. 2014 Apr 9;14:248. doi: 10.1186/1471-2407-14-248.
• [3944] Anticancer effect of Limonin against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice and the inhibition of A549 cell proliferation through apoptotic pathway.J Biochem Mol Toxicol. 2019 Dec;33(12):e22374. doi: 10.1002/jbt.22374. Epub 2019 Nov 8.
• [3945] The testis-specific expression pattern of the growth hormone/placental lactogen (GH/PL) gene cluster changes with malignancy.Hum Pathol. 1999 Oct;30(10):1201-6. doi: 10.1016/s0046-8177(99)90038-2.
• [3946] Dysregulation of GTPase IMAP family members in hepatocellular cancer.Mol Med Rep. 2016 Nov;14(5):4119-4123. doi: 10.3892/mmr.2016.5764. Epub 2016 Sep 22.
• [3947] Clinicopathological significance of PSF3 expression in uterine endometrial carcinomas.Hum Pathol. 2018 Oct;80:104-112. doi: 10.1016/j.humpath.2018.06.010. Epub 2018 Jun 21.
• [3948] Knockdown of ovarian cancer amplification target ADRM1 leads to downregulation of GIPC1 and upregulation of RECK.Genes Chromosomes Cancer. 2011 Jun;50(6):434-41. doi: 10.1002/gcc.20868. Epub 2011 Mar 22.
• [3949] Molecular cloning and characterization of human GIPC2, a novel gene homologous to human GIPC1 and Xenopus Kermit.Int J Oncol. 2002 Mar;20(3):571-6.
• [3950] Inhibiting GIT1 reduces the growth, invasion, and angiogenesis of osteosarcoma.Cancer Manag Res. 2018 Nov 29;10:6445-6455. doi: 10.2147/CMAR.S181066. eCollection 2018.
• [3951] Combination of PET and CXCR4-Targeted Peptide Molecule Agents for Noninvasive Tumor Monitoring.J Cancer. 2019 Jun 9;10(15):3420-3426. doi: 10.7150/jca.31087. eCollection 2019.
• [3952] GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.Int J Oncol. 2018 Dec;53(6):2458-2472. doi: 10.3892/ijo.2018.4572. Epub 2018 Sep 26.
• [3953] Regulatory role for Krppel-like zinc-finger protein Gli-similar 1 (Glis1) in PMA-treated and psoriatic epidermis.J Invest Dermatol. 2006 Jan;126(1):49-60. doi: 10.1038/sj.jid.5700018.
• [3954] PICOT binding to chromatin-associated EED negatively regulates cyclin D2 expression by increasing H3K27me3 at the CCND2 gene promoter.Cell Death Dis. 2019 Sep 17;10(10):685. doi: 10.1038/s41419-019-1935-0.
• [3955] GLS2 is protumorigenic in breast cancers.Oncogene. 2020 Jan;39(3):690-702. doi: 10.1038/s41388-019-1007-z. Epub 2019 Sep 20.
• [3956] Glucocorticoid modulatory element-binding protein 1 (GMEB1) interacts with the de-ubiquitinase USP40 to stabilize CFLAR(L) and inhibit apoptosis in human non-small cell lung cancer cells.J Exp Clin Cancer Res. 2019 May 2;38(1):181. doi: 10.1186/s13046-019-1182-3.
• [3957] Bile acids affect the growth of human cholangiocarcinoma via NF-kB pathway.Cancer Invest. 2013 Feb;31(2):111-20. doi: 10.3109/07357907.2012.762781.
• [3958] Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures. Am J Hum Genet. 2016 May 5;98(5):1001-1010. doi: 10.1016/j.ajhg.2016.03.011. Epub 2016 Apr 21.
• [3959] Mutations in G protein subunits promote transformation and kinase inhibitor resistance. Nat Med. 2015 Jan;21(1):71-5. doi: 10.1038/nm.3751. Epub 2014 Dec 8.
• [3960] Identification of novel VHL target genes and relationship to hypoxic response pathways.Oncogene. 2005 Jun 30;24(28):4549-58. doi: 10.1038/sj.onc.1208649.
• [3961] Nucleostemin promotes hepatocellular carcinoma by regulating the function of STAT3.Exp Cell Res. 2020 Feb 1;387(1):111748. doi: 10.1016/j.yexcr.2019.111748. Epub 2019 Nov 27.
• [3962] Granulysin: The attractive side of a natural born killer.Immunol Lett. 2020 Jan;217:126-132. doi: 10.1016/j.imlet.2019.11.005. Epub 2019 Nov 11.
• [3963] Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma.Toxicol Appl Pharmacol. 2019 Sep 1;378:114607. doi: 10.1016/j.taap.2019.114607. Epub 2019 Jun 3.
• [3964] GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10784-91. eCollection 2015.
• [3965] Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer.Cancer Lett. 2007 Jun 28;251(2):228-36. doi: 10.1016/j.canlet.2006.11.021. Epub 2007 Jan 8.
• [3966] Golgi integral membrane protein 4 manipulates cellular proliferation, apoptosis, and cell cycle in human head and neck cancer.Biosci Rep. 2018 Aug 31;38(4):BSR20180454. doi: 10.1042/BSR20180454. Print 2018 Aug 31.
• [3967] GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1089-1099. doi: 10.1093/jnen/nlz093.
• [3968] SCYL1 binding protein 1 promotes the ubiquitin-dependent degradation of Pirh2 and has tumor-suppressive function in the development of hepatocellular carcinoma.Carcinogenesis. 2012 Aug;33(8):1581-8. doi: 10.1093/carcin/bgs162. Epub 2012 May 7.
• [3969] Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Prognosis in Colorectal Cancers.Int J Med Sci. 2017 Apr 9;14(6):515-522. doi: 10.7150/ijms.19368. eCollection 2017.
• [3970] Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPAR activation exerting cancer growth suppression.EBioMedicine. 2019 Mar;41:134-145. doi: 10.1016/j.ebiom.2019.02.015. Epub 2019 Feb 10.
• [3971] Metastasis-associated gene, mag-1 improves tumour microenvironmental adaptation and potentiates tumour metastasis.J Cell Mol Med. 2012 Dec;16(12):3037-51. doi: 10.1111/j.1582-4934.2012.01633.x.
• [3972] A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy.Nanomedicine (Lond). 2019 Sep;14(17):2339-2353. doi: 10.2217/nnm-2019-0063. Epub 2019 Aug 15.
• [3973] MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/-catenin signaling via targeting Glypican-5.Eur J Pharmacol. 2019 Jul 5;854:39-47. doi: 10.1016/j.ejphar.2019.03.057. Epub 2019 Apr 3.
• [3974] Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.PLoS One. 2019 Jun 14;14(6):e0218067. doi: 10.1371/journal.pone.0218067. eCollection 2019.
• [3975] Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo.Clin Cancer Res. 2018 Aug 15;24(16):4030-4043. doi: 10.1158/1078-0432.CCR-17-3167. Epub 2018 Apr 24.
• [3976] Bottom-up synthesis of MoS(2) nanospheres for photothermal treatment of tumors.Photochem Photobiol Sci. 2018 Oct 10;17(10):1337-1345. doi: 10.1039/c8pp00198g.
• [3977] Basal Suppression of the Sonic Hedgehog Pathway by the G-Protein-Coupled Receptor Gpr161 Restricts Medulloblastoma Pathogenesis.Cell Rep. 2018 Jan 30;22(5):1169-1184. doi: 10.1016/j.celrep.2018.01.018.
• [3978] Expression of MAS1 in breast cancer.Cancer Sci. 2015 Sep;106(9):1240-8. doi: 10.1111/cas.12719. Epub 2015 Jul 20.
• [3979] Genetic ablation of Gpr37l1 delays tumor occurrence in Ptch1(+/-) mouse models of medulloblastoma.Exp Neurol. 2019 Feb;312:33-42. doi: 10.1016/j.expneurol.2018.11.004. Epub 2018 Nov 16.
• [3980] Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.EBioMedicine. 2019 Oct;48:264-276. doi: 10.1016/j.ebiom.2019.09.016. Epub 2019 Sep 14.
• [3981] The orphan GPR50 receptor promotes constitutive TGF receptor signaling and protects against cancer development.Nat Commun. 2018 Mar 23;9(1):1216. doi: 10.1038/s41467-018-03609-x.
• [3982] GPR68: An Emerging Drug Target in Cancer.Int J Mol Sci. 2019 Jan 28;20(3):559. doi: 10.3390/ijms20030559.
• [3983] DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia.Epigenetics. 2014 Apr;9(4):503-12. doi: 10.4161/epi.27644. Epub 2014 Jan 17.
• [3984] Glasgow prognostic score predicts therapeutic outcome after hepatic resection for hepatocellular carcinoma.Oncol Lett. 2017 Jul;14(1):293-298. doi: 10.3892/ol.2017.6104. Epub 2017 Apr 28.
• [3985] Activator of G protein signaling 3 modulates prostate tumor development and progression.Carcinogenesis. 2019 Dec 31;40(12):1504-1513. doi: 10.1093/carcin/bgz076.
• [3986] High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.Tumour Biol. 2017 Mar;39(3):1010428317695971. doi: 10.1177/1010428317695971.
• [3987] GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment.Redox Biol. 2019 Jul;25:101051. doi: 10.1016/j.redox.2018.11.009. Epub 2018 Nov 17.
• [3988] GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5.Sci Rep. 2016 Sep 2;6:31963. doi: 10.1038/srep31963.
• [3989] Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.Eur Urol. 2018 Jun;73(6):949-960. doi: 10.1016/j.eururo.2018.02.019. Epub 2018 Mar 12.
• [3990] Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target.J Med Chem. 2017 Nov 22;60(22):9349-9359. doi: 10.1021/acs.jmedchem.7b01320. Epub 2017 Nov 10.
• [3991] GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): A novel CTNNB1 rearrangement.Genes Chromosomes Cancer. 2019 Mar;58(3):155-163. doi: 10.1002/gcc.22694. Epub 2019 Jan 7.
• [3992] Coordinated expression and genetic polymorphisms in Grainyhead-like genes in human non-melanoma skin cancers.BMC Cancer. 2018 Jan 4;18(1):23. doi: 10.1186/s12885-017-3943-8.
• [3993] Stage-dependent therapeutic efficacy in PI3K/mTOR-driven squamous cell carcinoma of the skin.Cell Death Differ. 2018 Jun;25(6):1146-1159. doi: 10.1038/s41418-017-0032-0. Epub 2017 Dec 13.
• [3994] GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.J Cell Sci. 2018 Aug 3;131(15):jcs213009. doi: 10.1242/jcs.213009.
• [3995] Iron oxide nanoparticles as nanocarriers to improve chlorin e6-based sonosensitivity in sonodynamic therapy.Drug Des Devel Ther. 2018 Dec 10;12:4207-4216. doi: 10.2147/DDDT.S184679. eCollection 2018.
• [3996] Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol.BMC Immunol. 2018 Feb 2;19(1):7. doi: 10.1186/s12865-018-0246-z.
• [3997] Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness.Clin Cancer Res. 2019 Aug 1;25(15):4846-4858. doi: 10.1158/1078-0432.CCR-18-2381. Epub 2019 May 7.
• [3998] Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.PLoS One. 2016 Nov 11;11(11):e0166422. doi: 10.1371/journal.pone.0166422. eCollection 2016.
• [3999] Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis.Cancer Discov. 2020 Feb;10(2):254-269. doi: 10.1158/2159-8290.CD-19-0672. Epub 2019 Dec 3.
• [4000] Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers.Int J Mol Sci. 2017 Mar 2;18(3):535. doi: 10.3390/ijms18030535.
• [4001] GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer.Oncotarget. 2018 Apr 24;9(31):21696-21714. doi: 10.18632/oncotarget.24796. eCollection 2018 Apr 24.
• [4002] p52 expression enhances lung cancer progression.Sci Rep. 2018 Apr 17;8(1):6078. doi: 10.1038/s41598-018-24488-8.
• [4003] Intestinal GUCY2C prevents TGF- secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.Cancer Res. 2013 Nov 15;73(22):6654-66. doi: 10.1158/0008-5472.CAN-13-0887. Epub 2013 Oct 1.
• [4004] Aptamer-Modified Magnetic Nanosensitizer for In Vivo MR Imaging of HER2-Expressing Cancer.Nanoscale Res Lett. 2018 Sep 18;13(1):288. doi: 10.1186/s11671-018-2682-3.
• [4005] A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.Cancer Res. 2019 Feb 1;79(3):534-545. doi: 10.1158/0008-5472.CAN-18-2357. Epub 2018 Dec 24.
• [4006] Germline genetic variants in men with prostate cancer and one or more additional cancers.Cancer. 2017 Oct 15;123(20):3925-3932. doi: 10.1002/cncr.30817. Epub 2017 Jun 28.
• [4007] Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1- a]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links.J Med Chem. 2019 Mar 14;62(5):2404-2418. doi: 10.1021/acs.jmedchem.8b01689. Epub 2019 Feb 28.
• [4008] Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer.Genome Res. 2012 Feb;22(2):307-21. doi: 10.1101/gr.118919.110. Epub 2011 Jul 25.
• [4009] Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway.Sci Rep. 2019 Apr 23;9(1):6458. doi: 10.1038/s41598-019-42611-1.
• [4010] Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.Curr Treat Options Neurol. 2019 Jul 10;21(8):37. doi: 10.1007/s11940-019-0577-y.
• [4011] Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.Acta Neuropathol Commun. 2017 Apr 17;5(1):28. doi: 10.1186/s40478-017-0436-6.
• [4012] Plasma Histone H4 and H4K20 Trimethylation Levels Differ Between Colon Cancer and Precancerous Polyps.In Vivo. 2019 Sep-Oct;33(5):1653-1658. doi: 10.21873/invivo.11651.
• [4013] Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.Clin Endocrinol (Oxf). 2017 Jun;86(6):837-844. doi: 10.1111/cen.13316. Epub 2017 Mar 23.
• [4014] Glypican-3 (GPC3) targeted Fe(3)O(4) core/Au shell nanocomplex for fluorescence/MRI/photoacoustic imaging-guided tumor photothermal therapy.Biomater Sci. 2019 Dec 1;7(12):5258-5269. doi: 10.1039/c9bm01248f. Epub 2019 Oct 11.
• [4015] Giant Olfactory Groove Meningioma-2-Staged Approach: 2-Dimensional Operative Video.Oper Neurosurg (Hagerstown). 2019 Jan 1;16(1):115-116. doi: 10.1093/ons/opy092.
• [4016] Huntingtin-associated protein 1: a potential biomarker of breast cancer.Oncol Rep. 2013 May;29(5):1881-7. doi: 10.3892/or.2013.2303. Epub 2013 Feb 22.
• [4017] Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma.Clin Cancer Res. 2009 Apr 15;15(8):2602-11. doi: 10.1158/1078-0432.CCR-08-2755. Epub 2009 Apr 7.
• [4018] HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.Tumour Biol. 2015 Jul;36(7):5441-50. doi: 10.1007/s13277-015-3210-z. Epub 2015 May 2.
• [4019] Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer.J Exp Clin Cancer Res. 2019 Feb 1;38(1):47. doi: 10.1186/s13046-019-1044-z.
• [4020] High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma.J Cancer. 2019 Feb 23;10(6):1434-1443. doi: 10.7150/jca.28317. eCollection 2019.
• [4021] Structure optimisation to improve the delivery efficiency and cell selectivity of a tumour-targeting cell-penetrating peptide.J Drug Target. 2018 Nov;26(9):777-792. doi: 10.1080/1061186X.2018.1424858. Epub 2018 Jan 16.
• [4022] Matrix metalloproteinase-13is a target gene of high-mobility group box-containing protein 1 in modulating oral cancer cell invasion.J Cell Physiol. 2019 Apr;234(4):4375-4384. doi: 10.1002/jcp.27223. Epub 2018 Sep 7.
• [4023] Characterization of novel Bovine Leukemia Virus (BLV) antisense transcripts by deep sequencing reveals constitutive expression in tumors and transcriptional interaction with viral microRNAs.Retrovirology. 2016 May 3;13(1):33. doi: 10.1186/s12977-016-0267-8.
• [4024] Normal and functional TP53 in genetically stable myxoid/round cell liposarcoma.PLoS One. 2014 Nov 13;9(11):e113110. doi: 10.1371/journal.pone.0113110. eCollection 2014.
• [4025] Traditional Chinese Medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer.Cancer Med. 2018 Apr;7(4):1546-1559. doi: 10.1002/cam4.1419. Epub 2018 Mar 13.
• [4026] Knockdown of HPIP Inhibits the Proliferation and Invasion of Head-and-Neck Squamous Cell Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway.Oncol Res. 2016;24(3):153-60. doi: 10.3727/096504016X14612603423476.
• [4027] HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2786-2793. doi: 10.26355/eurrev_201904_17553.
• [4028] Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.Immunology. 2017 Nov;152(3):472-483. doi: 10.1111/imm.12784. Epub 2017 Jul 27.
• [4029] HDGF-related protein-2 (HRP-2) acts as an oncogene to promote cell growth in hepatocellular carcinoma.Biochem Biophys Res Commun. 2015 Mar 20;458(4):849-55. doi: 10.1016/j.bbrc.2015.02.042. Epub 2015 Feb 14.
• [4030] Insight into the roles of hepatoma derived growth factor related protein-3 under physiological and pathological conditions.Biochem Cell Biol. 2018 Dec;96(6):707-712. doi: 10.1139/bcb-2018-0098. Epub 2018 Aug 3.
• [4031] HEATR1 modulates cell survival in non-small cell lung cancer via activation of the p53/PUMA signaling pathway.Onco Targets Ther. 2019 May 21;12:4001-4011. doi: 10.2147/OTT.S195826. eCollection 2019.
• [4032] Glycogen synthase kinase 3 as a potential therapeutic target in synovial sarcoma and fibrosarcoma.Cancer Sci. 2020 Feb;111(2):429-440. doi: 10.1111/cas.14271. Epub 2019 Dec 30.
• [4033] The E3 ligase HECTD3 promotes esophageal squamous cell carcinoma (ESCC) growth and cell survival through targeting and inhibiting caspase-9 activation.Cancer Lett. 2017 Sep 28;404:44-52. doi: 10.1016/j.canlet.2017.07.004. Epub 2017 Jul 15.
• [4034] Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC.JCI Insight. 2019 Apr 4;4(7):e126140. doi: 10.1172/jci.insight.126140. eCollection 2019 Apr 4.
• [4035] Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment.Integr Cancer Ther. 2018 Jun;17(2):165-178. doi: 10.1177/1534735417735379. Epub 2017 Oct 17.
• [4036] MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.Cell Physiol Biochem. 2018;46(1):82-92. doi: 10.1159/000488411. Epub 2018 Mar 20.
• [4037] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain.Mol Med Rep. 2019 Mar;19(3):2115-2124. doi: 10.3892/mmr.2019.9841. Epub 2019 Jan 10.
• [4038] Transcriptomic Profiling of MDA-MB-231 Cells Exposed to Boswellia Serrata and 3-O-Acetyl-B-Boswellic Acid; ER/UPR Mediated Programmed Cell Death.Cancer Genomics Proteomics. 2017 Nov-Dec;14(6):409-425. doi: 10.21873/cgp.20051.
• [4039] The oncogenic effects of HES1 on salivary adenoid cystic carcinoma cell growth and metastasis.BMC Cancer. 2018 Apr 17;18(1):436. doi: 10.1186/s12885-018-4350-5.
• [4040] LncSHRG promotes hepatocellular carcinoma progression by activating HES6.Oncotarget. 2017 Aug 3;8(41):70630-70641. doi: 10.18632/oncotarget.19906. eCollection 2017 Sep 19.
• [4041] Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model.Oncotarget. 2017 Dec 8;9(2):2058-2075. doi: 10.18632/oncotarget.23156. eCollection 2018 Jan 5.
• [4042] HEY2 acting as a co-repressor with smad3 and smad4 interferes with the response of TGF-beta in hepatocellular carcinoma.Am J Transl Res. 2019 Jul 15;11(7):4367-4381. eCollection 2019.
• [4043] The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo.BMC Cancer. 2019 Dec 3;19(1):1181. doi: 10.1186/s12885-019-6396-4.
• [4044] Malignant and Nonmalignant Complications of the Rectal Stump in Patients with Inflammatory Bowel Disease.Inflamm Bowel Dis. 2019 Jan 10;25(2):377-384. doi: 10.1093/ibd/izy253.
• [4045] Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy.Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):E3050-7. doi: 10.1073/pnas.1508057112. Epub 2015 May 26.
• [4046] A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition.Cancer Res. 2020 Feb 15;80(4):757-770. doi: 10.1158/0008-5472.CAN-19-0942. Epub 2019 Dec 16.
• [4047] HHIP overexpression inhibits the proliferation, migration and invasion of non-small cell lung cancer.PLoS One. 2019 Nov 25;14(11):e0225755. doi: 10.1371/journal.pone.0225755. eCollection 2019.
• [4048] Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients.Cancer Cell Int. 2019 Apr 16;19:101. doi: 10.1186/s12935-019-0813-2. eCollection 2019.
• [4049] Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment.Int J Mol Sci. 2019 May 22;20(10):2524. doi: 10.3390/ijms20102524.
• [4050] Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.J Cell Biochem. 2019 Apr;120(4):6471-6481. doi: 10.1002/jcb.27938. Epub 2018 Nov 11.
• [4051] HILPDA Regulates Lipid Metabolism, Lipid Droplet Abundance, and Response to Microenvironmental Stress in Solid Tumors.Mol Cancer Res. 2019 Oct;17(10):2089-2101. doi: 10.1158/1541-7786.MCR-18-1343. Epub 2019 Jul 15.
• [4052] Clinical significance of down-regulated HINT2 in hepatocellular carcinoma.Medicine (Baltimore). 2019 Nov;98(48):e17815. doi: 10.1097/MD.0000000000017815.
• [4053] Knockdown of HIP1 expression promotes ligandinduced endocytosis of EGFR in HeLa cells.Oncol Rep. 2017 Dec;38(6):3387-3391. doi: 10.3892/or.2017.6025. Epub 2017 Oct 12.
• [4054] Novel roles of holocarboxylase synthetase in gene regulation and intermediary metabolism.Nutr Rev. 2014 Jun;72(6):369-76. doi: 10.1111/nure.12103. Epub 2014 Mar 28.
• [4055] Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma.Sci Rep. 2019 Jan 29;9(1):895. doi: 10.1038/s41598-018-37273-4.
• [4056] Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.Head Neck. 2019 Aug;41(8):2591-2601. doi: 10.1002/hed.25726. Epub 2019 Mar 4.
• [4057] High CTLA-4 expression correlates with poor prognosis in thymoma patients.Oncotarget. 2018 Mar 30;9(24):16665-16677. doi: 10.18632/oncotarget.24645. eCollection 2018 Mar 30.
• [4058] HLA and KIR Associations of Cervical Neoplasia.J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.
• [4059] Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma.Int J Cancer. 2013 Jan 1;132(1):82-9. doi: 10.1002/ijc.27621. Epub 2012 May 17.
• [4060] Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.Cancer Sci. 2016 Jul;107(7):890-8. doi: 10.1111/cas.12945. Epub 2016 Jun 13.
• [4061] Helicase-like transcription factor (Hltf) gene-deletion promotes oxidative phosphorylation (OXPHOS) in colorectal tumors of AOM/DSS-treated mice.PLoS One. 2019 Aug 28;14(8):e0221751. doi: 10.1371/journal.pone.0221751. eCollection 2019.
• [4062] H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.Tumour Biol. 2016 May;37(5):6419-28. doi: 10.1007/s13277-015-4490-z. Epub 2015 Dec 2.
• [4063] Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon.Mol Cancer Res. 2015 Nov;13(11):1478-86. doi: 10.1158/1541-7786.MCR-15-0224. Epub 2015 Jul 20.
• [4064] HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1.Cancer Manag Res. 2019 May 31;11:5075-5089. doi: 10.2147/CMAR.S204357. eCollection 2019.
• [4065] The nucleosome binding protein 1 promotes the growth of gastric cancer cells.J Cancer. 2019 Jan 29;10(5):1132-1137. doi: 10.7150/jca.29292. eCollection 2019.
• [4066] Galectin-3 Interacts with C/EBP and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer.Mol Cancer Res. 2020 Mar;18(3):403-413. doi: 10.1158/1541-7786.MCR-19-0811. Epub 2019 Dec 10.
• [4067] HnRNP-F regulates EMT in bladder cancer by mediating the stabilization of Snail1 mRNA by binding to its 3' UTR.EBioMedicine. 2019 Jul;45:208-219. doi: 10.1016/j.ebiom.2019.06.017. Epub 2019 Jun 18.
• [4068] Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma.Clin Chem Lab Med. 2018 Feb 23;56(3):479-484. doi: 10.1515/cclm-2017-0327.
• [4069] The emerging roles of hnRNPK.J Cell Physiol. 2020 Mar;235(3):1995-2008. doi: 10.1002/jcp.29186. Epub 2019 Sep 19.
• [4070] hnRNPM induces translation switch under hypoxia to promote colon cancer development.EBioMedicine. 2019 Mar;41:299-309. doi: 10.1016/j.ebiom.2019.02.059. Epub 2019 Mar 7.
• [4071] p120-catenin in cancer - mechanisms, models and opportunities for intervention.J Cell Sci. 2013 Aug 15;126(Pt 16):3515-25. doi: 10.1242/jcs.134411.
• [4072] Clinicopathological and prognostic significance of SHP2 and Hook1 expression in patients with thyroid carcinoma.Hum Pathol. 2018 Nov;81:105-112. doi: 10.1016/j.humpath.2018.06.016. Epub 2018 Jun 25.
• [4073] Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance.J Hepatol. 2004 Jan;40(1):117-23. doi: 10.1016/s0168-8278(03)00503-8.
• [4074] Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer.Oncotarget. 2019 Oct 15;10(57):5906-5918. doi: 10.18632/oncotarget.27187. eCollection 2019 Oct 15.
• [4075] KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.Leuk Lymphoma. 2018 Jan;59(1):204-213. doi: 10.1080/10428194.2017.1324156. Epub 2017 May 25.
• [4076] HOXA10 expression profiling in prostate cancer.Prostate. 2019 Apr;79(5):554-563. doi: 10.1002/pros.23761. Epub 2019 Jan 6.
• [4077] Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma.Oncotarget. 2013 Nov;4(11):2154-65. doi: 10.18632/oncotarget.1367.
• [4078] HOXA4, down-regulated in lung cancer, inhibits the growth, motility and invasion of lung cancer cells.Cell Death Dis. 2018 May 1;9(5):465. doi: 10.1038/s41419-018-0497-x.
• [4079] Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells.Int J Oncol. 2018 Jun;52(6):2093-2100. doi: 10.3892/ijo.2018.4352. Epub 2018 Apr 2.
• [4080] HOXB1 Is a Tumor Suppressor Gene Regulated by miR-3175 in Glioma.PLoS One. 2015 Nov 13;10(11):e0142387. doi: 10.1371/journal.pone.0142387. eCollection 2015.
• [4081] A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.BMC Cancer. 2018 Feb 13;18(1):182. doi: 10.1186/s12885-018-4097-z.
• [4082] Identification of the transcription factor HOXB4 as a novel target of miR-23a.Genes Chromosomes Cancer. 2013 Aug;52(8):709-15. doi: 10.1002/gcc.22066. Epub 2013 Apr 30.
• [4083] The let-7c/HoxB7 axis regulates the cell proliferation, migration and apoptosis in hepatocellular carcinoma.Anticancer Drugs. 2020 Jan;31(1):6-18. doi: 10.1097/CAD.0000000000000843.
• [4084] Experimental and clinicopathological analysis of HOXB9 in gastric cancer.Oncol Lett. 2019 Mar;17(3):3097-3102. doi: 10.3892/ol.2019.10008. Epub 2019 Feb 4.
• [4085] HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma.FEBS J. 2018 Jun;285(12):2278-2291. doi: 10.1111/febs.14476. Epub 2018 May 25.
• [4086] Overexpression of HOXC11 homeobox gene in clear cell renal cell carcinoma induces cellular proliferation and is associated with poor prognosis.Tumour Biol. 2015 Apr;36(4):2821-9. doi: 10.1007/s13277-014-2909-6. Epub 2014 Dec 5.
• [4087] Posterior HOX genes and HOTAIR expression in the proximal and distal colon cancer pathogenesis.J Transl Med. 2018 Dec 12;16(1):350. doi: 10.1186/s12967-018-1725-y.
• [4088] Expression of the homeobox gene HOXC4 in keratinocytes of normal skin and epithelial skin tumors is correlated with differentiation.J Invest Dermatol. 1994 Sep;103(3):341-6. doi: 10.1111/1523-1747.ep12394888.
• [4089] HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-/smad signaling pathway in cervical carcinoma cells.Cancer Cell Int. 2018 Dec 12;18:204. doi: 10.1186/s12935-018-0680-2. eCollection 2018.
• [4090] HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGF1 in non-small cell lung cancer.Oncogenesis. 2018 Jan 17;7(2):1. doi: 10.1038/s41389-017-0016-4.
• [4091] MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene.Cancer Lett. 2015 Feb 1;357(1):105-113. doi: 10.1016/j.canlet.2014.11.002. Epub 2014 Nov 11.
• [4092] Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1331-9. doi: 10.1158/1055-9965.EPI-13-1000. Epub 2014 Apr 9.
• [4093] High HOXD4 protein expression in gastric adenocarcinoma tissues indicates unfavorable clinical outcomes.Saudi J Gastroenterol. 2019 Jan-Feb;25(1):46-54. doi: 10.4103/sjg.SJG_105_18.
• [4094] HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer.Int J Biochem Cell Biol. 2017 Jul;88:1-13. doi: 10.1016/j.biocel.2017.04.011. Epub 2017 Apr 27.
• [4095] Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.Gynecol Oncol. 2019 Nov;155(2):340-348. doi: 10.1016/j.ygyno.2019.08.026. Epub 2019 Aug 30.
• [4096] Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice.Clin Cancer Res. 1999 Mar;5(3):711-20.
• [4097] The immunoexpression of heparanase 2 in normal epithelium, intraepithelial, and invasive squamous neoplasia of the cervix.J Low Genit Tract Dis. 2012 Jul;16(3):256-62. doi: 10.1097/LGT.0b013e3182422c69.
• [4098] Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.Oncologist. 2019 Aug;24(8):1095-1102. doi: 10.1634/theoncologist.2018-0695. Epub 2019 Apr 11.
• [4099] Synergistic silencing by promoter methylation and reduced AP-2 transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.Am J Pathol. 2013 Jan;182(1):84-95. doi: 10.1016/j.ajpath.2012.09.018. Epub 2012 Nov 13.
• [4100] Mutational landscape of penile squamous cell carcinoma in a Chinese population.Int J Cancer. 2019 Sep 1;145(5):1280-1289. doi: 10.1002/ijc.32373. Epub 2019 May 8.
• [4101] Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.Inflamm Bowel Dis. 2013 Jan;19(1):165-73. doi: 10.1002/ibd.22994.
• [4102] Silencing HS6ST3 inhibits growth and progression of breast cancer cells through suppressing IGF1R and inducing XAF1.Exp Cell Res. 2017 Jan 15;350(2):380-389. doi: 10.1016/j.yexcr.2016.12.019. Epub 2016 Dec 23.
• [4103] A novel conditional gene silencing method using a tumor-specific and heat-inducible siRNA system.J Ind Microbiol Biotechnol. 2016 Jun;43(6):761-70. doi: 10.1007/s10295-016-1759-1. Epub 2016 Mar 31.
• [4104] Role of Hydroxysteroid Dehydrogenase-Like 2 (HSDL2) in Human Ovarian Cancer.Med Sci Monit. 2018 Jun 12;24:3997-4008. doi: 10.12659/MSM.909418.
• [4105] Membrane Localization of HspA1A, a Stress Inducible 70-kDa Heat-Shock Protein, Depends on Its Interaction with Intracellular Phosphatidylserine.Biomolecules. 2019 Apr 17;9(4):152. doi: 10.3390/biom9040152.
• [4106] RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.Cell Death Differ. 2020 Mar;27(3):1105-1118. doi: 10.1038/s41418-019-0400-z. Epub 2019 Aug 13.
• [4107] Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial.Cancer Sci. 2019 Oct;110(10):3049-3060. doi: 10.1111/cas.14165. Epub 2019 Sep 19.
• [4108] The expression of HtrA2 and its diagnostic value in patients with hepatocellular carcinoma.Medicine (Baltimore). 2018 Apr;97(14):e0128. doi: 10.1097/MD.0000000000010128.
• [4109] Antagonism between HTRA3 and TGF1 Contributes to Metastasis in Non-Small Cell Lung Cancer.Cancer Res. 2019 Jun 1;79(11):2853-2864. doi: 10.1158/0008-5472.CAN-18-2507. Epub 2019 Apr 2.
• [4110] Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.Breast Cancer Res Treat. 2015 Jan;149(1):91-8. doi: 10.1007/s10549-014-3227-9. Epub 2014 Dec 17.
• [4111] HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma.Mol Carcinog. 2019 Jan;58(1):76-87. doi: 10.1002/mc.22908. Epub 2018 Sep 19.
• [4112] Differential susceptible loci expression in keloid and hypertrophic scars in the Chinese Han population.Ann Plast Surg. 2015 Jan;74(1):26-9. doi: 10.1097/SAP.0000000000000364.
• [4113] Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion.Nat Commun. 2019 Jun 14;10(1):2625. doi: 10.1038/s41467-019-10374-y.
• [4114] Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling.Matrix Biol. 2019 May;78-79:165-179. doi: 10.1016/j.matbio.2018.05.002. Epub 2018 May 10.
• [4115] High-Molecular-Weight Hyaluronan Is a Hippo Pathway Ligand Directing Cell Density-Dependent Growth Inhibition via PAR1b.Dev Cell. 2019 May 20;49(4):590-604.e9. doi: 10.1016/j.devcel.2019.04.018. Epub 2019 May 9.
• [4116] HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.Eur Rev Med Pharmacol Sci. 2019 Jan;23(10):4126-4135. doi: 10.26355/eurrev_201901_17914.
• [4117] Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor.Cancer Biomark. 2019;24(3):351-361. doi: 10.3233/CBM-181572.
• [4118] Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma.Front Oncol. 2019 Oct 25;9:1117. doi: 10.3389/fonc.2019.01117. eCollection 2019.
• [4119] IBTK contributes to B-cell lymphomagenesis in E-myc transgenic mice conferring resistance to apoptosis.Cell Death Dis. 2019 Apr 11;10(4):320. doi: 10.1038/s41419-019-1557-6.
• [4120] Novel SRF-ICA1L Fusions in Cellular Myoid Neoplasms With Potential For Malignant Behavior.Am J Surg Pathol. 2020 Jan;44(1):55-60. doi: 10.1097/PAS.0000000000001336.
• [4121] ICAM3 mediates inflammatory signaling to promote cancer cell stemness.Cancer Lett. 2018 May 28;422:29-43. doi: 10.1016/j.canlet.2018.02.034. Epub 2018 Mar 2.
• [4122] Overexpression of Id3 induces apoptosis of A549 human lung adenocarcinoma cells.Cell Prolif. 2012 Feb;45(1):1-8. doi: 10.1111/j.1365-2184.2011.00792.x. Epub 2011 Dec 7.
• [4123] The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients.Oncogene. 2012 Aug 16;31(33):3796-806. doi: 10.1038/onc.2011.535. Epub 2011 Nov 28.
• [4124] IER5 as a promising predictive marker promotes irradiation-induced apoptosis in cervical cancer tissues from patients undergoing chemoradiotherapy.Oncotarget. 2017 May 30;8(22):36438-36448. doi: 10.18632/oncotarget.16857.
• [4125] Lentivirus mediated -interferon-inducible lysosomal thiol reductase (GILT) knockdown suppresses human glioma U373MG cell proliferation.Biochem Biophys Res Commun. 2019 Jan 29;509(1):182-187. doi: 10.1016/j.bbrc.2018.12.099. Epub 2018 Dec 23.
• [4126] The effects of IFITM1 and IFITM3 gene deletion on IFN stimulated protein synthesis.Cell Signal. 2019 Aug;60:39-56. doi: 10.1016/j.cellsig.2019.03.024. Epub 2019 Apr 2.
• [4127] Molecular evidence supporting field effect in urothelial carcinogenesis.Clin Cancer Res. 2005 Sep 15;11(18):6512-9. doi: 10.1158/1078-0432.CCR-05-0891.
• [4128] Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.IUBMB Life. 2019 Nov;71(11):1806-1814. doi: 10.1002/iub.2152. Epub 2019 Aug 16.
• [4129] The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21.Hum Genet. 1997 Mar;99(3):334-41. doi: 10.1007/s004390050368.
• [4130] Small molecules targeted to the microtubule-Hec1 interaction inhibit cancer cell growth through microtubule stabilization.Oncogene. 2018 Jan 11;37(2):231-240. doi: 10.1038/onc.2017.320. Epub 2017 Sep 18.
• [4131] Characterization of the distribution, retention, and efficacy of internal radiation of (188)Re-lipid nanocapsules in an immunocompromised human glioblastoma model.J Neurooncol. 2017 Jan;131(1):49-58. doi: 10.1007/s11060-016-2289-4. Epub 2016 Oct 25.
• [4132] Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness.Sci Rep. 2017 Jan 26;7(1):1. doi: 10.1038/s41598-016-0028-x.
• [4133] Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma.Oncotarget. 2017 Jun 20;8(25):40693-40704. doi: 10.18632/oncotarget.17244.
• [4134] Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis.Oncogene. 2019 May;38(21):4182-4196. doi: 10.1038/s41388-019-0797-3. Epub 2019 Apr 1.
• [4135] microRNA?88 acts as a tumour suppressor in glioma by directly targeting the IGF2BP2 gene.Mol Med Rep. 2017 Nov;16(5):7124-7130. doi: 10.3892/mmr.2017.7433. Epub 2017 Sep 7.
• [4136] Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer.Oncol Lett. 2019 Nov;18(5):4744-4752. doi: 10.3892/ol.2019.10835. Epub 2019 Sep 10.
• [4137] Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.Nucleic Acids Res. 2018 Sep 28;46(17):8832-8847. doi: 10.1093/nar/gky589.
• [4138] Altered genome-wide methylation in endometriosis.Reprod Sci. 2014 Oct;21(10):1237-43. doi: 10.1177/1933719114532841. Epub 2014 Apr 30.
• [4139] Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.Neoplasia. 2009 Jan;11(1):77-86, 4p following 86. doi: 10.1593/neo.81180.
• [4140] WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma.Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):454-461. doi: 10.1097/PAI.0000000000000449.
• [4141] A strategy of targeting B10cell by CD19scFv-IL10R for tumor therapy.Biochem Biophys Res Commun. 2018 Dec 2;506(4):990-996. doi: 10.1016/j.bbrc.2018.10.191. Epub 2018 Nov 4.
• [4142] A multifunctional theranostic contrast agent for ultrasound/near infrared fluorescence imaging-based tumor diagnosis and ultrasound-triggered combined photothermal and gene therapy.Acta Biomater. 2019 Nov;99:373-386. doi: 10.1016/j.actbio.2019.09.015. Epub 2019 Sep 13.
• [4143] IL-17R deletion predicts high-grade colorectal cancer and poor clinical outcomes.Int J Cancer. 2019 Jul 15;145(2):548-558. doi: 10.1002/ijc.32122. Epub 2019 Jan 28.
• [4144] Lineage tracing and targeting of IL17RB(+) tuft cell-like human colorectal cancer stem cells.Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):12996-13005. doi: 10.1073/pnas.1900251116. Epub 2019 Jun 10.
• [4145] CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation.J Immunother Cancer. 2018 May 10;6(1):34. doi: 10.1186/s40425-018-0347-5.
• [4146] IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.Oncol Rep. 2019 Apr;41(4):2148-2158. doi: 10.3892/or.2019.7007. Epub 2019 Feb 11.
• [4147] The IL4I1 Enzyme: A New Player in the Immunosuppressive Tumor Microenvironment.Cells. 2019 Jul 20;8(7):757. doi: 10.3390/cells8070757.
• [4148] Pharmacologic IL-6R inhibition in cholangiocarcinoma promotes cancer cell growth and survival.Biochim Biophys Acta Mol Basis Dis. 2019 Feb 1;1865(2):308-321. doi: 10.1016/j.bbadis.2018.11.006. Epub 2018 Nov 9.
• [4149] Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target.Mol Cancer Ther. 2019 Feb;18(2):413-420. doi: 10.1158/1535-7163.MCT-17-1079. Epub 2018 Oct 31.
• [4150] High expression of IL-9R promotes the progression of human hepatocellular carcinoma and indicates a poor clinical outcome.Oncol Rep. 2015 Aug;34(2):795-802. doi: 10.3892/or.2015.4060. Epub 2015 Jun 15.
• [4151] IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.Oncotarget. 2017 Sep 21;8(52):89736-89745. doi: 10.18632/oncotarget.21116. eCollection 2017 Oct 27.
• [4152] Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806.J Nucl Med. 2010 Jun;51(6):967-72. doi: 10.2967/jnumed.109.068395. Epub 2010 May 19.
• [4153] Suppression of Tafazzin promotes thyroid cancer apoptosis via activating the JNK signaling pathway and enhancing INF2-mediated mitochondrial fission.J Cell Physiol. 2019 Sep;234(9):16238-16251. doi: 10.1002/jcp.28287. Epub 2019 Feb 11.
• [4154] ING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks.Cell Death Differ. 2019 Nov;26(11):2344-2357. doi: 10.1038/s41418-019-0305-x. Epub 2019 Feb 25.
• [4155] The Tumor Suppressor ING5 Is a Dimeric, Bivalent Recognition Molecule of the Histone H3K4me3 Mark.J Mol Biol. 2019 May 31;431(12):2298-2319. doi: 10.1016/j.jmb.2019.04.018. Epub 2019 Apr 24.
• [4156] Inhibin- gene mutations and mRNA levels in human lymphoid and myeloid leukemia cells.Int J Oncol. 2017 Apr;50(4):1403-1412. doi: 10.3892/ijo.2017.3895. Epub 2017 Mar 2.
• [4157] INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.Oncogene. 2017 Mar;36(10):1430-1439. doi: 10.1038/onc.2016.311. Epub 2016 Sep 19.
• [4158] Investigating the duality of Inpp4b function in the cellular transformation of mouse fibroblasts.Oncotarget. 2019 Oct 29;10(59):6378-6390. doi: 10.18632/oncotarget.27293. eCollection 2019 Oct 29.
• [4159] A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.Oncogene. 2017 Oct 26;36(43):5969-5984. doi: 10.1038/onc.2017.208. Epub 2017 Jun 26.
• [4160] Upregulation of SHIP2 participates in the development of breast cancer via promoting Wnt/-catenin signaling.Onco Targets Ther. 2019 Aug 30;12:7067-7077. doi: 10.2147/OTT.S223422. eCollection 2019.
• [4161] INSL3 in the benign hyperplastic and neoplastic human prostate gland. Int J Oncol. 2005 Aug;27(2):307-15.
• [4162] Role of INSL4 Signaling in Sustaining the Growth and Viability of LKB1-Inactivated Lung Cancer.J Natl Cancer Inst. 2019 Jul 1;111(7):664-674. doi: 10.1093/jnci/djy166.
• [4163] Correlation of type I insulin-like growth factor receptor (IGF-I-R) and insulin receptor-related receptor (IRR) messenger RNA levels in tumor cell lines from pediatric tumors of neuronal origin.Regul Pept. 1999 Oct 22;84(1-3):37-42. doi: 10.1016/s0167-0115(99)00065-8.
• [4164] Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer.Cancer Chemother Pharmacol. 2019 Jul;84(1):61-72. doi: 10.1007/s00280-019-03848-9. Epub 2019 Apr 29.
• [4165] The ANK repeats of Notch-4/Int3 activate NF-B canonical pathway in the absence of Rbpj and causes mammary tumorigenesis.Sci Rep. 2017 Oct 20;7(1):13690. doi: 10.1038/s41598-017-13989-7.
• [4166] Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.Urol Oncol. 2018 Jun;36(6):311.e1-311.e13. doi: 10.1016/j.urolonc.2018.03.001. Epub 2018 Mar 27.
• [4167] Differential Proteomic Analysis between Small Cell Lung Carcinoma (SCLC) and Pulmonary Carcinoid Tumors Reveals Molecular Signatures for Malignancy in Lung Cancer.Proteomics Clin Appl. 2018 Nov;12(6):e1800015. doi: 10.1002/prca.201800015. Epub 2018 Jul 5.
• [4168] IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/-catenin signaling.Sci Rep. 2019 May 17;9(1):7539. doi: 10.1038/s41598-019-44048-y.
• [4169] Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.Cell Commun Signal. 2018 Jan 5;16(1):1. doi: 10.1186/s12964-017-0212-z.
• [4170] IRF-2 Inhibits Gastric Cancer Invasion and Migration by Down-Regulating MMP-1.Dig Dis Sci. 2020 Jan;65(1):168-177. doi: 10.1007/s10620-019-05739-8. Epub 2019 Jul 26.
• [4171] Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers.Nat Commun. 2019 Sep 3;10(1):3974. doi: 10.1038/s41467-019-11911-5.
• [4172] IRF6 Is Directly Regulated by ZEB1 and ELF3, and Predicts a Favorable Prognosis in Gastric Cancer.Front Oncol. 2019 Apr 4;9:220. doi: 10.3389/fonc.2019.00220. eCollection 2019.
• [4173] Iroquois Homeobox 1 Acts as a True Tumor Suppressor in Multiple Organs by Regulating Cell Cycle Progression.Neoplasia. 2019 Oct;21(10):1003-1014. doi: 10.1016/j.neo.2019.08.001. Epub 2019 Aug 23.
• [4174] VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.Am J Surg Pathol. 2018 Dec;42(12):1571-1584. doi: 10.1097/PAS.0000000000001150.
• [4175] SDHC Promoter Methylation, a Novel Pathogenic Mechanism in Parasympathetic Paragangliomas.J Clin Endocrinol Metab. 2018 Jan 1;103(1):295-305. doi: 10.1210/jc.2017-01702.
• [4176] ISL1, a novel regulator of CCNB1, CCNB2 and c-MYC genes, promotes gastric cancer cell proliferation and tumor growth.Oncotarget. 2016 Jun 14;7(24):36489-36500. doi: 10.18632/oncotarget.9269.
• [4177] Cognitive functioning in patients with low-grade glioma: effects of hemispheric tumor location and surgical procedure.J Neurosurg. 2019 Nov 15;133(6):1671-1682. doi: 10.3171/2019.8.JNS191667.
• [4178] Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3 pathway.Carcinogenesis. 2020 Aug 12;41(8):1123-1133. doi: 10.1093/carcin/bgz188.
• [4179] TIP: A Web Server for Resolving Tumor Immunophenotype Profiling.Cancer Res. 2018 Dec 1;78(23):6575-6580. doi: 10.1158/0008-5472.CAN-18-0689. Epub 2018 Aug 28.
• [4180] CENP-R acts bilaterally as a tumor suppressor and as an oncogene in the two-stage skin carcinogenesis model.Cancer Sci. 2017 Nov;108(11):2142-2148. doi: 10.1111/cas.13348. Epub 2017 Aug 30.
• [4181] Integrin 5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways.Oncogene. 2013 Jun 20;32(25):3049-58. doi: 10.1038/onc.2012.320. Epub 2012 Jul 23.
• [4182] Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling.Tumour Biol. 2016 Feb;37(2):1663-9. doi: 10.1007/s13277-015-3919-8. Epub 2015 Aug 26.
• [4183] Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis.BMC Cancer. 2008 Jan 28;8:25. doi: 10.1186/1471-2407-8-25.
• [4184] ITIH5 induces a shift in TGF- superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.Mol Carcinog. 2018 Feb;57(2):167-181. doi: 10.1002/mc.22742. Epub 2017 Oct 30.
• [4185] Integral membrane protein 2A inhibits cell growth in human breast cancer via enhancing autophagy induction.Cell Commun Signal. 2019 Aug 22;17(1):105. doi: 10.1186/s12964-019-0422-7.
• [4186] Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.J Clin Oncol. 2011 Feb 20;29(6):660-6. doi: 10.1200/JCO.2010.31.1258. Epub 2011 Jan 10.
• [4187] Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.J Clin Invest. 2019 May 13;129(6):2431-2445. doi: 10.1172/JCI124550. eCollection 2019 May 13.
• [4188] Canine Parvovirus ns1 gene and Chicken Anemia vp3 gene induce partial oncolysis of Canine Transmissible Venereal Tumor.Sci Rep. 2017 Nov 13;7(1):15419. doi: 10.1038/s41598-017-15734-6.
• [4189] Jade family PHD finger 3 (JADE3) increases cancer stem cell-like properties and tumorigenicity in colon cancer.Cancer Lett. 2018 Aug 1;428:1-11. doi: 10.1016/j.canlet.2018.04.012. Epub 2018 Apr 13.
• [4190] JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer.Cancer Manag Res. 2019 Mar 27;11:2457-2470. doi: 10.2147/CMAR.S189937. eCollection 2019.
• [4191] Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia.Mol Cell Proteomics. 2018 Feb;17(2):290-303. doi: 10.1074/mcp.RA117.000425. Epub 2017 Dec 1.
• [4192] Next-generation Sequencing of an Ovarian Spindle Cell Tumor Identified an Ovarian Low-grade Endometrial Stromal Sarcoma: A Rare Entity.Int J Gynecol Pathol. 2019 Sep;38(5):474-478. doi: 10.1097/PGP.0000000000000540.
• [4193] JmjC domain-containing protein 8 (JMJD8) represses Ku70/Ku80 expression via attenuating AKT/NF-B/COX-2 signaling.Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118541. doi: 10.1016/j.bbamcr.2019.118541. Epub 2019 Aug 29.
• [4194] Epigenomic and Functional Characterization of Junctophilin 3 (JPH3) as a Novel Tumor Suppressor Being Frequently Inactivated by Promoter CpG Methylation in Digestive Cancers.Theranostics. 2017 May 30;7(7):2150-2163. doi: 10.7150/thno.18185. eCollection 2017.
• [4195] Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.Int J Cancer. 2009 Mar 15;124(6):1358-65. doi: 10.1002/ijc.24071.
• [4196] Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.Breast Cancer Res Treat. 2020 Jan;179(2):349-357. doi: 10.1007/s10549-019-05466-8. Epub 2019 Nov 2.
• [4197] Sulfated polysaccharide of Sepiella Maindroni ink inhibits the migration, invasion and matrix metalloproteinase-2 expression through suppressing EGFR-mediated p38/MAPK and PI3K/Akt/mTOR signaling pathways in SKOV-3 cells.Int J Biol Macromol. 2018 Feb;107(Pt A):349-362. doi: 10.1016/j.ijbiomac.2017.08.178. Epub 2017 Sep 9.
• [4198] Lysyl-tRNA synthetase-expressing colon spheroids induce M2 macrophage polarization to promote metastasis.J Clin Invest. 2018 Nov 1;128(11):5034-5055. doi: 10.1172/JCI99806. Epub 2018 Oct 8.
• [4199] LAPSER1 is a putative cytokinetic tumor suppressor that shows the same centrosome and midbody subcellular localization pattern as p80 katanin.FASEB J. 2007 Jul;21(9):2086-100. doi: 10.1096/fj.06-7254com. Epub 2007 Mar 9.
• [4200] The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice.Oncogene. 2010 Jul 15;29(28):4058-67. doi: 10.1038/onc.2010.156. Epub 2010 May 17.
• [4201] Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia.PLoS One. 2010 Jul 6;5(7):e11451. doi: 10.1371/journal.pone.0011451.
• [4202] Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.Cancer Res. 2001 May 15;61(10):3969-77.
• [4203] Distribution and association study in copy number variation of KCNJ12 gene across four Chinese cattle populations.Gene. 2019 Mar 20;689:90-96. doi: 10.1016/j.gene.2018.12.019. Epub 2018 Dec 17.
• [4204] Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure.Environ Res. 2014 Jan;128:57-63. doi: 10.1016/j.envres.2013.10.006. Epub 2013 Nov 22.
• [4205] Induction of tumor suppressor KCTD11 during periovulatory period in rat ovary.Reprod Biol. 2019 Jun;19(2):173-178. doi: 10.1016/j.repbio.2019.05.003. Epub 2019 May 28.
• [4206] KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.Blood Adv. 2019 Sep 10;3(17):2537-2549. doi: 10.1182/bloodadvances.2018028522.
• [4207] KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RAR.Cancer Cell Int. 2019 Oct 4;19:256. doi: 10.1186/s12935-019-0979-7. eCollection 2019.
• [4208] Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.Cancer Res. 2019 Jan 1;79(1):86-98. doi: 10.1158/0008-5472.CAN-18-1310. Epub 2018 Nov 20.
• [4209] KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC.Oncogene. 2019 Jan;38(1):17-32. doi: 10.1038/s41388-018-0414-x. Epub 2018 Aug 2.
• [4210] The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.Ann Surg Oncol. 2019 Dec;26(13):4723-4729. doi: 10.1245/s10434-019-07805-x. Epub 2019 Sep 9.
• [4211] A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas.Mol Diagn Ther. 2019 Aug;23(4):537-545. doi: 10.1007/s40291-019-00403-3.
• [4212] Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre.Clin Oncol (R Coll Radiol). 2020 Jan;32(1):e27-e35. doi: 10.1016/j.clon.2019.07.007. Epub 2019 Jul 23.
• [4213] High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.Thorac Cancer. 2019 May;10(5):1103-1110. doi: 10.1111/1759-7714.13051. Epub 2019 Mar 25.
• [4214] Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis.Bioinformatics. 2015 Jan 15;31(2):216-24. doi: 10.1093/bioinformatics/btu586. Epub 2014 Sep 18.
• [4215] Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.Cancer Prev Res (Phila). 2010 Sep;3(9):1093-103. doi: 10.1158/1940-6207.CAPR-10-0115. Epub 2010 Aug 26.
• [4216] Roles and mechanisms of Kinesin-6 KIF20A in spindle organization during cell division.Eur J Cell Biol. 2019 Jun;98(2-4):74-80. doi: 10.1016/j.ejcb.2018.12.002. Epub 2018 Dec 16.
• [4217] Prognostic significance of KIF2A and KIF20A expression in human cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2019 Nov;98(46):e18040. doi: 10.1097/MD.0000000000018040.
• [4218] Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Colon Cancer.Cancer Biother Radiopharm. 2020 Feb;35(1):50-57. doi: 10.1089/cbr.2019.3045. Epub 2019 Oct 29.
• [4219] Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients.Lung Cancer. 2016 Feb;92:53-61. doi: 10.1016/j.lungcan.2015.11.018. Epub 2015 Nov 27.
• [4220] Effects of KIF2A on the prognosis of nasopharyngeal carcinoma and nasopharyngeal carcinoma cells.Oncol Lett. 2019 Sep;18(3):2718-2723. doi: 10.3892/ol.2019.10597. Epub 2019 Jul 9.
• [4221] Functional characterization of MCAK/Kif2C cancer mutations using high-throughput microscopic analysis.Mol Biol Cell. 2020 Mar 19;31(7):580-588. doi: 10.1091/mbc.E19-09-0503. Epub 2019 Nov 20.
• [4222] Combined deletion of Vhl, Trp53 and Kif3a causes cystic and neoplastic renal lesions.J Pathol. 2016 Jul;239(3):365-73. doi: 10.1002/path.4736. Epub 2016 May 30.
• [4223] Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer.Clin Cancer Res. 2020 Mar 15;26(6):1516-1528. doi: 10.1158/1078-0432.CCR-19-0396. Epub 2019 Dec 3.
• [4224] A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.EBioMedicine. 2019 Jul;45:92-107. doi: 10.1016/j.ebiom.2019.06.009. Epub 2019 Jun 14.
• [4225] Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma.Aging (Albany NY). 2019 Dec 16;11(24):12114-12130. doi: 10.18632/aging.102543. Epub 2019 Dec 16.
• [4226] Low expression of KIF7 indicates poor prognosis in epithelial ovarian cancer.Cancer Biomark. 2019;26(4):481-489. doi: 10.3233/CBM-190328.
• [4227] KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.Oncogene. 2019 Jan;38(3):406-420. doi: 10.1038/s41388-018-0440-8. Epub 2018 Aug 16.
• [4228] Kinesin light chain-4 depletion induces apoptosis of radioresistant cancer cells by mitochondrial dysfunction via calcium ion influx.Cell Death Dis. 2018 May 1;9(5):496. doi: 10.1038/s41419-018-0549-2.
• [4229] Sequence-specific recruitment of heterochromatin protein 1 via interaction with Krppel-like factor 11, a human transcription factor involved in tumor suppression and metabolic diseases.J Biol Chem. 2012 Apr 13;287(16):13026-39. doi: 10.1074/jbc.M112.342634. Epub 2012 Feb 8.
• [4230] Dysregulation of Krppel-like factor 12 in the development of endometrial cancer.Gynecol Oncol. 2019 Jan;152(1):177-184. doi: 10.1016/j.ygyno.2018.10.028. Epub 2018 Oct 25.
• [4231] Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion.Onco Targets Ther. 2019 Feb 22;12:1509-1520. doi: 10.2147/OTT.S188270. eCollection 2019.
• [4232] miR-4262 Promotes Proliferation and Invasion of Human Breast Cancer Cells Through Directly Targeting KLF6 and KLF15.Oncol Res. 2017 Jan 26;25(2):277-283. doi: 10.3727/096504016X14732514133203. Epub 2016 Sep 13.
• [4233] Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.Oncol Rep. 2019 Nov;42(5):2117-2129. doi: 10.3892/or.2019.7324. Epub 2019 Sep 18.
• [4234] KLF2 Inhibits the Migration and Invasion of Prostate Cancer Cells by Downregulating MMP2.Am J Mens Health. 2019 Jan-Feb;13(1):1557988318816907. doi: 10.1177/1557988318816907. Epub 2018 Dec 6.
• [4235] MiR-326/Sp1/KLF3: A novel regulatory axis in lung cancer progression.Cell Prolif. 2019 Mar;52(2):e12551. doi: 10.1111/cpr.12551. Epub 2018 Nov 28.
• [4236] Synthesis and evaluation of radioactive/fluorescent peptide probes for imaging of legumain activity.Bioorg Med Chem Lett. 2019 Oct 1;29(19):126629. doi: 10.1016/j.bmcl.2019.126629. Epub 2019 Aug 19.
• [4237] HRAS, EGFR, MET, and RON Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2.J Virol. 2017 Sep 27;91(20):e00467-17. doi: 10.1128/JVI.00467-17. Print 2017 Oct 15.
• [4238] Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation.Biochem Biophys Res Commun. 2018 May 15;499(3):433-440. doi: 10.1016/j.bbrc.2018.03.152. Epub 2018 Mar 31.
• [4239] KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing.Nature. 2018 May;557(7706):585-589. doi: 10.1038/s41586-018-0128-9. Epub 2018 May 16.
• [4240] KLHL5 knockdown increases cellular sensitivity to anticancer drugs.Oncotarget. 2018 Dec 21;9(100):37429-37438. doi: 10.18632/oncotarget.26462. eCollection 2018 Dec 21.
• [4241] KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma.Cell Cycle. 2019 Feb;18(3):249-256. doi: 10.1080/15384101.2019.1568765. Epub 2019 Jan 24.
• [4242] Homozygous deletions at 3p22, 5p14, 6q15, and 9p21 result in aberrant expression of tumor suppressor genes in gastric cancer.Genes Chromosomes Cancer. 2015 Mar;54(3):142-55. doi: 10.1002/gcc.22226. Epub 2014 Dec 17.
• [4243] NES1/KLK10 and hNIS gene therapy enhanced iodine-131 internal radiation in PC3 proliferation inhibition.Front Med. 2019 Dec;13(6):646-657. doi: 10.1007/s11684-018-0643-y. Epub 2019 May 22.
• [4244] Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.PLoS One. 2017 Nov 2;12(11):e0186847. doi: 10.1371/journal.pone.0186847. eCollection 2017.
• [4245] Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia.Cancer Sci. 2010 Mar;101(3):693-9. doi: 10.1111/j.1349-7006.2009.01450.x. Epub 2009 Nov 27.
• [4246] LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.Mol Ther Nucleic Acids. 2019 Sep 6;17:563-577. doi: 10.1016/j.omtn.2019.06.003. Epub 2019 Jun 15.
• [4247] Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8(+) Tumor-Infiltrating T Lymphocyte Responses.Cancer Immunol Res. 2019 Aug;7(8):1293-1306. doi: 10.1158/2326-6066.CIR-18-0885. Epub 2019 Jun 18.
• [4248] NKT-Like (CD3+CD56+) Cells in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors.Front Immunol. 2019 Oct 22;10:2493. doi: 10.3389/fimmu.2019.02493. eCollection 2019.
• [4249] Tumor-infiltrating lymphocyte-derived MLL2 independently predicts disease-free survival for patients with early-stage oral squamous cell carcinoma.J Oral Pathol Med. 2020 Feb;49(2):126-136. doi: 10.1111/jop.12969. Epub 2019 Nov 19.
• [4250] Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.Blood. 2020 Jan 30;135(5):360-370. doi: 10.1182/blood.2019001904.
• [4251] NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.Front Immunol. 2019 Apr 9;10:719. doi: 10.3389/fimmu.2019.00719. eCollection 2019.
• [4252] Effect of KNL1 on the proliferation and apoptosis of colorectal cancer cells.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819858668. doi: 10.1177/1533033819858668.
• [4253] KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition.J Cancer. 2019 Jun 24;10(17):3914-3925. doi: 10.7150/jca.31448. eCollection 2019.
• [4254] Inhibition of KPNA4 attenuates prostate cancer metastasis.Oncogene. 2017 May 18;36(20):2868-2878. doi: 10.1038/onc.2016.440. Epub 2016 Dec 12.
• [4255] Kremen1 and Dickkopf1 control cell survival in a Wnt-independent manner.Cell Death Differ. 2016 Feb;23(2):323-32. doi: 10.1038/cdd.2015.100. Epub 2015 Jul 24.
• [4256] Bowen Disease With Sebaceous Differentiation: A Case Report and Immunohistochemical Analysis of Adipophilin and Cytokeratin 1.Am J Dermatopathol. 2018 Nov;40(11):841-845. doi: 10.1097/DAD.0000000000001175.
• [4257] Cytologic Grading of Cutaneous Sebaceous Neoplasms: Does it Help to Differentiate Benign From Malignant?.Am J Dermatopathol. 2019 Oct;41(10):722-732. doi: 10.1097/DAD.0000000000001434.
• [4258] Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer.J Med Virol. 2009 May;81(5):897-907. doi: 10.1002/jmv.21406.
• [4259] KRT18 is correlated with the malignant status and acts as an oncogene in colorectal cancer.Biosci Rep. 2019 Aug 13;39(8):BSR20190884. doi: 10.1042/BSR20190884. Print 2019 Aug 30.
• [4260] Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.Cell Death Dis. 2017 Jul 27;8(7):e2961. doi: 10.1038/cddis.2017.339.
• [4261] Molecular characterization of histopathological ependymoma variants.Acta Neuropathol. 2020 Feb;139(2):305-318. doi: 10.1007/s00401-019-02090-0. Epub 2019 Nov 2.
• [4262] Downregulation of keratin 76 expression during oral carcinogenesis of human, hamster and mouse.PLoS One. 2013 Jul 30;8(7):e70688. doi: 10.1371/journal.pone.0070688. Print 2013.
• [4263] Changes in keratin 8/18 expression in human granulosa cell lineage are associated to cell death/survival events: potential implications for the maintenance of the ovarian reserve.Hum Reprod. 2018 Apr 1;33(4):680-689. doi: 10.1093/humrep/dey010.
• [4264] SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ER breast cancer.Nat Commun. 2019 May 9;10(1):2115. doi: 10.1038/s41467-019-09676-y.
• [4265] Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?.Neuro Oncol. 2015 Oct;17(10):1365-73. doi: 10.1093/neuonc/nov039. Epub 2015 Mar 19.
• [4266] SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.Mol Cancer. 2017 Jan 5;16(1):1. doi: 10.1186/s12943-016-0568-5.
• [4267] L(3)mbt and the LINT complex safeguard cellular identity in the Drosophila ovary.Development. 2018 Apr 4;145(7):dev160721. doi: 10.1242/dev.160721.
• [4268] LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.Oncogene. 2018 Oct;37(41):5534-5551. doi: 10.1038/s41388-018-0352-7. Epub 2018 Jun 13.
• [4269] SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.Sci Signal. 2018 Jan 30;11(515):eaan0949. doi: 10.1126/scisignal.aan0949.
• [4270] Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics.Exp Hematol. 1987 Sep;15(8):822-32.
• [4271] Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.J Mol Med (Berl). 2007 Mar;85(3):293-304. doi: 10.1007/s00109-006-0126-5. Epub 2006 Dec 2.
• [4272] BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer.Clin Cancer Res. 2016 Oct 1;22(19):4923-4933. doi: 10.1158/1078-0432.CCR-15-2664. Epub 2016 May 3.
• [4273] Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway.Cancer Biol Ther. 2019;20(5):711-719. doi: 10.1080/15384047.2018.1564558. Epub 2019 Feb 12.
• [4274] Macrophage depletion using clodronate liposomes decreases tumorigenesis and alters gut microbiota in the AOM/DSS mouse model of colon cancer.Am J Physiol Gastrointest Liver Physiol. 2018 Jan 1;314(1):G22-G31. doi: 10.1152/ajpgi.00229.2017. Epub 2017 Oct 12.
• [4275] Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.J Clin Lab Anal. 2020 Feb;34(2):e23045. doi: 10.1002/jcla.23045. Epub 2019 Oct 22.
• [4276] Identification of RNA-Binding Protein LARP4B as a Tumor Suppressor in Glioma.Cancer Res. 2016 Apr 15;76(8):2254-64. doi: 10.1158/0008-5472.CAN-15-2308. Epub 2016 Mar 1.
• [4277] Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis.Exp Mol Med. 2008 Apr 30;40(2):229-36. doi: 10.3858/emm.2008.40.2.229.
• [4278] The lipid raft protein NTAL participates in AKT signaling in mantle cell lymphoma.Leuk Lymphoma. 2019 Nov;60(11):2658-2668. doi: 10.1080/10428194.2019.1607326. Epub 2019 May 7.
• [4279] LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.
• [4280] A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.PLoS One. 2015 Dec 10;10(12):e0144484. doi: 10.1371/journal.pone.0144484. eCollection 2015.
• [4281] Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival.Transl Oncol. 2018 Oct;11(5):1090-1096. doi: 10.1016/j.tranon.2018.06.006. Epub 2018 Jul 11.
• [4282] Cytotoxic effect of a replication-incompetent adenoviral vector with cytosine deaminase gene driven by L-plastin promoter in hepatocellular carcinoma cells.Arch Pharm Res. 2007 Jun;30(6):770-7. doi: 10.1007/BF02977641.
• [4283] LDB1 overexpression is a negative prognostic factor in colorectal cancer.Oncotarget. 2016 Dec 20;7(51):84258-84270. doi: 10.18632/oncotarget.12481.
• [4284] Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect.Nat Commun. 2019 Dec 5;10(1):5566. doi: 10.1038/s41467-019-13485-8.
• [4285] Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma.Hepatology. 2019 Jan;69(1):160-178. doi: 10.1002/hep.30140. Epub 2018 Dec 22.
• [4286] SNAIL1 employs -Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.Int J Cancer. 2020 Apr 15;146(8):2229-2242. doi: 10.1002/ijc.32644. Epub 2019 Sep 18.
• [4287] Wnt3a-dependent and -independent protein interaction networks of chromatin-bound -catenin in mouse embryonic stem cells.Mol Cell Proteomics. 2013 Jul;12(7):1980-94. doi: 10.1074/mcp.M112.026914. Epub 2013 Apr 15.
• [4288] MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management.Contrast Media Mol Imaging. 2018 Aug 26;2018:8382148. doi: 10.1155/2018/8382148. eCollection 2018.
• [4289] Glycoprotein 90K Promotes E-Cadherin Degradation in a Cell Density-Dependent Manner via Dissociation of E-Cadherin-p120-Catenin Complex.Int J Mol Sci. 2017 Dec 2;18(12):2601. doi: 10.3390/ijms18122601.
• [4290] Detection of malignancy-associated phosphoproteome changes in human colorectal cancer induced by cell surface binding of growth-inhibitory galectin-4.IUBMB Life. 2019 Mar;71(3):364-375. doi: 10.1002/iub.1987. Epub 2018 Dec 14.
• [4291] Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.ACS Nano. 2019 Feb 26;13(2):1136-1152. doi: 10.1021/acsnano.8b05482. Epub 2019 Jan 18.
• [4292] Molecular and clinical characterization of Galectin-9 in glioma through 1,027 samples.J Cell Physiol. 2020 May;235(5):4326-4334. doi: 10.1002/jcp.29309. Epub 2019 Oct 14.
• [4293] Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4.Cancer Sci. 2009 Aug;100(8):1485-93. doi: 10.1111/j.1349-7006.2009.01187.x. Epub 2009 May 19.
• [4294] MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.Biosci Rep. 2019 Mar 1;39(3):BSR20180879. doi: 10.1042/BSR20180879. Print 2019 Mar 29.
• [4295] Absence of HMGIC-LHFP fusion in pulmonary chondroid hamartomas with aberrations involving chromosomal regions 12q13 through 15 and 13q12 through q14.Cancer Genet Cytogenet. 2002 Feb;133(1):90-3. doi: 10.1016/s0165-4608(01)00553-2.
• [4296] The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.Oncogene. 2019 Jan;38(1):60-72. doi: 10.1038/s41388-018-0413-y. Epub 2018 Aug 3.
• [4297] LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling.Mol Oncol. 2014 Mar;8(2):401-16. doi: 10.1016/j.molonc.2013.12.009. Epub 2013 Dec 25.
• [4298] Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt/-catenin and P53 signaling pathways.Environ Pollut. 2019 Sep;252(Pt A):216-226. doi: 10.1016/j.envpol.2019.05.049. Epub 2019 May 15.
• [4299] A Novel Benzocoumarin-Stilbene Hybrid as a DNA ligase I inhibitor with in vitro and in vivo anti-tumor activity in breast cancer models.Sci Rep. 2017 Sep 6;7(1):10715. doi: 10.1038/s41598-017-10864-3.
• [4300] Temozolomide analog PMX 465 downregulates MGMT expression in HCT116 colorectal carcinoma cells.J Cell Biochem. 2018 Jul;119(7):5350-5358. doi: 10.1002/jcb.26674. Epub 2018 Mar 25.
• [4301] Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.Int J Cancer. 2018 Nov 15;143(10):2537-2550. doi: 10.1002/ijc.31786. Epub 2018 Sep 19.
• [4302] LIMCH1 suppress the growth of lung cancer by interacting with HUWE1 to sustain p53 stability.Gene. 2019 Sep 5;712:143963. doi: 10.1016/j.gene.2019.143963. Epub 2019 Jul 5.
• [4303] Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.Int J Cancer. 2017 Jun 1;140(11):2484-2497. doi: 10.1002/ijc.30680. Epub 2017 Mar 21.
• [4304] Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.Oncogene. 2019 Jun;38(23):4527-4539. doi: 10.1038/s41388-019-0735-4. Epub 2019 Feb 11.
• [4305] The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth.Nature. 2015 Jun 25;522(7557):482-6. doi: 10.1038/nature14298. Epub 2015 Apr 15.
• [4306] Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.Int J Cancer. 2018 Apr 15;142(8):1627-1639. doi: 10.1002/ijc.31179. Epub 2017 Dec 11.
• [4307] Metabolic enzymes expressed by cancer cells impact the immune infiltrate.Oncoimmunology. 2019 Mar 30;8(6):e1571389. doi: 10.1080/2162402X.2019.1571389. eCollection 2019.
• [4308] Identification of cancer/testis genes by database mining and mRNA expression analysis.Int J Cancer. 2002 Apr 1;98(4):485-92. doi: 10.1002/ijc.10276.
• [4309] LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway.Cell Mol Neurobiol. 2019 Aug;39(6):871-882. doi: 10.1007/s10571-019-00686-4. Epub 2019 May 16.
• [4310] LLGL2 rescues nutrient stress by promoting leucine uptake in ER(+) breast cancer.Nature. 2019 May;569(7755):275-279. doi: 10.1038/s41586-019-1126-2. Epub 2019 Apr 17.
• [4311] High frequency of LMAN1 abnormalities in colorectal tumors with microsatellite instability.Cancer Res. 2009 Jan 1;69(1):292-9. doi: 10.1158/0008-5472.CAN-08-3314.
• [4312] RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.Oncotarget. 2017 Mar 28;8(13):21429-21443. doi: 10.18632/oncotarget.15249.
• [4313] Lamin B2 binding to minichromosome maintenance complex component 7 promotes non-small cell lung carcinogenesis.Oncotarget. 2017 Aug 18;8(62):104813-104830. doi: 10.18632/oncotarget.20338. eCollection 2017 Dec 1.
• [4314] LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.Cancer Cell. 2017 Sep 11;32(3):310-323.e5. doi: 10.1016/j.ccell.2017.08.002. Epub 2017 Aug 31.
• [4315] LMO4 mediates trastuzumab resistance in HER2 positive breast cancer cells.Am J Cancer Res. 2018 Apr 1;8(4):594-609. eCollection 2018.
• [4316] LRIG1? and LMO7 immunoreactivity in vulvar squamous cell carcinoma: Association with prognosis in relation to HPVDNA and p16INK4a status.Oncol Rep. 2019 Jul;42(1):142-150. doi: 10.3892/or.2019.7138. Epub 2019 May 2.
• [4317] Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3/Wnt/-catenin signaling.Biochem Biophys Res Commun. 2019 Oct 1;517(4):722-728. doi: 10.1016/j.bbrc.2019.07.122. Epub 2019 Aug 5.
• [4318] LNX1 contributes to tumor growth by down-regulating p53 stability.FASEB J. 2019 Dec;33(12):13216-13227. doi: 10.1096/fj.201900366R. Epub 2019 Sep 18.
• [4319] Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo.Cancer Res. 2003 Apr 1;63(7):1657-66.
• [4320] LOXL1 Is Regulated by Integrin 11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity.Cancers (Basel). 2019 May 22;11(5):705. doi: 10.3390/cancers11050705.
• [4321] Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability.Cell Death Differ. 2018 May;25(5):935-950. doi: 10.1038/s41418-017-0030-2. Epub 2017 Dec 11.
• [4322] Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis.Cell Stem Cell. 2018 Feb 1;22(2):206-220.e4. doi: 10.1016/j.stem.2017.12.017.
• [4323] Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1.Cell Physiol Biochem. 2019;53(1):19-35. doi: 10.33594/000000118.
• [4324] Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.Cell Physiol Biochem. 2018;47(6):2250-2260. doi: 10.1159/000491536. Epub 2018 Jul 5.
• [4325] Nuclear receptor CAR-regulated expression of the FAM84A gene during the development of mouse liver tumors.Int J Oncol. 2011 Jun;38(6):1511-20. doi: 10.3892/ijo.2011.980. Epub 2011 Mar 17.
• [4326] IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1(+) stem cells.J Exp Med. 2019 Jan 7;216(1):195-214. doi: 10.1084/jem.20171849. Epub 2018 Dec 21.
• [4327] LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle.Oncogenesis. 2018 Jan 23;7(1):3. doi: 10.1038/s41389-017-0019-1.
• [4328] The role of low density lipoprotein receptor-related protein 11 as a tumor promoter in cervical cancer.Cancer Manag Res. 2019 Aug 30;11:8081-8093. doi: 10.2147/CMAR.S211912. eCollection 2019.
• [4329] Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2057-65. doi: 10.1073/pnas.1603223113. Epub 2016 Mar 22.
• [4330] RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells.Autophagy. 2018;14(4):637-653. doi: 10.1080/15548627.2018.1427022. Epub 2018 Mar 21.
• [4331] The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/-Catenin Signaling.Stem Cell Reports. 2018 Nov 13;11(5):1040-1050. doi: 10.1016/j.stemcr.2018.09.008. Epub 2018 Oct 18.
• [4332] Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15(+) Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy.Cancer Discov. 2020 Feb;10(2):232-253. doi: 10.1158/2159-8290.CD-19-0644. Epub 2019 Nov 7.
• [4333] Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma. BMC Syst Biol. 2010 Apr 27;4:51.
• [4334] The clinical value of LRRC3B gene expression and promoter hypermethylation in breast carcinomas.Cell Biochem Biophys. 2014 Nov;70(2):1035-41. doi: 10.1007/s12013-014-0018-1.
• [4335] LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.Am J Pathol. 2019 Oct;189(10):1973-1985. doi: 10.1016/j.ajpath.2019.06.006. Epub 2019 Jul 16.
• [4336] Loss of LSR affects epithelial barrier integrity and tumor xenograft growth of CaCo-2 cells.Oncotarget. 2017 Jun 6;8(23):37009-37022. doi: 10.18632/oncotarget.10425.
• [4337] SYGL-1 and LST-1 link niche signaling to PUF RNA repression for stem cell maintenance in Caenorhabditis elegans.PLoS Genet. 2017 Dec 12;13(12):e1007121. doi: 10.1371/journal.pgen.1007121. eCollection 2017 Dec.
• [4338] Expression and clinical significance of latent-transforming growth factor beta-binding protein 2 in primary hepatocellular carcinoma.Medicine (Baltimore). 2019 Sep;98(39):e17216. doi: 10.1097/MD.0000000000017216.
• [4339] LTBP3 promotes early metastatic events during cancer cell dissemination.Oncogene. 2018 Apr;37(14):1815-1829. doi: 10.1038/s41388-017-0075-1. Epub 2018 Jan 19.
• [4340] Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.Cell Oncol (Dordr). 2011 Oct;34(5):419-34. doi: 10.1007/s13402-011-0023-y. Epub 2011 Apr 6.
• [4341] Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production.Oncotarget. 2014 May 30;5(10):2962-73. doi: 10.18632/oncotarget.1561.
• [4342] Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer.Oncotarget. 2016 Jun 21;7(25):38551-38565. doi: 10.18632/oncotarget.9535.
• [4343] The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy.Sci Rep. 2019 Mar 26;9(1):5120. doi: 10.1038/s41598-019-41379-8.
• [4344] Overexpression of Lymphocyte Antigen 6 Complex, Locus E in Gastric Cancer Promotes Cancer Cell Growth and Metastasis.Cell Physiol Biochem. 2018;45(3):1219-1229. doi: 10.1159/000487453. Epub 2018 Feb 9.
• [4345] LYG1 exerts antitumor function through promoting the activation, proliferation, and function of CD4(+) T cells.Oncoimmunology. 2017 Mar 7;6(4):e1292195. doi: 10.1080/2162402X.2017.1292195. eCollection 2017.
• [4346] The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer.Cell Rep. 2019 Oct 22;29(4):889-903.e10. doi: 10.1016/j.celrep.2019.09.032.
• [4347] Cancer mortality in relatives of women with breast cancer: the OPCS Study. Office of Population Censuses and Surveys.Int J Cancer. 1996 Jan 26;65(3):275-83. doi: 10.1002/(SICI)1097-0215(19960126)65:3<275::AID-IJC1>3.0.CO;2-X.
• [4348] Inhibition of cell proliferation and migration in nonsmall cell lung cancer cells through the suppression of LYPLA1.Oncol Rep. 2019 Feb;41(2):973-980. doi: 10.3892/or.2018.6857. Epub 2018 Nov 9.
• [4349] LYRM2 directly regulates complex I activity to support tumor growth in colorectal cancer by oxidative phosphorylation.Cancer Lett. 2019 Jul 28;455:36-47. doi: 10.1016/j.canlet.2019.04.021. Epub 2019 Apr 17.
• [4350] Biomimetic nanoassemblies of 1-O-octodecyl-2-conjugated linoleoyl-sn-glycero-3-phosphatidyl gemcitabine with phospholipase A(2)-triggered degradation for the treatment of cancer.Colloids Surf B Biointerfaces. 2017 Apr 1;152:467-474. doi: 10.1016/j.colsurfb.2017.02.001. Epub 2017 Feb 3.
• [4351] Combinations of Tyrosine Kinase Inhibitor and ERAD Inhibitor Promote Oxidative Stress-Induced Apoptosis through ATF4 and KLF9 in Medullary Thyroid Cancer.Mol Cancer Res. 2019 Mar;17(3):751-760. doi: 10.1158/1541-7786.MCR-18-0354. Epub 2018 Dec 14.
• [4352] LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.World J Surg Oncol. 2018 Mar 2;16(1):42. doi: 10.1186/s12957-018-1349-y.
• [4353] In silico characterization of LZTS3, a potential tumor suppressor.Oncol Rep. 2005 Aug;14(2):547-51.
• [4354] Microtubule actin cross-linking factor 1, a novel potential target in cancer.Cancer Sci. 2017 Oct;108(10):1953-1958. doi: 10.1111/cas.13344. Epub 2017 Sep 21.
• [4355] CDK5-dependent phosphorylation and nuclear translocation of TRIM59 promotes macroH2A1 ubiquitination and tumorigenicity.Nat Commun. 2019 Sep 5;10(1):4013. doi: 10.1038/s41467-019-12001-2.
• [4356] Loss of histone variant macroH2A2 expression associates with progression of anal neoplasm.J Clin Pathol. 2016 Jul;69(7):627-31. doi: 10.1136/jclinpath-2015-203367. Epub 2015 Dec 10.
• [4357] MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.Biomed Pharmacother. 2017 Aug;92:1038-1044. doi: 10.1016/j.biopha.2017.05.092. Epub 2017 Jun 10.
• [4358] Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.Cell Death Dis. 2019 Feb 13;10(2):145. doi: 10.1038/s41419-019-1351-5.
• [4359] Tissue-specific Co-expression of Long Non-coding and Coding RNAs Associated with Breast Cancer.Sci Rep. 2016 Sep 6;6:32731. doi: 10.1038/srep32731.
• [4360] Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04).J Bone Oncol. 2018 Sep 27;13:123-135. doi: 10.1016/j.jbo.2018.09.008. eCollection 2018 Nov.
• [4361] Involvement of MAF1homolog, negative regulator of RNA polymeraseIII in colorectal cancer progression.Int J Oncol. 2019 Mar;54(3):1001-1009. doi: 10.3892/ijo.2019.4678. Epub 2019 Jan 7.
• [4362] Molecular mechanisms of regulation and action of microRNA-199a in testicular germ cell tumor and glioblastomas.PLoS One. 2013 Dec 31;8(12):e83980. doi: 10.1371/journal.pone.0083980. eCollection 2013.
• [4363] Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.Gastroenterology. 2018 Aug;155(2):557-571.e14. doi: 10.1053/j.gastro.2018.04.032. Epub 2018 May 5.
• [4364] The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients.Ann Nucl Med. 2020 Jan;34(1):65-73. doi: 10.1007/s12149-019-01416-y. Epub 2019 Nov 14.
• [4365] The role of NRAGE subcellular location and epithelial-mesenchymal transition on radiation resistance of esophageal carcinoma cell.J Cancer Res Ther. 2018 Jan;14(1):46-51. doi: 10.4103/jcrt.JCRT_687_17.
• [4366] Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer-Amplified Ubiquitin Ligase.Mol Cell. 2018 Jan 4;69(1):113-125.e6. doi: 10.1016/j.molcel.2017.11.010. Epub 2017 Dec 7.
• [4367] Apoptosis-related protein-1 acts as a tumor suppressor in cholangiocarcinoma cells by inducing cell cycle arrest via downregulation of cyclin-dependent kinase subunits.Oncol Rep. 2016 Feb;35(2):809-16. doi: 10.3892/or.2015.4422. Epub 2015 Nov 16.
• [4368] TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/-Catenin Signaling.Cancer Res. 2019 Jul 1;79(13):3332-3346. doi: 10.1158/0008-5472.CAN-18-2986. Epub 2019 Apr 24.
• [4369] MAGI3 negatively regulates Wnt/-catenin signaling and suppresses malignant phenotypes of glioma cells.Oncotarget. 2015 Nov 3;6(34):35851-65. doi: 10.18632/oncotarget.5323.
• [4370] Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commission.Regul Toxicol Pharmacol. 2019 Nov;108:104444. doi: 10.1016/j.yrtph.2019.104444. Epub 2019 Aug 18.
• [4371] Multiple functions of HuR in urinary tumors.J Cancer Res Clin Oncol. 2019 Jan;145(1):11-18. doi: 10.1007/s00432-018-2778-2. Epub 2018 Oct 28.
• [4372] Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6496-505. doi: 10.1073/pnas.1519556112. Epub 2015 Nov 11.
• [4373] Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis.Ann Diagn Pathol. 2017 Apr;27:79-82. doi: 10.1016/j.anndiagpath.2017.01.010. Epub 2017 Feb 1.
• [4374] Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.Br J Cancer. 2019 Nov;121(11):944-953. doi: 10.1038/s41416-019-0607-2. Epub 2019 Oct 29.
• [4375] -1,2-Mannosidase MAN1C1 Inhibits Proliferation and Invasion of Clear Cell Renal Cell Carcinoma.J Cancer. 2018 Nov 24;9(24):4618-4626. doi: 10.7150/jca.27673. eCollection 2018.
• [4376] Tumor autophagy is associated with survival outcomes in patients with resected non-small cell lung cancer.Lung Cancer. 2019 Mar;129:85-91. doi: 10.1016/j.lungcan.2019.01.001. Epub 2019 Jan 8.
• [4377] MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer.Cancer Res. 2014 Jan 1;74(1):162-72. doi: 10.1158/0008-5472.CAN-13-1310. Epub 2013 Nov 14.
• [4378] Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma.Cell Signal. 2018 Nov;51:222-232. doi: 10.1016/j.cellsig.2018.08.008. Epub 2018 Aug 11.
• [4379] Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma.JAMA Ophthalmol. 2017 Nov 1;135(11):1221-1230. doi: 10.1001/jamaophthalmol.2017.4097.
• [4380] Regulation of human mitogen-activated protein kinase 15 (extracellular signal-regulated kinase 7/8) and its functions: A recent update.J Cell Physiol. 2018 Jan;234(1):75-88. doi: 10.1002/jcp.27053. Epub 2018 Aug 2.
• [4381] MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.J Clin Invest. 2019 Mar 1;129(3):1015-1029. doi: 10.1172/JCI97712. Epub 2019 Jan 28.
• [4382] Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non-Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab.Clin Cancer Res. 2018 Aug 15;24(16):3857-3866. doi: 10.1158/1078-0432.CCR-17-3451. Epub 2018 May 1.
• [4383] MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K-AKT--catenin pathways.J Cell Mol Med. 2019 May;23(5):3386-3401. doi: 10.1111/jcmm.14235. Epub 2019 Feb 22.
• [4384] Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer.Oncologist. 2016 Aug;21(8):974-80. doi: 10.1634/theoncologist.2016-0101. Epub 2016 Jun 21.
• [4385] Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11).Oncotarget. 2016 Feb 23;7(8):8756-70. doi: 10.18632/oncotarget.6752.
• [4386] MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.Cell Physiol Biochem. 2018;50(1):92-107. doi: 10.1159/000493961. Epub 2018 Oct 2.
• [4387] Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma.Exp Cell Res. 2019 Oct 15;383(2):111542. doi: 10.1016/j.yexcr.2019.111542. Epub 2019 Aug 2.
• [4388] Local alignment vectors reveal cancer cell-induced ECM fiber remodeling dynamics.Sci Rep. 2017 Jan 3;7:39498. doi: 10.1038/srep39498.
• [4389] MARVELD1 attenuates arsenic trioxide-induced apoptosis in liver cancer cells by inhibiting reactive oxygen species production. Ann Transl Med. 2019 May;7(9):200. doi: 10.21037/atm.2019.04.38.
• [4390] A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes.PLoS One. 2013 May 22;8(5):e64873. doi: 10.1371/journal.pone.0064873. Print 2013.
• [4391] pH-triggered degradable polymeric micelles for targeted anti-tumor drug delivery.Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:912-922. doi: 10.1016/j.msec.2017.04.137. Epub 2017 Apr 25.
• [4392] Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, suppresses the growth and invasion of human oral squamous cell carcinoma cells via the NF-B pathway.J Biochem Mol Toxicol. 2017 Sep;31(9). doi: 10.1002/jbt.21934. Epub 2017 May 26.
• [4393] Myoglobin induces mitochondrial fusion, thereby inhibiting breast cancer cell proliferation.J Biol Chem. 2019 May 3;294(18):7269-7282. doi: 10.1074/jbc.RA118.006673. Epub 2019 Mar 14.
• [4394] Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin.Curr Mol Med. 2013 Mar;13(3):387-400.
• [4395] The Expression of MBD6 Is Associated with Tumor Size in Uterine Leiomyomas.Genet Test Mol Biomarkers. 2019 Aug;23(8):523-532. doi: 10.1089/gtmb.2019.0070. Epub 2019 Jul 16.
• [4396] Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma.Int J Cancer. 2014 Mar 1;134(5):1112-22. doi: 10.1002/ijc.28440. Epub 2013 Sep 4.
• [4397] Conjugation of DM1 to anti-CD30 antibody has potential antitumor activity in CD30-positive hematological malignancies with lower systemic toxicity.MAbs. 2019 Aug/Sep;11(6):1149-1161. doi: 10.1080/19420862.2019.1618674. Epub 2019 Jun 4.
• [4398] Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer.J Cancer Res Clin Oncol. 2019 Sep;145(9):2383-2396. doi: 10.1007/s00432-019-02974-4. Epub 2019 Jul 6.
• [4399] GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.Cancer Sci. 2016 Apr;107(4):469-77. doi: 10.1111/cas.12883. Epub 2016 Feb 9.
• [4400] Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis.PLoS One. 2013 Jul 17;8(7):e69607. doi: 10.1371/journal.pone.0069607. Print 2013.
• [4401] Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib.Cancer Sci. 2019 Mar;110(3):1044-1053. doi: 10.1111/cas.13941. Epub 2019 Feb 14.
• [4402] Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression.Oncotarget. 2016 Jul 12;7(28):43654-43668. doi: 10.18632/oncotarget.9661.
• [4403] Expression of 58-kD Microspherule Protein (MSP58) is Highly Correlated with PET Imaging of Tumor Malignancy and Cell Proliferation in Glioma Patients.Cell Physiol Biochem. 2016;38(2):635-45. doi: 10.1159/000438656. Epub 2016 Feb 8.
• [4404] I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functions.Virology. 2015 Dec;486:219-27. doi: 10.1016/j.virol.2015.09.020. Epub 2015 Oct 27.
• [4405] Cytosolic malate dehydrogenase activity helps support glycolysis in actively proliferating cells and cancer.Oncogene. 2017 Jul 6;36(27):3915-3924. doi: 10.1038/onc.2017.36. Epub 2017 Mar 6.
• [4406] Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene. J Natl Cancer Inst. 2015 Mar 11;107(5):djv053. doi: 10.1093/jnci/djv053.
• [4407] Expression and prognostic roles of magnesium-dependent phosphatase-1 in gastric cancer.Eur Rev Med Pharmacol Sci. 2017 Jun;21(11):2617-2625.
• [4408] Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.Oncotarget. 2017 Jun 20;8(25):40434-40453. doi: 10.18632/oncotarget.17107.
• [4409] Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation.Cell Death Dis. 2019 Sep 18;10(10):694. doi: 10.1038/s41419-019-1940-3.
• [4410] Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.Cancer Lett. 2019 Mar 1;444:105-115. doi: 10.1016/j.canlet.2018.12.008. Epub 2018 Dec 21.
• [4411] Clinical significance of microRNAs in chronic and acute human leukemia.Mol Cancer. 2016 May 14;15(1):37. doi: 10.1186/s12943-016-0518-2.
• [4412] Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.Mol Carcinog. 2014 Oct;53(10):833-40. doi: 10.1002/mc.22041. Epub 2013 Apr 27.
• [4413] Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model.Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:32-38. doi: 10.1016/j.msec.2017.03.292. Epub 2017 Apr 6.
• [4414] MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer.Int J Cancer. 2011 Dec 1;129(11):2553-65. doi: 10.1002/ijc.25924. Epub 2011 Mar 25.
• [4415] The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer.Anticancer Res. 2017 Dec;37(12):6685-6695. doi: 10.21873/anticanres.12127.
• [4416] Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.Br J Cancer. 2018 Apr;118(8):1142-1151. doi: 10.1038/s41416-018-0041-x. Epub 2018 Mar 28.
• [4417] Overexpression of MEF2D contributes to oncogenic malignancy and chemotherapeutic resistance in ovarian carcinoma.Am J Cancer Res. 2019 May 1;9(5):887-905. eCollection 2019.
• [4418] Transcriptome profiling of caspase-2 deficient EMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling.Cell Death Dis. 2019 Jan 22;10(2):56. doi: 10.1038/s41419-018-1296-0.
• [4419] Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.Am J Transl Res. 2018 Nov 15;10(11):3567-3578. eCollection 2018.
• [4420] MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.Clin Cancer Res. 2018 Aug 1;24(15):3668-3680. doi: 10.1158/1078-0432.CCR-17-3673. Epub 2018 May 1.
• [4421] Aberrant expression of embryonic mesendoderm factor MESP1 promotes tumorigenesis.EBioMedicine. 2019 Dec;50:55-66. doi: 10.1016/j.ebiom.2019.11.012. Epub 2019 Nov 21.
• [4422] ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/-catenin signalling pathway.Cell Death Dis. 2019 Feb 20;10(3):169. doi: 10.1038/s41419-019-1335-5.
• [4423] METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN.J Mol Med (Berl). 2019 Nov;97(11):1535-1545. doi: 10.1007/s00109-019-01830-9. Epub 2019 Aug 28.
• [4424] N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.Gene. 2020 Jan 5;722:144076. doi: 10.1016/j.gene.2019.144076. Epub 2019 Aug 24.
• [4425] The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.Med Sci Monit. 2019 Dec 11;25:9435-9445. doi: 10.12659/MSM.920381.
• [4426] Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma.Virchows Arch. 2020 Mar;476(3):383-390. doi: 10.1007/s00428-019-02649-y. Epub 2019 Aug 18.
• [4427] Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.Pathol Oncol Res. 2018 Jul;24(3):617-622. doi: 10.1007/s12253-017-0287-2. Epub 2017 Aug 12.
• [4428] Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.Oncogene. 2019 Mar;38(11):1876-1891. doi: 10.1038/s41388-018-0531-6. Epub 2018 Nov 1.
• [4429] Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer-specific molecule.Cancer Sci. 2019 Feb;110(2):761-770. doi: 10.1111/cas.13907. Epub 2019 Jan 4.
• [4430] Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.Oncotarget. 2016 Mar 22;7(12):13667-79. doi: 10.18632/oncotarget.7269.
• [4431] Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.J Biol Chem. 2014 Nov 7;289(45):31534-49. doi: 10.1074/jbc.M114.602680. Epub 2014 Oct 1.
• [4432] Microneedle-Based Generation of Microbubbles in Cancer Tumors to Improve Ultrasound-Assisted Drug Delivery.Adv Healthc Mater. 2019 Sep;8(17):e1900613. doi: 10.1002/adhm.201900613. Epub 2019 Jul 22.
• [4433] Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells.Cancers (Basel). 2019 Jan 14;11(1):85. doi: 10.3390/cancers11010085.
• [4434] Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca(2+) levels and tumor growth.EMBO J. 2019 Jan 15;38(2):e99435. doi: 10.15252/embj.201899435. Epub 2018 Nov 30.
• [4435] Genetic ablation of TAZ induces HepG2 liver cancer cell apoptosis through activating the CaMKII/MIEF1 signaling pathway.Onco Targets Ther. 2019 Mar 1;12:1765-1779. doi: 10.2147/OTT.S196142. eCollection 2019.
• [4436] MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition.Sci Rep. 2017 Sep 8;7(1):11000. doi: 10.1038/s41598-017-11374-y.
• [4437] MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability.Oncogene. 2015 Jan 8;34(2):237-45. doi: 10.1038/onc.2013.536. Epub 2013 Dec 16.
• [4438] MIIP inhibits the growth of prostate cancer via interaction with PP1 and negative modulation of AKT signaling.Cell Commun Signal. 2019 May 15;17(1):44. doi: 10.1186/s12964-019-0355-1.
• [4439] Association of aquaporin? with tumor migration, invasion and vasculogenic mimicry in glioblastoma multiforme.Mol Med Rep. 2018 Feb;17(2):3206-3211. doi: 10.3892/mmr.2017.8265. Epub 2017 Dec 12.
• [4440] Chemical Antibody Mimics Inhibit Cadherin-Mediated Cell-Cell Adhesion: A Promising Strategy for Cancer Therapy.Angew Chem Int Ed Engl. 2020 Feb 10;59(7):2816-2822. doi: 10.1002/anie.201910373. Epub 2019 Nov 27.
• [4441] Eribulin Suppresses Clear Cell Sarcoma Growth by Inhibiting Cell Proliferation and Inducing Melanocytic Differentiation Both Directly and Via Vascular Remodeling.Mol Cancer Ther. 2020 Mar;19(3):742-754. doi: 10.1158/1535-7163.MCT-19-0358. Epub 2019 Dec 3.
• [4442] Evaluating a potential technique with local optical flow vectors for automatic organ-at-risk (OAR) intrusion detection and avoidance during radiotherapy.Phys Med Biol. 2019 Jul 16;64(14):145008. doi: 10.1088/1361-6560/ab2db4.
• [4443] Antiproliferative activity of ((6)-arene)ruthenacarborane sandwich complexes against HCT116 and MCF7 cell lines.Dalton Trans. 2017 Sep 28;46(36):12067-12080. doi: 10.1039/c7dt02027a. Epub 2017 Aug 11.
• [4444] Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes.Nat Commun. 2018 Aug 24;9(1):3417. doi: 10.1038/s41467-018-05979-8.
• [4445] The Interaction of TXNIP and AFq1 Genes Increases the Susceptibility of Schizophrenia.Mol Neurobiol. 2017 Aug;54(6):4806-4812. doi: 10.1007/s12035-016-9954-7. Epub 2016 Aug 10.
• [4446] Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.Oncologist. 2019 Dec;24(12):e1388-e1400. doi: 10.1634/theoncologist.2019-0063. Epub 2019 Jul 4.
• [4447] Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine.Inflamm Bowel Dis. 2008 May;14(5):612-9. doi: 10.1002/ibd.20364.
• [4448] Putative Prostate Cancer Risk SNP in an Androgen Receptor-Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites.Hum Mutat. 2016 Jan;37(1):52-64. doi: 10.1002/humu.22909. Epub 2015 Oct 19.
• [4449] Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth In Vivo.Cancer Res. 2019 Jul 1;79(13):3178-3184. doi: 10.1158/0008-5472.CAN-18-3658. Epub 2019 May 13.
• [4450] Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer.Biochem Biophys Res Commun. 2014 Jul 18;450(1):844-50. doi: 10.1016/j.bbrc.2014.06.075. Epub 2014 Jun 24.
• [4451] Matrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.Am J Respir Crit Care Med. 2014 Oct 1;190(7):780-90. doi: 10.1164/rccm.201310-1903OC.
• [4452] Expression Pattern of Matrix Metalloproteinase 20 (MMP20) in Human Tumors.Anticancer Res. 2016 Jun;36(6):2713-8.
• [4453] Non-small cell lung cancer invasion and metastasis promoted by MMP-26.Mol Med Rep. 2011 Nov-Dec;4(6):1201-9. doi: 10.3892/mmr.2011.540. Epub 2011 Jul 26.
• [4454] Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable Prognosis.Int J Biol Sci. 2019 Feb 19;15(4):812-825. doi: 10.7150/ijbs.31335. eCollection 2019.
• [4455] Matrigel Plug Assay for In Vivo Evaluation of Angiogenesis.Methods Mol Biol. 2019;1952:219-232. doi: 10.1007/978-1-4939-9133-4_18.
• [4456] Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers.J Immunother Cancer. 2019 Oct 17;7(1):264. doi: 10.1186/s40425-019-0737-3.
• [4457] MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance.J Exp Clin Cancer Res. 2018 Nov 26;37(1):284. doi: 10.1186/s13046-018-0956-3.
• [4458] Cytotoxicity profiling of deep eutectic solvents to human skin cells.Sci Rep. 2019 Mar 8;9(1):3932. doi: 10.1038/s41598-019-39910-y.
• [4459] Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.Nat Commun. 2017 Sep 25;8(1):695. doi: 10.1038/s41467-017-00795-y.
• [4460] Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.J Clin Invest. 2012 Dec;122(12):4505-18. doi: 10.1172/JCI63735. Epub 2012 Nov 12.
• [4461] Identification and characterization of a novel human hepatocellular carcinoma-associated gene.Br J Cancer. 2001 Oct 19;85(8):1162-7. doi: 10.1054/bjoc.2001.2059.
• [4462] A Designed Peptide Targets Two Types of Modifications of p53 with Anti-cancer Activity.Cell Chem Biol. 2018 Jun 21;25(6):761-774.e5. doi: 10.1016/j.chembiol.2018.03.010. Epub 2018 Apr 19.
• [4463] Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.J Neurosurg. 2018 Mar 16;130(1):56-66. doi: 10.3171/2017.9.JNS172036.
• [4464] MPDZ promotes DLL4-induced Notch signaling during angiogenesis.Elife. 2018 Apr 5;7:e32860. doi: 10.7554/eLife.32860.
• [4465] Metallopanstimulin-1 (MPS-1) mediates the promotion effect of leptin on colorectal cancer through activation of JNK/c-Jun signaling pathway.Cell Death Dis. 2019 Sep 10;10(9):655. doi: 10.1038/s41419-019-1911-8.
• [4466] A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management.Sci Transl Med. 2018 Mar 7;10(431):eaan8840. doi: 10.1126/scitranslmed.aan8840.
• [4467] Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.Cancer Gene Ther. 2006 Jul;13(7):706-19. doi: 10.1038/sj.cgt.7700945. Epub 2006 Mar 3.
• [4468] Baseline clinical and imaging predictors of treatment response and overall survival of patients with metastatic melanoma undergoing immunotherapy.Eur J Radiol. 2019 Dec;121:108688. doi: 10.1016/j.ejrad.2019.108688. Epub 2019 Oct 22.
• [4469] MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.Cancer Biol Ther. 2019;20(6):897-911. doi: 10.1080/15384047.2019.1579960. Epub 2019 Mar 12.
• [4470] MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.Cancer Biomark. 2012;11(2-3):99-106. doi: 10.3233/CBM-2012-0264.
• [4471] Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.J Immunother Cancer. 2019 Apr 8;7(1):100. doi: 10.1186/s40425-019-0565-5.
• [4472] Membrane-bound versus soluble major histocompatibility complex Class I-related chain A and major histocompatibility complex Class I-related chain B differential expression: Mechanisms of tumor eradication versus evasion and current drug development strategies.J Cancer Res Ther. 2016 Oct-Dec;12(4):1224-1233. doi: 10.4103/0973-1482.176169.
• [4473] Expression and clinical contribution of MRGD mRNA in non-small cell lung cancers.J BUON. 2015 Jul-Aug;20(4):1101-6.
• [4474] Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.J Biol Chem. 2017 Dec 8;292(49):20208-20217. doi: 10.1074/jbc.M117.809012. Epub 2017 Oct 4.
• [4475] The oncogenic effects of p53-inducible gene 3 (PIG3) in colon cancer cells.Korean J Physiol Pharmacol. 2017 Mar;21(2):267-273. doi: 10.4196/kjpp.2017.21.2.267. Epub 2017 Feb 21.
• [4476] High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomes.Tumour Biol. 2017 Jul;39(7):1010428317709127. doi: 10.1177/1010428317709127.
• [4477] EVI1 promotes tumor growth via transcriptional repression of MS4A3.J Hematol Oncol. 2015 Mar 21;8:28. doi: 10.1186/s13045-015-0124-6.
• [4478] Human colorectal cancer derived-MSCs promote tumor cells escape from senescence via P53/P21 pathway.Clin Transl Oncol. 2020 Apr;22(4):503-511. doi: 10.1007/s12094-019-02152-5. Epub 2019 Jun 19.
• [4479] Msx1 loss suppresses formation of the ectopic crypts developed in the Apc-deficient small intestinal epithelium.Sci Rep. 2019 Feb 7;9(1):1629. doi: 10.1038/s41598-018-38310-y.
• [4480] MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma.Front Oncol. 2019 Aug 27;9:816. doi: 10.3389/fonc.2019.00816. eCollection 2019.
• [4481] Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.Cancer Discov. 2018 Nov;8(11):1376-1389. doi: 10.1158/2159-8290.CD-17-0841. Epub 2018 Aug 16.
• [4482] MTFP1 overexpression promotes the growth of oral squamous cell carcinoma by inducing ROS production.Cell Biol Int. 2020 Mar;44(3):821-829. doi: 10.1002/cbin.11278. Epub 2019 Dec 19.
• [4483] The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma.Scand J Gastroenterol. 2018 May;53(5):533-540. doi: 10.1080/00365521.2017.1407440. Epub 2017 Nov 24.
• [4484] Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer.Oncotarget. 2016 Aug 2;7(31):50490-50506. doi: 10.18632/oncotarget.10466.
• [4485] Circ-MTO1 correlates with favorable prognosis and inhibits cell proliferation, invasion as well as miR-17-5p expression in prostate cancer.J Clin Lab Anal. 2020 Mar;34(3):e23086. doi: 10.1002/jcla.23086. Epub 2019 Nov 11.
• [4486] MTSS1 hypermethylation is associated with prostate cancer progression.J Cell Physiol. 2020 Mar;235(3):2687-2697. doi: 10.1002/jcp.29172. Epub 2019 Sep 20.
• [4487] Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer.Breast Cancer Res Treat. 2020 Jan;179(2):267-273. doi: 10.1007/s10549-019-05463-x. Epub 2019 Oct 12.
• [4488] Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer.Int J Oncol. 2016 Jul;49(1):294-304. doi: 10.3892/ijo.2016.3528. Epub 2016 May 17.
• [4489] Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.Oncogene. 2018 Nov;37(46):6041-6053. doi: 10.1038/s41388-018-0403-0. Epub 2018 Jul 11.
• [4490] Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas.PLoS One. 2019 Apr 11;14(4):e0215237. doi: 10.1371/journal.pone.0215237. eCollection 2019.
• [4491] Current and future roles of mucins in cholangiocarcinoma-recent evidences for a possible interplay with bile acids.Ann Transl Med. 2018 Sep;6(17):333. doi: 10.21037/atm.2018.07.16.
• [4492] Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer.Clin Exp Metastasis. 2010 Apr;27(4):251-9. doi: 10.1007/s10585-010-9323-2. Epub 2010 Apr 3.
• [4493] Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer.Oncol Rep. 2018 Apr;39(4):1747-1756. doi: 10.3892/or.2018.6229. Epub 2018 Jan 22.
• [4494] The MicroRNA-382-5p/MXD1 Axis Relates to Breast Cancer Progression and Promotes Cell Malignant Phenotypes.J Surg Res. 2020 Feb;246:442-449. doi: 10.1016/j.jss.2019.09.018. Epub 2019 Oct 18.
• [4495] Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma.Genes Chromosomes Cancer. 2018 Nov;57(11):557-563. doi: 10.1002/gcc.22668.
• [4496] Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer.Cancers (Basel). 2019 Feb 18;11(2):235. doi: 10.3390/cancers11020235.
• [4497] Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients.Onco Targets Ther. 2019 Feb 11;12:1129-1135. doi: 10.2147/OTT.S188820. eCollection 2019.
• [4498] Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.J Cancer Res Clin Oncol. 2018 Oct;144(10):1945-1957. doi: 10.1007/s00432-018-2720-7. Epub 2018 Aug 6.
• [4499] Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias.Gastroenterology. 2010 Nov;139(5):1519-25. doi: 10.1053/j.gastro.2010.08.001. Epub 2010 Aug 11.
• [4500] Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells in vitro and in vivo.Front Pharmacol. 2018 Sep 18;9:1045. doi: 10.3389/fphar.2018.01045. eCollection 2018.
• [4501] Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma.Elife. 2017 Jan 12;6:e19214. doi: 10.7554/eLife.19214.
• [4502] Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures.Oncotarget. 2019 Oct 22;10(58):6168-6183. doi: 10.18632/oncotarget.27249. eCollection 2019 Oct 22.
• [4503] Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma.PLoS One. 2017 Apr 7;12(4):e0175280. doi: 10.1371/journal.pone.0175280. eCollection 2017.
• [4504] Cholesterol uptake and regulation in high-grade and lethal prostate cancers.Carcinogenesis. 2017 Aug 1;38(8):806-811. doi: 10.1093/carcin/bgx058.
• [4505] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.Diagn Pathol. 2018 Nov 3;13(1):85. doi: 10.1186/s13000-018-0763-3.
• [4506] Brush border myosin Ia inactivation in gastric but not endometrial tumors.Int J Cancer. 2013 Apr 15;132(8):1790-9. doi: 10.1002/ijc.27856. Epub 2012 Oct 20.
• [4507] Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.Gynecol Oncol. 2018 Apr;149(1):188-197. doi: 10.1016/j.ygyno.2018.01.024. Epub 2018 Feb 1.
• [4508] Selective expression of myosin IC Isoform A in mouse and human cell lines and mouse prostate cancer tissues.PLoS One. 2014 Sep 26;9(9):e108609. doi: 10.1371/journal.pone.0108609. eCollection 2014.
• [4509] Plasma Membrane Localization of Apoptotic Caspases for Non-apoptotic Functions.Dev Cell. 2018 May 21;45(4):450-464.e3. doi: 10.1016/j.devcel.2018.04.020.
• [4510] Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation.PLoS Biol. 2019 Nov 4;17(11):e3000531. doi: 10.1371/journal.pbio.3000531. eCollection 2019 Nov.
• [4511] Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.Mod Pathol. 2018 May;31(5):816-828. doi: 10.1038/modpathol.2017.185. Epub 2018 Jan 12.
• [4512] Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum.Am J Surg Pathol. 2019 Jun;43(6):747-754. doi: 10.1097/PAS.0000000000001238.
• [4513] The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses.Oncogene. 2018 Nov;37(48):6275-6284. doi: 10.1038/s41388-018-0398-6. Epub 2018 Jul 17.
• [4514] Unsupervised Segmentation of 5D Hyperpolarized Carbon-13 MRI Data Using a Fuzzy Markov Random Field Model.IEEE Trans Med Imaging. 2018 Apr;37(4):840-850. doi: 10.1109/TMI.2017.2737232. Epub 2017 Sep 4.
• [4515] Mysm1 epigenetically regulates the immunomodulatory function of adipose-derived stem cells in part by targeting miR-150.J Cell Mol Med. 2019 May;23(5):3737-3746. doi: 10.1111/jcmm.14281. Epub 2019 Mar 20.
• [4516] The crucial role of DNA-dependent protein kinase and myelin transcription factor 1-like protein in the miR-141 tumor suppressor network.Cell Cycle. 2019 Nov;18(21):2876-2892. doi: 10.1080/15384101.2019.1652033. Epub 2019 Sep 16.
• [4517] Inverse correlation between Naa10p and Pirh2 expression and the combined prognostic value in oral squamous cell carcinoma patients.J Oral Pathol Med. 2019 Sep;48(8):686-695. doi: 10.1111/jop.12886. Epub 2019 Jun 9.
• [4518] Design, synthesis and invitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC(1)-Receptors concomitantly overexpressed on various malignancies - Is the concept feasible?.Eur J Med Chem. 2018 Jul 15;155:84-95. doi: 10.1016/j.ejmech.2018.05.047. Epub 2018 May 29.
• [4519] NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression.Cell Death Dis. 2019 Mar 11;10(3):236. doi: 10.1038/s41419-019-1487-3.
• [4520] Crystal structure of the LUFS domain of human single-stranded DNA binding Protein 2 (SSBP2).Protein Sci. 2019 Apr;28(4):788-793. doi: 10.1002/pro.3581. Epub 2019 Feb 12.
• [4521] Overexpression of nuclear apoptosis-inducing factor 1 altered the proteomic profile of human gastric cancer cell MKN45 and induced cell cycle arrest at G1/S phase.PLoS One. 2014 Jun 13;9(6):e100216. doi: 10.1371/journal.pone.0100216. eCollection 2014.
• [4522] Downregulation of microRNA-1 and microRNA-145 contributes synergistically to the development of colon cancer.Int J Mol Med. 2015 Dec;36(6):1630-8. doi: 10.3892/ijmm.2015.2364. Epub 2015 Oct 9.
• [4523] NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells.Adv Exp Med Biol. 2018;1032:105-113. doi: 10.1007/978-3-319-98788-0_8.
• [4524] Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).Anticancer Res. 2000 Jan-Feb;20(1A):305-10.
• [4525] TMEM207 hinders the tumour suppressor function of WWOX in oral squamous cell carcinoma.J Cell Mol Med. 2018 Feb;22(2):1026-1033. doi: 10.1111/jcmm.13456. Epub 2017 Nov 22.
• [4526] An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model.Cancer Immunol Res. 2019 Feb;7(2):219-229. doi: 10.1158/2326-6066.CIR-18-0317. Epub 2018 Dec 4.
• [4527] N-Acetylaspartate Metabolism Outside the Brain: Lipogenesis, Histone Acetylation, and Cancer.Front Endocrinol (Lausanne). 2017 Sep 20;8:240. doi: 10.3389/fendo.2017.00240. eCollection 2017.
• [4528] Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.Genes Chromosomes Cancer. 2013 Feb;52(2):191-201. doi: 10.1002/gcc.22019. Epub 2012 Oct 25.
• [4529] AIBP and APOA-I synergistically inhibit intestinal tumor growth and metastasis by promoting cholesterol efflux.J Transl Med. 2019 May 17;17(1):161. doi: 10.1186/s12967-019-1910-7.
• [4530] Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma.Exp Hematol. 2009 Feb;37(2):234-44. doi: 10.1016/j.exphem.2008.10.014.
• [4531] Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect.Oncotarget. 2016 Jun 7;7(23):33855-65. doi: 10.18632/oncotarget.8944.
• [4532] Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12.
• [4533] Effects of neuroblastoma breakpoint family member 1 (NBPF1) gene on growth and Akt-p53-Cyclin D pathway in cutaneous squamous carcinoma cells.Neoplasma. 2019 Jul 23;66(4):584-592. doi: 10.4149/neo_2018_181123N888. Epub 2019 Apr 24.
• [4534] hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature.Am J Surg Pathol. 2008 Feb;32(2):205-9. doi: 10.1097/PAS.0b013e318124a865.
• [4535] Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.Oncol Res. 2018 Mar 5;26(2):269-276. doi: 10.3727/096504017X15075967560980. Epub 2017 Oct 18.
• [4536] NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-B/miR-188-3p pathways.EBioMedicine. 2019 Jun;44:237-249. doi: 10.1016/j.ebiom.2019.05.053. Epub 2019 Jun 5.
• [4537] Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer.Int J Biol Markers. 2018 Jan;33(1):124-131. doi: 10.5301/ijbm.5000264.
• [4538] SPIN90 Depletion and Microtubule Acetylation Mediate Stromal Fibroblast Activation in Breast Cancer Progression.Cancer Res. 2017 Sep 1;77(17):4710-4722. doi: 10.1158/0008-5472.CAN-17-0657. Epub 2017 Jun 26.
• [4539] Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A Morphologic and Molecular Study of 26 Cases Confirms Recurrent NCOA1-3 Rearrangement.Am J Surg Pathol. 2020 Jan;44(1):30-42. doi: 10.1097/PAS.0000000000001348.
• [4540] Low expression of NCOA5 predicts poor prognosis in human cervical cancer and promotes proliferation, migration, and invasion of cervical cancer cell lines by regulating notch3 signaling pathway.J Cell Biochem. 2019 Apr;120(4):6237-6249. doi: 10.1002/jcb.27911. Epub 2018 Oct 18.
• [4541] Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.Oncotarget. 2015 Sep 8;6(26):22724-33. doi: 10.18632/oncotarget.4261.
• [4542] Abnormally localized DLK1 interacts with NCOR1 in non-small cell lung cancer cell nuclear.Biosci Rep. 2019 Dec 20;39(12):BSR20192362. doi: 10.1042/BSR20192362.
• [4543] GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy.Front Immunol. 2019 Oct 10;10:2361. doi: 10.3389/fimmu.2019.02361. eCollection 2019.
• [4544] Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma.Hepatology. 2019 Mar;69(3):1165-1179. doi: 10.1002/hep.30235. Epub 2019 Feb 14.
• [4545] The integrated stress response promotes B7H6 expression.J Mol Med (Berl). 2020 Jan;98(1):135-148. doi: 10.1007/s00109-019-01859-w. Epub 2019 Dec 14.
• [4546] Complete sequence of the ATP6 and ND3 mitochondrial genes in breast cancer tissue of postmenopausal women with different body mass indexes.Ann Diagn Pathol. 2018 Feb;32:23-27. doi: 10.1016/j.anndiagpath.2017.09.001. Epub 2017 Sep 10.
• [4547] miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line.Biochem Biophys Res Commun. 2018 Sep 3;503(1):323-329. doi: 10.1016/j.bbrc.2018.06.023. Epub 2018 Jun 14.
• [4548] HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma. Lab Invest. 2011 Jan;91(1):124-37. doi: 10.1038/labinvest.2010.136. Epub 2010 Jul 26.
• [4549] NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma.Biosci Rep. 2018 Dec 7;38(6):BSR20180907. doi: 10.1042/BSR20180907. Print 2018 Dec 21.
• [4550] NDRG4 in gastric cancer determines tumor cell proliferation and clinical outcome.Mol Carcinog. 2018 Jun;57(6):762-771. doi: 10.1002/mc.22798. Epub 2018 Mar 24.
• [4551] Specifically Increased Paclitaxel Release in Tumor and Synergetic Therapy by a Hyaluronic Acid-Tocopherol Nanomicelle.ACS Appl Mater Interfaces. 2017 Jun 21;9(24):20385-20398. doi: 10.1021/acsami.7b02606. Epub 2017 Jun 6.
• [4552] Alteration of colonic epithelial cell differentiation in mice deficient for glucosaminyl N-deacetylase/N-sulfotransferase 4.Oncotarget. 2016 Dec 20;7(51):84938-84950. doi: 10.18632/oncotarget.12915.
• [4553] Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.ANZ J Surg. 2017 Dec;87(12):E251-E255. doi: 10.1111/ans.13617. Epub 2016 May 25.
• [4554] Peptides as Potential Anticancer Agents.Curr Top Med Chem. 2019;19(17):1491-1511. doi: 10.2174/1568026619666190125161517.
• [4555] Downregulation of NDUFB6 due to 9p24.1-p13.3 loss is implicated in metastatic clear cell renal cell carcinoma.Cancer Med. 2015 Jan;4(1):112-24. doi: 10.1002/cam4.351. Epub 2014 Oct 15.
• [4556] The opposite prognostic effect of NDUFS1 and NDUFS8 in lung cancer reflects the oncojanus role of mitochondrial complex I.Sci Rep. 2016 Aug 12;6:31357. doi: 10.1038/srep31357.
• [4557] Nectin-2 in ovarian cancer: How is it expressed and what might be its functional role?.Cancer Sci. 2019 Jun;110(6):1872-1882. doi: 10.1111/cas.13992. Epub 2019 May 2.
• [4558] Decreased expression of NEDD4L contributes to NSCLC progression and metastasis.Biochem Biophys Res Commun. 2019 May 28;513(2):398-404. doi: 10.1016/j.bbrc.2019.04.001. Epub 2019 Apr 6.
• [4559] Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.Gastroenterology. 2013 Dec;145(6):1424-35.e1-25. doi: 10.1053/j.gastro.2013.08.055. Epub 2013 Sep 5.
• [4560] A newly synthesized oleanolic acid derivative inhibits the growth of osteosarcoma cells in vitro and in vivo by decreasing c-MYC-dependent glycolysis.J Cell Biochem. 2019 Jun;120(6):9264-9276. doi: 10.1002/jcb.28202. Epub 2018 Dec 14.
• [4561] The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates.Clin Cancer Res. 2005 Aug 15;11(16):5764-8. doi: 10.1158/1078-0432.CCR-04-2388.
• [4562] Polymorphisms in NEIL-2, APE-1, CYP2E1 and MDM2 Genes are Independent Predictors of Gastric Cancer Risk in a Northern Jiangsu Population (China).J Nanosci Nanotechnol. 2015 Jul;15(7):4815-28. doi: 10.1166/jnn.2015.10028.
• [4563] Transcriptome and cytogenetic profiling analysis of matched in situ/invasive cutaneous squamous cell carcinomas from immunocompetent patients.Genes Chromosomes Cancer. 2019 Mar;58(3):164-174. doi: 10.1002/gcc.22712. Epub 2019 Jan 7.
• [4564] Overexpression of NELFCD promotes colorectal cancer cells proliferation, migration, and invasion.Onco Targets Ther. 2018 Dec 5;11:8741-8750. doi: 10.2147/OTT.S186266. eCollection 2018.
• [4565] NRP-2 in tumor lymphangiogenesis and lymphatic metastasis.Cancer Lett. 2018 Apr 1;418:176-184. doi: 10.1016/j.canlet.2018.01.040. Epub 2018 Jan 12.
• [4566] The tumor suppressor Caliban regulates DNA damage-induced apoptosis through p53-dependent and -independent activity.Oncogene. 2013 Aug 15;32(33):3857-66. doi: 10.1038/onc.2012.395. Epub 2012 Sep 10.
• [4567] Loss of Neogenin1 in human colorectal carcinoma cells causes a partial EMT and wound-healing response.Sci Rep. 2019 Mar 11;9(1):4110. doi: 10.1038/s41598-019-40886-y.
• [4568] Deregulation of sialidases in human normal and tumor tissues.Cancer Biomark. 2018 Feb 14;21(3):591-601. doi: 10.3233/CBM-170548.
• [4569] p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.Int J Cancer. 2018 May 1;142(9):1817-1828. doi: 10.1002/ijc.31209. Epub 2017 Dec 23.
• [4570] Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.Am J Gastroenterol. 2011 Jun;106(6):1110-8. doi: 10.1038/ajg.2011.6. Epub 2011 Feb 15.
• [4571] Islet Cells Serve as Cells of Origin of Pancreatic Gastrin-Positive Endocrine Tumors.Mol Cell Biol. 2015 Oct;35(19):3274-83. doi: 10.1128/MCB.00302-15. Epub 2015 Jul 13.
• [4572] Copy number variation, increased gene expression, and molecular mechanisms of neurofascin in lung cancer.Mol Carcinog. 2017 Sep;56(9):2076-2085. doi: 10.1002/mc.22664. Epub 2017 May 2.
• [4573] Tonicity-responsive enhancer-binding protein promotes hepatocellular carcinogenesis, recurrence and metastasis.Gut. 2019 Feb;68(2):347-358. doi: 10.1136/gutjnl-2017-315348. Epub 2018 Feb 2.
• [4574] Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3.Cell Death Dis. 2019 Jun 3;10(6):430. doi: 10.1038/s41419-019-1658-2.
• [4575] Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer.Oncogene. 2017 May 18;36(20):2835-2845. doi: 10.1038/onc.2016.434. Epub 2016 Nov 28.
• [4576] Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.Blood. 2019 Apr 18;133(16):1766-1777. doi: 10.1182/blood-2018-09-875047. Epub 2019 Feb 12.
• [4577] Nfe2l1-silenced insulinoma cells acquire aggressiveness and chemoresistance.Endocr Relat Cancer. 2018 Mar;25(3):185-200. doi: 10.1530/ERC-17-0458. Epub 2017 Dec 4.
• [4578] Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.J Neurooncol. 2020 Jan;146(1):41-53. doi: 10.1007/s11060-019-03352-3. Epub 2019 Nov 23.
• [4579] YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.Nat Commun. 2019 Sep 2;10(1):3914. doi: 10.1038/s41467-019-11884-5.
• [4580] Cellular prion protein transcriptionally regulated by NFIL3 enhances lung cancer cell lamellipodium formation and migration through JNK signaling.Oncogene. 2020 Jan;39(2):385-398. doi: 10.1038/s41388-019-0994-0. Epub 2019 Sep 2.
• [4581] NF-YA overexpression protects from glutamine deprivation.Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118571. doi: 10.1016/j.bbamcr.2019.118571. Epub 2019 Nov 9.
• [4582] Neuroglobin: A Novel Player in the Oxidative Stress Response of Cancer Cells.Oxid Med Cell Longev. 2019 Jul 1;2019:6315034. doi: 10.1155/2019/6315034. eCollection 2019.
• [4583] Open resection of hypothalamic hamartomas for intractable epilepsy revisited, using intraoperative MRI.Childs Nerv Syst. 2018 Sep;34(9):1663-1673. doi: 10.1007/s00381-018-3786-x. Epub 2018 May 11.
• [4584] Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer.Oncogene. 2019 Aug;38(35):6301-6318. doi: 10.1038/s41388-019-0879-2. Epub 2019 Jul 16.
• [4585] Enhanced expression of nidogen 1 around the nest of basal cell carcinoma compared with that around squamous cell carcinoma.Med Mol Morphol. 2019 Jun;52(2):99-105. doi: 10.1007/s00795-018-0207-x. Epub 2018 Oct 1.
• [4586] Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients.DNA Cell Biol. 2013 Jul;32(7):386-92. doi: 10.1089/dna.2013.2030. Epub 2013 May 19.
• [4587] Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11500-11505. doi: 10.1073/pnas.1711814114. Epub 2017 Oct 9.
• [4588] Centrosomal Nlp is an oncogenic protein that is gene-amplified in human tumors and causes spontaneous tumorigenesis in transgenic mice.J Clin Invest. 2010 Feb;120(2):498-507. doi: 10.1172/JCI39447. Epub 2010 Jan 19.
• [4589] Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway.Onco Targets Ther. 2018 Apr 5;11:1941-1948. doi: 10.2147/OTT.S158655. eCollection 2018.
• [4590] NIT1 suppresses tumour proliferation by activating the TGF1-Smad2/3 signalling pathway in colorectal cancer.Cell Death Dis. 2018 Feb 15;9(3):263. doi: 10.1038/s41419-018-0333-3.
• [4591] Downregulation of NIT2 inhibits colon cancer cell proliferation and induces cell cycle arrest through the caspase-3 and PARP pathways.Int J Mol Med. 2015 May;35(5):1317-22. doi: 10.3892/ijmm.2015.2125. Epub 2015 Mar 4.
• [4592] NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.J Exp Clin Cancer Res. 2019 Jul 6;38(1):291. doi: 10.1186/s13046-019-1281-1.
• [4593] NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.Tumour Biol. 2016 Oct;37(10):14059-14067. doi: 10.1007/s13277-016-5173-0. Epub 2016 Aug 9.
• [4594] Low expression of NKD2 is associated with enhanced cell proliferation and poor prognosis in human hepatocellular carcinoma.Hum Pathol. 2018 Feb;72:80-90. doi: 10.1016/j.humpath.2017.09.016. Epub 2017 Nov 8.
• [4595] NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma.Clin Cancer Res. 2015 Jun 1;21(11):2499-505. doi: 10.1158/1078-0432.CCR-14-2206. Epub 2015 Mar 4.
• [4596] Ectopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications.PLoS One. 2013 Apr 29;8(4):e61447. doi: 10.1371/journal.pone.0061447. Print 2013.
• [4597] NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer.EBioMedicine. 2019 May;43:238-252. doi: 10.1016/j.ebiom.2019.04.041. Epub 2019 Apr 29.
• [4598] Cloning, expression and chromosomal location of NKX6B TO 10Q26, a region frequently deleted in brain tumors.Mamm Genome. 2001 Feb;12(2):157-62. doi: 10.1007/s003350010247.
• [4599] Modulation of Angiopoietin 2 release from endothelial cells and angiogenesis by the synaptic protein Neuroligin 2.Biochem Biophys Res Commun. 2018 Jun 18;501(1):165-171. doi: 10.1016/j.bbrc.2018.04.204. Epub 2018 May 4.
• [4600] Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.Nature. 2017 Sep 28;549(7673):533-537. doi: 10.1038/nature24014. Epub 2017 Sep 20.
• [4601] ATRX driver mutation in a composite malignant pheochromocytoma.Cancer Genet. 2016 Jun;209(6):272-7. doi: 10.1016/j.cancergen.2016.04.058. Epub 2016 Apr 26.
• [4602] Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.Cancer Lett. 2018 Sep 1;431:43-53. doi: 10.1016/j.canlet.2018.05.032. Epub 2018 May 25.
• [4603] The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma.Hum Pathol. 2018 Dec;82:273-281. doi: 10.1016/j.humpath.2018.07.031. Epub 2018 Aug 4.
• [4604] Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.Oncogene. 2019 Mar;38(13):2351-2363. doi: 10.1038/s41388-018-0592-6. Epub 2018 Dec 5.
• [4605] NLRP6, decreased in gastric cancer, suppresses tumorigenicity of gastric cancer cells.Cancer Manag Res. 2018 Nov 27;10:6431-6444. doi: 10.2147/CMAR.S182980. eCollection 2018.
• [4606] Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.Am J Physiol Gastrointest Liver Physiol. 2005 Apr;288(4):G718-28. doi: 10.1152/ajpgi.00156.2004. Epub 2004 Nov 4.
• [4607] NMI promotes cell proliferation through TGF/Smad pathway by upregulating STAT1 in colorectal cancer.J Cell Physiol. 2020 Jan;235(1):429-441. doi: 10.1002/jcp.28983. Epub 2019 Jun 23.
• [4608] Evaluation of [(11)C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90.Theranostics. 2019 Jan 1;9(2):554-572. doi: 10.7150/thno.27213. eCollection 2019.
• [4609] Effects of the pesticide chlorpyrifos on breast cancer disease. Implication of epigenetic mechanisms.J Steroid Biochem Mol Biol. 2019 Feb;186:96-104. doi: 10.1016/j.jsbmb.2018.09.021. Epub 2018 Oct 2.
• [4610] Modulation of tumor microenvironment using a TLR-7/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination.Biomaterials. 2020 Feb;230:119629. doi: 10.1016/j.biomaterials.2019.119629. Epub 2019 Nov 15.
• [4611] Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.Gynecol Oncol. 2012 Feb;124(2):296-302. doi: 10.1016/j.ygyno.2011.10.028. Epub 2011 Nov 3.
• [4612] The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression.Oncogene. 2013 Sep 12;32(37):4377-86. doi: 10.1038/onc.2012.464. Epub 2012 Oct 22.
• [4613] Expression of tetraspanins NET-6 and CD151 in breast cancer as a potential tumor biomarker.Clin Exp Med. 2019 Aug;19(3):377-384. doi: 10.1007/s10238-019-00554-x. Epub 2019 Apr 20.
• [4614] Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation.Oncotarget. 2017 Jan 17;8(3):4373-4386. doi: 10.18632/oncotarget.13875.
• [4615] NOMO-1 gene is deleted in early-onset colorectal cancer.Oncotarget. 2017 Apr 11;8(15):24429-24436. doi: 10.18632/oncotarget.15478.
• [4616] Abnormal Expression of PICT-1 and Its Codon 389 Polymorphism Is a Risk Factor for Human Endometrial Cancer.Oncology. 2018;95(1):43-51. doi: 10.1159/000487189. Epub 2018 Apr 4.
• [4617] Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis.Oncogene. 2014 Jul 3;33(27):3519-27. doi: 10.1038/onc.2013.338. Epub 2013 Sep 9.
• [4618] Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway.Int J Mol Sci. 2016 Nov 18;17(11):1859. doi: 10.3390/ijms17111859.
• [4619] NF-B-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells.Oncogene. 2019 May;38(22):4250-4263. doi: 10.1038/s41388-019-0702-0. Epub 2019 Jan 30.
• [4620] Altered circadian genes expression in breast cancer tissue according to the clinical characteristics.PLoS One. 2018 Jun 29;13(6):e0199622. doi: 10.1371/journal.pone.0199622. eCollection 2018.
• [4621] NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.Am J Pathol. 2011 Jul;179(1):462-76. doi: 10.1016/j.ajpath.2011.03.044. Epub 2011 May 19.
• [4622] Protein kinase C-mediated modulation of FIH-1 expression by the homeodomain protein CDP/Cut/Cux.Mol Cell Biol. 2007 Oct;27(20):7345-53. doi: 10.1128/MCB.02201-06. Epub 2007 Aug 6.
• [4623] NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.Prostate. 2019 Jan;79(1):44-53. doi: 10.1002/pros.23709. Epub 2018 Sep 3.
• [4624] Identification of novel tumor antigens with patient-derived immune-selected antibodies.Cancer Immunol Immunother. 2009 Feb;58(2):221-34. doi: 10.1007/s00262-008-0543-0. Epub 2008 Jun 21.
• [4625] As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma.Biosci Rep. 2019 Jun 4;39(6):BSR20181662. doi: 10.1042/BSR20181662. Print 2019 Jun 28.
• [4626] Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor and blocking testicular orphan nuclear receptor2.Oncol Rep. 2013 Jan;29(1):297-305. doi: 10.3892/or.2012.2107. Epub 2012 Oct 26.
• [4627] Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis.Nat Commun. 2016 Feb 3;7:10637. doi: 10.1038/ncomms10637.
• [4628] Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion.J Mol Neurosci. 2019 Jun;68(2):234-242. doi: 10.1007/s12031-019-01281-4. Epub 2019 Mar 30.
• [4629] Cutaneous Squamous Cell Carcinoma With Sclerosing Features: An Uncommon and Potentially Aggressive Variant.Am J Dermatopathol. 2018 Aug;40(8):575-579. doi: 10.1097/DAD.0000000000001169.
• [4630] Application of Bld-1-Embedded Elastin-Like Polypeptides in Tumor Targeting.Sci Rep. 2018 Mar 1;8(1):3892. doi: 10.1038/s41598-018-21910-z.
• [4631] Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients.Oncotarget. 2016 Aug 31;8(38):64427-64439. doi: 10.18632/oncotarget.11749. eCollection 2017 Sep 8.
• [4632] Notch-regulated ankyrin-repeat protein is a novel tissue biomarker that predicts poor prognosis in non-small cell lung cancer.Oncol Lett. 2018 Aug;16(2):1885-1891. doi: 10.3892/ol.2018.8826. Epub 2018 May 30.
• [4633] High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer.J Cancer. 2019 Jul 10;10(18):4270-4277. doi: 10.7150/jca.32656. eCollection 2019.
• [4634] Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3.Cancer Sci. 2017 May;108(5):910-917. doi: 10.1111/cas.13204. Epub 2017 Apr 24.
• [4635] Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection.Cancer Res. 2001 May 15;61(10):4190-6.
• [4636] High collagen density augments mTOR-dependent cancer stem cells in ER+ mammary carcinomas, and increases mTOR-independent lung metastases.Cancer Lett. 2018 Oct 1;433:1-9. doi: 10.1016/j.canlet.2018.06.025. Epub 2018 Jun 20.
• [4637] A novel human TINP1 gene promotes cell proliferation through inhibition of p53 and p21 expression.Oncol Rep. 2013 Oct;30(4):1848-52. doi: 10.3892/or.2013.2647. Epub 2013 Aug 1.
• [4638] Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.Int J Cancer. 2016 Aug 1;139(3):628-38. doi: 10.1002/ijc.30110.
• [4639] Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors.J Enzyme Inhib Med Chem. 2019 Dec;34(1):1199-1209. doi: 10.1080/14756366.2019.1629432.
• [4640] Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites.EBioMedicine. 2019 Feb;40:394-405. doi: 10.1016/j.ebiom.2019.01.037. Epub 2019 Jan 30.
• [4641] [(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery.Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2159-2169. doi: 10.1007/s00259-018-4045-9. Epub 2018 May 15.
• [4642] Partial deletion of chromosome 1 in a case of acute myelocytic leukemia.Cancer Genet Cytogenet. 2002 Nov;139(1):60-2. doi: 10.1016/s0165-4608(02)00597-6.
• [4643] Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype.Cancer Cell. 2019 Feb 11;35(2):256-266.e5. doi: 10.1016/j.ccell.2018.12.011.
• [4644] Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N-terminal trimethylation.Protein Sci. 2017 Aug;26(8):1639-1652. doi: 10.1002/pro.3202. Epub 2017 Jun 11.
• [4645] The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration.Oncotarget. 2017 Feb 7;8(6):9767-9782. doi: 10.18632/oncotarget.14213.
• [4646] Expression in bladder transitional cell carcinoma by real-time quantitative reverse transcription polymerase chain reaction array of 65 genes at the tumor suppressor locus 9q34.1-2: identification of 5 candidates tumor suppressor genes.Int J Cancer. 2004 Sep 10;111(4):539-42. doi: 10.1002/ijc.20283.
• [4647] Hydrophilic (18)F-labeled trans-5-oxocene (oxoTCO) for efficient construction of PET agents with improved tumor-to-background ratios in neurotensin receptor (NTR) imaging.Chem Commun (Camb). 2019 Feb 21;55(17):2485-2488. doi: 10.1039/c8cc09747j.
• [4648] Expression of family with sequence similarity 172 member A and nucleotide-binding protein 1 is associated with the poor prognosis of colorectal carcinoma.Oncol Lett. 2017 Sep;14(3):3587-3593. doi: 10.3892/ol.2017.6585. Epub 2017 Jul 15.
• [4649] High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion.Onco Targets Ther. 2019 Feb 18;12:1309-1318. doi: 10.2147/OTT.S184560. eCollection 2019.
• [4650] NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.Carcinogenesis. 2019 Apr 29;40(2):370-379. doi: 10.1093/carcin/bgy142.
• [4651] NUDT1: A potential independent predictor for the prognosis of patients with oral squamous cell carcinoma.J Oral Pathol Med. 2020 Mar;49(3):210-218. doi: 10.1111/jop.12974. Epub 2019 Dec 3.
• [4652] NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.Oncogene. 2020 Jan;39(4):891-904. doi: 10.1038/s41388-019-1030-0. Epub 2019 Sep 30.
• [4653] Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.Cancers (Basel). 2019 Sep 10;11(9):1337. doi: 10.3390/cancers11091337.
• [4654] Nucleoporin 107 Promotes the Survival of Tumor Cells in Cervical Cancers.Gynecol Obstet Invest. 2020;85(1):41-52. doi: 10.1159/000502788. Epub 2019 Sep 5.
• [4655] NUP153 overexpression suppresses the proliferation of colorectal cancer by negatively regulating Wnt/-catenin signaling pathway and predicts good prognosis.Cancer Biomark. 2019;24(1):61-70. doi: 10.3233/CBM-181703.
• [4656] Nuclear pore proteins and cancer.Semin Cell Dev Biol. 2009 Jul;20(5):620-30. doi: 10.1016/j.semcdb.2009.03.003. Epub 2009 Mar 18.
• [4657] The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype.BMC Cancer. 2018 May 3;18(1):519. doi: 10.1186/s12885-018-4454-y.
• [4658] Expression of Nup93 is associated with the proliferation, migration and invasion capacity of cervical cancer cells.Acta Biochim Biophys Sin (Shanghai). 2019 Dec 13;51(12):1276-1285. doi: 10.1093/abbs/gmz131.
• [4659] Inhibition of ROS/NUPR1-dependent autophagy antagonises repeated cadmium exposure -induced oral squamous cell carcinoma cell migration and invasion.Toxicol Lett. 2019 Oct 10;314:142-152. doi: 10.1016/j.toxlet.2019.07.017. Epub 2019 Jul 15.
• [4660] Nogo-B Receptor Directs Mitochondria-Associated Membranes to Regulate Vascular Smooth Muscle Cell Proliferation.Int J Mol Sci. 2019 May 10;20(9):2319. doi: 10.3390/ijms20092319.
• [4661] NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma.Hum Pathol. 2017 Jul;65:225-230. doi: 10.1016/j.humpath.2017.01.012. Epub 2017 Feb 8.
• [4662] Vitamin D and the nutritional environment in functions of intestinal stem cells: Implications for tumorigenesis and prevention.J Steroid Biochem Mol Biol. 2020 Apr;198:105556. doi: 10.1016/j.jsbmb.2019.105556. Epub 2019 Nov 26.
• [4663] Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.J Cell Biochem. 2019 Oct;120(10):18041-18052. doi: 10.1002/jcb.29107. Epub 2019 Jul 11.
• [4664] OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug.Proc Natl Acad Sci U S A. 2019 Mar 12;116(11):5071-5076. doi: 10.1073/pnas.1815071116. Epub 2019 Feb 27.
• [4665] Effect of Oaz1 overexpression on goose ovarian granulosa cells.Amino Acids. 2017 Jun;49(6):1123-1132. doi: 10.1007/s00726-017-2411-8. Epub 2017 Mar 21.
• [4666] Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.J Cell Biochem. 2017 Nov;118(11):3635-3642. doi: 10.1002/jcb.25593. Epub 2017 Jul 31.
• [4667] MicroRNA?55 contributes to the occurrence of epilepsy through the PI3K/Akt/mTOR signaling pathway.Int J Mol Med. 2018 Sep;42(3):1577-1584. doi: 10.3892/ijmm.2018.3711. Epub 2018 Jun 1.
• [4668] High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.Pathol Int. 2018 Nov;68(11):596-604. doi: 10.1111/pin.12724. Epub 2018 Oct 15.
• [4669] Quantitative Evaluation of Vascular Microcirculation Using Contrast-Enhanced Ultrasound Imaging In Rabbit Models of Choroidal Melanoma.Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1251-1262. doi: 10.1167/iovs.17-22197.
• [4670] Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features.Br J Dermatol. 2010 Apr;162(4):772-9. doi: 10.1111/j.1365-2133.2009.09568.x. Epub 2009 Nov 3.
• [4671] O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth.Oncogene. 2020 Jan;39(3):560-573. doi: 10.1038/s41388-019-0975-3. Epub 2019 Sep 9.
• [4672] A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis.Clin Cancer Res. 2019 Sep 1;25(17):5407-5421. doi: 10.1158/1078-0432.CCR-18-4113. Epub 2019 Jun 7.
• [4673] Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.Onco Targets Ther. 2019 Dec 4;12:10639-10650. doi: 10.2147/OTT.S222967. eCollection 2019.
• [4674] A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies.Leukemia. 2018 Jun;32(6):1327-1337. doi: 10.1038/s41375-018-0083-3. Epub 2018 Mar 3.
• [4675] Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.J Neurooncol. 2004 May;67(3):265-71. doi: 10.1023/b:neon.0000024190.56750.81.
• [4676] CEST MRI of 3-O-methyl-D-glucose uptake and accumulation in brain tumors.Magn Reson Med. 2019 Mar;81(3):1993-2000. doi: 10.1002/mrm.27489. Epub 2018 Sep 11.
• [4677] Targeted Notch1 inhibition with a Notch1 antibody, OMP-A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression.J Cell Biochem. 2019 Oct;120(10):16946-16955. doi: 10.1002/jcb.28954. Epub 2019 May 17.
• [4678] HNF6 promotes tumor growth in colorectal cancer and enhances liver metastasis in mouse model.J Cell Physiol. 2019 Apr;234(4):3675-3684. doi: 10.1002/jcp.27140. Epub 2018 Sep 7.
• [4679] Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex.Behav Brain Res. 2019 May 2;363:135-144. doi: 10.1016/j.bbr.2019.01.040. Epub 2019 Jan 23.
• [4680] PEGylated peptide to TIP1 is a novel targeting agent that binds specifically to various cancers in vivo.J Control Release. 2019 Mar 28;298:194-201. doi: 10.1016/j.jconrel.2019.02.008. Epub 2019 Feb 11.
• [4681] Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.Eur J Endocrinol. 2013 Jan 17;168(2):253-61. doi: 10.1530/EJE-12-0814. Print 2013 Feb.
• [4682] Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22.Hum Genet. 2001 Apr;108(4):304-9. doi: 10.1007/s004390100498.
• [4683] Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein in hepatocellular carcinomas.Oncotarget. 2015 Jun 30;6(18):16106-19. doi: 10.18632/oncotarget.3867.
• [4684] Delivery of Constitutively Active Mutant MKK6(E) With TAT-OSBP Induces Apoptosis in Human Ovarian Carcinoma HO8910 Cells.Int J Gynecol Cancer. 2015 Nov;25(9):1548-56. doi: 10.1097/IGC.0000000000000538.
• [4685] Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.Parasitol Int. 2012 Mar;61(1):136-9. doi: 10.1016/j.parint.2011.07.003. Epub 2011 Jul 8.
• [4686] Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.J Cell Physiol. 2018 Jun;233(6):5002-5013. doi: 10.1002/jcp.26349. Epub 2018 Jan 4.
• [4687] Docosahexaenoic acid increases the expression of oxidative stress-induced growth inhibitor 1 through the PI3K/Akt/Nrf2 signaling pathway in breast cancer cells. Food Chem Toxicol. 2017 Oct;108(Pt A):276-288. doi: 10.1016/j.fct.2017.08.010. Epub 2017 Aug 12.
• [4688] Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the promoter in colorectal cancer.FEBS Open Bio. 2018 Dec 20;9(1):26-34. doi: 10.1002/2211-5463.12554. eCollection 2019 Jan.
• [4689] The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11.Cancer Res. 2019 Apr 15;79(8):1913-1924. doi: 10.1158/0008-5472.CAN-18-3037. Epub 2019 Feb 1.
• [4690] OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.Theranostics. 2019 Jan 1;9(1):179-195. doi: 10.7150/thno.29545. eCollection 2019.
• [4691] Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.Breast Cancer Res. 2015 Sep 14;17(1):125. doi: 10.1186/s13058-015-0637-5.
• [4692] Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells.J Hepatol. 2013 Nov;59(5):1037-44. doi: 10.1016/j.jhep.2013.06.024. Epub 2013 Jul 2.
• [4693] FSH3 mediated cell death is dependent on NUC1 in Saccharomyces cerevisiae.FEMS Yeast Res. 2019 May 1;19(3):foz017. doi: 10.1093/femsyr/foz017.
• [4694] Tubal Origin of "Ovarian" Low-Grade Serous Carcinoma: A Gene Expression Profile Study.J Oncol. 2019 Mar 5;2019:8659754. doi: 10.1155/2019/8659754. eCollection 2019.
• [4695] Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.Cancer Res. 2018 May 1;78(9):2205-2218. doi: 10.1158/0008-5472.CAN-17-2341. Epub 2018 Feb 8.
• [4696] PHD4 stimulates tumor angiogenesis in osteosarcoma cells via TGF-.Mol Cancer Res. 2013 Nov;11(11):1337-48. doi: 10.1158/1541-7786.MCR-13-0201. Epub 2013 Sep 18.
• [4697] Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer.Cancer Sci. 2014 Sep;105(9):1135-41. doi: 10.1111/cas.12472. Epub 2014 Sep 3.
• [4698] Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer.Int J Cancer. 2019 Sep 15;145(6):1529-1537. doi: 10.1002/ijc.32227. Epub 2019 Mar 19.
• [4699] PARK2 and PACRG are commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome.Genes Chromosomes Cancer. 2013 Mar;52(3):265-73. doi: 10.1002/gcc.22026. Epub 2012 Nov 2.
• [4700] Loss of PACS-2 delays regeneration in DSS-induced colitis but does not affect the Apc(Min) model of colorectal cancer.Oncotarget. 2017 Nov 26;8(65):108303-108315. doi: 10.18632/oncotarget.22661. eCollection 2017 Dec 12.
• [4701] Pt(II) and Pd(II) complexes with a thiazoline derivative ligand: Synthesis, structural characterization, antiproliferative activity and evaluation of pro-apoptotic ability in tumor cell lines HT-29 and U-937.J Inorg Biochem. 2020 Jan;202:110870. doi: 10.1016/j.jinorgbio.2019.110870. Epub 2019 Oct 22.
• [4702] Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance.Br J Cancer. 2006 May 22;94(10):1516-23. doi: 10.1038/sj.bjc.6603108.
• [4703] Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study.Int J Cancer. 2017 Aug 15;141(4):678-686. doi: 10.1002/ijc.30762. Epub 2017 May 15.
• [4704] Correlation between chemotherapy resistance in osteosarcoma patients and PAK5 and Ezrin gene expression.Oncol Lett. 2018 Jan;15(1):879-884. doi: 10.3892/ol.2017.7355. Epub 2017 Nov 6.
• [4705] Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma.J Surg Res. 2014 Jun 1;189(1):81-8. doi: 10.1016/j.jss.2014.01.049. Epub 2014 Jan 29.
• [4706] Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression.Cytoskeleton (Hoboken). 2015 Aug;72(8):402-11. doi: 10.1002/cm.21239. Epub 2015 Sep 3.
• [4707] Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.Oncol Rep. 2015 Jan;33(1):267-73. doi: 10.3892/or.2014.3581. Epub 2014 Nov 3.
• [4708] Panx1 promotes invasion-metastasis cascade in hepatocellular carcinoma.J Cancer. 2019 Sep 7;10(23):5681-5688. doi: 10.7150/jca.32986. eCollection 2019.
• [4709] Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion.J Natl Cancer Inst. 2019 Sep 1;111(9):970-982. doi: 10.1093/jnci/djy209.
• [4710] PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer.Onco Targets Ther. 2019 May 13;12:3625-3633. doi: 10.2147/OTT.S181432. eCollection 2019.
• [4711] High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.Genome Res. 2000 Feb;10(2):244-57. doi: 10.1101/gr.10.2.244.
• [4712] Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-B signaling.Cancer Med. 2019 May;8(5):2288-2302. doi: 10.1002/cam4.2063. Epub 2019 Mar 7.
• [4713] High expression of partitioning defective 3-like protein is associated with malignancy in colorectal cancer.Tumour Biol. 2017 Apr;39(4):1010428317698393. doi: 10.1177/1010428317698393.
• [4714] Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma.J Hepatol. 2013 Jan;58(1):190-3. doi: 10.1016/j.jhep.2012.09.005. Epub 2012 Sep 16.
• [4715] Knockdown of PARP6 or survivin promotes cell apoptosis and inhibits cell invasion of colorectal adenocarcinoma cells.Oncol Rep. 2017 Apr;37(4):2245-2251. doi: 10.3892/or.2017.5441. Epub 2017 Feb 14.
• [4716] PARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma.Br J Cancer. 2015 Jan 20;112(2):338-44. doi: 10.1038/bjc.2014.590. Epub 2014 Nov 25.
• [4717] The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening.Mol Genet Genomic Med. 2019 Mar;7(3):e506. doi: 10.1002/mgg3.506. Epub 2019 Jan 12.
• [4718] Downregulated Pancreatic Beta Cell Genes Indicate Poor Prognosis in Patients With Pancreatic Neuroendocrine Neoplasms.Ann Surg. 2020 Apr;271(4):732-739. doi: 10.1097/SLA.0000000000002911.
• [4719] DNA repair genes PAXIP1 and TP53BP1 expression is associated with breast cancer prognosis.Cancer Biol Ther. 2017 Jun 3;18(6):439-449. doi: 10.1080/15384047.2017.1323590. Epub 2017 May 5.
• [4720] circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.Oncogene. 2019 Oct;38(42):6850-6866. doi: 10.1038/s41388-019-0926-z. Epub 2019 Aug 12.
• [4721] SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression.Cell Rep. 2018 Apr 24;23(4):1166-1177. doi: 10.1016/j.celrep.2018.03.124.
• [4722] EWSR1-PBX3 gene fusion in cutaneous syncytial myoepithelioma.J Cutan Pathol. 2019 Jun;46(6):421-424. doi: 10.1111/cup.13450. Epub 2019 Apr 3.
• [4723] A Lipophilic IR-780 Dye-Encapsulated Zwitterionic Polymer-Lipid Micellar Nanoparticle for Enhanced Photothermal Therapy and NIR-Based Fluorescence Imaging in a Cervical Tumor Mouse Model.Int J Mol Sci. 2018 Apr 13;19(4):1189. doi: 10.3390/ijms19041189.
• [4724] Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma.Cancer Manag Res. 2019 Feb 18;11:1601-1613. doi: 10.2147/CMAR.S191102. eCollection 2019.
• [4725] PCDH20acts as a tumour-suppressor gene through the Wnt/-catenin signalling pathway in hypopharyngeal squamous cell carcinoma.Cancer Biomark. 2019;26(2):209-217. doi: 10.3233/CBM-190442.
• [4726] Modulation of Mutant Kras(G12D) -Driven Lung Tumorigenesis In Vivo by Gain or Loss of PCDH7 Function.Mol Cancer Res. 2019 Feb;17(2):594-603. doi: 10.1158/1541-7786.MCR-18-0739. Epub 2018 Nov 8.
• [4727] Exome sequencing reveals the genetic landscape and frequent inactivation of PCDHB3 in Chinese rectal cancers.J Pathol. 2018 Jun;245(2):222-234. doi: 10.1002/path.5073. Epub 2018 Apr 20.
• [4728] Protocadherin -A7 is down-regulated in colorectal cancer and associated with the prognosis in patients with wild-type KRAS.Hum Pathol. 2019 Jan;83:14-21. doi: 10.1016/j.humpath.2018.08.007. Epub 2018 Aug 16.
• [4729] Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways.Oncogene. 2012 Oct 4;31(40):4409-19. doi: 10.1038/onc.2011.609. Epub 2012 Jan 16.
• [4730] Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.Mod Pathol. 2019 Apr;32(4):490-498. doi: 10.1038/s41379-018-0165-9. Epub 2018 Nov 6.
• [4731] Mn-Porphyrin-Based Metal-Organic Framework with High Longitudinal Relaxivity for Magnetic Resonance Imaging Guidance and Oxygen Self-Supplementing Photodynamic Therapy.ACS Appl Mater Interfaces. 2019 Nov 13;11(45):41946-41956. doi: 10.1021/acsami.9b15083. Epub 2019 Oct 29.
• [4732] Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment.Oncotarget. 2016 Apr 12;7(15):19610-9. doi: 10.18632/oncotarget.7526.
• [4733] PDCD5 regulates cell proliferation, cell cycle progression and apoptosis.Oncol Lett. 2018 Jan;15(1):1177-1183. doi: 10.3892/ol.2017.7401. Epub 2017 Nov 14.
• [4734] The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression.Cancers (Basel). 2019 Mar 21;11(3):398. doi: 10.3390/cancers11030398.
• [4735] 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma.Blood. 1993 Oct 1;82(7):2157-62.
• [4736] A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet. 2008 Oct;16(10):1245-53. doi: 10.1038/ejhg.2008.85. Epub 2008 Apr 23.
• [4737] A Tumor Suppressor Gene Product, Platelet-Derived Growth Factor Receptor-Like Protein Controls Chondrocyte Proliferation and Differentiation.J Cell Biochem. 2017 Nov;118(11):4033-4044. doi: 10.1002/jcb.26059. Epub 2017 May 23.
• [4738] Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.Nat Genet. 2018 Feb;50(2):219-228. doi: 10.1038/s41588-017-0026-3. Epub 2018 Jan 15.
• [4739] PDIA4: The basic characteristics, functions and its potential connection with cancer.Biomed Pharmacother. 2020 Feb;122:109688. doi: 10.1016/j.biopha.2019.109688. Epub 2019 Nov 30.
• [4740] PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer.Genet Mol Res. 2015 Jun 26;14(2):6960-7. doi: 10.4238/2015.June.26.4.
• [4741] Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.Oncogene. 2019 Oct;38(42):6867-6879. doi: 10.1038/s41388-019-0927-y. Epub 2019 Aug 12.
• [4742] PDZ and LIM domain protein 1(PDLIM1)/CLP36 promotes breast cancer cell migration, invasion and metastasis through interaction with -actinin.Oncogene. 2015 Mar 5;34(10):1300-11. doi: 10.1038/onc.2014.64. Epub 2014 Mar 24.
• [4743] PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling.Life Sci. 2019 Sep 15;233:116715. doi: 10.1016/j.lfs.2019.116715. Epub 2019 Jul 31.
• [4744] A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity.Nat Commun. 2017 Jan 17;8:14059. doi: 10.1038/ncomms14059.
• [4745] Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.Mater Sci Eng C Mater Biol Appl. 2017 Jan 1;70(Pt 1):418-429. doi: 10.1016/j.msec.2016.09.019. Epub 2016 Sep 7.
• [4746] PDRG1 gene silencing contributes to inhibit the growth and induce apoptosis of gastric cancer cells.Pathol Res Pract. 2019 Oct;215(10):152567. doi: 10.1016/j.prp.2019.152567. Epub 2019 Jul 27.
• [4747] Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation.J Histochem Cytochem. 2016 Jan;64(1):7-17. doi: 10.1369/0022155415616161. Epub 2015 Oct 20.
• [4748] miR-363 acts as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2.Oncol Rep. 2019 May;41(5):2729-2738. doi: 10.3892/or.2019.7078. Epub 2019 Mar 19.
• [4749] PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor- (TGF-) signaling.J Biol Chem. 2019 Mar 29;294(13):4966-4980. doi: 10.1074/jbc.RA118.004153. Epub 2019 Feb 4.
• [4750] Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of carcinogenesis.Cancer Genet Cytogenet. 2010 Aug;201(1):15-23. doi: 10.1016/j.cancergencyto.2010.04.018.
• [4751] PDZRN4 acts as a suppressor of cell proliferation in human liver cancer cell lines.Cell Biochem Funct. 2015 Oct;33(7):443-9. doi: 10.1002/cbf.3130. Epub 2015 Oct 20.
• [4752] PEA?5 contributes to the clinicopathology and AKTregulated cisplatin resistance in gastric cancer.Oncol Rep. 2019 Mar;41(3):1949-1959. doi: 10.3892/or.2018.6934. Epub 2018 Dec 18.
• [4753] The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer.Cancer Lett. 2019 Feb 1;442:383-395. doi: 10.1016/j.canlet.2018.11.014. Epub 2018 Nov 22.
• [4754] PEG10 Promoter-Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer.Cancer Res. 2019 Nov 1;79(21):5668-5680. doi: 10.1158/0008-5472.CAN-19-2181. Epub 2019 Sep 17.
• [4755] Decorin-inducible Peg3 Evokes Beclin 1-mediated Autophagy and Thrombospondin 1-mediated Angiostasis.J Biol Chem. 2017 Mar 24;292(12):5055-5069. doi: 10.1074/jbc.M116.753632. Epub 2017 Feb 7.
• [4756] PELP1 is a novel oncogene in gastric tumorigenesis and negatively regulated by miR-15 family microRNAs.Cancer Biomark. 2019;26(1):1-9. doi: 10.3233/CBM-182279.
• [4757] Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.Cancer Med. 2019 Mar;8(3):1034-1043. doi: 10.1002/cam4.1994. Epub 2019 Jan 28.
• [4758] Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.Mol Cancer Ther. 2013 Apr;12(4):481-90. doi: 10.1158/1535-7163.MCT-12-0654. Epub 2013 Jan 31.
• [4759] Potential Markers from Serum-Purified Exosomes for Detecting Oral Squamous Cell Carcinoma Metastasis.Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1668-1681. doi: 10.1158/1055-9965.EPI-18-1122. Epub 2019 Jul 26.
• [4760] PFDN1, an indicator for colorectal cancer prognosis, enhances tumor cell proliferation and motility through cytoskeletal reorganization.Med Oncol. 2015 Dec;32(12):264. doi: 10.1007/s12032-015-0710-z. Epub 2015 Nov 9.
• [4761] Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.Nat Commun. 2017 Oct 16;8(1):949. doi: 10.1038/s41467-017-00906-9.
• [4762] Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma.Exp Cell Res. 2018 Sep 1;370(1):46-57. doi: 10.1016/j.yexcr.2018.06.007. Epub 2018 Jun 15.
• [4763] Profilin 1, negatively regulated by microRNA-19a-3p, serves as a tumor suppressor in human hepatocellular carcinoma.Pathol Res Pract. 2019 Mar;215(3):499-505. doi: 10.1016/j.prp.2018.12.012. Epub 2018 Dec 12.
• [4764] Rab11-FIP2 suppressed tumor growth via regulation of PGK1 ubiquitination in non-small cell lung cancer.Biochem Biophys Res Commun. 2019 Jan 1;508(1):60-65. doi: 10.1016/j.bbrc.2018.11.108. Epub 2018 Nov 22.
• [4765] FasL and the NKG2D receptor are required for the secretion of the Tag7/PGRP-S-Hsp70 complex by the cytotoxic CD8(+) lymphocytes.IUBMB Life. 2017 Jan;69(1):30-36. doi: 10.1002/iub.1587. Epub 2016 Nov 20.
• [4766] MiR-26b regulates 5-FU-resistance in human colorectal cancer via down-regulation of Pgp.Am J Cancer Res. 2018 Dec 1;8(12):2518-2527. eCollection 2018.
• [4767] Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.World J Gastroenterol. 2018 Mar 14;24(10):1152-1166. doi: 10.3748/wjg.v24.i10.1152.
• [4768] Polycomb group molecule PHC3 regulates polycomb complex composition and prognosis of osteosarcoma.Cancer Sci. 2010 Jul;101(7):1646-52. doi: 10.1111/j.1349-7006.2010.01586.x. Epub 2010 Apr 7.
• [4769] Expression and inactivation of osteopontin-degrading PHEX enzyme in squamous cell carcinoma.Int J Biochem Cell Biol. 2016 Aug;77(Pt A):155-164. doi: 10.1016/j.biocel.2016.05.016. Epub 2016 Jun 4.
• [4770] Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway.Cancer Cell Int. 2019 Nov 27;19:314. doi: 10.1186/s12935-019-1040-6. eCollection 2019.
• [4771] PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation.Blood. 2019 Oct 3;134(14):1176-1189. doi: 10.1182/blood.2019000578. Epub 2019 Aug 5.
• [4772] The prognostic significance of nuclear expression of PHF2 and C/EBP in clear cell renal cell carcinoma with consideration of adipogenic metabolic evolution.Oncotarget. 2017 Aug 4;9(1):142-151. doi: 10.18632/oncotarget.19949. eCollection 2018 Jan 2.
• [4773] Molecular genetic characterization reveals linear tumor evolution in a pulmonary sarcomatoid carcinomas patient with a novel PHF20-NTRK1 fusion: a case report.BMC Cancer. 2019 Jun 17;19(1):592. doi: 10.1186/s12885-019-5780-4.
• [4774] PHF20L1 antagonizes SOX2 proteolysis triggered by the MLL1/WDR5 complexes. Lab Invest. 2018 Dec;98(12):1627-1641. doi: 10.1038/s41374-018-0106-8. Epub 2018 Aug 8.
• [4775] RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.Eur Urol. 2019 Aug;76(2):157-166. doi: 10.1016/j.eururo.2019.03.011. Epub 2019 Mar 23.
• [4776] PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/-catenin signaling pathway.J Exp Clin Cancer Res. 2017 Jun 23;36(1):85. doi: 10.1186/s13046-017-0560-y.
• [4777] BRAF Mutation in Colorectal Rhabdoid and Poorly Differentiated Medullary Carcinomas.Cancers (Basel). 2019 Aug 26;11(9):1252. doi: 10.3390/cancers11091252.
• [4778] The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells.Blood. 2019 Jun 6;133(23):2495-2506. doi: 10.1182/blood.2019000468. Epub 2019 Mar 27.
• [4779] Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.J Am Heart Assoc. 2019 Aug 20;8(16):e011830. doi: 10.1161/JAHA.118.011830. Epub 2019 Aug 20.
• [4780] Oncogenic effect of PHLDB2 is associated with epithelial-mesenchymal transition and E-cadherin regulation in colorectal cancer.Cancer Cell Int. 2019 Jul 16;19:184. doi: 10.1186/s12935-019-0903-1. eCollection 2019.
• [4781] Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma.Diagn Interv Radiol. 2019 Nov;25(6):451-458. doi: 10.5152/dir.2019.18138.
• [4782] Overexpression of PHRF1 attenuates the proliferation and tumorigenicity of non-small cell lung cancer cells.Oncotarget. 2016 Sep 27;7(39):64360-64370. doi: 10.18632/oncotarget.11842.
• [4783] Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.Oncogene. 2015 Jan 15;34(3):373-83. doi: 10.1038/onc.2013.562. Epub 2014 Jan 27.
• [4784] Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP.Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7623-7628. doi: 10.1073/pnas.1700996114. Epub 2017 Jun 30.
• [4785] ROS-PIAS cross talk channelizes ATM signaling from resistance to apoptosis during chemosensitization of resistant tumors.Cell Death Dis. 2014 Jan 23;5(1):e1021. doi: 10.1038/cddis.2013.534.
• [4786] PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.Int J Cancer. 2004 Oct 20;112(1):51-60. doi: 10.1002/ijc.20326.
• [4787] PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.Clin Cancer Res. 2014 Feb 15;20(4):827-36. doi: 10.1158/1078-0432.CCR-13-2053. Epub 2013 Dec 3.
• [4788] PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.Cell Oncol. 2010;32(1-2):29-42. doi: 10.3233/CLO-2009-0492.
• [4789] The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma.Adv Clin Exp Med. 2018 Aug;27(8):1025-1031. doi: 10.17219/acem/71080.
• [4790] Molecular insight of regorafenib treatment for colorectal cancer.Cancer Treat Rev. 2019 Dec;81:101912. doi: 10.1016/j.ctrv.2019.101912. Epub 2019 Oct 28.
• [4791] Biomineralized Gd(2) O(3) @HSA Nanoparticles as a Versatile Platform for Dual-Modal Imaging and Chemo-Phototherapy-Synergized Tumor Ablation.Adv Healthc Mater. 2019 Dec;8(24):e1901005. doi: 10.1002/adhm.201901005. Epub 2019 Nov 18.
• [4792] A single nucleotide polymorphism in the human PIGK gene associates with low PIGK expression in colorectal cancer patients.Int J Oncol. 2012 Oct;41(4):1405-10. doi: 10.3892/ijo.2012.1567. Epub 2012 Jul 23.
• [4793] Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.Hepatology. 2017 Jun;65(6):1948-1962. doi: 10.1002/hep.29036. Epub 2017 Apr 28.
• [4794] Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2 Scaffolding Function.Cancer Cell. 2017 Oct 9;32(4):444-459.e7. doi: 10.1016/j.ccell.2017.09.002.
• [4795] Downregulation of class II phosphoinositide 3-kinase PI3K-C2 delays cell division and potentiates the effect of docetaxel on cancer cell growth.J Exp Clin Cancer Res. 2019 Nov 21;38(1):472. doi: 10.1186/s13046-019-1472-9.
• [4796] Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity.Clin Cancer Res. 2019 Oct 15;25(20):6180-6194. doi: 10.1158/1078-0432.CCR-18-4134. Epub 2019 Jul 26.
• [4797] p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation.Int J Cancer. 2004 Nov 10;112(3):393-8. doi: 10.1002/ijc.20443.
• [4798] Analysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma.Oncol Lett. 2017 Jan;13(1):488-496. doi: 10.3892/ol.2016.5438. Epub 2016 Nov 28.
• [4799] Up-regulation of FAM64A promotes epithelial-to-mesenchymal transition and enhances stemness features in breast cancer cells.Biochem Biophys Res Commun. 2019 May 28;513(2):472-478. doi: 10.1016/j.bbrc.2019.03.207. Epub 2019 Apr 9.
• [4800] Insight into the structural stability of wild-type and histidine mutants in Pin1 by experimental and computational methods.Sci Rep. 2019 Jun 10;9(1):8413. doi: 10.1038/s41598-019-44926-5.
• [4801] Parkin, PINK1 and DJ1 as possible modulators of mTOR pathway in ganglioglioma.Int J Neurosci. 2018 Feb;128(2):167-174. doi: 10.1080/00207454.2017.1366906. Epub 2017 Aug 28.
• [4802] Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window.J Nucl Med. 2019 May;60(5):656-663. doi: 10.2967/jnumed.118.221150. Epub 2018 Dec 14.
• [4803] Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.Blood. 2013 Nov 7;122(19):3298-307. doi: 10.1182/blood-2013-03-491316. Epub 2013 Aug 30.
• [4804] PIR promotes tumorigenesis of breast cancer by upregulating cell cycle activator E2F1.Cell Cycle. 2019 Nov;18(21):2914-2927. doi: 10.1080/15384101.2019.1662259. Epub 2019 Sep 10.
• [4805] Functional Isolation of Tumor-Initiating Cells using Microfluidic-Based Migration Identifies Phosphatidylserine Decarboxylase as a Key Regulator.Sci Rep. 2018 Jan 10;8(1):244. doi: 10.1038/s41598-017-18610-5.
• [4806] Pd@Au Bimetallic Nanoplates Decorated Mesoporous MnO(2) for Synergistic Nucleus-Targeted NIR-II Photothermal and Hypoxia-Relieved Photodynamic Therapy.Adv Healthc Mater. 2020 Jan;9(2):e1901528. doi: 10.1002/adhm.201901528. Epub 2019 Dec 10.
• [4807] Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows.Adv Mater. 2019 Feb;31(5):e1805919. doi: 10.1002/adma.201805919. Epub 2018 Dec 9.
• [4808] MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.Cell Biol Int. 2019 Mar;43(3):253-264. doi: 10.1002/cbin.11083. Epub 2019 Jan 28.
• [4809] The Prognosis Value of PIWIL1 and PIWIL2 Expression in Pancreatic Cancer.J Clin Med. 2019 Aug 22;8(9):1275. doi: 10.3390/jcm8091275.
• [4810] PIWIL2 stabilizes -catenin to promote cell cycle and proliferation in tumor cells.Biochem Biophys Res Commun. 2019 Aug 27;516(3):819-824. doi: 10.1016/j.bbrc.2019.06.136. Epub 2019 Jun 28.
• [4811] CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature.BMC Cancer. 2019 Jan 16;19(1):76. doi: 10.1186/s12885-018-5221-9.
• [4812] lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.Int J Oncol. 2019 Jul;55(1):45-58. doi: 10.3892/ijo.2019.4798. Epub 2019 May 6.
• [4813] Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.
• [4814] PREP1 tumor suppressor protects the late-replicating DNA by controlling its replication timing and symmetry.Sci Rep. 2018 Feb 16;8(1):3198. doi: 10.1038/s41598-018-21363-4.
• [4815] Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.Biomed Pharmacother. 2019 Mar;111:1234-1242. doi: 10.1016/j.biopha.2018.12.135. Epub 2019 Jan 15.
• [4816] Plakophilin3 loss leads to an increase in lipocalin2 expression, which is required for tumour formation.Exp Cell Res. 2018 Aug 15;369(2):251-265. doi: 10.1016/j.yexcr.2018.05.026. Epub 2018 May 24.
• [4817] Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2).J Biol Chem. 2005 Jul 1;280(26):24987-98. doi: 10.1074/jbc.M502088200. Epub 2005 Apr 29.
• [4818] Overexpression of the phospholipase A2 group V gene in glioma tumors is associated with poor patient prognosis.Cancer Manag Res. 2019 Apr 11;11:3139-3152. doi: 10.2147/CMAR.S199207. eCollection 2019.
• [4819] Preservation of KIT genotype in a novel pair of patient-derived orthotopic xenograft mouse models of metastatic pediatric CNS germinoma.J Neurooncol. 2016 May;128(1):47-56. doi: 10.1007/s11060-016-2098-9. Epub 2016 Mar 8.
• [4820] Ectopic expression of PLC-2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.Mol Carcinog. 2019 May;58(5):708-721. doi: 10.1002/mc.22964. Epub 2019 Jan 16.
• [4821] PLCG2 promotes hepatocyte proliferation in vitro via NF-B and ERK pathway by targeting bcl2, myc and ccnd1.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3786-3792. doi: 10.1080/21691401.2019.1669616.
• [4822] PLC promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathwaymediated glycolysis.Oncol Rep. 2019 May;41(5):2844-2854. doi: 10.3892/or.2019.7056. Epub 2019 Mar 13.
• [4823] Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.J Exp Clin Cancer Res. 2018 Jul 11;37(1):146. doi: 10.1186/s13046-018-0796-1.
• [4824] FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signaling.Exp Cell Res. 2019 Jan 1;374(1):12-18. doi: 10.1016/j.yexcr.2018.11.002. Epub 2018 Nov 5.
• [4825] Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice.Mol Med Rep. 2015 Jul;12(1):1023-9. doi: 10.3892/mmr.2015.3501. Epub 2015 Mar 17.
• [4826] PLEKHM2-ALK: A novel fusion in small-cell lung cancer and durable response to ALK inhibitors.Lung Cancer. 2020 Jan;139:146-150. doi: 10.1016/j.lungcan.2019.11.002. Epub 2019 Nov 6.
• [4827] PLEKHO1 knockdown inhibits RCC cell viability in vitro and in vivo, potentially by the Hippo and MAPK/JNK pathways.Int J Oncol. 2019 Jul;55(1):81-92. doi: 10.3892/ijo.2019.4819. Epub 2019 May 30.
• [4828] Genome-wide analysis of noncoding regulatory mutations in cancer.Nat Genet. 2014 Nov;46(11):1160-5. doi: 10.1038/ng.3101. Epub 2014 Sep 28.
• [4829] Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy.Front Oncol. 2019 Aug 14;9:742. doi: 10.3389/fonc.2019.00742. eCollection 2019.
• [4830] Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression.Mol Cell Biol. 2011 Mar;31(6):1225-39. doi: 10.1128/MCB.00607-10. Epub 2011 Jan 18.
• [4831] PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway.Cell Death Dis. 2019 Feb 15;10(3):156. doi: 10.1038/s41419-019-1405-8.
• [4832] Evaluation of liver parenchyma stiffness in patients with liver tumours: optimal strategy for shear wave elastography.Eur Radiol. 2019 Mar;29(3):1479-1488. doi: 10.1007/s00330-018-5676-8. Epub 2018 Aug 13.
• [4833] Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.Ann Surg Oncol. 2014 Oct;21(11):3680-90. doi: 10.1245/s10434-013-3366-y. Epub 2013 Nov 12.
• [4834] Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling.Blood. 2011 Oct 13;118(15):4285-96. doi: 10.1182/blood-2011-03-341388. Epub 2011 Aug 10.
• [4835] Divergent roles of Plexin D1 in cancer.Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):103-110. doi: 10.1016/j.bbcan.2019.05.004. Epub 2019 May 30.
• [4836] Polyamine-modulated factor-1 methylation predicts Bacillus Calmette-Gurin response in patients with high-grade non-muscle-invasive bladder carcinoma.Eur Urol. 2013 Feb;63(2):364-70. doi: 10.1016/j.eururo.2012.05.050. Epub 2012 Jun 5.
• [4837] Evidence for a potential role for HDL as an important source of cholesterol in human adrenocortical tumors via the CLA-1 pathway.Endocr J. 1999 Feb;46(1):27-34. doi: 10.1507/endocrj.46.27.
• [4838] Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM(+) Hepatocellular Carcinoma.Cancer Res. 2019 May 1;79(9):2379-2391. doi: 10.1158/0008-5472.CAN-18-3015. Epub 2019 Mar 12.
• [4839] Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD.J Drug Target. 2018 Sep;26(8):643-648. doi: 10.1080/1061186X.2017.1401077. Epub 2017 Nov 15.
• [4840] Hints on ATGL implications in cancer: beyond bioenergetic clues.Cell Death Dis. 2018 Feb 22;9(3):316. doi: 10.1038/s41419-018-0345-z.
• [4841] Tumor suppressor PNRC1 blocks rRNA maturation by recruiting the decapping complex to the nucleolus.EMBO J. 2018 Dec 3;37(23):e99179. doi: 10.15252/embj.201899179. Epub 2018 Oct 29.
• [4842] Podocalyxin-like, targeted by miR-138, promotes colorectal cancer cell proliferation, migration, invasion and EMT.Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8664-8674. doi: 10.26355/eurrev_201812_16631.
• [4843] Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.Oncol Rep. 2019 Dec;42(6):2473-2485. doi: 10.3892/or.2019.7368. Epub 2019 Oct 14.
• [4844] Human CAP10-Like Protein 46kDa Gene Promotes Malignancy in Colorectal Cancer.OMICS. 2017 May;21(5):266-274. doi: 10.1089/omi.2017.0037.
• [4845] Loss of the p12 subunit of DNA polymerase delta leads to a defect in HR and sensitization to PARP inhibitors.DNA Repair (Amst). 2019 Jan;73:64-70. doi: 10.1016/j.dnarep.2018.11.003. Epub 2018 Nov 13.
• [4846] Overexpression of DNA polymerase iota (Pol) in esophageal squamous cell carcinoma.Cancer Sci. 2012 Aug;103(8):1574-9. doi: 10.1111/j.1349-7006.2012.02309.x. Epub 2012 May 30.
• [4847] Expression and Clinical Significance of POLR1D in Colorectal Cancer.Oncology. 2020;98(3):138-145. doi: 10.1159/000504174. Epub 2019 Nov 13.
• [4848] Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach.Breast Cancer Res Treat. 2019 Jun;175(2):317-326. doi: 10.1007/s10549-019-05163-6. Epub 2019 Feb 22.
• [4849] Rpb3 promotes hepatocellular carcinoma through its N-terminus.Oncotarget. 2014 Oct 15;5(19):9256-68. doi: 10.18632/oncotarget.2389.
• [4850] Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.Cancer Res. 2017 Sep 15;77(18):4934-4946. doi: 10.1158/0008-5472.CAN-16-3541. Epub 2017 Jul 20.
• [4851] INMAP overexpression inhibits cell proliferation, induces genomic instability and functions through p53/p21 pathways.PLoS One. 2015 Jan 30;10(1):e0115704. doi: 10.1371/journal.pone.0115704. eCollection 2015.
• [4852] MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.Mol Cell. 2015 Jul 16;59(2):243-57. doi: 10.1016/j.molcel.2015.05.036. Epub 2015 Jul 2.
• [4853] Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer.World J Gastroenterol. 2012 May 21;18(19):2423-9. doi: 10.3748/wjg.v18.i19.2423.
• [4854] Expression of the POTE gene family in human ovarian cancer.Sci Rep. 2018 Nov 20;8(1):17136. doi: 10.1038/s41598-018-35567-1.
• [4855] Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.Mol Carcinog. 2018 Jul;57(7):886-895. doi: 10.1002/mc.22809. Epub 2018 Apr 6.
• [4856] Oct1/Pou2f1 is selectively required for colon regeneration and regulates colon malignancy.PLoS Genet. 2019 May 6;15(5):e1007687. doi: 10.1371/journal.pgen.1007687. eCollection 2019 May.
• [4857] BRN2, a POUerful driver of melanoma phenotype switching and metastasis.Pigment Cell Melanoma Res. 2019 Jan;32(1):9-24. doi: 10.1111/pcmr.12710. Epub 2018 Jun 5.
• [4858] The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer.Oncogene. 2015 Jan 8;34(2):199-208. doi: 10.1038/onc.2013.547. Epub 2013 Dec 23.
• [4859] The murine Pou6f2 gene is temporally and spatially regulated during kidney embryogenesis and its human homolog is overexpressed in a subset of Wilms tumors.J Pediatr Hematol Oncol. 2006 Dec;28(12):791-7. doi: 10.1097/MPH.0b013e31802d3e65.
• [4860] Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF- signaling.Free Radic Biol Med. 2019 Jan;130:163-173. doi: 10.1016/j.freeradbiomed.2018.10.450. Epub 2018 Nov 1.
• [4861] Dihydromyricetin affect the pharmacokinetics of triptolide in rats.Xenobiotica. 2020 Mar;50(3):332-338. doi: 10.1080/00498254.2019.1616851. Epub 2019 May 27.
• [4862] Cyclophilin J PPIase Inhibitors Derived from 2,3-Quinoxaline-6 Amine Exhibit Antitumor Activity.Front Pharmacol. 2018 Feb 21;9:126. doi: 10.3389/fphar.2018.00126. eCollection 2018.
• [4863] Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.Biomed Pharmacother. 2017 Mar;87:366-374. doi: 10.1016/j.biopha.2016.12.103. Epub 2017 Jan 6.
• [4864] Low tumour PPM1H indicates poor prognosis in colorectal cancer via activation of cancer-associated fibroblasts.Br J Cancer. 2019 May;120(10):987-995. doi: 10.1038/s41416-019-0450-5. Epub 2019 Apr 16.
• [4865] Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients.Genes Chromosomes Cancer. 2010 Feb;49(2):99-106. doi: 10.1002/gcc.20724.
• [4866] Ribonucleotide Reductase Inhibitor 3-AP Induces Oncogenic Virus Infected Cell Death and Represses Tumor Growth.J Cancer. 2018 Oct 31;9(23):4503-4509. doi: 10.7150/jca.27437. eCollection 2018.
• [4867] MYPT1 is targeted by miR-145 inhibiting viability, migration and invasion in 2D and 3D HeLa cultures.Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):348-354. doi: 10.1016/j.bbrc.2018.11.039. Epub 2018 Nov 14.
• [4868] CPI-17 Overexpression and Its Correlation With the NF2 Mutation Spectrum in Sporadic Vestibular Schwannomas.Otol Neurotol. 2020 Jan;41(1):e94-e102. doi: 10.1097/MAO.0000000000002430.
• [4869] Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway.Biol Chem. 2007 May;388(5):489-95. doi: 10.1515/BC.2007.062.
• [4870] Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer.J Cancer Res Clin Oncol. 2016 Aug;142(8):1705-14. doi: 10.1007/s00432-016-2177-5. Epub 2016 May 13.
• [4871] Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.Oncogene. 2016 Apr 7;35(14):1847-56. doi: 10.1038/onc.2015.250. Epub 2015 Jun 29.
• [4872] Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.Cancer Res. 2005 Sep 15;65(18):8397-405. doi: 10.1158/0008-5472.CAN-05-1203.
• [4873] Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway.Neoplasia. 2019 Jan;21(1):30-40. doi: 10.1016/j.neo.2018.10.009. Epub 2018 Nov 27.
• [4874] Possible predisposition for colorectal carcinogenesis due to altered gene expressions in normal appearing mucosa from patients with colorectal neoplasia.BMC Cancer. 2019 Jun 28;19(1):643. doi: 10.1186/s12885-019-5833-8.
• [4875] MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer.Mol Cancer Ther. 2018 Jul;17(7):1430-1440. doi: 10.1158/1535-7163.MCT-17-1049. Epub 2018 Apr 27.
• [4876] Protein phosphatase 2A-B55 enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.J Exp Clin Cancer Res. 2016 Apr 14;35:67. doi: 10.1186/s13046-016-0341-z.
• [4877] Protein phosphatase 2 regulatory subunit B''Alpha silencing inhibits tumor cell proliferation in liver cancer.Cancer Med. 2019 Dec;8(18):7741-7753. doi: 10.1002/cam4.2620. Epub 2019 Oct 24.
• [4878] Downregulation of PPP2R5E expression by miR-23a suppresses apoptosis to facilitate the growth of gastric cancer cells.FEBS Lett. 2014 Aug 25;588(17):3160-9. doi: 10.1016/j.febslet.2014.05.068. Epub 2014 Jul 2.
• [4879] PPP3CB contributes to poor prognosis through activating nuclear factor of activated T-cells signaling in neuroblastoma.Mol Carcinog. 2019 Mar;58(3):426-435. doi: 10.1002/mc.22939. Epub 2018 Dec 13.
• [4880] Involvement of DPP9 in gene fusions in serous ovarian carcinoma.BMC Cancer. 2017 Sep 11;17(1):642. doi: 10.1186/s12885-017-3625-6.
• [4881] Polycomb Repressor Complex 2 in Genomic Instability and Cancer.Int J Mol Sci. 2017 Jul 30;18(8):1657. doi: 10.3390/ijms18081657.
• [4882] Long noncoding RNA HOXB13-AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma.Cancer Med. 2018 Sep;7(9):4718-4728. doi: 10.1002/cam4.1718. Epub 2018 Aug 13.
• [4883] PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.Cancer Manag Res. 2018 Jul 25;10:2241-2248. doi: 10.2147/CMAR.S166789. eCollection 2018.
• [4884] Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - 1 (TGF-1) and potential effects on migration and invasion.BMC Cancer. 2017 May 19;17(1):350. doi: 10.1186/s12885-017-3349-7.
• [4885] Tumor suppressors: enhancers or suppressors of regeneration?.Development. 2013 Jun;140(12):2502-12. doi: 10.1242/dev.084210.
• [4886] pRb2/p130 localizes to the cytoplasm in diffuse gastric cancer.J Cell Physiol. 2015 Apr;230(4):802-5. doi: 10.1002/jcp.24805.
• [4887] JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/Tcell lymphoma, nasal type.Oncol Rep. 2019 Jun;41(6):3219-3232. doi: 10.3892/or.2019.7112. Epub 2019 Apr 12.
• [4888] Loss of PRDM11 promotes MYC-driven lymphomagenesis.Blood. 2015 Feb 19;125(8):1272-81. doi: 10.1182/blood-2014-03-560805. Epub 2014 Dec 12.
• [4889] PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.Clin Transl Oncol. 2020 Jul;22(7):1126-1137. doi: 10.1007/s12094-019-02239-z. Epub 2019 Nov 18.
• [4890] PRDM16 functions as a suppressor of lung adenocarcinoma metastasis.J Exp Clin Cancer Res. 2019 Jan 25;38(1):35. doi: 10.1186/s13046-019-1042-1.
• [4891] Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution.Histopathology. 2019 Mar;74(4):654-662. doi: 10.1111/his.13783. Epub 2019 Jan 31.
• [4892] Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.Gynecol Oncol. 2020 Feb;156(2):423-429. doi: 10.1016/j.ygyno.2019.12.003. Epub 2019 Dec 13.
• [4893] TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression.Oncogene. 2020 Jan;39(2):356-367. doi: 10.1038/s41388-019-0991-3. Epub 2019 Sep 2.
• [4894] Prx2 links ROS homeostasis to stemness of cancer stem cells.Free Radic Biol Med. 2019 Apr;134:260-267. doi: 10.1016/j.freeradbiomed.2019.01.001. Epub 2019 Jan 4.
• [4895] Peroxiredoxin III Protects Tumor Suppressor PTEN from Oxidation by 15-Hydroperoxy-eicosatetraenoic Acid.Oxid Med Cell Longev. 2019 Sep 15;2019:2828493. doi: 10.1155/2019/2828493. eCollection 2019.
• [4896] Differential Expression And Effects Of Peroxiredoxin-6 On Drug Resistance And Cancer Stem Cell-Like Properties In Non-Small Cell Lung Cancer.Onco Targets Ther. 2019 Dec 2;12:10477-10486. doi: 10.2147/OTT.S211125. eCollection 2019.
• [4897] PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells.Oncogene. 2020 Feb;39(6):1318-1334. doi: 10.1038/s41388-019-1064-3. Epub 2019 Oct 21.
• [4898] Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.Int J Cancer. 2017 May 15;140(10):2284-2297. doi: 10.1002/ijc.30652.
• [4899] A sequential targeting nanoplatform for anaplastic thyroid carcinoma theranostics.Acta Biomater. 2020 Jan 15;102:367-383. doi: 10.1016/j.actbio.2019.11.043. Epub 2019 Nov 26.
• [4900] DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint.Int J Cancer. 2019 Feb 1;144(3):615-630. doi: 10.1002/ijc.31788. Epub 2018 Nov 21.
• [4901] Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer.PLoS One. 2017 Jul 27;12(7):e0180616. doi: 10.1371/journal.pone.0180616. eCollection 2017.
• [4902] AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3.Int J Cancer. 2019 Oct 15;145(8):2082-2090. doi: 10.1002/ijc.32261. Epub 2019 Mar 26.
• [4903] Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma.Histopathology. 2019 Aug;75(2):193-201. doi: 10.1111/his.13854. Epub 2019 Jun 18.
• [4904] Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101.Mol Cancer Ther. 2015 Jun;14(6):1306-16. doi: 10.1158/1535-7163.MCT-14-0945. Epub 2015 Apr 7.
• [4905] Somatic and germline mutations in the tumor suppressor gene PARK2 impair PINK1/Parkin-mediated mitophagy in lung cancer cells.Acta Pharmacol Sin. 2020 Jan;41(1):93-100. doi: 10.1038/s41401-019-0260-6. Epub 2019 Jul 8.
• [4906] Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma.Endocr Relat Cancer. 2013 Jul 4;20(4):551-64. doi: 10.1530/ERC-13-0098. Print 2013 Aug.
• [4907] Regulated expression of the TP isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3153-3169. doi: 10.1016/j.bbadis.2017.09.005. Epub 2017 Sep 8.
• [4908] Intestinal PPAR Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.Gastroenterology. 2019 Sep;157(3):744-759.e4. doi: 10.1053/j.gastro.2019.05.057. Epub 2019 May 30.
• [4909] Diagnostic value of PRND gene expression profiles in astrocytomas: relationship to tumor grades of malignancy.Oncol Rep. 2007 May;17(5):989-96. doi: 10.3892/or.17.5.989.
• [4910] The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis.Physiol Rev. 2018 Apr 1;98(2):1055-1082. doi: 10.1152/physrev.00012.2017.
• [4911] A small molecule, (E)-2-methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl) phenol suppresses tumor growth via inhibition of IkappaB kinase in colorectal cancer in vivo and in vitro.Oncotarget. 2017 Aug 24;8(53):91258-91269. doi: 10.18632/oncotarget.20440. eCollection 2017 Oct 31.
• [4912] Prp19 Arrests Cell Cycle via Cdc5L in Hepatocellular Carcinoma Cells.Int J Mol Sci. 2017 Apr 7;18(4):778. doi: 10.3390/ijms18040778.
• [4913] Precursor RNA processing 3 is required for male fertility, and germline stem cell self-renewal and differentiation via regulating spliceosome function in Drosophila testes.Sci Rep. 2019 Jul 10;9(1):9988. doi: 10.1038/s41598-019-46419-x.
• [4914] COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.J Cancer Res Clin Oncol. 2017 Jul;143(7):1133-1141. doi: 10.1007/s00432-017-2381-y. Epub 2017 Mar 3.
• [4915] Over-expression of adenine nucleotide translocase 1 (ANT1) induces apoptosis and tumor regression in vivo.BMC Cancer. 2008 Jun 4;8:160. doi: 10.1186/1471-2407-8-160.
• [4916] Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.J Mol Neurosci. 2016 Oct;60(2):145-56. doi: 10.1007/s12031-016-0783-y. Epub 2016 Jun 25.
• [4917] Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through -catenin signaling.Gene. 2019 Jan 10;681:7-14. doi: 10.1016/j.gene.2018.09.036. Epub 2018 Sep 21.
• [4918] Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer.Pharmacogenomics J. 2019 Feb;19(1):15-24. doi: 10.1038/s41397-018-0013-9. Epub 2018 Feb 22.
• [4919] PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.PLoS One. 2019 Oct 9;14(10):e0218839. doi: 10.1371/journal.pone.0218839. eCollection 2019.
• [4920] PRR5 encodes a conserved proline-rich protein predominant in kidney: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas.Genomics. 2005 Mar;85(3):338-51. doi: 10.1016/j.ygeno.2004.11.002.
• [4921] KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.DNA Cell Biol. 2002 Oct;21(10):707-15. doi: 10.1089/104454902760599681.
• [4922] PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p.Neoplasia. 2019 Feb;21(2):216-229. doi: 10.1016/j.neo.2018.12.001. Epub 2019 Jan 7.
• [4923] The thymus-specific serine protease TSSP/PRSS16 is crucial for the antitumoral role of CD4(+) T cells.Cell Rep. 2015 Jan 6;10(1):39-46. doi: 10.1016/j.celrep.2014.12.009. Epub 2014 Dec 24.
• [4924] PRSS23 knockdown inhibits gastric tumorigenesis through EIF2 signaling.Pharmacol Res. 2019 Apr;142:50-57. doi: 10.1016/j.phrs.2019.02.008. Epub 2019 Feb 12.
• [4925] PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene. 2007 Dec 13;26(57):7921-32. doi: 10.1038/sj.onc.1210589. Epub 2007 Jun 18.
• [4926] Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.BMC Cancer. 2019 Jun 6;19(1):542. doi: 10.1186/s12885-019-5772-4.
• [4927] Selective and augmented -glucuronidase expression combined with DOX-GA3 application elicits the potent suppression of prostate cancer.Oncol Rep. 2016 Mar;35(3):1417-24. doi: 10.3892/or.2015.4454. Epub 2015 Nov 26.
• [4928] Multifunctional Nanoparticles Loading with Docetaxel and GDC0941 for Reversing Multidrug Resistance Mediated by PI3K/Akt Signal Pathway.Mol Pharm. 2017 Apr 3;14(4):1120-1132. doi: 10.1021/acs.molpharmaceut.6b01045. Epub 2017 Mar 22.
• [4929] Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities.J Biotechnol. 2019 Jul 20;300:70-77. doi: 10.1016/j.jbiotec.2019.05.016. Epub 2019 May 28.
• [4930] Association of PSMA4 polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.Clin Transl Oncol. 2015 Jul;17(7):564-9. doi: 10.1007/s12094-015-1279-x. Epub 2015 Mar 6.
• [4931] Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.Cell Physiol Biochem. 2018;45(2):819-831. doi: 10.1159/000487174. Epub 2018 Jan 31.
• [4932] Knockdown of PSMC3IP suppresses the proliferation and xenografted tumorigenesis of hepatocellular carcinoma cell.J Cell Biochem. 2019 Apr;120(4):5449-5458. doi: 10.1002/jcb.27824. Epub 2018 Oct 25.
• [4933] Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.Nat Cell Biol. 2016 Feb;18(2):202-12. doi: 10.1038/ncb3289. Epub 2015 Dec 14.
• [4934] Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.Anticancer Res. 2003 May-Jun;23(3A):2159-66.
• [4935] POH1 contributes to hyperactivation of TGF- signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF- receptors and caveolin-1.EBioMedicine. 2019 Mar;41:320-332. doi: 10.1016/j.ebiom.2019.01.058. Epub 2019 Feb 7.
• [4936] Expression of liver cancer associated gene HCCA3.World J Gastroenterol. 2001 Dec;7(6):821-5. doi: 10.3748/wjg.v7.i6.821.
• [4937] Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.Mol Med. 1999 Aug;5(8):526-41.
• [4938] Race-associated biological differences among Luminal A breast tumors.Breast Cancer Res Treat. 2015 Jul;152(2):437-48. doi: 10.1007/s10549-015-3474-4. Epub 2015 Jun 25.
• [4939] LncRNA PAPAS promotes hepatocellular carcinoma by interacting with miR-188-5p.J Cell Biochem. 2019 Aug;120(8):13494-13500. doi: 10.1002/jcb.28623. Epub 2019 Mar 28.
• [4940] PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1.J Exp Clin Cancer Res. 2019 Jul 10;38(1):301. doi: 10.1186/s13046-019-1312-y.
• [4941] Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery.Oncotarget. 2017 Jun 30;8(45):79618-79628. doi: 10.18632/oncotarget.18896. eCollection 2017 Oct 3.
• [4942] Epigenetic targeting DNMT1 of pancreatic ductal adenocarcinoma using interstitial control release biodegrading polymer reduced tumor growth through hedgehog pathway inhibition.Pharmacol Res. 2019 Jan;139:50-61. doi: 10.1016/j.phrs.2018.10.015. Epub 2018 Oct 29.
• [4943] Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment.Mol Oncol. 2018 Jun;12(7):1104-1124. doi: 10.1002/1878-0261.12314. Epub 2018 May 21.
• [4944] Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients.EMBO J. 2017 Dec 15;36(24):3650-3665. doi: 10.15252/embj.201796700. Epub 2017 Nov 10.
• [4945] The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.Cancer Lett. 2019 Oct 10;462:33-42. doi: 10.1016/j.canlet.2019.07.018. Epub 2019 Aug 1.
• [4946] Prothymosin- enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.Cancer Sci. 2019 Apr;110(4):1208-1219. doi: 10.1111/cas.13963. Epub 2019 Mar 5.
• [4947] Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.J Exp Clin Cancer Res. 2019 Aug 6;38(1):341. doi: 10.1186/s13046-019-1349-y.
• [4948] High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer.BMC Cancer. 2019 Oct 12;19(1):944. doi: 10.1186/s12885-019-6182-3.
• [4949] PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation.Biomed Pharmacother. 2020 Jan;121:109583. doi: 10.1016/j.biopha.2019.109583. Epub 2019 Nov 6.
• [4950] Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.PLoS One. 2018 Mar 28;13(3):e0194913. doi: 10.1371/journal.pone.0194913. eCollection 2018.
• [4951] PTPN9 induces cell apoptosis by mitigating the activation of Stat3 and acts as a tumor suppressor in colorectal cancer.Cancer Manag Res. 2019 Feb 8;11:1309-1319. doi: 10.2147/CMAR.S187001. eCollection 2019.
• [4952] Interdependence between EGFR and Phosphatases Spatially Established by Vesicular Dynamics Generates a Growth Factor Sensing and Responding Network.Cell Syst. 2018 Sep 26;7(3):295-309.e11. doi: 10.1016/j.cels.2018.06.006. Epub 2018 Aug 22.
• [4953] Integrated analyses of murine breast cancer models reveal critical parallels with human disease.Nat Commun. 2019 Jul 22;10(1):3261. doi: 10.1038/s41467-019-11236-3.
• [4954] The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion.Elife. 2019 Mar 29;8:e44597. doi: 10.7554/eLife.44597.
• [4955] PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors.Endocr Connect. 2019 Aug 1;8(8):1126-1135. doi: 10.1530/EC-19-0279.
• [4956] Partial chromosome 7 duplication with a phenotype mimicking the HOXA1 spectrum disorder.Ophthalmic Genet. 2013 Mar-Jun;34(1-2):90-6. doi: 10.3109/13816810.2012.718850. Epub 2012 Sep 6.
• [4957] MiR-6803-5p Promotes Cancer Cell Proliferation and Invasion via PTPRO/NF-B Axis in Colorectal Cancer.Mediators Inflamm. 2019 Nov 20;2019:8128501. doi: 10.1155/2019/8128501. eCollection 2019.
• [4958] A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis.Oncotarget. 2017 Feb 7;8(6):10091-10102. doi: 10.18632/oncotarget.14350.
• [4959] Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia.J Clin Endocrinol Metab. 1989 May;68(5):976-81. doi: 10.1210/jcem-68-5-976.
• [4960] PBF, a Proto-oncogene in Esophageal Carcinoma.Open Med (Wars). 2019 Oct 13;14:748-756. doi: 10.1515/med-2019-0086. eCollection 2019.
• [4961] SPIN1 is a proto-oncogene and SPIN3 is a tumor suppressor in human seminoma.Oncotarget. 2018 Aug 21;9(65):32466-32477. doi: 10.18632/oncotarget.25977. eCollection 2018 Aug 21.
• [4962] A cyclin D1-positive diffuse large B-cell lymphoma of germinal center B-cell-like subtype in the right tonsil: A rare case report.Medicine (Baltimore). 2017 Mar;96(11):e6311. doi: 10.1097/MD.0000000000006311.
• [4963] Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.J Hepatol. 2020 Apr;72(4):725-735. doi: 10.1016/j.jhep.2019.10.026. Epub 2019 Nov 11.
• [4964] Somatic mutations of the mixed-lineage leukemia 3 (MLL3) gene in primary breast cancers.Pathol Oncol Res. 2011 Jun;17(2):429-33. doi: 10.1007/s12253-010-9316-0. Epub 2010 Nov 30.
• [4965] Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors.J Cell Commun Signal. 2019 Mar;13(1):75-84. doi: 10.1007/s12079-018-0476-0. Epub 2018 Jul 5.
• [4966] Frameshift mutation of candidate tumor suppressor genes QK1 and TMEFF2 in gastric and colorectal cancers.Cancer Biomark. 2019;24(1):1-6. doi: 10.3233/CBM-160559.
• [4967] GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.Oncotarget. 2017 May 23;8(21):34750-34761. doi: 10.18632/oncotarget.16160.
• [4968] Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo.Mol Cancer Ther. 2020 Jan;19(1):112-122. doi: 10.1158/1535-7163.MCT-19-0233. Epub 2019 Oct 1.
• [4969] Oncomutations as biomarkers of cancer risk.Environ Mol Mutagen. 2010 Oct-Dec;51(8-9):836-50. doi: 10.1002/em.20600.
• [4970] miR?78a?p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.Int J Mol Med. 2018 Jul;42(1):381-391. doi: 10.3892/ijmm.2018.3639. Epub 2018 Apr 24.
• [4971] High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer.Int J Oncol. 2017 Feb;50(2):396-404. doi: 10.3892/ijo.2016.3828. Epub 2016 Dec 30.
• [4972] RAB14 activates MAPK signaling to promote bladder tumorigenesis.Carcinogenesis. 2019 Nov 25;40(11):1341-1351. doi: 10.1093/carcin/bgz039.
• [4973] Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.Oncol Rep. 2019 May;41(5):2717-2728. doi: 10.3892/or.2019.7071. Epub 2019 Mar 15.
• [4974] RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer.Int J Cancer. 2019 Oct 15;145(8):2209-2224. doi: 10.1002/ijc.32338. Epub 2019 Apr 30.
• [4975] Overexpression of RAB34 correlates with poor prognosis and tumor progression in hepatocellular carcinoma.Oncol Rep. 2017 Nov;38(5):2967-2974. doi: 10.3892/or.2017.5957. Epub 2017 Sep 18.
• [4976] Rab35-dependent extracellular nanovesicles are required for induction of tumour supporting stroma.Nanoscale. 2018 May 10;10(18):8547-8559. doi: 10.1039/c8nr02417k.
• [4977] Rab37 mediates exocytosis of secreted frizzled-related protein 1 to inhibit Wnt signaling and thus suppress lung cancer stemness.Cell Death Dis. 2018 Aug 29;9(9):868. doi: 10.1038/s41419-018-0915-0.
• [4978] Rab3a promotes brain tumor initiation and progression.Mol Biol Rep. 2014 Sep;41(9):5903-11. doi: 10.1007/s11033-014-3465-2. Epub 2014 Jun 26.
• [4979] MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression.Aging (Albany NY). 2018 Jun 10;10(6):1294-1305. doi: 10.18632/aging.101468.
• [4980] Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway.Oncol Lett. 2018 Apr;15(4):5155-5160. doi: 10.3892/ol.2018.7949. Epub 2018 Feb 5.
• [4981] Determination of eumelanin and pheomelanin in melanomas using solid-phase extraction and high performance liquid chromatography-diode array detection (HPLC-DAD) analysis.J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Apr 15;1113:60-68. doi: 10.1016/j.jchromb.2019.03.010. Epub 2019 Mar 11.
• [4982] MicroRNA expression profiles of granulocytic myeloidderived suppressor cells from mice bearing Lewis lung carcinoma.Mol Med Rep. 2016 Nov;14(5):4567-4574. doi: 10.3892/mmr.2016.5845. Epub 2016 Oct 13.
• [4983] Down-regulation of c9orf86 in human breast cancer cells inhibits cell proliferation, invasion and tumor growth and correlates with survival of breast cancer patients.PLoS One. 2013 Aug 14;8(8):e71764. doi: 10.1371/journal.pone.0071764. eCollection 2013.
• [4984] RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma.Int J Oncol. 2019 Sep;55(3):645-656. doi: 10.3892/ijo.2019.4849. Epub 2019 Jul 26.
• [4985] Rac GTPase activating protein 1 promotes oncogenic progression of epithelial ovarian cancer.Cancer Sci. 2018 Jan;109(1):84-93. doi: 10.1111/cas.13434. Epub 2017 Nov 22.
• [4986] Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.Oncotarget. 2015 Nov 3;6(34):35755-69. doi: 10.18632/oncotarget.5928.
• [4987] Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer.Surg Oncol. 2018 Jun;27(2):225-230. doi: 10.1016/j.suronc.2018.04.004. Epub 2018 Apr 26.
• [4988] Subcellular distribution of RAD23B controls XPC degradation and DNA damage repair in response to chemotherapy drugs.Cell Signal. 2017 Aug;36:108-116. doi: 10.1016/j.cellsig.2017.04.023. Epub 2017 May 1.
• [4989] Detection and screening of chromosomal rearrangements in uterine leiomyomas by long-distance inverse PCR.Genes Chromosomes Cancer. 2016 Mar;55(3):215-26. doi: 10.1002/gcc.22317. Epub 2015 Nov 26.
• [4990] Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.Int J Cancer. 2018 Sep 15;143(6):1416-1425. doi: 10.1002/ijc.31526. Epub 2018 Apr 25.
• [4991] Distinct roles of RAD52 and POLQ in chromosomal break repair and replication stress response.PLoS Genet. 2019 Aug 5;15(8):e1008319. doi: 10.1371/journal.pgen.1008319. eCollection 2019 Aug.
• [4992] RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.Biomed Pharmacother. 2019 Oct;118:109341. doi: 10.1016/j.biopha.2019.109341. Epub 2019 Aug 21.
• [4993] Cross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes.Cancer Cell. 2015 May 11;27(5):712-27. doi: 10.1016/j.ccell.2015.04.005.
• [4994] The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.Blood. 2009 Jul 9;114(2):310-7. doi: 10.1182/blood-2008-12-196287. Epub 2009 May 12.
• [4995] NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting.Clin Cancer Res. 2009 Nov 15;15(22):6993-7002. doi: 10.1158/1078-0432.CCR-09-0991. Epub 2009 Oct 27.
• [4996] Glial TLR2-driven innate immune responses and CD8(+) T cell activation against brain tumor.Glia. 2019 Jun;67(6):1179-1195. doi: 10.1002/glia.23597. Epub 2019 Feb 5.
• [4997] Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells.J Cancer. 2019 Oct 18;10(25):6341-6348. doi: 10.7150/jca.34910. eCollection 2019.
• [4998] Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.Clin Epigenetics. 2018 May 23;10:69. doi: 10.1186/s13148-018-0501-4. eCollection 2018.
• [4999] Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis.Carcinogenesis. 2019 Dec 31;40(12):1535-1544. doi: 10.1093/carcin/bgz082.
• [5000] Multiple drug resistance, the MDR gene, and the law of maximum perversity as it applies to oncology: an hypothesis.Hematol Oncol. 1994 Jul-Aug;12(4):155-61. doi: 10.1002/hon.2900120402.
• [5001] Hypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a.Cancer Biol Ther. 2018;19(11):984-993. doi: 10.1080/15384047.2018.1456608. Epub 2018 May 14.
• [5002] Rap1b enhances the invasion and migration of hepatocellular carcinoma cells by up-regulating Twist 1.Exp Cell Res. 2018 Jun 1;367(1):56-64. doi: 10.1016/j.yexcr.2018.03.019. Epub 2018 Mar 17.
• [5003] Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.Cancer Biomark. 2018;22(3):375-384. doi: 10.3233/CBM-170832.
• [5004] The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.Mol Cancer Res. 2014 Jan;12(1):130-42. doi: 10.1158/1541-7786.MCR-13-0362. Epub 2013 Nov 6.
• [5005] Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.Endocr Relat Cancer. 2011 Apr 2;18(3):301-10. doi: 10.1530/ERC-10-0320. Print 2011 Jun.
• [5006] Rap2B promotes cell adhesion, proliferation, migration and invasion of human glioma.J Neurooncol. 2019 Jun;143(2):221-229. doi: 10.1007/s11060-019-03163-6. Epub 2019 Apr 17.
• [5007] Ras-related protein Rap2c promotes the migration and invasion of human osteosarcoma cells.Oncol Lett. 2018 Apr;15(4):5352-5358. doi: 10.3892/ol.2018.7987. Epub 2018 Feb 7.
• [5008] circRAPGEF5 Contributes to Papillary Thyroid Proliferation and Metastatis by Regulation miR-198/FGFR1.Mol Ther Nucleic Acids. 2019 Mar 1;14:609-616. doi: 10.1016/j.omtn.2019.01.003. Epub 2019 Jan 15.
• [5009] The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.Clin Sci (Lond). 2019 Mar 5;133(5):681-695. doi: 10.1042/CS20181023. Print 2019 Mar 15.
• [5010] Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts.Leuk Res. 2011 Apr;35(4):479-83. doi: 10.1016/j.leukres.2010.08.012. Epub 2010 Sep 22.
• [5011] Rasal2 suppresses breast cancer cell proliferation modulated by secretory autophagy.Mol Cell Biochem. 2019 Dec;462(1-2):115-122. doi: 10.1007/s11010-019-03615-7. Epub 2019 Aug 31.
• [5012] RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.JCI Insight. 2019 Jun 25;5(15):e127552. doi: 10.1172/jci.insight.127552.
• [5013] RasGRP3 controls cell proliferation and migration in papillary thyroid cancer by regulating the Akt-MDM2 pathway.Gene. 2017 Oct 30;633:35-41. doi: 10.1016/j.gene.2017.08.024. Epub 2017 Aug 31.
• [5014] Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels.Oncotarget. 2015 Oct 6;6(30):28755-73. doi: 10.18632/oncotarget.4810.
• [5015] DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas.Brain Pathol. 2012 Jan;22(1):17-25. doi: 10.1111/j.1750-3639.2011.00507.x. Epub 2011 Aug 16.
• [5016] RASSF10 Is a TGF-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer.Cancers (Basel). 2019 Dec 8;11(12):1976. doi: 10.3390/cancers11121976.
• [5017] The microRNA-200 family acts as an oncogene in colorectal cancer by inhibiting the tumor suppressor RASSF2.Oncol Lett. 2019 Oct;18(4):3994-4007. doi: 10.3892/ol.2019.10753. Epub 2019 Aug 16.
• [5018] Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck.Eur J Cancer. 2014 Feb;50(3):582-92. doi: 10.1016/j.ejca.2013.11.009. Epub 2013 Nov 29.
• [5019] Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression.Cancer Res. 2018 Mar 1;78(5):1155-1168. doi: 10.1158/0008-5472.CAN-17-1544. Epub 2017 Dec 19.
• [5020] Truncated RASSF7 promotes centrosomal defects and cell death.Dev Biol. 2016 Jan 15;409(2):502-17. doi: 10.1016/j.ydbio.2015.11.001. Epub 2015 Nov 10.
• [5021] The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.EBioMedicine. 2019 Jun;44:182-193. doi: 10.1016/j.ebiom.2019.05.032. Epub 2019 May 31.
• [5022] PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.J Exp Clin Cancer Res. 2018 Sep 4;37(1):215. doi: 10.1186/s13046-018-0890-4.
• [5023] Effects of ALA-PDT on HPV16-immortalized cervical epithelial cell.Neoplasma. 2017;64(2):175-181. doi: 10.4149/neo_2017_202.
• [5024] Retinoblastoma Binding Protein 5 Correlates with the Progression in Hepatocellular Carcinoma.Biomed Res Int. 2018 Nov 7;2018:1073432. doi: 10.1155/2018/1073432. eCollection 2018.
• [5025] RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial-mesenchymal transition and promotes metastasis of colorectal cancer.Cell Death Dis. 2019 Nov 4;10(11):833. doi: 10.1038/s41419-019-2070-7.
• [5026] RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma.Oncol Lett. 2018 Dec;16(6):7204-7211. doi: 10.3892/ol.2018.9543. Epub 2018 Oct 3.
• [5027] Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.PLoS One. 2015 Apr 10;10(4):e0123882. doi: 10.1371/journal.pone.0123882. eCollection 2015.
• [5028] The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.Mol Carcinog. 2019 Feb;58(2):196-205. doi: 10.1002/mc.22919. Epub 2018 Oct 28.
• [5029] RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.Theranostics. 2017 Jul 22;7(12):3138-3154. doi: 10.7150/thno.19506. eCollection 2017.
• [5030] Salinomycin-loaded Nanofibers for Glioblastoma Therapy.Sci Rep. 2018 Jun 20;8(1):9377. doi: 10.1038/s41598-018-27733-2.
• [5031] RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.Oncogene. 2020 Jan;39(5):1031-1040. doi: 10.1038/s41388-019-1034-9. Epub 2019 Oct 7.
• [5032] Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.Cell Physiol Biochem. 2019;52(4):787-801. doi: 10.33594/000000055.
• [5033] Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).Eur J Cancer. 2019 Nov;121:130-143. doi: 10.1016/j.ejca.2019.08.022. Epub 2019 Sep 28.
• [5034] Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells.Am J Pathol. 2003 Nov;163(5):1781-90. doi: 10.1016/S0002-9440(10)63538-9.
• [5035] Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.Oncotarget. 2017 Dec 15;9(5):6188-6200. doi: 10.18632/oncotarget.23486. eCollection 2018 Jan 19.
• [5036] Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression.Cancer Res. 2019 Feb 15;79(4):807-818. doi: 10.1158/0008-5472.CAN-18-2209. Epub 2018 Dec 27.
• [5037] CAPER- alternative splicing regulates the expression of vascular endothelial growth factor?in Ewing sarcoma cells.Cancer. 2012 Apr 15;118(8):2106-16. doi: 10.1002/cncr.26488. Epub 2011 Aug 25.
• [5038] Expression analysis of a panel of cancer-testis antigens in bladder cancer.Per Med. 2018 Nov;15(6):511-520. doi: 10.2217/pme-2018-0049. Epub 2018 Oct 26.
• [5039] The RNA-binding protein RBM47 is a novel regulator of cell fate decisions by transcriptionally controlling the p53-p21-axis.Cell Death Differ. 2020 Apr;27(4):1274-1285. doi: 10.1038/s41418-019-0414-6. Epub 2019 Sep 11.
• [5040] RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer.J Exp Clin Cancer Res. 2018 Dec 4;37(1):298. doi: 10.1186/s13046-018-0968-z.
• [5041] The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.J Exp Clin Cancer Res. 2019 Feb 28;38(1):105. doi: 10.1186/s13046-019-1111-5.
• [5042] Expression and mutation analysis of heterogeneous nuclear ribonucleoprotein G in human oral cancer.Oral Oncol. 2011 Nov;47(11):1011-6. doi: 10.1016/j.oraloncology.2011.07.012. Epub 2011 Aug 12.
• [5043] Blockade of the vascular endothelial growth factor-receptor 2 pathway inhibits the growth of human renal cell carcinoma, RBM1-IT4, in the kidney but not in the bone of nude mice.Int J Oncol. 2007 Apr;30(4):937-45.
• [5044] Retinoblastoma: messenger RNA for interphotoreceptor retinoid binding protein.Curr Eye Res. 1992 May;11(5):425-33. doi: 10.3109/02713689209001796.
• [5045] Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer.Adv Ther. 2018 Jun;35(6):779-784. doi: 10.1007/s12325-018-0711-3. Epub 2018 May 17.
• [5046] Clinicopathological significance of RCAN2 production in gastric carcinoma.Histopathology. 2019 Feb;74(3):430-442. doi: 10.1111/his.13764.
• [5047] CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.Int J Cancer. 2002 Jun 10;99(5):689-96. doi: 10.1002/ijc.10393.
• [5048] Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.Int J Clin Exp Pathol. 2015 Nov 1;8(11):14257-69. eCollection 2015.
• [5049] RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.Biochem Biophys Res Commun. 2019 Aug 27;516(3):999-1006. doi: 10.1016/j.bbrc.2019.06.097. Epub 2019 Jul 2.
• [5050] Downregulated PIRH2 Can Decrease the Proliferation of Breast Cancer Cells.Arch Med Res. 2016 Apr;47(3):186-95. doi: 10.1016/j.arcmed.2016.06.004. Epub 2016 Jul 6.
• [5051] Irradiation of Epithelial Carcinoma Cells Upregulates Calcium-Binding Proteins That Promote Survival under Hypoxic Conditions.J Proteome Res. 2016 Dec 2;15(12):4258-4264. doi: 10.1021/acs.jproteome.6b00340. Epub 2016 Nov 10.
• [5052] Retinal Degeneration Protein 3 (RD3) in normal human tissues: Novel insights.Sci Rep. 2017 Oct 13;7(1):13154. doi: 10.1038/s41598-017-13337-9.
• [5053] Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-B axis.Oncotarget. 2017 Oct 27;8(62):105262-105275. doi: 10.18632/oncotarget.22166. eCollection 2017 Dec 1.
• [5054] Clinical significance and function of RDH16 as a tumor-suppressing gene in hepatocellular carcinoma.Hepatol Res. 2020 Jan;50(1):110-120. doi: 10.1111/hepr.13432. Epub 2019 Dec 8.
• [5055] Brcal Defective Breast Cancer Cells Induce in vitro Transformation of Cancer Associated Fibroblasts (CAFs) to Metastasis Associated Fibroblasts (MAF).Sci Rep. 2018 Sep 17;8(1):13903. doi: 10.1038/s41598-018-32370-w.
• [5056] Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma.Oncol Lett. 2018 Apr;15(4):4248-4254. doi: 10.3892/ol.2018.7860. Epub 2018 Jan 25.
• [5057] Decreased RECQL5 correlated with disease progression of osteosarcoma.Biochem Biophys Res Commun. 2015 Nov 27;467(4):617-22. doi: 10.1016/j.bbrc.2015.10.114. Epub 2015 Oct 22.
• [5058] Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients.Digestion. 2019;99(1):6-13. doi: 10.1159/000494406. Epub 2018 Dec 14.
• [5059] Regenerating gene 1B silencing inhibits colon cancer cell HCT116 proliferation and invasion.Int J Biol Markers. 2015 May 26;30(2):e217-25. doi: 10.5301/jbm.5000133.
• [5060] Attenuated TRAF3 Fosters Activation of Alternative NF-B and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers.Cancer Res. 2018 Aug 15;78(16):4613-4626. doi: 10.1158/0008-5472.CAN-17-0642. Epub 2018 Jun 19.
• [5061] Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.Cancer Med. 2018 Apr;7(4):1359-1368. doi: 10.1002/cam4.1379. Epub 2018 Mar 15.
• [5062] Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway.Mol Carcinog. 2019 Aug;58(8):1427-1437. doi: 10.1002/mc.23025. Epub 2019 Jun 4.
• [5063] Repin1 deficiency in liver tissue alleviates NAFLD progression in mice.J Adv Res. 2018 Nov 22;16:99-111. doi: 10.1016/j.jare.2018.11.003. eCollection 2019 Mar.
• [5064] A single neonatal administration of Bisphenol A induces higher tumour weight associated to changes in tumour microenvironment in the adulthood.Sci Rep. 2017 Sep 5;7(1):10573. doi: 10.1038/s41598-017-10135-1.
• [5065] Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.ACS Chem Biol. 2017 Jul 21;12(7):1903-1912. doi: 10.1021/acschembio.6b01144. Epub 2017 Jun 9.
• [5066] Integrative genomic analyses of a novel cytokine, interleukin-34 and its potential role in cancer prediction.Int J Mol Med. 2015 Jan;35(1):92-102. doi: 10.3892/ijmm.2014.2001. Epub 2014 Nov 12.
• [5067] RFX-B, a MHC class II transcription factor, suppressed in human colorectal adenocarcinomas.Int J Mol Med. 2002 Mar;9(3):213-6.
• [5068] Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer.Cancer Immunol Immunother. 2015 Mar;64(3):357-66. doi: 10.1007/s00262-014-1638-4. Epub 2014 Dec 2.
• [5069] Response gene to complement 32 expression in macrophages augments paracrine stimulation-mediated colon cancer progression.Cell Death Dis. 2019 Oct 10;10(10):776. doi: 10.1038/s41419-019-2006-2.
• [5070] Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.J Surg Oncol. 2017 Jun;115(8):917-923. doi: 10.1002/jso.24610. Epub 2017 Apr 13.
• [5071] Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis.Cancer Lett. 2013 Oct 1;339(1):33-41. doi: 10.1016/j.canlet.2013.07.025. Epub 2013 Jul 30.
• [5072] lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR?65/RGS20 in oral squamous cell carcinoma.Oncol Rep. 2018 Apr;39(4):1948-1956. doi: 10.3892/or.2018.6283. Epub 2018 Feb 26.
• [5073] RGS22, a novel cancer/testis antigen, inhibits epithelial cell invasion and metastasis.Clin Exp Metastasis. 2011 Aug;28(6):541-9. doi: 10.1007/s10585-011-9390-z. Epub 2011 May 1.
• [5074] Regulator of G-protein signaling 3 targeted by miR-126 correlates with poor prognosis in gastric cancer patients.Anticancer Drugs. 2017 Feb;28(2):161-169. doi: 10.1097/CAD.0000000000000446.
• [5075] Clonal analyses of refractory testicular germ cell tumors.PLoS One. 2019 Mar 14;14(3):e0213815. doi: 10.1371/journal.pone.0213815. eCollection 2019.
• [5076] Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression.Oncol Rep. 2018 Aug;40(2):909-915. doi: 10.3892/or.2018.6489. Epub 2018 Jun 14.
• [5077] Model of human recurrent respiratory papilloma on chicken embryo chorioallantoic membrane for tumor angiogenesis research.Histol Histopathol. 2017 Jul;32(7):699-710. doi: 10.14670/HH-11-831. Epub 2016 Oct 10.
• [5078] Treatment of a Malignant Soft Tissue Tumor Arising in the Vicinity of the Sciatic Nerve with an In-Situ Preparation Technique and Intensive Multidisciplinary Therapy.Cancers (Basel). 2019 Apr 10;11(4):506. doi: 10.3390/cancers11040506.
• [5079] Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.J Clin Invest. 2016 Sep 1;126(9):3526-40. doi: 10.1172/JCI86120. Epub 2016 Aug 2.
• [5080] The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.Int J Oncol. 2013 Feb;42(2):676-82. doi: 10.3892/ijo.2012.1746. Epub 2012 Dec 20.
• [5081] DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.Oncogene. 2017 May 18;36(20):2802-2812. doi: 10.1038/onc.2016.441. Epub 2016 Dec 12.
• [5082] Effect of RhoC silencing on multiple myeloma xenografts and angiogenesis in nude mice.J Biol Regul Homeost Agents. 2019 September-October,;33(5):1387-1394.
• [5083] Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC/DIABLO, and RHOF.Genes Chromosomes Cancer. 2008 Dec;47(12):1067-75. doi: 10.1002/gcc.20601.
• [5084] Development of (99m)Tc-labeled trivalent isonitrile radiotracer for folate receptor imaging.Bioorg Med Chem. 2019 May 15;27(10):1925-1931. doi: 10.1016/j.bmc.2019.04.013. Epub 2019 Apr 10.
• [5085] RIF1 promotes tumor growth and cancer stem cell-like traits in NSCLC by protein phosphatase 1-mediated activation of Wnt/-catenin signaling.Cell Death Dis. 2018 Sep 20;9(10):942. doi: 10.1038/s41419-018-0972-4.
• [5086] Dermal Sinus Tract of Lumbosacral Spine in Children: Patterns on Magnetic Resonance Imaging and Scoring System.Cureus. 2017 Dec 4;9(12):e1906. doi: 10.7759/cureus.1906.
• [5087] The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking.Sci Signal. 2015 Feb 17;8(364):ra18. doi: 10.1126/scisignal.2005547.
• [5088] NLGP counterbalances the immunosuppressive effect of tumor-associated mesenchymal stem cells to restore effector T cell functions.Stem Cell Res Ther. 2019 Sep 23;10(1):296. doi: 10.1186/s13287-019-1349-z.
• [5089] Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B.Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6332-E6341. doi: 10.1073/pnas.1619932114. Epub 2017 Jul 18.
• [5090] Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk.PLoS One. 2017 Mar 6;12(3):e0172247. doi: 10.1371/journal.pone.0172247. eCollection 2017.
• [5091] The Rio1 protein kinases/ATPases: conserved regulators of growth, division, and genomic stability.Curr Genet. 2019 Apr;65(2):457-466. doi: 10.1007/s00294-018-0912-y. Epub 2018 Dec 4.
• [5092] Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer.Oncogene. 2019 Jun;38(25):5038-5049. doi: 10.1038/s41388-019-0774-x. Epub 2019 Mar 11.
• [5093] Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy.Oncol Rep. 2018 Jul;40(1):101-110. doi: 10.3892/or.2018.6407. Epub 2018 Apr 30.
• [5094] RIPK3-Induced Inflammation by I-MDSCs Promotes Intestinal Tumors.Cancer Res. 2019 Apr 1;79(7):1587-1599. doi: 10.1158/0008-5472.CAN-18-2153. Epub 2019 Feb 20.
• [5095] PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.Mol Cancer. 2010 Dec 29;9:319. doi: 10.1186/1476-4598-9-319.
• [5096] (212)Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.Int J Mol Sci. 2018 Mar 21;19(4):925. doi: 10.3390/ijms19040925.
• [5097] RALBP1 regulates oral cancer cells via Akt and is a novel target of miR-148a-3p and miR-148b-3p.J Oral Pathol Med. 2019 Nov;48(10):919-928. doi: 10.1111/jop.12936. Epub 2019 Aug 18.
• [5098] Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.J Control Release. 2018 Nov 28;290:1-10. doi: 10.1016/j.jconrel.2018.09.031. Epub 2018 Oct 2.
• [5099] The value of macrophage inhibitory cytokine-1 level in differentiating benign from malignant solitary pulmonary nodules.Clin Respir J. 2018 Apr;12(4):1473-1478. doi: 10.1111/crj.12693. Epub 2017 Sep 14.
• [5100] Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop.Mol Biol Rep. 2018 Oct;45(5):1277-1287. doi: 10.1007/s11033-018-4288-3. Epub 2018 Aug 3.
• [5101] Nanoscale ATP-Responsive Zeolitic Imidazole Framework-90 as a General Platform for Cytosolic Protein Delivery and Genome Editing.J Am Chem Soc. 2019 Mar 6;141(9):3782-3786. doi: 10.1021/jacs.8b11996. Epub 2019 Feb 8.
• [5102] CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors.J Immunol. 2007 Aug 1;179(3):1996-2004. doi: 10.4049/jimmunol.179.3.1996.
• [5103] RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.Oncol Rep. 2016 Jul;36(1):173-80. doi: 10.3892/or.2016.4802. Epub 2016 May 10.
• [5104] The RND1 Small GTPase: Main Functions and Emerging Role in Oncogenesis.Int J Mol Sci. 2019 Jul 24;20(15):3612. doi: 10.3390/ijms20153612.
• [5105] Rnd3 in Cancer: A Review of the Evidence for Tumor Promoter or Suppressor.Mol Cancer Res. 2016 Nov;14(11):1033-1044. doi: 10.1158/1541-7786.MCR-16-0164. Epub 2016 Aug 23.
• [5106] The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.Oncogene. 2016 Jul 7;35(27):3514-23. doi: 10.1038/onc.2015.412. Epub 2015 Nov 2.
• [5107] Biologic false-positive serologic tests for syphilis and other serologic abnormalities in autoimmune hemolytic anemia and thrombocytopenic purpura.Medicine (Baltimore). 1989 Mar;68(2):67-84. doi: 10.1097/00005792-198903000-00001.
• [5108] RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.Int J Oncol. 2018 Mar;52(3):861-871. doi: 10.3892/ijo.2018.4253. Epub 2018 Jan 24.
• [5109] Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.Hepatol Int. 2015 Jul;9(3):438-46. doi: 10.1007/s12072-015-9642-0. Epub 2015 Jun 12.
• [5110] E3 Ubiquitin ligase RNF126 regulates the progression of tongue cancer.Cancer Med. 2016 Aug;5(8):2043-7. doi: 10.1002/cam4.771. Epub 2016 May 26.
• [5111] Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.Oncol Rep. 2018 Dec;40(6):3285-3296. doi: 10.3892/or.2018.6744. Epub 2018 Sep 28.
• [5112] Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.Int J Hematol. 2017 Feb;105(2):226-229. doi: 10.1007/s12185-016-2100-5. Epub 2016 Sep 29.
• [5113] The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168.Nat Cell Biol. 2018 Mar;20(3):320-331. doi: 10.1038/s41556-017-0033-8. Epub 2018 Feb 5.
• [5114] Screening and verification of proteins that interact with HSPC238.Oncol Rep. 2015 Dec;34(6):3097-103. doi: 10.3892/or.2015.4289. Epub 2015 Sep 18.
• [5115] Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells.Chin J Cancer. 2017 Jul 31;36(1):63. doi: 10.1186/s40880-017-0228-1.
• [5116] Ring1b-dependent epigenetic remodelling is an essential prerequisite for pancreatic carcinogenesis.Gut. 2019 Nov;68(11):2007-2018. doi: 10.1136/gutjnl-2018-317208. Epub 2019 Apr 6.
• [5117] Early Loss of Histone H2B Monoubiquitylation Alters Chromatin Accessibility and Activates Key Immune Pathways That Facilitate Progression of Ovarian Cancer.Cancer Res. 2019 Feb 15;79(4):760-772. doi: 10.1158/0008-5472.CAN-18-2297. Epub 2018 Dec 18.
• [5118] PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia.Nat Cell Biol. 2016 Jul;18(7):803-813. doi: 10.1038/ncb3376. Epub 2016 Jun 20.
• [5119] RNF216 contributes to proliferation and migration of colorectal cancer via suppressing BECN1-dependent autophagy.Oncotarget. 2016 Aug 9;7(32):51174-51183. doi: 10.18632/oncotarget.9433.
• [5120] Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor B (NF-B) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.Mol Cell Proteomics. 2015 Jul;14(7):1814-30. doi: 10.1074/mcp.M114.041335. Epub 2015 Apr 22.
• [5121] Expression of the three components of linear ubiquitin assembly complex in breast cancer.PLoS One. 2018 May 15;13(5):e0197183. doi: 10.1371/journal.pone.0197183. eCollection 2018.
• [5122] Overexpression of RNF38 facilitates TGF- signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.J Exp Clin Cancer Res. 2019 Mar 5;38(1):113. doi: 10.1186/s13046-019-1113-3.
• [5123] Role of RNF20 in cancer development and progression - a comprehensive review.Biosci Rep. 2018 Jul 12;38(4):BSR20171287. doi: 10.1042/BSR20171287. Print 2018 Aug 31.
• [5124] Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.Oncotarget. 2017 Jul 18;8(29):47110-47120. doi: 10.18632/oncotarget.16943.
• [5125] Long interspersed element-1 ribonucleoprotein particles protect telomeric ends in alternative lengthening of telomeres dependent cells.Neoplasia. 2020 Feb;22(2):61-75. doi: 10.1016/j.neo.2019.11.002. Epub 2019 Dec 14.
• [5126] Reactive Oxygen Species Modulator 1 (Romo1) Predicts Poor Outcomes in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy.Cancer Res Treat. 2017 Jan;49(1):141-149. doi: 10.4143/crt.2016.133. Epub 2016 May 18.
• [5127] Telomere length regulators are activated in young men after pediatric kidney transplantation compared to healthy controls and survivors of childhood cancer-A cross-sectional study.Pediatr Transplant. 2019 Nov;23(7):e13550. doi: 10.1111/petr.13550. Epub 2019 Jul 11.
• [5128] Proteomic analysis of BRCA1-depleted cell line reveals a putative role for replication protein A2 up-regulation in BRCA1 breast tumor development.Proteomics Clin Appl. 2010 May;4(5):489-98. doi: 10.1002/prca.200900107. Epub 2010 Jan 4.
• [5129] Elevated Expression of RPA3 Is Involved in Gastric Cancer Tumorigenesis and Associated with Poor Patient Survival.Dig Dis Sci. 2017 Sep;62(9):2369-2375. doi: 10.1007/s10620-017-4696-6. Epub 2017 Aug 1.
• [5130] The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma.Eur J Cancer. 2009 Jul;45(11):2041-9. doi: 10.1016/j.ejca.2009.04.012. Epub 2009 May 4.
• [5131] Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.PLoS One. 2015 Jun 12;10(6):e0129216. doi: 10.1371/journal.pone.0129216. eCollection 2015.
• [5132] GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.EMBO Rep. 2017 Jan;18(1):123-137. doi: 10.15252/embr.201642444. Epub 2016 Nov 17.
• [5133] Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.PLoS One. 2015 Nov 30;10(11):e0143659. doi: 10.1371/journal.pone.0143659. eCollection 2015.
• [5134] Identification of valid reference genes for gene expression studies of human stomach cancer by reverse transcription-qPCR.BMC Cancer. 2010 May 28;10:240. doi: 10.1186/1471-2407-10-240.
• [5135] Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles.Oncotarget. 2016 Nov 29;7(48):79670-79687. doi: 10.18632/oncotarget.13216.
• [5136] Silencing of Ribosomal Protein L34 (RPL34) Inhibits the Proliferation and Invasion of Esophageal Cancer Cells.Oncol Res. 2017 Aug 7;25(7):1061-1068. doi: 10.3727/096504016X14830466773541. Epub 2017 Jan 20.
• [5137] RPL36 as a prognostic marker in hepatocellular carcinoma.Pathol Int. 2011 Nov;61(11):638-44. doi: 10.1111/j.1440-1827.2011.02716.x. Epub 2011 Sep 23.
• [5138] RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors.RNA Biol. 2014;11(1):33-41. doi: 10.4161/rna.27427. Epub 2013 Dec 20.
• [5139] Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.Cancer Res. 2007 Apr 15;67(8):3555-9. doi: 10.1158/0008-5472.CAN-06-2763.
• [5140] Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells in vitro and in vivo.Biosci Rep. 2019 May 7;39(5):BSR20182448. doi: 10.1042/BSR20182448. Print 2019 May 31.
• [5141] MicroRNA-300 inhibits the growth of hepatocellular carcinoma cells by downregulating CREPT/Wnt/-catenin signaling.Oncol Lett. 2019 Oct;18(4):3743-3753. doi: 10.3892/ol.2019.10712. Epub 2019 Aug 5.
• [5142] The relationship between DNA methylation and Reprimo gene expression in gastric cancer cells.Oncotarget. 2017 Sep 28;8(65):108610-108623. doi: 10.18632/oncotarget.21296. eCollection 2017 Dec 12.
• [5143] Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/-catenin-induced FGF18 expression in hepatocellular carcinoma.Oncogene. 2018 Mar;37(9):1220-1236. doi: 10.1038/s41388-017-0017-y. Epub 2017 Dec 15.
• [5144] Identification of valid reference housekeeping genes for gene expression analysis in tumor neovascularization studies.Clin Transl Oncol. 2013 Mar;15(3):211-8. doi: 10.1007/s12094-012-0904-1. Epub 2012 Jul 25.
• [5145] The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1.J Immunol. 2017 Apr 1;198(7):2989-2999. doi: 10.4049/jimmunol.1602057. Epub 2017 Feb 22.
• [5146] RPS2: a novel therapeutic target in prostate cancer.J Exp Clin Cancer Res. 2009 Jan 12;28(1):6. doi: 10.1186/1756-9966-28-6.
• [5147] HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.Leukemia. 2017 Oct;31(10):2235-2243. doi: 10.1038/leu.2017.74. Epub 2017 Mar 6.
• [5148] A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.J Immunother Cancer. 2019 Feb 28;7(1):60. doi: 10.1186/s40425-019-0539-7.
• [5149] pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer.Endocr Connect. 2019 Jul 1;8(7):863-869. doi: 10.1530/EC-19-0101.
• [5150] MSK2 promotes proliferation and tumor formation in squamous cervical cancer via PAX8/RB-E2F1/cyclin A2 axis.J Cell Biochem. 2019 Jul;120(7):11432-11440. doi: 10.1002/jcb.28421. Epub 2019 Feb 12.
• [5151] RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.Urol Oncol. 2019 May;37(5):297.e1-297.e7. doi: 10.1016/j.urolonc.2019.01.011. Epub 2019 Feb 6.
• [5152] Gene expression profiling in women with breast cancer in a Saudi population.Saudi Med J. 2008 Apr;29(4):507-13.
• [5153] Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisis.Exp Hematol. 2014 May;42(5):369-379.e3. doi: 10.1016/j.exphem.2014.01.009. Epub 2014 Jan 31.
• [5154] A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.Cancer Res. 2008 Dec 1;68(23):9799-808. doi: 10.1158/0008-5472.CAN-08-0247.
• [5155] Effects of goal-directed crystalloid vs. colloid fluid therapy on microcirculation during free flap surgery: A randomised clinical trial.Eur J Anaesthesiol. 2019 Aug;36(8):592-604. doi: 10.1097/EJA.0000000000001024.
• [5156] A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.Medicine (Baltimore). 2015 Aug;94(31):e1289. doi: 10.1097/MD.0000000000001289.
• [5157] MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1.Cell Cycle. 2019 Oct;18(20):2757-2769. doi: 10.1080/15384101.2019.1657338. Epub 2019 Aug 23.
• [5158] RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.Cancer Lett. 2017 Aug 28;402:153-165. doi: 10.1016/j.canlet.2017.05.024. Epub 2017 Jun 6.
• [5159] Identification of Ras suppressor-1 (RSU-1) as a potential breast cancer metastasis biomarker using a three-dimensional in vitro approach.Oncotarget. 2017 Apr 18;8(16):27364-27379. doi: 10.18632/oncotarget.16062.
• [5160] Suicide gene/prodrug therapy for pancreatic adenocarcinoma by E. coli purine nucleoside phosphorylase and 6-methylpurine 2'-deoxyriboside.Pancreas. 2004 Mar;28(2):E54-64. doi: 10.1097/00006676-200403000-00020.
• [5161] Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.Theranostics. 2017 Oct 17;7(19):4805-4824. doi: 10.7150/thno.20771. eCollection 2017.
• [5162] Differences in survival according to malignancy type and degree of immunodeficiency in HIV-infected patients.Med Clin (Barc). 2020 Apr 24;154(8):295-300. doi: 10.1016/j.medcli.2019.06.019. Epub 2019 Aug 27.
• [5163] Expression and biological function of rhotekin in gastric cancer through regulating p53 pathway.Cancer Manag Res. 2019 Jan 25;11:1069-1080. doi: 10.2147/CMAR.S185345. eCollection 2019.
• [5164] MicroRNA-181 Functions as an Antioncogene and Mediates NF-B Pathway by Targeting RTKN2 in Ovarian Cancers.Reprod Sci. 2019 Aug;26(8):1071-1081. doi: 10.1177/1933719118805865. Epub 2018 Oct 11.
• [5165] The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma.Cancer Genet Cytogenet. 2007 Aug;177(1):6-15. doi: 10.1016/j.cancergencyto.2007.04.007.
• [5166] C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.J Transl Med. 2016 Feb 23;14:55. doi: 10.1186/s12967-016-0801-4.
• [5167] Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma.Hepatology. 2007 Oct;46(4):1108-18. doi: 10.1002/hep.21770.
• [5168] von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.Cell Death Dis. 2019 Mar 19;10(4):266. doi: 10.1038/s41419-019-1507-3.
• [5169] ETS1 targets RYBP transcription to inhibit tumor cell proliferation.Biochem Biophys Res Commun. 2019 Feb 12;509(3):810-816. doi: 10.1016/j.bbrc.2019.01.006. Epub 2019 Jan 10.
• [5170] S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-B positive feedback loop.J Cell Mol Med. 2019 Oct;23(10):6907-6918. doi: 10.1111/jcmm.14574. Epub 2019 Aug 20.
• [5171] Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.Thorac Cancer. 2018 Sep;9(9):1136-1144. doi: 10.1111/1759-7714.12797. Epub 2018 Jul 26.
• [5172] Prognostic and clinicopathological significance of S100A14 expression in cancer patients: A meta-analysis.Medicine (Baltimore). 2019 Jul;98(28):e16356. doi: 10.1097/MD.0000000000016356.
• [5173] S100A16 is a prognostic marker for colorectal cancer.J Surg Oncol. 2018 Feb;117(2):275-283. doi: 10.1002/jso.24822. Epub 2017 Sep 6.
• [5174] Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.Int J Oncol. 2018 Sep;53(3):1171-1182. doi: 10.3892/ijo.2018.4455. Epub 2018 Jun 26.
• [5175] Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy.PLoS One. 2013;8(2):e57053. doi: 10.1371/journal.pone.0057053. Epub 2013 Feb 25.
• [5176] Serum amyloid A expression in the breast cancer tissue is associated with poor prognosis.Oncotarget. 2016 Jun 14;7(24):35843-35852. doi: 10.18632/oncotarget.8561.
• [5177] SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways.Cell Commun Signal. 2019 Jul 25;17(1):82. doi: 10.1186/s12964-019-0392-9.
• [5178] No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p.BMC Med Genet. 2008 Dec 13;9:108. doi: 10.1186/1471-2350-9-108.
• [5179] OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia.J Pathol. 2011 Aug;224(4):473-83. doi: 10.1002/path.2919. Epub 2011 Jun 27.
• [5180] SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex.Mol Cancer. 2018 Apr 6;17(1):78. doi: 10.1186/s12943-018-0824-y.
• [5181] SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes.Mol Oncol. 2018 Jun;12(7):1026-1046. doi: 10.1002/1878-0261.12308. Epub 2018 May 21.
• [5182] Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.PLoS One. 2015 Dec 23;10(12):e0145700. doi: 10.1371/journal.pone.0145700. eCollection 2015.
• [5183] Vaccination efficacy with marrow mesenchymal stem cell against cancer was enhanced under simulated microgravity.Biochem Biophys Res Commun. 2017 Apr 8;485(3):606-613. doi: 10.1016/j.bbrc.2017.01.136. Epub 2017 Feb 24.
• [5184] SAMD9 is a (epi-) genetically regulated anti-inflammatory factor activated in RA patients.Mol Cell Biochem. 2019 Jun;456(1-2):135-144. doi: 10.1007/s11010-019-03499-7. Epub 2019 Feb 4.
• [5185] Towards an Organ-Sparing Approach for Locally Advanced Esophageal Cancer.Dig Surg. 2019;36(6):462-469. doi: 10.1159/000493435. Epub 2018 Sep 18.
• [5186] Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1453-60. doi: 10.1245/s10434-015-4524-1. Epub 2015 Mar 25.
• [5187] Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms.Clin Endocrinol (Oxf). 2001 May;54(5):627-32. doi: 10.1046/j.1365-2265.2001.01253.x.
• [5188] Imaging Tumor Oxidative Stress with Surface Enhanced Raman Scattering Gold Nanoparticles.J Biomed Nanotechnol. 2019 Oct 1;15(10):2130-2141. doi: 10.1166/jbn.2019.2819.
• [5189] Exosomal and extracellular HMGB1 have opposite effects on SASH1 expression in rat astrocytes and glioma C6 cells.Biochem Biophys Res Commun. 2019 Oct 15;518(2):325-330. doi: 10.1016/j.bbrc.2019.08.057. Epub 2019 Aug 14.
• [5190] Overexpression of SASH1 Inhibits TGF-1-Induced EMT in Gastric Cancer Cells.Oncol Res. 2016;24(1):17-23. doi: 10.3727/096504016X14570992647203.
• [5191] Methylation status of normal background mucosa is correlated with occurrence and development of neoplasia in the distal colon.Hum Pathol. 2010 Jan;41(1):38-47. doi: 10.1016/j.humpath.2009.06.002. Epub 2009 Sep 5.
• [5192] SAV1, regulated by microRNA-21, suppresses tumor growth in colorectal cancer.Biochem Cell Biol. 2019 Apr;97(2):91-99. doi: 10.1139/bcb-2018-0034. Epub 2019 Jan 25.
• [5193] Human SBK1 is dysregulated in multiple cancers and promotes survival of ovary cancer SK-OV-3 cells.Mol Biol Rep. 2011 Jun;38(5):3551-9. doi: 10.1007/s11033-010-0465-8. Epub 2010 Nov 20.
• [5194] The Role of Survivorship Care for Patients with Glioma.Semin Oncol Nurs. 2018 Dec;34(5):547-552. doi: 10.1016/j.soncn.2018.10.015. Epub 2018 Nov 13.
• [5195] Overexpression of Suprabasin is Associated with Proliferation and Tumorigenicity of Esophageal Squamous Cell Carcinoma.Sci Rep. 2016 Feb 22;6:21549. doi: 10.1038/srep21549.
• [5196] MZF1 and SCAND1 Reciprocally Regulate CDC37 Gene Expression in Prostate Cancer.Cancers (Basel). 2019 Jun 8;11(6):792. doi: 10.3390/cancers11060792.
• [5197] Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.Proteomics Clin Appl. 2018 Sep;12(5):e1700180. doi: 10.1002/prca.201700180. Epub 2018 May 30.
• [5198] Characterization of the EM66 Biomarker in the Pituitary and Plasma of Healthy Subjects With Different Gonadotroph Status and Patients With Gonadotroph Tumor.Front Endocrinol (Lausanne). 2019 Feb 22;10:102. doi: 10.3389/fendo.2019.00102. eCollection 2019.
• [5199] Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5... Asian Pac J Cancer Prev. 2015;16(2):541-9.
• [5200] A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell death.Elife. 2018 Dec 7;7:e37854. doi: 10.7554/eLife.37854.
• [5201] Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration-resistant prostate cancer cells.FEBS Open Bio. 2018 Apr 10;8(5):743-750. doi: 10.1002/2211-5463.12412. eCollection 2018 May.
• [5202] Sodium Channel Subunit SCNN1B Suppresses Gastric Cancer Growth and Metastasis via GRP78 Degradation.Cancer Res. 2017 Apr 15;77(8):1968-1982. doi: 10.1158/0008-5472.CAN-16-1595. Epub 2017 Feb 15.
• [5203] The Tumor Suppressor SCRIB is a Negative Modulator of the Wnt/-Catenin Signaling Pathway.Proteomics. 2019 Nov;19(21-22):e1800487. doi: 10.1002/pmic.201800487. Epub 2019 Oct 20.
• [5204] The SNAIL family member SCRATCH1 is not expressed in human tumors.Oncol Rep. 2010 Feb;23(2):523-9.
• [5205] Potential Therapeutic Applications of MDA-9/Syntenin-NF-B-RKIP Loop in Human Liver Carcinoma.Curr Mol Med. 2018;18(9):630-639. doi: 10.2174/1566524019666190104105043.
• [5206] HPV8-E6 Interferes with Syntenin-2 Expression through Deregulation of Differentiation, Methylation and Phosphatidylinositide-Kinase Dependent Mechanisms.Front Microbiol. 2017 Sep 8;8:1724. doi: 10.3389/fmicb.2017.01724. eCollection 2017.
• [5207] SDH5 Depletion Enhances Radiosensitivity by Regulating p53: A New Method for Noninvasive Prediction of Radiotherapy Response.Theranostics. 2019 Aug 14;9(22):6380-6395. doi: 10.7150/thno.34443. eCollection 2019.
• [5208] SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma.PLoS One. 2013;8(1):e52184. doi: 10.1371/journal.pone.0052184. Epub 2013 Jan 14.
• [5209] Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression.Cancer Sci. 2017 Jan;108(1):143-150. doi: 10.1111/cas.13121.
• [5210] Identification of genetic alterations in pancreatic cancer by the combined use of tissue microdissection and array-based comparative genomic hybridisation.Br J Cancer. 2007 Jan 29;96(2):373-82. doi: 10.1038/sj.bjc.6603563.
• [5211] Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers.Hum Pathol. 2015 Apr;46(4):514-23. doi: 10.1016/j.humpath.2014.06.006. Epub 2014 Jun 26.
• [5212] Expression of 3q oncogene SEC62 in atypical fibroxanthoma-immunohistochemical analysis of 41 cases and correlation with clinical, viral and histopathologic features.Oncol Lett. 2019 Feb;17(2):1768-1776. doi: 10.3892/ol.2018.9767. Epub 2018 Nov 27.
• [5213] Overexpression of Aurora-A bypasses cytokinesis through phosphorylation of suppressed in lung cancer.Am J Physiol Cell Physiol. 2019 Sep 1;317(3):C600-C612. doi: 10.1152/ajpcell.00032.2019. Epub 2019 Jul 17.
• [5214] Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism.Eur J Nutr. 2008 Feb;47(1):47-54. doi: 10.1007/s00394-008-0696-9. Epub 2008 Jan 31.
• [5215] The Anti-Tumorigenic Activity of Sema3C in the Chick Embryo Chorioallantoic Membrane Model.Int J Mol Sci. 2019 Nov 12;20(22):5672. doi: 10.3390/ijms20225672.
• [5216] Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice.Gastroenterology. 2019 Sep;157(3):838-850.e6. doi: 10.1053/j.gastro.2019.05.065. Epub 2019 Jun 1.
• [5217] MiR-4282 suppresses proliferation and mobility of human colorectal carcinoma cells by targeting semaphorin 3E.Panminerva Med. 2016 Sep;58(3):197-205. Epub 2016 Apr 27.
• [5218] Semaphorin-plexin signalling genes associated with human breast tumourigenesis.Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.
• [5219] The miR-608 rs4919510 polymorphism may modify cancer susceptibility based on type.Tumour Biol. 2017 Jun;39(6):1010428317703819. doi: 10.1177/1010428317703819.
• [5220] Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis.Oncotarget. 2017 Dec 23;9(5):5931-5943. doi: 10.18632/oncotarget.23644. eCollection 2018 Jan 19.
• [5221] MiR-563 restrains cell proliferation via targeting LIN28B in human lung cancer.Thorac Cancer. 2020 Jan;11(1):55-61. doi: 10.1111/1759-7714.13257. Epub 2019 Nov 25.
• [5222] Semaphorin-7A on Exosomes: A Promigratory Signal in the Glioma Microenvironment.Cancers (Basel). 2019 May 30;11(6):758. doi: 10.3390/cancers11060758.
• [5223] Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts. Epigenetics. 2015;10(3):237-46.
• [5224] SENP2 exerts an antitumor effect on chronic lymphocytic leukemia cells through the inhibition of the Notch and NFB signaling pathways.Int J Oncol. 2019 Feb;54(2):455-466. doi: 10.3892/ijo.2018.4635. Epub 2018 Nov 14.
• [5225] The human homolog of yeast SEP1 is a novel candidate tumor suppressor gene in osteogenic sarcoma.Gene. 2002 Oct 2;298(2):121-7. doi: 10.1016/s0378-1119(02)00929-0.
• [5226] Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen.Cancer Sci. 2012 Apr;103(4):821-7. doi: 10.1111/j.1349-7006.2012.02221.x. Epub 2012 Mar 4.
• [5227] Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.Leuk Res. 2010 May;34(5):615-21. doi: 10.1016/j.leukres.2009.08.018. Epub 2009 Sep 12.
• [5228] ARTS-based anticancer therapy: taking aim at cancer stem cells.Future Oncol. 2011 Oct;7(10):1185-94. doi: 10.2217/fon.11.96.
• [5229] MicroRNA-127-3p promotes glioblastoma cell migration and invasion by targeting the tumor-suppressor gene SEPT7.Oncol Rep. 2014 May;31(5):2261-9. doi: 10.3892/or.2014.3055. Epub 2014 Mar 5.
• [5230] siRNA-mediated knockdown of hTDE2 retards cell cycle progression through transcriptional activation of p21.Oncol Rep. 2014 Mar;31(3):1314-22. doi: 10.3892/or.2014.2980. Epub 2014 Jan 14.
• [5231] Blocking the proliferation of human tumor cell lines by peptidase inhibitors from Bauhinia seeds.Planta Med. 2013 Mar;79(3-4):227-35. doi: 10.1055/s-0032-1328156. Epub 2013 Jan 23.
• [5232] Validation of a peritoneal surface disease severity score in stage IIIC-IV ovarian cancer treated with cytoreduction and hyperthermic intraperitoneal chemotherapy.Surg Oncol. 2019 Mar;28:57-61. doi: 10.1016/j.suronc.2018.11.005. Epub 2018 Nov 9.
• [5233] Downregulation of SERPINB13 expression in head and neck squamous cell carcinomas associates with poor clinical outcome.Int J Cancer. 2009 Oct 1;125(7):1542-50. doi: 10.1002/ijc.24507.
• [5234] The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.Anticancer Res. 2018 Jul;38(7):4159-4167. doi: 10.21873/anticanres.12709.
• [5235] Morphology, p16, HPV, and outcomes in squamous cell carcinoma of the penis: a multi-institutional study.Hum Pathol. 2020 Feb;96:79-86. doi: 10.1016/j.humpath.2019.09.013. Epub 2019 Nov 5.
• [5236] MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer.Dig Liver Dis. 2012 Jul;44(7):589-96. doi: 10.1016/j.dld.2012.02.016. Epub 2012 Mar 28.
• [5237] SEI1 induces genomic instability by inhibiting DNA damage response in ovarian cancer.Cancer Lett. 2017 Jan 28;385:271-279. doi: 10.1016/j.canlet.2016.09.032. Epub 2016 Oct 3.
• [5238] TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.J Transl Med. 2009 Jan 20;7:8. doi: 10.1186/1479-5876-7-8.
• [5239] Somatic SETBP1 mutations in myeloid neoplasms.Int J Hematol. 2017 Jun;105(6):732-742. doi: 10.1007/s12185-017-2241-1. Epub 2017 Apr 26.
• [5240] Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.J Biol Chem. 2017 Jun 2;292(22):9022-9033. doi: 10.1074/jbc.M117.778001. Epub 2017 Apr 25.
• [5241] SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.Cancer Res. 2019 Sep 15;79(18):4729-4743. doi: 10.1158/0008-5472.CAN-19-1084. Epub 2019 Jul 15.
• [5242] SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis.Nat Cell Biol. 2019 Feb;21(2):214-225. doi: 10.1038/s41556-018-0266-1. Epub 2019 Jan 28.
• [5243] SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.Cancer Res. 2019 Oct 15;79(20):5204-5217. doi: 10.1158/0008-5472.CAN-18-3965. Epub 2019 Aug 20.
• [5244] Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.Clin Cancer Res. 2017 Jul 1;23(13):3428-3441. doi: 10.1158/1078-0432.CCR-16-2020. Epub 2016 Nov 22.
• [5245] Secreted Frizzled-Related Protein 2 Is Associated with Disease Progression and Poor Prognosis in Breast Cancer.Dis Markers. 2019 Mar 3;2019:6149381. doi: 10.1155/2019/6149381. eCollection 2019.
• [5246] Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.J Cancer Res Clin Oncol. 2019 Oct;145(10):2495-2506. doi: 10.1007/s00432-019-03012-z. Epub 2019 Sep 7.
• [5247] Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.J Virol. 2001 Apr;75(7):3314-24. doi: 10.1128/JVI.75.7.3314-3324.2001.
• [5248] Functional role of SGK3 in PI3K/Pten driven liver tumor development.BMC Cancer. 2019 Apr 11;19(1):343. doi: 10.1186/s12885-019-5551-2.
• [5249] Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer.FASEB J. 2017 Sep;31(9):3816-3830. doi: 10.1096/fj.201601225RR. Epub 2017 May 18.
• [5250] Screening and characterization of a novel high-efficiency tumor-homing cell-penetrating peptide from the buffalo cathelicidin family.J Pept Sci. 2019 Sep;25(9):e3201. doi: 10.1002/psc.3201. Epub 2019 Jul 15.
• [5251] EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.Oncogene. 1996 Dec 19;13(12):2649-58.
• [5252] Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.Hepatology. 2016 Sep;64(3):828-42. doi: 10.1002/hep.28684. Epub 2016 Jul 15.
• [5253] SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.Leuk Lymphoma. 2018 Apr;59(4):918-930. doi: 10.1080/10428194.2017.1344843. Epub 2017 Jul 6.
• [5254] TIP-B1 promotes kidney clear cell carcinoma growth and metastasis via EGFR/AKT signaling.Aging (Albany NY). 2019 Sep 27;11(18):7914-7937. doi: 10.18632/aging.102298. Epub 2019 Sep 27.
• [5255] SH3-domain binding protein 1 in the tumor microenvironment promotes hepatocellular carcinoma metastasis through WAVE2 pathway.Oncotarget. 2016 Apr 5;7(14):18356-70. doi: 10.18632/oncotarget.7786.
• [5256] The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma.Cancers (Basel). 2019 Nov 8;11(11):1754. doi: 10.3390/cancers11111754.
• [5257] Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy.ACS Nano. 2019 Nov 26;13(11):12638-12652. doi: 10.1021/acsnano.9b04181. Epub 2019 Oct 22.
• [5258] Bif-1 promotes tumor cell migration and metastasis via Cdc42 expression and activity.Clin Exp Metastasis. 2017 Jan;34(1):11-23. doi: 10.1007/s10585-016-9825-7. Epub 2016 Oct 11.
• [5259] Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis.Cancers (Basel). 2017 Jul 28;9(8):97. doi: 10.3390/cancers9080097.
• [5260] Positive surgical margins and early oncological outcomes of robotic vs open radical prostatectomy at a medium case-load institution.Minerva Urol Nefrol. 2017 Feb;69(1):63-68. doi: 10.23736/S0393-2249.16.02518-2. Epub 2016 Mar 9.
• [5261] SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.EBioMedicine. 2016 Nov;13:80-89. doi: 10.1016/j.ebiom.2016.10.040. Epub 2016 Oct 28.
• [5262] A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis.Oncogene. 2018 Mar;37(13):1805-1814. doi: 10.1038/s41388-017-0019-9. Epub 2018 Jan 18.
• [5263] Reversed expression of GRIM-1 and GRP78 in human non-small cell lung cancer.Hum Pathol. 2014 Sep;45(9):1936-43. doi: 10.1016/j.humpath.2014.04.023. Epub 2014 Jun 18.
• [5264] The substrate binding domains of human SIAH E3 ubiquitin ligases are now crystal clear.Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3095-3105. doi: 10.1016/j.bbagen.2016.10.019. Epub 2016 Oct 21.
• [5265] Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer.Onco Targets Ther. 2019 Oct 11;12:8401-8410. doi: 10.2147/OTT.S215898. eCollection 2019.
• [5266] Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma.Urol Oncol. 2017 Oct;35(10):607.e1-607.e8. doi: 10.1016/j.urolonc.2017.05.016. Epub 2017 Jun 12.
• [5267] The difficulty in interpreting gene expression profiling in BAP-negative melanocytic tumors.J Cutan Pathol. 2018 May 12. doi: 10.1111/cup.13277. Online ahead of print.
• [5268] Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.Diagn Cytopathol. 2018 Jan;46(1):15-21. doi: 10.1002/dc.23838. Epub 2017 Oct 24.
• [5269] Cross-talk between SIM2s and NFB regulates cyclooxygenase 2 expression in breast cancer.Breast Cancer Res. 2019 Nov 29;21(1):131. doi: 10.1186/s13058-019-1224-y.
• [5270] The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3.Cancer Res. 2019 Jun 15;79(12):3076-3087. doi: 10.1158/0008-5472.CAN-18-0359. Epub 2019 Jan 28.
• [5271] Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence.Cancer Res. 2017 Oct 1;77(19):5339-5348. doi: 10.1158/0008-5472.CAN-16-3410. Epub 2017 Aug 14.
• [5272] Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest.Oncol Lett. 2019 Feb;17(2):2171-2176. doi: 10.3892/ol.2018.9877. Epub 2018 Dec 28.
• [5273] Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.Gastroenterology. 2020 Feb;158(3):664-678.e24. doi: 10.1053/j.gastro.2019.10.025. Epub 2019 Oct 31.
• [5274] Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene.Onco Targets Ther. 2018 Oct 1;11:6361-6367. doi: 10.2147/OTT.S173001. eCollection 2018.
• [5275] Six2 promotes non-small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E-cadherin.Cell Prolif. 2019 Jul;52(4):e12617. doi: 10.1111/cpr.12617. Epub 2019 Apr 22.
• [5276] SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B.J Hematol Oncol. 2017 Jun 8;10(1):115. doi: 10.1186/s13045-017-0483-2.
• [5277] ERBB-2 overexpression as a risk factor for malignant phaeochromocytomas and paraganglinomas.Clin Endocrinol (Oxf). 2016 Jun;84(6):822-9. doi: 10.1111/cen.13019. Epub 2016 Feb 25.
• [5278] Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis.Breast Cancer Res Treat. 2019 Nov;178(1):185-197. doi: 10.1007/s10549-019-05366-x. Epub 2019 Jul 24.
• [5279] Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth.Cancer Cell. 2015 Nov 9;28(5):569-581. doi: 10.1016/j.ccell.2015.09.021.
• [5280] DNA methylation pattern of the SLC25A43 gene in breast cancer.Epigenetics. 2012 Mar;7(3):300-6. doi: 10.4161/epi.7.3.19064.
• [5281] Shuttling SLC2A4RG is regulated by 14-3-3 to modulate cell survival via caspase-3 and caspase-6 in human glioma.EBioMedicine. 2019 Feb;40:163-175. doi: 10.1016/j.ebiom.2019.01.030. Epub 2019 Jan 25.
• [5282] Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.Onco Targets Ther. 2019 Dec 10;12:10771-10786. doi: 10.2147/OTT.S229332. eCollection 2019.
• [5283] Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Int J Cancer. 2006 Jul 15;119(2):406-13. doi: 10.1002/ijc.21843.
• [5284] Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells.Eur J Med Chem. 2019 Oct 1;179:347-357. doi: 10.1016/j.ejmech.2019.06.060. Epub 2019 Jun 23.
• [5285] Cationic amino acid transporter PQLC2 is a potential therapeutic target in gastric cancer.Cancer Sci. 2019 Apr;110(4):1453-1463. doi: 10.1111/cas.13966. Epub 2019 Mar 19.
• [5286] A CD10-positive subset of malignant cells is identified in multiple myeloma using PCR with patient-specific immunoglobulin gene primers.Leukemia. 1995 Nov;9(11):1948-53.
• [5287] SLFN11 can sensitize tumor cells towards IFN--mediated T cell killing.PLoS One. 2019 Feb 12;14(2):e0212053. doi: 10.1371/journal.pone.0212053. eCollection 2019.
• [5288] Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.Cell Physiol Biochem. 2019;53(6):999-1014. doi: 10.33594/000000191.
• [5289] Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers.Br J Cancer. 2004 Dec 13;91(12):2071-8. doi: 10.1038/sj.bjc.6602222.
• [5290] Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3/-catenin pathway.BMC Cancer. 2018 Jun 1;18(1):621. doi: 10.1186/s12885-018-4326-5.
• [5291] SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.World J Gastroenterol. 2015 Jul 21;21(27):8398-407. doi: 10.3748/wjg.v21.i27.8398.
• [5292] Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-B and Akt pathways.Cancer Cell Int. 2019 Aug 23;19:220. doi: 10.1186/s12935-019-0942-7. eCollection 2019.
• [5293] Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression.Oncogene. 2016 Sep 8;35(36):4719-29. doi: 10.1038/onc.2015.517. Epub 2016 Jan 25.
• [5294] The SLX4 complex is a SUMO E3 ligase that impacts on replication stress outcome and genome stability.Mol Cell. 2015 Jan 8;57(1):123-37. doi: 10.1016/j.molcel.2014.11.014. Epub 2014 Dec 18.
• [5295] Overexpression of the small transmembrane and glycosylated protein SMAGP supports metastasis formation of a rat pancreatic adenocarcinoma line.Int J Cancer. 2005 Dec 20;117(6):913-22. doi: 10.1002/ijc.21275.
• [5296] Paraneoplastic disorders associated with miscellaneous neoplasms with focus on selected soft tissue and Undifferentiated/ rhabdoid malignancies.Semin Diagn Pathol. 2019 Jul;36(4):269-278. doi: 10.1053/j.semdp.2019.02.001. Epub 2019 Feb 20.
• [5297] Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.Mol Cancer Ther. 2019 Mar;18(3):656-666. doi: 10.1158/1535-7163.MCT-18-0067. Epub 2018 Nov 26.
• [5298] SMARCAD1 in Breast Cancer Progression.Cell Physiol Biochem. 2018;50(2):489-500. doi: 10.1159/000494163. Epub 2018 Oct 11.
• [5299] Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution.Oncogene. 2017 May 4;36(18):2553-2564. doi: 10.1038/onc.2016.408. Epub 2016 Oct 31.
• [5300] SMARCD1 is a transcriptional target of specific non-hotspot mutant p53 forms.J Cell Physiol. 2020 May;235(5):4559-4570. doi: 10.1002/jcp.29332. Epub 2019 Oct 21.
• [5301] Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes. Nat Genet. 2017 May;49(5):742-752. doi: 10.1038/ng.3833. Epub 2017 Apr 3.
• [5302] Anaplastic Astrocytoma in a Child With Coffin-Siris Syndrome and a Germline SMARCE1 Mutation: A Case Report.J Pediatr Hematol Oncol. 2020 Apr;42(3):e177-e180. doi: 10.1097/MPH.0000000000001361.
• [5303] SMC1 promotes proliferation and inhibits apoptosis through the NFB signaling pathway in colorectal cancer.Oncol Rep. 2019 Oct;42(4):1329-1342. doi: 10.3892/or.2019.7273. Epub 2019 Aug 8.
• [5304] Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.Oncotarget. 2017 Mar 28;8(13):21733-21740. doi: 10.18632/oncotarget.15562.
• [5305] Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.Antiviral Res. 2019 Dec;172:104618. doi: 10.1016/j.antiviral.2019.104618. Epub 2019 Oct 7.
• [5306] Epigenetic regulator Smchd1 functions as a tumor suppressor.Cancer Res. 2013 Mar 1;73(5):1591-9. doi: 10.1158/0008-5472.CAN-12-3019. Epub 2012 Dec 26.
• [5307] SMDT1-driven change in mitochondrial dynamics mediate cell apoptosis in PDAC.Biochem Biophys Res Commun. 2019 Apr 2;511(2):323-329. doi: 10.1016/j.bbrc.2019.02.043. Epub 2019 Feb 16.
• [5308] A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.Acta Biomater. 2019 Jan 1;83:379-389. doi: 10.1016/j.actbio.2018.11.002. Epub 2018 Nov 3.
• [5309] Evidence for association between structural variants in lissencephaly-related genes and executive deficits in schizophrenia or bipolar patients from a Spanish isolate population.Psychiatr Genet. 2008 Dec;18(6):313-7. doi: 10.1097/YPG.0b013e3283118725.
• [5310] Evaluation of the accuracy of the CyberKnife Synchrony?Respiratory Tracking System using a plastic scintillator.Med Phys. 2018 Jun 1. doi: 10.1002/mp.13028. Online ahead of print.
• [5311] Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival.J Cancer Res Clin Oncol. 2017 Sep;143(9):1823-1831. doi: 10.1007/s00432-017-2425-3. Epub 2017 Apr 24.
• [5312] Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma.J Cancer. 2017 Oct 17;8(18):3812-3827. doi: 10.7150/jca.20775. eCollection 2017.
• [5313] Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice.J Lipid Res. 2018 May;59(5):795-804. doi: 10.1194/jlr.M080879. Epub 2018 Mar 22.
• [5314] Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.J Exp Clin Cancer Res. 2017 Feb 6;36(1):25. doi: 10.1186/s13046-017-0496-2.
• [5315] Interaction with tumorassociated macrophages promotes PRL?induced invasion of colorectal cancer cells via MAPK pathwayinduced EMT and NFB signalinginduced angiogenesis.Oncol Rep. 2019 May;41(5):2790-2802. doi: 10.3892/or.2019.7049. Epub 2019 Mar 7.
• [5316] Value of histomorphometric tumour thickness and smoothelin for conventional m-classification in early oesophageal adenocarcinoma.World J Gastrointest Oncol. 2017 Nov 15;9(11):444-451. doi: 10.4251/wjgo.v9.i11.444.
• [5317] Deletion of SMURF 1 represses ovarian cancer invasion and EMT by modulating the DAB2IP/AKT/Skp2 feedback loop.J Cell Biochem. 2019 Jun;120(6):10643-10651. doi: 10.1002/jcb.28354. Epub 2019 Jan 22.
• [5318] Altered Expression and Localization of Tumor Suppressive E3 Ubiquitin Ligase SMURF2 in Human Prostate and Breast Cancer.Cancers (Basel). 2019 Apr 18;11(4):556. doi: 10.3390/cancers11040556.
• [5319] miR-200c overexpression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing lncRNA HOTAIR in mice.J Cell Biochem. 2020 Feb;121(2):1514-1523. doi: 10.1002/jcb.29387. Epub 2019 Sep 18.
• [5320] SNAP23 suppresses cervical cancer progression via modulating the cell cycle.Gene. 2018 Oct 5;673:217-224. doi: 10.1016/j.gene.2018.06.028. Epub 2018 Jun 23.
• [5321] SND1 promotes the proliferation of osteosarcoma cells by upregulating COX?/PGE2 expression via activation of NFB.Oncol Rep. 2019 Jan;41(1):579-589. doi: 10.3892/or.2018.6822. Epub 2018 Oct 24.
• [5322] Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.Endocrine. 2018 Feb;59(2):426-437. doi: 10.1007/s12020-017-1482-3. Epub 2017 Dec 1.
• [5323] Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition.Hum Pathol. 2018 Oct;80:28-39. doi: 10.1016/j.humpath.2018.03.025. Epub 2018 Apr 7.
• [5324] An oncogenic gene, SNRPA1, regulates PIK3R1, VEGFC, MKI67, CDK1 and other genes in colorectal cancer.Biomed Pharmacother. 2019 Sep;117:109076. doi: 10.1016/j.biopha.2019.109076. Epub 2019 Jun 14.
• [5325] Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer.PeerJ. 2018 May 29;6:e4829. doi: 10.7717/peerj.4829. eCollection 2018.
• [5326] Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.BMC Cancer. 2019 Jun 10;19(1):555. doi: 10.1186/s12885-019-5769-z.
• [5327] WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells.J Exp Clin Cancer Res. 2019 Feb 26;38(1):102. doi: 10.1186/s13046-019-1108-0.
• [5328] SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.Leukemia. 2019 Aug;33(8):1881-1894. doi: 10.1038/s41375-019-0412-1. Epub 2019 Feb 28.
• [5329] Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis.World J Surg. 2012 Feb;36(2):362-72. doi: 10.1007/s00268-011-1358-2.
• [5330] A novel SOCS5/miR-18/miR-25 axis promotes tumorigenesis in liver cancer.Int J Cancer. 2019 Jan 15;144(2):311-321. doi: 10.1002/ijc.31857. Epub 2018 Nov 9.
• [5331] SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer.Curr Cancer Drug Targets. 2018;18(9):894-904. doi: 10.2174/1568009618666180102101442.
• [5332] In vitro and in vivo effects of suppressor of cytokine signalling 7 knockdown in breast cancer: the influence on cellular response to hepatocyte growth factor.Biomed Res Int. 2014;2014:648040. doi: 10.1155/2014/648040. Epub 2014 Aug 4.
• [5333] SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2.Nat Commun. 2018 Feb 8;9(1):575. doi: 10.1038/s41467-018-03079-1.
• [5334] Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/-catenin signaling pathway.Mol Carcinog. 2019 Jun;58(6):1008-1018. doi: 10.1002/mc.22989. Epub 2019 Mar 5.
• [5335] The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts.Genome Biol. 2018 Mar 16;19(1):35. doi: 10.1186/s13059-018-1412-6.
• [5336] Personalized oncology with artificial intelligence: The case of temozolomide.Artif Intell Med. 2019 Aug;99:101693. doi: 10.1016/j.artmed.2019.07.001. Epub 2019 Aug 12.
• [5337] Methylation of SOX1 and VIM promoters in serum as potential biomarkers for hepatocellular carcinoma.Neoplasma. 2017;64(5):745-753. doi: 10.4149/neo_2017_513.
• [5338] Utility of Sry-Related HMG-Box Gene 10 (SOX10) as a marker of melanoma in effusion cytology.Diagn Cytopathol. 2019 Jul;47(7):653-658. doi: 10.1002/dc.24162. Epub 2019 Feb 22.
• [5339] SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis.Cell Death Dis. 2019 Mar 11;10(3):239. doi: 10.1038/s41419-019-1481-9.
• [5340] MiR-185 inhibits tumor growth and enhances chemo-resistance via targeting SRY-related high mobility group box transcription factor 13 in non-small-cell carcinoma.Am J Transl Res. 2018 Aug 15;10(8):2600-2609. eCollection 2018.
• [5341] Downregulation of microR-147b represses the proliferation and invasion of thyroid carcinoma cells by inhibiting Wnt/-catenin signaling via targeting SOX15.Mol Cell Endocrinol. 2020 Feb 5;501:110662. doi: 10.1016/j.mce.2019.110662. Epub 2019 Nov 21.
• [5342] Lentiviral-Mediated Overexpression of MicroRNA-141 Promotes Cell Proliferation and Inhibits Apoptosis in Human Esophageal Squamous Cell Carcinoma.Recent Pat Anticancer Drug Discov. 2019;14(2):170-176. doi: 10.2174/1574892814666181231142136.
• [5343] Endovascular progenitors infiltrate melanomas and differentiate towards a variety of vascular beds promoting tumor metastasis.Nat Commun. 2019 Jan 3;10(1):18. doi: 10.1038/s41467-018-07961-w.
• [5344] SOX21-AS1 is associated with clinical stage and regulates cell proliferation in nephroblastoma.Biosci Rep. 2019 May 17;39(5):BSR20190602. doi: 10.1042/BSR20190602. Print 2019 May 31.
• [5345] miR-138 mediates sorafenib-induced cell survival and is associated with poor prognosis in cholangiocarcinoma cells.Clin Exp Pharmacol Physiol. 2020 Mar;47(3):459-465. doi: 10.1111/1440-1681.13205. Epub 2019 Nov 25.
• [5346] microRNA-181b suppresses the metastasis of lung cancer cells by targeting sex determining region Y-related high mobility group-box 6 (Sox6).Pathol Res Pract. 2019 Feb;215(2):335-342. doi: 10.1016/j.prp.2018.12.009. Epub 2018 Dec 11.
• [5347] Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.J Cell Physiol. 2019 Aug;234(10):17589-17599. doi: 10.1002/jcp.28383. Epub 2019 Mar 1.
• [5348] The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies.Clin Cancer Res. 2004 Oct 1;10(19):6544-50. doi: 10.1158/1078-0432.CCR-04-0911.
• [5349] Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells.Oncogene. 2007 Mar 8;26(11):1533-45. doi: 10.1038/sj.onc.1209961. Epub 2006 Sep 18.
• [5350] Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.J Immunother. 2011 Jan;34(1):28-44. doi: 10.1097/CJI.0b013e3181fb64fa.
• [5351] Spermassociated antigen 4 (SPAG4) as a new cancer marker interacts with Nesprin3 to regulate cell migration in lung carcinoma.Oncol Rep. 2018 Aug;40(2):783-792. doi: 10.3892/or.2018.6473. Epub 2018 Jun 4.
• [5352] SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.J Hematol Oncol. 2019 Feb 8;12(1):14. doi: 10.1186/s13045-019-0700-2.
• [5353] SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway.Am J Transl Res. 2019 Aug 15;11(8):5249-5260. eCollection 2019.
• [5354] SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically.Int J Cancer. 2006 Mar 15;118(6):1436-44. doi: 10.1002/ijc.21499.
• [5355] Aberrant methylation status of SPG20 promoter in hepatocellular carcinoma: A potential tumor metastasis biomarker.Cancer Genet. 2019 Apr;233-234:48-55. doi: 10.1016/j.cancergen.2019.04.003. Epub 2019 Apr 12.
• [5356] Emerging microtubule targets in glioma therapy.Semin Pediatr Neurol. 2015 Mar;22(1):49-72. doi: 10.1016/j.spen.2015.03.009. Epub 2015 Apr 4.
• [5357] Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.Cancer Sci. 2018 Dec;109(12):3910-3920. doi: 10.1111/cas.13824. Epub 2018 Nov 2.
• [5358] SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3509-14. doi: 10.1073/pnas.0712269105. Epub 2008 Feb 26.
• [5359] SPC24 is critical for anaplastic thyroid cancer progression.Oncotarget. 2017 Mar 28;8(13):21884-21891. doi: 10.18632/oncotarget.15670.
• [5360] Upregulation of Circular RNA VPS13C-has-circ-001567 Promotes Ovarian Cancer Cell Proliferation and Invasion.Cancer Biother Radiopharm. 2019 Mar;34(2):110-118. doi: 10.1089/cbr.2018.2641. Epub 2018 Oct 30.
• [5361] Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.Mod Pathol. 2018 May;31(5):753-762. doi: 10.1038/modpathol.2017.191. Epub 2018 Jan 12.
• [5362] Spi-B-Mediated Silencing of Claudin-2 Promotes Early Dissemination of Lung Cancer Cells from Primary Tumors.Cancer Res. 2017 Sep 15;77(18):4809-4822. doi: 10.1158/0008-5472.CAN-17-0020. Epub 2017 Jul 28.
• [5363] SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer.Cancer Lett. 2020 Feb 1;470:54-63. doi: 10.1016/j.canlet.2019.11.032. Epub 2019 Nov 29.
• [5364] Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo.Pharmacol Res. 2019 May;143:73-85. doi: 10.1016/j.phrs.2019.03.009. Epub 2019 Mar 9.
• [5365] A novel tumor suppressor SPINK5 targets Wnt/-catenin signaling pathway in esophageal cancer.Cancer Med. 2019 May;8(5):2360-2371. doi: 10.1002/cam4.2078. Epub 2019 Mar 13.
• [5366] Decreased expression of SPINT1-AS1 and SPINT1 mRNA might be independent unfavorable prognostic indicators in esophageal squamous cell carcinoma.Onco Targets Ther. 2019 Jun 20;12:4755-4763. doi: 10.2147/OTT.S206448. eCollection 2019.
• [5367] Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2.Cell Oncol (Dordr). 2020 Feb;43(1):107-121. doi: 10.1007/s13402-019-00475-7. Epub 2019 Nov 7.
• [5368] SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3.Am J Cancer Res. 2018 Apr 1;8(4):624-635. eCollection 2018.
• [5369] Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.J Int Med Res. 2019 Feb;47(2):569-579. doi: 10.1177/0300060518803232. Epub 2018 Oct 14.
• [5370] Secreted phosphoprotein 24kD (Spp24) inhibits growth of hepatocellular carcinoma in vivo.Environ Toxicol Pharmacol. 2017 Apr;51:51-55. doi: 10.1016/j.etap.2017.03.001. Epub 2017 Mar 4.
• [5371] Oncofetal protein, IMP-3, a potential marker for prediction of postoperative peritoneal dissemination in gastric adenocarcinoma.J Surg Oncol. 2012 Jun 15;105(8):780-5. doi: 10.1002/jso.22108. Epub 2011 Oct 19.
• [5372] A Pilot Study of Aberrant CpG Island Hypermethylation of SPRED1 in Acute Myeloloid Leukemia.Int J Med Sci. 2019 Jan 1;16(2):324-330. doi: 10.7150/ijms.27757. eCollection 2019.
• [5373] Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease.Mol Cancer Res. 2018 Dec;16(12):1912-1926. doi: 10.1158/1541-7786.MCR-18-0056. Epub 2018 Aug 14.
• [5374] Quantitative evaluation of SPRR3 expression in esophageal squamous cell carcinoma by qPCR and its potential use as a biomarker.Exp Mol Pathol. 2011 Oct;91(2):584-9. doi: 10.1016/j.yexmp.2011.06.006. Epub 2011 Jul 12.
• [5375] Differential expression of sprouty genes in hepatocellular carcinoma.J Surg Oncol. 2012 Mar;105(3):273-6. doi: 10.1002/jso.22095. Epub 2011 Sep 19.
• [5376] 4.1N is involved in a flotillin-1/-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.Tumour Biol. 2016 Sep;37(9):12713-12723. doi: 10.1007/s13277-016-5146-3. Epub 2016 Jul 22.
• [5377] SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.PLoS Genet. 2017 Mar 8;13(3):e1006650. doi: 10.1371/journal.pgen.1006650. eCollection 2017 Mar.
• [5378] The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.Cell Death Differ. 2020 Feb;27(2):790-807. doi: 10.1038/s41418-019-0386-6. Epub 2019 Jul 8.
• [5379] Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.Diabetes. 2018 Apr;67(4):717-730. doi: 10.2337/db17-0755. Epub 2017 Dec 14.
• [5380] Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues.J Exp Clin Cancer Res. 2009 Aug 9;28(1):111. doi: 10.1186/1756-9966-28-111.
• [5381] Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway.Oncol Rep. 2018 Dec;40(6):3313-3322. doi: 10.3892/or.2018.6777. Epub 2018 Oct 9.
• [5382] Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.Cells. 2019 Jan 11;8(1):41. doi: 10.3390/cells8010041.
• [5383] BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.Nat Commun. 2014 Aug 5;5:4581. doi: 10.1038/ncomms5581.
• [5384] Machine learning for semi-automated classification of glioblastoma, brain metastasis and central nervous system lymphoma using magnetic resonance advanced imaging.Ann Transl Med. 2019 Jun;7(11):232. doi: 10.21037/atm.2018.08.05.
• [5385] Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.Mol Oncol. 2019 Apr;13(4):894-908. doi: 10.1002/1878-0261.12444. Epub 2019 Mar 1.
• [5386] SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.Cancer Res. 2019 Oct 15;79(20):5288-5301. doi: 10.1158/0008-5472.CAN-19-1504. Epub 2019 Aug 28.
• [5387] RON alternative splicing regulation in primary ovarian cancer.Oncol Rep. 2015 Jul;34(1):423-30. doi: 10.3892/or.2015.3995. Epub 2015 May 19.
• [5388] SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1161-1172. doi: 10.1016/j.bbamcr.2018.05.017. Epub 2018 May 30.
• [5389] The splicing factor SRSF6 is amplified and is an oncoprotein inlung and colon cancers.J Pathol. 2013 Mar;229(4):630-9. doi: 10.1002/path.4129.
• [5390] Novel role of sex-determining region Y-box 7 (SOX7) in tumor biology and cardiovascular developmental biology.Semin Cancer Biol. 2020 Dec;67(Pt 1):49-56. doi: 10.1016/j.semcancer.2019.08.032. Epub 2019 Aug 29.
• [5391] LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.Virchows Arch. 2018 May;472(5):727-737. doi: 10.1007/s00428-018-2298-0. Epub 2018 Jan 19.
• [5392] Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dub tumour suppressor gene (FLCN).Oncogene. 2014 Feb 20;33(8):956-65. doi: 10.1038/onc.2013.27. Epub 2013 Feb 18.
• [5393] Expression of SSX genes in human tumors.Int J Cancer. 1998 Jul 3;77(1):19-23. doi: 10.1002/(sici)1097-0215(19980703)77:1<19::aid-ijc4>3.0.co;2-2.
• [5394] Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.J Neurooncol. 2011 Sep;104(2):497-507. doi: 10.1007/s11060-010-0522-0. Epub 2011 Feb 24.
• [5395] Carboxy-terminus Hsc70 interacting protein exerts a tumor inhibition function in head and neck cancer.Oncol Rep. 2017 Sep;38(3):1629-1636. doi: 10.3892/or.2017.5827. Epub 2017 Jul 17.
• [5396] Sialylation of vasorin by ST3Gal1 facilitates TGF-1-mediated tumor angiogenesis and progression.Int J Cancer. 2019 Apr 15;144(8):1996-2007. doi: 10.1002/ijc.31891. Epub 2019 Jan 3.
• [5397] Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.Oncology. 2003;65(2):139-45. doi: 10.1159/000072339.
• [5398] The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.Blood. 2014 Sep 11;124(11):1765-76. doi: 10.1182/blood-2014-03-560862. Epub 2014 Jul 24.
• [5399] 2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.J Physiol Biochem. 2019 Jun;75(2):199-207. doi: 10.1007/s13105-019-00674-8. Epub 2019 Apr 10.
• [5400] Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma.Oncotarget. 2016 Aug 12;9(3):3112-3120. doi: 10.18632/oncotarget.11258. eCollection 2018 Jan 9.
• [5401] Suppression of the proliferation and invasion of breast cancer cells by ST7L occurs through inhibition of activation of Wnt/GSK-3/-catenin signalling.Clin Exp Pharmacol Physiol. 2020 Jan;47(1):119-126. doi: 10.1111/1440-1681.13166. Epub 2019 Sep 9.
• [5402] TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.PLoS One. 2018 Apr 26;13(4):e0196369. doi: 10.1371/journal.pone.0196369. eCollection 2018.
• [5403] The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line.Immunol Lett. 2017 Oct;190:20-25. doi: 10.1016/j.imlet.2017.07.005. Epub 2017 Jul 15.
• [5404] Synthetic lethal interaction between the tumour suppressor STAG2 and its paralog STAG1.Oncotarget. 2017 Jun 6;8(23):37619-37632. doi: 10.18632/oncotarget.16838.
• [5405] Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation.Cell Stem Cell. 2019 Nov 7;25(5):682-696.e8. doi: 10.1016/j.stem.2019.08.003. Epub 2019 Sep 5.
• [5406] Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.Tumour Biol. 2015 Sep;36(10):7915-27. doi: 10.1007/s13277-015-3509-9. Epub 2015 May 8.
• [5407] Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.Int J Cancer. 2010 Mar 15;126(6):1445-53. doi: 10.1002/ijc.24826.
• [5408] Ioncopy: anovel method for calling copy number alterations in amplicon sequencing data including significance assessment.Oncotarget. 2016 Mar 15;7(11):13236-47. doi: 10.18632/oncotarget.7451.
• [5409] GTT1/StarD7, a novel phosphatidylcholine transfer protein-like highly expressed in gestational trophoblastic tumour: cloning and characterization.Placenta. 2004 Jan;25(1):37-44. doi: 10.1016/S0143-4004(03)00214-5.
• [5410] Downregulation of STARD8 in gastric cancer and its involvement in gastric cancer progression.Onco Targets Ther. 2018 May 21;11:2955-2961. doi: 10.2147/OTT.S154524. eCollection 2018.
• [5411] Oncogenic Ki-ras inhibits the expression of interferon-responsive genes through inhibition of STAT1 and STAT2 expression.J Biol Chem. 2003 Nov 21;278(47):46278-87. doi: 10.1074/jbc.M304721200. Epub 2003 Sep 12.
• [5412] SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization.Nat Commun. 2016 Dec 22;7:13875. doi: 10.1038/ncomms13875.
• [5413] Quantitative proteomics identifies STEAP4 as a critical regulator of mitochondrial dysfunction linking inflammation and colon cancer.Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9608-E9617. doi: 10.1073/pnas.1712946114. Epub 2017 Oct 23.
• [5414] The human oncogene SCL/TAL1 interrupting locus (STIL) promotes tumor growth through MAPK/ERK, PI3K/Akt and AMPK pathways in prostate cancer.Gene. 2019 Feb 20;686:220-227. doi: 10.1016/j.gene.2018.11.048. Epub 2018 Nov 16.
• [5415] The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.Oncogene. 2020 Feb;39(8):1652-1664. doi: 10.1038/s41388-019-1108-8. Epub 2019 Nov 18.
• [5416] STK10 missense mutations associated with anti-apoptotic function.Oncol Rep. 2013 Oct;30(4):1542-8. doi: 10.3892/or.2013.2605. Epub 2013 Jul 9.
• [5417] Tumor suppressor C-RASSF proteins.Cell Mol Life Sci. 2018 May;75(10):1773-1787. doi: 10.1007/s00018-018-2756-5. Epub 2018 Jan 20.
• [5418] MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial-Mesenchymal Transition In Gastric Cancer.Cancer Manag Res. 2019 Nov 5;11:9353-9369. doi: 10.2147/CMAR.S219689. eCollection 2019.
• [5419] Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.Oncol Rep. 2017 Jul;38(1):427-439. doi: 10.3892/or.2017.5642. Epub 2017 May 15.
• [5420] Serine/threonine kinase 32C is overexpressed in bladder cancer and contributes to tumor progression.Cancer Biol Ther. 2019;20(3):307-320. doi: 10.1080/15384047.2018.1529098. Epub 2018 Oct 25.
• [5421] Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells.Cell Physiol Biochem. 2018;45(2):808-818. doi: 10.1159/000487172. Epub 2018 Jan 31.
• [5422] Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells.PLoS One. 2019 Dec 11;14(12):e0225860. doi: 10.1371/journal.pone.0225860. eCollection 2019.
• [5423] Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation.Cancer Res. 2014 Nov 1;74(21):6341-51. doi: 10.1158/0008-5472.CAN-14-1052. Epub 2014 Sep 18.
• [5424] Multifaceted C-terminus of HSP70-interacting protein regulates tumorigenesis via protein quality control.Arch Pharm Res. 2019 Jan;42(1):63-75. doi: 10.1007/s12272-018-1101-8. Epub 2019 Jan 1.
• [5425] STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas.Cancer Sci. 2015 Oct;106(10):1455-62. doi: 10.1111/cas.12742. Epub 2015 Aug 13.
• [5426] STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1684-1692. doi: 10.1016/j.bbadis.2018.01.031. Epub 2018 Feb 2.
• [5427] Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition.Front Immunol. 2018 May 29;9:1186. doi: 10.3389/fimmu.2018.01186. eCollection 2018.
• [5428] Essential role of STX6 in esophageal squamous cell carcinoma growth and migration.Biochem Biophys Res Commun. 2016 Mar 25;472(1):60-7. doi: 10.1016/j.bbrc.2016.02.061. Epub 2016 Feb 22.
• [5429] Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.J Biol Chem. 2011 Mar 25;286(12):10505-14. doi: 10.1074/jbc.M110.162321. Epub 2011 Jan 14.
• [5430] MiRNA-194 activates the Wnt/-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.Cancer Lett. 2017 Jan 28;385:117-127. doi: 10.1016/j.canlet.2016.10.035. Epub 2016 Oct 31.
• [5431] Sulfatase 1 expression in pancreatic cancer and its correlation with clinicopathological features and postoperative prognosis.Cancer Biomark. 2018;22(4):701-707. doi: 10.3233/CBM-181210.
• [5432] Invasive Duct Carcinoma of the Breast With Dominant Signet-Ring Cell Differentiation: A Microsatellite Stable Tumor With Aggressive Behavior.Appl Immunohistochem Mol Morphol. 2017 Nov/Dec;25(10):720-724. doi: 10.1097/PAI.0000000000000366.
• [5433] SUMO1 modification of KHSRP regulates tumorigenesis by preventing the TL-G-Rich miRNA biogenesis.Mol Cancer. 2017 Oct 11;16(1):157. doi: 10.1186/s12943-017-0724-6.
• [5434] Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.BMC Cancer. 2015 Oct 12;15:675. doi: 10.1186/s12885-015-1665-3.
• [5435] SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer.Sci Rep. 2015 Dec 10;5:17940. doi: 10.1038/srep17940.
• [5436] Mitochondrial genome instability resulting from SUV3 haploinsufficiency leads to tumorigenesis and shortened lifespan.Oncogene. 2013 Feb 28;32(9):1193-201. doi: 10.1038/onc.2012.120. Epub 2012 May 7.
• [5437] SURF4 has oncogenic potential in NIH3T3 cells.Biochem Biophys Res Commun. 2018 Jul 7;502(1):43-47. doi: 10.1016/j.bbrc.2018.05.116. Epub 2018 May 21.
• [5438] SUSD2 is frequently downregulated and functions as a tumor suppressor in RCC and lung cancer.Tumour Biol. 2016 Jul;37(7):9919-30. doi: 10.1007/s13277-015-4734-y. Epub 2016 Jan 27.
• [5439] Molecular characterization of prostatic small-cell neuroendocrine carcinoma.Prostate. 2003 Apr 1;55(1):55-64. doi: 10.1002/pros.10217.
• [5440] SVEP1 expression is regulated in estrogen-dependent manner.J Cell Physiol. 2007 Mar;210(3):732-9. doi: 10.1002/jcp.20895.
• [5441] Regulation of p53wt glioma cell proliferation by androgen receptor-mediated inhibition of small VCP/p97-interacting protein expression.Oncotarget. 2017 Apr 4;8(14):23142-23154. doi: 10.18632/oncotarget.15509.
• [5442] A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets.Cancer Res. 2014 Sep 1;74(17):4694-705. doi: 10.1158/0008-5472.CAN-13-3725. Epub 2014 Jun 26.
• [5443] Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses.Int J Mol Med. 2018 Dec;42(6):3542-3550. doi: 10.3892/ijmm.2018.3870. Epub 2018 Sep 11.
• [5444] Synaptonemal complex protein 3 is a prognostic marker in cervical cancer.PLoS One. 2014 Jun 6;9(6):e98712. doi: 10.1371/journal.pone.0098712. eCollection 2014.
• [5445] Overexpression of SYF2 promotes cell proliferation and correlates with poor prognosis in human breast cancer.Oncotarget. 2017 May 23;8(51):88453-88463. doi: 10.18632/oncotarget.18188. eCollection 2017 Oct 24.
• [5446] A case of nasal low-grade non-intestinal-type adenocarcinoma with aberrant CDX2 expression and a novel SYN2-PPARG gene fusion in a 13-year-old girl.Virchows Arch. 2019 May;474(5):619-623. doi: 10.1007/s00428-019-02524-w. Epub 2019 Jan 21.
• [5447] Engineering carboxypeptidase G2 circular permutations for the design of an autoinhibited enzyme.Protein Eng Des Sel. 2017 Apr 1;30(4):321-331. doi: 10.1093/protein/gzx005.
• [5448] SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.J Exp Clin Cancer Res. 2016 Jul 20;35(1):115. doi: 10.1186/s13046-016-0385-0.
• [5449] Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.J Pathol. 2018 Jan;244(1):71-83. doi: 10.1002/path.4995.
• [5450] Synaptotagmin 7 in twist-related protein 1-mediated epithelial - Mesenchymal transition of non-small cell lung cancer.EBioMedicine. 2019 Aug;46:42-53. doi: 10.1016/j.ebiom.2019.07.071. Epub 2019 Aug 6.
• [5451] Daphnane diterpenes inhibit the metastatic potential of B16F10 murine melanoma cells in vitro and in vivo.BMC Cancer. 2018 Aug 29;18(1):856. doi: 10.1186/s12885-018-4693-y.
• [5452] Targeting of TGF--activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer.Oncotarget. 2015 Jan 20;6(2):995-1007. doi: 10.18632/oncotarget.2739.
• [5453] miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819875168. doi: 10.1177/1533033819875168.
• [5454] Neurokinin-immunoreactivity in human neuroblastomas. Evidence for selective expression of the preprotachykinin (PPT) II gene.FEBS Lett. 1990 Dec 17;277(1-2):83-7. doi: 10.1016/0014-5793(90)80814-y.
• [5455] TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.Mol Endocrinol. 2012 May;26(5):748-61. doi: 10.1210/me.2011-1242. Epub 2012 Mar 28.
• [5456] ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.Breast Cancer Res. 2016 Nov 16;18(1):113. doi: 10.1186/s13058-016-0770-9.
• [5457] Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.Hum Pathol. 2014 May;45(5):1084-91. doi: 10.1016/j.humpath.2014.01.007. Epub 2014 Jan 28.
• [5458] Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.Pathol Oncol Res. 2017 Jan;23(1):125-130. doi: 10.1007/s12253-016-0107-0. Epub 2016 Aug 29.
• [5459] miR-21-5p promotes lung adenocarcinoma progression partially through targeting SET/TAF-I.Life Sci. 2019 Aug 15;231:116539. doi: 10.1016/j.lfs.2019.06.014. Epub 2019 Jun 6.
• [5460] TAFA5 promotes proliferation and migration in gastric cancer.Mol Med Rep. 2019 Nov;20(5):4477-4488. doi: 10.3892/mmr.2019.10724. Epub 2019 Oct 2.
• [5461] Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.Sci Rep. 2019 Mar 26;9(1):5179. doi: 10.1038/s41598-019-41675-3.
• [5462] Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer.FASEB J. 2018 Oct;32(10):5365-5377. doi: 10.1096/fj.201701103R. Epub 2018 May 15.
• [5463] Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9353-E9361. doi: 10.1073/pnas.1809465115. Epub 2018 Sep 13.
• [5464] Expression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significance.Int J Clin Exp Pathol. 2015 Aug 1;8(8):9089-96. eCollection 2015.
• [5465] Noncaloric Sweeteners Induce Peripheral Serotonin Secretion via the T1R3-Dependent Pathway in Human Gastric Parietal Tumor Cells (HGT-1).J Agric Food Chem. 2018 Jul 11;66(27):7044-7053. doi: 10.1021/acs.jafc.8b02071. Epub 2018 Jun 25.
• [5466] Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.BMC Gastroenterol. 2017 Sep 15;17(1):104. doi: 10.1186/s12876-017-0659-9.
• [5467] LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.Cancer Biol Ther. 2019;20(3):261-271. doi: 10.1080/15384047.2018.1529091. Epub 2018 Nov 27.
• [5468] Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.J Hepatol. 2008 Nov;49(5):746-57. doi: 10.1016/j.jhep.2008.06.019. Epub 2008 Jul 9.
• [5469] Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma.Oncogene. 2014 Mar 20;33(12):1558-69. doi: 10.1038/onc.2013.97. Epub 2013 Apr 8.
• [5470] Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.Med Sci Monit. 2018 Jun 12;24:3987-3996. doi: 10.12659/MSM.906736.
• [5471] Development and preclinical pharmacology of a novel dCK inhibitor, DI-87.Biochem Pharmacol. 2020 Feb;172:113742. doi: 10.1016/j.bcp.2019.113742. Epub 2019 Dec 6.
• [5472] Nanoscale Metal-Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer Immunotherapy.J Am Chem Soc. 2018 May 2;140(17):5670-5673. doi: 10.1021/jacs.8b01072. Epub 2018 Apr 23.
• [5473] Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.Oncotarget. 2016 Jan 19;7(3):2391-400. doi: 10.18632/oncotarget.6165.
• [5474] Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.Oncol Lett. 2017 Jul;14(1):390-396. doi: 10.3892/ol.2017.6140. Epub 2017 May 9.
• [5475] HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.PLoS One. 2010 Apr 29;5(4):e10338. doi: 10.1371/journal.pone.0010338.
• [5476] TBX2 overexpression promotes proliferation and invasion through epithelial-mesenchymal transition and ERK signaling pathway.Exp Ther Med. 2019 Jan;17(1):723-729. doi: 10.3892/etm.2018.7028. Epub 2018 Nov 28.
• [5477] The roles and regulation of TBX3 in development and disease.Gene. 2020 Feb 5;726:144223. doi: 10.1016/j.gene.2019.144223. Epub 2019 Oct 26.
• [5478] Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer.Cell Death Dis. 2019 May 29;10(6):424. doi: 10.1038/s41419-019-1663-5.
• [5479] Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7.Mol Ther. 2019 Nov 6;27(11):1939-1949. doi: 10.1016/j.ymthe.2019.07.011. Epub 2019 Jul 22.
• [5480] LncRNATCF7 up-regulates DNMT1 mediated by HPV-18 E6 and regulates biological behavior of cervical cancer cells by inhibiting miR-155.Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8779-8787. doi: 10.26355/eurrev_201910_19272.
• [5481] TCF7L1 promotes skin tumorigenesis independently of -catenin through induction of LCN2.Elife. 2017 May 3;6:e23242. doi: 10.7554/eLife.23242.
• [5482] Advances in pathological understanding of high-grade B cell lymphomas.Expert Rev Hematol. 2018 Aug;11(8):637-648. doi: 10.1080/17474086.2018.1494567. Epub 2018 Jul 10.
• [5483] Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization.J Dermatol Sci. 2017 Sep;87(3):300-306. doi: 10.1016/j.jdermsci.2017.06.013. Epub 2017 Jun 16.
• [5484] Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.Sci Rep. 2016 Sep 7;6:32417. doi: 10.1038/srep32417.
• [5485] TCP10L acts as a tumor suppressor by inhibiting cell proliferation in hepatocellular carcinoma.Biochem Biophys Res Commun. 2014 Mar 28;446(1):61-7. doi: 10.1016/j.bbrc.2014.02.049. Epub 2014 Feb 21.
• [5486] MiR-216a-5p targets TCTN1 to inhibit cell proliferation and induce apoptosis in esophageal squamous cell carcinoma.Cell Mol Biol Lett. 2019 Jun 28;24:46. doi: 10.1186/s11658-019-0166-9. eCollection 2019.
• [5487] TCTN2: a novel tumor marker with oncogenic properties.Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10.
• [5488] Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer Cells.Sci Rep. 2017 Jul 11;7(1):5153. doi: 10.1038/s41598-017-04955-4.
• [5489] In Vivo Characterization of 4 (68)Ga-Labeled Multimeric RGD Peptides to Image (v)(3) Integrin Expression in 2 Human Tumor Xenograft Mouse Models.J Nucl Med. 2018 Aug;59(8):1296-1301. doi: 10.2967/jnumed.117.206979. Epub 2018 Apr 6.
• [5490] Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 binding to TEA domain transcription factor 4 by molecular dynamics simulation and molecular mechanics generalized Born/surface area) calculation.J Biomol Struct Dyn. 2019 Jul;37(10):2538-2545. doi: 10.1080/07391102.2018.1491889. Epub 2018 Nov 9.
• [5491] Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer.Ann Oncol. 2019 Feb 1;30(2):266-273. doi: 10.1093/annonc/mdy505.
• [5492] FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of -catenin.Exp Mol Med. 2018 Dec 10;50(12):1-12. doi: 10.1038/s12276-018-0184-0.
• [5493] TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis.Cancer Commun (Lond). 2019 Feb 6;39(1):3. doi: 10.1186/s40880-019-0347-y.
• [5494] Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.Theranostics. 2019 Jan 24;9(3):761-777. doi: 10.7150/thno.29520. eCollection 2019.
• [5495] Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3.Eur J Cancer. 2019 Apr;111:138-147. doi: 10.1016/j.ejca.2019.01.105. Epub 2019 Mar 7.
• [5496] Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/catenin pathway.Oncol Rep. 2019 Dec;42(6):2600-2610. doi: 10.3892/or.2019.7376. Epub 2019 Oct 16.
• [5497] Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis.Mol Cancer. 2017 Apr 26;16(1):84. doi: 10.1186/s12943-017-0653-4.
• [5498] Iron deprivation suppresses hepatocellular carcinoma growth in experimental studies.Clin Cancer Res. 2011 Dec 15;17(24):7625-33. doi: 10.1158/1078-0432.CCR-10-3099. Epub 2011 Nov 3.
• [5499] TFAP2B overexpression contributes to tumor growth and progression of thyroid cancer through the COX-2 signaling pathway.Cell Death Dis. 2019 May 21;10(6):397. doi: 10.1038/s41419-019-1600-7.
• [5500] CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.Cell Death Dis. 2019 Sep 9;10(9):644. doi: 10.1038/s41419-019-1894-5.
• [5501] NetSig: network-based discovery from cancer genomes.Nat Methods. 2018 Jan;15(1):61-66. doi: 10.1038/nmeth.4514. Epub 2017 Dec 4.
• [5502] MiT family translocation renal cell carcinomas: A 15th anniversary update.Histol Histopathol. 2020 Feb;35(2):125-136. doi: 10.14670/HH-18-159. Epub 2019 Sep 6.
• [5503] Resveratrol suppresses melanoma by inhibiting NF-B/miR-221 and inducing TFG expression.Arch Dermatol Res. 2017 Dec;309(10):823-831. doi: 10.1007/s00403-017-1784-6. Epub 2017 Sep 21.
• [5504] Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.Histopathology. 2019 Jul;75(1):63-73. doi: 10.1111/his.13847. Epub 2019 May 16.
• [5505] HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression.Cell Death Dis. 2019 Nov 18;10(12):873. doi: 10.1038/s41419-019-2114-z.
• [5506] Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).Virchows Arch. 2019 Mar;474(3):341-351. doi: 10.1007/s00428-018-02512-6. Epub 2019 Jan 15.
• [5507] A transcriptional regulatory role of the THAP11-HCF-1 complex in colon cancer cell function.Mol Cell Biol. 2012 May;32(9):1654-70. doi: 10.1128/MCB.06033-11. Epub 2012 Feb 27.
• [5508] Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer.Cancer Res. 2016 Apr 1;76(7):1714-23. doi: 10.1158/0008-5472.CAN-15-0338. Epub 2016 Feb 8.
• [5509] THAP7 promotes cell proliferation by regulating the G1/S phase transition via epigenetically silencing p21 in lung adenocarcinoma.Onco Targets Ther. 2019 Jul 12;12:5651-5660. doi: 10.2147/OTT.S208908. eCollection 2019.
• [5510] Network analysis of icb-1 gene function in human breast cancer cells.J Cell Biochem. 2012 Sep;113(9):2979-88. doi: 10.1002/jcb.24175.
• [5511] Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer.Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):53-8. doi: 10.1016/j.bbrc.2015.10.166. Epub 2015 Nov 3.
• [5512] Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death.Oncogene. 2016 Jul 21;35(29):3872-9. doi: 10.1038/onc.2015.433. Epub 2015 Nov 9.
• [5513] Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.Breast Cancer Res. 2014 Dec 4;16(6):481. doi: 10.1186/s13058-014-0481-z.
• [5514] Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.Mol Cancer Res. 2008 Apr;6(4):592-603. doi: 10.1158/1541-7786.MCR-07-0154.
• [5515] Expression of THSD7A in neoplasm tissues and its relationship with proteinuria.BMC Nephrol. 2019 Aug 23;20(1):332. doi: 10.1186/s12882-019-1489-5.
• [5516] Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.J Exp Med. 1996 May 1;183(5):2283-91. doi: 10.1084/jem.183.5.2283.
• [5517] LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathway.Oncotarget. 2016 Mar 29;7(13):15787-800. doi: 10.18632/oncotarget.7487.
• [5518] Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide.Int J Mol Sci. 2019 Mar 1;20(5):1061. doi: 10.3390/ijms20051061.
• [5519] Cascade-Reaction-Based Nanodrug for Combined Chemo/Starvation/Chemodynamic Therapy against Multidrug-Resistant Tumors.ACS Appl Mater Interfaces. 2019 Dec 11;11(49):46112-46123. doi: 10.1021/acsami.9b15848. Epub 2019 Nov 25.
• [5520] Asparaginyl endopeptidase induces endothelial permeability and tumor metastasis via downregulating zonula occludens protein ZO-1.Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2267-2275. doi: 10.1016/j.bbadis.2019.05.003. Epub 2019 May 13.
• [5521] Alu-related transcript of TJP2 gene as a marker for colorectal cancer.Gene. 2013 Jul 25;524(2):268-74. doi: 10.1016/j.gene.2013.04.006. Epub 2013 Apr 20.
• [5522] Altered gene expression profiles of NIH3T3 cells regulated by human lung cancer associated gene CT120.Cell Res. 2004 Dec;14(6):487-96. doi: 10.1038/sj.cr.7290252.
• [5523] Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study.Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):680-688. doi: 10.1158/1055-9965.EPI-17-1101. Epub 2018 Mar 12.
• [5524] TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.Cancer Biol Ther. 2019;20(1):101-108. doi: 10.1080/15384047.2018.1507257. Epub 2018 Sep 12.
• [5525] A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.Endocrine. 2013 Feb;43(1):161-9. doi: 10.1007/s12020-012-9783-z. Epub 2012 Nov 3.
• [5526] Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.Leukemia. 2015 Dec;29(12):2317-27. doi: 10.1038/leu.2015.162. Epub 2015 Jun 25.
• [5527] NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.J Transl Med. 2008 Feb 26;6:9. doi: 10.1186/1479-5876-6-9.
• [5528] TLX3 repressed SNAI1-induced epithelial-mesenchymal transition by directly constraining STAT3 phosphorylation and functionally sensitized 5-FU chemotherapy in hepatocellular carcinoma.Int J Biol Sci. 2019 Jun 5;15(8):1696-1711. doi: 10.7150/ijbs.33844. eCollection 2019.
• [5529] TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth.PLoS One. 2019 Mar 21;14(3):e0211711. doi: 10.1371/journal.pone.0211711. eCollection 2019.
• [5530] Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene.Sci Rep. 2018 Oct 17;8(1):15327. doi: 10.1038/s41598-018-33527-3.
• [5531] The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells.EMBO Rep. 2009 Dec;10(12):1348-54. doi: 10.1038/embor.2009.236. Epub 2009 Nov 6.
• [5532] Genetic variant of TMBIM1 is associated with the susceptibility of colorectal cancer in the Chinese population.Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):324-329. doi: 10.1016/j.clinre.2018.10.013. Epub 2018 Nov 15.
• [5533] Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.Cancer Causes Control. 2016 Jun;27(6):809-15. doi: 10.1007/s10552-016-0749-y. Epub 2016 Apr 20.
• [5534] Identification of stage-specific breast markers using quantitative proteomics.J Proteome Res. 2013 Dec 6;12(12):5696-708. doi: 10.1021/pr400662k. Epub 2013 Oct 29.
• [5535] TMEFF1 and brain tumors.Oncogene. 2003 May 8;22(18):2723-7. doi: 10.1038/sj.onc.1206351.
• [5536] TMEM100 expression suppresses metastasis and enhances sensitivity to chemotherapy in gastric cancer.Biol Chem. 2020 Feb 25;401(2):285-296. doi: 10.1515/hsz-2019-0161.
• [5537] TMEM106A inhibits cell proliferation, migration, and induces apoptosis of lung cancer cells.J Cell Biochem. 2019 May;120(5):7825-7833. doi: 10.1002/jcb.28057. Epub 2018 Nov 19.
• [5538] Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.J Natl Cancer Inst. 2015 Sep 14;107(11):djv223. doi: 10.1093/jnci/djv223. Print 2015 Nov.
• [5539] CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells.Cancer Sci. 2019 Jan;110(1):256-268. doi: 10.1111/cas.13885. Epub 2018 Dec 14.
• [5540] TMEM158 promotes pancreatic cancer aggressiveness by activation of TGF1 and PI3K/AKT signaling pathway.J Cell Physiol. 2020 Mar;235(3):2761-2775. doi: 10.1002/jcp.29181. Epub 2019 Sep 17.
• [5541] TMEM17 promotes malignant progression of breast cancer via AKT/GSK3 signaling.Cancer Manag Res. 2018 Aug 2;10:2419-2428. doi: 10.2147/CMAR.S168723. eCollection 2018.
• [5542] Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/-catenin pathway.Cell Death Dis. 2018 Jan 24;9(2):91. doi: 10.1038/s41419-017-0128-y.
• [5543] Potential targets of TMEM176A in the growth of glioblastoma cells.Onco Targets Ther. 2018 Nov 2;11:7763-7775. doi: 10.2147/OTT.S179725. eCollection 2018.
• [5544] Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation.Cancer Cell. 2019 May 13;35(5):767-781.e6. doi: 10.1016/j.ccell.2019.04.003.
• [5545] Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer.J Cancer Res Clin Oncol. 2007 Apr;133(4):213-8. doi: 10.1007/s00432-006-0159-8. Epub 2006 Oct 28.
• [5546] TMEM196 hypermethylation as a novel diagnostic and prognostic biomarker for lung cancer.Mol Carcinog. 2019 Apr;58(4):474-487. doi: 10.1002/mc.22942. Epub 2018 Dec 11.
• [5547] Cytoplasmic transfer of heritable elements other than mtDNA from SAMP1 mice into mouse tumor cells suppresses their ability to form tumors in C57BL6 mice.Biochem Biophys Res Commun. 2017 Nov 4;493(1):252-257. doi: 10.1016/j.bbrc.2017.09.035. Epub 2017 Sep 9.
• [5548] Transmembrane protein 215 promotes angiogenesis by maintaining endothelial cell survival.J Cell Physiol. 2019 Jun;234(6):9525-9534. doi: 10.1002/jcp.27641. Epub 2018 Oct 28.
• [5549] Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response.Oncotarget. 2016 Jun 21;7(25):38408-38426. doi: 10.18632/oncotarget.9493.
• [5550] A biosystems approach to identify the molecular signaling mechanisms of TMEM30A during tumor migration.PLoS One. 2017 Jun 22;12(6):e0179900. doi: 10.1371/journal.pone.0179900. eCollection 2017.
• [5551] High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.J Transl Med. 2018 Jan 19;16(1):9. doi: 10.1186/s12967-017-1377-3.
• [5552] Knockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cells.Int J Clin Exp Pathol. 2015 Oct 1;8(10):12657-67. eCollection 2015.
• [5553] Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.Clin Cancer Res. 2007 Dec 1;13(23):6978-83. doi: 10.1158/1078-0432.CCR-07-1417.
• [5554] Tumor suppressor NGX6 inhibits the growth and metastasis of multiple cancers.Tumour Biol. 2016 May;37(5):5751-60. doi: 10.1007/s13277-016-4966-5. Epub 2016 Feb 15.
• [5555] Identification of transmembrane protein 98 as a novel chemoresistance-conferring gene in hepatocellular carcinoma.Mol Cancer Ther. 2014 May;13(5):1285-97. doi: 10.1158/1535-7163.MCT-13-0806. Epub 2014 Mar 7.
• [5556] Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis.Anticancer Res. 2018 Jul;38(7):3943-3950. doi: 10.21873/anticanres.12680.
• [5557] Expression of the TP and TP isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.Oncotarget. 2016 Nov 8;7(45):73171-73187. doi: 10.18632/oncotarget.12256.
• [5558] Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: a case-control study and meta-analysis.J Gastroenterol Hepatol. 2013 Nov;28(11):1717-24. doi: 10.1111/jgh.12335.
• [5559] Human DESC1 serine protease confers tumorigenic properties to MDCK cells and it is upregulated in tumours of different origin.Br J Cancer. 2007 Jul 16;97(2):201-9. doi: 10.1038/sj.bjc.6603856. Epub 2007 Jun 19.
• [5560] Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.Oncol Res. 2018 Jan 19;26(1):95-101. doi: 10.3727/096504017X14920318811695. Epub 2017 Apr 12.
• [5561] Thymosin 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma.Biosci Rep. 2019 Mar 15;39(3):BSR20182355. doi: 10.1042/BSR20182355. Print 2019 Mar 29.
• [5562] Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes.Mol Med Rep. 2018 Mar;17(3):4337-4344. doi: 10.3892/mmr.2018.8451. Epub 2018 Jan 17.
• [5563] MiR-424 Promotes Non-Small Cell Lung Cancer Progression and Metastasis through Regulating the Tumor Suppressor Gene TNFAIP1.Cell Physiol Biochem. 2017;42(1):211-221. doi: 10.1159/000477314. Epub 2017 May 25.
• [5564] TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells.Lab Invest. 2019 Nov;99(11):1702-1713. doi: 10.1038/s41374-019-0285-y. Epub 2019 Jul 1.
• [5565] Hyaluronan preconditioning of monocytes/macrophages affects their angiogenic behavior and regulation of TSG-6 expression in a tumor type-specific manner.FEBS J. 2019 Sep;286(17):3433-3449. doi: 10.1111/febs.14871. Epub 2019 May 16.
• [5566] SCC-S2 Facilitates Tumor Proliferation and Invasion via Activating Wnt Signaling and Depressing Hippo Signaling in Colorectal Cancer Cells and Predicts Poor Prognosis of Patients.J Histochem Cytochem. 2019 Jan;67(1):65-75. doi: 10.1369/0022155418799957. Epub 2018 Sep 14.
• [5567] TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis.J Exp Med. 2020 Feb 3;217(2):e20182005. doi: 10.1084/jem.20182005.
• [5568] TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.BMC Cancer. 2018 Mar 6;18(1):260. doi: 10.1186/s12885-018-4177-0.
• [5569] Association of EGFR and KRAS mutations with expression of p-AKT, DR5 and DcR1 in non-small cell lung cancer.Neoplasma. 2017;64(2):182-191. doi: 10.4149/neo_2017_203.
• [5570] The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression.Genome Biol. 2019 May 24;20(1):103. doi: 10.1186/s13059-019-1696-1.
• [5571] Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8(+) T Cells in HCC.Mol Ther. 2019 Nov 6;27(11):1906-1918. doi: 10.1016/j.ymthe.2019.07.019. Epub 2019 Aug 5.
• [5572] Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma.Cancer Res. 2018 Dec 1;78(23):6621-6631. doi: 10.1158/0008-5472.CAN-18-0545. Epub 2018 Sep 13.
• [5573] Identification of protein targets and the mechanism of the cytotoxic action of Ipomoea turpethum extract loaded nanoparticles against breast cancer cells.J Mater Chem B. 2019 Oct 9;7(39):6048-6063. doi: 10.1039/c9tb00824a.
• [5574] MicroRNA-371a-3p promotes progression of gastric cancer by targeting TOB1.Cancer Lett. 2019 Feb 28;443:179-188. doi: 10.1016/j.canlet.2018.11.021. Epub 2018 Dec 4.
• [5575] TOG-tubulin binding specificity promotes microtubule dynamics and mitotic spindle formation.J Cell Biol. 2017 Jun 5;216(6):1641-1657. doi: 10.1083/jcb.201610090. Epub 2017 May 16.
• [5576] Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.Semin Oncol. 2017 Jun;44(3):218-225. doi: 10.1053/j.seminoncol.2017.10.003. Epub 2017 Oct 10.
• [5577] Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.J Ovarian Res. 2019 Mar 27;12(1):30. doi: 10.1186/s13048-019-0498-0.
• [5578] Identification of New Tumor Suppressor Genes in Triple-Negative Breast Cancer.Cancer Res. 2017 Aug 1;77(15):4089-4101. doi: 10.1158/0008-5472.CAN-17-0785. Epub 2017 Jul 19.
• [5579] A novel long non-coding RNA TONSL-AS1 regulates progression of gastric cancer via activating TONSL.Exp Cell Res. 2019 Sep 1;382(1):111453. doi: 10.1016/j.yexcr.2019.05.034. Epub 2019 May 31.
• [5580] The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis.Nat Commun. 2019 Jan 8;10(1):83. doi: 10.1038/s41467-018-07922-3.
• [5581] Topoisomerase II-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation.Oncogene. 2019 Apr;38(17):3274-3287. doi: 10.1038/s41388-018-0633-1. Epub 2019 Jan 10.
• [5582] Integration of transcriptome and proteome profiles in glioblastoma: looking for the missing link.BMC Mol Biol. 2018 Nov 21;19(1):13. doi: 10.1186/s12867-018-0115-6.
• [5583] Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers.PLoS One. 2012;7(4):e34850. doi: 10.1371/journal.pone.0034850. Epub 2012 Apr 4.
• [5584] Polymorphisms in the TOX3/LOC643714 and risk of breast cancer in south China.Int J Biol Markers. 2018 Apr 1:1724600818755633. doi: 10.1177/1724600818755633. Online ahead of print.
• [5585] Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer.J BUON. 2019 May-Jun;24(3):967-974.
• [5586] Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.Inflamm Bowel Dis. 2013 Mar;19(3):461-70. doi: 10.1097/MIB.0b013e3182802bac.
• [5587] Metabolic alterations of zinc and prostaglandins in both human and animal colonic tumor cells.J Am Coll Nutr. 1995 Oct;14(5):473-9. doi: 10.1080/07315724.1995.10718538.
• [5588] Hypoxia-Induced TPM2 Methylation is Associated with Chemoresistance and Poor Prognosis in Breast Cancer.Cell Physiol Biochem. 2018;45(2):692-705. doi: 10.1159/000487162. Epub 2018 Jan 31.
• [5589] The clinical significance and biological function of tropomyosin 4 in colon cancer.Biomed Pharmacother. 2018 May;101:1-7. doi: 10.1016/j.biopha.2018.01.166. Epub 2018 Feb 22.
• [5590] TRA2A promotes proliferation, migration, invasion and epithelial mesenchymal transition of glioma cells.Brain Res Bull. 2018 Oct;143:138-144. doi: 10.1016/j.brainresbull.2018.10.006. Epub 2018 Oct 24.
• [5591] miR-335 inhibited cell proliferation of lung cancer cells by target Tra2.Cancer Sci. 2018 Feb;109(2):289-296. doi: 10.1111/cas.13452. Epub 2017 Dec 15.
• [5592] Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma.Cancer Sci. 2016 Mar;107(3):320-5. doi: 10.1111/cas.12876. Epub 2016 Feb 19.
• [5593] Elevated Choline Kinase -Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B Lymphocytes.J Immunol. 2020 Jan 15;204(2):459-471. doi: 10.4049/jimmunol.1900658. Epub 2019 Dec 11.
• [5594] Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.Biochem Biophys Res Commun. 2018 Jun 7;500(3):810-816. doi: 10.1016/j.bbrc.2018.04.164. Epub 2018 Apr 24.
• [5595] Overexpression of Translocation Associated Membrane Protein 2 Leading to Cancer-Associated Matrix Metalloproteinase Activation as a Putative Metastatic Factor for Human Oral Cancer.J Cancer. 2018 Sep 7;9(18):3326-3333. doi: 10.7150/jca.25666. eCollection 2018.
• [5596] The role of ERK2 in colorectal carcinogenesis is partly regulated by TRAPPC4.Mol Carcinog. 2014 Feb;53 Suppl 1:E72-84. doi: 10.1002/mc.22031. Epub 2013 Apr 26.
• [5597] TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-B pathway in non-small-cell lung carcinoma cells.Gene. 2019 Oct 5;715:144015. doi: 10.1016/j.gene.2019.144015. Epub 2019 Jul 26.
• [5598] Reduced levels of methyltransferase DNMT2 sensitize human fibroblasts to oxidative stress and DNA damage that is accompanied by changes in proliferation-related miRNA expression.Redox Biol. 2018 Apr;14:20-34. doi: 10.1016/j.redox.2017.08.012. Epub 2017 Aug 18.
• [5599] High TRIAP1 expression in penile carcinoma is associated with high risk of recurrence and poor survival.Ann Transl Med. 2019 Jul;7(14):330. doi: 10.21037/atm.2019.06.47.
• [5600] Sex-related DNA methylation differences in B cell chronic lymphocytic leukemia.Biol Sex Differ. 2019 Jan 7;10(1):2. doi: 10.1186/s13293-018-0213-7.
• [5601] A Trib2-p38 axis controls myeloid leukaemia cell cycle and stress response signalling.Cell Death Dis. 2018 May 1;9(5):443. doi: 10.1038/s41419-018-0467-3.
• [5602] TRIM11 promotes tumor angiogenesis via activation of STAT3/VEGFA signaling in lung adenocarcinoma.Am J Cancer Res. 2019 Sep 1;9(9):2019-2027. eCollection 2019.
• [5603] High Levels of TRIM14 Are Associated with Poor Prognosis in Hepatocellular Carcinoma.Oncol Res Treat. 2018;41(3):129-134. doi: 10.1159/000485625. Epub 2018 Feb 27.
• [5604] Role of the focal adhesion protein TRIM15 in colon cancer development.Biochim Biophys Acta. 2015 Feb;1853(2):409-21. doi: 10.1016/j.bbamcr.2014.11.007. Epub 2014 Nov 15.
• [5605] Cancer-associated mutation abolishes the impact of TRIM21 on the invasion of breast cancer cells.Int J Biol Macromol. 2020 Jan 1;142:782-789. doi: 10.1016/j.ijbiomac.2019.10.019. Epub 2019 Oct 14.
• [5606] MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.Life Sci. 2019 May 1;224:1-11. doi: 10.1016/j.lfs.2019.03.028. Epub 2019 Mar 12.
• [5607] Trim32 suppresses cerebellar development and tumorigenesis by degrading Gli1/sonic hedgehog signaling.Cell Death Differ. 2020 Apr;27(4):1286-1299. doi: 10.1038/s41418-019-0415-5. Epub 2019 Sep 17.
• [5608] Cloning and characterisation of the RBCC728/TRIM36 zinc-binding protein from the tumor suppressor gene region at chromosome 5q22.3.Gene. 2004 May 12;332:45-50. doi: 10.1016/j.gene.2004.02.045.
• [5609] High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.Biosci Rep. 2019 Mar 6;39(3):BSR20181639. doi: 10.1042/BSR20181639. Print 2019 Mar 29.
• [5610] TRIM45 Suppresses the Development of Non-small Cell Lung Cancer.Curr Mol Med. 2020;20(4):299-306. doi: 10.2174/1566524019666191017143833.
• [5611] TRIM50 acts as a novel Src suppressor and inhibits ovarian cancer progression.Biochim Biophys Acta Mol Cell Res. 2019 Sep;1866(9):1412-1420. doi: 10.1016/j.bbamcr.2019.06.002. Epub 2019 Jun 6.
• [5612] TRIM58 suppresses the tumor growth in gastric cancer by inactivation of -catenin signaling via ubiquitination.Cancer Biol Ther. 2020;21(3):203-212. doi: 10.1080/15384047.2019.1679554. Epub 2019 Nov 21.
• [5613] Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.J Exp Clin Cancer Res. 2016 Oct 28;35(1):170. doi: 10.1186/s13046-016-0445-5.
• [5614] Genetic pathways of multiple esophageal squamous cell carcinomas.Oncol Rep. 2011 Feb;25(2):453-9. doi: 10.3892/or.2010.1110. Epub 2010 Dec 14.
• [5615] TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression.Cancer Res. 2019 Aug 15;79(16):4086-4098. doi: 10.1158/0008-5472.CAN-18-3614. Epub 2019 Jun 25.
• [5616] The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein.Cell Death Differ. 2020 Jun;27(6):1819-1831. doi: 10.1038/s41418-019-0464-9. Epub 2019 Dec 4.
• [5617] The mRNA repressor TRIM71 cooperates with Nonsense-Mediated Decay factors to destabilize the mRNA of CDKN1A/p21.Nucleic Acids Res. 2019 Dec 16;47(22):11861-11879. doi: 10.1093/nar/gkz1057.
• [5618] TRIM72 Immunohistochemical Expression Can Predict Relapse in Colorectal Carcinoma.Pathol Oncol Res. 2020 Apr;26(2):861-865. doi: 10.1007/s12253-019-00629-w. Epub 2019 Mar 9.
• [5619] The significance of TRIP11 and T3 signalling pathway in renal cancer progression and survival of patients.Endokrynol Pol. 2017;68(6):631-641. doi: 10.5603/EP.a2017.0052. Epub 2017 Oct 12.
• [5620] Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4.Cell Oncol (Dordr). 2020 Apr;43(2):279-295. doi: 10.1007/s13402-019-00487-3. Epub 2019 Dec 17.
• [5621] TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.Cancer Lett. 2019 Jun 28;452:1-13. doi: 10.1016/j.canlet.2019.03.017. Epub 2019 Mar 21.
• [5622] Combined liver transplant and pancreaticoduodenectomy for inflammatory hilar myofibroblastic tumor: Case report and review of the literature.Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12846. Epub 2016 Dec 20.
• [5623] Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer.Genes Chromosomes Cancer. 2007 Jul;46(7):694-707. doi: 10.1002/gcc.20454.
• [5624] Functional correlation of trophinin expression with the malignancy of testicular germ cell tumor.Cancer Res. 2004 Jun 15;64(12):4257-62. doi: 10.1158/0008-5472.CAN-04-0732.
• [5625] TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.Cell Rep. 2018 Oct 30;25(5):1255-1267.e5. doi: 10.1016/j.celrep.2018.10.023.
• [5626] Expression and prognostic roles of TRPV5 and TRPV6 in non-small cell lung cancer after curative resection.Asian Pac J Cancer Prev. 2014;15(6):2559-63. doi: 10.7314/apjcp.2014.15.6.2559.
• [5627] The interplay between TGF--stimulated TSC22 domain family proteins regulates cell-cycle dynamics in medulloblastoma cells.J Cell Physiol. 2019 Aug;234(10):18349-18360. doi: 10.1002/jcp.28468. Epub 2019 Mar 25.
• [5628] Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.PLoS One. 2011 Mar 14;6(3):e17149. doi: 10.1371/journal.pone.0017149.
• [5629] Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors.Biochem Biophys Res Commun. 2001 Jul 13;285(2):400-8. doi: 10.1006/bbrc.2001.5165.
• [5630] Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;6).Oncogene. 2000 Nov 23;19(50):5821-5. doi: 10.1038/sj.onc.1203943.
• [5631] Tspan15 Is a New Stemness-Related Marker in Hepatocellular Carcinoma.Proteomics. 2019 Nov;19(21-22):e1900025. doi: 10.1002/pmic.201900025. Epub 2019 Sep 2.
• [5632] miR?78a?p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17.Oncol Rep. 2019 Nov;42(5):1957-1971. doi: 10.3892/or.2019.7283. Epub 2019 Aug 20.
• [5633] Ullrich-Turner Syndrome and Tumor Risk: Is There Another Chance to Early Gonadectomy in Positive TSPY and SRY Patients?.Eur J Pediatr Surg. 2016 Jun;26(3):273-6. doi: 10.1055/s-0035-1551568. Epub 2015 May 15.
• [5634] Battle of the sexes: contrasting roles of testis-specific protein Y-encoded (TSPY) and TSPX in human oncogenesis.Asian J Androl. 2019 May-Jun;21(3):260-269. doi: 10.4103/aja.aja_43_18.
• [5635] Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.BMC Cancer. 2017 Feb 24;17(1):158. doi: 10.1186/s12885-017-3134-7.
• [5636] Landscape of tumor-infiltrating T cell repertoire of human cancers.Nat Genet. 2016 Jul;48(7):725-32. doi: 10.1038/ng.3581. Epub 2016 May 30.
• [5637] TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1/Derlin-1 pathway.J Hematol Oncol. 2017 Feb 20;10(1):52. doi: 10.1186/s13045-017-0422-2.
• [5638] Identification and characterization of TPARM gene in silico.Int J Oncol. 2003 Oct;23(4):1213-7.
• [5639] LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers.Gynecol Oncol. 2017 Dec;147(3):642-647. doi: 10.1016/j.ygyno.2017.09.032. Epub 2017 Oct 9.
• [5640] HBP21, a chaperone of heat shock protein 70, functions as a tumor suppressor in hepatocellular carcinoma.Carcinogenesis. 2015 Oct;36(10):1111-20. doi: 10.1093/carcin/bgv116. Epub 2015 Aug 5.
• [5641] Increased glutamate uptake in astrocytes via propentofylline results in increased tumor cell apoptosis using the CNS-1 glioma model.J Neurooncol. 2013 Aug;114(1):33-42. doi: 10.1007/s11060-013-1158-7. Epub 2013 May 22.
• [5642] The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value.Oncotarget. 2015 Sep 22;6(28):26388-99. doi: 10.18632/oncotarget.4557.
• [5643] Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.Int J Cancer. 2010 Dec 1;127(11):2542-53. doi: 10.1002/ijc.25261.
• [5644] Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon.EMBO J. 2014 Oct 1;33(19):2247-60. doi: 10.15252/embj.201488466. Epub 2014 Sep 1.
• [5645] Aggregate analysis based on TCGA: TTN missense mutation correlates with favorable prognosis in lung squamous cell carcinoma.J Cancer Res Clin Oncol. 2019 Apr;145(4):1027-1035. doi: 10.1007/s00432-019-02861-y. Epub 2019 Feb 27.
• [5646] WITHDRAWN: Prognostic biomarker AASS suppresses proliferation, migration and predicts a good survival of hepatocellular carcinoma in vivo and in vitro.Life Sci. 2019 May 31:S0024-3205(19)30436-9. doi: 10.1016/j.lfs.2019.05.080. Online ahead of print.
• [5647] Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration.Eur J Cancer. 2016 Apr;57:39-49. doi: 10.1016/j.ejca.2016.01.002. Epub 2016 Feb 6.
• [5648] Dithiolethiones inhibit NF-B activity via covalent modification in human estrogen receptor-negative breast cancer.Cancer Res. 2012 May 1;72(9):2394-404. doi: 10.1158/0008-5472.CAN-11-3115. Epub 2012 Mar 21.
• [5649] The Transsulfuration Pathway Makes, the Tumor Takes.Cell Metab. 2019 Nov 5;30(5):845-846. doi: 10.1016/j.cmet.2019.10.009.
• [5650] Targeting Cell Adhesion Molecules via Carbonate Apatite-Mediated Delivery of Specific siRNAs to Breast Cancer Cells In Vitro and In Vivo.Pharmaceutics. 2019 Jul 2;11(7):309. doi: 10.3390/pharmaceutics11070309.
• [5651] Expression of the Arp11 gene suppresses the tumorigenicity of PC-14 human lung adenocarcinoma cells.Biochem Biophys Res Commun. 2003 Dec 26;312(4):889-96. doi: 10.1016/j.bbrc.2003.10.200.
• [5652] Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.Carcinogenesis. 2019 Dec 31;40(12):1480-1491. doi: 10.1093/carcin/bgz069.
• [5653] Long noncoding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis.Oncogene. 2019 Apr;38(16):3061-3076. doi: 10.1038/s41388-018-0645-x. Epub 2019 Jan 7.
• [5654] Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.Cancer Res. 2012 Jan 1;72(1):220-9. doi: 10.1158/0008-5472.CAN-11-1976. Epub 2011 Nov 9.
• [5655] High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome.Int J Cancer. 2020 Apr 1;146(7):2007-2018. doi: 10.1002/ijc.32818. Epub 2019 Dec 19.
• [5656] Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathway.Oncotarget. 2013 Oct;4(10):1791-803. doi: 10.18632/oncotarget.1324.
• [5657] MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.Neuro Oncol. 2013 Oct;15(10):1302-16. doi: 10.1093/neuonc/not090. Epub 2013 Jun 28.
• [5658] Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways.Biochem Pharmacol. 2019 Sep;167:44-49. doi: 10.1016/j.bcp.2018.09.028. Epub 2018 Sep 27.
• [5659] Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.Clin Cancer Res. 2011 Nov 15;17(22):7003-14. doi: 10.1158/1078-0432.CCR-11-1870. Epub 2011 Oct 5.
• [5660] Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer.Transl Oncol. 2019 Jan;12(1):43-48. doi: 10.1016/j.tranon.2018.09.003. Epub 2018 Sep 25.
• [5661] Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1 stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment.Oncogene. 2019 Jan;38(1):103-119. doi: 10.1038/s41388-018-0423-9. Epub 2018 Aug 6.
• [5662] MMR gene expression pattern in sporadic colorectal cancer.J Gastrointestin Liver Dis. 2010 Jun;19(2):155-9.
• [5663] ANKRD33 is overexpressed in gastric adenocarcinoma and predictive for poor prognosis.Biosci Biotechnol Biochem. 2019 Nov;83(11):2075-2081. doi: 10.1080/09168451.2019.1642100. Epub 2019 Jul 17.
• [5664] MUDENG Expression Profiling in Cohorts and Brain Tumor Biospecimens to Evaluate Its Role in Cancer.Front Genet. 2019 Sep 19;10:884. doi: 10.3389/fgene.2019.00884. eCollection 2019.
• [5665] HBV triggers APOBEC2 expression through miR?22 regulation and affects the proliferation of liver cancer cells.Int J Oncol. 2019 Nov;55(5):1137-1148. doi: 10.3892/ijo.2019.4870. Epub 2019 Sep 4.
• [5666] Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.Ann Transl Med. 2019 Aug;7(16):380. doi: 10.21037/atm.2019.07.59.
• [5667] Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.Clin Cancer Res. 2010 Apr 15;16(8):2375-82. doi: 10.1158/1078-0432.CCR-09-3275. Epub 2010 Apr 6.
• [5668] Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodes.PLoS One. 2014 Dec 29;9(12):e115346. doi: 10.1371/journal.pone.0115346. eCollection 2014.
• [5669] ARHGAP21 modulates FAK activity and impairs glioblastoma cell migration.Biochim Biophys Acta. 2009 May;1793(5):806-16. doi: 10.1016/j.bbamcr.2009.02.010. Epub 2009 Mar 4.
• [5670] Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.Glia. 2013 Sep;61(9):1402-17. doi: 10.1002/glia.22521. Epub 2013 Jul 6.
• [5671] ARHGAP30 suppressed lung cancer cell proliferation, migration, and invasion through inhibition of the Wnt/-catenin signaling pathway.Onco Targets Ther. 2018 Oct 24;11:7447-7457. doi: 10.2147/OTT.S175255. eCollection 2018.
• [5672] RICH2, a potential tumor suppressor in hepatocellular carcinoma.Front Biosci (Landmark Ed). 2019 Jun 1;24(8):1363-1376. doi: 10.2741/4784.
• [5673] ARID3B Directly Regulates Ovarian Cancer Promoting Genes.PLoS One. 2015 Jun 29;10(6):e0131961. doi: 10.1371/journal.pone.0131961. eCollection 2015.
• [5674] Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN. Laboratory investigation.J Neurosurg. 2008 Feb;108(2):299-303. doi: 10.3171/JNS/2008/108/2/0299.
• [5675] ARMc8 indicates aggressive colon cancers and promotes invasiveness and migration of colon cancer cells.Tumour Biol. 2015 Nov;36(11):9005-13. doi: 10.1007/s13277-015-3664-z. Epub 2015 Jun 18.
• [5676] ARPC2 promotes breast cancer proliferation and metastasis.Oncol Rep. 2019 Jun;41(6):3189-3200. doi: 10.3892/or.2019.7113. Epub 2019 Apr 12.
• [5677] Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/ATF1 signaling.Int J Biol Macromol. 2019 Jun 1;130:24-33. doi: 10.1016/j.ijbiomac.2019.02.083. Epub 2019 Feb 18.
• [5678] Intragenic DNA methylation concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker.Asian Pac J Cancer Prev. 2012;13(11):5563-8. doi: 10.7314/apjcp.2012.13.11.5563.
• [5679] cis-Expression QTL analysis of established colorectal cancer risk variants in colon tumors and adjacent normal tissue.PLoS One. 2012;7(2):e30477. doi: 10.1371/journal.pone.0030477. Epub 2012 Feb 17.
• [5680] Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.PLoS One. 2018 Nov 19;13(11):e0207483. doi: 10.1371/journal.pone.0207483. eCollection 2018.
• [5681] Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.Oncogene. 2013 May 16;32(20):2586-91. doi: 10.1038/onc.2012.263. Epub 2012 Jul 2.
• [5682] The interplay between Eps8 and IRSp53 contributes to Src-mediated transformation.Oncogene. 2010 Jul 8;29(27):3977-89. doi: 10.1038/onc.2010.144. Epub 2010 Apr 26.
• [5683] A Unique Family of Neuronal Signaling Proteins Implicated in Oncogenesis and Tumor Suppression.Front Oncol. 2019 Apr 17;9:289. doi: 10.3389/fonc.2019.00289. eCollection 2019.
• [5684] The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis.J Biomed Sci. 2017 Aug 26;24(1):61. doi: 10.1186/s12929-017-0360-x.
• [5685] Brevican knockdown reduces late-stage glioma tumor aggressiveness.J Neurooncol. 2014 Oct;120(1):63-72. doi: 10.1007/s11060-014-1541-z. Epub 2014 Jul 23.
• [5686] BCL9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia.BMC Cancer. 2016 Aug 18;16:648. doi: 10.1186/s12885-016-2707-1.
• [5687] Loss of angiotensin-converting enzyme 2 promotes growth of gallbladder cancer.Tumour Biol. 2015 Jul;36(7):5171-7. doi: 10.1007/s13277-015-3171-2. Epub 2015 Feb 9.
• [5688] Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: a novel in vitro model.Int J Cancer. 2011 Jan 15;128(2):274-82. doi: 10.1002/ijc.25343. Epub 2010 Mar 22.
• [5689] Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes.PLoS One. 2013 Sep 17;8(9):e73968. doi: 10.1371/journal.pone.0073968. eCollection 2013.
• [5690] BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.PLoS One. 2012;7(6):e38541. doi: 10.1371/journal.pone.0038541. Epub 2012 Jun 7.
• [5691] Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus.Cancer Res. 2009 Aug 1;69(15):6290-8. doi: 10.1158/0008-5472.CAN-09-0782. Epub 2009 Jul 21.
• [5692] Search for chromosome rearrangements: new approaches toward discovery of novel translocations in head and neck squamous cell carcinoma.Head Neck. 2013 Jun;35(6):831-5. doi: 10.1002/hed.23037. Epub 2012 Jul 17.
• [5693] BRAF and KRAS mutations in sporadic glomus tumors.Am J Dermatopathol. 2012 Jul;34(5):533-5. doi: 10.1097/DAD.0b013e31823931b4.
• [5694] Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.Glia. 2009 Jul;57(9):989-99. doi: 10.1002/glia.20823.
• [5695] Aldosterone producing adrenal adenomas are characterized by activation of calcium/calmodulin-dependent protein kinase (CaMK) dependent pathways.Horm Metab Res. 2011 Feb;43(2):106-11. doi: 10.1055/s-0030-1269899. Epub 2011 Jan 19.
• [5696] Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.Angiogenesis. 2009;12(1):91-100. doi: 10.1007/s10456-009-9137-5. Epub 2009 Feb 19.
• [5697] CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.Thorac Cancer. 2019 Jun;10(6):1479-1488. doi: 10.1111/1759-7714.13097. Epub 2019 May 23.
• [5698] CCL3 augments tumor rejection and enhances CD8(+) T cell infiltration through NK and CD103(+) dendritic cell recruitment via IFN.Oncoimmunology. 2017 Nov 20;7(3):e1393598. doi: 10.1080/2162402X.2017.1393598. eCollection 2018.
• [5699] Live or let die: CCM2 provides the link.Neuron. 2009 Sep 10;63(5):559-60. doi: 10.1016/j.neuron.2009.08.030.
• [5700] Antrocin, a bioactive component from Antrodia cinnamomea, suppresses breast carcinogenesis and stemness via downregulation of -catenin/Notch1/Akt signaling.Phytomedicine. 2019 Jan;52:70-78. doi: 10.1016/j.phymed.2018.09.213. Epub 2018 Sep 27.
• [5701] CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity.Oncol Rep. 2019 May;41(5):2679-2688. doi: 10.3892/or.2019.7037. Epub 2019 Feb 28.
• [5702] A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer.BMC Syst Biol. 2011 Feb 26;5:35. doi: 10.1186/1752-0509-5-35.
• [5703] Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array.Invest Ophthalmol Vis Sci. 2012 Jun 5;53(7):3331-9. doi: 10.1167/iovs.11-9027.
• [5704] High CD3(+) lymphocytes, low CD66b(+) neutrophils, and scarce tumor budding in the invasive front of lip squamous cell carcinomas.Arch Oral Biol. 2019 Aug;104:46-51. doi: 10.1016/j.archoralbio.2019.05.027. Epub 2019 May 27.
• [5705] Smart Bacterial Magnetic Nanoparticles for Tumor-Targeting Magnetic Resonance Imaging of HER2-Positive Breast Cancers.ACS Appl Mater Interfaces. 2019 Jan 30;11(4):3654-3665. doi: 10.1021/acsami.8b15838. Epub 2018 Dec 20.
• [5706] Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.PLoS One. 2013;8(4):e60613. doi: 10.1371/journal.pone.0060613. Epub 2013 Apr 5.
• [5707] Helicobacter pylori induces somatic mutations in TP53 via overexpression of CHAC1 in infected gastric epithelial cells.FEBS Open Bio. 2018 Mar 9;8(4):671-679. doi: 10.1002/2211-5463.12402. eCollection 2018 Apr.
• [5708] Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression.J Clin Invest. 2012 Feb;122(2):600-11. doi: 10.1172/JCI58780. Epub 2012 Jan 3.
• [5709] Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors.Jpn J Clin Oncol. 2017 Jun 1;47(6):520-528. doi: 10.1093/jjco/hyx032.
• [5710] Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.J Thorac Oncol. 2010 May;5(5):658-66. doi: 10.1097/JTO.0b013e3181d5e447.
• [5711] Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.Adv Med Sci. 2013;58(2):196-206. doi: 10.2478/ams-2013-0025.
• [5712] Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A.PLoS One. 2013 Jun 3;8(6):e63313. doi: 10.1371/journal.pone.0063313. Print 2014.
• [5713] Expression of tight junction molecules in breast carcinomas analysed by array PCR and immunohistochemistry.Pathol Oncol Res. 2012 Jul;18(3):593-606. doi: 10.1007/s12253-011-9481-9. Epub 2011 Dec 23.
• [5714] Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer.J Thorac Oncol. 2019 Dec;14(12):2084-2096. doi: 10.1016/j.jtho.2019.09.014. Epub 2019 Oct 9.
• [5715] Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.Kaohsiung J Med Sci. 2019 Jun;35(6):332-340. doi: 10.1002/kjm2.12058. Epub 2019 Mar 23.
• [5716] An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease.Genome Res. 2014 Feb;24(2):227-40. doi: 10.1101/gr.166223.113. Epub 2013 Dec 9.
• [5717] LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome.J Neuroimmunol. 2019 Oct 15;335:577008. doi: 10.1016/j.jneuroim.2019.577008. Epub 2019 Jul 18.
• [5718] "Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome.Int J Biochem Cell Biol. 2016 Dec;81(Pt A):195-207. doi: 10.1016/j.biocel.2016.08.017. Epub 2016 Aug 18.
• [5719] Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit 2 renders tumor cells dependent on its paralogous gene COPZ1.Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12449-54. doi: 10.1073/pnas.1103842108. Epub 2011 Jul 11.
• [5720] Predictors of Successful Discharge of Patients on Postoperative Day 1 After Craniotomy for Brain Tumor.World Neurosurg. 2019 Jun;126:e869-e877. doi: 10.1016/j.wneu.2019.03.004. Epub 2019 Mar 9.
• [5721] A Macropinocytosis-Intensifying Albumin Domain-Based scFv Antibody and Its Conjugate Directed against K-Ras Mutant Pancreatic Cancer.Mol Pharm. 2018 Jun 4;15(6):2403-2412. doi: 10.1021/acs.molpharmaceut.8b00234. Epub 2018 May 23.
• [5722] Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells.Mol Cancer Ther. 2011 Sep;10(9):1720-7. doi: 10.1158/1535-7163.MCT-11-0220. Epub 2011 Jun 28.
• [5723] Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.Mod Pathol. 2009 Dec;22(12):1575-81. doi: 10.1038/modpathol.2009.126. Epub 2009 Sep 11.
• [5724] Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis.J Pathol. 2010 Feb;220(3):348-60. doi: 10.1002/path.2644.
• [5725] Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer.Clin Cancer Res. 2019 Nov 15;25(22):6671-6682. doi: 10.1158/1078-0432.CCR-19-1176. Epub 2019 Aug 22.
• [5726] Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.Cancer Res. 2007 Jul 1;67(13):6293-303. doi: 10.1158/0008-5472.CAN-06-3884.
• [5727] Downregulation of CYB5D2 is associated with breast cancer progression.Sci Rep. 2019 Apr 29;9(1):6624. doi: 10.1038/s41598-019-43006-y.
• [5728] MicroRNA-300 Regulates the Ubiquitination of PTEN through the CRL4B(DCAF13) E3 Ligase in Osteosarcoma Cells.Mol Ther Nucleic Acids. 2018 Mar 2;10:254-268. doi: 10.1016/j.omtn.2017.12.010. Epub 2017 Dec 22.
• [5729] Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPAR and TNF signaling.PLoS One. 2013 Aug 19;8(8):e72638. doi: 10.1371/journal.pone.0072638. eCollection 2013.
• [5730] SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of SCCRO (DCUN1D1).J Biol Chem. 2014 Dec 12;289(50):34728-42. doi: 10.1074/jbc.M114.585505. Epub 2014 Oct 27.
• [5731] Elevated DDX21 regulates c-Jun activity and rRNA processing in human breast cancers.Breast Cancer Res. 2014 Sep 28;16(5):449. doi: 10.1186/s13058-014-0449-z.
• [5732] Baicalin induces cellular senescence in human colon cancer cells via upregulation of DEPP and the activation of Ras/Raf/MEK/ERK signaling.Cell Death Dis. 2018 Feb 13;9(2):217. doi: 10.1038/s41419-017-0223-0.
• [5733] Aberrant accumulation of Dickkopf 4 promotes tumor progression via forming the immune suppressive microenvironment in gastrointestinal stromal tumor.Cancer Med. 2019 Sep;8(11):5352-5366. doi: 10.1002/cam4.2437. Epub 2019 Jul 29.
• [5734] Fluorine-18-Labeled PET Radiotracers for Imaging Tryptophan Uptake and Metabolism: a Systematic Review.Mol Imaging Biol. 2020 Aug;22(4):805-819. doi: 10.1007/s11307-019-01430-6.
• [5735] Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas.J Pathol. 2006 Jul;209(3):360-8. doi: 10.1002/path.1995.
• [5736] DNA promoter methylation-dependent transcription of the double C2-like domain (DOC2B) gene regulates tumor growth in human cervical cancer.J Biol Chem. 2014 Apr 11;289(15):10637-10649. doi: 10.1074/jbc.M113.491506. Epub 2014 Feb 25.
• [5737] Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination.Cancer Res. 2013 Apr 1;73(7):2199-210. doi: 10.1158/0008-5472.CAN-12-4400. Epub 2013 Feb 4.
• [5738] Zinc ion coordination significantly improved the transfection efficiency of low molecular weight polyethylenimine.Biomater Sci. 2019 Mar 26;7(4):1716-1728. doi: 10.1039/c9bm00039a.
• [5739] Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new "B2" configuration of the RA-6 nuclear reactor.Radiat Environ Biophys. 2017 Nov;56(4):377-387. doi: 10.1007/s00411-017-0710-9. Epub 2017 Sep 4.
• [5740] E4F1 deficiency results in oxidative stress-mediated cell death of leukemic cells.J Exp Med. 2011 Jul 4;208(7):1403-17. doi: 10.1084/jem.20101995. Epub 2011 Jun 27.
• [5741] Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2.Proc Natl Acad Sci U S A. 2009 May 19;106(20):8227-32. doi: 10.1073/pnas.0806780106. Epub 2009 May 1.
• [5742] Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells.J Biol Chem. 2019 Mar 1;294(9):3207-3218. doi: 10.1074/jbc.RA118.006682. Epub 2018 Dec 28.
• [5743] Intergrated analysis of ELMO1, serves as a link between tumour mutation burden and epithelial-mesenchymal transition in hepatocellular carcinoma.EBioMedicine. 2019 Aug;46:105-118. doi: 10.1016/j.ebiom.2019.07.002. Epub 2019 Jul 16.
• [5744] Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.Oncogene. 2011 Mar 17;30(11):1290-301. doi: 10.1038/onc.2010.510. Epub 2010 Nov 8.
• [5745] CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia.Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16852-7. doi: 10.1073/pnas.1007896107. Epub 2010 Sep 14.
• [5746] High-Dose Radiation Increases Notch1 in Tumor Vasculature.Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):857-866. doi: 10.1016/j.ijrobp.2019.11.010. Epub 2019 Nov 20.
• [5747] Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells.Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):E3659-67. doi: 10.1073/pnas.1207673110. Epub 2012 Dec 10.
• [5748] Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.Anticancer Agents Med Chem. 2018;18(8):1184-1196. doi: 10.2174/1871520618666180412123833.
• [5749] Genomic Landscape of Intramedullary Spinal Cord Gliomas.Sci Rep. 2019 Dec 10;9(1):18722. doi: 10.1038/s41598-019-54286-9.
• [5750] Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis.JCI Insight. 2018 Apr 19;3(8):e97349. doi: 10.1172/jci.insight.97349. eCollection 2018 Apr 19.
• [5751] Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.PLoS One. 2014 May 5;9(5):e95307. doi: 10.1371/journal.pone.0095307. eCollection 2014.
• [5752] FRMD3, a novel putative tumour suppressor in NSCLC.Oncogene. 2007 Jun 28;26(30):4464-8. doi: 10.1038/sj.onc.1210225. Epub 2007 Jan 29.
• [5753] Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2.Tumour Biol. 2014 Dec;35(12):12583-92. doi: 10.1007/s13277-014-2579-4. Epub 2014 Sep 6.
• [5754] G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancer.Cell Cycle. 2017;16(21):2146-2155. doi: 10.1080/15384101.2017.1371884. Epub 2017 Sep 14.
• [5755] Galanin and its three receptors in human pituitary adenoma.Neuropeptides. 2012 Oct;46(5):195-201. doi: 10.1016/j.npep.2012.07.003. Epub 2012 Aug 11.
• [5756] Exploration of Shh and BMP paracrine signaling in a prostate cancer xenograft.Differentiation. 2010 Jan;79(1):41-7. doi: 10.1016/j.diff.2009.08.009. Epub 2009 Sep 20.
• [5757] The nonlysosomal -glucosidase GBA2 promotes endoplasmic reticulum stress and impairs tumorigenicity of human melanoma cells.FASEB J. 2013 Feb;27(2):489-98. doi: 10.1096/fj.12-215152. Epub 2012 Oct 16.
• [5758] Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response.Breast Cancer. 2014 Jul;21(4):491-9. doi: 10.1007/s12282-012-0404-8. Epub 2012 Sep 22.
• [5759] Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.Int J Mol Med. 2012 Mar;29(3):428-34. doi: 10.3892/ijmm.2011.858. Epub 2011 Dec 12.
• [5760] Prognostic Value of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in Patients With Single Tumor Size ?5 cm Hepatocellular Carcinoma After Radical Resection.Front Oncol. 2019 May 21;9:347. doi: 10.3389/fonc.2019.00347. eCollection 2019.
• [5761] Candidate driver genes in microsatellite-unstable colorectal cancer.Int J Cancer. 2012 Apr 1;130(7):1558-66. doi: 10.1002/ijc.26167. Epub 2011 Aug 3.
• [5762] -elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor and induces sensitization to cisplatin.Oncol Rep. 2011 Aug;26(2):405-13. doi: 10.3892/or.2011.1276. Epub 2011 Apr 20.
• [5763] Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.Hum Genet. 2011 Feb;129(2):189-97. doi: 10.1007/s00439-010-0915-3. Epub 2010 Nov 16.
• [5764] An Extendable Star-Like Nanoplatform for Functional and Anatomical Imaging-Guided Photothermal Oncotherapy.ACS Nano. 2019 Apr 23;13(4):4379-4391. doi: 10.1021/acsnano.8b09607. Epub 2019 Mar 26.
• [5765] Near-infrared light-regulated cancer theranostic nanoplatform based on aggregation-induced emission luminogen encapsulated upconversion nanoparticles.Theranostics. 2019 Jan 1;9(1):246-264. doi: 10.7150/thno.30174. eCollection 2019.
• [5766] Chromogenic Tissue-Based Methods for Detection of Gene Amplifications (or Rearrangements) Combined with Protein Overexpression in Clinical Samples.Methods Mol Biol. 2019;1953:301-314. doi: 10.1007/978-1-4939-9145-7_19.
• [5767] Ignition of p53 bomb sensitizes tumor cells to granzyme K-mediated cytolysis.J Immunol. 2009 Feb 15;182(4):2152-9. doi: 10.4049/jimmunol.0802307.
• [5768] A review of epigenetic and gene expression alterations associated with intracranial meningiomas.Neurosurg Focus. 2013 Dec;35(6):E5. doi: 10.3171/2013.10.FOCUS13360.
• [5769] Increasing the complexity of chromatin: functionally distinct roles for replication-dependent histone H2A isoforms in cell proliferation and carcinogenesis.Nucleic Acids Res. 2013 Nov;41(20):9284-95. doi: 10.1093/nar/gkt736. Epub 2013 Aug 16.
• [5770] PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis.FEBS Lett. 2014 Mar 18;588(6):981-9. doi: 10.1016/j.febslet.2014.01.058. Epub 2014 Feb 14.
• [5771] Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas.J Biol Chem. 2009 Sep 25;284(39):26547-56. doi: 10.1074/jbc.M109.013185. Epub 2009 Jul 24.
• [5772] Hodgkin lymphoma and Epstein-Barr virus (EBV): no evidence to support hit-and-run mechanism in cases classified as non-EBV-associated.Int J Cancer. 2003 May 1;104(5):624-30. doi: 10.1002/ijc.10979.
• [5773] Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.Oncol Rep. 2014 May;31(5):2328-34. doi: 10.3892/or.2014.3111. Epub 2014 Mar 24.
• [5774] Headcase is a Repressor of Lamellocyte Fate in Drosophila melanogaster.Genes (Basel). 2019 Mar 5;10(3):173. doi: 10.3390/genes10030173.
• [5775] Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.PLoS One. 2015 Jun 19;10(6):e0128106. doi: 10.1371/journal.pone.0128106. eCollection 2015.
• [5776] HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia.Genes Dev. 2014 Dec 15;28(24):2712-25. doi: 10.1101/gad.247528.114.
• [5777] Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells.BMC Cancer. 2016 Jan 22;16:35. doi: 10.1186/s12885-016-2058-y.
• [5778] Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent.J Am Chem Soc. 2019 Apr 24;141(16):6453-6457. doi: 10.1021/jacs.8b13681. Epub 2019 Apr 15.
• [5779] Knockdown of Hnrnpa0, a del(5q) gene, alters myeloid cell fate in murine cells through regulation of AU-rich transcripts.Haematologica. 2014 Jun;99(6):1032-40. doi: 10.3324/haematol.2013.098657. Epub 2014 Feb 14.
• [5780] Upregulation of AUF1 is involved in the proliferation of esophageal squamous cell carcinoma through GCH1.Int J Oncol. 2016 Nov;49(5):2001-2010. doi: 10.3892/ijo.2016.3713. Epub 2016 Sep 28.
• [5781] High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.PLoS One. 2015 Jul 31;10(7):e0134614. doi: 10.1371/journal.pone.0134614. eCollection 2015.
• [5782] Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.Cancer Res. 2012 May 1;72(9):2339-49. doi: 10.1158/0008-5472.CAN-11-4149. Epub 2012 Mar 9.
• [5783] Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.Cancer Res. 2011 Dec 15;71(24):7683-93. doi: 10.1158/0008-5472.CAN-11-1139. Epub 2011 Oct 24.
• [5784] CTL recognition of a novel HLA-A*0201-binding peptide derived from glioblastoma multiforme tumor cells.Cancer Immunol Immunother. 2011 Sep;60(9):1319-32. doi: 10.1007/s00262-011-1032-4. Epub 2011 May 29.
• [5785] Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy.Cancer Gene Ther. 2012 May;19(5):352-7. doi: 10.1038/cgt.2012.8. Epub 2012 Mar 9.
• [5786] Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer.BMC Urol. 2018 Sep 24;18(1):82. doi: 10.1186/s12894-018-0388-6.
• [5787] PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.Mol Biol Rep. 2019 Jun;46(3):3333-3347. doi: 10.1007/s11033-019-04795-7. Epub 2019 Apr 12.
• [5788] IFN-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.Cancer Res. 2019 Mar 15;79(6):1098-1112. doi: 10.1158/0008-5472.CAN-18-2207. Epub 2018 Nov 30.
• [5789] Role of BAG3 in cancer progression: A therapeutic opportunity.Semin Cell Dev Biol. 2018 Jun;78:85-92. doi: 10.1016/j.semcdb.2017.08.049. Epub 2017 Aug 31.
• [5790] Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells.Int J Mol Med. 2012 Oct;30(4):945-52. doi: 10.3892/ijmm.2012.1064. Epub 2012 Jul 16.
• [5791] Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.Genes Chromosomes Cancer. 2020 May;59(5):295-308. doi: 10.1002/gcc.22831. Epub 2019 Dec 31.
• [5792] Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.Cancer Res. 2008 Mar 15;68(6):1707-14. doi: 10.1158/0008-5472.CAN-07-6325.
• [5793] Small RNA-induced INTS6 gene up-regulation suppresses castration-resistant prostate cancer cells by regulating -catenin signaling.Cell Cycle. 2018;17(13):1602-1613. doi: 10.1080/15384101.2018.1475825. Epub 2018 Aug 2.
• [5794] Characterization of novel CD55 isoforms expression innormal and neoplastic tissues.Tissue Antigens. 2013 Jul;82(1):26-34. doi: 10.1111/tan.12138. Epub 2013 May 21.
• [5795] Phenolic Composition and Bioactivity of Lavandula pedunculata (Mill.) Cav. Samples from Different Geographical Origin.Molecules. 2018 Apr 28;23(5):1037. doi: 10.3390/molecules23051037.
• [5796] Downregulation of IQGAP2 Correlates with Prostate Cancer Recurrence and Metastasis.Transl Oncol. 2019 Feb;12(2):236-244. doi: 10.1016/j.tranon.2018.10.009. Epub 2018 Nov 11.
• [5797] Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer.Oncotarget. 2018 Feb 7;9(18):14354-14365. doi: 10.18632/oncotarget.24436. eCollection 2018 Mar 6.
• [5798] IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.Pediatr Blood Cancer. 2019 Aug;66(8):e27770. doi: 10.1002/pbc.27770. Epub 2019 Apr 22.
• [5799] IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility.Hum Mol Genet. 2012 May 1;21(9):2076-85. doi: 10.1093/hmg/dds025. Epub 2012 Feb 8.
• [5800] Proinflammatory homeobox gene, ISX, regulates tumor growth and survival in hepatocellular carcinoma.Cancer Res. 2013 Jan 15;73(2):508-18. doi: 10.1158/0008-5472.CAN-12-2795. Epub 2012 Dec 5.
• [5801] Integrin 4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.Cancer Res. 2020 Feb 15;80(4):771-783. doi: 10.1158/0008-5472.CAN-19-1145. Epub 2019 Dec 16.
• [5802] Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer.PLoS One. 2014 Oct 31;9(10):e110990. doi: 10.1371/journal.pone.0110990. eCollection 2014.
• [5803] Depletion of regulatory T cells by targeting folate receptor 4 enhances the potency of a GM-CSF-secreting tumor cell immunotherapy.Clin Immunol. 2013 Aug;148(2):287-98. doi: 10.1016/j.clim.2013.05.011. Epub 2013 May 25.
• [5804] COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status.BMC Cancer. 2011 Jun 13;11:238. doi: 10.1186/1471-2407-11-238.
• [5805] Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-B.Mol Ther Oncolytics. 2017 Oct 26;7:76-85. doi: 10.1016/j.omto.2017.10.003. eCollection 2017 Dec 15.
• [5806] Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors.Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21715-21726. doi: 10.1073/pnas.1912858116. Epub 2019 Oct 7.
• [5807] Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271.Cancer Biol Med. 2019 Aug;16(3):498-513. doi: 10.20892/j.issn.2095-3941.2019.0073.
• [5808] Loss of KDM6A confers drug resistance in acute myeloid leukemia.Leukemia. 2020 Jan;34(1):50-62. doi: 10.1038/s41375-019-0497-6. Epub 2019 Jun 14.
• [5809] KIF3B Promotes the Proliferation of Pancreatic Cancer.Cancer Biother Radiopharm. 2019 Aug;34(6):355-361. doi: 10.1089/cbr.2018.2716. Epub 2019 Jun 3.
• [5810] Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF- signaling.Cancer Lett. 2015 Nov 1;368(1):105-114. doi: 10.1016/j.canlet.2015.07.037. Epub 2015 Aug 10.
• [5811] Receptorinteracting serine/threonineprotein kinase 1 promotes the progress and lymph metastasis of gallbladder cancer.Oncol Rep. 2019 Dec;42(6):2435-2449. doi: 10.3892/or.2019.7331. Epub 2019 Sep 23.
• [5812] ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.Transl Res. 2019 Jan;203:49-56. doi: 10.1016/j.trsl.2018.08.007. Epub 2018 Sep 12.
• [5813] A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy.PLoS One. 2019 Oct 2;14(10):e0218642. doi: 10.1371/journal.pone.0218642. eCollection 2019.
• [5814] Androgenic and estrogenic 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase in human ovarian epithelial tumors: evidence for the type 1, 2 and 5 isoforms.J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):343-51. doi: 10.1016/s0960-0760(02)00117-6.
• [5815] Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.Cancer Res. 2015 Jul 15;75(14):2949-60. doi: 10.1158/0008-5472.CAN-14-3297. Epub 2015 May 27.
• [5816] MiR-145-targeted HBXIP modulates human breast cancer cell proliferation.Thorac Cancer. 2019 Jan;10(1):71-77. doi: 10.1111/1759-7714.12903. Epub 2018 Oct 31.
• [5817] LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.Tumour Biol. 2017 Feb;39(2):1010428317691188. doi: 10.1177/1010428317691188.
• [5818] Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.Sci Rep. 2017 Aug 31;7(1):10209. doi: 10.1038/s41598-017-09491-9.
• [5819] Molecular characteristics of a pancreatic adenocarcinoma associated with Shwachman-Diamond syndrome.Pediatr Blood Cancer. 2013 May;60(5):754-60. doi: 10.1002/pbc.24453. Epub 2013 Jan 9.
• [5820] A study on the role of (+)-catechin in suppression of HepG2 proliferation via caspase dependent pathway and enhancement of its in vitro and in vivo cytotoxic potential through liposomal formulation.Eur J Pharm Sci. 2013 Nov 20;50(3-4):353-65. doi: 10.1016/j.ejps.2013.08.005. Epub 2013 Aug 15.
• [5821] Platelet-derived growth factor receptor in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.Oncotarget. 2017 Jun 13;8(24):39534-39546. doi: 10.18632/oncotarget.17134.
• [5822] Aptamer-derived peptides as potent inhibitors of the oncogenic RhoGEF Tgat.Chem Biol. 2009 Apr 24;16(4):391-400. doi: 10.1016/j.chembiol.2009.02.006.
• [5823] Melanoma LAMP-2C Modulates Tumor Growth and Autophagy.Front Cell Dev Biol. 2018 Aug 29;6:101. doi: 10.3389/fcell.2018.00101. eCollection 2018.
• [5824] Chromosome 1 open reading frame 190 promotes activation of NF-B canonical pathway and resistance of dendritic cells to tumor-associated inhibition in vitro.J Immunol. 2010 Dec 1;185(11):6719-27. doi: 10.4049/jimmunol.0903869. Epub 2010 Nov 3.
• [5825] Concomitant tumor and autoantigen vaccination supports renal cell carcinoma rejection.J Immunol. 2010 Jul 15;185(2):902-16. doi: 10.4049/jimmunol.0902683. Epub 2010 Jun 14.
• [5826] miR-27b-3p/MARCH7 regulates invasion and metastasis of endometrial cancer cells through Snail-mediated pathway.Acta Biochim Biophys Sin (Shanghai). 2019 May 23;51(5):492-500. doi: 10.1093/abbs/gmz030.
• [5827] Differential signature of the centrosomal MARK4 isoforms in glioma.Anal Cell Pathol (Amst). 2011;34(6):319-38. doi: 10.3233/ACP-2011-0031.
• [5828] Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.J Clin Invest. 2019 Oct 1;129(10):4110-4123. doi: 10.1172/JCI125963.
• [5829] Pilocytic astrocytoma: a review of genetic and molecular factors, diagnostic and prognostic markers.Histol Histopathol. 2014 Oct;29(10):1235-48. doi: 10.14670/HH-29.1235. Epub 2014 Feb 20.
• [5830] Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors.Anticancer Res. 2019 Mar;39(3):1151-1159. doi: 10.21873/anticanres.13224.
• [5831] Mitochondrial calcium uniporter complex modulation in cancerogenesis.Cell Cycle. 2019 May;18(10):1068-1083. doi: 10.1080/15384101.2019.1612698. Epub 2019 May 10.
• [5832] Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus.Int J Gynecol Pathol. 2019 Sep;38(5):414-419. doi: 10.1097/PGP.0000000000000511.
• [5833] Combination therapy for the treatment of pancreatic cancer through hyaluronic acid-decorated nanoparticles loaded with quercetin and gemcitabine: A preliminary in vitro study.J Cell Physiol. 2019 Apr;234(4):4959-4969. doi: 10.1002/jcp.27297. Epub 2018 Oct 18.
• [5834] Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1.Mol Cancer. 2019 Nov 25;18(1):168. doi: 10.1186/s12943-019-1084-1.
• [5835] Comparative analysis of co-occurring mutations of specific tumor suppressor genes in lung adenocarcinoma between Asian and Caucasian populations.J Cancer Res Clin Oncol. 2019 Mar;145(3):747-757. doi: 10.1007/s00432-018-02828-5. Epub 2019 Jan 23.
• [5836] Overexpression of MICAL2, a novel tumor-promoting factor, accelerates tumor progression through regulating cell proliferation and EMT.J Cancer. 2018 Jan 1;9(3):521-527. doi: 10.7150/jca.22355. eCollection 2018.
• [5837] Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.Hum Pathol. 2007 Mar;38(3):500-7. doi: 10.1016/j.humpath.2006.09.020.
• [5838] Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBP to prevent Trib1-driven acute myeloid leukemia.Blood Adv. 2017 Sep 1;1(20):1682-1693. doi: 10.1182/bloodadvances.2017007054. eCollection 2017 Sep 12.
• [5839] Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1).Cell Cycle. 2009 Feb 1;8(3):460-72. doi: 10.4161/cc.8.3.7651. Epub 2009 Feb 18.
• [5840] RACK1/TRAF2 regulation of modulator of apoptosis-1 (MOAP-1).Biochim Biophys Acta Mol Cell Res. 2018 May;1865(5):684-694. doi: 10.1016/j.bbamcr.2018.02.006. Epub 2018 Feb 19.
• [5841] Characterization of an evolutionarily conserved metallophosphoesterase that is expressed in the fetal brain and associated with the WAGR syndrome.J Biol Chem. 2009 Feb 20;284(8):5217-28. doi: 10.1074/jbc.M805996200. Epub 2008 Nov 12.
• [5842] RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.Theranostics. 2019 Jun 2;9(12):3659-3673. doi: 10.7150/thno.32126. eCollection 2019.
• [5843] An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth.Mol Cell. 2013 Dec 12;52(5):679-92. doi: 10.1016/j.molcel.2013.10.004. Epub 2013 Nov 7.
• [5844] Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.BMC Med Genomics. 2011 Oct 27;4:75. doi: 10.1186/1755-8794-4-75.
• [5845] Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer.BMC Mol Biol. 2010 Feb 1;11:12. doi: 10.1186/1471-2199-11-12.
• [5846] Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesis.Oncol Lett. 2019 Nov;18(5):4984-4991. doi: 10.3892/ol.2019.10833. Epub 2019 Sep 10.
• [5847] Knockdown MTMR14 promotes cell apoptosis and inhibits migration in liver cancer cells.Gene. 2019 Apr 5;691:106-113. doi: 10.1016/j.gene.2018.11.099. Epub 2018 Dec 23.
• [5848] Expression of mucin (MUC) genes in mucoepidermoid carcinoma.Laryngoscope. 2011 Jan;121(1):167-70. doi: 10.1002/lary.21164.
• [5849] Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.Am J Dermatopathol. 2012 Aug;34(6):626-31. doi: 10.1097/DAD.0b013e31824d689c.
• [5850] RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.Breast Cancer Res Treat. 2014 Aug;146(3):515-23. doi: 10.1007/s10549-014-3049-9. Epub 2014 Jul 10.
• [5851] A meta-analysis of the prevalence of somatic mutations in the hMLH1 and hMSH2 genes in colorectal cancer.Colorectal Dis. 2012 Mar;14(3):e80-9. doi: 10.1111/j.1463-1318.2011.02858.x.
• [5852] MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.Blood. 2012 Sep 27;120(13):2719-22. doi: 10.1182/blood-2012-04-422352. Epub 2012 Jun 7.
• [5853] In-Depth Proteomics Analysis to Identify Biomarkers of Papillary Thyroid Cancer Patients Older Than 45 Years with Different Degrees of Lymph Node Metastases.Proteomics Clin Appl. 2019 Sep;13(5):e1900030. doi: 10.1002/prca.201900030. Epub 2019 Jun 7.
• [5854] The microRNA profile of prostate carcinoma obtained by deep sequencing.Mol Cancer Res. 2010 Apr;8(4):529-38. doi: 10.1158/1541-7786.MCR-09-0443. Epub 2010 Mar 30.
• [5855] Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes.Oncotarget. 2017 Nov 15;8(63):106296-106310. doi: 10.18632/oncotarget.22435. eCollection 2017 Dec 5.
• [5856] Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells.Front Immunol. 2019 Aug 20;10:1973. doi: 10.3389/fimmu.2019.01973. eCollection 2019.
• [5857] NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.Oncotarget. 2016 Jan 19;7(3):3018-32. doi: 10.18632/oncotarget.6576.
• [5858] Association of NEFL Gene Polymorphisms with Wilms' Tumor Susceptibility in Chinese Children.J Oncol. 2019 Apr 1;2019:3518149. doi: 10.1155/2019/3518149. eCollection 2019.
• [5859] NELFE promoted pancreatic cancer metastasis and the epithelialtomesenchymal transition by decreasing the stabilization of NDRG2 mRNA.Int J Oncol. 2019 Dec;55(6):1313-1323. doi: 10.3892/ijo.2019.4890. Epub 2019 Oct 2.
• [5860] Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.Blood. 2016 Dec 8;128(23):2666-2670. doi: 10.1182/blood-2016-03-704528. Epub 2016 Sep 26.
• [5861] NKAIN2 functions as a novel tumor suppressor in prostate cancer.Oncotarget. 2016 Sep 27;7(39):63793-63803. doi: 10.18632/oncotarget.11690.
• [5862] A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2R-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors.Cancer Discov. 2019 Jun;9(6):711-721. doi: 10.1158/2159-8290.CD-18-1495. Epub 2019 Apr 15.
• [5863] Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer.Eur J Cancer Prev. 2013 Nov;22(6):512-22. doi: 10.1097/CEJ.0b013e328361625d.
• [5864] Nitric oxide (NO) enhances pemetrexed cytotoxicity via NOcGMP signaling in lung adenocarcinoma cells invitro and invivo.Int J Oncol. 2012 Jul;41(1):24-30. doi: 10.3892/ijo.2012.1461. Epub 2012 May 2.
• [5865] A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing.Elife. 2019 Mar 4;8:e44305. doi: 10.7554/eLife.44305.
• [5866] Nephronectin is Decreased in Metastatic Breast Carcinoma and Related to Metastatic Organs.Pathol Oncol Res. 2018 Jul;24(3):679-688. doi: 10.1007/s12253-017-0289-0. Epub 2017 Aug 25.
• [5867] Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency virus-associated lymphomas.Cancer Res. 1994 Apr 15;54(8):2069-72.
• [5868] NUMB and NUMBL differences in gene regulation.Oncotarget. 2018 Jan 11;9(10):9219-9234. doi: 10.18632/oncotarget.24186. eCollection 2018 Feb 6.
• [5869] Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage.Mol Cancer Ther. 2012 Dec;11(12):2588-99. doi: 10.1158/1535-7163.MCT-12-0245. Epub 2012 Sep 20.
• [5870] Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting.Biomaterials. 2019 May;203:73-85. doi: 10.1016/j.biomaterials.2019.02.012. Epub 2019 Feb 14.
• [5871] Diminished origin-licensing capacity specifically sensitizes tumor cells to replication stress.Mol Cancer Res. 2013 Apr;11(4):370-80. doi: 10.1158/1541-7786.MCR-12-0491. Epub 2013 Jan 30.
• [5872] The deubiquitinating enzyme OTUD1 antagonizes BH3-mimetic inhibitor induced cell death through regulating the stability of the MCL1 protein.Cancer Cell Int. 2019 Aug 27;19:222. doi: 10.1186/s12935-019-0936-5. eCollection 2019.
• [5873] Complementation of non-tumorigenicity of HPV18-positive cervical carcinoma cells involves differential mRNA expression of cellular genes including potential tumor suppressor genes on chromosome 11q13.Cancer Genet. 2013 Jul-Aug;206(7-8):279-92. doi: 10.1016/j.cancergen.2013.06.002. Epub 2013 Sep 14.
• [5874] Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.Pathol Oncol Res. 2020 Apr;26(2):1279-1285. doi: 10.1007/s12253-019-00687-0. Epub 2019 Jul 2.
• [5875] Bridging the molecular divide: alcohol-induced downregulation of PAX9 and tumour development.J Pathol. 2018 Apr;244(4):386-388. doi: 10.1002/path.5041. Epub 2018 Feb 26.
• [5876] Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma.Oncogene. 2017 Jun 22;36(25):3609-3617. doi: 10.1038/onc.2016.520. Epub 2017 Feb 6.
• [5877] PEST-containing nuclear protein regulates cell proliferation, migration, and invasion in lung adenocarcinoma.Oncogenesis. 2019 Mar 14;8(3):22. doi: 10.1038/s41389-019-0132-4.
• [5878] Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase.Cancer Res. 2014 Jul 1;74(13):3630-42. doi: 10.1158/0008-5472.CAN-13-3615. Epub 2014 May 1.
• [5879] RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells.Nat Cell Biol. 2018 Mar;20(3):272-284. doi: 10.1038/s41556-018-0034-2. Epub 2018 Feb 19.
• [5880] Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a.Clin Cancer Res. 2019 Aug 15;25(16):5156-5166. doi: 10.1158/1078-0432.CCR-18-3052. Epub 2019 Jun 21.
• [5881] PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5766-E5775. doi: 10.1073/pnas.1804779115. Epub 2018 Jun 4.
• [5882] The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A.Int J Oncol. 2009 Mar;34(3):697-705. doi: 10.3892/ijo_00000196.
• [5883] Human PIF1 helicase supports DNA replication and cell growth under oncogenic-stress.Oncotarget. 2014 Nov 30;5(22):11381-98. doi: 10.18632/oncotarget.2501.
• [5884] Overexpression of PIP5KL1 suppresses the growth of human cervical cancer cells in vitro and in vivo.Cell Biol Int. 2010 Feb 22;34(3):309-15. doi: 10.1042/CBI20090040.
• [5885] Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.BMC Cancer. 2018 Nov 12;18(1):1107. doi: 10.1186/s12885-018-4965-6.
• [5886] Original tumour suppressor gene polycystic kidney and hepatic disease 1-like 1 is associated with thyroid cancer cell progression.Oncol Lett. 2019 Sep;18(3):3227-3235. doi: 10.3892/ol.2019.10632. Epub 2019 Jul 18.
• [5887] Multiple hits for the association of uterine fibroids on human chromosome 1q43.PLoS One. 2013;8(3):e58399. doi: 10.1371/journal.pone.0058399. Epub 2013 Mar 14.
• [5888] Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma.Cancer Sci. 2011 Mar;102(3):583-90. doi: 10.1111/j.1349-7006.2011.01863.x.
• [5889] Elevated DNA polymerase iota (Poli) is involved in the acquisition of aggressive phenotypes of human esophageal squamous cell cancer.Int J Clin Exp Pathol. 2015 Apr 1;8(4):3591-601. eCollection 2015.
• [5890] Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.J Pineal Res. 2013 Jan;54(1):80-8. doi: 10.1111/j.1600-079X.2012.01027.x. Epub 2012 Aug 1.
• [5891] The POPX2 phosphatase regulates cancer cell motility and invasiveness.Cell Cycle. 2010 Jan 1;9(1):179-87. doi: 10.4161/cc.9.1.10406. Epub 2010 Jan 22.
• [5892] Phosphatase 1 Nuclear Targeting Subunit (PNUTS) Regulates Aurora Kinases and Mitotic Progression.Mol Cancer Res. 2019 Jan;17(1):10-19. doi: 10.1158/1541-7786.MCR-17-0670. Epub 2018 Sep 6.
• [5893] Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.PLoS One. 2013 Sep 24;8(9):e69884. doi: 10.1371/journal.pone.0069884. eCollection 2013.
• [5894] Long term curative effects of sequential therapy with all-trans retinoic acid, arsenious oxide and chemotherapy on patients with acute promyelocytic leukemia.Hematology. 2012 Nov;17(6):311-6. doi: 10.1179/102453312X13451850327262.
• [5895] Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers.Cell Res. 2019 Oct;29(10):832-845. doi: 10.1038/s41422-019-0225-9. Epub 2019 Sep 3.
• [5896] High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer.J Surg Oncol. 2019 Jun;119(8):1108-1121. doi: 10.1002/jso.25448. Epub 2019 Mar 25.
• [5897] A polymerase-chain-reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)-gene-family members.Int J Cancer. 1993 Sep 9;55(2):311-9. doi: 10.1002/ijc.2910550223.
• [5898] Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo.Oncol Rep. 2014 Mar;31(3):1271-6. doi: 10.3892/or.2014.2991. Epub 2014 Jan 21.
• [5899] The proteasome activator PA200 regulates tumor cell responsiveness to glutamine and resistance to ionizing radiation.Mol Cancer Res. 2012 Jul;10(7):937-44. doi: 10.1158/1541-7786.MCR-11-0493-T. Epub 2012 May 1.
• [5900] PSPC1 mediates TGF-1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.Nat Cell Biol. 2018 Apr;20(4):479-491. doi: 10.1038/s41556-018-0062-y. Epub 2018 Mar 28.
• [5901] Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.Front Med (Lausanne). 2019 Oct 31;6:247. doi: 10.3389/fmed.2019.00247. eCollection 2019.
• [5902] Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis.Cancers (Basel). 2019 Apr 2;11(4):463. doi: 10.3390/cancers11040463.
• [5903] Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study.Tech Coloproctol. 2019 Sep;23(9):831-842. doi: 10.1007/s10151-019-02049-z. Epub 2019 Aug 6.
• [5904] Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.BMC Cancer. 2015 Jul 10;15:514. doi: 10.1186/s12885-015-1463-y.
• [5905] Previous Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination Chemotherapy.Anticancer Res. 2019 Sep;39(9):4987-4993. doi: 10.21873/anticanres.13688.
• [5906] Role of RNA-binding protein 5 in the diagnosis and chemotherapeutic response of lung cancer.Oncol Lett. 2019 Feb;17(2):2013-2019. doi: 10.3892/ol.2018.9818. Epub 2018 Dec 10.
• [5907] A Y(1) receptor ligand synergized with a P-glycoprotein inhibitor improves the therapeutic efficacy of multidrug resistant breast cancer.Biomater Sci. 2019 Nov 1;7(11):4748-4757. doi: 10.1039/c9bm00337a. Epub 2019 Sep 11.
• [5908] ROQUIN/RC3H1 alterations are not found in angioimmunoblastic T-cell lymphoma.PLoS One. 2013 Jun 25;8(6):e64536. doi: 10.1371/journal.pone.0064536. Print 2013.
• [5909] A novel role for an RCAN3-derived peptide as a tumor suppressor in breast cancer.Carcinogenesis. 2015 Jul;36(7):792-9. doi: 10.1093/carcin/bgv056. Epub 2015 Apr 26.
• [5910] Polymorphisms of the apoptosis-associated gene DP1L1 (deleted in polyposis 1-like 1) in colon cancer and inflammatory bowel disease.J Cancer Res Clin Oncol. 2010 Jun;136(6):795-802. doi: 10.1007/s00432-009-0719-9. Epub 2009 Nov 19.
• [5911] Deficiency in Embryonic Stem Cell Marker Reduced Expression 1 Activates Mitogen-Activated Protein Kinase Kinase 6-Dependent p38 Mitogen-Activated Protein Kinase Signaling to Drive Hepatocarcinogenesis.Hepatology. 2020 Jul;72(1):183-197. doi: 10.1002/hep.31020. Epub 2020 Apr 8.
• [5912] Tissue-factor fusion proteins induce occlusion of tumor vessels.Thromb Res. 2010 Apr;125 Suppl 2:S143-50. doi: 10.1016/S0049-3848(10)70033-5.
• [5913] RMI1 attenuates tumor development and is essential for early embryonic survival.Mol Carcinog. 2011 Feb;50(2):80-8. doi: 10.1002/mc.20694. Epub 2010 Nov 23.
• [5914] A role for metaphase spindle elongation forces in correction of merotelic kinetochore attachments.Curr Biol. 2012 Feb 7;22(3):225-30. doi: 10.1016/j.cub.2011.12.022. Epub 2012 Jan 19.
• [5915] Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors.Hum Pathol. 2011 Feb;42(2):194-203. doi: 10.1016/j.humpath.2010.04.020. Epub 2010 Oct 30.
• [5916] Dimerization of p15RS mediated by a leucine zipper-like motif is critical for its inhibitory role on Wnt signaling.J Biol Chem. 2018 May 18;293(20):7618-7628. doi: 10.1074/jbc.RA118.001969. Epub 2018 Apr 4.
• [5917] Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation.Oncotarget. 2016 Apr 26;7(17):23885-96. doi: 10.18632/oncotarget.8127.
• [5918] Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target.Clin Cancer Res. 2010 Feb 1;16(3):814-24. doi: 10.1158/1078-0432.CCR-09-1592. Epub 2010 Jan 26.
• [5919] Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells.Cancer Biol Ther. 2012 May;13(7):542-52. doi: 10.4161/cbt.19604. Epub 2012 May 1.
• [5920] Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.Cell Physiol Biochem. 2018;46(5):1861-1867. doi: 10.1159/000489370. Epub 2018 Apr 25.
• [5921] Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.JAMA Oncol. 2016 Jul 1;2(7):922-8. doi: 10.1001/jamaoncol.2016.0256.
• [5922] Effects of SEMA3G on migration and invasion of glioma cells.Oncol Rep. 2012 Jul;28(1):269-75. doi: 10.3892/or.2012.1796. Epub 2012 May 4.
• [5923] Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.Blood. 2008 Jan 1;111(1):351-8. doi: 10.1182/blood-2007-06-094151. Epub 2007 Sep 26.
• [5924] Sesn3 deficiency promotes carcinogen-induced hepatocellular carcinoma via regulation of the hedgehog pathway.Biochim Biophys Acta Mol Basis Dis. 2019 Oct 1;1865(10):2685-2693. doi: 10.1016/j.bbadis.2019.07.011. Epub 2019 Jul 24.
• [5925] DPY30 regulates cervical squamous cell carcinoma by mediating epithelial-mesenchymal transition (EMT).Onco Targets Ther. 2019 Sep 2;12:7139-7147. doi: 10.2147/OTT.S209315. eCollection 2019.
• [5926] Seizure 6-like (SEZ6L) gene and risk for lung cancer.Cancer Res. 2007 Sep 1;67(17):8406-11. doi: 10.1158/0008-5472.CAN-06-4784.
• [5927] Association of ki67 and tumor marker p53 in locally advanced breast cancer patients and evaluation of response to neoadjuvant chemotherapy: a survey in South Iran.Cancer Manag Res. 2019 Jul 11;11:6489-6497. doi: 10.2147/CMAR.S203831. eCollection 2019.
• [5928] Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression.Cancer Manag Res. 2019 Jul 29;11:7123-7134. doi: 10.2147/CMAR.S210568. eCollection 2019.
• [5929] Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.J Biol Chem. 2014 Nov 28;289(48):33481-91. doi: 10.1074/jbc.M114.593129. Epub 2014 Oct 15.
• [5930] Oncolytic measles virus retargeting by ligand display.Methods Mol Biol. 2012;797:141-62. doi: 10.1007/978-1-61779-340-0_11.
• [5931] HER2-Overexpressing/Amplified Breast Cancer as a Testing Ground for Antibody-Drug Conjugate Drug Development in Solid Tumors.Clin Cancer Res. 2020 Feb 15;26(4):775-786. doi: 10.1158/1078-0432.CCR-18-1976. Epub 2019 Oct 3.
• [5932] ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia.Leuk Lymphoma. 2013 Jun;54(6):1171-6. doi: 10.3109/10428194.2012.742527. Epub 2012 Nov 19.
• [5933] Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumab.Mol Cancer Ther. 2014 Feb;13(2):540-52. doi: 10.1158/1535-7163.MCT-13-0494. Epub 2013 Nov 20.
• [5934] Integrin v3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-B ligand signaling axis.Mol Cancer. 2012 Sep 11;11:66. doi: 10.1186/1476-4598-11-66.
• [5935] Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray.J Surg Oncol. 2010 Oct 1;102(5):454-61. doi: 10.1002/jso.21585.
• [5936] SMYD5 Controls Heterochromatin and Chromosome Integrity during Embryonic Stem Cell Differentiation.Cancer Res. 2017 Dec 1;77(23):6729-6745. doi: 10.1158/0008-5472.CAN-17-0828. Epub 2017 Sep 26.
• [5937] An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.Int J Cancer. 2016 Jan 1;138(1):74-86. doi: 10.1002/ijc.29677. Epub 2015 Jul 17.
• [5938] Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma.Hepatology. 2011 Oct;54(4):1227-36. doi: 10.1002/hep.24495. Epub 2011 Aug 24.
• [5939] SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line.PLoS One. 2017 Sep 19;12(9):e0184686. doi: 10.1371/journal.pone.0184686. eCollection 2017.
• [5940] SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer.Endocr Relat Cancer. 2019 Mar;26(3):303-319. doi: 10.1530/ERC-18-0529.
• [5941] The contribution of SP100 to cottontail rabbit papillomavirus transcription and replication.J Gen Virol. 2018 Mar;99(3):344-354. doi: 10.1099/jgv.0.001012.
• [5942] Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia.PLoS One. 2012;7(1):e29632. doi: 10.1371/journal.pone.0029632. Epub 2012 Jan 3.
• [5943] Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness.PLoS One. 2009;4(2):e4478. doi: 10.1371/journal.pone.0004478. Epub 2009 Feb 12.
• [5944] Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion.Genes Chromosomes Cancer. 2011 Aug;50(8):619-32. doi: 10.1002/gcc.20884. Epub 2011 May 11.
• [5945] Genetic relationship between multiple squamous cell carcinomas arising in the oral cavity.Head Neck. 2014 Jan;36(1):94-100. doi: 10.1002/hed.23259. Epub 2013 Apr 30.
• [5946] Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo.Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12646-51. doi: 10.1073/pnas.0909862107. Epub 2010 Jun 28.
• [5947] Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells.Cancers (Basel). 2019 Aug 28;11(9):1267. doi: 10.3390/cancers11091267.
• [5948] RETRACTED: Stress induced phosphoprotein 1 promotes tumor growth and metastasis of melanoma via modulating JAK2/STAT3 pathway.Biomed Pharmacother. 2019 Aug;116:108962. doi: 10.1016/j.biopha.2019.108962. Epub 2019 May 16.
• [5949] A DNA polymerase-{alpha}{middle dot}primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells.J Biol Chem. 2009 Feb 27;284(9):5807-18. doi: 10.1074/jbc.M807593200. Epub 2008 Dec 31.
• [5950] Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer.Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4233-8. doi: 10.1073/pnas.1321937111. Epub 2014 Feb 3.
• [5951] The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.BMC Cancer. 2015 Oct 19;15:737. doi: 10.1186/s12885-015-1734-7.
• [5952] Exogenous expression of synaptotagmin XIII suppresses the neoplastic phenotype of a rat liver tumor cell line through molecular pathways related to mesenchymal to epithelial transition.Exp Mol Pathol. 2010 Dec;89(3):209-16. doi: 10.1016/j.yexmp.2010.09.001. Epub 2010 Sep 16.
• [5953] Deregulation of Rab and Rab effector genes in bladder cancer.PLoS One. 2012;7(6):e39469. doi: 10.1371/journal.pone.0039469. Epub 2012 Jun 19.
• [5954] SZRD1 is a Novel Protein that Functions as a Potential Tumor Suppressor in Cervical Cancer.J Cancer. 2017 Jul 14;8(11):2132-2141. doi: 10.7150/jca.18806. eCollection 2017.
• [5955] A novel triarylboron based ratiometric fluorescent probe for in vivo targeting and specific imaging of cancer cells expressing abnormal concentration of GGT.Biosens Bioelectron. 2019 Oct 1;142:111497. doi: 10.1016/j.bios.2019.111497. Epub 2019 Jul 10.
• [5956] Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.Oncol Rep. 2012 Jan;27(1):286-92. doi: 10.3892/or.2011.1483. Epub 2011 Oct 3.
• [5957] TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB.Oncogene. 2010 Jun 24;29(25):3619-29. doi: 10.1038/onc.2010.116. Epub 2010 Apr 26.
• [5958] Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in multiple cancer types.Clin Epigenetics. 2019 Aug 5;11(1):114. doi: 10.1186/s13148-019-0710-5.
• [5959] Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis.Genes Chromosomes Cancer. 2010 Apr;49(4):353-67. doi: 10.1002/gcc.20747.
• [5960] MicroRNA-1251-5p Promotes Carcinogenesis and Autophagy via Targeting the Tumor Suppressor TBCC in Ovarian Cancer Cells.Mol Ther. 2019 Sep 4;27(9):1653-1664. doi: 10.1016/j.ymthe.2019.06.005. Epub 2019 Jun 14.
• [5961] Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.Carcinogenesis. 2013 Feb;34(2):475-85. doi: 10.1093/carcin/bgs365. Epub 2012 Nov 21.
• [5962] DNA methylation biomarker candidates for early detection of colon cancer.Tumour Biol. 2012 Apr;33(2):363-72. doi: 10.1007/s13277-011-0302-2. Epub 2012 Jan 12.
• [5963] Repression of transcription factor AP-2 alpha by PPAR reveals a novel transcriptional circuit in basal-squamous bladder cancer.Oncogenesis. 2019 Nov 26;8(12):69. doi: 10.1038/s41389-019-0178-3.
• [5964] Depletion of TFAP2E attenuates adriamycin-mediated apoptosis in human neuroblastoma cells.Oncol Rep. 2017 Apr;37(4):2459-2464. doi: 10.3892/or.2017.5477. Epub 2017 Feb 24.
• [5965] Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.World J Gastroenterol. 2012 Nov 7;18(41):5965-71. doi: 10.3748/wjg.v18.i41.5965.
• [5966] TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.EMBO J. 2019 Jul 1;38(13):e101067. doi: 10.15252/embj.2018101067. Epub 2019 May 31.
• [5967] Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice.Cancer Gene Ther. 2013 Mar;20(3):186-94. doi: 10.1038/cgt.2013.6. Epub 2013 Feb 8.
• [5968] High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.Breast Cancer. 2012 Apr;19(2):153-60. doi: 10.1007/s12282-010-0228-3. Epub 2010 Oct 23.
• [5969] TM2D3 rs675436 or FGFR2 rs755793 polymorphisms and susceptibility to Epstein-Barr virus-associated tumors in Chinese Han population.J Med Virol. 2018 Jun;90(6):1128-1133. doi: 10.1002/jmv.25057. Epub 2018 Feb 27.
• [5970] TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.BMC Cancer. 2019 Mar 15;19(1):237. doi: 10.1186/s12885-019-5417-7.
• [5971] Human tetraspanin transmembrane 4 superfamily member 4 or intestinal and liver tetraspan membrane protein is overexpressed in hepatocellular carcinoma and accelerates tumor cell growth.Acta Biochim Biophys Sin (Shanghai). 2012 Mar;44(3):224-32. doi: 10.1093/abbs/gmr124. Epub 2012 Jan 10.
• [5972] Identification of novel transmembrane proteins in scirrhous-type gastric cancer by the Escherichia coli ampicillin secretion trap (CAST) method: TM9SF3 participates in tumor invasion and serves as a prognostic factor.Pathobiology. 2014;81(3):138-48. doi: 10.1159/000357821. Epub 2014 Mar 8.
• [5973] Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.Breast Cancer Res. 2011;13(6):R114. doi: 10.1186/bcr3057. Epub 2011 Nov 17.
• [5974] TMF/ARA160 downregulates proangiogenic genes and attenuates the progression of PC3 xenografts.Int J Cancer. 2009 Jul 1;125(1):43-53. doi: 10.1002/ijc.24277.
• [5975] CD28H expression identifies resident memory CD8+T cells with less cytotoxicity in human peripheral tissues and cancers.Oncoimmunology. 2018 Nov 5;8(2):e1538440. doi: 10.1080/2162402X.2018.1538440. eCollection 2019.
• [5976] Transmembrane Protease TMPRSS11B Promotes Lung Cancer Growth by Enhancing Lactate Export and Glycolytic Metabolism.Cell Rep. 2018 Nov 20;25(8):2223-2233.e6. doi: 10.1016/j.celrep.2018.10.100.
• [5977] TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer.Oncotarget. 2015 Dec 29;6(42):44927-40. doi: 10.18632/oncotarget.6743.
• [5978] TNPO2 operates downstream of DYNC1I1 and promotes gastric cancer cell proliferation and inhibits apoptosis.Cancer Med. 2019 Dec;8(17):7299-7312. doi: 10.1002/cam4.2582. Epub 2019 Oct 11.
• [5979] Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.Oncotarget. 2016 May 10;7(19):27552-66. doi: 10.18632/oncotarget.8487.
• [5980] Tropomyosin-1 Functions as a Tumor Suppressor with Respect to Cell Proliferation, Angiogenesis and Metastasis in Renal Cell Carcinoma.J Cancer. 2019 May 21;10(10):2220-2228. doi: 10.7150/jca.28261. eCollection 2019.
• [5981] Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.Gastroenterology. 2014 Dec;147(6):1350-62.e4. doi: 10.1053/j.gastro.2014.08.036. Epub 2014 Aug 28.
• [5982] TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.J Invest Dermatol. 2017 Jun;137(6):1322-1332. doi: 10.1016/j.jid.2016.12.026. Epub 2017 Jan 25.
• [5983] TRAF3-interacting protein 3, a new oncotarget, promotes tumor growth in melanoma.Melanoma Res. 2018 Jun;28(3):185-194. doi: 10.1097/CMR.0000000000000440.
• [5984] Dysregulation of miR484-TUSC5 axis takes part in the progression of hepatocellular carcinoma.J Biochem. 2019 Sep 1;166(3):271-279. doi: 10.1093/jb/mvz034.
• [5985] TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role.Genes (Basel). 2017 Nov 28;8(12):354. doi: 10.3390/genes8120354.
• [5986] Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis.Int J Cancer. 2004 Nov 10;112(3):365-75. doi: 10.1002/ijc.20431.